Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"4LNZ",,"X-RAY DIFFRACTION",2.28,46.13,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM Tris pH 7.0, 0.2 M succidic acid, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0082065",,"4LNZ",45.11,"3.11","3.11","Crystal structure of human Myosin 5b globular domain","GPLGSQRKEKDFQGMLEYHKEDEALLIRNLVTDLKPQMLSGTVPCLPAYILYMCIRHADYTNDDLKVHSLLTSTINGIKKVLKKHNDDFEMTSFWLSNTCRLLHCLKQYSGDEGFMTQNTAKQNEHCLKNFDLTEYRQVLSDLSIQIYQQLIKIAEGVLQPMIVSAMLENESIQGLSGVKPTGYRKRSSSMADGDNSYCLEAIIRQMNAFHTVMCDQGLDPEIILQVFKQLFYMINAVTLNNLLLRKDVCSWSTGMQLRYNISQLEEWLRGRNLHQSGAVQTMEPLIQAAQLLQLKKKTQEDAEAICSLCTSLSTQQIVKILNLYTPLNEFEERVTVAFIRTIQAQLQERNDPQQLLLDAKHMFPVLFPFNPSSLTMDSIHIPACLNLEFLNEV","Homo sapiens","MYO5B, KIAA1119","Unconventional myosin-Vb","1","4LNZ"
"4LO9",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",7,"2 microliter protein solution (around 5.0-7.0 mg/ml protein in 20 mM Tris pH 7.6, 150 mM NaCl, 10 mM DTT) were mixed with 2 microliter reservoir buffer(100 mM HEPES, 30 % (w/v) polyethylene glycol (PEG) 6000, pH 7.0), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444913020830",,"4LO9",98.67,"2.5","2.5","Human p53 Core Domain Mutant N235K","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYKYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4LO9"
"4LOE",,"X-RAY DIFFRACTION",2.09,41.28,"VAPOR DIFFUSION, SITTING DROP",7.6,"2 microliter protein solution (around 5.0-7.0 mg/ml protein in 20 mM Tris pH 7.6, 150 mM NaCl, 10 mM DTT) were mixed with 2 microliter reservoir buffer(200 mM lithium acetate, 20% (w/v) PEG 3350), VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1107/S0907444913020830",,"4LOE",98.81,"1.85","1.85","Human p53 Core Domain Mutant N239Y","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4LOE"
"4LOF",,"X-RAY DIFFRACTION",1.88,34.47,"VAPOR DIFFUSION",7.6,"2 microliters protein solution (around 5.0-7.0 mg/ml protein in 20 mM Tris pH 7.6, 150 mM NaCl, 10 mM DTT) were mixed with 2 microliters reservoir buffer with 200 mM di-sodium hydrogen phosphate dehydrate (Na2HPO4), 20% (w/v) PEG 3350, VAPOR DIFFUSION",,"10.1107/S0907444913020830",,"4LOF",24.76,"2","2","Human p53 Core Domain Mutant V157F/N235K/N239Y","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRFRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYKYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","4LOF"
"4LOH",,"X-RAY DIFFRACTION",2.94,58.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.01 M NiCl2, 0.1 M Tris, 20% PEG2000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2013.07.023","1SY","4LOH",43.72,"2.25","2.25","Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(3',5')p]","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4LOH"
"4LOI",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.6 M NaH2PO4, 0.4 M Na2HPO4, 0.1 M phosphate-citrate, pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2013.07.023","1YC","4LOI",43.82,"1.89","1.89","Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(2',5')p]","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4LOI"
"4LOR",,"X-RAY DIFFRACTION",3.02,59.3,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Tris, 100 mM NaBr, 24% PEG 3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1311113110",,"4LOR",38.94,"2.5","2.5","C1s CUB1-EGF-CUB2 in complex with a collagen-like peptide from C1q","PTMYGEILSPNYPQAYPSEVEKSWDIEVPEGYGIHLYFTHLDIELSENCAYDSVQIISGDTEEGRLCGQRSSNNPHSPIVEEFQVPYNKLQVIFKSDFSNEERFTGFAAYYVATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHDDMKNCGVNCSGDVFTALIGEIASPNYPKPYPENSRCEYQIRLEKGFQVVVTLRREDFDVEAADSAGNCLDSLVFVAGDRQFGPYCGHGFPGPLNIETKSNALDIIFQTDLTGQKKGWKLRYHGDPM","Homo sapiens","C1S","Complement C1s subcomponent heavy chain","1","4LOR"
,,,,,,,,,,,,,,,,"XGPPGPPGPPGPPGKLGPPGPPGPPGPPX",,,"collagen-like peptide from C1q","2","4LOR"
"4LOS",,"X-RAY DIFFRACTION",4.25,71.09,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Tris/acetate, 200 mM KH2PO4 + 20% PEG 10K , pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1311113110",,"4LOS",20.76,"1.996","1.996","C1s CUB2-CCP1","GVNCSGDVFTALIGEIASPNYPKPYPENSRCEYQIRLEKGFQVVVTLRREDFDVEAADSAGNCLDSLVFVAGDRQFGPYCGHGFPGPLNIETKSNALDIIFQTDLTGQKKGWKLRYHGDPMPCPKEDTPNSVWEPAKAKYVFRDVVQITCLDGFEVVEGRVGATSFYSTCQSNGKWSNSKLKCQPVD","Homo sapiens","C1S","Complement C1s subcomponent heavy chain","1","4LOS"
"4LOT",,"X-RAY DIFFRACTION",3.9,68.46,"VAPOR DIFFUSION, SITTING DROP",6.3,"24% PEG 8K in Bis-tris propane-HCL, containing 200 mM potassium citrate, pH 6.3, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1311113110",,"4LOT",27.51,"2.92","2.92","C1s CUB2-CCP1-CCP2","CSGDVFTALIGEIASPNYPKPYPENSRCEYQIRLEKGFQVVVTLRREDFDVEAADSAGNCLDSLVFVAGDRQFGPYCGHGFPGPLNIETKSNALDIIFQTDLTGQKKGWKLRYHGDPMPCPKEDTPNSVWEPAKAKYVFRDVVQITCLDGFEVVEGRVGATSFYSTCQSNGKWSNSKLKCQPVDCGIPESIENGKVEDPESTLFGSVIRYTCEEPYYYMENGGGGEYHCAGNGSWVNEVLGPELPKCVP","Homo sapiens","C1S","Complement C1s subcomponent heavy chain","1","4LOT"
"4LP4",,"X-RAY DIFFRACTION",3.36,63.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5 M sodium acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/febs.12556",,"4LP4",46.35,"2.4","2.4","Crystal structure of the human RAGE VC1 fragment in space group P62","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4LP4"
"4LP5",,"X-RAY DIFFRACTION",3.5,64.88,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris, 10% Ethanol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/febs.12556",,"4LP5",65.36,"3.8","3.8","Crystal structure of the full-length human RAGE extracellular domain (VC1C2 fragment)","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQLVVEPEGGAVAPGGTVTLTCEVPAQPSPQIHWMKDGVPLPLPPSPVLILPEIGPQDQGTYSCVATHSSHGPQESRAVSISIIEP","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4LP5"
"4LP6",,"X-RAY DIFFRACTION",2.51,51.05,"VAPOR DIFFUSION, HANGING DROP",7.15,"ZnAc, NaCac, PEG 8000, NaN3, pH 7.15, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.201309160",,"4LP6",62.1,"2.15","2.15","Crystal Structure of Human Carbonic Anhydrase II in complex with a quinoline oligoamide foldamer","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4LP6"
"4LPG",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"17% PEG10000, 6.8% ethylene glycol, 15% glycerol, 0.085 M HEPES, microseeding (see primary citation for details), pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K",295.15,"10.1021/jm500629e","1MV","4LPG",43.66,"2.35","2.35","Crystal structure of human FPPS in complex with CL01131","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4LPG"
"4LPH",,"X-RAY DIFFRACTION",2.76,55.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"17% PEG10000, 6.8% ethylene glycol, 15% glycerol, 0.085 M HEPES, microseeding (see primary citation for details), pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K",295.15,"10.1021/jm500629e","YL3","4LPH",43.58,"2.3","2.3","Crystal structure of human FPPS in complex with CL03093","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4LPH"
"4LPK",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"19% PEG3350, 0.2M CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature12796",,"4LPK",39.67,"1.5","1.5","Crystal Structure of K-Ras WT, GDP-bound","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LPK"
"4LQD",,"X-RAY DIFFRACTION",4.83,74.53,"VAPOR DIFFUSION, HANGING DROP",9,"5%MPD,100mM Ches pH 9.0, 100mM NaCl and 24% glycerol cryo, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.523407",,"4LQD",16.1,"2.451","2.451","The crystal structures of the Brucella protein TcpB and the TLR adaptor protein TIRAP show structural differences in microbial TIR mimicry","GVDRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","4LQD"
"4LQG",,"X-RAY DIFFRACTION",3.29,62.58,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.5b01850","CTW","4LQG",84.16,"1.77","1.77","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor CTT1056","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4LQG"
"4LQM",,"X-RAY DIFFRACTION",3.45,64.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"40% PEG400, 0.15M NACL, 0.1M HEPES 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/scitranslmed.3007205","DJK","4LQM",38.12,"2.5","2.5","EGFR L858R in complex with PD168393","GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4LQM"
"4LQY",,"X-RAY DIFFRACTION",2.75,55.2,"hanging drop",6.5,"200 mM ammonium citrate dibasic, 17.5% to 19.5% (w/v) PEG 3350, pH 6.5, hanging drop, temperature 293K",293,"10.1074/jbc.M113.505867","AMP","4LQY",47.45,"1.54","1.54","Crystal Structure of Human ENPP4 with AMP","FRSDSSSSLPPKLLLVSFDGFRADYLKNYEFPHLQNFIKEGVLVEHVKNVFITKTFPNHYSIVTGLYEESHGIVANSMYDAVTKKHFSDSNDKDPFWWNEAVPIWVTNQLQENRSSAAAMWPGTDVPIHDTISSYFMNYNSSVSFEERLNNITMWLNNSNPPVTFATLYWEEPDASGHKYGPEDKENMSRVLKKIDDLIGDLVQRLKMLGLWENLNVIITSDHGMTQCSQDRLINLDSCIDHSYYTLIDLSPVAAILPKINRTEVYNKLKNCSPHMNVYLKEDIPNRFYYQHNDRIQPIILVADEGWTIVLNESSQKLGDHGYDNSLPSMHPFLAAHGPAFHKGYKHSTINIVDIYPMMCHILGLKPHPNNGTFGHTKCLLVDQWCINLPEALINENLYFQ","Homo sapiens","ENPP4, KIAA0879, NPP4","Bis(5'-adenosyl)-triphosphatase ENPP4","1","4LQY"
"4LR2",,"X-RAY DIFFRACTION",2.77,55.64,,,,,"10.1074/jbc.M113.505867",,"4LR2",47.3,"1.5","1.5","Crystal Structure of Human ENPP4 (apo)","FRSDSSSSLPPKLLLVSFDGFRADYLKNYEFPHLQNFIKEGVLVEHVKNVFITKTFPNHYSIVTGLYEESHGIVANSMYDAVTKKHFSDSNDKDPFWWNEAVPIWVTNQLQENRSSAAAMWPGTDVPIHDTISSYFMNYNSSVSFEERLNNITMWLNNSNPPVTFATLYWEEPDASGHKYGPEDKENMSRVLKKIDDLIGDLVQRLKMLGLWENLNVIITSDHGMTQCSQDRLINLDSCIDHSYYTLIDLSPVAAILPKINRTEVYNKLKNCSPHMNVYLKEDIPNRFYYQHNDRIQPIILVADEGWTIVLNESSQKLGDHGYDNSLPSMHPFLAAHGPAFHKGYKHSTINIVDIYPMMCHILGLKPHPNNGTFGHTKCLLVDQWCINLPEALINENLYFQ","Homo sapiens","ENPP4, KIAA0879, NPP4","Bis(5'-adenosyl)-triphosphatase ENPP4","1","4LR2"
"4LR6",,"X-RAY DIFFRACTION",2.02,39.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"3.682 M Formate, 10% Glycerol, 0.1 M Tris-HCl pH 8.5, vapor diffusion, sitting drop, temperature 278K",278,"10.1021/ml4001485","1XA","4LR6",15.39,"1.29","1.29","Structure of BRD4 bromodomain 1 with a 3-methyl-4-phenylisoxazol-5-amine fragment","GSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, BRD4_HUMAN, HUNK1","Bromodomain-containing protein 4","1","4LR6"
"4LRG",,"X-RAY DIFFRACTION",2.13,42.38,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Bis-Tris pH 7.0, 150mM NaCl, 25% PEG3350.   
Cryo used: 23% Glycerol in well solution, temperature 278K, VAPOR DIFFUSION, SITTING DROP",278,"10.1021/ml4001485","1XB","4LRG",15.53,"2.21","2.21","Structure of BRD4 bromodomain 1 with a dimethyl thiophene isoxazole azepine carboxamide","GSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, BRD4_HUMAN, HUNK1","Bromodomain-containing protein 4","1","4LRG"
"4LRH",,"X-RAY DIFFRACTION",3.36,63.34,"VAPOR DIFFUSION",6.5,"PEG 2000,potassium sodium tartrate, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1038/nature12327","FOL","4LRH",212.75,"2.8","2.8","Crystal structure of human folate receptor alpha in complex with folic acid","QTRIAWARTELLNVCMNAKHHKEKPGPEDKLHEQCRPWRKNACCSTNTSQEAHKDVSYLYRFNWNHCGEMAPACKRHFIQDTCLYECSPNLGPWIQQVDQSWRKERVLNVPLCKEDCEQWWEDCRTSYTCKSNWHKGWNWTSGFNKCAVGAACQPFHFYFPTPTVLCNEIWTHSYKVSNYSRGSGRCIQMWFDPAQGNPNEEVARFYAAAMSGTLVPR","Homo sapiens","FOLR1, FOLR","Folate receptor alpha","1","4LRH"
"4LRI",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1mM Hepes pH 7.5, 70% MPD, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1404653111",,"4LRI",97.81,"1.65","1.65","Anti CMV Fab Fragment","DIVMTQSPLSLSVTPGEPASISCRSSQSLLHTNGYNYLDWYVQKPGQSPQLLIYLASNRASGVPDRFSGSGSGTDFTLKISRVETEDVGVYYCMQALQIPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"MSL-109 Light Chain","1","4LRI"
,,,,,,,,,,,,,,,,"EEQVLESGGGLVKPGGSLRLSCAASGFTFSPYSVFWVRQAPGKGLEWVSSINSDSTYKYYADSVKGRFTISRDNAENSIFLQMNSLRAEDTAVYYCARDRSYYAFSSGSLSDYYYGLDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"MSL-109 Heavy Chain","2","4LRI"
"4LRM",,"X-RAY DIFFRACTION",3.07,59.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris, 2% PEG400, 5mM tris(2-carboxyethyl)-phosphine (TCEP), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/scitranslmed.3007205","YUN","4LRM",191.36,"3.526","3.526","EGFR D770_N771insNPG in complex with PD168393","GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPGNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4LRM"
"4LRW",,"X-RAY DIFFRACTION",1.97,37.44,"VAPOR DIFFUSION, HANGING DROP",8,"30% PEG4000, 0.2M MgSO4, 0.1M TRIS, pH 8.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LRW",39.69,"2.151","2.151","Crystal Structure of K-Ras G12C (cysteine-light), GDP-bound","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LRW"
"4LS0",,"X-RAY DIFFRACTION",3.69,66.64,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate, 40mM UDAO, 20.8mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LS0",44.52,"2.07","2.07","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH01B0033","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4LS0"
"4LS1",,"X-RAY DIFFRACTION",3.44,64.2,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate, 40mM UDAO, 20.8mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LS1",43.94,"2.2","2.2","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A312","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4LS1"
"4LS2",,"X-RAY DIFFRACTION",3.4,63.82,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate, 40mM UDAO, 20.8mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LS2",44.14,"2.27","2.27","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A313","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4LS2"
"4LSD",,"X-RAY DIFFRACTION",3.45,64.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"citrate, cacodylate buffer, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.516641",,"4LSD",89.73,"2.28","2.28","Myokine structure","MSPSAPVNVTVRHLKANSAVVSWDVLEDEVVIGFAISQQKKDVRMLRFIQEVNTTTRSCALWDLEEDTEYIVHVQAISIQGQSPASEPVLFKTPREAEK","Homo sapiens","FNDC5, FRCP2","Fibronectin type III domain-containing protein 5","1","4LSD"
"4LSJ",,"X-RAY DIFFRACTION",2.07,40.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M bis-tris propane pH 5.5, 0.3 M Magnesium Formate, VAPOR DIFFUSION, SITTING DROP, temperature 294.15K",294.15,"10.1021/jm401616g","LSJ","4LSJ",32.39,"2.35","2.35","Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Bound to a Dibenzoxapine Sulfonamide","SLPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","4LSJ"
,,,,,,,,,,,,,,,,"HSSRLWELLMEAT",,,"D30 peptide","2","4LSJ"
"4LT6",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, HANGING DROP",8.5,"20%(W/V) PEG 8000, 50mM Tris-HCl, 100mM (NH4)2SO4, 5mM CaCl2, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2013.09.025",,"4LT6",119.64,"2.79","2.79","Crystal Structure of human poly(A) polymerase gamma","HHHHHHMKEMSANTVLDSQRQQKHYGITSPISLASPKEIDHIYTQKLIDAMKPFGVFEDEEELNHRLVVLGKLNNLVKEWISDVSESKNLPPSVVATVGGKIFTFGSYRLGVHTKGADIDALCVAPRHVERSDFFQSFFEKLKHQDGIRNLRAVEDAFVPVIKFEFDGIEIDLVFARLAIQTISDNLDLRDDSRLRSLDIRCIRSLNGCRVTDEILHLVPNKETFRLTLRAVKLWAKRRGIYSNMLGFLGGVSWAMLVARTCQLYPNAAASTLVHKFFLVFSKWEWPNPVLLKQPEESNLNLPVWDPRVNPSDRYHLMPIITPAYPQQNSTYNVSTSTRTVMVEEFKQGLAVTDEILQGKSDWSKLLEPPNFFQKYRHYIVLTASASTEENHLEWVGLVESKIRVLVGNLERNEFITLAHVNPQSFPGNKEHHKDNNYVSMWFLGIIFRRVENAESVNIDLTYDIQSFTDTVYRQANNINMLKEGMKIEATHVKKKQLHHYLPAEILQKKKKQS","Homo sapiens","PAPOLG, PAP2, PAPG","Poly(A) polymerase gamma","1","4LT6"
"4LTB",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",,"6-12% PEG 4000, 10 mM sodium acetate, pH 5.3-6.6, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1073/pnas.1318962111",,"4LTB",43.74,"2.59","2.59","Coiled-coil domain of TRIM25","ASLSQASADLEATLRHKLTVMYSQINGASRALDDVRNRQQDVRMTANRKVEQLQQEYTEMKALLDASETTSTRKIKEEEKRVNSKFDTIYQILLKKKSEIQTLKEEIEQSLTKRDEFEFLEKASKLRGISTKPVYIPEVELNHKLIKGIHQSTIDLKNELKQCIGRLQELTPSSGDPGEHDPASTHKSTRP","Homo sapiens","TRIM25, EFP, RNF147, ZNF147","Tripartite motif-containing 25 variant","1","4LTB"
"4LTE",,"X-RAY DIFFRACTION",4.01,69.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 20 %  PEGMME-5000, 12 % tacsimate, 10 % dioxane, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature13297",,"4LTE",228.53,"2.705","2.705","Structure of Cysteine-free Human Insulin Degrading Enzyme in Complex with Macrocyclic Inhibitor","MNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4LTE"
,,,,,,,,,,,,,,,,"QFXKX",,,"Macrocyclic Inhibitor","2","4LTE"
"4LTS",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.11.006","LTS","4LTS",115.58,"1.692","1.692","Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LTS"
"4LU3",,"X-RAY DIFFRACTION",3.14,60.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"2M Ammonium sulfate, 0.1M TRIS-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/bip.22456","AZM","4LU3",33.08,"2","2","The crystal structure of the human carbonic anhydrase XIV","ADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDIQTDSVTFDPDLPALQPHGYDQPGTEPLDLHNNGHTVQLSLPSTLYLGGLPRKYVAAQLHLHWGQKGSPGGSEHQINSEATFAELHIVHYDSDSYDSLSEAAERPQGLAVLGILIEVGETKNIAYEHILSHLHEVRHKDQKTSVPPFNLRELLPKQLGQYFRYNGSLTTPPCYQSVLWTVFYRRSQISMEQLEKLQGTLFSTEEEPSKLLVQNYRALQPLNQRMVFASFIQAGSSYTTGEMLVPR","Homo sapiens","CA14, UNQ690/PRO1335","Carbonic anhydrase 14","1","4LU3"
"4LUC",,"X-RAY DIFFRACTION",1.96,37.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG8000, 0.1M CaCl2, 0.1M TRIS, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LUC",40.56,"1.29","1.29","Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LUC"
"4LUD",,"X-RAY DIFFRACTION",3.05,59.69,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M Calcium Acetate, 20% Glycerol, 24% PEG 6000, 2mM SKF86002, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1107/S1399004713028654",,"4LUD",105.06,"2.85","2.85","Crystal Structure of HCK in complex with the fluorescent compound SKF86002","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","4LUD"
"4LUE",,"X-RAY DIFFRACTION",3,58.93,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M Calcium Acetate, 20% Glycerol, 24% PEG 6000, 2mM SKF86002, soaked with 2mM inhibitor in DMSO., pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1107/S1399004713028654","VSE","4LUE",105.55,"3.04","3.04","Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","4LUE"
"4LUO",,"X-RAY DIFFRACTION",2.03,39.26,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","1DZ","4LUO",14.05,"1.54","1.54","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4LUO"
"4LUV",,"X-RAY DIFFRACTION",2.03,39.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","1XS, 1DZ","4LUV",14.02,"1.4","1.4","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4LUV"
"4LUZ",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","1XT","4LUZ",13.99,"1.9","1.9","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4LUZ"
"4LV6",,"X-RAY DIFFRACTION",2,38.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG8000, 0.1M CaCl2, 0.1M TRIS, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LV6",40.53,"1.5","1.5","Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LV6"
"4LV9",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20J","4LV9",115.31,"1.807","1.807","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LV9"
"4LVA",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20M","4LVA",116.21,"1.55","1.55","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LVA"
"4LVB",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20N","4LVB",114.7,"1.836","1.836","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LVB"
"4LVD",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","1EB","4LVD",114.74,"1.75","1.75","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LVD"
"4LVE",,"X-RAY DIFFRACTION",2.4,49,,7.5,"pH 7.5",,"10.1016/s0969-2126(98)00107-5",,"4LVE",25.24,"2.3","2.3","LEN K30T MUTANT: A DOMAIN FLIP AS A RESULT OF A SINGLE AMINO ACID SUBSTITUTION","DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNSTNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYSFGQGTKLEIKR","Homo sapiens","IGKV4-1","LEN","1","4LVE"
"4LVF",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074",,"4LVF",115.54,"1.5","1.5","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LVF"
"4LVG",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20O","4LVG",115.83,"1.702","1.702","Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LVG"
"4LVS",,"X-RAY DIFFRACTION",2.29,46.33,"VAPOR DIFFUSION, SITTING DROP",8,"50mM Imidazole, 350mM NaCl, 17% PEG3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.cell.2013.05.048",,"4LVS",48.57,"2.002","2.002","DNA polymerase beta mismatched substrate complex with Mn2+, 2.5 min","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4LVS"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","2","4LVS"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","4LVS"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","4","4LVS"
"4LVT",,"X-RAY DIFFRACTION",1.99,38.13,"VAPOR DIFFUSION",4.2,"0.5 M (NH4)2SO4, 0.1 M Na Acetate, 0.2 M NaCl, pH 4.2, VAPOR DIFFUSION, temperature 296K",296,"10.1038/nm.3048","1XJ","4LVT",40.72,"2.05","2.05","Bcl_2-Navitoclax (ABT-263) Complex","MAHPGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","4LVT"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2"
"4LW1",,"X-RAY DIFFRACTION",2.05,39.93,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","1XS","4LW1",13.98,"1.631","1.631","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4LW1"
"4LWC",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","1XU","4LWC",14.08,"1.61","1.61","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4LWC"
"4LWD",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"It was crystallized by mixing 1 to l protein (10 mg/ml in 20 mM Tris at pH 8.0, 150 mM NaCl, and 5 mM DTT) with 1 to l of the reservoir solution containing 1.4 M MgSO4 and 100 mM MES at pH 6.5 in a hanging drop vapor diffusion system at 20 oC., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2013.08.032",,"4LWD",11.7,"1.792","1.792","Human CARMA1 CARD domain","GSHMEEDALWENVECNRHMLSRYINPAKLTPYLRQCKVIDEQDEDEVLNAPMLPSKINRAGRLLDILHTKGQRGYVVFLESLEFYYPELYKLVTGKE","Homo sapiens","CARD11, CARMA1","Caspase recruitment domain-containing protein 11","1","4LWD"
"4LWE",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Sodium cacodylate 6.5, 0.2M Mgcl2, 20-25% PEG2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.ejmech.2014.09.065","FJ2","4LWE",23.64,"1.5","1.5","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ2","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4LWE"
"4LWF",,"X-RAY DIFFRACTION",3.11,60.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% (w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.ejmech.2014.09.065",,"4LWF",23.5,"1.75","1.75","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ3","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4LWF"
"4LWG",,"X-RAY DIFFRACTION",3.06,59.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% (w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.ejmech.2014.09.065",,"4LWG",23.56,"1.599","1.599","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ4","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4LWG"
"4LWH",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% (w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate pH 6.5,, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.ejmech.2014.09.065","FJ5","4LWH",23.87,"1.7","1.7","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ5","EVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4LWH"
"4LWI",,"X-RAY DIFFRACTION",3.14,60.83,,,,,"10.1016/j.ejmech.2014.09.065","FJ6","4LWI",23.67,"1.7","1.7","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ6","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4LWI"
"4LWW",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.11.006","LWW","4LWW",116.23,"1.641","1.641","Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4LWW"
"4LX1",,"X-RAY DIFFRACTION",2.78,55.73,"VAPOR DIFFUSION, HANGING DROP",6,"MES pH6 12% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1314329110",,"4LX1",90.94,"1.87","1.87","Crystal structure of Myo5a globular tail domain","VNIPRKEKDFQGMLEYKKEDEQKLVKNLILELKPRGVAVNLIPGLPAYILFMCVRHADYLNDDQKVRSLLTSTINSIKKVLKKRGDDFETVSFWLSNTCRFLHCLKQYSGEEGFMKHNTSRQNEHCLTNFDLAEYRQVLSDLAIQIYQQLVRVLENILQPMIVSGMLEHETIQGVSGVKPTGLRKRTSSIADEGTYTLDSILRQLNSFHSVMCQHGMDPELIKQVVKQMFYIIGAITLNNLLLRKDMCSWSKGMQIRYNVSQLEEWLRDKNLMNSGAKETLEPLIQAAQLLQVKKKTDDDAEAICSMCNALTTAQIVKVLNLYTPVNEFEERVSVSFIRTIQMRLRDRKDSPQLLMDAKHIFPVTFPFNPSSLALETIQIPASLGLGFISRV","Homo sapiens","MYO5A, MYH12","Unconventional myosin-Va","1","4LX1"
"4LXA",,"X-RAY DIFFRACTION",3.05,59.7,"VAPOR DIFFUSION, HANGING DROP",5,"1.0M ammonium phosphate, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.07.071","1YS","4LXA",136.27,"1.95","1.95","Crystal Structure of Human Beta Secretase in Complex with Compound 11a","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4LXA"
"4LXD",,"X-RAY DIFFRACTION",3.48,64.65,"VAPOR DIFFUSION",6.5,"1.5 M (NH4)2SO4, 0.1 M MES, 8%(V/V) PEG400, pH 6.5, VAPOR DIFFUSION, temperature 296K",296,"10.1038/nm.3048","1XV","4LXD",20.08,"1.9","1.9","Bcl_2-Navitoclax Analog (without Thiophenyl) Complex","MAHPGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","4LXD"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2"
"4LXK",,"X-RAY DIFFRACTION",3.09,60.15,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M ammonium sulfate in water, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.07.071","1YT","4LXK",136.11,"2.05","2.05","Crystal Structure of Human Beta Secretase in Complex with compound 11d","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4LXK"
"4LXM",,"X-RAY DIFFRACTION",3.12,60.51,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M ammonium sulfate in water, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.07.071","1YU","4LXM",136.09,"2.3","2.3","Crystal Structure of Human Beta Secretase in Complex with compound 12a","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4LXM"
"4LXO",,"X-RAY DIFFRACTION",2.95,58.33,"VAPOR DIFFUSION, HANGING DROP",7.6,"0.2M calcium acetate, 7%(w/v) PEG10000, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4LXO",42.1,"1.42","1.42","Crystal structure of 9,10Fn3-elegantin chimera","MHHHHHHGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSIVALNGREESPPLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYACRARGDNPDCSKPISINYRT","Homo sapiens","FN1, FN","Fibronectin","1","4LXO"
"4LXZ",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1M CHES, pH 9.5, 40% PEG-600, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.490706","SHH","4LXZ",130.04,"1.85","1.85","Structure of Human HDAC2 in complex with SAHA (vorinostat)","GKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","4LXZ"
"4LY1",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1M CHES, pH 9.5, 40% PEG-600, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.490706","20Y","4LY1",130.3,"1.57","1.57","Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phenyl]benzamide","GKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","4LY1"
"4LY9",,"X-RAY DIFFRACTION",3.01,59.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M bis-tris, 0.2M NaI, 16% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature12724","1YY","4LY9",145.77,"2.35","2.35","Human GKRP complexed to AMG-1694 [(2R)-1,1,1-trifluoro-2-{4-[(2S)-2-{[(3S)-3-methylmorpholin-4-yl]methyl}-4-(thiophen-2-ylsulfonyl)piperazin-1-yl]phenyl}propan-2-ol] and sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQ","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4LY9"
"4LYF",,"X-RAY DIFFRACTION",1.98,38.01,"VAPOR DIFFUSION, HANGING DROP",5.6,"31% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LYF",59.8,"1.568","1.568","Crystal Structure of small molecule vinylsulfonamide 8 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LYF"
"4LYG",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1371/journal.pone.0120304",,"4LYG",72.33,"3","3","Crystal structure of human PRS1 E43T mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVTIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4LYG"
"4LYH",,"X-RAY DIFFRACTION",1.98,38.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9M (NH4)2SO4, 0.2M NaCl, 0.1M Na-cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LYH",60.61,"1.371","1.371","Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LYH"
"4LYI",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION",8.3,"bis tris propane, PEG 3350, NaI, ethylene glycol, pH 8.3, vapor diffusion, temperature 293K",293,"10.1002/anie.201307652",,"4LYI",15.95,"1.3","1.3","Crystal Structure of apo-BRD4(1)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4LYI"
"4LYJ",,"X-RAY DIFFRACTION",1.89,35.06,"VAPOR DIFFUSION, HANGING DROP",5.6,"30% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4LYJ",20.34,"1.927","1.927","Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C, alternative space group","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","GTPase KRas","1","4LYJ"
"4LYN",,"X-RAY DIFFRACTION",2.04,39.71,,,,,"10.1021/jm0201520","1YG","4LYN",34.38,"2","2","Crystal structure of cyclin-dependent kinase 2 (cdk2-wt) complex with (2s)-n-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3-thiazol-2-yl)-2-phenylpropanamide","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4LYN"
"4LYS",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION",6.5,"bis tris, PEG 3350, NaCl, pH 6.5, vapor diffusion, temperature 293K",293,"10.1002/anie.201307652",,"4LYS",15.44,"1.83","1.83","Crystal Structure of BRD4(1) bound to Colchiceine","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4LYS"
"4LYW",,"X-RAY DIFFRACTION",1.92,35.92,"VAPOR DIFFUSION",7.5,"NaFormate, pH 7.5, vapor diffusion, temperature 293K",293,"10.1002/anie.201307652","21Q","4LYW",15.5,"1.95","1.95","Crystal Structure of BRD4(1) bound to inhibitor XD14","AMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4LYW"
"4LZ1",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, SITTING DROP",5.8,"PEG 3350 25%, 0.2 M ammonium acetate, 0.1 M Bis/Tris, pH 5.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/febs.12561",,"4LZ1",39.23,"1.65","1.65","X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 12 nucleobase","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","4LZ1"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","4LZ1"
,,,,,,,,,,,,,,,,"GGTTGGTGTGGNTGG",,,"Thrombin Binding Aptamer","3","4LZ1"
"4LZ2",,"X-RAY DIFFRACTION",3.47,64.58,"VAPOR DIFFUSION, SITTING DROP",8.4,"22% PEG3350, 0.1 M Tris, pH 8.4, 0.25 M magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2014.10.017",,"4LZ2",12.78,"1.76","1.76","Crystal structure of the bromodomain of human BAZ2A","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQ","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","4LZ2"
"4LZ4",,"X-RAY DIFFRACTION",3.25,62.1,"VAPOR DIFFUSION, SITTING DROP",7,"60% Tacsimate, 1-3% MPEG 5K or PEG 8000, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/febs.12561",,"4LZ4",78.47,"2.56","2.56","X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","4LZ4"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","4LZ4"
,,,,,,,,,,,,,,,,"GGNTGGTGTGGTTGG",,,"Thrombin Binding Aptamer (TBA)","3","4LZ4"
"4LZD",,"X-RAY DIFFRACTION",2.43,49.3,"VAPOR DIFFUSION, HANGING DROP",8,"Crystals were grown by mixing 1 uL of concentrated protein (10.7mg/mL) with 1 uL of mother liquor (50 mM imidazole pH 8, 0.8M sodium citrate) at room temperature, using the hanging drop vapor diffusion technique.  The crystals reached usable size within 24 hours, and were then directly transferred to a cryoprotectant solution containing 50mM imidazole pH 8, 75mM NaCl, 1M sodium citrate, 10% glycerol., VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2766",,"4LZD",40.24,"1.849","1.849","Human DNA polymerase mu- Apoenzyme","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","4LZD"
"4LZG",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"Crystals were grown by mixing 1uL of the protein/DNA complex with 1uL of mother liquor (85mM MES pH 6.5, 85mMCaCl2, 42.5mM NaCl, 8.5% PEG3350, 11% glycerol), using the sitting drop vapor diffusion technique.  Crystals were transferred to a cryoprotectant solution containing 0.1M MES pH 6.5, 0.1M CaCl2, 50mM NaCl, 10mM MgCl2, 20% PEG3350, 15% glycerol in three steps.  , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nsmb.2766",,"4LZG",45.39,"1.599","1.599","Binary complex of human DNA Polymerase Mu with DNA","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","4LZG"
,,,,,,,,,,,,,,,,"CGGCATACG",,,"template strand","2","4LZG"
,,,,,,,,,,,,,,,,"CGTA",,,"upstream primer strand","3","4LZG"
,,,,,,,,,,,,,,,,"GCCG",,,"downstream primer strand","4","4LZG"
"4LZN",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1371/journal.pone.0120304",,"4LZN",72.48,"2.14","2.14","Crystal structure of human PRS1 D65N mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINNNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4LZN"
"4LZO",,"X-RAY DIFFRACTION",2.41,49.02,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1371/journal.pone.0120304",,"4LZO",72.54,"3.31","3.31","Crystal structure of human PRS1 A87T mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTTVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4LZO"
"4LZR",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION",8.2,"1.4 M Na-K-phosphate, pH 8.2, VAPOR DIFFUSION, temperature 293K",293,"10.1002/anie.201307652","LOC","4LZR",15.44,"1.85","1.85","Crystal Structure of BRD4(1) bound to Colchicine","AMNPPPPETSNPNKPKRQTNQLEYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLEDNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALESLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4LZR"
"4LZS",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION",7.5,"NaCitrate, PEG 3,350, pH 7.5, vapor diffusion, temperature 293K",293,"10.1002/anie.201307652","L46","4LZS",15.31,"2.2","2.2","Crystal Structure of BRD4(1) bound to inhibitor XD46","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4LZS"
"4M04",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"Crystals were grown by mixing 1uL of protein/DNA mixture with 1uL mother liquor (85-90mM HEPES pH 7.5, 17-18% PEG4000), using the sitting drop vapor diffusion technique.  Crystals were then transferred to a cryoprotectant solution containing 0.1M HEPES pH 7.5, 10mM MgCl2, 50mM NaCl, 20% PEG4000, 5% glycerol, 1mM dUMPNPP in two steps.  , VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nsmb.2766",,"4M04",46.18,"1.898","1.898","Human DNA Polymerase Mu ternary complex","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","4M04"
,,,,,,,,,,,,,,,,"CGGCATACG",,,"template strand","2","4M04"
,,,,,,,,,,,,,,,,"CGTA",,,"upstream primer strand","3","4M04"
,,,,,,,,,,,,,,,,"GCCG",,,"downstream primer strand","4","4M04"
"4M0A",,"X-RAY DIFFRACTION",2.5,50.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"Crystals were grown by mixing 1uL protein/DNA mixture with 1uL mother liquor (85-90mM HEPES pH 7.5, 17-18% PEG4000), using the sitting drop vapor diffusion technique.  Crystals were transferred in two steps to a cryoprotectant solution containing 0.1M HEPES pH 7.5, 10mM MgCl2, 50mM NaCl, 20% PEG4000, 5% glycerol, 15% ethylene glycol, 10mM dTTP for 16 hours.  The crystals were then backsoaked in cryoprotectant containing 2mM pyrophosphate.  , VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nsmb.2766",,"4M0A",46.21,"1.85","1.85","Human DNA Polymerase Mu post-catalytic complex","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","4M0A"
,,,,,,,,,,,,,,,,"CGGCATACG",,,"template strand","2","4M0A"
,,,,,,,,,,,,,,,,"CGTAT",,,"upstream primer strand","3","4M0A"
,,,,,,,,,,,,,,,,"GCCG",,,"downstream primer strand","4","4M0A"
"4M0E",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ml400304w","1YL","4M0E",121.12,"2","2","Structure of human acetylcholinesterase in complex with dihydrotanshinone I","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4M0E"
"4M0F",,"X-RAY DIFFRACTION",4.33,71.56,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ml400304w","1YK","4M0F",121.62,"2.304","2.304","Structure of human acetylcholinesterase in complex with territrem B","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4M0F"
"4M0P",,"X-RAY DIFFRACTION",2.39,48.48,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1371/journal.pone.0120304",,"4M0P",72.42,"2.11","2.11","Crystal structure of human PRS1 M115T mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANTLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4M0P"
"4M0U",,"X-RAY DIFFRACTION",2.39,48.48,"VAPOR DIFFUSION",4.1,"pH 4.1, VAPOR DIFFUSION, temperature 295K",295,"10.1371/journal.pone.0120304",,"4M0U",72.22,"2.74","2.74","crystal structure of human PRS1 Q133P mutant","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASPIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","4M0U"
"4M0Y",,"X-RAY DIFFRACTION",2.22,44.5,"VAPOR DIFFUSION, HANGING DROP",7.2,"12% PEG3350, 0.1M Mg acetate, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BJ20131139","M0Y","4M0Y",31.24,"1.7","1.7","Crystal structure of ITK in complex with compound 1 [4-(carbamoylamino)-1-(naphthalen-1-yl)-1H-pyrazole-3-carboxamide]","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M0Y"
"4M0Z",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION",7.2,"12% PEG3350, 0.1M Mg Acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, temperature 298K",298,"10.1042/BJ20131139","M0Z","4M0Z",31.3,"2","2","Crystal structure of ITK in complex with compound 5 {4-(carbamoylamino)-1-(7-methoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide}","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M0Z"
"4M12",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION",7.2,"12% PEG3350, 0.1M Mg Acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, temperature 298K",298,"10.1042/BJ20131139","1YZ","4M12",30.99,"2.15","2.15","Crystal structure of ITK in complex with compound 7 [4-(carbamoylamino)-1-(7-ethoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide]","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M12"
"4M13",,"X-RAY DIFFRACTION",2.16,42.94,"VAPOR DIFFUSION",7.2,"12% PEG3350, 0.1M Mg Acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, temperature 298K",298,"10.1042/BJ20131139","1E0","4M13",31,"1.85","1.85","Crystal structure of ITK in complex with compound 8 [4-(carbamoylamino)-1-(7-propoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide]","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M13"
"4M14",,"X-RAY DIFFRACTION",2.15,42.91,"VAPOR DIFFUSION",7.2,"12% PEG3350, 0.1M Mg Acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, temperature 298K",298,"10.1042/BJ20131139",,"4M14",31.36,"1.55","1.55","Crystal structure of ITK in complex with compound 9 [4-(carbamoylamino)-1-[7-(propan-2-yloxy)naphthalen-1-yl]-1H-pyrazole-3-carboxamide]","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M14"
"4M15",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION",7.2,"12% PEG3350, 0.1M Mg Acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, temperature 298K",298,"10.1042/BJ20131139",,"4M15",31.43,"1.52","1.52","Crystal structure of ITK in complex with compound 9 [4-(carbamoylamino)-1-[7-(propan-2-yloxy)naphthalen-1-yl]-1H-pyrazole-3-carboxamide] and ADP","GSGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4M15"
"4M17",,"X-RAY DIFFRACTION",3.61,65.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"Purified D325A+R343V (12-15 mg/mL in 20 mM HEPES, pH 7.5, 150 mM sodium chloride, 10 mM calcium acetate) + reservoir solution (0.1 M HEPES, pH 7.5, 0.25 M sodium chloride, 20-22% w/v PEG3350), VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi4010683",,"4M17",192.02,"2.096","2.096","Crystal Structure of Surfactant Protein-D D325A/R343V mutant","QQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDAGGSEDCVEIFTNGKWNDVACGEKRLVVCEF","Homo sapiens","COLEC7, PSPD, SFTP4, SFTPD","Pulmonary surfactant-associated protein D","1","4M17"
"4M18",,"X-RAY DIFFRACTION",3.61,65.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"Purified D325A+R343V (12-15 mg/mL in 20 mM HEPES, pH 7.5, 150 mM sodium chloride, 10 mM calcium acetate) + reservoir solution (0.1 M HEPES, pH 7.5, 0.25 M sodium chloride, 20-22% w/v PEG3350), VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi4010683",,"4M18",197.83,"3.203","3.203","Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man)","QQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDAGGSEDCVEIFTNGKWNDVACGEKRLVVCEF","Homo sapiens","COLEC7, PSPD, SFTP4, SFTPD","Pulmonary surfactant-associated protein D","1","4M18"
"4M1D",,"X-RAY DIFFRACTION",2.98,58.71,"VAPOR DIFFUSION, HANGING DROP",4,"pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/bi400645e",,"4M1D",99.86,"1.8","1.8","Crystal structure of anti-HIV-1 Fab 447-52D in complex with V3 cyclic peptide MN","QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVLWYQQFPGTAPKLLIYGNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYFCATWDSGLSADWVFGGGTKLTVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"Fab mAb 447-52D Light Chain","1","4M1D"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKPGGSLRLTCVASGFTFSDVWLNWVRQAPGKGLEWVGRIKSRTDGGTTDYAASVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYSCTTDGFIMIRGVSEDYYYYYMDVWGKGTTVTVSSASTKGPSVFPLAPCSRSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEL","Homo sapiens",,"Fab mAb 447-52D Heavy Chain","2","4M1D"
,,,,,,,,,,,,,,,,"CRIHIGPGRAFYTC",,,"Cyclic V3 Arch Peptide","3","4M1D"
"4M1O",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, HANGING DROP",5.6,"31% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M1O",59.86,"1.571","1.571","Crystal Structure of small molecule vinylsulfonamide 7 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M1O"
"4M1S",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",5.6,"32% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M1S",59.78,"1.552","1.552","Crystal Structure of small molecule vinylsulfonamide 13 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M1S"
"4M1T",,"X-RAY DIFFRACTION",1.97,37.45,"VAPOR DIFFUSION, HANGING DROP",5.6,"30% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M1T",59.78,"1.703","1.703","Crystal Structure of small molecule vinylsulfonamide 14 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M1T"
"4M1W",,"X-RAY DIFFRACTION",2,38.52,"VAPOR DIFFUSION, HANGING DROP",5.6,"31% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M1W",60.68,"1.58","1.58","Crystal Structure of small molecule vinylsulfonamide covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M1W"
"4M1Y",,"X-RAY DIFFRACTION",1.97,37.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"31% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M1Y",59.84,"1.491","1.491","Crystal Structure of small molecule vinylsulfonamide 15 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M1Y"
"4M21",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, HANGING DROP",5.6,"29% PEG4000, 0.2M NH4CH3COO, 0.1M Na-citrate, pH 5.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M21",59.76,"1.94","1.94","Crystal Structure of small molecule acrylamide 11 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M21"
"4M22",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG3000, 0.2M NaCl, 0.1M TRIS, pH 7.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nature12796",,"4M22",60.15,"2.09","2.09","Crystal Structure of small molecule acrylamide 16 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS isoform 2B, KRAS2, RASK2","K-Ras GTPase","1","4M22"
"4M2R",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"Drops were prepared by mixing 7 uL of the final concentrated protein (~10 mg/mL) and 3uL of precipitant solution against 1 mL of precipitant solution. The precipitant solution conditions varied, and consisted of 50 mM Tris-HCl (pH 7.5) and 1.6 M sodium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2013.08.033","BZ1","4M2R",29.38,"1.993","1.993","Human Carbonic Anhydrase II in complex with Brinzolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4M2R"
"4M2U",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"Drops were prepared by mixing 7 uL of the final concentrated protein (~10 mg/mL) and 3 uL of precipitant solution against 1mL of precipitant solution. The precipitant solution conditions varied, and consisted of 50 mM Tris-HCl (pH 7.5) and 1.4M sodium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2013.08.033","ETS","4M2U",29.32,"1.999","1.999","Carbonic Anhydrase II in complex with Dorzolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4M2U"
"4M2V",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"Drops were prepared by mixing 7 uL of the final concentrated protein (~10 mg/mL) and 3 uL of precipitant solution against 1 mL of precipitant solution. The precipitant solution conditions varied, and consisted of 50 mM Tris-HCl (pH 7.5) and 1.6 M sodium citrate., VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmc.2013.08.033","BZ1","4M2V",29.24,"1.718","1.718","Genetically engineered Carbonic Anhydrase IX in complex with Brinzolamide","HWGYGAHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4M2V"
"4M2W",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"Drops were prepared by mixing 7 uL of the final concentrated protein (~10 mg/mL) and 3 uL of precipitant solution against 1 mL of precipitant solution. The precipitant solution conditions varied, and consisted of 50 mM Tris-HCl (pH 7.5) and 1.6 M sodium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2013.08.033","ETS","4M2W",29.23,"1.658","1.658","Genetically engineered Carbonic Anhydrase IX in complex with Dorzolamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4M2W"
"4M2Y",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG 3340, 350mM sodium acetate in 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M113.537803",,"4M2Y",46.67,"2.27","2.27","Structure of human DNA polymerase beta complexed with 8-BrG as the template base in a 1-nucleotide gapped DNA","LNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M2Y"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"template DNA strand","2","4M2Y"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"up-primer","3","4M2Y"
,,,,,,,,,,,,,,,,"GTCGG",,,"down-primer","4","4M2Y"
"4M3L",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, HANGING DROP",4.5,"35% MPD, 0.1M sodium acetate, 20% glycerol, 20mM sodium fluoride, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1098/rsob.130172",,"4M3L",29.66,"2.1","2.1","Crystal Structure of the coiled coil domain of MuRF1","GAMDTLYAILDEKKSELLQRITQEQEEKLSFIEALIQQYQEQLDKSTKLVETAIQSLDEPG","Homo sapiens","IRF, MURF1, RNF28, SMRZ, TRIM63","E3 ubiquitin-protein ligase TRIM63","1","4M3L"
"4M3P",,"X-RAY DIFFRACTION",2.31,46.76,"EVAPORATION",7.5,"20.0% PEG5000 MME, 0.2 M sodium/potassium tartrate, 1.4% 1,2,3-heptanetriol, pH 7.5, EVAPORATION, temperature 277K",277,"10.1002/prot.24619",,"4M3P",181.38,"1.895","1.895","Betaine-Homocysteine S-Methyltransferase from Homo sapiens complexed with Homocysteine","MPPVGGKKAKKGILERLNAGEIVIGDGGFVFALEKRGYVKAGPWTPEAAVEHPEAVRQLHREFLRAGSNVMQTFTFYASEDKLENRGNYVLEKISGQEVNEAACDIARQVADEGDALVAGGVSQTPSYLSCKSETEVKKVFLQQLEVFMKKNVDFLIAEYFEHVEEAVWAVETLIASGKPVAATMCIGPEGDLHGVPPGECAVRLVKAGASIIGVNCHFDPTISLKTVKLMKEGLEAAQLKAHLMSQPLAYHTPDCNKQGFIDLPEFPFGLEPRVATRWDIQKYAREAYNLGVRYIGGCCGFEPYHIRAIAEELAPERGFLPPASEKHGSWGSGLDMHTKPWVRARARKEYWENLRIASGRPYNPSMSKPDGWGVTKGTAELMQQKEATTEQQLKELFEKQKFKSQ","Homo sapiens","BHMT","Betaine--homocysteine S-methyltransferase 1","1","4M3P"
"4M3Q",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500 mM sodium chloride, 2 mM beta-mercaptoethanol, incubated with inhibitor (2.5 mM final concentration) overnight, Mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), vapor diffusion, sitting drop, temperature 288K, VAPOR DIFFUSION, SITTING DROP",288,"10.1021/jm401387j","24K","4M3Q",72.73,"2.718","2.718","Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1917","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MER, MERTK","Tyrosine-protein kinase Mer","1","4M3Q"
"4M47",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"14% - 23% PEG3400 and 350 mM sodium acetate in 50 mM imidazole , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1074/jbc.M113.537803",,"4M47",47.11,"2.37","2.37","structure of human DNA polymerase complexed with 8-BrG in the template base paired with incoming non-hydrolyzable GTP","NGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M47"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"a synthetic template","2","4M47"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"a synthetic upstream primer","3","4M47"
,,,,,,,,,,,,,,,,"GTCGG",,,"a synthetic downstream primer","4","4M47"
"4M49",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION, SITTING DROP",7.2,"PEG3350, HEPES, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.bmcl.2013.08.060","22Y","4M49",151.28,"2.052","2.052","Lactate Dehydrogenase A in complex with a substituted pyrazine inhibitor compound 18","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4M49"
"4M4E",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.2M Ammonium fluoride, 20%(w/v) Polyethylene glycol 3350, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1007/s13238-013-3068-z",,"4M4E",63.25,"2.6","2.6","TRAF domain of human TRAF4","LQELRRELEELSVGSDGVLIWKIGSYGRRLQEAKAKPNLECFSPAFYTHKYGYKLQVSAFLNGNGSGEGTHLSLYIRVLPGAFDNLLEWPFARRVTFSLLDQSDPGLAKPQHVTETFHPDPNWKNFQKPGTWRGSLDESSLGFGYPKFISHQDIRKRNYVRDDAVFIRAAVELPRLEHHHHHH","Homo sapiens","TRAF4, CART1, MLN62, RNF83","TNF receptor-associated factor 4","1","4M4E"
"4M4P",,"X-RAY DIFFRACTION",3.16,61.05,"VAPOR DIFFUSION, SITTING DROP",6,"22% PEG400, 0.1M MES buffer pH 6.0, 3% DMSO, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1311000110",,"4M4P",58.28,"2.081","2.081","Crystal structure of EPHA4 ectodomain","APANEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEKDVPKMYCGADGEWLVPIGNCLCNAGHEERSGECQACKIGYYKALSTDATCAKCPPHSYSVWEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDISYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTKVSITDLLAHTNYTFEIWAVNGVSKYNPNPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYEKDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRIIGDG","Homo sapiens","EPHA4, HEK8, SEK, TYRO1","Ephrin type-A receptor 4","1","4M4P"
"4M4Z",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Lithium chloride, 20% PEG 3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cellsig.2013.08.040",,"4M4Z",18.79,"2.1","2.1","SH3 and SH2 domains of human Src-like adaptor protein 2 (SLAP2)","GAMGSEAERSKATAVALGSFPAGGPAELSLRLGEPLTIVSEDGDWWTVLSEVSGREYNIPSVHVAKVSHGWLYEGLSREKAEELLLLPGNPGGAFLIRESQTRRGSYSLSVRLSRPASWDRIRHYRIHCLDNGWLYISPRLTFPSLQALVDHYSELADDICCLLKEPCVL","Homo sapiens","C20orf156, SLA2, SLAP2","Src-like-adapter 2","1","4M4Z"
"4M55",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, HANGING DROP",5.95,"0.5 M ammonium sulfate, 0.5 M sodium acetate, 0.1 M imidazole, 0.1 M HCl, pH 5.95, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi501357c",,"4M55",232.86,"2.86","2.86","Crystal structure of Human UDP-xylose synthase R236H substitution","EKDRKRILITGGAGFVGSHLTDKLMMDGHEVTVVDNFFTGRKRNVEHWIGHENFELINHDVVEPLYIEVDQIYHLASPASPPNYMYNPIKTLKTNTIGTLNMLGLAKRVGARLLLASTSEVYGDPEVHPQSEDYWGHVNPIGPRACYDEGKHVAETMCYAYMKQEGVEVRVARIFNTFGPRMHMNDGRVVSNFILQALQGEPLTVYGSGSQTRAFQYVSDLVNGLVALMNSNVSSPVNLGNPEEHTILEFAQLIKNLVGSGSEIQFLSEAQDDPQKRKPDIKKAKLMLGWEPVVPLEEGLNKAIHYFRKELEYQANNQYIPKPKPARIKKGRTRHS","Homo sapiens","UNQ2538/PRO6079, UXS, UXS1","UDP-glucuronic acid decarboxylase 1","1","4M55"
"4M5S",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M SPG, pH 6.0, 25% PEG1500, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1322673111",,"4M5S",11.25,"1.37","1.37","Human alphaB crystallin core domain in complex with C-terminal peptide","GMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVS","Homo sapiens","CRYA2, CRYAB, HSPB5","Alpha-crystallin B chain","1","4M5S"
,,,,,,,,,,,,,,,,"GERTIPITRE","Homo sapiens","CRYA2, CRYAB, HSPB5","Alpha-crystallin B chain","2","4M5S"
"4M5W",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 22% PEG3350, 0.2 M sodium bromide, 0.15 mM Cymal-7, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1107/S2053230X14002519",,"4M5W",41.47,"2.244","2.244","Crystal structure of the USP7/HAUSP catalytic domain","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQE","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","4M5W"
"4M5X",,"X-RAY DIFFRACTION",2.34,47.53,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 22% PEG3350, 0.2 M sodium bromide, 0.15 mM Cymal-7, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1107/S2053230X14002519",,"4M5X",82.54,"2.187","2.187","Crystal structure of the USP7/HAUSP catalytic domain","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQE","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","4M5X"
"4M5Y",,"X-RAY DIFFRACTION",3.41,63.98,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M calcium acetate, 11% PEG3350, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1128/JVI.01388-13",,"4M5Y",97.16,"1.55","1.55","Crystal structure of broadly neutralizing Fab 5J8","EVQLVESGPGLVKPSDILSLTCAVSGYSISSNYYWGWIRQPPGKGLEWIGSIYHSGSTYYKPSLESRLGISVDTSKNQFSLKLSFVSAADTAVYYCARHVRSGYPDTAYYFDKWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"Fab 5J8 heavy chain","1","4M5Y"
,,,,,,,,,,,,,,,,"SYVLTQPPSVSVAPGETARISCGGNNIGTKVLHWYQQTPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEVGDEADYYCQVWDISTDQAVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab 5J8 light chain","2","4M5Y"
"4M67",,"X-RAY DIFFRACTION",2.53,51.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 13% PEG 6000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.celrep.2013.08.044",,"4M67",33.63,"1.9","1.9","Crystal structure of the human MLKL kinase-like domain","YLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","4M67"
"4M6J",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION, SITTING DROP",9.5,"24% PEG6000, 100 mM Tris, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nsmb.2676",,"4M6J",22.23,"1.201","1.201","Crystal structure of human dihydrofolate reductase (DHFR) bound to NADPH","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4M6J"
"4M6K",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, SITTING DROP",4.2,"2 M ammonium sulfate, 100 mM phosphate/citrate, pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nsmb.2676",,"4M6K",22.76,"1.396","1.396","Crystal structure of human dihydrofolate reductase (DHFR) bound to NADP+ and folate","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4M6K"
"4M6L",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, SITTING DROP",4,"2.2 M ammonium sulfate, 100 mM sodium citrate, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nsmb.2676",,"4M6L",22.92,"1.7","1.7","Crystal structure of human dihydrofolate reductase (DHFR) bound to NADP+ and 5,10-dideazatetrahydrofolic acid","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4M6L"
"4M6M",,"X-RAY DIFFRACTION",2.82,56.32,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.1 M CHES, pH 9.5, 20% PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/prot.24554",,"4M6M",47.58,"2","2","Crystal structure of anti-IL-23 antibody CNTO1959 at pH 9.5","QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CNTO1959 light chain","1","4M6M"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"CNTO1959 heavy chain","2","4M6M"
"4M6N",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, pH 6.5, 2.5 M sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4M6N",47.37,"2","2","Crystal structure of anti-IL-23 antibody CNTO1959 at pH 6.5","QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CNTO1959 light chain","1","4M6N"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"CNTO1959 heavy chain","2","4M6N"
"4M6O",,"X-RAY DIFFRACTION",3.07,60,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, pH 6.5, 12% PEG20000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/prot.24554",,"4M6O",48.78,"2.8","2.8","Crystal structure of anti-NGF antibody CNTO7309","AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CNTO7309 light chain","1","4M6O"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"CNTO7309 heavy chain","2","4M6O"
"4M6P",,"X-RAY DIFFRACTION",2.34,47.4,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20R","4M6P",114.86,"1.75","1.75","Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4M6P"
"4M6Q",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, followed by in-situ adduct formation , pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.08.074","20T","4M6Q",115.77,"2.406","2.406","Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4M6Q"
"4M6R",,"X-RAY DIFFRACTION",2.74,55.04,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.04M citric acid, 0.06M bis-tris propane, 5%(v/v) glycerol, 21%(w/v) PEG 3350, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1073/pnas.1308768111",,"4M6R",101.48,"2","2","Structural and biochemical basis for the inhibition of cell death by APIP, a methionine salvage enzyme","MDKEHPRYLIPELCKQFYHLGWVTGTGGGISLKHGDEIYIAPSGVQKERIQPEDMFVCDINEKDISGPSPSKKLKKSQCTPLFMNAYTMRGAGAVIHTHSKAAVMATLLFPGREFKITHQEMIKGIKKCTSGGYYRYDDMLVVPIIENTPEEKDLKDRMAHAMNEYPDSCAVLVRRHGVYVWGETWEKAKTMCECYDYLFDIAVSMKKVGLDPSQLPVGENGIV","Homo sapiens","APIP, CGI-29","Methylthioribulose-1-phosphate dehydratase","1","4M6R"
"4M6S",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M malonate, pH 6.0, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja404900k",,"4M6S",15.97,"2.47","2.47","Crystal structure of the R111K:R132Y:Y134F:T54V:R59W:A32W mutant of the Cellular Retinoic Acid Binding Protein Type II in complex with All-Trans Retinal at 2.38 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIWVAAASKPAVEIKQEGDTFYIKVSTTVWTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTYVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4M6S"
"4M6T",,"X-RAY DIFFRACTION",4.72,73.96,"VAPOR DIFFUSION, SITTING DROP",7,"3.5M sodium formate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1093/nar/gkt819",,"4M6T",21.67,"2.498","2.498","Structure of human Paf1 and Leo1 complex","KDRDSQITAIEKTFEDAQKSISQHYSKPRVTPVEVMPVFPDFKMWINPCAQVIFDSDPAPKDTSGAAALEMMSQAMIRGMMSGENLYFQSGNDLYFVKLPNFLSVEPRPFDPQYYEDEFEDEEMLDEEGRTRLKLKVENTIRWRIRRDEEGNEIKESNARIVKWSDGSMSLHLGNEVFDVYKA","Homo sapiens","PAF1, LEO1","RNA polymerase II-associated factor 1 homolog, Linker, RNA polymerase-associated protein LEO1","1","4M6T"
,,,,,,,,,,,,,,,,,"Homo sapiens","PAF1, LEO1"
"4M7B",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",8,"19% PEG3350, 0.2M AmS, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401356t","28C","4M7B",55.65,"1.95","1.95","Human tankyrase 2 - catalytic Parp domain in complex with an inhibitor UPF1854","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","4M7B"
"4M7F",,"X-RAY DIFFRACTION",3.08,60.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.7M Ammonium sulphate, 7% Dioxane, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.520577",,"4M7F",52.31,"2.1","2.1","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with bound ManNAc","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","4M7F"
"4M7H",,"X-RAY DIFFRACTION",3.03,59.36,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6M Ammonium sulphate, 10% Dioxane, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.520577",,"4M7H",52.12,"2","2","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","4M7H"
"4M7I",,"X-RAY DIFFRACTION",3.35,63.25,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM BTP at pH 7.0 with a 3.5 4.9M linear gradient of ammonium acetate  
, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4M7I",35.21,"2.34","2.34","Crystal Structure of GSK6157 Bound to PERK (R587-R1092, delete A660-T867) at 2.34A Resolution","GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3","1","4M7I"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4M7M",,"X-RAY DIFFRACTION",3.23,61.88,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M malonate, pH 7.0, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja404900k",,"4M7M",15.94,"2.571","2.571","Crystal structure of the R111K:R132Q:Y134F:T54V:R59W:A32W mutant of the Cellular Retinoic Acid Binding Protein Type II in complex with All-Trans Retinal at 2.57 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIWVAAASKPAVEIKQEGDTFYIKVSTTVWTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4M7M"
"4M7R",,"X-RAY DIFFRACTION",2.18,43.61,"EVAPORATION",6.5,"0.17M sodium acetate trihydrate, 0.085M sodium cacodylate pH6.5, 25% PEG 8000, 15% Glycerol, EVAPORATION, temperature 289K",289,"10.1002/prot.24443",,"4M7R",42.77,"1.801","1.801","Crystal structure of the N-terminal methyltransferase-like domain of anamorsin","MHHHHHHSSGVDLGTENLYFQSNAMADFGISAGQFVAVVWDKSSPVEALKGLVDKLQALTGNEGRVSVENIKQLLQSAHKESSFDIILSGLVPGSTTLHSAEILAEIARILRPGGCLFLKEPVETAVDNNSKVKTASKLCSALTLSGLVEVKELQREPLTPEEVQSVREHLGHESDNLLFVQITGKKPNFEVGSSR","Homo sapiens","CIAPIN1, CUA001, PRO0915","Anamorsin","1","4M7R"
"4M8G",,"X-RAY DIFFRACTION",2.04,39.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M KSCN, 10.5% PEG 8K, 10% PEG 1K in 100 mM cacodylic acid-NaOH, pH 6.5, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.str.2014.02.013",,"4M8G",38.94,"2","2","Crystal structure of Se-Met hN33/Tusc3","ASKKENLLAEKVEQLMEWSSRRSIFRMNGDKFRKFIKAPPRNYSMIVMFTALQPQRQCSVCRQANEEYQILANSWRYSSAFSNKLFFSMVDYDEGTDVFQQLNMNSAPTFMHFPPKGRPKRADTFDLQRIGFAAEQLAKWIADRTDVHIRVFRLEHHHHHH","Homo sapiens","N33, TUSC3","Tumor suppressor candidate 3","1","4M8G"
"4M8V",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",5.7,"20%(w/v) PEG 3350, 0.1M Bis-tris, 0.2M Ammonium acetate, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4M8V",23.75,"1.951","1.951","Crystal structure of Human double mutant beta2-microglobulin Q8H-L65T","MIQRTPKIHVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLTYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","4M8V"
"4M90",,"X-RAY DIFFRACTION",2.04,39.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M KSCN, 10.5% PEG  
8K, 10% PEG 1K in 100 mM cacodylic acid-NaOH, pH 6.5, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.str.2014.02.013",,"4M90",19.14,"1.6","1.6","crystal structure of oxidized hN33/Tusc3","ASKKENLLAEKVEQLMEWSSRRSIFRMNGDKFRKFIKAPPRNYSMIVMFTALQPQRQCSVCRQANEEYQILANSWRYSSAFSNKLFFSMVDYDEGTDVFQQLNMNSAPTFMHFPPKGRPKRADTFDLQRIGFAAEQLAKWIADRTDVHIRVFRLEHHHHHH","Homo sapiens","TUSC3, N33","Tumor suppressor candidate 3","1","4M90"
"4M9G",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 300 mM sodium acetate pH 9, 50 mM HEPES pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.510891",,"4M9G",47.77,"2.01","2.01","DNA Polymerase Beta E295K Binary Complex","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M9G"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA Template Strand","2","4M9G"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA Primer Strand","3","4M9G"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA Downstream Strand","4","4M9G"
"4M9H",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 300 mM sodium acetate pH 9, 50 mM HEPES pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.510891","TTP","4M9H",48.26,"2.394","2.394","DNA Polymerase Beta E295K Soaked with dTTP","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M9H"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA Template Strand","2","4M9H"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA Primer Strand","3","4M9H"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA Downstream Strand","4","4M9H"
"4M9J",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 300 mM sodium acetate pH 9, 50 mM HEPES pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.510891",,"4M9J",48.3,"2.038","2.038","DNA Polymerase Beta E295K Soaked with dUMPNPP","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M9J"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA Template Strand","2","4M9J"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA Primer Strand","3","4M9J"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA Downstream Strand","4","4M9J"
"4M9L",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 300 mM sodium acetate pH 9, 50 mM HEPES pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.510891",,"4M9L",48.25,"2.091","2.091","DNA Polymerase Beta E295K Soaked with dCTP","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M9L"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA Template Strand","2","4M9L"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA Primer Strand","3","4M9L"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA Downstream Strand","4","4M9L"
"4M9N",,"X-RAY DIFFRACTION",2.38,48.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 300 mM sodium acetate pH 9, 50 mM HEPES pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,"10.1074/jbc.M113.510891",,"4M9N",48.25,"2.275","2.275","DNA Polymerase Beta E295K Soaked with dATP","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4M9N"
,,,,,,,,,,,,,,,,"CCGACAGCGCATCAGC",,,"DNA Template Strand","2","4M9N"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA Primer Strand","3","4M9N"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA Downstream Strand","4","4M9N"
"4M9P",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M sodium malonate, 12% w/v PEG3350, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M113.537456",,"4M9P",31.02,"1.72","1.72","Crystal structure of the human filamin A Ig-like domains 3-5","SMCNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAG","Homo sapiens","FLN, FLN1, FLNA","Filamin-A","1","4M9P"
"4MA4",,"X-RAY DIFFRACTION",3.31,62.85,"VAPOR DIFFUSION, SITTING DROP",6,"50 mM MES, pH 6.0, 7% (w/v) polyethylene glycol 4000, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1016/j.jmb.2013.11.021",,"4MA4",60.96,"2.23","2.23","S-glutathionylated PFKFB3","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","4MA4"
"4MAN",,"X-RAY DIFFRACTION",3.34,63.16,"VAPOR DIFFUSION",8.5,"1.5 M Li2SO4, 0.1 M Tris HCl, pH 8.5, VAPOR DIFFUSION, temperature 296K",296,"10.1038/nm.3048",,"4MAN",40.56,"2.07","2.07","Bcl_2-Navitoclax Analog (with Indole) Complex","MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","4MAN"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2"
"4MAS",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, SITTING DROP",5.5,"4 mg/ML wt-TTR in 10 mM sodium phosphate, 100 mM potassium chloride, pH 7.6, co-crystallized with inhibitor, crystallization solution: 1.395 M sodium citrate, 3.5% v/v glycerol, pH 5.5, cryoprotectant: 1.395 M sodium citrate, pH 5.5, 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4MAS",28.2,"1.22","1.22","High Resolution Structure of Wild Type Human Transthyretin in Complex with 3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'diol","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4MAS"
"4MBB",,"X-RAY DIFFRACTION",3.09,60.26,"VAPOR DIFFUSION, HANGING DROP",5.5,"Bis-Tris 0.1M, NaCl 0.2M, polyethylene glycol 3350 22%, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi401240x",,"4MBB",21.61,"1.849","1.849","Cubic crystal form of PIR1 dual specificity phosphatase core","GPLGSNHIPERWKDYLPVGQRMPGTRFIAFKVPLQKSFEKKLAPEECFSPLDLFNKIREQNEELGLIIDLTYTQRYYKPEDLPETVPYLKIFTVGHQVPDDETIFKFKHAVNGFLKENKDNDKLIGVHSTHGLNRTGYLICRYLIDVEGVRPDDAIELFNRCRGHCLERQNYIEDLQNGPIRKN","Homo sapiens","DUSP11, PIR1","RNA/RNP complex-1-interacting phosphatase","1","4MBB"
"4MBI",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",8.4,"10.5% PEG 400, 0.05 M Tris-Cl pH 8.4, 0.3 M NaCl, 0.01 M DTT, 0.01M EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.08.110","26K","4MBI",34.12,"2.3","2.3","Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVEHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4MBI"
"4MBJ",,"X-RAY DIFFRACTION",3.13,60.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG8000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.08.086","DFS","4MBJ",70.41,"3.6","3.6","Human B-Raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4MBJ"
"4MBL",,"X-RAY DIFFRACTION",3.35,63.28,"VAPOR DIFFUSION, HANGING DROP",8.4,"10.5% PEG 400, 0.05 M Tris-Cl pH 8.4, 0.3 M NaCl, 0.01 M DTT, 0.01M EDTA , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.08.110","26L","4MBL",34.2,"2.6","2.6","Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVEHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4MBL"
"4MCE",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.05 M sodium succinate pH 5.5 
0.5 mM spermine 
0.02 M magnesium chloride 
3 M ammonium sulfate , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/ncomms6395",,"4MCE",13.61,"2.205","2.205","Crystal structure of the Gas5 GRE Mimic","CAGUGGUCUU","Homo sapiens",,"Gas5 GREM Fwd","1","4MCE"
,,,,,,,,,,,,,,,,"AAGACUGCCUG","Homo sapiens",,"Gas5 GREM Rev","2","4MCE"
"4MCF",,"X-RAY DIFFRACTION",2.06,40.32,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M citric acid pH 4 
3 M ammonium sulfate , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/ncomms6395",,"4MCF",27.03,"1.899","1.899","Crystal structure of the Gas5 GRE Mimic","CAGUGGUCUU","Homo sapiens",,"Gas5 GREM Fwd","1","4MCF"
,,,,,,,,,,,,,,,,"AAGACUGCCUG","Homo sapiens",,"Gas5 GREM Rev","2","4MCF"
"4MCM",,"X-RAY DIFFRACTION",2.8,56.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M114.588798",,"4MCM",192.65,"2.2","2.2","Human SOD1 C57S Mutant, As-isolated","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGSTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","4MCM"
"4MCN",,"X-RAY DIFFRACTION",1.87,34.12,"VAPOR DIFFUSION, HANGING DROP",6,"3.2 M ammonium sulfate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M114.588798",,"4MCN",31.72,"2.6","2.6","Human SOD1 C57S Mutant, Metal-free","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGSTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","4MCN"
"4MCP",,"X-RAY DIFFRACTION",3.09,60.16,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 0.10 M Tris HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/febs.12857",,"4MCP",88.44,"1.65","1.65","A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyl-gamma-L-glutamic acid (pteroyldi-gamma-L-glutamic acid)","MKLCILLAVVAFVGLSLGRSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4MCP"
"4MCQ",,"X-RAY DIFFRACTION",3.11,60.46,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol, propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 0.10 M Tris HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/febs.12857",,"4MCQ",88.56,"2","2","A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyldi-gamma-L-glutamic acid (pteroyltri-gamma-L-glutamic acid)","MKLCILLAVVAFVGLSLGRSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4MCQ"
"4MCR",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 0.10 M Tris HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/febs.12857",,"4MCR",88.69,"1.65","1.65","A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyltri-gamma-L-glutamic acid (pteroyltetra-gamma-L-glutamic acid)","MKLCILLAVVAFVGLSLGRSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4MCR"
"4MCS",,"X-RAY DIFFRACTION",3.09,60.24,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5% (w/v) PEG 3350, 0.10 M Tris HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/febs.12857",,"4MCS",88.23,"1.83","1.83","A high resolution structure of human glutamate carboxypeptidase II (GCPII) His475Tyr variant in complex with glutamic acid","MKLCILLAVVAFVGLSLGRSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVYNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4MCS"
"4MD6",,"X-RAY DIFFRACTION",2.78,55.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10 mg/mL unliganded PDE5A1 in storage buffer (50 mM sodium chloride, 20 mM Tris-HCl, pH 7.5, 1 mM BME, 1 mM EDTA) against 0.2 M magnesium sulfate, 0.1 M sodium cacodylate, pH 6.5, 18% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bcp.2014.02.013","24E","4MD6",38.35,"2","2","Crystal structure of PDE5 in complex with inhibitor 5R","EETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4MD6"
"4MDG",,"X-RAY DIFFRACTION",2.11,41.58,,,,,"10.1002/anie.201307583","25X","4MDG",29.38,"1.35","1.35","Closo Carborane Carbonic Anhydrase Inhibitor","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MDG"
"4MDL",,"X-RAY DIFFRACTION",2.11,41.71,,,,,"10.1002/anie.201307583","25Y","4MDL",29.7,"1.516","1.516","Meta Carborane Carbonic Anhydrase Inhibitor","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MDL"
"4MDM",,"X-RAY DIFFRACTION",2.08,41,,,,,"10.1002/anie.201307583","26E","4MDM",29.37,"1.55","1.55","Nido-Carborane Carbonic Anhydrase Inhibitor","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MDM"
"4MDN",,"X-RAY DIFFRACTION",3.83,67.91,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium nitrate, 20% w/v PEG3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2013.09.006","Y30","4MDN",11.8,"1.905","1.905","Structure of a novel submicromolar MDM2 inhibitor","MQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4MDN"
"4MDQ",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium nitrate, 20% w/v PEG3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2013.09.006","28W","4MDQ",11.15,"2.119","2.119","Structure of a novel submicromolar MDM2 inhibitor","ETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4MDQ"
"4MEL",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES/imidazole, 30 mM Na Nitrate, 30 mM Na phosphate and 30 mM Na sulphate, 12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD., pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/bi500116x",,"4MEL",53.61,"2.899","2.899","Crystal Structure of the human USP11 DUSP-UBL domains","MDREPQHEELPGLDSQWRQIENGESGRERPLRAGESWFLVEKHWYKQWEAYVQGGDQDSSTFPGCINNATLFQDEINWRLKEGLVEGEDYVLLPAAAWHYLVSWYGLEHGQPPIERKVIELPNIQKVEVYPVELLLVRHNDLGKSHTVQFSHTDSIGLVLRTARERFLVEPQEDTRLWAKNSEGSLDRLYDTHITVLDAALETGQLIIMETRKKDGTWPSAQLEHHHHHH","Homo sapiens","UHX1, USP11","Ubiquitin carboxyl-terminal hydrolase 11","1","4MEL"
"4MEN",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M Na(malonate), 0.1M BTProp, 20.0% PEG 3350   
10.0% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm4011302","25K","4MEN",15.43,"1.81","1.81","Crystal Structure of the first bromodomain of human BRD4 in complex with a 5-methyl-triazolopyrimidine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MEN"
"4MEO",,"X-RAY DIFFRACTION",2.14,42.52,"VAPOR DIFFUSION, SITTING DROP",8,"0.20M LiCl, 0.1M TRIS, 20.0% PEG 6K, 10.0% EtGly, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm4011302","25V","4MEO",15.53,"1.72","1.72","Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-methyl-quinoline ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MEO"
"4MEP",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M NaBr, 0.1M BTProp, 20.0% PEG 3350, 10.0% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm4011302","24Y","4MEP",15.46,"1.85","1.85","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3-chloro-pyridone ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MEP"
"4MEQ",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M Na2SO4, 20.0% PEG 3350, 10.0% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm4011302","25O","4MEQ",15.39,"1.77","1.77","Crystal Structure of the first bromodomain of human BRD4 in complex with a 5-methyl-triazolopyrimidine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MEQ"
"4MEW",,"X-RAY DIFFRACTION",2.05,40.14,"VAPOR DIFFUSION",7.5,"0.1 M Tris-HCl, 16% PEG 2000 monomethyl ether, 0.15 M trimethylamine N-oxide, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1371/journal.pone.0101846",,"4MEW",42.13,"1.993","1.993","Structure of the core fragment of human PR70","SMFPRGRPQDSVNVDAVISKIESTFARFPHERATMDDMGLVAKACGCPLYWKGPLFYGAGGERTGSVSVHKFVAMWRKILQNCHDDAAKFVHLLMSPGCNYLVQEDFVPFLQDVVNTHPGLSFLKEASEFHSRYITTVIQRIFYAVNRSWSGRITCAELRRSSFLQNVALLEEEADINQLTEFFSYEHFYVIYCKFWELDTDHDLLIDADDLARHNDHALSTKMIDRIFSGAVTRGRKVQKEGKISYADFVWFLISEEDKKTPTSIEYWFRCMDLDGDGALSMFELEYFYEEQCRRLDSMAIEALPFQDCLCQMLDLVKPRTEGKITLQDLKRCKLANVFFDTFFNIEKYLDHEQK","Homo sapiens","PPP2R3B, PPP2R3L","Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta","1","4MEW"
"4MF0",,"X-RAY DIFFRACTION",2.44,49.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"potassium thiocyanate, PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.09.069","29Z","4MF0",61.29,"2.67","2.67","ITK kinase domain in complex with benzothiazole inhibitor compound 12a (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12a)","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","EMT, ITK, LYK","Tyrosine-protein kinase ITK/TSK","1","4MF0"
"4MF1",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, SITTING DROP",6,"PEG6000, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.09.069","29Y","4MF1",61.07,"2.113","2.113","ITK kinase domain in complex with benzothiazole inhibitor 12b (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL","Homo sapiens","EMT, ITK, LYK","Tyrosine-protein kinase ITK/TSK","1","4MF1"
"4MF2",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"14%   23% PEG3400, and 350 mM sodium acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ja500172d",,"4MF2",46.61,"2.4","2.4","Structure of human DNA polymerase beta complexed with O6MG as the template base in a 1-nucleotide gapped DNA","LNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4MF2"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"synthetic template DNA","2","4MF2"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"synthetic upstream primer","3","4MF2"
,,,,,,,,,,,,,,,,"GTCGG",,,"synthetic downstream primer","4","4MF2"
"4MF3",,"X-RAY DIFFRACTION",3.12,60.6,"VAPOR DIFFUSION",8,"Protein mixed 1:1 with 55% MPD, 0.2M NH4H2PO4, 0.1M TRIS pH 8.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2013.09.045",,"4MF3",59.97,"3","3","Crystal Structure of Human GRIK1 complexed with a 6-(tetrazolyl)aryl decahydroisoquinoline antagonist","SLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEG","Homo sapiens","GRIK1, GLUR5","Glutamate receptor ionotropic, kainate 1","1","4MF3"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIK1, GLUR5"
"4MF8",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"14%  23% PEG3400, and 350 mM sodium acetate , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4MF8",47.49,"2.32","2.32","Structure of human DNA polymerase beta complexed with nicked DNA containing a mismatched template O6MG and incoming CTP","PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4MF8"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"template","2","4MF8"
,,,,,,,,,,,,,,,,"GCTGATGCGAC",,,"primer","3","4MF8"
,,,,,,,,,,,,,,,,"GTCGG",,,"down primer","4","4MF8"
"4MFA",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"4% - 23% PEG3400, and 350 mM sodium acetate , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4MFA",47.05,"2.27","2.27","Structure of human DNA polymerase beta complexed with nicked DNA containing a mismatched template O6MG and incoming TTP","LNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4MFA"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"template","2","4MFA"
,,,,,,,,,,,,,,,,"GCTGATGCGAT",,,"up primer","3","4MFA"
,,,,,,,,,,,,,,,,"GTCGG",,,"dn primer","4","4MFA"
"4MFC",,"X-RAY DIFFRACTION",2.46,50.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"14% - 23% PEG3400, and 350 mM sodium acetate , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja500172d",,"4MFC",47.1,"2.13","2.13","Structure of human DNA polymerase beta complexed with O6MG in the template base paired with incoming non-hydrolyzable CTP","LNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4MFC"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"template","2","4MFC"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"up primer","3","4MFC"
,,,,,,,,,,,,,,,,"GTCGG",,,"dn primer","4","4MFC"
"4MFF",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"14% - 23% PEG3400, and 350 mM sodium acetate , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ja500172d",,"4MFF",47.14,"2.55","2.55","Structure of human DNA polymerase beta complexed with O6MG in the template base paired with incoming non-hydrolyzable TTP","LNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4MFF"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"template","2","4MFF"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"up primer","3","4MFF"
,,,,,,,,,,,,,,,,"GTCGG",,,"dn primer","4","4MFF"
"4MFU",,"X-RAY DIFFRACTION",3.74,67.08,"VAPOR DIFFUSION, HANGING DROP",9.5,"PEG8000, CAPs, NaCl, pH 9.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1107/S139900471303318X",,"4MFU",56.38,"2.744","2.744","Crystal structure of human CTNNBL1(residues 77~563)","GHMLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","CTNNBL1, C20orf33, PP8304","Beta-catenin-like protein 1","1","4MFU"
"4MFV",,"X-RAY DIFFRACTION",3.33,63.11,"VAPOR DIFFUSION, HANGING DROP",9.5,"PEG8000, CAPs, NaCl, pH 9.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1107/S139900471303318X",,"4MFV",123.36,"2.92","2.92","Crystal structure of human CTNNBL1(residues 33~563)","GHMTGTRERGRYREEEMTVVEEADDDKKRLLQIIDRDGEEEEEEEEPLDESSVKKMILTFEKRSYKNQELRIKFPDNPEKFMESELDLNDIIQEMHVVATMPDLYHLLVELNAVQSLLGLLGHDNTDVSIAVVDLLQELTDIDTLHESEEGAEVLIDALVDGQVVALLVQNLERLDESVKEEADGVHNTLAIVENMAEFRPEMCTEGAQQGLLQWLLKRLKAKMPFDANKLYCSEVLAILLQDNDENRELLGELDGIDVLLQQLSVFKRHNPSTAEEQEMMENLFDSLCSCLMLSSNRERFLKGEGLQLMNLMLREKKISRSSALKVLDHAMIGPEGTDNCHKFVDILGLRTIFPLFMKSPRKIKKVGTTEKEHEEHVCSILASLLRNLRGQQRTRLLNKFTENDSEKVDRLMELHFKYLGAMQVADKKIEGEKHDMVRRGEIIDNDTEEEFYLRRLDAGLFVLQHICYIMAEICNANVPQIRQRVHQILNMRGSSIKIVRHIIKEYAENIGDGRSPEFRENEQKRILGLLENF","Homo sapiens","C20orf33, CTNNBL1, PP8304","Beta-catenin-like protein 1","1","4MFV"
"4MG2",,"X-RAY DIFFRACTION",3.19,61.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 5000, 100mM sodium chloride, 50mM Magnesium chloride, 100mM cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4MG2",32.54,"2.3","2.3","ALKBH2 F102A cross-linked to undamaged dsDNA","MSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVAGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLM","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","4MG2"
,,,,,,,,,,,,,,,,"TCGACAGTGAGACAT",,,"DNA-1","2","4MG2"
,,,,,,,,,,,,,,,,"CTGTCTCAXTGTCGC",,,"DNA-2","3","4MG2"
"4MGT",,"X-RAY DIFFRACTION",3.23,61.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 5000, 100mM sodium chloride, 50mM Magnesium chloride, 100mM cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,,,"4MGT",31.57,"2.6","2.6","ALKBH2 R110A cross-linked to undamaged dsDNA","MSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPAKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLG","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","4MGT"
,,,,,,,,,,,,,,,,"TCGACAGTGAGACA",,,"DNA1","2","4MGT"
,,,,,,,,,,,,,,,,"TGTCTCAXTGTCG",,,"DNA2","3","4MGT"
"4MH7",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500mM sodium chloride, 2mM beta-mercaptoethanol, incubated with inhibitor (2.5 mM final concentration) overnight, mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1021/jm4013888","MH7","4MH7",72.49,"2.51","2.51","Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1896","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MER, MERTK","Tyrosine-protein kinase Mer","1","4MH7"
"4MHA",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500mM sodium chloride, 2mM beta-mercaptoethanol, incubated with inhibitor (2.5 mM final concentration) overnight, mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1021/jm4013888","4MH","4MHA",72.97,"2.59","2.59","Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MER, MERTK","Tyrosine-protein kinase Mer","1","4MHA"
"4MHE",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate, pH 5.6, 30% w/v Polyethylene glycol 4,000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1016/j.jmb.2015.01.012",,"4MHE",31.87,"2.1","2.1","Crystal structure of CC-chemokine 18","SAQVGTNKELCCLVYTSWQIPQKFIVDYSETSPQCPKPGVILLTKRGRQICADPNKKWVQKYISDLKLNA","Homo sapiens","CCL18, AMAC1, DCCK1, MIP4, PARC, SCYA18","C-C motif chemokine 18","1","4MHE"
"4MHL",,"X-RAY DIFFRACTION",1.83,32.96,"VAPOR DIFFUSION, SITTING DROP",9.5,"1.25 M ammonium sulfate, 0.2 M lithium sulfate, 0.1 M bis-tris propane, 10% formamide, 0.02% sodium azide, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714012267",,"4MHL",19.39,"2.09","2.09","The crystal structure of human interleukin-11","GPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGGLHLTLDWAVRGLLLLKTRL","Homo sapiens","IL11","Interleukin-11","1","4MHL"
"4MHQ",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M Na-acetate, 0.2M Tri-Na-citrate, 20% PEG3350, 0.1M Na-acetate , pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4MHQ",50.64,"2.2","2.2","Crystal structure of human primase catalytic subunit","GAMGSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRKGELLKKSDLQKDF","Homo sapiens","PRIM1","DNA primase small subunit","1","4MHQ"
"4MHV",,"X-RAY DIFFRACTION",3.47,64.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Cacadylate, pH 6.5, 14 % PEG 10K, 20 % Glycerol, 0.16 M Calcium Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4MHV",23.2,"2.45","2.45","Crystal structure of the PNT domain of human ETS2","SMKAVMSQALKATFSGFKKEQRRLGIPKNPWLWSEQQVCQWLLWATNEFSLVNVNLQRFGMNGQMLCNLGKERFLELAPDFVGDILWEHLEQMIKEN","Homo sapiens","ETS2","Protein C-ets-2","1","4MHV"
"4MHX",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% (w/v) polyethylene glycol (PEG) 3350, 200 mM MgCl2 and 100 mM HEPES buffer, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714002739",,"4MHX",118.54,"2","2","Crystal Structure of Sulfamidase","MSCPVPACCALLLVLGLCRARPRNALLLLADDGGFESGAYNNSAIATPHLDALARRSLLFRNAFTSVSSSSPSRASLLTGLPQHQNGMYGLHQDVHHFNSFDKVRSLPLLLSQAGVRTGIIGKKHVGPETVYPFDFAYTEENGSVLQVGRNITRIKLLVRKFLQTQDDRPFFLYVAFHDPHRCGHSQPQYGTFCEKFGNGESGMGRIPDWTPQAYDPLDVLVPYFVPNTPAARADLAAQYTTVGRMDQGVGLVLQELRDAGVLNDTLVIFTSDNGIPFPSGRTNLYWPGTAEPLLVSSPEHPKRWGQVSEAYVSLLDLTPTILDWFSIPYPSYAIFGSKTIHLTGRSLLPALEAEPLWATVFGSQSHHEVTMSYPMRSVQHRHFRLVHNLNFKMPFPIDQDFYVSPTFQDLLNRTTAGQPTGWYKDLRHYYYRARWELYDRSRDPHETQNLATDPRFAQLLEMLRDQLAKWQWETHDPWVCAPDGVLEEKLSPQCQPLHNELRSHHHHHH","Homo sapiens","SGSH, HSS","N-sulphoglucosamine sulphohydrolase","1","4MHX"
"4MI0",,"X-RAY DIFFRACTION",1.82,32.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2M Lithium Sulfate, 0.1M HEPES pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0083737",,"4MI0",27.1,"2","2","Human Enhancer of Zeste (Drosophila) Homolog 2(EZH2)","YQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIPHHHHHH","Homo sapiens","EZH2, KMT6","Histone-lysine N-methyltransferase EZH2","1","4MI0"
"4MI5",,"X-RAY DIFFRACTION",1.89,34.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES pH 6.5, 30% PEG MME 5K, 200mM Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1371/journal.pone.0084147",,"4MI5",26.46,"2","2","Crystal structure of the EZH2 SET domain","GSLQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP","Homo sapiens","EZH2, KMT6","Histone-lysine N-methyltransferase EZH2","1","4MI5"
"4MID",,"X-RAY DIFFRACTION",1.73,28.84,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris, 30% PEG 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1002/jbmr.2238",,"4MID",13.09,"2.139","2.139","Crystal Structure of Activin A/BMP2 chimera","MQAKHKQRKRLKSSCKRHPLYVDFSDVGWNDWIIAPSGYHANYCDGECPFPLADHLNSTNHAIVQTLVNSVNSKIPKACCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS","Homo sapiens","BMP2, BMP2A, INHBA","AB204 Activin A/BMP2 chimera","1","4MID"
"4MIK",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M Na cacodylate pH 5.6, 0.17 M LiCl, 9% PEG 6000, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,,,"4MIK",64.97,"1.9506","1.9506","Crystal Structure of hPNMT in Complex with bisubstrate inhibitor (2R,3R,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-(((2-(((7-nitro-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)amino)ethyl)thio)methyl)tetrahydrofuran-3,4-diol","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","4MIK"
"4MIV",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, SITTING DROP",5.1,"13% (w/v) polyethylene glycol (PEG) 8000, 200 mM MgCl2 and 100 mM Bis-Tris buffer, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714002739",,"4MIV",473.85,"2.4","2.4","Crystal Structure of Sulfamidase, Crystal Form L","MSCPVPACCALLLVLGLCRARPRNALLLLADDGGFESGAYNNSAIATPHLDALARRSLLFRNAFTSVSSSSPSRASLLTGLPQHQNGMYGLHQDVHHFNSFDKVRSLPLLLSQAGVRTGIIGKKHVGPETVYPFDFAYTEENGSVLQVGRNITRIKLLVRKFLQTQDDRPFFLYVAFHDPHRCGHSQPQYGTFCEKFGNGESGMGRIPDWTPQAYDPLDVLVPYFVPNTPAARADLAAQYTTVGRMDQGVGLVLQELRDAGVLNDTLVIFTSDNGIPFPSGRTNLYWPGTAEPLLVSSPEHPKRWGQVSEAYVSLLDLTPTILDWFSIPYPSYAIFGSKTIHLTGRSLLPALEAEPLWATVFGSQSHHEVTMSYPMRSVQHRHFRLVHNLNFKMPFPIDQDFYVSPTFQDLLNRTTAGQPTGWYKDLRHYYYRARWELYDRSRDPHETQNLATDPRFAQLLEMLRDQLAKWQWETHDPWVCAPDGVLEEKLSPQCQPLHNELRSHHHHHH","Homo sapiens","SGSH, HSS","N-sulphoglucosamine sulphohydrolase","1","4MIV"
"4MJ2",,"X-RAY DIFFRACTION",3.2,61.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.01 M HEPES, pH 7.5, 0.26 M sodium potassium tartrate, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 297K, temperature 298K",298,"10.1038/nchembio.1357",,"4MJ2",150.05,"2.1","2.1","Crystal structure of apo-iduronidase in the R3 form","MRPLRPRAALLALLASLLAAPPVAPAEAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4MJ2"
"4MJ4",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M magnesium chloride, 0.1 M HEPES, pH 7.5, 25% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nchembio.1357",,"4MJ4",74.35,"2.172","2.172","Human iduronidase apo structure P21 form","MRPLRPRAALLALLASLLAAPPVAPAEAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4MJ4"
"4MJJ",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",8,"14% PEG400, 100mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4MJJ",15.65,"2","2","Crystal structure of the C2A domain of DOC2A","GSYDSDDATALGTLEFDLLYDRASCTLHCSILRAKGLKPMDFNGLADPYVKLHLLPGACKANKLKTKTQRNTLNPVWNEDLTYSGITDDDITHKVLRIAVCDEDKLSHNEFIGEIRVPLRRLKPSQKKHFNICLERQV","Homo sapiens","DOC2A","Double C2-like domain-containing protein alpha","1","4MJJ"
"4MJO",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M ammonium acetate and 12% polyethylenglycol 3350 in 0.1 M HEPES, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1021/cb4007002","2C1","4MJO",299.15,"2.4","2.4","Human liver fructose-1,6-bisphosphatase(d-fructose-1,6-bisphosphate, 1-phosphohydrolase) (e.c.3.1.3.11) complexed with the allosteric inhibitor 3","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","Fructose-1,6-bisphosphatase 1","1","4MJO"
"4MK4",,"X-RAY DIFFRACTION",2.79,55.96,"EVAPORATION",6.5,"0.1M BIS-TRIS, 0.05M AMMONIUM ACETATE, PENTAERYTHRITOL ETHOXYLATE(15/4 EO/OH), pH 6.5, EVAPORATION",,,,"4MK4",84.88,"2.5","2.5","S197C variant of human ferrochelatase.","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCCTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","4MK4"
"4MKC",,"X-RAY DIFFRACTION",1.9,35.11,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG3350, 0.2M Sodium acetate trihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1158/2159-8290.CD-13-0846","4MK","4MKC",42.36,"2.01","2.01","Crystal Structure of Anaplastic Lymphoma Kinase Complexed with LDK378","MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4MKC"
"4MKP",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION",7.5,"PEG 3350, NH4NO3, NaCl, CYMAL-7, pH 7.5, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0076983",,"4MKP",42.61,"1.953","1.953","Crystal structure of human cGAS apo form","GSGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, CGAS, C6orf150","Cyclic GMP-AMP synthase","1","4MKP"
"4MKT",,"X-RAY DIFFRACTION",2.43,49.3,"LIQUID DIFFUSION",7,"50 mM Sodium Acetate, 22% (v/v) PEG 8000, 5 mM YbCl3, pH 7.0, LIQUID DIFFUSION, temperature 277K",277,"10.1073/pnas.1402136111","1V6","4MKT",70.43,"1.618","1.618","Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue and 4-(4-benzylphenyl)thiazol-2-amine","MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4, LTA4H","Leukotriene A-4 hydrolase","1","4MKT"
"4MLE",,"X-RAY DIFFRACTION",2.85,56.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG1500, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401116k","VO1","4MLE",51.49,"2.6","2.6","Human Glucokinase in Complex with Novel Amino Thiazole Activator","MALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4MLE"
"4MLH",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG1500, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401116k","VO2","4MLH",51.5,"2.9","2.9","Human Glucokinase in Complex with a Novel Amino Thiazole Allosteric Activator","MALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4MLH"
"4MLT",,"X-RAY DIFFRACTION",2.08,40.97,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 3.0 M Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja500616m","TM4","4MLT",29.9,"2","2","Structure of a monodentate 3-hydroxy-4H-pyran-4-thione ligand bound to hCAII","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MLT"
"4MLX",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM Tris, 3.0 M ammonium sulfate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja500616m","TM7","4MLX",29.9,"1.65","1.65","Structure of a bidentate 3-hydroxy-4H-pyran-4-thione ligand bound to hCAII","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MLX"
"4MMM",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",5.3,"22% PEG3350, 0.1M sodium citrate buffer (pH 5.3), 0.2M potassium sodium tartrate, 5mM 1,4-dithio-dl-threitol, 0.02%(w/v) sodium azide, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0102300","BP7","4MMM",71.71,"1.47","1.47","Human Pdrx5 complex with a ligand BP7","HHHHHHSAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL","Homo sapiens","PRDX5, ACR1, SBBI10","Peroxiredoxin-5, mitochondrial","1","4MMM"
"4MNF",,"X-RAY DIFFRACTION",2.65,53.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% PEG8000, 0.1 M HEPES, pH 7.5, 0.5 M sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.ccr.2014.07.007","29L","4MNF",75.29,"2.802","2.802","Crystal structure of BRAF-V600E bound to GDC0879","MSGAHHHHHHHHGGGGGLVPRGAMSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRA","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4MNF"
"4MNT",,"X-RAY DIFFRACTION",3.09,60.18,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Sodium Malonate, 20% w/v PEG 3350, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.535112",,"4MNT",20.04,"1.584","1.584","Crystal structure of human DJ-1 in complex with Cu","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4MNT"
"4MNV",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, HANGING DROP",4.25,"21% PEG4000, 16% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.25, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201309459",,"4MNV",29.73,"1.8","1.8","Crystal structure of bicyclic peptide UK729 bound as an acyl-enzyme intermediate to urokinase-type plasminogen activator (uPA)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","4MNV"
,,,,,,,,,,,,,,,,"TCRQSMCTAR",,,"acyl-enzyme intermediate of bicyclic peptide UK729","2","4MNV"
,,,,,,,,,,,,,,,,"TCPX",,,"acyl-enzyme intermediate of bicyclic peptide UK729","3","4MNV"
"4MNW",,"X-RAY DIFFRACTION",1.95,36.83,"VAPOR DIFFUSION, HANGING DROP",4.5,"22% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201309459",,"4MNW",30.27,"1.49","1.49","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK749","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","4MNW"
,,,,,,,,,,,,,,,,"QCWDRGCENRKCNX",,,"bicyclic peptide UK749","2","4MNW"
"4MNX",,"X-RAY DIFFRACTION",1.91,35.76,"VAPOR DIFFUSION, HANGING DROP",4.5,"22% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201309459",,"4MNX",29.7,"1.85","1.85","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK811","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","4MNX"
,,,,,,,,,,,,,,,,"LCSDRGCENRWCKX",,,"bicyclic peptide UK811","2","4MNX"
"4MNY",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",4.25,"20% PEG4000, 16% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.25, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/anie.201309459",,"4MNY",59.88,"1.7","1.7","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK903","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","4MNY"
,,,,,,,,,,,,,,,,"GCQVNYCPPVPCLX",,,"bicyclic peptide UK903","2","4MNY"
"4MO8",,"X-RAY DIFFRACTION",2.1,41.29,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M sodium citrate, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm4009532","2VQ","4MO8",29.6,"1.85","1.85","The crystal structure of the human carbonic anhydrase II in complex with N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]sulfamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MO8"
"4MOB",,"X-RAY DIFFRACTION",3.01,59.07,"VAPOR DIFFUSION, HANGING DROP",,"275 mM potassium phosphate dibasic, 12.5% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M114.589408","ADP","4MOB",38.31,"2.401","2.401","Acyl-Coenzyme A thioesterase 12 in complex with ADP","SMGEVVMSQAIQPAHATARGELSAGQLLKWIDTTACLAAEKHAGVSCVTASVDDIQFEETARVGQVITIKAKVTRAFSTSMEISIKVMVQDMLTGIEKLVSVAFSTFVAKPVGKEKIHLKPVTLLTEQDHVEHNLAAERRKVRLQHEDTFNNLMKESSKFDDLIFDEEEGAVSTRGTSVQSIELVLPPHANHHGNTFGGQIMAWMETVATISASRLCWAHPFLKSVDMFKFRGPSTVGDRLVFTAIVNNTFQTCVEVGVRVEAFDCQEWAEGRGRHINSAFLIYNAADDKENLITFPRIQPISKDDFRRYRGAIARKRIRLGRKYVISHKEE","Homo sapiens","ACOT12, CACH, CACH1, STARD15","Acyl-coenzyme A thioesterase 12","1","4MOB"
"4MOC",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, HANGING DROP",,"450 mM sodium thiocyanate, 22% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M114.589408",,"4MOC",37.88,"2.5","2.5","Human Acyl-coenzyme A Thioesterase 12","SMGEVVMSQAIQPAHATARGELSAGQLLKWIDTTACLAAEKHAGVSCVTASVDDIQFEETARVGQVITIKAKVTRAFSTSMEISIKVMVQDMLTGIEKLVSVAFSTFVAKPVGKEKIHLKPVTLLTEQDHVEHNLAAERRKVRLQHEDTFNNLMKESSKFDDLIFDEEEGAVSTRGTSVQSIELVLPPHANHHGNTFGGQIMAWMETVATISASRLCWAHPFLKSVDMFKFRGPSTVGDRLVFTAIVNNTFQTCVEVGVRVEAFDCQEWAEGRGRHINSAFLIYNAADDKENLITFPRIQPISKDDFRRYRGAIARKRIRLGRKYVISHKEE","Homo sapiens","ACOT12, CACH, CACH1, STARD15","Acyl-coenzyme A thioesterase 12","1","4MOC"
"4MOV",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, 1.0 M Lithium Chloride, 20% PEG 6000, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1317395111",,"4MOV",68.8,"1.4503","1.4503","1.45 A Resolution Crystal Structure of Protein Phosphatase 1","GHMGSLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAD","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","4MOV"
"4MP2",,"X-RAY DIFFRACTION",3.86,68.13,"VAPOR DIFFUSION",4.6,"0.9 M ammonium tartrate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.533885","PV1","4MP2",45.72,"1.751","1.751","Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA1","SKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial","1","4MP2"
"4MP7",,"X-RAY DIFFRACTION",3.81,67.7,"VAPOR DIFFUSION",4.6,"0.9 M ammonium tartrate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.533885","PFT","4MP7",45.64,"1.8","1.8","Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA7","SKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial","1","4MP7"
"4MPA",,"X-RAY DIFFRACTION",1.93,36.34,"VAPOR DIFFUSION, HANGING DROP",4.8,"100 mM sodium acetate, pH 4.8, 0.2 M ammonium acetate, 24% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0081904",,"4MPA",9.96,"1.097","1.097","Crystal structure of NHERF1-CXCR2 signaling complex in P21 space group","GMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETSTTL","Homo sapiens","NHERF, NHERF1, SLC9A3R1, CXCR2","Na(+)/H(+) exchange regulatory cofactor NHE-RF1, C-X-C chemokine receptor type 2 chimera","1","4MPA"
"4MPC",,"X-RAY DIFFRACTION",3.87,68.18,"VAPOR DIFFUSION",4.6,"0.9 M ammonium tartrate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.533885","PV2","4MPC",45.67,"1.699","1.699","Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS2","SKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial","1","4MPC"
"4MPE",,"X-RAY DIFFRACTION",3.85,68.07,"VAPOR DIFFUSION",4.6,"0.9 M ammonium tartrate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.533885","PV8","4MPE",45.69,"1.953","1.953","Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS8","SKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial","1","4MPE"
"4MPF",,"X-RAY DIFFRACTION",2.51,51.08,,4.6,"Protein in 10 mm HEPES, ph 7.5, 150 mm sodium chloride, 5% glycerol, reservoir: 1.1M ammonium tartrate dibasic, 0.1m sodium acetate:HCl, pH 4.6, cryoprotectant: 20% glycerol, vapor diffusion, sitting drop, temperature 298K",,,,"4MPF",60.53,"2.1","2.1","Crystal structure of human glutathione transferase theta-2, complex with inorganic phosphate, GSH free, target EFI-507257","MHHHHHHSSGVDLGTENLYFQSMGLELFLDLVSQPSRAVYIFAKKNGIPLELRTVDLVKGQHKSKEFLQINSLGKLPTLKDGDFILTESSAILIYLSCKYQTPDHWYPSDLQARARVHEYLGWHADCIRGTFGIPLWVQVLGPLIGVQVPKEKVERNRTAMDQALQWLEDKFLGDRPFLAGQQVTLADLMALEELMQPVALGYELFEGRPRLAAWRGRVEAFLGAELCQEAHSIILSILEQAAKKTLPTPSPEAYQAMLLRIARIP","Homo sapiens","GSTT2","Glutathione S-transferase theta-2","1","4MPF"
"4MPG",,"X-RAY DIFFRACTION",2.51,51.08,,7,"Protein in 10 mM HEPES, pH 7.5, 150 MM sodium chloride, 5% glycerol, reservoir: 2M sodium formate, 0.1M BIS-TRIS propane:HCl, pH 7.0, 5 mM GSH, cryoprotectant: none, vapor diffusion, sitting drop, temperature 298K",,,,"4MPG",60.89,"1.951","1.951","Crystal structure of human glutathione transferase theta-2, complex with glutathione and unknown ligand, target EFI-507257","MHHHHHHSSGVDLGTENLYFQSMGLELFLDLVSQPSRAVYIFAKKNGIPLELRTVDLVKGQHKSKEFLQINSLGKLPTLKDGDFILTESSAILIYLSCKYQTPDHWYPSDLQARARVHEYLGWHADCIRGTFGIPLWVQVLGPLIGVQVPKEKVERNRTAMDQALQWLEDKFLGDRPFLAGQQVTLADLMALEELMQPVALGYELFEGRPRLAAWRGRVEAFLGAELCQEAHSIILSILEQAAKKTLPTPSPEAYQAMLLRIARIP","Homo sapiens","GSTT2, GSTT2B","Glutathione S-transferase theta-2","1","4MPG"
"4MPL",,"X-RAY DIFFRACTION",3.58,65.66,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.12M magnesium nitrate, 12% PEG3350, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M114.579771",,"4MPL",12.93,"1.9","1.9","Crystal structure of BMP9 at 1.90 Angstrom","SHHHHHHAGAGSHCQKTSLRVNFEDIGWDSWIIAPKEYEAYECKGGCFFPLADDVTPTKHAIVQTLVHLKFPTKVGKACCVPTKLSPISVLYKDDMGVPTLKYHYEGMSVAECGCR","Homo sapiens","BMP9, GDF2","Growth/differentiation factor 2","1","4MPL"
"4MPM",,"X-RAY DIFFRACTION",1.95,37.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M magnesium acetate, tetrahydrate, 0.1 M sodium   
cacodylate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714000078",,"4MPM",35.14,"1.74","1.74","Wild-type human neuroglobin","MERPEPELIRQSWRAVSRSPLEHGTVLFARLFALEPDLLPLFQYNCRQFSSPEDCLSSPEFLDHIRKVMLVIDAAVTNVEDLSSLEEYLASLGRKHRAVGVKLSSFSTVGESLLYMLEKCLGPAFTPATRAAWSQLYGAVVQAMSRGWDGE","Homo sapiens","NGB","Neuroglobin","1","4MPM"
"4MPN",,"X-RAY DIFFRACTION",3.87,68.2,"VAPOR DIFFUSION",4.6,"0.9 M ammonium tartrate, 0.1 M sodium acetate pH 4.6, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M113.533885","PV0","4MPN",45.71,"1.752","1.752","Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS10","SKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial","1","4MPN"
"4MPU",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% PEG1500, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate, individual monocrystals equilibrated with 30% PEG1500, 0.1 M MES, pH 5.5, 0.2 M ammonium sulfate and soaked 20 hours in same solution supplemented with compound 2A, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/acsmedchemlett.8b00204",,"4MPU",57.02,"1.649","1.649","Human beta-tryptase co-crystal structure with (6S,8R)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6-(1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPS1, TPS2, TPSAB1, TPSB1","Tryptase alpha/beta-1","1","4MPU"
"4MPV",,"X-RAY DIFFRACTION",2.68,54.04,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% PEG1500, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate, individual monocrystals equilibrated with 30% PEG1500, 0.1 M MES, pH 5.5, 0.2 M ammonium sulfate and soaked 20 hours in same solution supplemented with compound 3A, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/acsmedchemlett.8b00204",,"4MPV",56.64,"2.305","2.305","Human beta-tryptase co-crystal structure with (2R,4S)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2-(2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPS1, TPS2, TPSAB1, TPSB1","Tryptase alpha/beta-1","1","4MPV"
"4MPW",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.9 mg/mL protein incubated with compound 4A 30 minutes on ice prior to setup with 30% PEG1500, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1159/000492078",,"4MPW",56.27,"1.95","1.95","Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone)","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPS1, TPS2, TPSAB1, TPSB1","Tryptase alpha/beta-1","1","4MPW"
"4MPX",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.9 mg/mL protein incubated with compound 6A 30 minutes on ice prior to setup with 30% PEG1500, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4MPX",56.86,"2","2","Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone)","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPS1, TPS2, TPSAB1, TPSB1","Tryptase alpha/beta-1","1","4MPX"
"4MQ1",,"X-RAY DIFFRACTION",3.24,61.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"15% PEG 300, 0.1M LiSO4, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.10.055","2C3","4MQ1",172.69,"2.35","2.35","The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","4MQ1"
"4MQ2",,"X-RAY DIFFRACTION",3.21,61.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"15% PEG 300, 0.1M LiSO4, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.10.055","2C4","4MQ2",171.79,"2.8","2.8","The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","4MQ2"
"4MQ4",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M Na cacodylate pH 5.6, 0.17 M LiCl, 9% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,,,"4MQ4",64.94,"2.2042","2.2042","Crystal Structure of hPNMT in Complex with bisubstrate inhibitor N-(3-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)thio)propyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","4MQ4"
"4MQA",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.9 mg/mL protein incubated with compound 13A 30 minutes on ice prior to setup with 30% PEG3350, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4MQA",56.47,"2.25","2.25","Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1-diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone)","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPS1, TPS2, TPSAB1, TPSB1","Tryptase alpha/beta-1","1","4MQA"
"4MQU",,"X-RAY DIFFRACTION",3.03,59.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"Well buffer: 0.1M Bis-tris, 0.2M NaI, 16% PEG 8K, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm4016747","MG9","4MQU",145.48,"2.22","2.22","Human GKRP complexed to AMG-3969 and S6P","MHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQ","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4MQU"
"4MR3",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M NaBr, 0.1M BTProp, 20.0% PEG3350, 10% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1310658110","1K0","4MR3",15.53,"1.68","1.68","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RVX-OH)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MR3"
"4MR4",,"X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Na2SO4, 20% PEG3350  
10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1310658110","1K0","4MR4",15.66,"1.66","1.66","Crystal Structure of the first bromodomain of human BRD4 in complex with a quinazolinone ligand (RVX-208)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4MR4"
"4MR5",,"X-RAY DIFFRACTION",2.25,45.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M Na(formate), 0.1M BTProp, 20.0% PEG 3350   
10.0% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1310658110","1K0","4MR5",14.07,"1.63","1.63","Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-OH)","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","4MR5"
"4MR6",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.2M KSCN, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1310658110","1K0","4MR6",14.01,"1.67","1.67","Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-208)","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","4MR6"
"4MRB",,"X-RAY DIFFRACTION",1.99,38.17,"VAPOR DIFFUSION",7.5,"100mM HEPES, 200mM CaCl2, 28% PEG400 v/v, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1073/pnas.1317488111",,"4MRB",27.63,"1.27","1.27","Wild Type Human Transthyretin pH 7.5","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4MRB"
"4MRC",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION",7.5,"100mM HEPES, 200mM CaCl2, 28% PEG400 v/v, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1073/pnas.1317488111",,"4MRC",27.54,"1.54","1.54","Human Transthyretin Ser52Pro Mutant","PTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSEPGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4MRC"
"4MRI",,"X-RAY DIFFRACTION",3.86,68.09,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG 3350, 0.05M sodium citrate, 0.3M potassium phosphate (dibasic), 3% ethylene glycol, 0.01M DTT, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500719k",,"4MRI",72,"2.8","2.8","Human brain aspartoacylase mutant F295S complex with intermediate analog (N-phosphonomethyl-L-aspartate)","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEASAKTTKLTLNAKSIRCCLH","Homo sapiens","ACY2, ASP, ASPA","Aspartoacylase","1","4MRI"
"4MRO",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION",7.5,"Well buffer: 0.1M Bis-tris, 0.2M NaI, 16% PEG 8K, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm4016747",,"4MRO",145.4,"2.2","2.2","Human GKRP bound to AMG-5980 and S6P","MHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQ","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4MRO"
"4MRW",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mN BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","MRW","4MRW",79.37,"1.96","1.96","Crystal structure of PDE10A2 with fragment ZT0120 (7-chloroquinolin-4-ol)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MRW"
"4MRZ",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2ZV","4MRZ",79.35,"1.58","1.58","Crystal structure of PDE10A2 with fragment ZT0429 (4-methyl-3-nitropyridin-2-amine)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MRZ"
"4MS0",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2ZX","4MS0",79.34,"1.79","1.79","Crystal structure of PDE10A2 with fragment ZT0443 (6-chloropyrimidine-2,4-diamine)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MS0"
"4MS6",,"X-RAY DIFFRACTION",2.4,48.65,"LIQUID DIFFUSION",7,"50 mM Sodium Acetate, 22% (w/v) PEG 8000, 5 mM YbCl3, pH 7.0, LIQUID DIFFUSION, temperature 277K",277,"10.1073/pnas.1402136111",,"4MS6",70.68,"1.72","1.72","Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue","MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4, LTA4H","Leukotriene A-4 hydrolase","1","4MS6"
"4MSA",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2ZM","4MSA",79.52,"1.62","1.62","Crystal structure of PDE10A2 with fragment ZT0449 (5-nitro-1H-benzimidazole)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MSA"
"4MSC",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2ZT","4MSC",79.48,"2.47","2.47","Crystal structure of PDE10A2 with fragment ZT1595 (2-[(quinolin-7-yloxy)methyl]quinoline)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MSC"
"4MSE",,"X-RAY DIFFRACTION",2.06,40.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493",,"4MSE",79.5,"2.81","2.81","Crystal structure of PDE10A2 with fragment ZT1597 (2-({[(2S)-2-methyl-2,3-dihydro-1,3-benzothiazol-5-yl]oxy}methyl)quinoline)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MSE"
"4MSG",,"X-RAY DIFFRACTION",2.38,48.37,"VAPOR DIFFUSION, HANGING DROP",5,"0.2/0.4 M Di Ammonium Tartarte, 12.5-25% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 5.0",277,"10.1021/jm401317z","2C6","4MSG",51.16,"1.8","1.8","Crystal structure of tankyrase 1 with compound 22","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4MSG"
"4MSH",,"X-RAY DIFFRACTION",2.03,39.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2D0","4MSH",79.38,"2.3","2.3","Crystal Structure of PDE10A2 with fragment ZT0143 ((2S)-4-chloro-2,3-dihydro-1,3-benzothiazol-2-amine)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MSH"
"4MSK",,"X-RAY DIFFRACTION",2.69,54.36,"VAPOR DIFFUSION, HANGING DROP",5,"0.2/0.4 M Di Ammonium Tartrate, 12.5-25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 5.0",277,"10.1021/jm401317z","2C8","4MSK",102.18,"2.3","2.3","Co-crystal structure of tankyrase 1 with compound 34","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4MSK"
"4MSL",,"X-RAY DIFFRACTION",3.64,66.19,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M HEPES-Tris, 0.4 M sodium malonate, 26 % (w/v) PEG 3350, 8 % (v/v) glycerol, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1107/S1399004713030149","2ET","4MSL",79.64,"2.7","2.7","Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with AF40431","SAPGEDEECGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPEKQNSKSNSGSAMIEGRGVGHHHHHH","Homo sapiens","SORT1","Sortilin","1","4MSL"
"4MSN",,"X-RAY DIFFRACTION",2.02,39.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% PEG 4450, 0.2M calcium acetate, 50mM BME, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1177/1087057113516493","2ZQ","4MSN",79.37,"2.3","2.3","Crystal structure of PDE10A2 with fragment ZT0451 (8-nitroquinoline)","GAGTSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MSN"
"4MSP",,"X-RAY DIFFRACTION",2.34,47.41,"VAPOR DIFFUSION, HANGING DROP",7.2,"25% 1,2-propanediol, 12% PEG 20000, 0.1M MES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/pro.2391",,"4MSP",47.05,"1.9","1.9","Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP22 (aka FKBP14) containing two EF-hand motifs","AMADIGSEFLIPEPEVKIEVLQKPFICHRKTKGGDLMLVHYEGYLEKDGSLFHSTHKHNNGQPIWFTLGILEALKGWDQGLKGMCVGEKRKLIIPPALGYGKEGKGKIPPESTLIFNIDLLEIRNGPRSHESFQEMDLNDDWKLSKDEVKAYLKKEFEKHGAVVNESHHDALVEDIFDKEDEDKDGFISAREFTYKHDEL","Homo sapiens","FKBP14, FKBP22, UNQ322/PRO381","Peptidyl-prolyl cis-trans isomerase FKBP14","1","4MSP"
"4MSU",,"X-RAY DIFFRACTION",2.99,58.89,"VAPOR DIFFUSION",7.5,"Well buffer: 0.1M Bis-tris, 0.2M NaI, 16% PEG 8K, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm4016735","2EU","4MSU",145.03,"2.5","2.5","Human GKRP bound to AMG-6861 and Sorbitol-6-phosphate","MHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQ","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4MSU"
"4MT9",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, HANGING DROP",5,"0.2/0.4 M Di Ammonium Tartrate, 12.5-25% PEG3350, pH 5.0-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401317z","2D6","4MT9",51.11,"2","2","Co-crystal structure of tankyrase 1 with compound 49","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4MT9"
"4MTA",,"X-RAY DIFFRACTION",3.22,61.75,"VAPOR DIFFUSION, HANGING DROP",5.4,"1.0 M ammonium dihydrogen phosphate, 0.2 M sodium chloride, 0.1 M sodium citrate, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1177/1087057114565080",,"4MTA",33.14,"2.2","2.2","Crystal structure of Pim-1 kinase domain in complex with 2-methyl-5-phenylfuran-3-carboxylic acid","GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4MTA"
"4MTC",,"X-RAY DIFFRACTION",3.11,60.41,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M Sodium Malonate, 20% w/v PEG 3350, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.535112",,"4MTC",19.95,"1.47","1.47","Crystal structure of human C53A DJ-1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVIAPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4MTC"
"4MTH",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, HANGING DROP",6,"22% PEG 8000, 0.1M MES pH 6.0, 0.1M NACL, 10MM NAAC, 5% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature12729",,"4MTH",15.62,"1.47","1.47","Crystal structure of mature human RegIIIalpha","MIRCPKGSKAYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERNPSTISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFTD","Homo sapiens","HIP, PAP, PAP1, REG3A","Regenerating islet-derived protein 3-alpha 15 kDa form","1","4MTH"
"4MTI",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION, SITTING DROP",8.2,"2.8M Na Cl, 0.06M Tris_base, 0.04M Tris Cl, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.09.067","2DX","4MTI",27.8,"2.15","2.15","Crystal structure of cIAP1 BIR3 bound to T3258042","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4MTI"
"4MTL",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION",7.5,"30% PEG3350, 0.2 M sodium chloride, 0.1 M HEPES, 0.005 M SAH, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"4MTL",55.75,"1.65","1.65","Human Methyltransferase-Like Protein 21C","GGGWLEAEKKGAPQKDSTGGVLEESNKIEPSLHSLQKFVPTDYASYTQEHYRFAGKEIVIQESIESYGAVVWPGAMALCQYLEEHAEELNFQDAKILEIGAGPGLVSIVASILGAQVTATDLPDVLGNLQYNLLKNTLQCTAHLPEVKELVWGEDLDKNFPKSAFYYDYVLASDVVYHHYFLDKLLTTMVYLSQPGTVLLWANKFRFSTDYEFLDKFKQVFDTTLLAEYPESSVKLFKGILKWD","Homo sapiens","METTL21C, C13orf39","Protein-lysine methyltransferase METTL21C","1","4MTL"
"4MTY",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.15 mM HCA2, 50 mM TRIS pH 8.5, 150 mM NaCl, 2mM 4-(hydroxymercury)benzoate, 2.7 M (NH4)2SO4, 3 mM NaN3, 0.75 mM benzamide N-(3-hydroxybenzyl)-4-sulfamoyl., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.201309160",,"4MTY",31.18,"1","1","Structure at 1A resolution of a helical aromatic foldamer-protein complex.","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4MTY"
"4MTZ",,"X-RAY DIFFRACTION",2.02,39.18,,9,"10% PEG 20000, 0.1 M BICINE, pH 9.0 and 2% (v/v) 1,4-Dioxane, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4MTZ",51.85,"2.1","2.1","Structure of XIAP-BIR1 in complex with NF023","MGSSHHHHHHSSGLVPQGSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLE","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4MTZ"
"4MU7",,"X-RAY DIFFRACTION",2.42,49.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"3.5M ammonium chloride, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.09.067","2DY","4MU7",27.9,"1.79","1.79","Crystal structure of cIAP1 BIR3 bound to T3450325","MGSSHHHHHHSSGENLYFQGGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","4MU7"
"4MUC",,"X-RAY DIFFRACTION",4.05,69.66,"VAPOR DIFFUSION, HANGING DROP",4.6,"2 M ammonium sulphate and 0.1 M sodium acetate , pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.630871",,"4MUC",29.15,"2.897","2.897","The 4th and 5th C-terminal domains of Factor H related protein 1","TGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWTAKQKLYLRTGESAEFVCKRGYRLSSRSHTLRTTCWDGKLEYPTCAK","Homo sapiens","CFHR1, CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, HFL1, HFL2","Complement factor H-related protein 1","1","4MUC"
"4MUM",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, HANGING DROP",4,"20 mM potassium phosphate monobasic, 8% PEG8000, 10% gycerol, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.3109/14756366.2013.879577",,"4MUM",25.23,"1.271","1.271","Crystal structure of mitochondrial 5'(3')-deoxy ribonucleotidase alternative spliced variant","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGKWPATGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRP","Homo sapiens","DNT1, NT5C, UMPH2, NT5M, DNT2","Mitochondrial 5' nucleotidase","1","4MUM"
"4MUW",,"X-RAY DIFFRACTION",4.14,70.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401234w","2F4","4MUW",83.83,"2.639","2.639","Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitor","MKHHHHHHHDEVDTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MUW"
"4MVH",,"X-RAY DIFFRACTION",4.11,70.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401234w","2F5","4MVH",83.37,"2.496","2.496","Crystal Structure of PDE10A with Novel Keto-Benzimidazole Inhibitor","MKHHHHHHHDEVDTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4MVH"
"4MVT",,"X-RAY DIFFRACTION",2.5,50.83,,8.5,"20% PEG 8000, 0.2 M Magnesium Chloride, 0.1 M Tris pH8.5,(1:800-1:1300) w/w chymotrypsin, vapor diffusion hanging drop, temperature 291K",291,,,"4MVT",168.05,"2.3","2.3","Crystal structure of SUMO E3 Ligase PIAS3","MHHHHHHSSGRENLYFQGEVDMHPPLPQPVHPDVTMKPLPFYEVYGELIRPTTLASTSSQRFEEAHFTFALTPQQVQQILTSREVLPGAKCDYTIQVQLRFCLCETSCPQEDYFPPNLFVKVNGKLCPLPGYLPPTKNGAEPKRPSRPINITPLARLSATVPNTIVVNWSSEFGRNYSLSVYLVRQLTAGTLLQKLRAKGIRNPDHSRALIKEKLTADPDSEVATTSLRVSLMCPLGKMRLTVPCRALTCAHLQSFDAALYLQMNEKKPTWTCPVCDKKAPYESLIIDGLFMEILSSCSDCDEIQFMEDGSWCPMKPKKEASEVCPPPGYGLDGLQYSPVQGGDPSENKKKVEVIDLTIESSSDEEDLPPTKKH","Homo sapiens","PIAS3","E3 SUMO-protein ligase PIAS3","1","4MVT"
"4MWI",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% w/v pentaerythitol propoxylate, 0.1M Tris chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1042/BJ20131270",,"4MWI",34.03,"1.7","1.7","Crystal structure of the human MLKL pseudokinase domain","GAMGSKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","4MWI"
"4MWO",,"X-RAY DIFFRACTION",3.13,60.68,"VAPOR DIFFUSION, HANGING DROP",4,"20 mM potassium phosphate monobasic, 8% PEG8000, 10% glycerol, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1039/c4ob01332h","2E2","4MWO",24.07,"1.67","1.67","Crystal structure of human mitochondrial 5'(3')-deoxyribonucleotidase in complex with the inhibitor CPB-T","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRP","Homo sapiens","DNT1, DNT2, NT5C, NT5M, UMPH2","5'(3')-deoxyribonucleotidase, mitochondrial","1","4MWO"
"4MWS",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG 3350, 0.1M sodium formate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.524280",,"4MWS",99.57,"2.8","2.8","Crystal structure of human PPCA (trigonal crystal form 1)","APDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYHHHHHH","Homo sapiens","CTSA, PPGB","Lysosomal protective protein","1","4MWS"
"4MWT",,"X-RAY DIFFRACTION",2.68,54.08,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG 3350, 0.1M ammonium tartrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.524280",,"4MWT",98.56,"3.85","3.85","Crystal structure of human PPCA (trigonal crystal form 2)","APDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYHHHHHH","Homo sapiens","CTSA, PPGB","Lysosomal protective protein","1","4MWT"
"4MXC",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v)PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/ml500066m","DWF","4MXC",36.63,"1.632","1.632","Crystal structure of CMET in complex with novel inhibitor","MGSSHHHHHHGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","CMET, MET","Hepatocyte growth factor receptor","1","4MXC"
"4MXE",,"X-RAY DIFFRACTION",2.42,49.18,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.4M dipotassium hydrogen phosphate, 1.6M sodium hydrogen phosphate and 0.1M phosphate citrate, pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2016.03.021",,"4MXE",49.62,"2.6","2.6","Human ESCO1 (Eco1/Ctf7 ortholog), acetyltransferase domain in complex with acetyl-CoA","MHHHHHHSSGVDLGTENLYFQSMKKERILAEYPDGRIIMVLPEDPKYALKKVDEIREMVDNDLGFQQAPLMCYSRTKTLLFISNDKKVVGCLIAEHIQWGYRVIEEKLPVIRSEEEKVRFERQKAWCCSTLPEPAICGISRIWVFSMMRRKKIASRMIECLRSNFIYGSYLSKEEIAFSDPTPDGKLFATQYCGTGQFLVYNFING","Homo sapiens","EFO1, ESCO1, KIAA1911","N-acetyltransferase ESCO1","1","4MXE"
"4MXO",,"X-RAY DIFFRACTION",2.93,58.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"0-4% PEG 3350, 0.2M ammonium acetate, 0.1M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1404","DB8","4MXO",66.48,"2.105","2.105","human Src kinase bound to kinase inhibitor bosutinib","GHMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4MXO"
"4MXU",,"X-RAY DIFFRACTION",3.85,68.09,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG 3350, 0.05M sodium citrate, 0.3M potassium phosphate (dibasic), 3% ethylene glycol, 0.01M DTT
, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500719k",,"4MXU",72.12,"2.6","2.6","Human brain aspartoacylase mutant K213E complex with intermediate analog (N-phosphonomethyl-L-aspartate)","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGEEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ACY2, ASP, ASPA","Aspartoacylase","1","4MXU"
"4MXX",,"X-RAY DIFFRACTION",2.92,57.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"0-4% PEG 3350, 0.2M Ammonium acetate, 0.1M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1404","DB8","4MXX",66.54,"2.6","2.6","Human Src A403T mutant bound to kinase inhibitor bosutinib","GHMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVTDFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4MXX"
"4MXY",,"X-RAY DIFFRACTION",2.93,57.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0-4% PEG 3350, 0.2M ammonium acetate, 0.1M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1404","DB8","4MXY",66.51,"2.582","2.582","Src M314L T338M double mutant bound to kinase inhibitor bosutinib","GHMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVLKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4MXY"
"4MXZ",,"X-RAY DIFFRACTION",2.93,57.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0-4% PEG 3350, 0.2M ammonium acetate, 0.1M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.1404","DB8","4MXZ",66.51,"2.582","2.582","Src M314L T338M double mutant bound to kinase inhibitor bosutinib","GHMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVLKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","4MXZ"
"4MY6",,"X-RAY DIFFRACTION",2.08,40.8,"VAPOR DIFFUSION, SITTING DROP",7,"2.2M ammonium sulphate, 200mM ammonium bromide, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1422054112",,"4MY6",26.77,"1.7","1.7","EnaH-EVH1 in complex with peptidomimetic low-molecular weight inhibitor Ac-[2-Cl-F]-[ProM-2]-[ProM-1]-OH","GSMSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVL","Homo sapiens","ENAH, MENA","Protein enabled homolog","1","4MY6"
"4MYG",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, HANGING DROP",6.2,"100 mM Bis-Tris, 21% PEG3350, 200 mM sodium chloride, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1107/S1399004715001212",,"4MYG",85.86,"2.594","2.594","MAPK13, active form","MGSSHHHHHHSSGLVPRGSHMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSPI","Homo sapiens","MAPK13, PRKM13, SAPK4","Mitogen-activated protein kinase 13","1","4MYG"
"4MYQ",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"VCID6271 PDE4 AT 7.9 MG/ML IN 20MM HEPES PH 7.5, 100 MM NACL, 1MM DTT, WITH 0.5MM A-33 AGAINST JCSG_ A10 (OPTIMIZATION SCREEN), 328.57MM POTASSIUM FORMATE, 24% W/V PEG 3350, CRYO 20% ETHYLENE GLYCOL AND 0.1MM COMPOUND, CRYSTAL TRACKING ID 232128E12, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K, temperature 289.0K",289,"10.1016/j.cellsig.2013.12.003","19T","4MYQ",43.5,"1.9","1.9","Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33","GSHMSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEG","Homo sapiens","DPDE4, PDE4, PDE4B","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","4MYQ"
"4MZ2",,"X-RAY DIFFRACTION",2.03,39.29,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 15% PEG20000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1314557110",,"4MZ2",14.57,"1.722","1.722","Crystal structure of the voltage-gated sodium channel beta 4 subunit extracellular domain","SNAEVSVGKATDIYAVNGTEILLPCTFSSAFGFEDLHFRWTYNSSDAFKILIEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTCHVKNPKENNLQHHATIFLQVVDRLEE","Homo sapiens","SCN4B","Sodium channel subunit beta-4","1","4MZ2"
"4MZ3",,"X-RAY DIFFRACTION",2.03,39.28,"VAPOR DIFFUSION, HANGING DROP",6,"20% PEG formate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1314557110",,"4MZ3",29.53,"1.741","1.741","Crystal structure of the voltage-gated sodium channel beta 4 subunit extracellular domain, C131W mutant","SNAEVSVGKATDIYAVNGTEILLPCTFSSCFGFEDLHFRWTYNSSDAFKILIEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTWHVKNPKENNLQHHATIFLQVVDRLEE","Homo sapiens","SCN4B","Sodium channel subunit beta-4","1","4MZ3"
"4MZ7",,"X-RAY DIFFRACTION",2.39,48.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES (pH 6.5), 25%(w/v) polyethylene glycol monomethyle ether 550, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1038/ncomms3722",,"4MZ7",128.18,"1.8","1.8","Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4MZ7"
"4MZI",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, HANGING DROP",6.8,"pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.jmb.2013.12.020",,"4MZI",22.6,"1.25","1.25","Crystal structure of a human mutant p53","MSSSVPSQKTYQGSYGFRLGFLHSGTAKFGTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKK","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","4MZI"
"4MZR",,"X-RAY DIFFRACTION",3.11,60.44,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M potassium sodium tartrate tetrahydrate, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.jmb.2013.12.020",,"4MZR",124.34,"2.9","2.9","Crystal structure of a polypeptide p53 mutant bound to DNA","MSSSVPSQKTYQGSYGFRLGFLHSGTAKFGTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKTMDGEYFTLQIRGRERFEQFRERNEALELKDAQATEE","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","4MZR"
,,,,,,,,,,,,,,,,"TGAGACTTGCCCAGACTTGCCCGTTT",,,"consensus DNA sense strand","2","4MZR"
,,,,,,,,,,,,,,,,"ACGGGCAAGTCTGGGCAAGTCTCAAA",,,"consensus DNA anti-sense strand","3","4MZR"
"4MZV",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M magnesium chloride, 0.1M TRIS-HCl, 30% w/v PEG 4000, 0.16 mM decyl-beta-D-maltopyranoside, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/ncomms5764",,"4MZV",28.76,"1.865","1.865","Crystal structure of extracellular part of human EpCAM","QEECVCENYKLAVNCFVNNNRQCQCTSVGAQNTVICSKLAAKCLVMKAEMQGSKLGRRAKPEGALQNNDGLYDPDCDESGLFKAKQCQGTSTCWCVNTAGVRRTDKDTEITCSERVRTYWIIIELKHKAREKPYDSKSLRTALQKEITTRYQLDPKFITSILYENNVITIDLVQQSSQKTQNDVDIADVAYYFEKDVKGESLFHSKKMDLTVNGEQLDLDPGQTLIYYVDEKAPEFSMQGLKHHHHHH","Homo sapiens","EPCAM, GA733-2, M1S2, M4S1, MIC18, TACSTD1, TROP1","Epithelial cell adhesion molecule","1","4MZV"
"4N00",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401635n","2EX","4N00",45.89,"1.8","1.8","Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNS","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4N00"
"4N0M",,"X-RAY DIFFRACTION",3.08,60.13,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M Sodium Malonate, 20% w/v PEG 3350, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.535112",,"4N0M",20.01,"1.95","1.95","Crystal structure of human C53A DJ-1 in complex with Cu","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVIAPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4N0M"
"4N0S",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.1 M - 1.4 M ammonium sulfate, 2% PEG 500 MME, 0.1 M HEPES-NaOH, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1158/1940-6207.CAPR-14-0141",,"4N0S",42.48,"1.7992","1.7992","Complex of ERK2 with caffeic acid","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4N0S"
"4N0X",,"X-RAY DIFFRACTION",2.15,42.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2 M sodium citrate, 100 mM Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4N0X",29.52,"1.63","1.63","Room temperature crystal structure of human carbonic anhydrase II in complex with thiophene-2-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4N0X"
"4N12",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M Sodium Malonate and 20% w/v PEG 3350, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.535112",,"4N12",20.06,"1.478","1.478","Crystal structure of human E18D DJ-1 in complex with Cu","MASKRALVILAKGAEEMDTVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4N12"
"4N14",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES, 15% (w/v) PEG 6000, and 5% MPD, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature13660","WR7","4N14",34.88,"2.1","2.1","Crystal structure of Cdc20 and apcin complex","GCRYIPSLPDRILDAPEIRNDYYLNLVDWSSGNVLAVALDNSVYLWSASSGDILQLLQMEQPGEYISSVAWIKEGNYLAVGTSSAEVQLWDVQQQKRLRNMTSHSARVGSLSWNSYILSSGSRSGHIHHHDVRVAEHHVATLSGHSQEVCGLRWAPDGRHLASGGNDNLVNVWPSAPGEGGWVPLQTFTQHQGAVKAVAWCPWQSNVLATGGGTSDRHIRIWNVCSGACLSAVDAHSQVCSILWSPHYKELISGHGFAQNQLVIWKYPTMAKVAELKGHTSRVLSLTMSPDGATVASAAADETLRLWRCFELDP","Homo sapiens","CDC20","Cell division cycle protein 20 homolog","1","4N14"
"4N16",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Citric Acid, 50mM Tris, pH 7.8, VAPOR DIFFUSION, HANGING DROP",,"10.1107/S1399004714007457","CHD","4N16",30.22,"1.54","1.54","Structure of cholate bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4N16"
"4N19",,"X-RAY DIFFRACTION",2.21,44.28,,,,,"10.1042/BJ20131429",,"4N19",11.97,"1.2","1.2","Structural basis of conformational transitions in the active site and 80 s loop in the FK506 binding protein FKBP12","GVQVETISPGDGRTFPKRGQTVVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPPIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","4N19"
"4N1B",,"X-RAY DIFFRACTION",3.21,61.63,"VAPOR DIFFUSION, HANGING DROP",,"1 UL OF PROTEIN AT 12 MG/ML IN 20 MM TRIS-HCL PH 7.5, 5 MM DTT, 5 MM COMPOUND 1 + 2 UL OF 2.15 M SODIUM ACETATE , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K",296,"10.1002/cmdc.201300525",,"4N1B",100.45,"2.55","2.55","STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S,2R)-2-[(1S)-1-[(1-oxo-2,3-dihydro-1H-isoindol-2-Yl)methyl]-1,2,3,4-tetrahydroisoquinoline-2-Carbonyl]cyclohexane-1-carboxylic acid","MGHAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLDLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTLEHHHHHH","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4N1B"
"4N1D",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.2M NaCl, 0.1 M Na acetate pH 4.6, 30% 2-Methyl-2,4-pentanediol, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1074/jbc.M113.529180",,"4N1D",13.58,"1.912","1.912","Nodal/BMP2 chimera NB250","MQAKHKQRKRLKSSCKRHPLYVDFNLIGWGSWIIYPKQYNAYRCEGECPNPVGEEFHPTNHAYIQSLLKRYQPHRVPSTCCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR","Homo sapiens","BMP2, BMP2A, NODAL","Nodal/BMP2 chimera protein","1","4N1D"
,,,,,,,,,,,,,,,,,"Homo sapiens","BMP2, BMP2A, NODAL"
,,,,,,,,,,,,,,,,,"Homo sapiens","BMP2, BMP2A, NODAL"
"4N1J",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 2.6 M Ammonium sulfate and 2% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714010311",,"4N1J",50.09,"2.6","2.6","Crystal structures of NLRP14 pyrin domain reveal a conformational switch mechanism, regulating its molecular interactions","GSHMADSSSSSFFPDFGLLLYLEELNKEELNTFKLFLKETMEPEHGLTPWNEVKKARREDLANLMKKYYPGEKAWSVSLKIFGKMNLKDLCERAKEEINWSAQLE","Homo sapiens","NLRP14, NALP14, NOD5","NACHT, LRR and PYD domains-containing protein 14","1","4N1J"
"4N1K",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Cesium chloride and 2.2 M Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714010311",,"4N1K",49,"3","3","Crystal structures of NLRP14 pyrin domain reveal a conformational switch mechanism, regulating its molecular interactions","GSHMADSSSSSFFPDFGLLLYLEELNKEELNTFKLFLKETMEPEHGLTPWNEVKKARREDLANLMKKYYPGEKAWSVSLKIFGKMNLKVLCERAKEEINWSAQLE","Homo sapiens","NLRP14, NALP14, NOD5","NACHT, LRR and PYD domains-containing protein 14","1","4N1K"
"4N1L",,"X-RAY DIFFRACTION",1.9,35.31,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Ammonium acetate and 2.2 M Ammonium sulfate , pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714010311",,"4N1L",12.31,"1.986","1.986","Crystal structures of NLRP14 pyrin domain reveal a conformational switch mechanism, regulating its molecular interactions","GSHMADSSSSSFFPDFGLLLYLEELNKEELNTFKLFLKETMEPEHGLTPWNEVKKARREDLANLMKKYYPGEKAWSVSLKIFGKMNRKDLCERAKEEINWSAQLE","Homo sapiens","NLRP14, NALP14, NOD5","NACHT, LRR and PYD domains-containing protein 14","1","4N1L"
"4N1M",,"X-RAY DIFFRACTION",2.6,52.66,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1M",18.58,"1.15","1.15","Structure of Cyclophilin A in complex with GlyPro.","SHMMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1M"
"4N1N",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1N",18.16,"1.5","1.5","Structure of Cyclophilin A in complex with Benzamide.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1N"
"4N1O",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1O",18.95,"1.75","1.75","Structure of Cyclophilin A in complex with Saccharin.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1O"
"4N1P",,"X-RAY DIFFRACTION",2.81,56.18,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1P",18.4,"1.9","1.9","Structure of Cyclophilin A in complex with Picolinamide.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1P"
"4N1Q",,"X-RAY DIFFRACTION",2.86,57.06,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1Q",18.16,"1.65","1.65","Structure of Cyclophilin A in complex with cyclohexanecarboxamide.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1Q"
"4N1R",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1R",18.21,"1.8","1.8","Structure of Cyclophilin A in complex with benzenesulfonohydrazide.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1R"
"4N1S",,"X-RAY DIFFRACTION",2.78,55.73,"VAPOR DIFFUSION, HANGING DROP",8,"Tris, PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4N1S",18.31,"1.47","1.47","Structure of Cyclophilin A in complex with benzohydrazide.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","4N1S"
"4N1T",,"X-RAY DIFFRACTION",1.98,37.93,"VAPOR DIFFUSION, SITTING DROP",3.5,"32% PEG 6000, 0.1 M Sodium Acetate pH 3.5, 0.2 M Lithium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/nature13181","2GD","4N1T",18.91,"1.6","1.6","Structure of human MTH1 in complex with TH287","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","4N1T"
"4N1U",,"X-RAY DIFFRACTION",1.9,35.3,"VAPOR DIFFUSION, SITTING DROP",3.5,"22% PEG 6000, 0.1 M Sodium Acetate pH 3.5, 0.2 M Lithium Sulfate, temperature 292K, VAPOR DIFFUSION, SITTING DROP",292,"10.1038/nature13181","2GE","4N1U",38.05,"1.6","1.6","Structure of human MTH1 in complex with TH588","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDT","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","4N1U"
"4N1Z",,"X-RAY DIFFRACTION",2.63,53.29,,5.2,"1.2M Na/K phosphate, 25% glycerol, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/scitranslmed.3010382",,"4N1Z",40.68,"2.35","2.35","Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1222","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4N1Z"
"4N20",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N20",79.17,"1.657","1.657","Crystal structure of Protein Arginine Deiminase 2 (0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N20"
"4N22",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N22",79.14,"1.889","1.889","Crystal structure of Protein Arginine Deiminase 2 (50 uM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N22"
"4N24",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N24",79.35,"1.968","1.968","Crystal structure of Protein Arginine Deiminase 2 (100 uM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N24"
"4N25",,"X-RAY DIFFRACTION",2.43,49.28,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N25",79.29,"1.931","1.931","Crystal structure of Protein Arginine Deiminase 2 (250 uM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N25"
"4N26",,"X-RAY DIFFRACTION",2.44,49.49,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N26",79.29,"1.943","1.943","Crystal structure of Protein Arginine Deiminase 2 (500 uM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N26"
"4N28",,"X-RAY DIFFRACTION",2.44,49.66,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N28",79.41,"1.879","1.879","Crystal structure of Protein Arginine Deiminase 2 (1 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N28"
"4N2A",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2A",79.46,"1.7","1.7","Crystal structure of Protein Arginine Deiminase 2 (5 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2A"
"4N2B",,"X-RAY DIFFRACTION",2.44,49.49,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2B",79.35,"1.69","1.69","Crystal structure of Protein Arginine Deiminase 2 (10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2B"
"4N2C",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION, SITTING DROP",5.6,"10% MPD, 10% ethanol, 50 mM MES, pH 5.6, 20 mM magnesium chloride, 1 mM spermidine, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2C",78.76,"3.022","3.022","Crystal structure of Protein Arginine Deiminase 2 (F221/222A, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPAAGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2C"
"4N2D",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2D",79.11,"2","2","Crystal structure of Protein Arginine Deiminase 2 (D123N, 0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVNADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2D"
"4N2E",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2E",79.35,"1.858","1.858","Crystal structure of Protein Arginine Deiminase 2 (D123N, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVNADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2E"
"4N2F",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2F",79.24,"1.8","1.8","Crystal structure of Protein Arginine Deiminase 2 (D169A, 0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRAEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2F"
"4N2G",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2G",79.53,"1.85","1.85","Crystal structure of Protein Arginine Deiminase 2 (D169A, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRAEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2G"
"4N2H",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2H",79.06,"1.808","1.808","Crystal structure of Protein Arginine Deiminase 2 (D177A, 0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEALKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2H"
"4N2I",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2I",79.42,"1.9","1.9","Crystal structure of Protein Arginine Deiminase 2 (D177A, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEALKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2I"
"4N2K",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2K",79.14,"1.57","1.57","Crystal structure of Protein Arginine Deiminase 2 (Q350A, 0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIADEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2K"
"4N2L",,"X-RAY DIFFRACTION",2.42,49.28,,,,,"10.1021/cb500933j",,"4N2L",79.7,"2.1","2.1","Crystal structure of Protein Arginine Deiminase 2 (Q350A, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIADEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2L"
"4N2M",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2M",79.19,"1.599","1.599","Crystal structure of Protein Arginine Deiminase 2 (E354A, 0 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIAFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2M"
"4N2N",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% MPD, 50 mM MES, pH 5.6, 0.12 M sodium acetate, VAPOR DIFFUSION, SITTING DROP",,"10.1021/cb500933j",,"4N2N",79.25,"1.8","1.8","Crystal structure of Protein Arginine Deiminase 2 (E354A, 10 mM Ca2+)","MGHHHHHHHHHHSSGHIEGRHMLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIAFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVPSRRS","Homo sapiens","PADI2, KIAA0994, PDI2, PAD2","Protein-arginine deiminase type-2","1","4N2N"
"4N32",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 60mM alpha-Me-GlcNAc. The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N32",63.41,"1.75","1.75","Structure of langerin CRD with alpha-Me-GlcNAc.","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N32"
"4N33",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 15mM TR54.  
The reservoir solution contained 0.1 M HEPES, 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N33",64.49,"1.85","1.85","Structure of langerin CRD complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N33"
"4N34",,"X-RAY DIFFRACTION",2.32,47.01,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 50mM alpha-Me-GlcNAc.   
The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N34",63.35,"1.75","1.75","Structure of langerin CRD I313 with alpha-MeGlcNAc","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDITFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N34"
"4N35",,"X-RAY DIFFRACTION",2.33,47.28,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 15mM TR54.   
The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N35",64.43,"1.85","1.85","Structure of langerin CRD I313 complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDITFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N35"
"4N36",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 50mM MeGlcNAc.   
The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N36",63.37,"1.85","1.85","Structure of langerin CRD I313 D288 complexed with Me-GlcNAc","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNDAGNNEHCGNIKAPSLQAWNDAPCDITFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N36"
"4N37",,"X-RAY DIFFRACTION",2.32,46.93,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 50mM MeMan. The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N37",63.19,"2","2","Structure of langerin CRD I313 D288 complexed with Me-Man","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNDAGNNEHCGNIKAPSLQAWNDAPCDITFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N37"
"4N38",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 2.3-4.0 mg/mL langerin, 2.5 mM CaCl2, 10-100 mM Tris (pH 8.0), 25 mM NaCl and 15mM TR55. The reservoir solution contained 0.1 M HEPES (pH 7.0), 0.1-0.2 M MgCl2, and 20-35% polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.528000",,"4N38",63.97,"2","2","Structure of langerin CRD I313 D288 complexed with GlcNAc-beta1-3Gal-beta1-4GlcNAc-beta-CH2CH2N3","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNDAGNNEHCGNIKAPSLQAWNDAPCDITFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","4N38"
"4N3R",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, HANGING DROP",,"0.2-0.4 M DiAmmonium Tartrate, 12.5-25% PEG 3350, pH 5.0-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml4003315","2GU","4N3R",51.12,"1.9","1.9","Co-crystal structure of tankyrase 1 with compound 2 (5-(2-aminoquinazolin-6-yl)-N-(4,4-dimethyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)-2-fluorobenzamide)","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4N3R"
"4N3X",,"X-RAY DIFFRACTION",1.99,38.25,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.10M NaAc, 17.5% MPD, 2% PEG4000 
 
, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.7554/eLife.02687",,"4N3X",24.33,"2","2","Crystal structure of Rabex-5 CC domain","GSHMQMYKNLDLLSQLNERQERIMNEAKKLEKDLIDWTDGIAREVQDIVEK","Homo sapiens","RABEX5, RABGEF1","Rab5 GDP/GTP exchange factor","1","4N3X"
"4N40",,"X-RAY DIFFRACTION",4.01,69.35,"VAPOR DIFFUSION, HANGING DROP",8,"100mM MES, 14% MPEG 5000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1016/j.febslet.2014.07.019",,"4N40",33.07,"3.106","3.106","Crystal structure of human Epithelial cell-transforming sequence 2 protein","EMPQIETRVILVQEAGKQEELIKALKDIKVGFVKMESVEEFEGLDSPEFENVFVVTDFQDSVFNDLYKADCRVIGPPVVLNCSQKGEPLPFSCRPLYCTSMMNLVLCFTGFRKKEELVRLVTLVHHMGGVIRKDFNSKVTHLVANCTQGEKFRVAVSLGTPIMKPEWIYKAWERRNEQDFYAAVDDFRNEFKVPPFQDCILSFLGFSDEEKTNMEEMTEMQGGKYLPLGDERCTHLVVEENIVKDLPFEPSKKLYVVKQEWFWGSIQMDARAGETMYLYEK","Homo sapiens","ECT2","Protein ECT2","1","4N40"
"4N48",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION",6.5,"30% PEG 3350, 100 mM Bis-Tris [pH 6.5], and 100 mM NaBr, VAPOR DIFFUSION, temperature 291K",291,"10.1038/ncomms4004",,"4N48",102.23,"2.704","2.704","Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Protein in complex with capped RNA fragment","GAMRGLGLTLRGFDQELNVDWRDEPEPSACEQVSWFPECTTEIPDTQEMSDWMVVGKRKMIIEDETEFCGEELLHSVLQCKSVFDVLDGEEMRRARTRANPYEMIRGVFFLNRAAMKMANMDFVFDRMFTNPRDSYGKPLVKDREAELLYFADVCAGPGGFSEYVLWRKKWHAKGFGMTLKGPNDFKLEDFYSASSELFEPYYGEGGIDGDGDITRPENISAFRNFVLDNTDRKGVHFLMADGGFSVEGQENLQEILSKQLLLCQFLMALSIVRTGGHFICKTFDLFTPFSVGLVYLLYCCFERVCLFKPITSRPANSERYVVCKGLKVGIDDVRDYLFAVNIKLNQLRNTDSDVNLVVPLEVIKGDHEFTDYMIRSNESHCSLQIKALAKIHAFVQDTTLSEPRQAEIRKECLRLWGIPDQARVAPS","Homo sapiens","FTSJD2, KIAA0082, MTR1, CMTR1","Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1","1","4N48"
,,,,,,,,,,,,,,,,"GAUC",,,"capped RNA","2","4N48"
"4N49",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION",6.5,"30% PEG 3350, 100 mM Bis-Tris [pH 6.5], and 100 mM NaBr, VAPOR DIFFUSION, temperature 291K",291,"10.1038/ncomms4004",,"4N49",49.9,"1.9","1.9","Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Protein in complex with m7GpppG and SAM","GAMRGLGLTLRGFDQELNVDWRDEPEPSACEQVSWFPECTTEIPDTQEMSDWMVVGKRKMIIEDETEFCGEELLHSVLQCKSVFDVLDGEEMRRARTRANPYEMIRGVFFLNRAAMKMANMDFVFDRMFTNPRDSYGKPLVKDREAELLYFADVCAGPGGFSEYVLWRKKWHAKGFGMTLKGPNDFKLEDFYSASSELFEPYYGEGGIDGDGDITRPENISAFRNFVLDNTDRKGVHFLMADGGFSVEGQENLQEILSKQLLLCQFLMALSIVRTGGHFICKTFDLFTPFSVGLVYLLYCCFERVCLFKPITSRPANSERYVVCKGLKVGIDDVRDYLFAVNIKLNQLRNTDSDVNLVVPLEVIKGDHEFTDYMIRSNESHCSLQIKALAKIHAFVQDTTLSEPRQAEIRKECLRLWGIPDQARVAPS","Homo sapiens","FTSJD2, KIAA0082, MTR1, CMTR1","Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1","1","4N49"
"4N4A",,"X-RAY DIFFRACTION",3.63,66.1,"VAPOR DIFFUSION",7,"35% Tacsimate , pH 7.0, VAPOR DIFFUSION, temperature 291K",291,"10.1038/ncomms4004",,"4N4A",48.94,"2.35","2.35","Cystal structure of Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1","GAMRGLGLTLRGFDQELNVDWRDEPEPSACEQVSWFPECTTEIPDTQEMSDWMVVGKRKMIIEDETEFCGEELLHSVLQCKSVFDVLDGEEMRRARTRANPYEMIRGVFFLNRAAMKMANMDFVFDRMFTNPRDSYGKPLVKDREAELLYFADVCAGPGGFSEYVLWRKKWHAKGFGMTLKGPNDFKLEDFYSASSELFEPYYGEGGIDGDGDITRPENISAFRNFVLDNTDRKGVHFLMADGGFSVEGQENLQEILSKQLLLCQFLMALSIVRTGGHFICKTFDLFTPFSVGLVYLLYCCFERVCLFKPITSRPANSERYVVCKGLKVGIDDVRDYLFAVNIKLNQLRNTDSDVNLVVPLEVIKGDHEFTDYMIRSNESHCSLQIKALAKIHAFVQDTTLSEPRQAEIRKECLRLWGIPDQARVAPS","Homo sapiens","FTSJD2, KIAA0082, MTR1, CMTR1","Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1","1","4N4A"
"4N4V",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION, HANGING DROP",,"0.2-0.4 M DiAmmonium Tartrate, 12.5-25% PEG 3350, pH 5.0-6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml4003315","2GY","4N4V",51.1,"2","2","Co-crystal structure of tankyrase 1 with compound 4 [(4S)-3-{trans-4-[6-amino-5-(pyrimidin-2-yl)pyridin-3-yl]cyclohexyl}-5,5-dimethyl-4-phenyl-1,3-oxazolidin-2-one]","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEHHHHHH","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4N4V"
"4N5D",,"X-RAY DIFFRACTION",2.03,39.26,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2FQ","4N5D",65.24,"2.06","2.06","Tailoring Small Molecules for an Allosteric Site on Procaspase-6: Cpd1","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4N5D"
"4N5G",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG3330, 0.2M Na Acetate, 100 mM NaCl, 20 mM Tris-Cl, 0.5 mM ligand K-8012, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2014.02.017","K09","4N5G",109.83,"2.11","2.11","Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012","GSHMTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","4N5G"
"4N5U",,"X-RAY DIFFRACTION",1.9,35.28,"VAPOR DIFFUSION, SITTING DROP",10.5,"Protein (20 mM Hepes, pH 7.5, 150 mM NaCl, 5% glycerol, Reservoir (0.2M Lithium Sulfate, 0.1M CAPS, 1.2M NaH2PO4/0.8M K2HPO4), Cryoprotection (2M Li2SO4), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4N5U",13.1,"1.456","1.456","Crystal structure of the 4th FN3 domain of human Protein Tyrosine phosphatase, receptor type F [PSI-NYSGRC-006240]","QDYGGTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDEAENLYFQ","Homo sapiens","LAR, PTPRF","Receptor-type tyrosine-protein phosphatase F","1","4N5U"
"4N5X",,"X-RAY DIFFRACTION",1.85,33.56,"VAPOR DIFFUSION, HANGING DROP",9.1,"100 mM CHES (pH 9.1) and 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.10.018",,"4N5X",23.24,"2.1","2.1","Crystal structure of N-terminal calmodulin-like Calcium sensor of human mitochondrial ATP-Mg/Pi carrier SCaMC1","MLRWLRDFVLPTAASQDAEQPTRYETLFQALDRNGDGVVDIGELQEGLRNLGIPLGQDAEEKIFTTGDVNKDGKLDFEEFMKYLKDHEKKMKLAFKSLDKNNDGKIEASEIVQSLQTLGLTISEQQAELILQSIDVDGTMTVDWNEWRDYFLFNPVTDIEEIIRFWKHSTGIDIGDSLTIPDEFTEDEKKSGQHHHHHH","Homo sapiens","SLC25A24, APC1, MCSC1, SCAMC1","Calcium-binding mitochondrial carrier protein SCaMC-1","1","4N5X"
"4N68",,"X-RAY DIFFRACTION",1.78,30.86,"VAPOR DIFFUSION, SITTING DROP",4.2,"Protein (20 mM Hepes, pH 7.5, 150 mM NaCl, 5% glycerol), Reservoir (0.1M Na2HPO4:Citric acid, 2M Ammonium sulfate), Cryoprotection (2M Li2SO4), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4N68",12.59,"1.8","1.8","Crystal structure of an internal FN3 domain from human Contactin-5 [PSI-NYSGRC-005804]","QDYGGAEGEPSAAPTDVKATSVSVSEILVAWKHIKESLGRPQGFEVGYWKDMEQEDTAETVKTRGNESFVILTGLEGNTLYHFTVRAYNGAGYGPPSSEVSATTKKAENLYFQ","Homo sapiens","CNTN5","Contactin-5","1","4N68"
"4N6G",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424",,"4N6G",65.22,"2.142","2.142","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4N6G"
"4N6J",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH 6.5, 0.2M MgCl2, 23% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M113.529297",,"4N6J",12.31,"2.001","2.001","Crystal structure of human Striatin-3 coiled coil domain","STMDWEVERAELQARIAMLQGERKGQENLKKDLVRRIKMLEMALKQERAK","Homo sapiens","GS2NA, SG2NA, STRN3","Striatin-3","1","4N6J"
"4N6L",,"X-RAY DIFFRACTION",1.98,37.81,"VAPOR DIFFUSION, SITTING DROP",4.6,"30 % PEG 4000, 100 mM sodium acetate pH 4.6, 200 mM ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201409135",,"4N6L",14.92,"1.952","1.952","Crystal structure of human cystatin E/M","MDRPQERMVGELRDLSPDDPQVQKAAQAAVASYNMGSNSIYYFRDTHIIKAQSQLVAGIKYFLTMEMGSTDCRKTRVTGDHVDLTTCPLAAGAQQEKLRCDFEVLVVPWQNSSQLLKHNCVQMLEHHHHHH","Homo sapiens","CST6","Cystatin-M","1","4N6L"
"4N6M",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION, SITTING DROP",6.5,"22 % PEG 8000, 100 mM MES sodium salt pH 6.5, 200 mM ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/anie.201409135",,"4N6M",29.94,"2.9","2.9","Crystal structure of human cystatin E/M produced in LEXSY","SLERPQERMVGELRDLSPDDPQVQKAAQAAVASYNMGSNSIYYFRDTHIIKAQSQLVAGIKYFLTMEMGSTDCRKTRVTGDHVDLTTCPLAAGAQQEKLRCDFEVLVVPWQNSSQLLKHNCVQMGTHHHHHH","Homo sapiens","CST6","Cystatin-M","1","4N6M"
"4N6V",,"X-RAY DIFFRACTION",2.78,55.72,"VAPOR DIFFUSION, SITTING DROP",10.5,"0.1M CAPS buffer, 0.2M Li2SO4, 2M ammonium sulfate, pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714000091",,"4N6V",105.16,"1.8","1.8","Partial rotational order disorder structure of human stefin B","ATQPATAETQHIADQVRSQLEEKENKKFPVFKAVSFKSQVVAGTNYFIKVHVGDEDFVHLRVFQSLPHENKPLTLSNYQTNKAKHDELTYF","Homo sapiens","CSTB, CST6, STFB","Cystatin-B","1","4N6V"
"4N6X",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, pH 4.6, 2.7 M sodium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0081904",,"4N6X",10,"1.051","1.051","Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1","GMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETSTTL","Homo sapiens","NHERF, NHERF1, SLC9A3R1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1/Chemokine Receptor CXCR2 fusion protein","1","4N6X"
"4N6Y",,"X-RAY DIFFRACTION",2.96,58.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"RESERVOIR SOLUTION - 0.7M (NH4)2HPO4, 0.3M NACL, 0.1M NACITRATE, PH 5.5, PROTEIN SOLUTION - 7.5MG/ML IN 20MM HEPES, 100MM NACL, 5MM DTT, PH 8, COMPOUND WAS SOAKED IN, TEMPERATURE 298.0K, VAPOR DIFFUSION, HANGING DROP",298,"10.1021/ml400307j","2HV","4N6Y",37.94,"2.6","2.6","Pim1 Complexed with a phenylcarboxamide","MAHHHHHHLEVLFQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4N6Y"
"4N6Z",,"X-RAY DIFFRACTION",2.94,58.15,"VAPOR DIFFUSION, HANGING DROP",5.5,"RESERVOIR SOLUTION - 0.7M (NH4)2HPO4, 0.3M NACL, 0.1M NACITRATE, PH 5.5, PROTEIN SOLUTION - 7.5MG/ML IN 20MM HEPES, 100MM NACL, 5MM DTT, PH 8, COMPOUND WAS SOAKED IN, TEMPERATURE 298.0K, VAPOR DIFFUSION, HANGING DROP",298,"10.1021/ml400307j","2HW","4N6Z",38.19,"2.2","2.2","Pim1 Complexed with a pyridylcarboxamide","MAHHHHHHLEVLFQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4N6Z"
"4N70",,"X-RAY DIFFRACTION",2.99,58.81,"VAPOR DIFFUSION, HANGING DROP",5.5,"RESERVOIR SOLUTION - 0.7M (NH4)2HPO4, 0.3M NACL, 0.1M NACITRATE, PH 5.5, PROTEIN SOLUTION - 7.5MG/ML IN 20MM HEPES, 100MM NACL, 5MM DTT, PH 8, COMPOUND WAS SOAKED IN, TEMPERATURE 298.0K, VAPOR DIFFUSION, HANGING DROP",298,"10.1021/ml400307j","2HX","4N70",38.05,"2.1","2.1","Pim1 Complexed with a pyridylcarboxamide","MAHHHHHHLEVLFQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4N70"
"4N73",,"X-RAY DIFFRACTION",2.78,55.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.7M ammonium sulfate, 4% Jeffamine and 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1074/jbc.M113.545111",,"4N73",23.07,"1.8662","1.8662","Crystal structure of the ligand binding domain (LBD) of REV-ERB beta bound to Cobalt Protoporphyrin IX","GHLVCPMSKSPYVDPHKSGHEIWEEFSMSFTPAVKEVVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLSGKKYSVDDLHSMGAGDLLNSMFEFSEKLNALQLSDEEMSLFTAVVLVSADRSGIENVNSVEALQETLIRALRTLIMKNHPNEASIFTKLLLKLPDLRSLNNMHSEELLAFKVH","Homo sapiens","NR1D2, R1D2","Nuclear receptor subfamily 1 group D member 2","1","4N73"
"4N79",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,"10.1073/pnas.1414126111",,"4N79",24.92,"2.62","2.62","Structure of Cathepsin K-dermatan sulfate complex","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4N79"
"4N7E",,"X-RAY DIFFRACTION",3.57,65.58,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M HEPES-Tris, 0.4 M sodium malonate, 27 % (w/v) PEG 3350, 4.5 % (v/v) glycerol, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.11.046","2JQ","4N7E",79.28,"2.7","2.7","Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with AF38469","SAPGEDEECGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPEKQNSKSNSGSAMIEGRGVGHHHHHH","Homo sapiens","SORT1","Sortilin","1","4N7E"
"4N7F",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",8,"3.0M NaCl, 100mM Tris-HCl 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M113.527473",,"4N7F",8.89,"1.102","1.102","Crystal structure of 3rd WW domain of human Nedd4-1","AMGSFLPKGWEVRHAPNGRPFFIDHNTKTTTWEDPRLK","Homo sapiens","KIAA0093, NEDD4, NEDD4-1, PIG53","E3 ubiquitin-protein ligase NEDD4","1","4N7F"
"4N7I",,"X-RAY DIFFRACTION",2.51,50.95,"vapour diffusion, Sitting drop",7.2,"0.2M MgCl2, 22%PEG3350, pH 7.2, vapour diffusion, Sitting drop, temperature 298K",298,"10.1016/j.immuni.2014.03.003",,"4N7I",22.24,"1.4015","1.4015","Crystal Structure of Intracellular B30.2 Domain of BTN3A1","MGAYNEWKKALFKPADVILDPKTADPILLVSEDQRSVERAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALE","Homo sapiens","BTF5, BTN3A1","Butyrophilin subfamily 3 member A1","1","4N7I"
"4N7J",,"X-RAY DIFFRACTION",2.07,40.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2GQ","4N7J",65.32,"1.673","1.673","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4N7J"
"4N7M",,"X-RAY DIFFRACTION",2.06,40.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2GQ","4N7M",65.32,"2.125","2.125","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4N7M"
"4N7U",,"X-RAY DIFFRACTION",2.51,51.05,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M MgCl2, 22%PEG3350, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.immuni.2014.03.003","2JA","4N7U",22.19,"1.4598","1.4598","Crystal Structure of Intracellular B30.2 Domain of BTN3A1 in Complex with CHDMAPP","MGAYNEWKKALFKPADVILDPKTADPILLVSEDQRSVERAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALE","Homo sapiens","BTF5, BTN3A1","Butyrophilin subfamily 3 member A1","1","4N7U"
"4N85",,"X-RAY DIFFRACTION",1.72,28.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"34-40% PEG 400, 0.4M CaCl2, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401832j",,"4N85",34.74,"1.6","1.6","Crystal structure of human transthyretin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4N85"
"4N86",,"X-RAY DIFFRACTION",1.71,27.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"34.2% PEG 400, 0.36M CaCl2, 0.09M HEPES, 1mM glabridin, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401832j",,"4N86",35.31,"2.001","2.001","Crystal structure of human transthyretin complexed with glabridin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4N86"
"4N87",,"X-RAY DIFFRACTION",1.7,27.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"32% PEG 400, 0.4M CaCl2, 0.1M HEPES, 0.5mM Glabridin, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401832j",,"4N87",35.33,"1.794","1.794","Crystal structure of V30M mutant human transthyretin complexed with glabridin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4N87"
"4N8D",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",8,"2 UL PROTEIN + 0.4 UL RESERVOIR + 0.25 UL WATER. PROTEIN SOLUTION: 5.2 MG/ML DPP-IV, 25 MM TRIS PH 8.0, 25 MM NACL, 0.9 MM SYN-7AA, 9% DMSO. RESERVOIR SOLUTION: 30% PEG 1000, 200 MM TRIS PH 8.0, 200 MM AMMONIUMSULFATE, 5% GLYCEROL. CRYO: DROP + 2.5 UL RESERVOIR PLUS 0.5 UL 1,6- HEXANDIOL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.12.118","2KS","4N8D",176.45,"1.65","1.65","DPP4 complexed with syn-7aa","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLIDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPAAASWSHPQFEK","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4N8D"
"4N8E",,"X-RAY DIFFRACTION",3.3,62.75,"VAPOR DIFFUSION, HANGING DROP",8,"2 UL PROTEIN + 0.4 UL RESERVOIR + 0.25 UL WATER. PROTEIN SOLUTION: 5.2 MG/ML DPP-IV, 25 MM TRIS PH 8.0, 25 MM NACL, 0.9 MM COMPOUND12A, 9% DMSO. RESERVOIR SOLUTION: 30% PEG 1000, 200 MM TRIS PH 8.0, 200 MM AMMONIUMSULFATE, 5% GLYCEROL. CRYO: DROP + 2.5 UL RESERVOIR PLUS 0.5 UL 1,6-HEXANDIOL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2013.12.118","2KV","4N8E",176.45,"2.3","2.3","DPP4 complexed with compound 12a","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLIDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPAAASWSHPQFEK","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","4N8E"
"4N8R",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG3330, 0.2M Mg Formate, 100 MM NACL, 20 MM TRIS-CL, 0.5 MM LIGAND K-8008, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2014.02.017","K08","4N8R",109.79,"2.03","2.03","Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008","GSHMTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","4N8R"
"4N8W",,"X-RAY DIFFRACTION",2.11,41.79,"VAPOR DIFFUSION",4.5,"24% (v/v) 2-methyl-2,4-pentanediol, 100 mM sodium acetate and 100 mM calcium chloride, pH 4.5, VAPOR DIFFUSION, temperature 290K",290,"10.1073/pnas.1414126111",,"4N8W",24.92,"2.02","2.02","cathepsin K - chondroitin sulfate complex","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4N8W"
"4N9B",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, HANGING DROP",8.6,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.12.062","2HH","4N9B",114.48,"2.859","2.859","Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4N9B"
"4N9C",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, HANGING DROP",8.6,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.12.062","2ZM","4N9C",114.4,"1.751","1.751","Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4N9C"
"4N9D",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",8.6,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.12.062","2HJ","4N9D",115.29,"1.701","1.701","Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4N9D"
"4N9E",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, HANGING DROP",8.6,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.12.062","2HL","4N9E",116.5,"1.72","1.72","Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4N9E"
"4N9J",,"X-RAY DIFFRACTION",3.75,67.19,"VAPOR DIFFUSION, SITTING DROP",5.5,"100 mM Bis-Tris (pH 5.5), 2.0 M ammonium sulfate, 1% (v/v) methanol , VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nsmb.2846",,"4N9J",53.18,"2.601","2.601","Crystal structure of the cryptic polo box domain of human Plk4","GYQNRTLRSITSPLVAHRLKPIRQKTKKAVVSILDSEEVCVELVKEYASQEYVKEVLQISSDGNTITIYYPNGGRGFPLADRPPSPTDNISRYSFDNLPEKYWRKYQYASRFVQLVRSKSPKITYFTRYAKCILMENSPGADFEVWFYDGVKIHKTEDFIQVIEKTGKSYTLKSESEVNSLKEEIKMYMDHANEGHRICLALESIISEEERKTRSAPFFPIIIGRKPG","Homo sapiens","PLK4, SAK, STK18","Serine/threonine-protein kinase PLK4","1","4N9J"
"4N9U",,"X-RAY DIFFRACTION",2.49,50.54,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4CL, PEG6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4N9U",43.58,"2.11","2.11","The role of lysine 200 in the human farnesyl pyrophosphate synthase catalytic mechanism and the mode of inhibition by the nitrogen-containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNTIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYGTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4N9U"
"4NA7",,"X-RAY DIFFRACTION",3.11,60.46,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM Sodium Acetate, pH 4.5, 25%(W/V) PEG 8000, 100 mM ammonium sulfate, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm401670x","1T5","4NA7",28.59,"2.8","2.8","Factor XIA in complex with the inhibitor 3'-[(2S,4R)-6-carbamimidoyl-4-methyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]-4-carbamoyl-5'-[(3-methylbutanoyl)amino]biphenyl-2-carboxylic acid","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","4NA7"
"4NA8",,"X-RAY DIFFRACTION",3.59,65.72,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, pH 4.6, 26% (w/v) MEPEG2000, 200 mM ammonium sulfate, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm401670x","1T6","4NA8",28.43,"2.3","2.3","Factor XIa in complex with the inhibitor 5-aminocarbonyl-2-[3-[(2s,4r)-6-carbamimidoyl-4-methyl-4-phenyl-2,3-dihydro-1h-quinolin-2-yl]phenyl]benzoic acid","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","4NA8"
"4NA9",,"X-RAY DIFFRACTION",3.84,67.98,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm401670x","1T7","4NA9",34.64,"2.24","2.24","Factor VIIa in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Coagulation factor VII heavy chain","1","4NA9"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Coagulation factor VII light chain","2","4NA9"
"4NAC",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION",7,"2.2M DL-Malic acid, 0.1M Bis-Tris propane, pH 7.0, VAPOR DIFFUSION, temperature 291K",291,,,"4NAC",32.64,"2.002","2.002","Crystal Structure of the N-terminal Domain of p15RS","MSAFSEAALEKKLSELSNSQQSVQTLSLWLIHHRKHSRPIVTVWERELRKAKPNRKLTFLYLANDVIQNSKRKGPEFTKDFAPVIVEAFKHVSSETDESCKKHLGRVLSIWEERSVYENDVLEQLKQALYGLEHHHHHH","Homo sapiens","P15RS, RPRD1A","Regulation of nuclear pre-mRNA domain-containing protein 1A","1","4NAC"
"4NAD",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, HANGING DROP",5.2,"28% PEG 3350, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4NAD",34.17,"2.8","2.8","Crystal Structure of the C-terminal Domain of CREPT","AMGSTEELIKALQDLENAASGDATVRQKIASLPQEVQDVSLLEKITDKEAAERLSKTVDEACLLLAEYNGRLAAELEDRRQLARMLVEYTQNQKDVLSEKEKKLEEYKQKLARVTQVRKELKSHIQSLPDLSLLPNVTGGLAPLPSAGDLFSTD","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4NAD"
"4NB3",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis-Tris, 200 mM ammonium acetate, 25% PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm401730y",,"4NB3",31.4,"1.35","1.35","Crystal structure of RPA70N in complex with a 3,4 dichlorophenylalanine ATRIP derived peptide","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4NB3"
,,,,,,,,,,,,,,,,"XDFTADDLEEWFALA",,,"3,4 dichlorophenylalanine ATRIP derived peptide","2","4NB3"
"4NB6",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, HANGING DROP",7,"drops were composed of 1uL of RORC-agonist complex (20 mM Trish-HCL pH 7.0, 200 mM NaCl, 4% glycerol, 5 mM DTT) plus 1 uL of well solution (400 mM Na/K tartrate), VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2013.10.054","444","4NB6",59.05,"2.85","2.85","Crystal structure of the ligand binding domain of RORC with T0901317","GSAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGNS","Homo sapiens","NR1F3, RORC, RORG, RZRG","Nuclear receptor ROR-gamma","1","4NB6"
"4NBK",,"X-RAY DIFFRACTION",2.06,40.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2J5","4NBK",65.41,"1.936","1.936","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4NBK"
"4NBL",,"X-RAY DIFFRACTION",2.06,40.36,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2J6","4NBL",65.49,"1.756","1.756","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4NBL"
"4NBN",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"2-Methyl-2,4-pentanediol, 0.3 M Ammonium Phosphate monobasic, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201300424","2J7","4NBN",65.8,"1.75","1.75","Tailoring Small Molecules for an Allosteric Site on Procaspase-6","MGSAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQAARGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNGNSHHHHHH","Homo sapiens","CASP6, MCH2, procaspase-6","Caspase-6","1","4NBN"
"4NBO",,"X-RAY DIFFRACTION",3.63,66.15,"VAPOR DIFFUSION, HANGING DROP",6.8,"1.4-2.0 Malonate(Na+), 0.1 M Mops as precipitant, stabilized in 2.4 M Malonate, 0.1 M MOPS pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.01.006",,"4NBO",25.49,"2.807","2.807","Human steroid receptor RNA activator protein carboxy-terminal domain","MESEAVMEDVLRPLEQALEDCRGHTRKQVCDDISRRLALLQEQWAGGKLSIPVKKRMALLVQELSSHRWDAADDIHRSLMVDHVTEVSQWMVGVKRLIAEKRSLFSEEAAN","Homo sapiens","PP7684, sra, SRA1","Steroid receptor RNA activator 1","1","4NBO"
"4NC5",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, HANGING DROP",8,"SODIUM/POTASSIUM PHOSPHATE BUFFER, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/anie.201309675",,"4NC5",42.89,"2.513","2.513","Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate)","GSMASLPVLQKESVFQSGAHAYRIPALLYLPGQQSLLAFAEQRASKKAEHAELIVLRRGDYDAPTHQVQWQAQEVVAQARLDGHRSMNPCPLYDAQTGTLFLFFIAIPGQVTEQQQLQTRANVTRLCQVTSTDHGRTWSSPRDLTDAAIGPAYREWSTFAVGPGHCLQLNDRARSLVVPAYAYRKLHPIQRPIPSAFCFLSHDHGRTWARGHFVAQDTLECQVAEVETGEQRVVTLNARSHLRARVQAQSTNDGLDFQESQLVKKLVEPPPQGCQGSVISFPSPRSGPGSPAQWLLYTHPTHSWQRADLGAYLNPRPPAPEAWSEPVLLAKGSCAYSDLQSMGTGPDGSPLFGCLYEANDYEEIVFLMFTLKQAFPAEYLPQ","Homo sapiens","NEU2","Sialidase-2","1","4NC5"
"4NC6",,"X-RAY DIFFRACTION",1.98,37.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"27%(W/V) PEG2000 MME, 100MM NA ACETATE , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,,,"4NC6",37.2,"1.8","1.8","Tbc domain of human rab gtpase-activating protein 1","KILETWGELLSKWHLNLNVRPKQLSSLVRNGVPEALRGEVWQLLAGCHNNDHLVEKYRILITKESPQDSAITRDINRTFPAHDYFKDTGGDGQDSLYKICKAYSVYDEEIGYCQGQSFLAAVLLLHMPEEQAFSVLVKIMFDYGLRELFKQNFEDLHCKFYQLERLMQEYIPDLYNHFLDISLEAHMYASQWFLTLFTAKFPLYMVFHIIDLLLCEGISVIFNVALGLLKTSKDDLLLTDFEGALKFFRVQLPKRYRSEENAKKLMELACNMKISQKKLKKYEKEYHTMREQQAQQEDPIERFERENRRLQEAN","Homo sapiens","RABGAP1, HSPC094","Rab GTPase-activating protein 1","1","4NC6"
"4NCS",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, HANGING DROP",8,"Sodium/potassium phosphate buffer, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/anie.201309675",,"4NCS",42.89,"2.201","2.201","Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate)","GSMASLPVLQKESVFQSGAHAYRIPALLYLPGQQSLLAFAEQRASKKAEHAELIVLRRGDYDAPTHQVQWQAQEVVAQARLDGHRSMNPCPLYDAQTGTLFLFFIAIPGQVTEQQQLQTRANVTRLCQVTSTDHGRTWSSPRDLTDAAIGPAYREWSTFAVGPGHCLQLNDRARSLVVPAYAYRKLHPIQRPIPSAFCFLSHDHGRTWARGHFVAQDTLECQVAEVETGEQRVVTLNARSHLRARVQAQSTNDGLDFQESQLVKKLVEPPPQGCQGSVISFPSPRSGPGSPAQWLLYTHPTHSWQRADLGAYLNPRPPAPEAWSEPVLLAKGSCAYSDLQSMGTGPDGSPLFGCLYEANDYEEIVFLMFTLKQAFPAEYLPQ","Homo sapiens","NEU2","Sialidase-2","1","4NCS"
"4NCT",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.1 M KSCN; 0.05M LiCl; 10% PEG 3350, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004715005106","2K2","4NCT",172.98,"2.597","2.597","Human DYRK1A in complex with PKC412","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","4NCT"
,,,,,,,,,,,,,,,,"GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","2","4NCT"
"4NDF",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION",8.5,"200 mM potassium sodium tartrate, 20% w/v PEG3350, pH 8.5, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nature12824",,"4NDF",55.77,"1.944","1.944","Human Aprataxin (Aptx) bound to RNA-DNA, AMP, and Zn - product complex","GSHMGHWSQGLKISMQDPKMQVYKDEQVVVIKDKYPKARYHWLVLPWTSISSLKAVAREHLELLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHVISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ","Homo sapiens","APTX, AXA1","Aprataxin","1","4NDF"
,,,,,,,,,,,,,,,,"GTTATGATTC",,,"5'-R(P*G)-D(P*TP*TP*AP*TP*GP*AP*TP*TP*C)-3'","2","4NDF"
,,,,,,,,,,,,,,,,"GAATCATAAC",,,"5'-D(*GP*AP*AP*TP*CP*AP*TP*AP*AP*C)-3'","3","4NDF"
"4NDG",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION",7.5,"100 mM sodium formate, 20% w/v PEG3350, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nature12824",,"4NDG",55.56,"2.541","2.541","Human Aprataxin (Aptx) bound to RNA-DNA and Zn - adenosine vanadate transition state mimic complex","GSHMGHWSQGLKISMQDPKMQVYKDEQVVVIKDKYPKARYHWLVLPWTSISSLKAVAREHLELLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHVISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ","Homo sapiens","APTX, AXA1","Aprataxin","1","4NDG"
,,,,,,,,,,,,,,,,"GTTATGATTC",,,"5'-R(P*G)-D(P*TP*TP*AP*TP*GP*AP*TP*TP*C)-3'","2","4NDG"
,,,,,,,,,,,,,,,,"GAATCATAAC",,,"5'-D(*GP*AP*AP*TP*CP*AP*TP*AP*AP*C)-3'","3","4NDG"
"4NDH",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION",8.5,"100 mM Tris, 20% w/v PEG10000, pH 8.5, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nature12824",,"4NDH",55.52,"1.848","1.848","Human Aprataxin (Aptx) bound to DNA, AMP, and Zn - product complex","GSHMGHWSQGLKISMQDPKMQVYKDEQVVVIKDKYPKARYHWLVLPWTSISSLKAVAREHLELLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHVISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ","Homo sapiens","APTX, AXA1","Aprataxin","1","4NDH"
,,,,,,,,,,,,,,,,"GTTCTAGAAC",,,"5'-D(P*GP*TP*TP*CP*TP*AP*GP*AP*AP*C)-3'","2","4NDH"
"4NDI",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION",7.5,"200 mM potassium acetate, 20% w/v PEG3350, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nature12824",,"4NDI",55.9,"1.9","1.9","Human Aprataxin (Aptx) AOA1 variant K197Q bound to RNA-DNA, AMP, and Zn - product complex","GSHMGHWSQGLKISMQDPKMQVYKDEQVVVIKDKYPQARYHWLVLPWTSISSLKAVAREHLELLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHVISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ","Homo sapiens","APTX, AXA1","Aprataxin","1","4NDI"
,,,,,,,,,,,,,,,,"GTTATGATTC",,,"5'-R(P*G)-D(P*TP*TP*AP*TP*GP*AP*TP*TP*C)-3'","2","4NDI"
,,,,,,,,,,,,,,,,"GAATCATAAC",,,"5'-D(*GP*AP*AP*TP*CP*AP*TP*AP*AP*C)-3'","3","4NDI"
"4NEF",,"X-RAY DIFFRACTION",3.18,61.32,,8,"22% PEG400, 0.1M Tris, 0.1M NaCl, 0.15M MgCl2. 0.1M CdCl2, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1321406111",,"4NEF",101.24,"2.75","2.75","X-ray structure of human Aquaporin 2","GSELRSIAFSRAVFAEFLATLLFVFFGLGSALNWPQALPSVLQIAMAFGLGIGTLVQALGHISGAHINPAVTVACLVGCHVSVLRAAFYVAAQLLGAVAGAALLHEITPADIRGDLAVNALSNSTTAGQAVTVELFLTLQLVLCIFASTDERRGENPGTPALSIGFSVALGHLLGIHYTGCSMNPARSLAPAVVTGKFDDHWVFWIGPLVGAILGSLLYNYVLFPPAKSLSERLAVLKGLEP","Homo sapiens","AQP2","Aquaporin-2","1","4NEF"
"4NEJ",,"X-RAY DIFFRACTION",2.21,44.3,"VAPOR DIFFUSION, HANGING DROP",5,"34% PEG 8K, 0.1 M NaOAc, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4NEJ",15.4,"1.919","1.919","Small molecular fragment bound to crystal contact interface of Interleukin-2","SSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFSQSIISTLT","Homo sapiens","IL2","Interleukin-2","1","4NEJ"
"4NEM",,"X-RAY DIFFRACTION",2.03,39.29,"VAPOR DIFFUSION, HANGING DROP",5,"34% PEG 8K, 0.1 M NaOAc, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4NEM",15.44,"1.934","1.934","Small molecular fragment bound to crystal contact interface of Interleukin-2","SSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFSQSIISTLT","Homo sapiens","IL2","Interleukin-2","1","4NEM"
"4NEU",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Potasium Chloride, 0.05 BisTris, pH=6.5, 40 % v/v pentaerythritol propoxylate (5/4 PO/OH) 
Crystals were looped and plunged into liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ml400382p","Q1A","4NEU",77.25,"2.57","2.57","X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline inhibitor","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLD","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","4NEU"
"4NFA",,"X-RAY DIFFRACTION",2.77,55.57,"VAPOR DIFFUSION, HANGING DROP",9,"120-300 KSCN, 100 mM BisTris Propane (pH 8.6-9.2), 17 % (v/v) PEG 3350 and 1 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.019",,"4NFA",24.49,"2.497","2.497","Structure of the C-terminal doamin of Knl1","SLSEWDVVEWSDDQAVFTFVYDTIQLTITFEESVVGFPFLDKRYRKIVDVNFQSLLDEDQAPPSSLLVHKLIFQYVEEKESWKKTCTTQHQLPKMLEEFSLVVHHCRLLGEEIEYLKRWGPNYNLMNIDINNNELRLLFSSSAAFAKFEITLFLSAYYPSVPLPSTIQNHVGNTSQDDIATILSKVPLENNYLKNVVKQIYQDLFQD","Homo sapiens","CASC5, KIAA1570, KNL1","Protein CASC5","1","4NFA"
"4NFB",,"X-RAY DIFFRACTION",1.83,32.64,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M sodium citrate tribasic dehydrate pH 5.6, 20%(v/v) 2-propanol, 20%(w/v) polyethylene glycol 4,000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1320716111",,"4NFB",14.07,"1.6","1.6","Structure of paired immunoglobulin-like type 2 receptor (PILR )","MLYGVTQPKHLSASMGGSVEIPFSFYYPWELATAPDVRISWRRGHFHRQSFYSTRPPSIHKDYVNRLFLNWTEGQKSGFLRISNLQKQDQSVYFCRVELDTRSSGRQQWQSIEGTKLSIT","Homo sapiens","PILR, PILRA","Paired immunoglobulin-like type 2 receptor alpha","1","4NFB"
"4NFC",,"X-RAY DIFFRACTION",2.45,49.82,,8.5,"3%(w/v) dextran sulfate sodium salt, 0.1M BICINE pH 8.5, 15%(w/v) polyethylene glycol 20,000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1320716111",,"4NFC",28.1,"2.2","2.2","Structure of paired immunoglobulin-like type 2 receptor (PILR )","MLYGVTQPKHLSASMGGSVEIPFSFYYPWELAIVPNVRISWRRGHFHGQSFYSTRPPSIHKDYVNRLFLNWTEGQESGFLRISNLRKEDQSVYFCRVELDTRRSGRQQLQSIKGTKLTIT","Homo sapiens","FDFACT, PILR, PILRB, PP1551","Paired immunoglobulin-like type 2 receptor beta","1","4NFC"
"4NFD",,"X-RAY DIFFRACTION",1.95,36.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES sodium pH 7.5, 1.4M sodium citrate tribasic dehydrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1320716111",,"4NFD",14.43,"1.708","1.708","Structure of PILR L108W mutant in complex with sialic acid","MLYGVTQPKHLSASMGGSVEIPFSFYYPWELAIVPNVRISWRRGHFHGQSFYSTRPPSIHKDYVNRLFLNWTEGQESGFLRISNLRKEDQSVYFCRVELDTRRSGRQQWQSIKGTKLTIT","Homo sapiens","FDFACT, PILR, PILRB, PP1551","Paired immunoglobulin-like type 2 receptor beta","1","4NFD"
"4NFE",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, SITTING DROP",7,"0.5M ammonium sulfate, 1M lithium sulfate, 100mM sodium citrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M114.598201",,"4NFE",26.72,"1.9","1.9","Human kallikrein-related peptidase 2 in complex with benzamidine","IVGGWECEKHSQPWQVAVYSHGWAHCGGVLVHPQWVLTAAHCLKKNSQVWLGRHNLFEPEDTGQRVPVSHSFPHPLYNMSLLKHQSLRPDEDSSHDLMLLRLSEPAKITDVVKVLGLPTQEPALGTTCYASGWGSIEPEEFLRPRSLQCVSLHLLSNDMCARAYSEKVTEFMLCAGLWTGGKDTCGGDSGGPLVCNGVLQGITSWGPEPCALPEKPAVYTKVVHYRKWIKDTIAANP","Homo sapiens","KLK2","Kallikrein-2","1","4NFE"
"4NFF",,"X-RAY DIFFRACTION",2.33,47.16,"VAPOR DIFFUSION, SITTING DROP",9,"800mM ammonium sulfate, 100mM bicine, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M114.598201",,"4NFF",26.64,"1.9","1.9","Human kallikrein-related peptidase 2 in complex with PPACK","IVGGWECEKHSQPWQVAVYSHGWAHCGGVLVHPQWVLTAAHCLKKNSQVWLGRHNLFEPEDTGQRVPVSHSFPHPLYNMSLLKHQSLRPDEDSSHDLMLLRLSEPAKITDVVKVLGLPTQEPALGTTCYASGWGSIEPEEFLRPRSLQCVSLHLLSNDMCARAYSEKVTEFMLCAGLWTGGKDTCGGDSGGPLVCNGVLQGITSWGPEPCALPEKPAVYTKVVHYRKWIKDTIAANP","Homo sapiens","KLK2","Kallikrein-2","1","4NFF"
"4NFI",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, SITTING DROP",5.9,"20% PEG 3350, 0.2M magnesium formate, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0186447","JD5","4NFI",43.62,"1.85","1.85","Crystal structure of human FPPS in complex with magnesium and JDS05120","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NFI"
"4NFJ",,"X-RAY DIFFRACTION",2.43,49.48,"VAPOR DIFFUSION, SITTING DROP",4.6,"25.5% PEG MME 2000, 0.17M ammonium sulfate, 15% glycerol, 0.09M sodium acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0186447","JD5","4NFJ",43.71,"2.05","2.05","Crystal structure of human FPPS in complex with magnesium, JDS05120, and sulfate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NFJ"
"4NFK",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.85M lithium sulfate, 0.01M nickel chloride, 15% glycerol, 0.09M TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0186447","JD5","4NFK",43.82,"1.85","1.85","Crystal structure of human FPPS in complex with nickel, JDS05120, and sulfate","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NFK"
"4NFL",,"X-RAY DIFFRACTION",3.1,60.32,"VAPOR DIFFUSION, HANGING DROP",4,"20 mM potassium phosphate monobasic, 8% PEG8000, 10% glycerol, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c4ob01332h","2JW","4NFL",25.25,"1.375","1.375","Crystal structure of human mitochondrial 5'(3')-deoxyribonucleotidase in complex with the inhibitor NPB-T","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRP","Homo sapiens","NT5M, DNT2","5'(3')-deoxyribonucleotidase, mitochondrial","1","4NFL"
"4NFM",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Ammonium Acetate, pH 7.0, 19% (w/v) PEG5000 (methyl ester), 100 mM Ammonium Acetate, unbuffered, vapor diffusion, hanging drop, temperature 277K",277,"10.1107/S2053230X14000144",,"4NFM",37.98,"2.12","2.12","Human tau tubulin kinase 1 (TTBK1)","GHMSGGGEQADILPANYVVKDRWKVLKKIGGGGFGEIYEAMDLLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNEKFNYVVMQLQGRNLADLRRSQPRGTFTLSTTLRLGKQILESIEAIHSVGFLHRDIKPSNFAMGRLPSTYRKCYMLDFGLARQYTNTTGDVRPPRNVAGFRGTVRYASVNAHKNREMGRHDDLWSLFYMLVEFAVGQLPWRKIKDKEQVGMIKEKYEHRMLLKHMPSEFHLFLDHIASLDYFTKPDYQLIMSVFENSMKERGIAENEAFDWEKAGTDALLSTSTSTPPQQNTRQTAAMFGVVNV","Homo sapiens","TTBK1, BDTK, KIAA1855","Tau-tubulin kinase 1","1","4NFM"
"4NFN",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Ammonium Acetate, pH 7.0, 19% (w/v) PEG5000 (methyl ester), 100 mM Ammonium Acetate, unbuffered, vapor diffusion, hanging drop, temperature 277K",277,"10.1107/S2053230X14000144","2KC","4NFN",36.18,"1.42","1.42","Human tau tubulin kinase 1 (TTBK1) complexed with 3-({5-[(4-amino-4-methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-bromophenol","GHMSGGGEQADILPANYVVKDRWKVLKKIGGGGFGEIYEAMDLLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNEKFNYVVMQLQGRNLADLRRSQPRGTFTLSTTLRLGKQILESIEAIHSVGFLHRDIKPSNFAMGRLPSTYRKCYMLDFGLARQYTNTTGDVRPPRNVAGFRGTVRYASVNAHKNREMGRHDDLWSLFYMLVEFAVGQLPWRKIKDKEQVGMIKEKYEHRMLLKHMPSEFHLFLDHIASLDYFTKPDYQLIMSVFENSMKERGIAENEAFDWEKAGTDALLS","Homo sapiens","TTBK1, BDTK, KIAA1855","Tau-tubulin kinase 1","1","4NFN"
"4NFR",,"X-RAY DIFFRACTION",3.92,68.64,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG 3350, 0.05M sodium citrate, 0.3M potassium phosphate (dibasic), 3% ethylene glycol, 0.01M DTT, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500719k",,"4NFR",72.01,"3","3","Human brain aspartoacylase mutant E285A complex with intermediate analog (N-phosphonomethyl-L-aspartate)","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNAAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ACY2, ASP, ASPA","Aspartoacylase","1","4NFR"
"4NG6",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4CL, PEG 6000, 
10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4NG6",43.73,"2.35","2.35","The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYLTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NG6"
"4NG9",,"X-RAY DIFFRACTION",3.9,68.44,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/ml400453z",,"4NG9",35.27,"2.2","2.2","Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3-sulfamoylbenzyl)ethanamide","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4NG9"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4NG9"
"4NGA",,"X-RAY DIFFRACTION",3.88,68.29,,6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/ml400453z",,"4NGA",35.39,"2.15","2.15","Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-N-[2-(propan-2-ylsulfonyl)benzyl]ethanamide","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4NGA"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4NGA"
"4NGB",,"X-RAY DIFFRACTION",2.84,56.66,"VAPOR DIFFUSION, HANGING DROP",6.3,"0.8 M sodium/potassium tartrate, 0.1 M sodium citrate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NGB",38.72,"2.25","2.25","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 12-mer siRNA having UU-3' ends (2.25 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NGB"
,,,,,,,,,,,,,,,,"GCGAAUUCGCUU",,,"5'-R(*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NGB"
"4NGC",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M sodium/potassium tartrate, 0.1 M Bis-Tris propane, pH 7.0, 18-22% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NGC",38.74,"2.104","2.104","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 12-mer siRNA having UA-3' ends (2.1 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NGC"
,,,,,,,,,,,,,,,,"GCGAAUUCGCUA",,,"5'-R(*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*A)-3'","2","4NGC"
"4NGD",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M lithium sulfate, 0.1 M HEPES, pH 7.0-7.5, 16% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NGD",39.12,"1.958","1.958","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 12-mer siRNA having 5'-p and UU-3' ends (1.95 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NGD"
,,,,,,,,,,,,,,,,"GCGAAUUCGCUU",,,"5'-R(P*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NGD"
"4NGF",,"X-RAY DIFFRACTION",2.95,58.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.08 M HEPES sodium, pH 7.5, 8% 2-propanol, 16% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NGF",161.61,"3.101","3.101","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 17-mer siRNA having 5'-p and UU-3' ends (3.1 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELKKSGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NGF"
,,,,,,,,,,,,,,,,"UCGAAGGUCCUUCGUUU",,,"5'-R(P*UP*CP*GP*AP*AP*GP*GP*UP*CP*CP*UP*UP*CP*GP*UP*UP*U)-3'","2","4NGF"
"4NGG",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.2 M sodium chloride, 0.1 M sodium/potassium phosphate, pH 6.0-6.4, 10% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NGG",39.14,"2.6","2.6","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 13-mer siRNA having 5'-A and UU-3' ends (2.6 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NGG"
,,,,,,,,,,,,,,,,"AGCGAAUUCGCUU",,,"5'-R(*AP*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NGG"
"4NGH",,"X-RAY DIFFRACTION",3.16,61.02,"VAPOR DIFFUSION, SITTING DROP",5.5,"Reservoir solution:0.2 M MgCl2, 0.1 M MES pH5.5, 40% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1038/nsmb.2922",,"4NGH",49.67,"2.68","2.68","Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB LIGHT CHAIN","1","4NGH"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"FAB HEAVY CHAIN","2","4NGH"
,,,,,,,,,,,,,,,,"XNWFNITNVLWLIXKKK",,,"MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41)","3","4NGH"
"4NGM",,"X-RAY DIFFRACTION",3.15,60.91,"hanging drop",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, hanging drop, temperature 289K",289,"10.1016/j.bmc.2014.05.061","JB7","4NGM",87.19,"1.84","1.84","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGM"
"4NGN",,"X-RAY DIFFRACTION",3.14,60.87,"hanging drop",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, hanging drop, temperature 289K",289,"10.1016/j.bmc.2014.05.061",,"4NGN",87.58,"1.64","1.64","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGN"
"4NGP",,"X-RAY DIFFRACTION",3.21,61.64,"VAPOR DIFFUSION, HANGING DROP",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, temperature 289K, VAPOR DIFFUSION, HANGING DROP",289,"10.1016/j.bmc.2014.05.061","J31","4NGP",87.93,"1.63","1.63","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGP"
"4NGQ",,"X-RAY DIFFRACTION",3.14,60.87,"VAPOR DIFFUSION, HANGING DROP",8,"Tris-Hcl, PEG, pentaerythritol propoxylate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmc.2014.05.061",,"4NGQ",87.79,"2.08","2.08","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGQ"
"4NGR",,"X-RAY DIFFRACTION",3.13,60.7,"VAPOR DIFFUSION, HANGING DROP",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmc.2014.05.061","J21","4NGR",86.7,"1.9","1.9","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGR"
"4NGS",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmc.2014.05.061","J34","4NGS",87.62,"1.68","1.68","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGS"
"4NGT",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION, HANGING DROP",8,"Tris-HCl, PEG 3350, pentaerythritol propoxylate, pH 8.0, temperature 289K, VAPOR DIFFUSION, HANGING DROP",289,"10.1016/j.bmc.2014.05.061","J42","4NGT",86.73,"2.31","2.31","Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4NGT"
"4NH3",,"X-RAY DIFFRACTION",2.76,55.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M sodium chloride, 0.1 M sodium citrate, pH 6.5, 18% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NH3",39.02,"2.616","2.616","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 13-mer siRNA having 5'-pU and UU-3' ends (2.6 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NH3"
,,,,,,,,,,,,,,,,"UGCGAAUUCGCUU",,,"5'-R(P*UP*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NH3"
"4NH5",,"X-RAY DIFFRACTION",3.06,59.86,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M sodium formate, 0.1 M bicine, pH 8.1-8.5, 16-19% PEG5000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NH5",39.33,"2.55","2.55","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 14-mer siRNA having 5'-pUU and UU-3' ends (2.55 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NH5"
,,,,,,,,,,,,,,,,"UUGCGAAUUCGCUU",,,"5'-R(P*UP*UP*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NH5"
"4NH6",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M sodium chloride, 0.05 M Tris-HCl, pH 8.3-8.8, 12-15% PEG20000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NH6",39.64,"2.551","2.551","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 15-mer siRNA having 5'-pUUU and UU-3' ends (2.55 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELAASGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NH6"
,,,,,,,,,,,,,,,,"UUUGCGAAUUCGCUU",,,"5'-R(P*UP*UP*UP*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*UP*U)-3'","2","4NH6"
"4NH7",,"X-RAY DIFFRACTION",2.83,56.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% PEGMME 2000, 100mM cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.11.036","E0G","4NH7",53.76,"2","2","Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4NH7"
"4NH8",,"X-RAY DIFFRACTION",2.87,57.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% PEGMME2K, 100mM MgCl2, 100mM cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2013.11.036","2LC","4NH8",26.58,"1.65","1.65","Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4NH8"
"4NH9",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION",7.6,"25-30% PEG400, 50-200mM MgCl2, 100mM TRIS pH 7.6, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2013.11.036","2LC","4NH9",31.49,"2.77","2.77","Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity","GSHMLREKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKKYSQFINFPIYVWSSKTETVEEPMEEEEAAKEEKEESDDEAAVEEEEEEKKPKTKKVEKTVWDWELMN","Homo sapiens","HSP90B1, GRP94, TRA1","Endoplasmin","1","4NH9"
"4NHA",,"X-RAY DIFFRACTION",3.53,65.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M potassium chloride, 0.1 M magnesium acetate, 0.05 M sodium cacodylate, pH 6.5, 12 % PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.01.003",,"4NHA",40.32,"3.401","3.401","Structure of human Dicer Platform-PAZ-Connector Helix cassette in complex with 16-mer siRNA having 5'-p and UU-3' ends (3.4 Angstrom resolution)","SDQPCYLYVIGMVLTTPLPDELNFRRRKLYPPEDTTRCFGILTAKPIPQIPHFPVYTRSGEVTISIELKKSGFMLSLQMLELITRLHQYIFSHILRLEKPALEFKPTDADSAYCVLPLNVVNDSSTLDIDFKFMEDIEKSEARIGIPSTKYTKETPFVFKLEDYQDAVIIPRYRNFDQPHRFYVADVYTDLTPLSKFPSPEYETFAEYYKTKYNLDLTNLNQPLLDVDHTSSRLNLLTPRHLNQKGKALPLSSAEKRKAKWESLQNKQILVPELCAIHPIPASLWRKAVCLPSILYRLHCLL","Homo sapiens","DICER, DICER1, HERNA, KIAA0928","Endoribonuclease Dicer","1","4NHA"
,,,,,,,,,,,,,,,,"GCGUUGGCCAACGCUU",,,"5'-R(P*GP*CP*GP*UP*UP*GP*GP*CP*CP*AP*AP*CP*GP*CP*UP*U)-3'","2","4NHA"
"4NHC",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, SITTING DROP",6.2,"Reservoir solution: 0.2 M NaCl, 0.1 M Na/K Phosphate pH 6.2, 50% PEG 200, VAPOR DIFFUSION, SITTING DROP, temperature 22K, temperature 295K",295,"10.1038/nsmb.2922",,"4NHC",49.8,"2.912","2.912","Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB LIGHT CHAIN","1","4NHC"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"FAB HEAVY CHAIN","2","4NHC"
,,,,,,,,,,,,,,,,"XNWFNITNVLWLIKKKK",,,"MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41)","3","4NHC"
"4NHG",,"X-RAY DIFFRACTION",6.58,81.3,"VAPOR DIFFUSION, HANGING DROP",7,"1.2 M ammonium sulfate, 100 mM HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2013.11.015",,"4NHG",437.32,"8.001","8.001","Crystal Structure of 2G12 IgG Dimer","EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTSTCPPCPAPELLGG","Homo sapiens",,"2G12 IgG dimer heavy chain","1","4NHG"
,,,,,,,,,,,,,,,,"VVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2G12 IgG dimer light chain","2","4NHG"
,,,,,,,,,,,,,,,,"PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYNSTYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKG","Homo sapiens",,"Hepatitis B virus receptor binding protein","3","4NHG"
"4NHH",,"X-RAY DIFFRACTION",3.05,59.65,"VAPOR DIFFUSION, HANGING DROP",7,"5% Tascimate, 10% PEGMME5000, 100 mM HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2013.11.015",,"4NHH",428.58,"6.5","6.5","Structure of 2G12 IgG Dimer","PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVDGVQVHNAKTKPREQQYNSTYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKG","Homo sapiens",,"2G12 IgG dimer heavy chain","3","4NHH"
,,,,,,,,,,,,,,,,"VVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2G12 IgG dimer light chain","1","4NHH"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKRVEDTAIYYCARKGSDRLDAWGPGTVVTVSPASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTSTCPPCPAPELLGG","Homo sapiens",,"Hepatitis B virus receptor binding protein","2","4NHH"
"4NHO",,"X-RAY DIFFRACTION",2.85,56.9,"VAPOR DIFFUSION, SITTING DROP",9,"2.2 M ammonium sulfate, 20 % (v/v) glycerol, 0.1 M CAPS, mixing 1 ul of protein with 1 ul of reservoir solution, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S1399004714006439",,"4NHO",56.1,"2","2","Structure of the spliceosomal DEAD-box protein Prp28","GPLGSARLRKLRKKEAKQRWDDRHWSQKKLDEMTDRDWRIFREDYSITTKGGKIPNPIRSWKDSSLPPHILEVIDKCGYKEPTPIQRQAIPIGLQNRDIIGVAETGSGKTAAFLIPLLVWITTLPKIDRIEESDQGPYAIILAPTRELAQQIEEETIKFGKPLGIRTVAVIGGISREDQGFRLRMGCEIVIATPGRLIDVLENRYLVLSRCTYVVLDEADRMIDMGFEPDVQKILEHMPVSNQKPDTDEAEDPEKMLANFESGKHKYRQTVMFTATMPPAVERLARSYLRRPAVVYIGSAGKPHERVEQKVFLMSESEKRKKLLAILEQGFDPPIIIFVNQKKGCDVLAKSLEKMGYNACTLHGGKGQEQREFALSNLKAGAKDILVATDVAGRGIDIQDVSMVVNYDMAKNIEDYIHRIGRTGRAGKSGVAITFLTKEDSAVFYELKQAILESPVSSCPPELANHPDAQHKPGTILTKKRREETIFA","Homo sapiens","DDX23","Probable ATP-dependent RNA helicase DDX23","1","4NHO"
"4NHX",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.7 mM MnCl2, 1.0 mM OGA, 25% (w/v) PEG 1500, 100 mM MIB buffer and 100 mM glycine, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2015.01.014",,"4NHX",65.82,"2.105","2.105","Crystal structure of human OGFOD1, 2-oxoglutarate and iron-dependent oxygenase domain containing 1, in complex with N-oxalylglycine (NOG)","MGSSHHHHHHSSGLVPRGSHMNGKRPAEPGPARVGKKGKKEVMAEFSDAVTEETLKKQVAEAWSRRTPFSHEVIVMDMDPFLHCVIPNFIQSQDFLEGLQKELMNLDFHEKYNDLYKFQQSDDLKKRREPHISTLRKILFEDFRSWLSDISKIDLESTIDMSCAKYEFTDALLCHDDELEGRRIAFILYLVPPWDRSMGGTLDLYSIDEHFQPKQIVKSLIPSWNKLVFFEVSPVSFHQVSEVLSEEKSRLSISGWFHGPSLTRPPNYFEPPIPRSPHIPQDHEILYDWINPTYLDMDYQVQIQEEFEESSEILLKEFLKPEKFTKVCEALEHGHVEWSSRGPPNKRFYEKAEESKLPEILKECMKLFRSEALFLLLSNFTGLKLHFLAPSEEDEMNDKKEAETTDITEEGTSHSPPEPENNQMAISNNSQQSNEQTDPEPEENETKKESSVPMCQGELRHWKTGHYTLIHDHSKAEFALDLILYCGCEGWEPEYGGFTSYIAKGEDEELLTVNPESNSLALVYRDRETLKFVKHINHRSLEQKKTFPNRTGFWDFSFIYYE","Homo sapiens","OGFOD1, KIAA1612, TPA1","2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1","1","4NHX"
"4NHY",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, SITTING DROP",7,"2.0 mM MnCl2, 2.0 mM PD2, 20% (w/v) PEG 6000, 100 mM HEPES buffer and 200 mM MgCl2, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2015.01.014",,"4NHY",263.16,"2.603","2.603","Crystal structure of human OGFOD1, 2-oxoglutarate and iron-dependent oxygenase domain containing 1, in complex with pyridine-2,4-dicarboxylic acid (2,4-PDCA)","MGSSHHHHHHSSGLVPRGSHMNGKRPAEPGPARVGKKGKKEVMAEFSDAVTEETLKKQVAEAWSRRTPFSHEVIVMDMDPFLHCVIPNFIQSQDFLEGLQKELMNLDFHEKYNDLYKFQQSDDLKKRREPHISTLRKILFEDFRSWLSDISKIDLESTIDMSCAKYEFTDALLCHDDELEGRRIAFILYLVPPWDRSMGGTLDLYSIDEHFQPKQIVKSLIPSWNKLVFFEVSPVSFHQVSEVLSEEKSRLSISGWFHGPSLTRPPNYFEPPIPRSPHIPQDHEILYDWINPTYLDMDYQVQIQEEFEESSEILLKEFLKPEKFTKVCEALEHGHVEWSSRGPPNKRFYEKAEESKLPEILKECMKLFRSEALFLLLSNFTGLKLHFLAPSEEDEMNDKKEAETTDITEEGTSHSPPEPENNQMAISNNSQQSNEQTDPEPEENETKKESSVPMCQGELRHWKTGHYTLIHDHSKAEFALDLILYCGCEGWEPEYGGFTSYIAKGEDEELLTVNPESNSLALVYRDRETLKFVKHINHRSLEQKKTFPNRTGFWDFSFIYYE","Homo sapiens","OGFOD1, KIAA1612, TPA1","2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1","1","4NHY"
"4NI7",,"X-RAY DIFFRACTION",2.31,51,"VAPOR DIFFUSION, SITTING DROP",5.5,"31% PEG 3350, 180 mM LiNO3, 100 mM Sodium Acetate (pH 5.5), 2.5% Hexamine Cobalt Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M113.532697",,"4NI7",32.59,"2.4","2.4","Crystal structure of human interleukin 6 in complex with a modified nucleotide aptamer (SOMAMER SL1025)","MAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM","Homo sapiens","IL6, IFNB2","Interleukin-6","1","4NI7"
,,,,,,,,,,,,,,,,"GGCAGGXXXGGXAXXAACACGXXAAGXCGXGG",,,"SOMAmer SL1025","2","4NI7"
"4NI9",,"X-RAY DIFFRACTION",2.31,51,"VAPOR DIFFUSION, SITTING DROP",5.5,"31% PEG 3350, 90 mM Magnesium Sulfate, 90 mM Sodium Acetate (pH 5.5) 100 mM LiCl, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M113.532697",,"4NI9",65.13,"2.55","2.55","Crystal structure of human interleukin 6 in complex with a modified nucleotide aptamer (SOMAMER SL1025), FORM 2","GGCAGGXXXGGXAXXAACACGXXAAGXCGXGG",,,"SOMAmer SL1025","1","4NI9"
,,,,,,,,,,,,,,,,"MAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM","Homo sapiens","IL6, IFNB2","Interleukin-6","2","4NI9"
"4NIB",,"X-RAY DIFFRACTION",3.39,63.68,"VAPOR DIFFUSION, HANGING DROP",8,"These insulin crystals were obtained from a  co-crystallization experiment with insulin receptor fragment IR310.T. Crystals were formed in the presence of IR310.T as detailed for the IR310.T complex with native human insulin - in Menting et al. 2013, Nature 493:241-245. Crystallant was 0.7 M trisodium citrate, 0.1 M imidazole-HCl pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1073/pnas.1412897111",,"4NIB",5.85,"1.4","1.4","Crystal structure of human insulin mutant B20 D-ala, B23 D-ala","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4NIB"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCAERAFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4NIB"
"4NIN",,"X-RAY DIFFRACTION",1.68,26.84,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES pH 6.0, 20% PEG 6000, and 5 mM ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1320786110",,"4NIN",0.79,"1.402","1.402","DSVISLS segment 101-107 from Human Superoxide Dismutase","DSVISLS","Homo sapiens","SOD1","DSVISLS segment from Superoxide dismutase [Cu-Zn]","1","4NIN"
"4NIO",,"X-RAY DIFFRACTION",1.48,16.89,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1 M sodium acetate pH 4.5, 0.7 M hexanediol, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1320786110",,"4NIO",0.64,"1.3","1.3","GVTGIAQ segment 147-153 from Human Superoxide Dismutase with I149T mutation associated with a familial form of amyotrophic lateral sclerosis","GVTGIAQ","Homo sapiens","SOD1","GVTGIAQ segment from Superoxide dismutase [Cu-Zn]","1","4NIO"
"4NIP",,"X-RAY DIFFRACTION",1.65,25.61,"VAPOR DIFFUSION, HANGING DROP",4.5,"1 M sodium acetate pH 4.5, 1.75 M ammonium sulfate, vapor diffusion, hanging drop, temperature 298K",298,"10.1073/pnas.1320786110",,"4NIP",0.66,"1.9","1.9","GVIGIAQ segment 147-153 from Human Superoxide Dismutase","GVIGIAQ","Homo sapiens","SOD1","GVTGIAQ segment from Superoxide dismutase [Cu-Zn]","1","4NIP"
"4NJ3",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",7.4,"50 MM NA-HEPES, 50 MM, AMMONIUM ACETATE, 8% PEG 4000, 4% GLYCEROL, 1 MM TCEP, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2013.11.041","2KD","4NJ3",34.54,"1.848","1.848","Modulating the interaction between CDK2 and Cyclin A with a Quinoline-based inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4NJ3"
"4NJ4",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"15% PEG 3350, 0.125 M potassium nitrate, 0.5 mM manganese (II) chloride, 2 mM UN9, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gku085",,"4NJ4",58.63,"2.02","2.02","Crystal Structure of Human ALKBH5","MHHHHHHSSGVDLGTENLYFQSMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4NJ4"
"4NJ8",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, HANGING DROP",6.6,"15% PEG-8000, 100mM sodium/potassium phosphate, 0.3M sodium chloride, pH 6.6, vapor diffusion, hanging drop, temperature 277K",277,"10.1186/1472-6807-14-17",,"4NJ8",15.98,"1.6","1.6","Crystal structure of the human ANKS3 SAM Domain L52A mutant","SRAPYSGPQDLAALLEQIGCLKYLQVFEEQDVDLRIFLTLTESDLKEIGITAFGPKRKMTSAIARWHSSAR","Homo sapiens","ANKS3, KIAA1977","Ankyrin repeat and SAM domain-containing protein 3","1","4NJ8"
"4NJD",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.6M sodium potassium tartrate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1016/j.canlet.2014.03.024","NJD","4NJD",33.83,"2.5","2.5","Structure of p21-activated kinase 4 with a novel inhibitor KY-04031","GSHMSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","4NJD"
"4NK9",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, HANGING DROP",6.75,"18-20% PEG 8000, 100mM PCTP, 200mM ammonium sulfate, 25% ethylene glycol, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1021/ml4004205","2K5","4NK9",71.68,"2.57","2.57","Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","FIBROBLAST GROWTH FACTOR RECEPTOR 1","1","4NK9"
"4NKA",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, HANGING DROP",6.75,"18-20% PEG 8000, 100mM PCTP, 200mM ammonium sulfate, 25% ethylene glycol, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1021/ml4004205","2K7","4NKA",71.62,"2.19","2.19","Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4NKA"
"4NKC",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, HANGING DROP",5.5,"di-Ammoniumhydrogen citrate,  
PEG6000= 5 % (m/V), DTT= 5,15 g/L, NADP+= 0,66 g/L    
Human Aldose Reductase= 15 mg/ml.    
Afterwards soaked into MES buffer, MES 50 mM 25% (m/V) PEG6000, saturated with the inhibitor, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4NKC",36.78,"1.12","1.12","Human Aldose Reductase complexed with Schl7764 at 1.12 A","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4NKC"
"4NKE",,"X-RAY DIFFRACTION",2.39,48.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4NKE",43.83,"1.46","1.46","The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNTIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFAQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NKE"
"4NKF",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG 6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"210","4NKF",43.58,"2","2","The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNTIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFAQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NKF"
"4NKI",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",,"The crystals were grown using hanging-drop vapor diffusion at 20   C by mixing equal volumes of the purified protein and the crystallization condition of 0.2M lithium sulfate monohydrate and 20% (wt/vol) polyethylene glycol 3350. , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/jmr.2418",,"4NKI",47.64,"2.41","2.41","Crystal structure of a Fab","EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCAAAHHHHHH","Homo sapiens",,"Fab light chain","1","4NKI"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab heavy chain","2","4NKI"
"4NKN",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 0.2M Mg Nitrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.7554/eLife.35898",,"4NKN",81.38,"2.79","2.79","The Crystal Structure of the N-terminal domain of COMMD9","MSGAMAALTAEHFAALQSLLKASSKDVVRQLCQESFSSSALGLKKLLDVTCSSLSVTQEEAEELLQALHRMTRLVAFRDLSSAEAILALFPENFHQNLKNLLTKIMLEHVSTWRTEAQANQ","Homo sapiens","COMMD9, HSPC166","COMM domain-containing protein 9","1","4NKN"
"4NKS",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, HANGING DROP",6.75,"16-20% PEG 8000, 100mM PCTP, 100-300mM ammonium sulfate, 25% ethylene glycol, pH 6.75, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1021/ml4004205","2M2","4NKS",71.02,"2.5","2.5","Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4NKS"
"4NKV",,"X-RAY DIFFRACTION",2.61,52.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 150 mM magnesium chloride hexahydrate, 25% PEG4000, 6% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.610998","AER","4NKV",226.99,"2.646","2.646","Human steroidogenic cytochrome P450 17A1 mutant A105L with inhibitor abiraterone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDILSNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, CYPc17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","4NKV"
"4NKW",,"X-RAY DIFFRACTION",2.56,51.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 150 mM magnesium chloride hexahydrate, 25% PEG4000, 6% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.610998","PLO","4NKW",226.86,"2.5","2.5","Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate pregnenolone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDILSNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","4NKW"
"4NKX",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 25% PEG4000, 150 mM magnesium chloride hexahydrate, 6% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.610998",,"4NKX",226.85,"2.794","2.794","Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate progesterone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDILSNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","4NKX"
"4NKY",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION, HANGING DROP",8.5,"175 mM Tris-HCl, 250 mM lithium sulfate, 30% PEG3350, 3% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.610998",,"4NKY",226.92,"2.55","2.55","Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate 17alpha-hydroxyprogesterone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDILSNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","4NKY"
"4NKZ",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 150 mM magnesium chloride hexahydrate, 25% PEG4000, 6% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.610998",,"4NKZ",226.92,"3.003","3.003","Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate 17alpha-hydroxypregnenolone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDILSNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","4NKZ"
"4NLH",,"X-RAY DIFFRACTION",2.34,47.44,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, MES 7.2, KBr, pH 8.0, vapor diffusion, hanging drop, temperature 298K",298,,,"4NLH",31.41,"1.9","1.9","SKICH domain of human TAX1BP1","GPSSPAHVIFQNVAKSYLPNAHLECHYTLTPYIHPHPKDWVGIFKVGWSTARDYYTFLWSPMPEHYVEGSTVNCVLAFQGYYLPNDDGEFYQFCYVTHKGEIRGASTPFQFRASSPVEELLTMEDEGNSDMLVVTTKA","Homo sapiens","HUMAN TAX1BP1, PRO0105, T6BP, TAX1BP1","Tax1-binding protein 1","1","4NLH"
"4NLK",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M113.537803",,"4NLK",47.64,"2.494","2.494","Structure of human DNA polymerase beta complexed with 8BrG in the template base-paired with incoming non-hydrolyzable CTP","CCGACGTCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(BGM)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4NLK"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3'","2","4NLK"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4NLK"
,,,,,,,,,,,,,,,,"PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4NLK"
"4NLN",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M113.537803",,"4NLN",47.56,"2.261","2.261","Structure of human DNA polymerase beta complexed with nicked DNA containing a template 8BrG and incoming CTP","PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4NLN"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(BGM)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4NLN"
,,,,,,,,,,,,,,,,"GCTGATGCGAC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*AP*C)-3'","3","4NLN"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4NLN"
"4NLZ",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M113.537803",,"4NLZ",47.58,"2.683","2.683","Structure of human DNA polymerase beta complexed with nicked DNA containing a mismatched template 8BrG and incoming GTP","PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4NLZ"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(BGM)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4NLZ"
,,,,,,,,,,,,,,,,"GCTGATGCGAG",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*AP*G)-3'","3","4NLZ"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4NLZ"
"4NM1",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M113.537803",,"4NM1",47.56,"2.415","2.415","Structure of human DNA polymerase beta complexed with a nicked DNA containing a 8BrG-C at N-1 position and G-C at N position","CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*(BGM)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4NM1"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3'","2","4NM1"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4NM1"
,,,,,,,,,,,,,,,,"PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4NM1"
"4NM2",,"X-RAY DIFFRACTION",2.45,49.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"14-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M113.537803",,"4NM2",47.46,"2.524","2.524","Structure of human DNA polymerase beta complexed with a nicked DNA containing a 8BrG-G at N-1 position and G-C at N position","PQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4NM2"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*(BGM)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4NM2"
,,,,,,,,,,,,,,,,"GCTGATGCGGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*GP*C)-3'","3","4NM2"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4NM2"
"4NM6",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, HANGING DROP",6.3,"23% PEG2000 MME, 0.1 M MES, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.cell.2013.11.020",,"4NM6",59.21,"2.026","2.026","Crystal structure of TET2-DNA complex","GGSDFPSCRCVEQIIEKDEGPFYTHLGAGPNVAAIREIMEERFGQKGKAIRIERVIYTGKEGKSSQGCPIAKWVVRRSSSEEKLLCLVRERAGHTCEAAVIVILILVWEGIPLSLADKLYSELTETLRKYGTLTNRRCALNEERTCACQGLDPETCGASFSFGCSWSMYYNGCKFARSKIPRKFKLLGDDPKEEEKLESHLQNLSTLMAPTYKKLAPDAYNNQIEYEHRAPECRLGLKEGRPFSGVTACLDFCAHAHRDLHNMQNGSTLVCTLTREDNREFGGKPEDEQLHVLPLYKVSDVDEFGSVEAQEEKKRSGAIQVLSSFRRKVRMLAEPVKTCRQRKLEAKKAAAEKLSGGGGSGGGGSGGGGSDEVWSDSEQSFLDPDIGGVAVAPTHGSILIECAKRELHATTPLKNPNRNHPTRISLVFYQHKSMNEPKHGLALWEAKMAEKAREKEEECEKYG","Homo sapiens","TET2, KIAA1546, Nbla00191","Methylcytosine dioxygenase TET2","1","4NM6"
,,,,,,,,,,,,,,,,,"Homo sapiens","TET2, KIAA1546, Nbla00191"
,,,,,,,,,,,,,,,,"ACCACCGGTGGT",,,"5'-D(*AP*CP*CP*AP*CP*(5CM)P*GP*GP*TP*GP*GP*T)-3'","2","4NM6"
"4NMM",,"X-RAY DIFFRACTION",1.93,36.34,,4,"0.2M MMT pH4.0, 28% PEG 6,000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1404639111",,"4NMM",19.93,"1.89","1.89","Crystal Structure of a G12C Oncogenic Variant of Human KRas Bound to a Novel GDP Competitive Covalent Inhibitor","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4NMM"
"4NMO",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"27% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMO",21.3,"1.4","1.4","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(Ac-K-1)(ANSRWPTS[Ac-K]I)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMO"
,,,,,,,,,,,,,,,,"ANSRWPTSKI",,,"iCAL36(Ac-K-1) peptide","2","4NMO"
"4NMP",,"X-RAY DIFFRACTION",1.97,37.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"34% (w/v) polyethylene glycol (PEG) 3350, 0.1 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMP",21.32,"1.3","1.3","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(Ac-K-3) (ANSRWP[Ac-K]SII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMP"
,,,,,,,,,,,,,,,,"ANSRWPKSII",,,"iCAL36(Ac-K-3) peptide","2","4NMP"
"4NMQ",,"X-RAY DIFFRACTION",1.93,36.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"40% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.1 tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMQ",21.33,"1.4","1.4","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(Ac-K-4) (ANSRW[Ac-K]TSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMQ"
,,,,,,,,,,,,,,,,"ANSRWKTSII",,,"iCAL36(Ac-K-4) peptide","2","4NMQ"
"4NMR",,"X-RAY DIFFRACTION",2.06,40.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris) pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 100.0K",,"10.1371/journal.pone.0103650",,"4NMR",21.06,"1.55","1.55","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(Ac-K-5) (ANSR[Ac-K]PTSII)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMR"
,,,,,,,,,,,,,,,,"ANSRKPTSII",,,"iCAL36(Ac-K-5) peptide","2","4NMR"
"4NMS",,"X-RAY DIFFRACTION",1.99,38.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"33% (w/v) polyethylene glycol, 0.2 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMS",21.46,"1.7","1.7","CFTR Associated Ligand (CAL)PDZ domain bound to peptide iCAL36(FLB-K-1) (ANSRWPTS[4-fluorobenzoic-acyl-K]I)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMS"
,,,,,,,,,,,,,,,,"ANSRWPTSKI",,,"iCAL36(FLB-K-1) peptide","2","4NMS"
"4NMT",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"33% (w/v) polyethylene glycol (PEG), 0.2 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMT",21.4,"1.4","1.4","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(TFA-K-1) (ANSRWPTS[Tfa-acyl-K]I)","ANSRWPTSKI",,,"iCAL36(TFA-K-1) peptide","2","4NMT"
,,,,,,,,,,,,,,,,"GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMT"
"4NMV",,"X-RAY DIFFRACTION",1.96,37.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% (w/v) polyethylene glycol (PEG), 0.1 M sodium chloride, 0.1 M tris(hydroxymethyl)aminomethane (Tris), pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0103650",,"4NMV",21.58,"1.4","1.4","CFTR Associated Ligand (CAL) PDZ domain bound to peptide iCAL36(BRB-K-1) (ANSRWPTS[4-bromobenzoic-acyl-K]I)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4NMV"
,,,,,,,,,,,,,,,,"ANSRWPTSKI",,,"iCAL36(BRB-K-1) peptide","2","4NMV"
"4NMX",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M lithium chloride, 10% w/v PEG6000, 0.05 M Tris, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1074/jbc.M113.514067",,"4NMX",48.54,"1.85","1.85","PCSK9(deltaCRD) in complex with phage-derived inhibitory peptide 2-8","AGSQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQ","Homo sapiens","NARC1, PCSK9, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","4NMX"
,,,,,,,,,,,,,,,,"SIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGNSHHHHHH","Homo sapiens","NARC1, PCSK9, PSEC0052","Proprotein convertase subtilisin/kexin type 9","2","4NMX"
,,,,,,,,,,,,,,,,"XTVFTSWEEYLDWVX",,,"peptide 2-8","3","4NMX"
"4NN0",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, HANGING DROP",5,"2 M ammonium sulfate, 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2014.02.001",,"4NN0",50.8,"1.42","1.42","Crystal structure of the C1QTNF5 globular domain in space group P63","ARSAFSAKRSESRVPPPSDAPLPFDRVLVNEQGHYDAVTGKFTCQVPGVYYFAVHATVYRASLQFDLVKNGESIASFFQFFGGWPKPASLSGGAMVRLEPEDQVWVQVGVGDYIGIYASIKTDSTFSGFLVYSDWHSSPVFAHHHHHH","Homo sapiens","C1QTNF5, CTRP5, UNQ303/PRO344","Complement C1q tumor necrosis factor-related protein 5","1","4NN0"
"4NN2",,"X-RAY DIFFRACTION",2.71,54.53,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M amminium acetate, 0.1M tri-sodium citrate dehydrate, 30% (w/v) PEG4000, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,,,"4NN2",29.37,"1.472","1.472","Protein Crystal Structure of Human Borjeson-Forssman-Lehmann Syndrome Associated Protein PHF6","GPSTRPKCGFCHVGEEENEARGKLHIFNAKKAAAHYKCMLFSSGTVQLTTTSRAEFGDFDIKTVLQEIKRGKRMKCTLCSQPGATIGCEIKACVKTYHYHCGVQDKAKYIENMSRGIYKLYCKNHSGND","Homo sapiens","PHF6, KIAA1823, CENP-31","PHD finger protein 6","1","4NN2"
"4NNL",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, HANGING DROP",5,"31% (w/v) polyethylene glycol (PEG), 0.2 M ammonium sulfate, 0.1 M sodium acetate pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4NNL",25.16,"1.5","1.5","Tax-Interacting Protein-1 (TIP-1) PDZ domain bound to F-iCAL36 (ANSRFPTSII) peptide","TAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQ","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","4NNL"
,,,,,,,,,,,,,,,,"ANSRFPTSII",,,"TIP-1 PDZ domain","2","4NNL"
"4NNM",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",6,"40% (w/v) polyethylene glycol (PEG) 3350, 0.15 M potassium thiocyanate (KSCN), 0.1 M 2-ethanesulfonic acid (MES), pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4NNM",26.49,"1.6","1.6","Tax-Interacting Protein-1 (TIP-1) PDZ domain bound to Y-iCAL36 (YPTSII) peptide","VTAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQSLQKAVQQ","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","4NNM"
,,,,,,,,,,,,,,,,"YPTSII",,,"TIP-1 PDZ domain","2","4NNM"
"4NNR",,"X-RAY DIFFRACTION",1.72,28.54,"VAPOR DIFFUSION, HANGING DROP",7,"VAPOR DIFFUSION, HANGING DROP, pH 7, temperature 298K",298,,,"4NNR",32.95,"1.98","1.98","FKBP13-FK506 Complex","MRLSWFRVLTVLSICLSAVATATGAEGKRKLQIGVKKRVDHCPIKSRKGDVLHMHYTGKLEDGTEFDSSLPQNQPFVFSLGTGQVIKGWDQGLLGMCEGEKRKLVIPSELGYGERGAPPKIPGGATLVFEVELLKIERRTEL","Homo sapiens","FKBP2, FKBP13","Peptidyl-prolyl cis-trans isomerase FKBP2","1","4NNR"
"4NNS",,"X-RAY DIFFRACTION",1.95,36.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Na-citrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"75D","4NNS",17.2,"1.53","1.53","Crystal structure of FABP4 in complex with novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","4NNS"
"4NNT",,"X-RAY DIFFRACTION",1.95,36.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Na-citrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"76D","4NNT",17.16,"1.53","1.53","Crystal structure of FABP4 in complex with novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","4NNT"
"4NO7",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444911036729","2N8","4NO7",53.6,"1.7","1.7","Human Glucokinase in complex with a nanomolar activator.","MGHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4NO7"
"4NOS",,"X-RAY DIFFRACTION",3.38,63.56,,6.9,"pH 6.90",,"10.1038/6675","ITU","4NOS",201.82,"2.25","2.25","HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE WITH INHIBITOR","PRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVIHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQDEKRRP","Homo sapiens","NOS2, NOS2A","INDUCIBLE NITRIC OXIDE SYNTHASE","1","4NOS"
"4NP8",,"X-RAY DIFFRACTION",1.56,21.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"reservoir contained 14% iso-Propanol, 0.07M HEPES-Na pH 7.5, 0.14M Sodium Citrate, and 30% Glycerol, vapor diffusion, hanging drop, temperature 298K",298,"10.1038/nsmb.1643",,"4NP8",0.75,"1.51","1.51","Structure of an amyloid forming peptide VQIVYK from the second repeat region of tau (alternate polymorph)","VQIVYK","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","4NP8"
"4NPJ",,"X-RAY DIFFRACTION",3.21,61.66,"VAPOR DIFFUSION, HANGING DROP",4.9,"2.25 M LiCl, 0.1 M sodium acetate, 0.125 M NaCl, 2.5% glycerol, 25% ethylene glycol, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2013.11.011",,"4NPJ",68.72,"2.101","2.101","Extended-Synaptotagmin 2, C2A- and C2B-domains","GNRITVPLVSEVQIAQLRFPVPKGVLRIHFIEAQDLQGKDTYLKGLVKGKSDPYGIIRVGNQIFQSRVIKENLSPKWNEVYEALVYEHPGQELEIELFDEDPDKDDFLGSLMIDLIEVEKERLLDEWFTLDEVPKGKLHLRLEWLTLMPNASNLDKVLTDIKADKDQANDGLSSALLILYLDSARNLPSGKKISSNPNPVVQMSVGHKAQESKIRYKTNEPVWEENFTFFIHNPKRQDLEVEVRDEQHQCSLGNLKVPLSQLLTSEDMTVSQRFQLSNSGPNSTIKMKIALRVLHLEKR","Homo sapiens","ESYT2, extended-synaptotagmin 2, FAM62B, KIAA1228","Extended synaptotagmin-2","1","4NPJ"
"4NPK",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG 8000, 0.1 M Hepes pH 8.0, 0.125 M NaCl, 2.5% glycerol, 0.02 M CaCl2, 0.5 mM TCEP, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.str.2013.11.011",,"4NPK",34.39,"2.552","2.552","Extended-Synaptotagmin 2, C2A- and C2B-domains, calcium bound","GNRITVPLVSEVQIAQLRFPVPKGVLRIHFIEAQDLQGKDTYLKGLVKGKSDPYGIIRVGNQIFQSRVIKENLSPKWNEVYEALVYEHPGQELEIELFDEDPDKDDFLGSLMIDLIEVEKERLLDEWFTLDEVPKGKLHLRLEWLTLMPNVSNLDKVLTDIKADKDQANDGLSSALLILYLDSARNLPSGKKISSNPNPVVQMSVGHKAQESKIRYKTNEPVWEENFTFFIHNPKRQDLEVEVRDEQHQCSLGNLKVPLSQLLTSEDMTVSQRFQLSNSGPNSTIKMKIALRVLHLEKR","Homo sapiens","ESYT2, extended-synaptotagmin 2, FAM62B, KIAA1228","Extended synaptotagmin-2","1","4NPK"
"4NPN",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",9.4,"0.1M Tris-HCl, 0.1M CHES, 30% PEG 600, pH 9.4, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20140521",,"4NPN",11.46,"1.633","1.633","Crystal structure of human tetra-SUMO-2","GSHMASMTGGQQMGRGSEFTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGGL","Homo sapiens","SMT3A, SMT3H2, SUMO2, SUMO2 SMT3A SMT3H2, SMT3B","Small ubiquitin-related modifier 2","1","4NPN"
"4NPV",,"X-RAY DIFFRACTION",3.13,60.71,,8.5,"0.1 M TRIS-HCL, 0.2 M MGCL2, 125 UM 5-(5-BROMO-2-PROPOXYPHENYL)-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE, 15% PEG 8000, PH 8.5, VAPOR DIFFUSION, TEMPERATURE 298K",,,"0NK","4NPV",42.53,"2.4","2.4","Crystal structure of human PDE1B bound to inhibitor 7A (6,7,8-trimethoxy-N-(pentan-3-yl)quinazolin-4-amine)","GSMTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITNQ","Homo sapiens","PDE1B, PDE1B1, PDES1B","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B","1","4NPV"
"4NPW",,"X-RAY DIFFRACTION",3.15,60.98,,8.5,"0.1 M TRIS-HCL, 0.2 M MGCL2, 125 UM 5-(5-BROMO-2-PROPOXYPHENYL)-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE, 15% PEG 8000, PH 8.5, VAPOR DIFFUSION, TEMPERATURE 298K",,,,"4NPW",42.55,"1.9","1.9","Crystal structure of human PDE1B bound to inhibitor 19A (7,8-dimethoxy-N-[(2S)-1-(3-methyl-1H-pyrazol-5-yl)propan-2-yl]quinazolin-4-amine)","GSMTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITNQ","Homo sapiens","PDE1B, PDE1B1, PDES1B","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B","1","4NPW"
"4NPY",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M magnesium acetate, 20% w/v PEG8000, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1003754",,"4NPY",96.72,"1.796","1.796","Crystal structure of germline Fab PGT121, a putative precursor of the broadly reactive and potent HIV-1 neutralizing antibody","SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSRGPTNWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens","IGH@","germline PGT121 light chain","1","4NPY"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTLHGRRIYGIVAFKEWFTYYYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens","IGH@","germline PGT121 heavy chain","2","4NPY"
"4NQJ",,"X-RAY DIFFRACTION",3.92,68.62,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/cr.2014.46",,"4NQJ",65.02,"2.152","2.152","Structure of coiled-coil domain","SVGQSKEFLQISDAVHFFMEELAIQQGQLETTLKELQTLRNMQKEAIAAHKENKLHLQQHVSMEFLKLHQFLHSKEKDILTELREEGKALNEEMELNLSQLQEQCLLAKDMLVSIQAKTEQQNSFDFLKDITTLLHSLEQGMKVLATRELISRKLNLGQYKGPIQYMVWREMQDTLCPG","Homo sapiens","TRIM69, RNF36, HSD-34, HSD34","E3 ubiquitin-protein ligase TRIM69","1","4NQJ"
"4NQM",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M SPG pH 8.0, 60.0% MPD, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"Y1Z","4NQM",15.75,"1.58","1.58","Crystal Structure of the first bromodomain of human BRD4 in complex with a triazolo-phthalazine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4NQM"
"4NQN",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.20M KSCN, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"Y1Z","4NQN",14.78,"1.73","1.73","Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","4NQN"
"4NQT",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, SITTING DROP",5,"25% PEG1500, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.jmb.2014.02.015",,"4NQT",24,"2.1","2.1","anti-parallel Fc-hole(T366S/L368A/Y407V) homodimer","LGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLSCAVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4NQT"
"4NQU",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG2000 MME, 0.2 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2014.02.015",,"4NQU",24.3,"2.5","2.5","anti-parallel Fc-knob (T366W) homodimer","LGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLWCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4NQU"
"4NR1",,"X-RAY DIFFRACTION",3.24,62.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"OGA","4NR1",43.33,"2.68","2.68","Factor inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)allyl-GLY peptide","GSHMAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","FIH1, HIF1AN","Hypoxia-inducible factor 1-alpha inhibitor","1","4NR1"
,,,,,,,,,,,,,,,,"HLEVVKLLLEHGADVXAQDK",,,"CONSENSUS ANKYRIN REPEAT DOMAIN-(D)allyl glycine","2","4NR1"
"4NR2",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, SITTING DROP",4.5,"2.3M sodium formate, 0.1M acetate pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4NR2",50.17,"2","2","Crystal structure of STK4 (MST1) SARAH domain","SMDYEFLKSWTVEDLQKRLLALDPMMEQEIEEIRQKYQSKRQPILDAIEAK","Homo sapiens","KRS2, MST1, STK4","Serine/threonine-protein kinase 4","1","4NR2"
"4NR4",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M MgCl, 0.1M Tris pH 8.0, 20% PEG 6K, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4NR4",29.61,"1.69","1.69","Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NR4"
"4NR5",,"X-RAY DIFFRACTION",2.02,39.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M NaNO3, 20.0% PEG 3350, 10.0% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"2LL","4NR5",14.78,"1.66","1.66","Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NR5"
"4NR6",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",6,"0.10M MgCl2, 0.1M MES pH 6.0, 20.0% PEG 6K, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4NR6",14.69,"1.66","1.66","Crystal structure of the bromodomain of human CREBBP in complex with an oxazepin ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NR6"
"4NR7",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, SITTING DROP",6,"0.20M NH4Cl, 0.1M MES pH 6.0, 20.0% PEG 6K, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"2LO","4NR7",14.92,"1.2","1.2","Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NR7"
"4NR8",,"X-RAY DIFFRACTION",1.93,36.11,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M NaI, 0.1M BTProp pH 8.5, 20.0% PEG 3350, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"2LL","4NR8",15.63,"1.635","1.635","Crystal structure of the first bromodomain of human BRD4 in complex with an isoxazolyl-benzimidazole ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4NR8"
"4NR9",,"X-RAY DIFFRACTION",4.23,70.91,"VAPOR DIFFUSION, SITTING DROP",6.7,"30% low MW PEG Smears, 0.1M MES pH 6.7, 15%(v/v) glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/jm401582c",,"4NR9",14.06,"1.98","1.98","Crystal Structure of the bromodomain of human BAZ2B in complex with acetylated lysine","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4NR9"
"4NRA",,"X-RAY DIFFRACTION",4.16,70.43,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% low MW PEG Smears, 0.1M MES pH 6.5, 15%(v/v) glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/jm401582c","2LW","4NRA",14.18,"1.85","1.85","Crystal Structure of the bromodomain of human BAZ2B in complex with compound-6 E11322","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4NRA"
"4NRB",,"X-RAY DIFFRACTION",4.16,70.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"19% PEG 1000, 15% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/jm401582c","2LX","4NRB",13.92,"2.08","2.08","Crystal Structure of the bromodomain of human BAZ2B in complex with compound-1 N01197","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4NRB"
"4NRC",,"X-RAY DIFFRACTION",4.16,70.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"19% PEG 1000, 12% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/jm401582c","2LY","4NRC",15.47,"1.86","1.86","Crystal Structure of the bromodomain of human BAZ2B in complex with compound-3 N01186","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4NRC"
"4NRE",,"X-RAY DIFFRACTION",3.94,68.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"1M (NH4)2SO4, 0.1M BisTris pH 5.5, 5% Glycerol, 24mM C8E4, 40mM CaCl2 soak for 30 min, VAPOR DIFFUSION, HANGING DROP, temperature 295.15K",295.15,"10.1074/jbc.M113.543777",,"4NRE",80.28,"2.63","2.63","The structure of human 15-lipoxygenase-2 with a substrate mimic","MGSSHHHHHHSSGLVPRGSHMAEFRVRVSTGEAFGAGTWDKVSVSIVGTRGESPPLPLDNLGKEFTAGAEEDFQVTLPEDVGRVLLLRVHKAPPVLPLLGPLAPDAWFCRWFQLTPPRGGHLLFPCYQWLEGAGTLVLQEGTAKVSWADHHPVLQQQRQEELQARQEMYQWKAYNPGWPHCLDEKTVEDLELNIKYSTAKNANFYLQAGSAFAEMKIKGLLDRKGLWRSLNEMKRIFNFRRTPAAEHAFEHWQEDAFFASQFLNGLNPVLIRRCHYLPKNFPVTDAMVASVLGPGTSLQAELEKGSLFLVDHGILSGIQTNVINGKPQFSAAPMTLLYQSPGCGPLLPLAIQLSQTPGPNSPIFLPTDDKWDWLLAKTWVRNAEFSFHEALTHLLHSHLLPEVFTLATLRQLPHCHPLFKLLIPHTRYTLHINTLARELLIVPGQVVDRSTGIGIEGFSELIQRNMKQLNYSLLCLPEDIRTRGVEDIPGYYYRDDGMQIWGAVERFVSEIIGIYYPSDESVQDDRELQAWVREIFSKGFLNQESSGIPSSLETREALVQYVTMVIFTCSAKHAAVSAGQFDSCAWMPNLPPSMQLPPPTSKGLATCEGFIATLPPVNATCDVILALWLLSKEPGDQRPLGTYPDEHFTEEAPRRSIATFQSRLAQISRGIQERNQGLVLPYTYLDPPLIENSVSI","Homo sapiens","ALOX15B","Arachidonate 15-lipoxygenase B","1","4NRE"
"4NRM",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 4K, 100mM CH3CO2NH4, 100mM Na-citrate , pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M113.546168",,"4NRM",26.63,"2.17","2.17","Crystal structure of human ALKBH5 in complex with citrate and acetate","GHMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4NRM"
"4NRO",,"X-RAY DIFFRACTION",2.17,43.24,,5,"20% PEG 4K, 100mM CH3CO2NH4, 100mM Na-citrate 
, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M113.546168",,"4NRO",26.59,"2.3","2.3","Crystal structure of human ALKBH5 in complex with alpha-ketoglutarate","GHMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4NRO"
"4NRP",,"X-RAY DIFFRACTION",2.18,43.55,,5,"20% PEG 4K, 100mM CH3CO2NH4, 100mM Na-citrate 
, pH 5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M113.546168",,"4NRP",26.59,"1.8","1.8","Crystal structure of human ALKBH5 in complex with N-oxalylglycine","GHMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4NRP"
"4NRQ",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 4K, 100mM CH3CO2NH4, 100mM Na-citrate 
, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M113.546168",,"4NRQ",26.61,"2.5","2.5","Crystal structure of human ALKBH5 in complex with pyridine-2,4-dicarboxylate","GHMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4NRQ"
"4NRV",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",8.5,"35% w/v PEG3350, 0.25 M lithium sulfate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1016/j.dnarep.2013.12.003",,"4NRV",33.78,"2.601","2.601","Crystal Structure of non-edited human NEIL1","PEGPELHLASQFVNEACRALVFGGCVEKSSVSRNPEVPFESSAYRISASARGKELRLILSPLPGAQPQQEPLALVFRFGMSGSFQLVPREELPRHAHLRFYTAPPGPRLALCFVDIRRFGRWDLGGKWQPGRGPCVLQEYQQFRESVLRNLADKAFDRPICEALLDQRFFNGIGNYLRAEILYRLKIPPFEKARSVLEALQQHRPSPELTLSQKIRTKLQNPDLLELCHSVPKEVVQLGGKGYGSESGEEDFAAFRAWLRCYGMPGMSSLQDRHGRTIWFQGDPGPLAPLEHHHHHH","Homo sapiens","Endonuclease VIII (nei) 1, NEIL1","Endonuclease 8-like 1","1","4NRV"
"4NRY",,"X-RAY DIFFRACTION",4.22,70.83,,4.5,"52.5% polyethylene glycol 400, 0.2 M calcium acetate, 0.1 M acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.02837-13",,"4NRY",98.15,"3.14","3.14","Crystal Structure of HIV-1 Neutralizing Antibody m66","DIQLTQSPSSLSASVGDRVTITCRASQSIGSYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYYCQQSYSTPFTFGPGTKVDIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECHVGSGT","Homo sapiens",,"m66 Heavy Chain","1","4NRY"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGESLKISCKVSGYNFASEWIGWVRQMPGKGLEWMGIIYPGDSDTKYSPSFQGQVIISADKSINTAYLQWSSLKASDTAIYYCARQNHYGSGSYFYRTAYYYAMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"m66 Light Chain","2","4NRY"
"4NRZ",,"X-RAY DIFFRACTION",2.92,57.94,"VAPOR DIFFUSION, HANGING DROP",6.5,"11% polyethylene glycol 8000, 0.05 M zinc acetate, 0.05 M sodium cacaodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.02837-13",,"4NRZ",97.62,"2.42","2.42","Crystal Structure of HIV-1 Neutralizing Antibody m66.6","QVQLVQSGAEVKKPGESLKISCKVSGYNFASEWIGWVRQMPGKGLEWMGIIYPGDSDTKYSPSFQGQVIISADKSINTAYLQWSSLKASDTAIYYCARQNHYGSGSYFYRTAYYYAMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"M66.6 HEAVY CHAIN","1","4NRZ"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASLGDKVTITCRASQHIKKYLNWYQQKPGKAPKLLIYGALNLQSGVPSRFSGRGSGTDFTLTISSLQPEDFATYYCQQSYSTPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"M66.6 LIGHT CHAIN","2","4NRZ"
"4NS5",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M Tris-HCl pH 9.0, 4% w/v Polyethylene glycol (PEG) 8000, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1038/cr.2014.38",,"4NS5",27.36,"1.9","1.9","Crystal structure of human BS69 Bromo-Zinc finger-PWWP","MNKQEMGTYLRFIVSRMKERAIDLNKKGKDNKHPMYRRLVHSAVDVPTIQEKVNEGKYRSYEEFKADAQLLLHNTVIFYGADSEQADIARMLYKDTCHELDELQLCKNCFYLSNARPDNWFCYPCIPNHELVWAKMKGFGFWPAKVMQKEDNQVDVRFFGHHHQRAWIPSENIQDITVNIHRLHVKRSMGWKKACDELELHQRFLREGRFWKSKNEDRGLEHHHHHH","Homo sapiens","ZMYND11, BS69, BRAM1","Zinc finger MYND domain-containing protein 11","1","4NS5"
,,,,,"VAPOR DIFFUSION, SITTING DROP",8.4,"0.1 M Bicine, pH8.4, 2% v/v 1, 4-Dioxane, 2% w/v PEG 20000, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285
"4NSC",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, HANGING DROP",7,"8% PEG 3350 and 0.075 M ammonium citrate tribasic pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/embj.201386523",,"4NSC",278.06,"3.2","3.2","Crystal Structure of CBARA1 in the Apo-form","MHHHHHHSSGLEVLFQGPGSMEEKKKKRSGFRDRKVMEYENRIRAYSTPDKIFRYFATLKVISEPGEAEVFMTPEDFVRSITPNEKQPEHLGLDQYIIKRFDGKKISQEREKFADEGSIFYTLGECGLISFSDYIFLTTVLSTPQRNFEIAFKMFDLNGDGEVDMEEFEQVQSIIRSQTSMGMRHRDRPTTGNTLKSGLCSALTTYFFGADLKGKLTIKNFLEFQRKLQHDVLKLEFERHDPVDGRITERQFGGMLLAYSGVQSKKLTAMQRQLKKHFKEGKGLTFQEVENFFTFLKNINDVDTALSFYHMAGASLDKVTMQQVARTVAKVELSDHVCDVVFALFDCDGNGELSNKEFVSIMKQRLMRGLEKPKDMGFTRLMQAMWKCAQETAWDFALPKQ","Homo sapiens","MICU1, CALC, CBARA1","Calcium uptake protein 1, mitochondrial","1","4NSC"
"4NSD",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, SITTING DROP",6.8,"43% reservoir solution composed of (w/v) 2-methyl-2,4-pentanediol, pH 6.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/embj.201386523",,"4NSD",81.55,"2.7","2.7","Crystal Structure of CBARA1 in the Ca2+ Binding Form","GSMEEKKKKRSGFRDRKVMEYENRIRAYSTPDKIFRYFATLKVISEPGEAEVFMTPEDFVRSITPNEKQPEHLGLDQYIIKRFDGKKISQEREKFADEGSIFYTLGECGLISFSDYIFLTTVLSTPQRNFEIAFKMFDLNGDGEVDMEEFEQVQSIIRSQTSMGMRHRDRPTTGNTLKSGLCSALTTYFFGADLKGKLTIKNFLEFQRKLQHDVLKLEFERHDPVDGRITERQFGGMLLAYSGVQSKKLTAMQRQLKKHFKEGKGLTFQEVENFFTFLKNINDVDTALSFYHMAGASLDKVTMQQVARTVAKVELSDHVCDVVFALFDCDGNGELSNKEFVSIMKQRLMRG","Homo sapiens","MICU1, CALC, CBARA1","Calcium uptake protein 1, mitochondrial","1","4NSD"
"4NSP",,"X-RAY DIFFRACTION",1.88,34.6,"EVAPORATION",7.5,"0.2M sodium formate, 0.1 M Tris-HCl PH7.5,19%PEG3350, EVAPORATION, temperature 298K",298,"10.1107/S139900471401356X",,"4NSP",27.94,"2.3","2.3","Crystal structure of human ENDOV","MTLSLWKREQARLKAHVVDRDTEAWQRDPAFSGLQRVGGVDVSFVKGDSVRACASLVVLSFPELEVVYEESRMVSLTAPYVSGFLAFREVPFLLELVQQLREKEPGLMPQVLLVDGNGVLHHRGFGVACHLGVLTDLPCVGVAKKLLQVDGLENNALHKEKIRLLQTRGDSFPLLGDSGTVLGMALRSHDRSTRPLYISVGHRMSLEAAVRLTCCCCRFRIPEPVRQADICSREHIRKSAAALEHHHHHH","Homo sapiens","ENDOV","Endonuclease V","1","4NSP"
"4NSQ",,"X-RAY DIFFRACTION",2.31,46.72,"VAPOR DIFFUSION",7.4,"0.2M Lithium Sulfate, 0.1M HEPES pH7.4, 1.2M Ammonium Sulfate and 10mM Trimethylamine HCl, VAPOR DIFFUSION, temperature 298K",298,"10.1186/1472-6807-14-2","COA","4NSQ",90.42,"2.3108","2.3108","Crystal structure of PCAF","MGSSHHHHHHSSGLVPRGSHMASKVIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFDPKHKTLALIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKHDILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTE","Homo sapiens","KAT2B, PCAF","Histone acetyltransferase KAT2B","1","4NSQ"
"4NSW",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M AMMONIUM CITRATE, 10% PEG3350, 6.0MM OCTYL BETA-THIOGLUCOPYRANOSIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.devcel.2014.08.020",,"4NSW",86.67,"2.2","2.2","Crystal structure of the BAR-PH domain of ACAP1","GPLGSMTVKLDFEECLKDSPRFRASIELVEAEVSELETRLEKLLKLGTGLLESGRHYLAASRAFVVGICDLARLGPPEPMMAECLEKFTVSLNHKLDSHAELLDATQHTLQQQIQTLVKEGLRGFREARRDFWRGAESLEAALTHNAEVPRRRAQEAEEAGAALRTARAGYRGRALDYALQINVIEDKRKFDIMEFVLRLVEAQATHFQQGHEELSRLSQYRKELGAQLHQLVLNSAREKRDMEQRHVLLKQKELGGEEPEPSLREGPGGLVMEGHLFKRASNAFKTWSRRWFTIQSNQLVYQKKYKDPVTVVVDDLRLCTVKLCPDSERRFCFEVVSTSKSCLLQADSERLLQLWVSAVQSSIASAFSQARLDDSPRGPGQ","Homo sapiens","ACAP1, CENTB1, KIAA0050","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1","1","4NSW"
"4NT5",,"X-RAY DIFFRACTION",8.56,85.63,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.3 M Lithium Sulfate, 0.1 M Bicine, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2013-11-523639",,"4NT5",12.83,"3.281","3.281","Crystal structure of human von Willebrand factor CTCK domain","HHHHHHLEVLFQGPEPECNDITARLQYVKVGSCKSEVEVDIHYCQGKCASKAMYSIDINDVQDQCSCCSPTRTEPMQVALHCTNGSVVYHEVLNAMECKCSPRKCSK","Homo sapiens","F8VWF, VWF","von Willebrand factor","1","4NT5"
"4NUA",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4NUA",43.89,"1.43","1.43","The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDAYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNTIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFAQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4NUA"
"4NUC",,"X-RAY DIFFRACTION",1.92,35.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 4000, 0.1 M Tris HCl pH  8.5, 0.2 M Magnesium Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/jm401334s","435","4NUC",15.54,"1.4","1.4","Crystal structure of the first bromodomain of human BRD4 in complex with MS435 inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4NUC"
"4NUD",,"X-RAY DIFFRACTION",1.83,32.88,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 4000, 0.1 M Tris HCl pH  8.5, 0.2 M Magnesium Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/jm401334s","NUD","4NUD",15.54,"1.2","1.2","Crystal structure of the first bromodomain of human BRD4 in complex with MS436 inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4NUD"
"4NUE",,"X-RAY DIFFRACTION",1.93,36.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"14% PEG 4,000, 0.2MgCl2, 0.1M Tris pH 8.5, 15% ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/jm401334s","NUE","4NUE",15.56,"1.3","1.3","Crystal structure of the first bromodomain of human BRD4 in complex with MS267 inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4NUE"
"4NUG",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION",4.2,"40% PEG 3350, 0.1M phosphate-citrate, pH 4.2, VAPOR DIFFUSION, temperature 293.15K",293.15,"10.1016/j.immuni.2014.04.008",,"4NUG",50.71,"1.8617","1.8617","Crystal structure of HIV-1 broadly neutralizing antibody PGT151","DIVMTQTPLSLSVTPGQPASISCKSSESLRQSNGKTSLYWYRQKPGQSPQLLVFEVSNRFSGVSDRFVGSGSGTDFTLRISRVEAEDVGFYYCMQSKDFPLTFGGGTKVDLKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PGT151 light chain","1","4NUG"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"RVQLVESGGGVVQPGKSVRLSCVVSDFPFSKYPMYWVRQAPGKGLEWVAAISGDAWHVVYSNSVQGRFLVSRDNVKNTLYLEMNSLKIEDTAVYRCARMFQESGPPRLDRWSGRNYYYYSGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"PGT151 heavy chain","2","4NUG"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"4NUS",,"X-RAY DIFFRACTION",2.59,52.45,"VAPOR DIFFUSION, HANGING DROP",,"12-24% PEG3350, 100 mM sodium malonate pH 5-7, microseeding, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1158/1541-7786.MCR-13-0595","2NK","4NUS",37.59,"2.39","2.39","Rsk2 N-terminal kinase in complex with LJH685","GPNPQTEEVSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4NUS"
"4NUX",,"X-RAY DIFFRACTION",2.9,57.64,"EVAPORATION",6,"0.1M MES, 5%PEG6000, pH 6.0, EVAPORATION, temperature 293K",293,"10.1107/S1399004714005227",,"4NUX",24.77,"2.295","2.295","Structure of receptor A","KPRKVWIIYSADHPLYVDVVLKFAQFLLTACGTEVALDLLEEQAISEAGVMTWVGRQKQEMVESNSKIIVLCSRGTRAKWQALLGRGAPVRLRCDHGKPVGDLFTAAMNMILPDFKRPACFGTYVVCYFSEVSCDGDVPDLFGAAPRYPLMDRFEEVYFRIQDLEMFQPGRMHRVGELSGDNYLRSPGGRQLRAALDRFRDWQVRCPDWFECENLY","Homo sapiens","IL17RA, IL17R","Interleukin-17 receptor A","1","4NUX"
"4NVP",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, SITTING DROP",8,"HCN4 521-723 (10 mg mL-1) and 7-CH-cAMP 0.5mM were mixed in a 2:1 ratio with 100 mM TrisCl pH 8.0, 20 % PEG4000 (w/v), VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb400904s","7CH","4NVP",24.83,"2.5","2.5","Structure of the cyclic nucleotide-binding domain of HCN4 channel complexed with 7-CH-cAMP","GPSSPMDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDRIGKKNSILLH","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","4NVP"
"4NVQ",,"X-RAY DIFFRACTION",2.38,48.41,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1 M BIS-TRIS, 17.0% PEG3350, pH 5.75, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ml400496h","SAH, 2OD","4NVQ",67.7,"2.03","2.03","Human G9a in Complex with Inhibitor A-366","GSHMNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","4NVQ"
"4NW3",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION",,"20% PEG3350, 0.05 M sodium tartrate, VAPOR DIFFUSION, temperature 291K",291,"10.1016/j.str.2017.11.022",,"4NW3",16.26,"2.82","2.82","Crystal structure of MLL CXXC domain in complex with a CpG DNA","MHHHHHHSSGRENLYFQGKKGRRSRRCGQCPGCQVPEDCGVCTNCLDKPKFGGRNIKKQCCKMRKCQNLQWMPSKA","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","Histone-lysine N-methyltransferase 2A","1","4NW3"
,,,,,,,,,,,,,,,,"GCCATCGATGGC",,,"5'-D(*GP*CP*CP*AP*TP*CP*GP*AP*TP*GP*GP*C)-3'","2","4NW3"
"4NW5",,"X-RAY DIFFRACTION",2.36,47.94,"VAPOR DIFFUSION, HANGING DROP",,"7-8 mg/mL protein mixed 1:1:0.5 with 12-24% PEG3350 plus 100 mM sodium malonate pH 5-7 and microseeds, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2014.01.058","2NR","4NW5",37.63,"1.94","1.94","Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 8","GPNPQTEEVSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4NW5"
"4NW6",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, HANGING DROP",,"7-8 mg/mL protein mixed 1:1:0.5 with 12-24% PEG3350 plus 100 mM sodium malonate pH 5-7 and microseeds, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2014.01.058","2NS","4NW6",37.62,"1.74","1.74","Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27","GPNPQTEEVSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP","Homo sapiens","RPS6KA3, ISPK1, MAPKAPK1B, RSK2","Ribosomal protein S6 kinase alpha-3","1","4NW6"
"4NW7",,"X-RAY DIFFRACTION",2.7,54.43,"VAPOR DIFFUSION, SITTING DROP",5.5,"VCID6271 PDE4 AT 7.9 MG/ML IN 20MM HEPES PH 7.5, 100 MM NACL, 1MM DTT, WITH 0.5MM T-028-1 (COMPOUND #7) AGAINST JCSG_B9 OPTIMIZATION SCREEN 0.1M SODIUM CITRATE TRIBASIC / CITRIC ACID, PH 5.5, 19.45% W/V PEG 6,000, CRYO 20% ETHYLENE GLYCOL AND 0.1MM T-028-1, CRYSTAL TRACKING ID 232699H5, VAPOR DIFFUSION, SITTING DROP, temperature 289.0K",289,"10.1016/j.bmcl.2014.06.002","2O5","4NW7",43.68,"2.15","2.15","PDE4 catalytic domain","GSHMSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEG","Homo sapiens","DPDE4, PDE4, PDE4B","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","4NW7"
"4NWF",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION",7.6,"13% PEG4000, 0.1M Tris buffer, 10% glycerol, 0.02M DDT, pH 7.6, VAPOR DIFFUSION, temperature 293K",293,,,"4NWF",124.54,"2.1","2.1","Crystal structure of the tyrosine phosphatase SHP-2 with N308D mutation","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINADIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKG","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4NWF"
"4NWG",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION",8,"14.5% PEG4000, 0.1M Tris buffer, 0.02M DDT, pH 8.0, VAPOR DIFFUSION, temperature 293K",293,,,"4NWG",124.87,"2.45","2.45","Crystal structure of the tyrosine phosphatase SHP-2 with E139D mutation","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRDSQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKG","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4NWG"
"4NWM",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, HANGING DROP",7.25,"pH 7.25, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2014.02.075","2P5","4NWM",62.86,"2.03","2.03","Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide","MEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4NWM"
"4NWY",,"X-RAY DIFFRACTION",1.95,37.06,"VAPOR DIFFUSION, HANGING DROP",9,"0.2 M sodium formate, 0.1 M Bicine pH 9.0, 18% PEG3350, 0.1 M cobaltous chloride, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/srep04464",,"4NWY",62.37,"2","2","Crystal structure of the b' domain of human protein disulfide isomerase-like protein of the testis (PDILT)","GPLGSVIEYNTENKDLISELHIMSHMLLFVSKSSESYGIIIQHYKLASKEFQNKILFILVDADEPRNGRVFKYFRVTEVDIPSVQILNLSSDARYKMPSDDITYESLKKFGRSFLSKNATKHQSSEEIPKYWDQ","Homo sapiens","PDILT","Protein disulfide-isomerase-like protein of the testis","1","4NWY"
"4NXO",,"X-RAY DIFFRACTION",3.76,67.24,,7,"0.1M HEPES, pH 7.0, 10% Tacsimate, 10%Dioxane, 10% PEG-5000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1038/ncomms9250","2H7","4NXO",232.18,"2.73","2.73","Crystal Structure of Insulin Degrading Enzyme in complex with BDM44768","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4NXO"
"4NXP",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, HANGING DROP",6.8,"1.5M Ammonium Sulfate, 0.1M Tris, pH=8.5, 12% Glycerol, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2016.08.019",,"4NXP",10.19,"2.3","2.3","Crystal Structure of Free T-cell Lymphoma Invasion and Metastasis-1 PDZ Domain Quadruple Mutant (QM)","GAMGKVTHSIHIEKSDTAADTYGFSLSSVEEDGIRRLYVNSVKETGLASKKGLKAGDEILEINNRAADALNSSMMEDFFSQPSVGLLVRTYPEL","Homo sapiens","TIAM1","T-lymphoma invasion and metastasis-inducing protein 1","1","4NXP"
"4NXS",,"X-RAY DIFFRACTION",2.65,53.56,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1 M acetate pH 4.5, 0.215 M ammonium sulfate, and 24% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb500143h","2OZ","4NXS",93.64,"2.5493","2.5493","Crystal structure of human alpha-galactosidase A in complex with 1-deoxygalactonojirimycin-pFPhT","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","4NXS"
"4NXT",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% PEG 8000, 0.1M HEPES, 10% 2-propanol, 0.2M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1083/jcb.201311014",,"4NXT",156.5,"2.12","2.12","Crystal structure of the cytosolic domain of human MiD51","GSARKGQVDLKKSRLRMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENPEYFPRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","candidate 7-like, MID51, MIEF1, SMCR7L, Smith-Magenis syndrome chromosome region","Mitochondrial dynamic protein MID51","1","4NXT"
"4NXU",,"X-RAY DIFFRACTION",2.38,48.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% PEG 8000, 0.1M HEPES, 10% 2-propanol, 0.2M ammonium sulfate, 0.01M ADP, 0.01M manganese chloride 
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1083/jcb.201311014","ADP","4NXU",157.57,"2.3","2.3","Crystal structure of the cytosolic domain of human MiD51","GSARKGQVDLKKSRLRMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENPEYFPRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","candidate 7-like, MID51, MIEF1, SMCR7L, Smith-Magenis syndrome chromosome region","Mitochondrial dynamic protein MID51","1","4NXU"
"4NXV",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% PEG 8000, 0.1M HEPES, 10% 2-propanol, 0.2M ammonium sulfate, 0.01M GDP, 0.02M manganese chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1083/jcb.201311014","GDP","4NXV",157.54,"2.3","2.3","Crystal structure of the cytosolic domain of human MiD51","GSARKGQVDLKKSRLRMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENPEYFPRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","candidate 7-like, MID51, MIEF1, SMCR7L, Smith-Magenis syndrome chromosome region","Mitochondrial dynamic protein MID51","1","4NXV"
"4NXW",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",6,"1.0M sodium malonate, 0.01M ADP, 0.01M manganese chloride, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1083/jcb.201311014",,"4NXW",38.62,"2.55","2.55","Crystal structure of the cytosolic domain of human MiD51","GSARKGQVDLKKSRLRMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","candidate 7-like, MID51, MIEF1, SMCR7L, Smith-Magenis syndrome chromosome region","Mitochondrial dynamic protein MID51","1","4NXW"
"4NXX",,"X-RAY DIFFRACTION",2.78,55.83,"VAPOR DIFFUSION, HANGING DROP",6,"1.0M sodium malonate, 0.01M GDP, 0.01M manganese chloride, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1083/jcb.201311014",,"4NXX",38.63,"2.55","2.55","Crystal structure of the cytosolic domain of human MiD51","GSARKGQVDLKKSRLRMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","candidate 7-like, MID51, MIEF1, SMCR7L, Smith-Magenis syndrome chromosome region","Mitochondrial dynamic protein MID51","1","4NXX"
"4NXZ",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"14%-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1021/ja500172d",,"4NXZ",47.3,"2.557","2.557","DNA polymerase beta with O6mG in the template base opposite to incoming non-hydrolyzable TTP with manganese in the active site","CCGACGTCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(6OG)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","4NXZ"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3'","2","4NXZ"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","4NXZ"
,,,,,,,,,,,,,,,,"TLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4NXZ"
"4NY0",,"X-RAY DIFFRACTION",3.03,59.36,"VAPOR DIFFUSION, HANGING DROP",5.5,"17% PEG 10000, 0.1M Ammonium Sulfate, 0.1M bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1002/embj.201386399",,"4NY0",172.51,"2.8","2.8","Crystal structure of FERM domain of human focal adhesion kinase","MGAMERVLKVFHYFESNSEPTTWASIIRHGDATDVRGIIQKIVDSHKVKHVACYGLRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEWKYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSYGEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESILKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFIIRPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEED","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4NY0"
"4NY4",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION",7.2,"PEG 4000, CaCl2, glycerol, pH 7.2, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.drudis.2014.03.012",,"4NY4",56.43,"2.95","2.95","Crystal structure of CYP3A4 in complex with an inhibitor","AYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A3, CYP3A4, CYP3A4 CYP3A3","Cytochrome P450 3A4","1","4NY4"
"4NY8",,"X-RAY DIFFRACTION",2.45,49.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"14%-23% PEG3400, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1021/ja500172d",,"4NY8",47.28,"2.246","2.246","DNA polymerase beta with O6mG in the template base opposite to incoming non-hydrolyzable CTP with manganese in the active site","TLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4NY8"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(6OG)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4NY8"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3'","3","4NY8"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","4NY8"
"4NY9",,"X-RAY DIFFRACTION",2.69,58.6,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1M imidazole, 8-10%(V/V)isopropanol. Apo crystal was soaked with 5 mM compound and Crystals  harvested next day using 32% ethylene glycol as cryoprotectant, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/jm5003167","2Q4","4NY9",33.98,"2.8","2.8","Crystal Structure Of the Human PXR-LBD In Complex With N-{(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl}-3-hydroxy-3-methylbutanamide","GLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGI","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","4NY9"
"4NYH",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION",5.5,"0.1 M Potassium thiocyanate, 30% w/v Polyethylene glycol monomethyl ether 2,000, pH 5.5, VAPOR DIFFUSION, temperature 290K",290,"10.1021/bi401240x",,"4NYH",64.09,"1.2","1.2","Orthorhombic crystal form of pir1 dual specificity phosphatase core","GPLGSNHIPERWKDYLPVGQRMPGTRFIAFKVPLQKSFEKKLAPEECFSPLDLFNKIREQNEELGLIIDLTYTQRYYKPEDLPETVPYLKIFTVGHQVPDDETIFKFKHAVNGFLKENKDNDKLIGVHSTHGLNRTGYLICRYLIDVEGVRPDDAIELFNRCRGHCLERQNYIEDLQNGPIR","Homo sapiens","DUSP11, PIR1","RNA/RNP complex-1-interacting phosphatase","1","4NYH"
"4NYL",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris HCl, 20% PEG 3350, 0.2M calcium chloride, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4NYL",192.33,"2.8","2.8","Crystal structure of adalimumab FAB fragment","DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Adalimumab Light Chain","1","4NYL"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Adalimumab Heavy Chain","2","4NYL"
"4NYT",,"X-RAY DIFFRACTION",2.53,51.32,"VAPOR DIFFUSION",7,"15%(w/v) PEG 8000, 200mM Ca acetate, 0.1M Hepes, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.4049/jimmunol.1400127","PC","4NYT",75.36,"2.25","2.25","L-Ficolin Complexed to Phosphocholine","PCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","Ficolin-2","1","4NYT"
"4NYV",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.15M KSCN, 25% PEG_3350, 5% ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4NYV",57.86,"1.83","1.83","Crystal Structure of the Bromodomain of human CREBBP in complex with a quinazolin-one ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NYV"
"4NYW",,"X-RAY DIFFRACTION",2.46,49.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 9% Ethylene Glycol, 0.18M KSCN, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4NYW",14.78,"1.43","1.43","Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NYW"
"4NYX",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION, SITTING DROP",8,"0.05M CaCl2, 0.1M TRIS, 20.0% PEG 6K, 10.0% EtGly, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"2O4","4NYX",14.63,"1.1","1.1","Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","4NYX"
"4NZ2",,"X-RAY DIFFRACTION",4.02,69.38,"VAPOR DIFFUSION",8,"PEG 4000, LiSO4, Tris-HCl, DTT, glycerol, pH 8.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.drudis.2014.03.012","2QJ","4NZ2",110.92,"2.45","2.45","Crystal structure of CYP2C9 in complex with an inhibitor","MAKKTSSKGRPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIEILSSPWIQVYNNFPALLDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPVHHHH","Homo sapiens","CYP2C10, CYP2C9, CYP2C9 CYP2C10","Cytochrome P450 2C9","1","4NZ2"
"4NZ6",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, HANGING DROP",8.5,"28% PEG 3350/glycerol, 0.1M Bicine/TRIS (pH 8.5), 10% amino acids mixture, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0094610",,"4NZ6",71.85,"2","2","Steroid receptor RNA Activator (SRA) modification by the human Pseudouridine Synthase 1 (hPus1p): RNA binding, activity, and atomic model","SKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTL","Homo sapiens","PUS1, PP8985","tRNA pseudouridine synthase A, mitochondrial","1","4NZ6"
"4NZ7",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",8,"17% PEG 8000, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0094610",,"4NZ7",36.02,"2.7","2.7","Steroid receptor RNA Activator (SRA) modification by the human Pseudouridine Synthase 1 (hPus1p): RNA binding, activity, and atomic model","SKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTAKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTL","Homo sapiens","PUS1, PP8985","tRNA pseudouridine synthase A, mitochondrial","1","4NZ7"
"4NZD",,"X-RAY DIFFRACTION",4.18,70.57,"VAPOR DIFFUSION, SITTING DROP",8.5,"5 mg/ml Protein in 10 mM Hepes, 150 mM NaCl, pH7.5  
Crystalized in 1M Potassium sodium tartrate tetrahydrate, 3% W/V Peg5000 and 0.1 M tris Ph 8.5. Drops were 1:1, VAPOR DIFFUSION, SITTING DROP, temperature 278K",278,,,"4NZD",80.6,"2.75","2.75","Interleukin 21 receptor","CPDLVCYTDYLQTVICILEMWNLHPSTLTLTWQDQYEELKDEATSCSLHRSAHNATHATYTCHMDVFHFMADDIFSVQITDQSGQYSQECGSFLLAESIKPAPPFDVTVTFSGQYQISWRSDYEDPAFYMLKGKLQYELQYRNRGDPWAVSPRRKLISVDSRSVSLLPLEFRKDSSYELQVRAGPMPGSSYQGTWSEWSDPVIFQTQSEELKEHHHHHH","Homo sapiens","IL21R, NILR, UNQ3121/PRO10273","Interleukin-21 receptor","1","4NZD"
"4NZM",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP with 2 mM CdCl2 Soaking under 22% PEG3350, 10 mM MgCl2 0.1 M Sodium Acetate, pH5.2 with 10 mM 5PA-InsP5, 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2014.03.009",,"4NZM",38.87,"2","2","Crystal structure of the catalytic domain of PPIP5K2 in complex with AMPPNP and 5-PA-InsP5","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4NZM"
"4NZN",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP with 2 mM CdCl2. Soaking under 22% PEG3350, 10 mM MgCl2 0.1 M Sodium Acetate, pH5.2 with 5 mM 2-O-Bn-5-PA-InsP4, 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2014.03.009",,"4NZN",38.86,"1.75","1.75","Crystal structure of the catalytic domain of PPIP5K2 in complex with AMPPNP and 2-O-BN-5-PA-INSP4","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4NZN"
"4NZO",,"X-RAY DIFFRACTION",2.72,54.81,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP with 2 mM CdCl2 Soaking under 22% PEG3350, 10 mM MgCl2 0.1 M HEPES, pH7.0 with 10 mM 2, 5-di-O-Bn-InsP4, 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2014.03.009",,"4NZO",38.83,"1.9","1.9","Crystal structure of the catalytic domain of PPIP5K2 in complex with AMPPNP and 2,5-DI-O-BN-INSP4","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4NZO"
"4NZQ",,"X-RAY DIFFRACTION",4.23,70.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, pH 8.5 and 30% PEG300, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1403779111",,"4NZQ",64.22,"2.807","2.807","Crystal structure of Ca2+-free prothrombin deletion mutant residues 146-167","ANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","4NZQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","F2"
"4NZU",,"X-RAY DIFFRACTION",2.26,45.45,"VAPOR DIFFUSION, SITTING DROP",4,"0.1 M citric acid, pH 4.0, 1.0 M lithium chloride, 23% PEG6000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1126/science.1246135",,"4NZU",47.08,"1.2","1.2","Crystal structure of the primary monoclonal antibody 13PL Fab' from a multiple myeloma patient","DIEMTQSPSSLSASTGDKVTITCQASQDIAKFLDWYQQRPGKTPKLLIYDASNLAIGVPSRFTGSGSGTDFTFTISSLQPEDIAVYYCQHYDDFPISFGPGTKLETKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR","Homo sapiens",,"13PL heavy chain","1","4NZU"
,,,,,,,,,,,,,,,,"AVSLVESGGGTVEPGSTLRLSCAASGFTFGSYAFHWVRQAPGDGLEWVAFISYNGSSKYYASFVSGRFTISRDNSSNTLSLQMNSLKASDTAVYYCARAPDCADADCHKGAFGYWGQGTLVTVSSASTKGPSVFPLAPSSKTSSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"13PL light chain","2","4NZU"
"4O00",,"X-RAY DIFFRACTION",1.96,37.33,"VAPOR DIFFUSION, SITTING DROP",4,"0.1M SPG buffer, 0.01M Tris-HCl, 31% PEG1500, 50mM NaCl, 1mM DTT, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4O00",23.02,"1.853","1.853","Crystal structure of the Titin A-band domain A3","SERPSPPVNLTSSDQTQSSVQLKWEPPLKDGGSPILGYIIERCEEGKDNWIRCNMKLVPELTYKVTGLEKGNKYLYRVSAENKAGVSDPSEILGPLTADDAFVE","Homo sapiens","TTN","Titin","1","4O00"
"4O03",,"X-RAY DIFFRACTION",4.92,75.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, pH 7.5, 10% PEG 4000 and 5% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1403779111",,"4O03",64.42,"3.38","3.38","Crystal structure of Ca2+ bound prothrombin deletion mutant residues 146-167","ANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","4O03"
,,,,,,,,,,,,,,,,,"Homo sapiens","F2"
"4O04",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%PEGMME2K, 0.2M MgCl2,0.1M cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500042s","2Q8","4O04",26.53,"1.82","1.82","Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4O04"
"4O05",,"X-RAY DIFFRACTION",2.9,57.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25$PEGMME2K, 100mM cacodylate pH 6.5, 200mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500042s","2Q9","4O05",26.62,"1.79","1.79","Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4O05"
"4O07",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%PEGMME2K, 100mM cacodylate pH 6.5, 200mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500042s","FGH","4O07",26.62,"1.86","1.86","Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4O07"
"4O09",,"X-RAY DIFFRACTION",2.9,57.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%PEGMME2K, 100mM cacodylate 6.5, 200mM magnesium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500042s","2R6","4O09",26.56,"1.96","1.96","Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s disease","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4O09"
"4O0A",,"X-RAY DIFFRACTION",2.03,39.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/jm401333u","2P9","4O0A",14.11,"1.2","1.2","Fragment-Based Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4O0A"
"4O0B",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%PEGMME2K, 100mM cacodylate pH 6.5, 200mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500042s","2QA","4O0B",26.57,"1.93","1.93","Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4O0B"
"4O0C",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0C",64.81,"1.5","1.5","High resolution crystal structure of uncleaved human L-asparaginase protein","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0C"
"4O0D",,"X-RAY DIFFRACTION",2.39,48.59,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0D",64.78,"1.95","1.95","Crystal structure of the human L-asparaginase protein T168S mutant","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGSVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0D"
"4O0E",,"X-RAY DIFFRACTION",2.36,47.77,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0E",64.51,"1.71","1.71","Crystal structure of the human L-asparaginase protein T186V mutant","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSVGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0E"
"4O0F",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0F",64.8,"1.92","1.92","Crystal structure of the human L-asparaginase protein T219A mutant","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTAGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0F"
"4O0G",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0G",64.51,"2.1","2.1","Crystal structure of the human L-asparaginase protein T219V mutant","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTVGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0G"
"4O0H",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",7,"2.2-2.5 M sodium Malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.04.016",,"4O0H",64.78,"1.97","1.97","Crystal structure of human L-asparaginase protein with covalently linked substrate L-asparagine","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4O0H"
"4O0R",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, SITTING DROP",7,"crystals were grown at 19  C from 1.0 uL + 1.0 uL vapor diffusion drops containing 10 mg/mL protein, 1 mM ligand, 0.15 M DL-Malic Acid, 20% - 30% PEG 3350, 4% 1,3-Propanediol and 0.1 M Sodium Malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm401768t","7KC","4O0R",67.58,"2.4","2.4","Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors","SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNHGNS","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","4O0R"
"4O0S",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M Ammonium sulfate, 0.1M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4O0S",32.96,"2.5","2.5","Crystal structures of human kinase Aurora A","ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4O0S"
"4O0T",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, SITTING DROP",7,"crystals were grown at 19  C from 1.0 uL + 1.0 uL vapor diffusion drops containing 10 mg/mL protein, 1 mM ligand, 0.15 M DL-Malic Acid pH 7.0, 20% - 30% PEG 3350, 4% 1,3-Propanediol and 0.1 M Sodium Malonate, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm401768t","2OL","4O0T",67.5,"2.6","2.6","Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors","SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNHGNS","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","4O0T"
"4O0U",,"X-RAY DIFFRACTION",2.76,55.41,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M Ammonium sulfate, 0.1M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4O0U",32.98,"2.6","2.6","Crystal structures of human kinase Aurora A","ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIRRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4O0U"
"4O0V",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, SITTING DROP",8.3,"500 uL of 0.2 M Tri-Potassium citrate and 20% PEG3350 in the reservoir, and drops set up by mixing 1.0 uL of reservoir solution and 1.0 uL of protein, pH 8.3, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm401768t","2OL","4O0V",33.47,"2.8","2.8","Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors","GSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","4O0V"
"4O0W",,"X-RAY DIFFRACTION",2.59,52.47,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M Ammonium sulfate, 0.1M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4O0W",32.98,"2.6","2.6","Crystal structures of human kinase Aurora A","ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIYRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4O0W"
"4O0X",,"X-RAY DIFFRACTION",2.93,58.09,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.2 M Tri-Potassium citrate and 20% PEG3350 in the reservoir, and drops set up by mixing 1.0 uL of reservoir solution and 1.0 uL of protein, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401768t","2OQ","4O0X",33.42,"2.483","2.483","Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors","GSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","4O0X"
"4O0Y",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.2 M Tri-Potassium citrate and 20% PEG3350 in the reservoir, and drops set up by mixing 1.0 uL of reservoir solution and 1.0 uL of protein, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401768t","2OO","4O0Y",33.41,"2.2","2.2","Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors","GSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","4O0Y"
"4O0Z",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1002/cbic.201402023","2RM","4O0Z",115.12,"2.049","2.049","Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O0Z"
"4O10",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1002/cbic.201402023","2QF","4O10",115.92,"1.55","1.55","Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O10"
"4O12",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1002/cbic.201402023","2QG","4O12",114.91,"2.498","2.498","Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O12"
"4O13",,"X-RAY DIFFRACTION",2.33,47.16,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366","2P1","4O13",115.68,"1.75","1.75","The crystal structure of NAMPT in complex with GNE-618","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O13"
"4O14",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O14",114.69,"1.871","1.871","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNFREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O14"
"4O15",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366","2P1","4O15",115.49,"1.8","1.8","The crystal structure of a mutant NAMPT (S165F) in complex with GNE-618","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNFREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O15"
"4O16",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, followed by in-situ adduct formation, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O16",58.64,"1.783","1.783","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNFREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O16"
"4O17",,"X-RAY DIFFRACTION",2.33,47.16,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O17",114.72,"1.82","1.82","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNYREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O17"
"4O18",,"X-RAY DIFFRACTION",2.31,46.66,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O18",114.42,"1.92","1.92","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKATDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O18"
"4O19",,"X-RAY DIFFRACTION",2.34,47.43,,,,,"10.1371/journal.pone.0109366",,"4O19",114.84,"1.75","1.75","The crystal structure of a mutant NAMPT (G217V)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKVTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O19"
"4O1A",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O1A",114.96,"1.87","1.87","The crystal structure of the mutant NAMPT G217R","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKRTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O1A"
"4O1B",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366","DGB","4O1B",115.93,"1.65","1.65","The crystal structure of a mutant NAMPT (G217R) in complex with an inhibitor APO866","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKRTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O1B"
"4O1C",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366",,"4O1C",114.24,"2.092","2.092","The crystal structures of a mutant NAMPT H191R","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLRDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O1C"
"4O1D",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, SITTING DROP",8.6,"0.1M Sodium phosphate, pH 8.6, 25% polyethylene glycol 3350, 0.2M NaCl and 1mM compound, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1371/journal.pone.0109366","DGB","4O1D",116.02,"1.705","1.705","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLRDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O1D"
"4O1L",,"X-RAY DIFFRACTION",1.98,37.74,,,,,"10.1021/jm500497v","HO4","4O1L",78.6,"2.5","2.5","Human Adenosine Kinase in complex with inhibitor","APQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH","Homo sapiens","ADK","Adenosine kinase","1","4O1L"
"4O1U",,"X-RAY DIFFRACTION",2.99,58.92,"VAPOR DIFFUSION, HANGING DROP",8.3,"35% saturated Ammonium Sulfate + 20mM BME + 0.1M TRIS, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"4O1U",75.73,"2.26","2.26","Crystal structure of human thymidylate synthase mutant Y202C","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFCVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","OK/SW-cl.29, TS, TYMS, TYSM","Thymidylate synthase","1","4O1U"
"4O1X",,"X-RAY DIFFRACTION",2,38.48,"VAPOR DIFFUSION, HANGING DROP",8.3,"25% saturated Ammonium Sulfate, 20mM BME, 0.1M TRIS pH8.3, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"4O1X",150.39,"2.32","2.32","Crystal structure of human thymidylate synthase double mutant C195S-Y202C","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPSHALCQFCVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","OK/SW-cl.29, TS, TYMS","Thymidylate synthase","1","4O1X"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPSHALCQFCVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","OK/SW-cl.29, TS, TYMS","Thymidylate synthase","2","4O1X"
"4O28",,"X-RAY DIFFRACTION",2.33,47.31,,,,,"10.1371/journal.pone.0109366","1QS","4O28",116.05,"2","2","Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNFREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4O28"
"4O2W",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 1500, 0.2 M Magnesium Choride, 0.1 M Hepes pH7.5, vapor diffusion hanging drop, temperature 291K",291,,,"4O2W",171.95,"2","2","Crystal structure of the third RCC1-like domain of HERC1","MHHHHHHSSGRENLYFQGGMDEQIMSWATSRPEDWHLGGKCDVYLWGAGRHGQLAEAGRNVMVPAAAPSFSQAQQVICGQNCTFVIQANGTVLACGEGSYGRLGQGNSDDLHVLTVISALQGFVVTQLVTSCGSDGHSMALTESGEVFSWGDGDYGKLGHGNSDRQRRPRQIEALQGEEVVQMSCGFKHSAVVTSDGKLFTFGNGDYGRLGLGNTSNKKLPERVTALEGYQIGQVACGLNHTLAVSADGSMVWAFGDGDYGKLGLGNSTAKSSPQKIDVLCGIGIKKVACGTQFSVALTKDGHVYTFGQDRLIGLPEGRARNHNRPQQIPVLAGVIIEDVAVGAEHTLALASNGDVYAWGSNSEGQLGLGHTNHVREPTLVTGLQGKNVRQISAGRCHSAAWTA","Homo sapiens","HERC1","E3 ubiquitin-protein ligase HERC1","1","4O2W"
"4O33",,"X-RAY DIFFRACTION",2.39,48.44,,8,"25-30% PEG 4000,0.1 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291 KK",291,"10.1038/nchembio.1657","3PG, TZN","4O33",45.23,"2.1","2.1","Crystal Structure of human PGK1 3PG and terazosin(TZN) ternary complex","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITTIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","Phosphoglycerate kinase 1","1","4O33"
"4O38",,"X-RAY DIFFRACTION",2.67,53.87,"VAPOR DIFFUSION, SITTING DROP",7,"1.0M succinic acid, 0.1M Bis-Tris Propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289.0K",289,,,"4O38",76.83,"2.097","2.097","Crystal structure of the human cyclin G associated kinase (GAK)","SMAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP","Homo sapiens","GAK","Cyclin-G-associated kinase","1","4O38"
"4O3M",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",6,"6-10% Isopropanol, 50mM MES, 10mM magnesium chloride., pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S139900471400501X",,"4O3M",88.21,"2.3","2.3","Ternary complex of Bloom's syndrome helicase","KHERFQSLSFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSPGVTVVISPLRSLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLARFVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYYVLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDGCQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFYTYHDVTRLKRLIMMEKDGNHHTRETHFNNLYSMVHYCENITECRRIQLLAYFGENGFNPDFCKKHPDVSCDNCCKTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHNAERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENSSSVKKQKALVAKVSQREEMVKKCLGELTEVCKSLGKVFGVHYFNIFNTVTLKKLAESLSSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPAEDSSPG","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein","1","4O3M"
,,,,,,,,,,,,,,,,"AGCGTCGAGATCCAAG",,,"5'-D(*AP*GP*CP*GP*TP*CP*GP*AP*GP*AP*TP*CP*CP*AP*AP*G)-3'","2","4O3M"
,,,,,,,,,,,,,,,,"CTTGGATCTCGACGCTCTCCCTTA",,,"5'-D(*CP*TP*TP*GP*GP*AP*TP*CP*TP*CP*GP*AP*CP*GP*CP*TP*CP*TP*CP*CP*CP*TP*TP*A)-3'","3","4O3M"
"4O3N",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES pH 5.5, 5mM magnesium chloride, 15.5% PEG 2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3N",55.31,"1.579","1.579","Crystal structure of human dna polymerase eta in ternary complex with native dna and incoming nucleotide (dcp)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3N"
,,,,,,,,,,,,,,,,"CATGATGACGCT",,,"DNA (5'-D(*CP*AP*TP*GP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3N"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4O3N"
"4O3O",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES pH 5.5, 5mM magnesium chloride, 15% PEG 2000 MME , VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3O",55.35,"1.698","1.698","Crystal structure of human polymerase eta inserting datp opposite an 8-oxog containing dna template","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3O"
,,,,,,,,,,,,,,,,"CATGATGACGCT",,,"DNA (5'-D(*CP*AP*TP*(8OG)P*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3O"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4O3O"
"4O3P",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5.5, 5mM magnesium chloride, 16% PEG 2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3P",55.42,"1.72","1.72","Crystal structure of human polymerase eta inserting dctp opposite an 8-oxog containing dna template","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3P"
,,,,,,,,,,,,,,,,"CATGATGACGCT",,,"DNA (5'-D(*CP*AP*TP*(8OG)P*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3P"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4O3P"
"4O3Q",,"X-RAY DIFFRACTION",2.08,41.01,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5.5, 5mM magnesium chloride, 16% PEG 2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3Q",55.37,"1.72","1.72","Crystal structure of human polymerase eta inserting dgtp opposite an 8-oxog containing dna template","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3Q"
,,,,,,,,,,,,,,,,"CATGATGACGCT",,,"DNA (5'-D(*CP*AP*TP*(8OG)P*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3Q"
,,,,,,,,,,,,,,,,"AGCGTCAT",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","4O3Q"
"4O3R",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5.5, 5mM magnesium chloride, 16.5% PEG 2000 MME , VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3R",55.45,"1.62","1.62","Crystal structure of human polymerase eta extending an 8-oxog dna lesion: post insertion of 8-oxog-da pair","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3R"
,,,,,,,,,,,,,,,,"CATGGTGACGCT",,,"DNA (5'-D(*CP*AP*TP*GP*(8OG)P*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3R"
,,,,,,,,,,,,,,,,"AGCGTCAA",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*A)-3')","3","4O3R"
"4O3S",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5.5, 5mM magnesium chloride, 17% PEG 2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M114.551820",,"4O3S",55.04,"1.717","1.717","Crystal structure of human polymerase eta extending an 8-oxog dna lesion: post insertion of 8-oxog-dc pair","MATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","4O3S"
,,,,,,,,,,,,,,,,"CATGGTGACGCT",,,"DNA (5'-D(*CP*AP*TP*GP*(8OG)P*TP*GP*AP*CP*GP*CP*T)-3')","2","4O3S"
,,,,,,,,,,,,,,,,"AGCGTCAC",,,"DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*C)-3')","3","4O3S"
"4O56",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M Ammonium sulfate, 100mM Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4O56",29.11,"1.8","1.8","Structure of PLK1 in complex with peptide","LGSPGIQGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4O56"
,,,,,,,,,,,,,,,,"GPMTSTPK",,,"synthetic peptide","2","4O56"
"4O61",,"X-RAY DIFFRACTION",2.19,43.79,,,"20% PEG3350, 0.2 M diammonium citrate, temperature 291K",291,"10.1074/jbc.M114.550350","CIT","4O61",51.25,"1.9","1.9","Structure of human ALKBH5 crystallized in the presence of citrate","GQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRLET","Homo sapiens","ALKBH5, ABH5, OFOXD1","RNA demethylase ALKBH5","1","4O61"
"4O64",,"X-RAY DIFFRACTION",2.8,56.3,"sitting drop",8.5,"25% PEG 8000, 0.2 M sodium chloride, 0.1 M tris, pH 8.5, sitting drop, temperature 291K",291,"10.1016/j.str.2017.11.022",,"4O64",40.84,"2.13","2.13","Zinc fingers of KDM2B","GRRRRTRCRKCEACLRTECGECHFCKDMKKFGGPGRMKQSCIMRQCIAPVLPHTAVCLVCGEAGKEDTVEEEEGKFNLMLMECSICNEIIHPGCLKIKESEGVVNDELPNCWECPKCN","Homo sapiens","KDM2B, CXXC2, FBL10, FBXL10, JHDM1B, PCCX2, NDY1","Lysine-specific demethylase 2B","1","4O64"
"4O67",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"2% Isopropanol, 0.01 M MgSO4, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2014.01.003",,"4O67",86.55,"2.444","2.444","Human cyclic GMP-AMP synthase (cGAS) in complex with GAMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","4O67"
"4O68",,"X-RAY DIFFRACTION",2.54,51.59,"VAPOR DIFFUSION, HANGING DROP",7.8,"6% PEG 3,350, 0.1 M Hepes, pH 7.8, 0.05 M NaCl, 0.01 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2014.01.003",,"4O68",43.92,"2.436","2.436","Structure of human cyclic GMP-AMP synthase (cGAS)","PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","4O68"
"4O69",,"X-RAY DIFFRACTION",4.18,70.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"2 M (NH4)2SO4, 0.1 M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.celrep.2014.01.003",,"4O69",42.89,"2.252","2.252","Human cyclic GMP-AMP synthase (cGAS) in complex with sulfate ion","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","4O69"
"4O6E",,"X-RAY DIFFRACTION",1.89,35.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4   C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.04.068","2SH","4O6E",43.1,"1.95","1.95","Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine Inhibitors of Erk2","MGSSHHHHHHSSGLVPRGSHMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4O6E"
"4O6L",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION",7.5,"0.2M Ammonium Sulfate, 0.1M HEPES pH7.5, 25% PEG3350, VAPOR DIFFUSION, temperature 293K",293,,"2QK","4O6L",66.59,"2.38","2.38","Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)","NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","4O6L"
"4O6W",,"X-RAY DIFFRACTION",1.85,33.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"13% (w/v) PEG 3350, 0.1 M HEPES pH 7.5 and 100 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/bip.22569",,"4O6W",28.22,"1.448","1.448","Peptide-Based Inhibitors of Plk1 Polo-box Domain","GAHMDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","4O6W"
,,,,,,,,,,,,,,,,"XPLXSTX",,,"Peptide-Based inhibitor","2","4O6W"
"4O6X",,"X-RAY DIFFRACTION",1.87,34.29,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG4000, NaAc, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24702",,"4O6X",27.64,"2.103","2.103","Crystal structure of human Ankyrin G death domain","MERTDIRMAIVADHLGLSWTELARELNFSVDEINQIRVENPNSLISQSFMLLKKWVTRDGKNATTDALTSVLTKINRIDIVTLLEGPIFDYGNISGTRSFADENNVFHDPVDGLEHHHHHH","Homo sapiens","ANK3, Ankyrin G","Ankyrin-3","1","4O6X"
"4O70",,"X-RAY DIFFRACTION",2.14,42.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM DINACICLIB, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","1QK","4O70",31.76,"1.55","1.55","Crystal structure of the first bromodomain of human BRD4 in complex with DINACICLIB","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O70"
"4O71",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM FLAVOPIRIDOL, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","CPB","4O71",31.31,"1.36","1.36","Crystal structure of the first bromodomain of human BRD4 in complex with FLAVOPIRIDOL","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O71"
"4O72",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM NU7441, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2R4","4O72",16.04,"1.4","1.4","Crystal structure of the first bromodomain of human BRD4 in complex with NU7441","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O72"
"4O74",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM BI2536, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","R78","4O74",31.53,"1.45","1.45","Crystal structure of the first bromodomain of human BRD4 in complex with BI 2536","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O74"
"4O75",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM FOSTAMATINIB, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RC","4O75",15.8,"1.55","1.55","Crystal structure of the first bromodomain of human BRD4 in complex with FOSTAMATINIB","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O75"
"4O76",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM TG101209, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","1M3","4O76",62.68,"1.7","1.7","Crystal structure of the first bromodomain of human BRD4 in complex with TG101209","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O76"
"4O77",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM SB 202190, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RE","4O77",30.86,"2","2","Crystal structure of the first bromodomain of human BRD4 in complex with SB 202190","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O77"
"4O78",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM GW612286X, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","SAV","4O78",16,"1.34","1.34","Crystal structure of the first bromodomain of human BRD4 in complex with GW612286X","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O78"
"4O7A",,"X-RAY DIFFRACTION",2.13,42.29,,7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM SB-409514, HANGING DROP, VAPOR-DIFFUSION, TEMPERATURE 291K",,"10.1021/cb500072z","2RF","4O7A",15.7,"1.34","1.34","Crystal structure of the first bromodomain of human BRD4 in complex with SB-409514","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O7A"
"4O7B",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM SB-284847-BT, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RJ","4O7B",15.73,"1.5","1.5","Crystal structure of the first bromodomain of human BRD4 in complex with SB-284847-BT","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O7B"
"4O7C",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM SB-614067-R, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RK","4O7C",15.53,"1.55","1.55","Crystal structure of the first bromodomain of human BRD4 in complex with SB-614067-R","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O7C"
"4O7D",,"X-RAY DIFFRACTION",5.470732,77.516716,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1M Bis-Tris propane (pH 7.2), 1.8M Lithium Sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/srep03827",,"4O7D",34.61,"2.3","2.3","Crystal structure of human glutaminase in complex DON","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYD","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","4O7D"
"4O7E",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM SB-610251-B, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RN","4O7E",31.64,"1.85","1.85","Crystal structure of the first bromodomain of human BRD4 in complex with SB-610251-B","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O7E"
"4O7F",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3350, 10% DMSO, 2 MM SB-251527, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2RQ","4O7F",31.5,"1.8","1.8","Crystal structure of the first bromodomain of human BRD4 in complex with SB-251527","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4O7F"
"4O7Q",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, HANGING DROP",4.7,"0.2 M CaCl2, 0.1 M Sodium Acetate, and 23 % PEG3350, pH 4.7, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.jmb.2013.12.029",,"4O7Q",10.84,"1.82","1.82","Crystal Structure of the F27G AIM2 Pyrin Domain Mutant and Similarities of its Self-association to DED/DED Interactions","AMESKYKEILLLTGLDNITDEELDRFKGFLSDEFNIATGKLHTANRIQVATLMIQNAGAVSAVMKTIRIFQKLNYMLLAKRLQEEKEKVDKQYK","Homo sapiens","AIM2","Interferon-inducible protein AIM2","1","4O7Q"
"4O7X",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 4K, 100mM CH3CO2NH4, 100mM Na-citrate, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M113.546168",,"4O7X",26.44,"1.78","1.78","Crystal structure of human ALKBH5 in complex with Mn2+","GHMPERSDYEEQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRL","Homo sapiens","ABH5, ALKBH5, OFOXD1","RNA demethylase ALKBH5","1","4O7X"
"4O8F",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"MORPHEUS A5: 10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.1 M MOPS/HEPES-Na, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714009638","BRL","4O8F",65.93,"2.6","2.6","Crystal Structure of the complex between PPARgamma mutant R357A and rosiglitazone","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLAKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","NR1C3, PPARG","Peroxisome proliferator-activated receptor gamma","1","4O8F"
"4O8H",,"X-RAY DIFFRACTION",2,38.4,"VAPOR DIFFUSION",7.5,"25% (w/v) PEG 4000, 100 mM Hepes, 200 NaCl, pH 7.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14009480",,"4O8H",18.08,"0.85","0.85","0.85A resolution structure of PEG 400 Bound Cyclophilin D","SGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4O8H"
"4O8I",,"X-RAY DIFFRACTION",1.87,34.18,"VAPOR DIFFUSION",8.5,"20% (w/v) PEG 8000, 100 mM Tris, 200 mM MgCl2, 20% (v/v) PEG 400, pH 8.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14009480",,"4O8I",17.98,"1.45","1.45","1.45A resolution structure of PEG 400 Bound Cyclophilin D","SGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4O8I"
"4O8Z",,"X-RAY DIFFRACTION",2.63,53.21,,,,,,,"4O8Z",34.62,"2","2","Crystal structure of human SIRT3 in complex with compound (2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone","HHHHHHDYDIPTTENLYFQGSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-dependent protein deacetylase sirtuin-3, mitochondrial","1","4O8Z"
"4O91",,"X-RAY DIFFRACTION",3.97,69,"VAPOR DIFFUSION, HANGING DROP",7,"0.65-0.75 M sodium citrate, 0.2 M NaCl, 0.1 M Tris, and 5mM adenosine. Adenosine bound TAK1-TAB1 crystals are backsoaked with inhibitor, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500480k",,"4O91",36,"2.393","2.393","Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1","SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGEQSVVTAP","Homo sapiens","MAP3K7, MAP3K7 TAK1 TAB1 MAP3K7IP1, TAK1","Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera","1","4O91"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K7, MAP3K7 TAK1 TAB1 MAP3K7IP1, TAK1"
"4O97",,"X-RAY DIFFRACTION",2.25,45.4,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris pH 8.3, 0.2M MgCl2, 20% PEG 8000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2014.04.013","NTX","4O97",27.43,"2.2","2.2","Crystal structure of matriptase in complex with inhibitor","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4O97"
,,,,,,,,,,,,,,,,"CGLR","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Peptide CGLR","2","4O97"
"4O9B",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, HANGING DROP",4.5,"24% PEGMME 2000, 0.1M sodium acetate, 0.02M magnesium chloride hexahydrate, 0.02M nickel chloride hexahydrate, 0.02M cadmium chloride hexahydrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0074735",,"4O9B",50.54,"2.604","2.604","The Structure of CC1-IH in human STIM1.","SKEHMKKLMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEEMEQVREALRKAEKELESHSS","Homo sapiens","GOK, STIM1","Stromal interaction molecule 1","1","4O9B"
"4O9I",,"X-RAY DIFFRACTION",2.82,56.43,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M Ammonium citrate, 20% PEG3350, pH 7.0 , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4O9I",25,"2.6","2.6","Structure of CHD4 double chromodomains depicts cooperative folding for DNA binding","MAHHHHHHVDDDDKENLYFQMKGKVQKILIWKWGQPPSPTPVPRPPDADPNTPSPKPLEGRPERQFFVKWQGMSYWHCSWVSELQLELHCQVMFRNYQRKNDMDEPPSGDFGGDEEKSRKRKNKDPKFAEMEERFYRYGIKPEWMMIHRILNHSVDKKGHVHYLIKWRDLPYDQASWESEDVEIQDYDLFKQSYWNHRELKK","Homo sapiens","CHD4","Chromodomain-helicase-DNA-binding protein 4","1","4O9I"
"4O9M",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Bis-Tris, 350 mM Sodium Acetate, 16% PEG3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/nsmb.2818",,"4O9M",48.55,"2.295","2.295","Human DNA polymerase beta complexed with adenylated tetrahydrofuran (abasic site) containing DNA","CCGACAGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*AP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","1","4O9M"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3')","2","4O9M"
,,,,,,,,,,,,,,,,"GTCGG",,,"(5'-D(P*GP*TP*CP*GP*G)-3');","3","4O9M"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","4O9M"
"4O9S",,"X-RAY DIFFRACTION",2.53,51.29,"VAPOR DIFFUSION, SITTING DROP",8,"1M ammonium phosphate dibasic, 0.1M imidazole, 0.2M sodium chloride, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.bmcl.2014.04.089","2RY","4O9S",52.64,"2.3","2.3","Crystal structure of Retinol-Binding Protein 4 (RBP4)in complex with a non-retinoid ligand","HISMASMSYYHHHHHHDYDIPTTENLYFQGAMERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL","Homo sapiens","RBP4, PRO2222","Retinol-binding protein 4","1","4O9S"
"4O9V",,"X-RAY DIFFRACTION",2.26,45.54,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris pH 8.3 0.2M MgCl2, 20% PEG 8000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2014.04.013","NT4","4O9V",27.4,"1.9","1.9","Crystal structure of matriptase in complex with inhibitor","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4O9V"
,,,,,,,,,,,,,,,,"CGLR","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Peptide CGLR","2","4O9V"
"4OA7",,"X-RAY DIFFRACTION",2.13,42.13,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Bis-Tris, 0.2 M MgCl2 and 25% PEG3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/MCB.00392-15",,"4OA7",100.05,"2.301","2.301","Crystal structure of Tankyrase1 in complex with IWR1","GPHMASGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKP","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4OA7"
"4OAS",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.9-2.4 M Ammonium Sulfate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401753e","2SW","4OAS",35.27,"1.7","1.7","co-crystal structure of MDM2 (17-111) in complex with compound 25","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OAS"
"4OAU",,"X-RAY DIFFRACTION",3.58,65.68,"VAPOR DIFFUSION",6.5,"RNase L (21-719) (15 mg/ml in buffer containing 20 mM HEPES pH 7.5, 109 mM NaCl, 5 mM MgCl 2, 5 mM DTT, 2.8 mM ATP or AMP-PCP, and 10% glycerol) was  
mixed with 2-5A and RNA18 at molar ratio 1:1.5:1.5, VAPOR DIFFUSION, temperature 277K",277,"10.1126/science.1249845",,"4OAU",80.83,"2.6","2.6","Complete human RNase L in complex with biological activators.","AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDLVMTARRNYDHSLVKVLLSHGAKEDFHPPAEDWKPQSSHWGAALKDLHRIYRPMIGKLKFFIDEKYKIADTSEGGIYLGFYEKQEVAVKTFCEGSPRAQREVSCLQSSRENSHLVTFYGSESHRGHLFVCVTLCEQTLEACLDVHRGEDVENEEDEFARNVLSSIFKAVQELHLSCGYTHQDLQPQNILIDSKKAAHLADFDKSIKWAGDPQEVKRDLEDLGRLVLYVVKKGSISFEDLKAQSNEEVVQLSPDEETKDLIHRLFHPGEHVRDCLSDLLGHPFFWTWESRYRTLRNVGNESDIKTRKSESEILRLLQPGPSEHSKSFDKWTTKINECVMKKMNKFYEKRGNFYQNTVGDLLKFIRNLGENIDEEKHKKMKLKIGDPSLYFQKTFPDLVIYVYTKLQNTEYRKHFPQT","Homo sapiens","RNASEL, RNS4","2-5A-dependent ribonuclease","1","4OAU"
,,,,,,,,,,,,,,,,"AAA",,,"RNA (5'-R(P*A*AP*A)-2')","2","4OAU"
"4OAV",,"X-RAY DIFFRACTION",3.41,63.95,"VAPOR DIFFUSION",6.5,"RNase L (21-719) (15 mg/ml in buffer containing 20 mM HEPES pH 7.5, 109 mM  
NaCl, 5 mM MgCl2, 5 mM DTT, 2.8 mM ATP or AMP-PCP, and 10% glycerol) was  
mixed with 2-5A and RNA18 at molar ratio 1:1.5:1, VAPOR DIFFUSION, temperature 277K",277,"10.1126/science.1249845",,"4OAV",163.47,"2.1","2.1","Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.","AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDLVMTARRNYDHSLVKVLLSHGAKEDFHPPAEDWKPQSSHWGAALKDLHRIYRPMIGKLKFFIDEKYKIADTSEGGIYLGFYEKQEVAVKTFCEGSPRAQREVSCLQSSRENSHLVTFYGSESHRGHLFVCVTLCEQTLEACLDVHRGEDVENEEDEFARNVLSSIFKAVQELHLSCGYTHQDLQPQNILIDSKKAAHLADFDKSIKWAGDPQEVKRDLEDLGRLVLYVVKKGSISFEDLKAQSNEEVVQLSPDEETKDLIHRLFHPGEHVRDCLSDLLGHPFFWTWESRYRTLRNVGNESDIKTRKSESEILRLLQPGPSEHSKSFDKWTTKINECVMKKMNKFYEKRGNFYQNTVGDLLKFIRNLGENIDEEKHKKMKLKIGDPSLYFQKTFPDLVIYVYTKLQNTEYRKHFPQT","Homo sapiens","RNASEL, RNS4","PROTEIN (RNase L)","1","4OAV"
,,,,,,,,,,,,,,,,"XXAAAAX",,,"RNA (5'-R(P*(PO4)P*(PO4)P*AP*AP*AP*AP*(PO4))-2')","2","4OAV"
"4OAW",,"X-RAY DIFFRACTION",3.5,64.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"23.5% PEG 4K/0.17M ammonium sulfate/15% glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1128/JVI.03153-13",,"4OAW",97.58,"2.8","2.8","Fab structure of anti-HIV gp120 V2 mAb 2158","DIQMTQSPSTLSASVGDRVTITCRASQTISSWLAWYQQKSGTAPKLLIYKASSIVSGVPSRFSGSGSGTEFTLTITSLQPDDFATYYCQQYNSSPETFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKLYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158","1","4OAW"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGSSVKVSCEASGVTSSSYTISWVRLAPGQGLEWMGRITPIFDITNYAQKFQGRVTLTADKSTGTTYMELSSLRSDDTAVYYCARDKSDVVVVTSIRPAYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKT","Homo sapiens",,"Heavy chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158","2","4OAW"
"4OBA",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",5,"1.6-2.3M Ammonium Sulfate, 0.1M citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401767k","2TW","4OBA",35.17,"1.602","1.602","Co-crystal structure of MDM2 with Inhibitor Compound 4","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OBA"
"4OBE",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate pH4.5, 0.1M Tris pH 8.5, 26% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1404639111",,"4OBE",39.59,"1.24","1.24","Crystal Structure of GDP-bound Human KRas","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4OBE"
"4OBO",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate pH 8.3, 20% PEG 3350, vapor diffusion, sitting drop, temperature 292K",292,"10.1021/jm500155b","2QV","4OBO",76.24,"2.1","2.1","MAP4K4 in complex with inhibitor (compound 22), 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","HGK, KIAA0687, MAP4K4, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4OBO"
"4OBP",,"X-RAY DIFFRACTION",2.14,42.64,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate pH 8.3, 20% PEG 3350, vapor diffusion, sitting drop, temperature 292K",292,"10.1021/jm500155b","2QU","4OBP",76.2,"2.27","2.27","MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","HGK, KIAA0687, MAP4K4, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4OBP"
"4OBQ",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate pH 8.3, 20% PEG 3350, vapor diffusion, sitting drop, temperature 292K",292,"10.1021/jm500155b","2QT","4OBQ",76.33,"2.19","2.19","MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PYRROLIDIN-1-YL)ACETAMIDE","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","HGK, KIAA0687, MAP4K4, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4OBQ"
"4OBR",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.01 M HEPES, pH 7.5, 0.26 M sodium potassium tartrate, 20% PEG3350, 50 mM ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4OBR",145.7,"2.46","2.46","Crystal structure of human alpha-L-iduronidase complex with alpha-L-iduronic acid","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4OBR"
"4OBS",,"X-RAY DIFFRACTION",2.27,45.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.18 M sodium potassium tartrate, 18% PEG3350, 50 mM ammonium sulfate, 10 mM HEPES, pH 7.5, 3% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4OBS",72.25,"2.26","2.26","Crystal structure of human alpha-L-iduronidase in the P212121 form","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","4OBS"
"4OBZ",,"X-RAY DIFFRACTION",2.37,48.03,"VAPOR DIFFUSION",5.5,"35% PEG2000, 0.1 M KCl, 0.1 M KSCN, pH 5.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2014.07.054","2S4","4OBZ",76.62,"2.9","2.9","Structure of Cathepsin D with inhibitor 2-(3,4-dimethoxyphenyl)-N-[N-(4-methylbenzyl)carbamimidoyl]acetamide","PAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQS","Homo sapiens","CPSD, CTSD","Cathepsin D light chain","1","4OBZ"
,,,,,,,,,,,,,,,,"GGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL","Homo sapiens","CPSD, CTSD","Cathepsin D heavy chain","2","4OBZ"
"4OC0",,"X-RAY DIFFRACTION",3.27,62.38,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2R7","4OC0",83.25,"1.85","1.85","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CCIBzL, a urea-based inhibitor N~2~-[(1-carboxycyclopropyl)carbamoyl]-N~6~-(4-iodobenzoyl)-L-lysine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC0"
"4OC1",,"X-RAY DIFFRACTION",3.29,62.59,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2QS","4OC1",83.28,"1.75","1.75","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with COIBzL, a urea-based inhibitor (2S)-2-[({(1S)-1-carboxy-2-[(2S)-oxiran-2-yl]ethyl}carbamoyl)amino]-6-[(4-iodobenzoyl)amino]hexanoic acid","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC1"
"4OC2",,"X-RAY DIFFRACTION",3.29,62.57,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2QQ","4OC2",83.72,"1.65","1.65","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CEIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxybut-3-yn-1-yl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC2"
"4OC3",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2QP","4OC3",83.62,"1.79","1.79","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CFIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxy-2-(furan-2-yl)ethyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC3"
"4OC4",,"X-RAY DIFFRACTION",3.29,62.67,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2QN","4OC4",83.32,"1.66","1.66","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CPIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxy-2-(pyridin-4-yl)ethyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC4"
"4OC5",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.066","2QM","4OC5",83.32,"1.7","1.7","X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CHIBzL, a urea-based inhibitor N~2~-{[(S)-carboxy(4-hydroxyphenyl)methyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OC5"
"4OC6",,"X-RAY DIFFRACTION",2.85,56.82,"VAPOR DIFFUSION",5.5,"PEG 3350, pH 5.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2014.07.054","2S1","4OC6",39.77,"2.64","2.64","Structure of Cathepsin D with inhibitor 2-bromo-N-[(2S,3S)-4-{[2-(2,4-dichlorophenyl)ethyl][3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanoyl]amino}-3-hydroxy-1-(3-phenoxyphenyl)butan-2-yl]-4,5-dimethoxybenzamide","PAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQS","Homo sapiens","CTSD, CPSD","Cathepsin D light chain","1","4OC6"
,,,,,,,,,,,,,,,,"GGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL","Homo sapiens","CTSD, CPSD","Cathepsin D heavy chain","2","4OC6"
"4OCC",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.9-2.4 M Ammonium Sulfate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2TZ","4OCC",35.14,"1.8","1.8","co-crystal structure of MDM2(17-111) in complex with compound 48","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OCC"
"4OCR",,"X-RAY DIFFRACTION",3.05,59.67,"VAPOR DIFFUSION, HANGING DROP",5.5,"32% PEG400, 4% PEG3350, 0.1 M sodium acetate, pH 5.5, cryoprotectant: 20% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4OCR",50.38,"1.895","1.895","Crystal structure of human Fab CAP256-VRC26.01, a potent V1V2-directed HIV-1 neutralizing antibody","QSVLTQPPSVSAAPGQKVTISCSGSSSTIGNNYVSWYRLLPGTAPKLLIYKNDNRPSGIPDRFSGSKSGTSATLGISGLQTGDEADYYCGTWDTSLSGGGVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.01 light chain","1","4OCR"
,,,,,,,,,,,,,,,,"EVQVVESGGGVVQPGRSLRLSCTASGFTFSNFAMGWVRQAPGKGLEWVAFISSDGSNKNYGDSVKGRFTISRDNSKNTVFLQMNSLRVEDTALYYCAKDVGDYKSDEWGTEYYDISISYPIQDPRAMVGAFDLWGQGTMVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.01 heavy chain","2","4OCR"
"4OCS",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG4000, 0.4 M sodium acetate, 0.1 M Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4OCS",50.94,"1.901","1.901","Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1 neutralizing antibody","QSVLTQPPSVSAAPGQKVTISCSGSSSNIGDNYVSWYQHLPGTAPKLLIYENTRRPSGIPDRFSGSKSGTSATLAITGLQTGDEADYYCGTWDVRPNRGAVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.10 light chain","1","4OCS"
,,,,,,,,,,,,,,,,"QAILVESGGGVVQPGRSLRLSCAASQFTFSGHGLHWVRQAPGKGLEWVASISFAGTKMDYADSVKGRFAISRDNSKNTLYLQMNSLRVEDTALYYCAKDMREYECEYWTSDYYDFGRPQPCIDRRGVVGIFDMWGQGTMVTVSTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.10 heavy chain","2","4OCS"
"4OCT",,"X-RAY DIFFRACTION",2.2,42.4,"VAPOR DIFFUSION",,"0.005 M of each manganous sulfate and 2-oxyglutarate were added to the protein stock solution. Reservoir: 20% PEG-3350, 0.2 M diammonium phosphate, vapor diffusion, temperature 291K",291,"10.1074/jbc.M114.550350","AKG","4OCT",51.08,"2.28","2.28","Crystal structure of human ALKBH5 crystallized in the presence of Mn^{2+} and 2-oxoglutarate","GQQLQKEEEARKVKSGIRQMRLFSQDECAKIEARIDEVVSRAEKGLYNEHTVDRAPLRNKYFFGEGYTYGAQLQKRGPGQERLYPPGDVDEIPEWVHQLVIQKLVEHRVIPEGFVNSAVINDYQPGGCIVSHVDPIHIFERPIVSVSFFSDSALCFGCKFQFKPIRVSEPVLSLPVRRGSVTVLSGYAADEITHCIRPQDIKERRAVIILRKTRLDAPRLET","Homo sapiens","ALKBH5, ABH5, OFOXD1","RNA demethylase ALKBH5","1","4OCT"
"4OCW",,"X-RAY DIFFRACTION",4.29,71.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"3 M sodium formate, 0.1 M Tris, pH 7.5, cryoprotectant: 20% xylitol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4OCW",50.49,"3.001","3.001","Crystal structure of human Fab CAP256-VRC26.06, a potent V1V2-directed HIV-1 neutralizing antibody","QSVLTQPPSVSAAPGQKVTISCSGSTSKIGQNSVSWYQQLPGTAPKLLIYENDRRPSGTPDRFSGSKSGTSATLAITGLQTGDEAEYYCETWDGSGGVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.06 light chain","1","4OCW"
,,,,,,,,,,,,,,,,"EVQLIESGGGVVQPGRSLRLSCGASGFSFNNYGMHWVRQAPGKGLEWVAGISFAGIKKYYGTSVKGRFTISRDNSKNNFYLQMNSLRVEDTALYYCARDLRELECEEWTLYNYYDFGSRGPCVDPRGVAGSFDVWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.06 heavy chain","2","4OCW"
"4OCZ",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG3350, 0-10% sucrose, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500694p","2RU","4OCZ",63.16,"2.94","2.94","Crystal structure of human soluble epoxide hydrolase complexed with 1-(1-isobutyrylpiperidin-4-yl)-3-(4-(trifluoromethyl)phenyl)urea","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4OCZ"
"4OD0",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG3350, 0-10% sucrose, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm500694p","2RV","4OD0",63.16,"2.92","2.92","Crystal structure of human soluble epoxide hydrolase complexed with 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4OD0"
"4OD1",,"X-RAY DIFFRACTION",2.68,54.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG8000, 5% MPD, 0.1 M imidazole, cryoprotectant: 20% xylitol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4OD1",51.05,"2.69","2.69","Crystal structure of human Fab CAP256-VRC26.03, a potent V1V2-directed HIV-1 neutralizing antibody","VQLVESGGGVVQPGKSLRLSCAASRFSFNRYGMHWVRQAPGKGLEWVAAISYDGTDKYHADKVWGRFTISRDNSKNTLYLQMNSLRAEDTALYYCAKDLREDECEEWWSDYYDFGKQLPCRKSRGVAGIFDGWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.03 heavy chain","1","4OD1"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNFVSWYQQRPGTAPKILIYENNKRPSETPDRFSGSKSGTSATLAITGLQTADEAEYYCATWSASLSSARVFGTGTRITVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.03 light chain","2","4OD1"
"4OD3",,"X-RAY DIFFRACTION",3.38,63.59,"VAPOR DIFFUSION, HANGING DROP",6,"4% PEG8000, 0.1 M zinc acetate, 0.1 M MES, pH 6, cryoprotectant: 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4OD3",51.44,"2.616","2.616","Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing antibody","QAVLTQPPSVSAAPGQNVTISCSGSGSNIGNNFVSWYQQRPGTAPKLLIYESNKRPSGIPDRFSGSKSGTSATLAITGLQTGDEAYYYCATWAARLNSARVFGTGTMVTVLGQPKANPTVTLYPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.07 light chain","1","4OD3"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCVGSQFSFNRYGMHWVRQAPGKGLEWVAGISFDGTDRYHADNVWGRFTISRDNSKNTLYLQMSSLRAEDTALYYCAKDLREDECEEWWSDYYDFGKKLPCRKSRGVAGVFDKWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.07 heavy chain","2","4OD3"
"4OD9",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION",5.5,"35% PEG2000, 0,1 M KCl, 0.1 M Na-Acetat (pH 5.5), VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2014.07.054","2RZ","4OD9",77.89,"1.9","1.9","Structure of Cathepsin D with inhibitor N-(3,4-dimethoxybenzyl)-Nalpha-{N-[(3,4-dimethoxyphenyl)acetyl]carbamimidoyl}-D-phenylalaninamide","PAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQS","Homo sapiens","CPSD, CTSD","Cathepsin D light chain","1","4OD9"
,,,,,,,,,,,,,,,,"GGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL","Homo sapiens","CPSD, CTSD","Cathepsin D heavy chain","2","4OD9"
"4ODE",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",5,"0.8-1.8M Ammonium Sulfate, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2U0","4ODE",12.93,"1.8","1.8","Co-Crystal Structure of MDM2 with Inhibitor Compound 4","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4ODE"
"4ODF",,"X-RAY DIFFRACTION",2.45,49.72,"VAPOR DIFFUSION, HANGING DROP",5,"0.8-1.8M Ammonium Sulfate, 0.1M sodium Citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2U1","4ODF",12.7,"2.2006","2.2006","Co-Crystal Structure of MDM2 with Inhibitor Compound 47","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4ODF"
"4ODH",,"X-RAY DIFFRACTION",2.01,38.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"27% PEG8000, 0.1 M HEPES, pH 7.5, cryoprotectant: 20% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4ODH",49.6,"2.894","2.894","Crystal structure of human Fab CAP256-VRC26.UCA, a potent V1V2-directed HIV-1 neutralizing antibody","QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGGVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.UCA light chain","1","4ODH"
,,,,,,,,,,,,,,,,"QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLGESENEEWATDYYDFSIGYPGQDPRGVVGAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"CAP256-VRC26.UCA heavy chain","2","4ODH"
"4OE5",,"X-RAY DIFFRACTION",2.1,41.43,"VAPOR DIFFUSION, SITTING DROP",7,"20 - 25 % (w/v) PEG 3350, 0.2 M MgCl2, and 0.1 M HEPES at pH 7.0 - 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi500048b",,"4OE5",241.26,"1.95","1.95","Structure of Human ALDH4A1 Crystallized in Space Group P21","GSHTGAGLRWKHTSSLKVANEPVLAFTQGSPERDALQKALKDLKGRMEAIPCVVGDEEVWTSDVQYQVSPFNHGHKVAKFCYADKSLLNKAIEAALAARKEWDLKPIADRAQIFLKAADMLSGPRRAEILAKTMVGQGKTVIQAEIDAAAELIDFFRFNAKYAVELEGQQPISVPPSTNSTVYRGLEGFVAAISPFNFTAIGGNLAGAPALMGNVVLWKPSDTAMLASYAVYRILREAGLPPNIIQFVPADGPLFGDTVTSSEHLCGINFTGSVPTFKHLWKQVAQNLDRFHTFPRLAGECGGKNFHFVHRSADVESVVSGTLRSAFEYGGQKCSACSRLYVPHSLWPQIKGRLLEEHSRIKVGDPAEDFGTFFSAVIDAKSFARIKKWLEHARSSPSLTILAGGKCDDSVGYFVEPCIVESKDPQEPIMKEEIFGPVLSVYVYPDDKYKETLQLVDSTTSYGLTGAVFSQDKDVVQEATKVLRNAAGNFYINDKSTGSIVGQQPFGGARASGTNDKPGGPHYILRWTSPQVIKETHKPLGDWSYAYMQ","Homo sapiens","ALDH4, ALDH4A1, P5CDH","Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial","1","4OE5"
"4OE9",,"X-RAY DIFFRACTION",1.96,37.38,"VAPOR DIFFUSION, HANGING DROP",4.9,"28% mPEG 5000, 0.2M citric acid, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.7554/eLife.35898",,"4OE9",27.74,"1.55","1.55","The crystal structure of the n-terminal domain of COMMD9","MSGAMAALTAEHFAALQSLLKASSKDVVRQLCQESFSSSALGLKKLLDVTCSSLSVTQEEAEELLQALHRMTRLVAFRDLSSAEAILALFPENFHQNLKNLLTKIMLEHVSTWRTEAQANQ","Homo sapiens","COMMD9, HSPC166","COMM domain-containing protein 9","1","4OE9"
"4OEA",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 
0.1M MES 
, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","DHT","4OEA",29.38,"2.12","2.12","Crystal structure of AR-LBD","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OEA"
"4OEE",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, HANGING DROP",4.2,"40% polyethylene glycol 600 and 100 mM Na2HPO4/citric acid, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 299K",299,"10.1021/cb500298q",,"4OEE",17.86,"1.5","1.5","Crystal Structure Analysis of FGF2-Disaccharide (S3I2) complex","MAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS","Homo sapiens","FGF2, FGFB","Fibroblast growth factor 2","1","4OEE"
"4OEF",,"X-RAY DIFFRACTION",1.79,31.41,"VAPOR DIFFUSION, HANGING DROP",4.2,"40% polyethylene glycol 600 and 100 mM Na2HPO4/citric acid, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 299K",299,"10.1021/cb500298q",,"4OEF",17.86,"1.8","1.8","Crystal Structure Analysis of FGF2-Disaccharide (S6I2) complex","MAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS","Homo sapiens","FGF2, FGFB","Fibroblast growth factor 2","1","4OEF"
"4OEG",,"X-RAY DIFFRACTION",1.78,30.91,"VAPOR DIFFUSION, HANGING DROP",4.2,"40% polyethylene glycol 600 and 100 mM Na2HPO4/citric acid, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 299K",299,"10.1021/cb500298q",,"4OEG",17.94,"1.6","1.6","Crystal Structure Analysis of FGF2-Disaccharide (S9I2) complex","MAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS","Homo sapiens","FGF2, FGFB","Fibroblast growth factor 2","1","4OEG"
"4OEL",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",,"16-26% polyethylene glycol-3350 at pH 6.0-6.9 in 200 mM MgCl2,   
100 mM Bis-Tris buffer, sitting drop, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/bi300719b",,"4OEL",50.74,"1.4","1.4","Crystal structure of Cathepsin C in complex with dipeptide substrates","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVGTASENVYVNTAHLKNSQEKYSNRLYKYDHNFVKAINAIQKSWTATTYMEYETLTLGDMIRRSGGHSRKIPRPKPAPLTAEIQQKILHLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CPPI, CTSC","Dipeptidyl peptidase 1 Heavy chain","1","4OEL"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKLE","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1 Light chain","2","4OEL"
"4OEM",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",,"16-26% polyethylene glycol-3350 at pH 6.0-6.9 in 200 mM MgCl2,   
100 mM Bis-Tris buffer, sitting drop, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,"10.1021/bi300719b",,"4OEM",51.02,"1.52","1.52","Crystal structure of Cathepsin C in complex with dipeptide substrates","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVGTASENVYVNTAHLKNSQEKYSNRLYKYDHNFVKAINAIQKSWTATTYMEYETLTLGDMIRRSGGHSRKIPRPKPAPLTAEIQQKILHLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CPPI, CTSC","Dipeptidyl peptidase 1 Heavy chain","1","4OEM"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKLE","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1 Light chain","2","4OEM"
"4OEO",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG2K MME, 0.1 M NaAc pH4.6, 0.2 M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M115.646695",,"4OEO",35.92,"1.9","1.9","High resolution crystal structure of the unliganded ZO-1 PDZ1 domain","GSHMIWEQHTVTLHRAPGFGFGIAISGGRDNPHFQSGETSIVISDVLKGGPAEGQLQENDRVAMVNGVSMDNVEHAFAVQQLRKSGKNAKITIRRKKGGGESLTGYV","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","4OEO"
"4OEP",,"X-RAY DIFFRACTION",3.32,62.91,"VAPOR DIFFUSION, HANGING DROP",4.6,"40% PEG2K MME, 0.1 M NaAc pH4.6, 0.2 M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M115.646695",,"4OEP",23.61,"2.35","2.35","Crystal structure of the ZO-1 PDZ1 domain in complex with the 7-mer Claudin1 C-terminal tail","GSHMIWEQHTVTLHRAPGFGFGIAISGGRDNPHFQSGETSIVISDVLKGGPAEGQLQENDRVAMVNGVSMDNVEHAFAVQQLRKSGKNAKITIRRKKGGGSSGKDYV","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","4OEP"
"4OEW",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v)PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm5002315","5IO","4OEW",40.73,"2.44","2.44","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4OEW"
"4OEX",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v)PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm5002315","5EO","4OEX",40.6,"2.14","2.14","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","4OEX"
"4OF5",,"X-RAY DIFFRACTION",4.33,71.57,"VAPOR DIFFUSION, HANGING DROP",7.4,"10% PEG6000, 0.1 M Tris_HCl pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1084/jem.20132526",,"4OF5",48.39,"2.803","2.803","Refinement of RAGE-DNA complex in 3S59 without DNA","GSVDAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEAAAS","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4OF5"
"4OFA",,"X-RAY DIFFRACTION",2.02,38.98,"VAPOR DIFFUSION, HANGING DROP",8,"33% ethylene glycol, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4OFA",29.85,"1.55","1.55","Structural basis for thymine glycosylase activity on T:O6-methylG mismatch by methyl-CpG binding domain protein 4: Implications for roles of Arg468 in mismatch recognition and catalysis","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEFMALSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPENHKLNKYHDWLWENHEKLSLS","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4OFA"
,,,,,,,,,,,,,,,,"CCAGCGTGCAGC",,,"12-mer DNA(T)","2","4OFA"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"12-mer DNA(G)","3","4OFA"
"4OFB",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Sodium Cacodylate, 0.1M Magnesium Acetate,24% PEG6000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/cb500757u",,"4OFB",26.19,"3.05","3.05","Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor","VNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","4OFB"
,,,,,,,,,,,,,,,,"XTIDFDEYRFRKTX",,,"nonphosphopeptide inhibitor","2","4OFB"
"4OFC",,"X-RAY DIFFRACTION",2.29,46.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Bis-Tris, 22% PEG 3350, 0.2 M lithium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/prot.24722",,"4OFC",228.12,"1.99","1.99","2.0 Angstroms X-ray crystal structure of human 2-amino-3-carboxymuconate-6-semialdehye decarboxylase","MKIDIHSHILPKEWPDLKKRFGYGGWVQLQHHSKGEAKLLKDGKVFRVVRENCWDPEVRIREMDQKGVTVQALSTVPVMFSYWAKPEDTLNLCQLLNNDLASTVVSYPRRFVGLGTLPMQAPELAVKEMERCVKELGFPGVQIGTHVNEWDLNAQELFPVYAAAERLKCSLFVHPWDMQMDGRMAKYWLPWLVGMPAETTIAICSMIMGGVFEKFPKLKVCFAHGGGAFPFTVGRISHGFSMRPDLCAQDNPMNPKKYLGSFYTDALVHDPLSLKLLTDVIGKDKVILGTDYPFPLGELEPGKLIESMEEFDEETKNKLKAGNALAFLGLERKQF","Homo sapiens","ACMSD","2-amino-3-carboxymuconate-6-semialdehyde decarboxylase","1","4OFC"
"4OFE",,"X-RAY DIFFRACTION",2.03,39.37,"VAPOR DIFFUSION, HANGING DROP",8,"15% PEG1500, 0.1M MES at pH of 6.5, 0.2M Na Acetate., VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4OFE",29.83,"2.15","2.15","Structural basis for thymine glycosylase activity on T:O6-methylG mismatch by methyl-CpG binding domain protein 4: Implications for roles of Arg468 in mismatch recognition and catalysis","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEFMALSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNKTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPENHKLNKYHDWLWENHEKLSLS","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4OFE"
,,,,,,,,,,,,,,,,"CCAGCGTGCAGC",,,"12-mer DNA(T)","2","4OFE"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"12-mer DNA(G)","3","4OFE"
"4OFH",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",8,"21% ethylene glycol, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4OFH",29.87,"2.22","2.22","Structural basis for thymine glycosylase activity on T:O6-methylG mismatch by methyl-CpG binding domain protein 4: Implications for roles of Arg468 in mismatch recognition and catalysis","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEFMALSPPRRKAFKKWTPPRSPFNLVQETLFHDPWKLLIATIFLNRTSGKMAIPVLWKFLEKYPSAEVARTADWRDVSELLKPLGLYDLRAKTIVKFSDEYLTKQWKYPIELHGIGKYGNDSYRIFCVNEWKQVHPENHKLNKYHDWLWENHEKLSLS","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","4OFH"
,,,,,,,,,,,,,,,,"CCAGCGTGCAGC",,,"12-mer DNA(T)","2","4OFH"
,,,,,,,,,,,,,,,,"GCTGCGCGCTGG",,,"12-mer DNA(O6MeG)","3","4OFH"
"4OFV",,"X-RAY DIFFRACTION",4.19,70.61,"VAPOR DIFFUSION",7.4,"12% PEG6000, 0.1 M Tris-HCl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1084/jem.20132526",,"4OFV",48.39,"3.1","3.1","Refinement of RAGE-DNA complex in 3S58 without DNA","GSVDAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEAAAS","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4OFV"
"4OG3",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2S6","4OG3",55,"2.01","2.01","Human menin with bound inhibitor MIV-3R","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG3"
"4OG4",,"X-RAY DIFFRACTION",2.27,45.91,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2VK","4OG4",55.25,"1.45","1.45","Human menin with bound inhibitor MIV-3S","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG4"
"4OG5",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2S7","4OG5",55.01,"1.63","1.63","Human menin with bound inhibitor MIV-5","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG5"
"4OG6",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2S9","4OG6",55.96,"1.49","1.49","Human menin with bound inhibitor MIV-4","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG6"
"4OG7",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2SE","4OG7",55.84,"2.08","2.08","Human menin with bound inhibitor MIV-7","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG7"
"4OG8",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl (pH 8.0), 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1021/jm401868d","2SF","4OG8",56.09,"1.53","1.53","Human menin with bound inhibitor MIV-6R","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4OG8"
"4OGB",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, HANGING DROP",,"20% (w/v) PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol and 100 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4OGB",171.27,"2.032","2.032","Crystal structure of the catalytic domain of PDE4D2 with compound 2","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLE","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","4OGB"
"4OGF",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 1.4 M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP",,"10.1111/febs.13085",,"4OGF",19.74,"1.6","1.6","Crystal Structure of Human DJ-1 with glyoxylate as substrate analog","ASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAIXAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLK","Homo sapiens","PARK7","Protein DJ-1","1","4OGF"
"4OGH",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OGH",29.45,"2.98","2.98","Crystal structure of T877A-AR-LBD","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OGH"
"4OGI",,"X-RAY DIFFRACTION",2.41,48.87,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M potassium citrate, 0.1 M Bis-Tris propane, pH 8.5, 20.0% PEG3350, 10% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nchembio.1471","R78","4OGI",31.37,"1.73","1.73","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor BI-2536","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4OGI"
"4OGJ",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20 M sodium potassium tartrate, 0.1 M Bis-Tris propane, pH 7.5, 20.0% PEG3350, 10% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nchembio.1471","2TA","4OGJ",31.43,"1.65","1.65","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor TG-101348","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4OGJ"
"4OGN",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",5,"0.8-1.8M Ammonium Sulfate, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2U5","4OGN",12.89,"1.377","1.377","Co-Crystal Structure of MDM2 with Inhbitor Compound 3","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OGN"
"4OGT",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",5,"0.8-1.8M Ammonium Sulfate, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2U6","4OGT",12.8,"1.5361","1.5361","Co-Crystal Structure of MDM2 with Inhbitor Compound 46","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OGT"
"4OGU",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl, PEG 6000, 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"210","4OGU",43.65,"2.1","2.1","The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNTIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFAQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4OGU"
"4OGV",,"X-RAY DIFFRACTION",2.16,43.17,"VAPOR DIFFUSION, HANGING DROP",5,"1.6-2.3M Ammonium Sulfate, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm401911v","2U7","4OGV",34.97,"2.197","2.197","Co-Crystal Structure of MDM2 with Inhibitor Compound 49","SQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OGV"
"4OGW",,"X-RAY DIFFRACTION",1.97,37.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"23% PEG3350, 0.1M Bis-Tris-Propane, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.abb.2014.09.008",,"4OGW",30,"2.05","2.05","Structure of a human CD38 mutant complexed with NMN","GSWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","4OGW"
"4OH2",,"X-RAY DIFFRACTION",3.85,68.07,"VAPOR DIFFUSION, HANGING DROP",7.6,"100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bpj.2014.07.068",,"4OH2",158.96,"2.384","2.384","Crystal Structure of Cu/Zn Superoxide Dismutase I149T","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVTGIAQ","Homo sapiens","Homo sapiens SOD1, SOD1","Superoxide dismutase [Cu-Zn]","1","4OH2"
"4OH5",,"X-RAY DIFFRACTION",2.13,42.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OH5",30.71,"2","2","Crystal structure of T877A-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OH5"
,,,,,,,,,,,,,,,,"RGAFQNLFQSV",,,"co-regulator peptide","2","4OH5"
"4OH9",,"X-RAY DIFFRACTION",1.92,35.82,"VAPOR DIFFUSION, HANGING DROP",7,"2.0 M NaCl, 8% polyethylene glycol (PEG) 6000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S139900471400947X",,"4OH9",12.19,"1.699","1.699","Crystal Structure of the human MST2 SARAH homodimer","GSDFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAK","Homo sapiens","STK3, KRS1, MST2","Serine/threonine-protein kinase 3","1","4OH9"
"4OHA",,"X-RAY DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OHA",30.84,"1.42","1.42","Crystal structure of T877A-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OHA"
,,,,,,,,,,,,,,,,"SDSAFSRLYTRS",,,"co-regulator peptide","2","4OHA"
"4OHD",,"X-RAY DIFFRACTION",1.9,35.32,"VAPOR DIFFUSION, HANGING DROP",7.3,"18% PEG3350, 300 mM KF, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi5002695",,"4OHD",61.79,"2.7","2.7","LEOPARD Syndrome-Associated SHP2/A461T mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSTGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTP2C, PTPN11, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4OHD"
"4OHE",,"X-RAY DIFFRACTION",2.05,39.91,"VAPOR DIFFUSION, HANGING DROP",6.8,"20% PEG3350, 300 mM LiCl, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi5002695",,"4OHE",61.78,"2.506","2.506","LEOPARD Syndrome-Associated SHP2/G464A mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIARTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTP2C, PTPN11, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4OHE"
"4OHH",,"X-RAY DIFFRACTION",2,38.62,"VAPOR DIFFUSION, HANGING DROP",7.3,"20% PEG3350, 200 mM KF, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi5002695",,"4OHH",61.73,"2.7","2.7","LEOPARD Syndrome-Associated SHP2/Q506P mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVPTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTP2C, PTPN11, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4OHH"
"4OHI",,"X-RAY DIFFRACTION",2.05,39.92,"VAPOR DIFFUSION, HANGING DROP",7.3,"18% PEG3350, 200 mM KF, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi5002695",,"4OHI",61.76,"2.2","2.2","LEOPARD Syndrome-Associated SHP2/Q510E mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAEYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTP2C, PTPN11, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4OHI"
"4OHK",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, HANGING DROP",7.5,".1M Bis-tris, .2M NaI, 16%PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5000497",,"4OHK",145.7,"2.8","2.8","Human GKRP bound to AMG-2526 and S6P","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4OHK"
"4OHL",,"X-RAY DIFFRACTION",2.14,42.54,"VAPOR DIFFUSION, HANGING DROP",7.3,"20% PEG3350, 300 mM KCOOH, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi5002695",,"4OHL",123.58,"2.4","2.4","LEOPARD Syndrome-Associated SHP2/T468M mutant","MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGMFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTP2C, PTPN11, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4OHL"
"4OHM",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16%PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5000497","2TF","4OHM",145.53,"2.4","2.4","Human GKRP bound to AMG-0771 and sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4OHM"
"4OHO",,"X-RAY DIFFRACTION",3.01,59.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5000497","2TG","4OHO",145.67,"2.58","2.58","Human GKRP bound to AMG-2668","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4OHO"
"4OHP",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5000497","2TJ","4OHP",145.46,"2.4","2.4","Human GKRP bound to AMG-3227 and S6P","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4OHP"
"4OI7",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",7.4,"12% PEG6000, 0.1 M Tris-HCl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1084/jem.20120201",,"4OI7",62.14,"3.104","3.104","RAGE recognizes nucleic acids and promotes inflammatory responses to DNA","CACGTTCGTAGCATCGTTGCAG",,,"5'-D(*CP*AP*CP*GP*TP*TP*CP*GP*TP*AP*GP*CP*AP*TP*CP*GP*TP*TP*GP*CP*AP*G)-3'","3","4OI7"
,,,,,,,,,,,,,,,,"GSVDAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEAAAS","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4OI7"
,,,,,,,,,,,,,,,,"CTGCAACGATGCTACGAACGTG",,,"5'-D(*CP*TP*GP*CP*AP*AP*CP*GP*AP*TP*GP*CP*TP*AP*CP*GP*AP*AP*CP*GP*TP*G)-3'","2","4OI7"
"4OI8",,"X-RAY DIFFRACTION",3.21,61.63,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M HEPES, pH 7.4, 5% PEG6000, 5% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1084/jem.20120201",,"4OI8",62.47,"3.101","3.101","RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.","GSVDAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEAAAS","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","4OI8"
,,,,,,,,,,,,,,,,"CCATGACTGTAGGAAACTCTAGA",,,"5'-D(*CP*CP*AP*TP*GP*AP*CP*TP*GP*TP*AP*GP*GP*AP*AP*AP*CP*TP*CP*TP*AP*GP*A)-3'","2","4OI8"
,,,,,,,,,,,,,,,,"CTCTAGAGTTTCCTACAGTCATG",,,"5'-D(*CP*TP*CP*TP*AP*GP*AP*GP*TP*TP*TP*CP*CP*TP*AP*CP*AP*GP*TP*CP*AP*TP*G)-3'","3","4OI8"
"4OI9",,"X-RAY DIFFRACTION",3.77,67.33,"VAPOR DIFFUSION",5.6,"100 mM Tris-HCl 8.5, 10% PEG4000, pH 5.6, VAPOR DIFFUSION, temperature 294K",294,"10.1107/S1399004714009468",,"4OI9",46.36,"2.5","2.5","Crystal Structure of ICAM-5 D1-D4 ectodomain fragment, Space Group P21","EPFWADLQPRVAFVERGGSLWLNCSTNCPRPERGGLETSLRRNGTQRGLRWLARQLVDIREPETQPVCFFRCARRTLQARGLIRTFQRPDRVELMPLPPWQPVGENFTLSCRVPGAGPRASLTLTLLRGAQELIRRSFAGEPPRARGAVLTATVLARREDHGANFSCRAELDLRPHGLGLFENSSAPRELRTFSLSPDAPRLAAPRLLEVGSERPVSCTLDGLFPASEARVYLALGDQNLSPDVTLEGDAFVATATATASAEQEGARQLVCNVTLGGENRETRENVTIYSFPAPLLTLSEPSVSEGQMVTVTCAAGAQALVTLEGVPAAVPGQPAQLQLNATENDDRRSFFCDATLDVDGETLIKNRSAELRVLYAPR","Homo sapiens","ICAM5, TLCN, TLN","Intercellular adhesion molecule 5","1","4OI9"
"4OIA",,"X-RAY DIFFRACTION",4.17,70.54,"VAPOR DIFFUSION",8.5,"100 mM Tris-HCl 8.5, 10% PEG4000 , VAPOR DIFFUSION, temperature 294K",294,"10.1107/S1399004714009468",,"4OIA",88.74,"3.7","3.7","Crystal Structure of ICAM-5 D1-D4 ectodomain fragment, Space Group P4322","EPFWADLQPRVAFVERGGSLWLNCSTNCPRPERGGLETSLRRNGTQRGLRWLARQLVDIREPETQPVCFFRCARRTLQARGLIRTFQRPDRVELMPLPPWQPVGENFTLSCRVPGAGPRASLTLTLLRGAQELIRRSFAGEPPRARGAVLTATVLARREDHGANFSCRAELDLRPHGLGLFENSSAPRELRTFSLSPDAPRLAAPRLLEVGSERPVSCTLDGLFPASEARVYLALGDQNLSPDVTLEGDAFVATATATASAEQEGARQLVCNVTLGGENRETRENVTIYSFPAPLLTLSEPSVSEGQMVTVTCAAGAQALVTLEGVPAAVPGQPAQLQLNATENDDRRSFFCDATLDVDGETLIKNRSAELRVLYAPR","Homo sapiens","ICAM5, TLCN, TLN","Intercellular adhesion molecule 5","1","4OIA"
"4OIB",,"X-RAY DIFFRACTION",8.52,85.55,"VAPOR DIFFUSION",5.6,"100 mM sodium acetate, 10% PEG 4000, VAPOR DIFFUSION, temperature 294K, pH 5.6",294,"10.1107/S1399004714009468",,"4OIB",45.62,"3.503","3.503","Crystal Structure of ICAM-5 D1-D4 ectodomain fragment, Space Group R3","EPFWADLQPRVAFVERGGSLWLNCSTNCPRPERGGLETSLRRNGTQRGLRWLARQLVDIREPETQPVCFFRCARRTLQARGLIRTFQRPDRVELMPLPPWQPVGENFTLSCRVPGAGPRASLTLTLLRGAQELIRRSFAGEPPRARGAVLTATVLARREDHGANFSCRAELDLRPHGLGLFENSSAPRELRTFSLSPDAPRLAAPRLLEVGSERPVSCTLDGLFPASEARVYLALGDQNLSPDVTLEGDAFVATATATASAEQEGARQLVCNVTLGGENRETRENVTIYSFPAPLLTLSEPSVSEGQMVTVTCAAGAQALVTLEGVPAAVPGQPAQLQLNATENDDRRSFFCDATLDVDGETLIKNRSAELRVLYAPR","Homo sapiens","ICAM5, TLCN, TLN","Intercellular adhesion molecule 5","1","4OIB"
"4OIL",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OIL",30.83,"2.51","2.51","Crystal structure of T877A-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OIL"
,,,,,,,,,,,,,,,,"NTTDTLFSQHYR",,,"co-regulator peptide","2","4OIL"
"4OIU",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OIU",30.77,"3.01","3.01","Crystal structure of T877A-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OIU"
,,,,,,,,,,,,,,,,"ANSSFRDWYTSS",,,"co-regulator peptide","2","4OIU"
"4OIV",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, HANGING DROP",5.9,"16-26% polyethylene glycol 2000 MME, 0.2M NaCl, 0.1M MES, pH 5.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M114.630475","XX9","4OIV",53.97,"1.7","1.7","Structural basis for small molecule NDB as a selective antagonist of FXR","ELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFAELLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLEEIW","Homo sapiens","NR1H4, BAR, FXR, HRR1, RIP14","Bile acid receptor","1","4OIV"
"4OJ2",,"X-RAY DIFFRACTION",3.1,60.37,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG 400, 0.1M sodium chloride, 0.1M MOPS, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"4OJ2",29.17,"3.05","3.05","The structure of aquaporin","SHVMWELRSIAFSRAVFAEFLATLLFVFFGLGSALNWPQALPSVLQIAMAFGLGIGTLVQALGHISGAHINPAVTVACLVGCHVSVLRAAFYVAAQLLGAVAGAALLHEITPADIRGDLAVNALSNSTTAGQAVTVELFLTLQLVLCIFASTDERRGENPGTPALSIGFSVALGHLLGIHYTGCSMNPARSLAPAVVTGKFDDHWVFWIGPLVGAILGSLLYNYVLFPPAKSLSERLAVLKGLEPDTDWEEREVRRRQAVELHSPQSLPRGTKA","Homo sapiens","AQP2","Aquaporin-2","1","4OJ2"
"4OJ4",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000 30%, CaCl2 200 mM, HEPES 100 mM, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4OJ4",32.14,"2.3","2.3","Crystal structure of V290M PPARgamma mutant in complex with diclofenac","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSMEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4OJ4"
"4OJ9",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","HFT","4OJ9",30.98,"3.31","3.31","Crystal structure of T877A-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OJ9"
,,,,,,,,,,,,,,,,"SDSAFSRYYTRS",,,"co-regulator peptide","2","4OJ9"
"4OJB",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","0U9, 198","4OJB",29.45,"2","2","Crystal structure of W741L-AR-LBD","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OJB"
"4OJN",,"X-RAY DIFFRACTION",3.48,64.63,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Bis-Tris propane, pH 7.0, 20% PEG400, 100 mM lithium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714024791",,"4OJN",301.64,"2.4","2.4","Crystal structure of human muscle L-lactate dehydrogenase","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4OJN"
"4OK1",,"X-RAY DIFFRACTION",2.05,39.96,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","0U9, 198","4OK1",30.71,"2.09","2.09","Crystal structure of W741L-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OK1"
,,,,,,,,,,,,,,,,"RGAFQNLFQSV",,,"co-regulator peptide","2","4OK1"
"4OKH",,"X-RAY DIFFRACTION",2.08,40.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 10% PEG 8000, 8% 1,2-ethanediol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/febs.12849",,"4OKH",69.53,"2.45","2.45","Crystal structure of calpain-3 penta-EF-hand domain","MGSSDQESEEQQQFRNIFKQIAGDDMEICADELKKVLNTVVNKHKDLKTHGFTLESCRSMIALMDTDGSGKLNLQEFHHLWNKIKAWQKIFKHYDTDQSGTINSYEMRNAVNDAGFHLNNQLYDIITMRYADKHMNIDFDSFICCFVRLEGMFRAFHAFDKDGDGIIKLNVLEWLQLTMYALEHHHHHH","Homo sapiens","CAN3, CANP3, CANPL3, CAPN3, NCL1","Calpain-3","1","4OKH"
"4OKN",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",7,"18% w/v PEG3350, 50 mM HEPES, pH 6.8, Silver Bullets Bio Screen 1 reagent A1 (Hampton Research), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714024791",,"4OKN",306.17,"2.1","2.1","Crystal structure of human muscle L-lactate dehydrogenase, ternary complex with NADH and oxalate","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4OKN"
"4OKT",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","0U9, 198","4OKT",30.84,"2.5","2.5","Crystal structure of W741L-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OKT"
,,,,,,,,,,,,,,,,"SDSAFSRLYTRS",,,"co-regulator peptide","2","4OKT"
"4OKW",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M magnesium sulphate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molonc.2014.06.009","0U9, 198","4OKW",30.93,"2","2","Crystal structure of W741L-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OKW"
,,,,,,,,,,,,,,,,"NTTDTLFSQHYR",,,"co-regulator peptide","2","4OKW"
"4OKX",,"X-RAY DIFFRACTION",2.18,43.64,,,,,"10.1016/j.molonc.2014.06.009","0U9, 198","4OKX",30.96,"2.1","2.1","Crystal structure of W741L-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OKX"
,,,,,,,,,,,,,,,,"ANSSFRDWYTSS",,,"co-regulator peptide","2","4OKX"
"4OLE",,"X-RAY DIFFRACTION",6.5,81.08,"VAPOR DIFFUSION, SITTING DROP",8.33,"2.35M ammonium sulfate, 0.1M TRIS pH 8.33, 0.01M Adenosine-5'-triphosphate disodium salt hydrate, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4OLE",56.32,"2.52","2.52","Crystal structure of a neighbor of BRCA1 gene 1 (NBR1) from Homo sapiens at 2.52 A resolution","GTSVMPMLSAAFVDENLPDGTHLQPGTKFIKHWRMKNTGNVKWSADTKLKFMWGNLTLASTEKKDVLVPCLKAGHVGVVSVEFIAPALEGTYTSHWRLSHKGQQFGPRVWCSIIVDPFPSEE","Homo sapiens","1A13B, BC009808, KIAA0049, M17S2, MIG19, NBR1","Next to BRCA1 gene 1 protein","1","4OLE"
"4OLH",,"X-RAY DIFFRACTION",3.05,59.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2 M NaI, 16% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5001979",,"4OLH",146.07,"2.4","2.4","Human GKRP Bound to AMG5106 and Sorbitol-6-Phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase Regulatory Protein","1","4OLH"
"4OLI",,"X-RAY DIFFRACTION",2.72,54.7,"VAPOR DIFFUSION, SITTING DROP",7.4,"15% PEG monomethylether 2000, HEPES pH 7.4 0.1 M, 1mM TCEP, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1401180111",,"4OLI",73.94,"2.8","2.8","The pseudokinase/kinase protein from JAK-family member TYK2","MSYYHHHHHHDYDIPTTENLYFQGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4OLI"
"4OLM",,"X-RAY DIFFRACTION",1.98,37.86,,,,,"10.1016/j.molonc.2014.06.009","198, 0U9","4OLM",30.89,"2.8","2.8","Crystal structure of W741L-AR-LBD bound with co-regulator peptide","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4OLM"
,,,,,,,,,,,,,,,,"SDSAFSRYYTRS",,,"co-regulator peptide","2","4OLM"
"4OM2",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, HANGING DROP",8,"200mM sodium thiocyanate, 15% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/embj.201387188",,"4OM2",73.71,"4","4","Crystal structure of TLE1 N-terminal Q-domain residues 1-156","GAMGSGQMFPQSRHPTPHQAAGQPFKFTIPESLDRIKEEFQFLQAQYHSLKLECEKLASEKTEMQRHYVMYYEMSYGLNIEMHKQTEIAKRLNTICAQVIPFLSQEHQQQVAQAVERAKQVTMAELNAIIGQQQLQAQHLSHGHGPPVPLTPHPSGLQPPGIP","Homo sapiens","TLE, TLE1","Transducin-like enhancer protein 1","1","4OM2"
"4OM3",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M HEPES pH 7.0 or 7.5, 15% Tacsimate pH 7.0, 10% PEG 3350, 10% 2-methyl, 2,4-pentanediol (MPD) and 100mM RbCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/embj.201387188",,"4OM3",66.79,"2.855","2.855","Crystal structure of human TLE1 Q-domain residues 20-156","GAMGSGQPFKFTIPESLDRIKEEFQFLQAQYHSLKLECEKLASEKTEMQRHYVMYYEMSYGLNIEMHKQTEIAKRLNTICAQVIPFLSQEHQQQVAQAVERAKQVTMAELNAIIGQQQLQAQHLSHGHGPPVPLTPHPSGLQPPGIP","Homo sapiens","TLE, TLE1","Transducin-like enhancer protein 1","1","4OM3"
"4OM7",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.2M lithium sulfate monohydrate, 0.1M Tris pH 8.6, 25%(w/v) polyethylene glycol 3350 and 4%(v/v) formamide, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2014.07.024",,"4OM7",42.42,"2.204","2.204","Crystal structure of TIR domain of TLR6","LQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKSMKLTLVTENNDVKSLEHHHHHH","Homo sapiens","TLR6","Toll-like receptor 6","1","4OM7"
"4OMC",,"X-RAY DIFFRACTION",2.85,56.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 0.015mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/cb500087x",,"4OMC",320.71,"2.3","2.3","X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba","DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH","Homo sapiens","FUR, FURIN, PACE, PCSK3","Furin","1","4OMC"
,,,,,,,,,,,,,,,,"XRVRX",,,"meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine","2","4OMC"
"4OMD",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 0.015mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/cb500087x",,"4OMD",319.73,"2.7","2.7","X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba","DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH","Homo sapiens","FURIN, FUR, PACE, PCSK3","Furin","1","4OMD"
,,,,,,,,,,,,,,,,"XRVRX",,,"phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine","2","4OMD"
"4OME",,"X-RAY DIFFRACTION",3.28,62.53,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4OME",83.16,"1.79","1.79","X-ray structure of human glutamate carboxypeptidase II in complex with DCCBL, a urea based inhibitor with distal carborane moiety","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","4OME"
"4OMJ",,"X-RAY DIFFRACTION",3.89,68.4,"VAPOR DIFFUSION, HANGING DROP",5.5,"1 M Ammonium sulfate, 0.1 M Bis-Tris, 1% PEG3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.jsb.2015.05.001","2TX","4OMJ",65.82,"1.6","1.6","Crystal structure of SPF bound to 2,3-oxidosqualene","GSHMSGRVGDLSPRQKEALAKFRENVQDVLPALPNPDDYFLLRWLRARSFDLQKSEAMLRKHVEFRKQKDIDNIISWQPPEVIQQYLSGGMCGYDLDGCPVWYDIIGPLDAKGLLFSASKQDLLRTKMRECELLLQECAHQTTKLGRKVETITIIYDCEGLGLKHLWKPAVEAYGEFLCMFEENYPETLKRLFVVKAPKLFPVAYNLIKPFLSEDTRKKIMVLGANWKEVLLKHISPDQVPVEYGGTMTDPDGNPKCKSKINYGGDIPRKYYVRDQVK","Homo sapiens","C22orf6, KIAA1186, KIAA1658, SEC14L2","SEC14-like protein 2","1","4OMJ"
"4OMK",,"X-RAY DIFFRACTION",3.83,67.9,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M Lithium sulfate, 0.1 M Bis-Tris, 25% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.jsb.2015.05.001","SQL","4OMK",65.57,"1.75","1.75","Crystal structure of SPF bound to squalene","GSHMSGRVGDLSPRQKEALAKFRENVQDVLPALPNPDDYFLLRWLRARSFDLQKSEAMLRKHVEFRKQKDIDNIISWQPPEVIQQYLSGGMCGYDLDGCPVWYDIIGPLDAKGLLFSASKQDLLRTKMRECELLLQECAHQTTKLGRKVETITIIYDCEGLGLKHLWKPAVEAYGEFLCMFEENYPETLKRLFVVKAPKLFPVAYNLIKPFLSEDTRKKIMVLGANWKEVLLKHISPDQVPVEYGGTMTDPDGNPKCKSKINYGGDIPRKYYVRDQVK","Homo sapiens","C22orf6, KIAA1186, KIAA1658, SEC14L2","SEC14-like protein 2","1","4OMK"
"4OMT",,"X-RAY DIFFRACTION",6.21,80.18,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.6 M LiNO3, 0.05 M NaF, 0.1 M sodium acetate, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1107/S2053230X14008723",,"4OMT",85.29,"6","6","Crystal structure of human muscle phosphofructokinase (dissociated homodimer)","MTHEEHHAAKTLGIGKAIAVLTSGGDAQGMNAAVRAVVRVGIFTGARVFFVHEGYQGLVDGGDHIKEATWESVSMMLQLGGTVIGSARCKDFREREGRLRAAYNLVKRGITNLCVIGGDGSLTGADTFRSEWSDLLSDLQKAGKITDEEATKSSYLNIVGLVGSIDNDFCGTDMTIGTDSALHRIMEIVDAITTTAQSHQRTFVLEVMGRHCGYLALVTSLSCGADWVFIPECPPDDDWEEHLCRRLSETRTRGSRLNIIIVAEGAIDKNGKPITSEDIKNLVVKRLGYDTRVTVLGHVQRGGTPSAFDRILGSRMGVEAVMALLEGTPDTPACVVSLSGNQAVRLPLMECVQVTKDVTKAMDEKKFDEALKLRGRSFMNNWEVYKLLAHVRPPVSKSGSHTVAVMNVGAPAAGMNAAVRSTVRIGLIQGNRVLVVHDGFEGLAKGQIEEAGWSYVGGWTGQGGSKLGTKRTLPKKSFEQISANITKFNIQGLVIIGGFEAYTGGLELMEGRKQFDELCIPFVVIPATVSNNVPGSDFSVGADTALNTICTTCDRIKQSAAGTKRRVFIIETMGGYCGYLATMAGLAAGADAAYIFEEPFTIRDLQANVEHLVQKMKTTVKRGLVLRNEKCNENYTTDFIFNLYSEEGKGIFDSRKNVLGHMQQGGSPTPFDRNFATKMGAKAMNWMSGKIKESYRNGRIFANTPDSGCVLGMRKRALVFQPVAELKDQTDFEHRIPKEQWWLKLRPILKILAKYEIDLDTSDHAHLEHITRKRSGEAAV","Homo sapiens","PFKM, PFKX","6-phosphofructokinase, muscle type","1","4OMT"
"4ON3",,"X-RAY DIFFRACTION",5.2,76.33,"VAPOR DIFFUSION",7,"4 M sodium nitrate, 0.1 M BIS-TRIS propane pH 7.0, vapor diffusion, temperature 293K",293,"10.1002/prot.24689",,"4ON3",52.77,"2.6","2.6","Crystal structure of human sorting nexin 10 (SNX10)","MFPEQQKEEFVSVWVRDPRIQKEDFWHSYIDYEICIHTNSMAFTMKTSCVRRRYREFVWLRQRLQSNALLVQLPELPSKNLFFNMNNRQHVDQRRQGLEDFLRKVLQNALLLSDSSLHLFLQSHLNSEDIEACVSGQTKYSVEEAIHKFALMNRRFPEEDEEGKKENDIDYDSESSSSGLGHSSDDSSSHGCKVNTAPQESLEHHHHHH","Homo sapiens","SNX10","Sorting nexin-10","1","4ON3"
"4ON9",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, HANGING DROP",6.8,"1:1 RIG-I SF2 (60mg/ml) : reservoir solution (100mM HEPES pH=6.8, 100mM ammonium sulfate, 6.7%(v/v) Isopropanol, 9%(v/v) PEG4000), 4days, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1107/S2053230X14012230",,"4ON9",132.63,"2.71","2.71","DECH box helicase domain","MGSSHHHHHHSQDPNSSEVSDTNLYSPFKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQIPVYEQQKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTIPSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNTDEALDYICKLCASLDASVIATVKHNLEELEQVVYKPQKFFRKVESRISDKFKYIIAQLMRDTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFLYTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESVSRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGILTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTSNAGVIEKEQINMYKEKMMNDSILRLQTWDEAVFREKILHIQTHEKFIRDS","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","4ON9"
"4ONO",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, SITTING DROP",9.4,"1.05 M sodium citrate, 100 mM CHES (pH 9.4), and 25 mM triglycine, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1408549111",,"4ONO",45.82,"2.705","2.705","CD1c in complex with PM (phosphomycoketide)","PIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDMGGGGSGGSGSGGGSSADASQEHVSFHVIQIFSFVNQSWARGQGSGWLDELQTHGWDSESGTIIFLHQWSKGQFSNEELSDLELLFRFYLFGLTREIQDHASQDYSKYPFEVQVKAGCELHSGGSPEGFFQVAFNGLDLLSFQQTTWVPSPGCGSLAQSVCHLLNHQYEGVTETVYNLIRSTCPRFLLGLLDAGKMYVHRQVKPEAWLSSGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQLGDILPNAQGTWYLRATLDVADGEAAGLSCRVKHSSLEGQDIILYWHH","Homo sapiens","CD1B CD1C B2M CDABP0092 HDCMA22P, CD1C","Beta-2-microglobulin/T-cell surface glycoprotein CD1c/T-cell surface glycoprotein CD1b chimeric protein","1","4ONO"
,,,,,,,,,,,,,,,,,"Homo sapiens","CD1B CD1C B2M CDABP0092 HDCMA22P, CD1C"
,,,,,,,,,,,,,,,,,"Homo sapiens","CD1B CD1C B2M CDABP0092 HDCMA22P, CD1C"
"4OO4",,"X-RAY DIFFRACTION",1.93,36.36,"VAPOR DIFFUSION, HANGING DROP",4,"20% PEG 3350, 0.1 M sodium acetate, 2 mM DTT, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4OO4",23.32,"0.97","0.97","Crystal Structure of Human Thioredoxin Mutant","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCADVASESEVKSMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","4OO4"
"4OO5",,"X-RAY DIFFRACTION",1.89,34.93,"VAPOR DIFFUSION, HANGING DROP",4,"21% PEG 3350, 0.1 M sodium acetate, pH 4, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4OO5",11.75,"1.54","1.54","Crystal Structure of S-nitrosated Human Thioredoxin Mutant","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASESEVKSMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","4OO5"
"4OO7",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, SITTING DROP",8,"35% PEG 3350, 0.1M Tris-HCL pH 8.0 and 50mM NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714005458",,"4OO7",15.74,"1.65","1.65","THE 1.55A CRYSTAL STRUCTURE of NAF1 (MINER1): THE REDOX-ACTIVE 2FE-2S PROTEIN","DSLINLKIQKENPKVVNEINIEDLSLTKAAYCRCWRSKTFPACDGSHNKHNELTGDNVGPLILKKKEV","Homo sapiens","CISD2, CDGSH2, ERIS, ZCD2","CDGSH iron-sulfur domain-containing protein 2","1","4OO7"
"4OOA",,"X-RAY DIFFRACTION",2.2,44.11,"VAPOR DIFFUSION, SITTING DROP",8,"35% PEG 3500, 100 mM Tris-HCl pH 8.0 and 100-200 mM NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714005458",,"4OOA",47,"1.58","1.58","CRYSTAL STRUCTURE of NAF1 (MINER1): H114C THE REDOX-ACTIVE 2FE-2S PROTEIN","DSLINLKIQKENPKVVNEINIEDLSLTKAAYCRCWRSKTFPACDGSCNKHNELTGDNVGPLILKKKEV","Homo sapiens","CISD2, CDGSH2, ERIS, ZCD2","CDGSH iron-sulfur domain-containing protein 2","1","4OOA"
"4OP1",,"X-RAY DIFFRACTION",3.02,59.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5018175",,"4OP1",145.9,"2.39","2.39","GKRP bound to AMG0556 and Sorbitol-6-Phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase Regulatory Protein","1","4OP1"
"4OP2",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16%PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5018175",,"4OP2",145.66,"2.24","2.24","GKRP bound to AMG-0471 and Sorbitol-6-Phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase Regulatory Protein","1","4OP2"
"4OP3",,"X-RAY DIFFRACTION",3.01,59.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5018175",,"4OP3",145.72,"2.82","2.82","Human GKRP bound to AMG-5112 and Sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase Regulatory Protein","1","4OP3"
"4OPX",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 mM HEPES, 150 mM sodium chloride, 1 mM EDTA, 0.1 mM TCEP, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm5002502","2UR","4OPX",191.55,"3.314","3.314","Structure of Human PARP-1 bound to a DNA double strand break in complex with (2R)-5-fluoro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxamide","MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKDIKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVALEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4OPX"
,,,,,,,,,,,,,,,,,"Homo sapiens","PARP1, ADPRT, PPOL"
,,,,,,,,,,,,,,,,"KSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLWLEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","2","4OPX"
,,,,,,,,,,,,,,,,"GCCTACCGGTTCGCGAACCGGTAGGC",,,"DNA (26-MER)","3","4OPX"
"4OQ3",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, HANGING DROP",8,"2.4M AmSO4, 0.1M Tris, 0.1M NaCitrate, pH 8.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2014.03.039","2V8","4OQ3",46.44,"2.3","2.3","Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction","GSQIPASEQETLVRPKPELLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4OQ3"
"4OQ4",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.3-1.6 M sodium citrate, 50 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1111/jnc.12763",,"4OQ4",20.2,"1.49","1.49","Crystal Structure of E18A Human DJ-1","GSHMASKRALVILAKGAEEMATVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4OQ4"
"4OQ5",,"X-RAY DIFFRACTION",2.69,54.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M ammonium sulfate, 0.1 M MES, 30% w/v PEG5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.02.010","2UU","4OQ5",114.1,"2.86","2.86","Crystal Structure of Human MCL-1 Bound to Inhibitor 4-(4-methylnaphthalen-1-yl)-2-{[(4-phenoxyphenyl)sulfonyl]amino}benzoic acid","GTLVPRGSMDLYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4OQ5"
"4OQ6",,"X-RAY DIFFRACTION",1.96,37.17,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.bmcl.2014.02.010","2UV","4OQ6",36.28,"1.81","1.81","Crystal Structure of Human MCL-1 Bound to Inhibitor 4-hydroxy-4'-propylbiphenyl-3-carboxylic acid","GSMDLYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4OQ6"
"4OQA",,"X-RAY DIFFRACTION",2.87,57.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 mM HEPES, 150 mM sodium chloride, 1 mM EDTA, 0.1 mM TCEP, 6.8% PEG3350, 2% ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm5002502","2US","4OQA",191.65,"3.65","3.65","Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-(2,4-dihydroxybenzylidene)-3-oxo-2,3-dihydro-1-benzofuran-7-carboxamide","MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKDIKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVALEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4OQA"
,,,,,,,,,,,,,,,,,"Homo sapiens","PARP1, ADPRT, PPOL"
,,,,,,,,,,,,,,,,"KSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLWLEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","2","4OQA"
,,,,,,,,,,,,,,,,"GCCTACCGGTTCGCGAACCGGTAGGC",,,"DNA (26-MER)","3","4OQA"
"4OQB",,"X-RAY DIFFRACTION",2.85,56.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 mM HEPES, 150 mM sodium chloride, 1 mM EDTA, 0.1 mM TCEP, 6.8% PEG3350, 2% ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm5002502","2UT","4OQB",191.75,"3.362","3.362","Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-{4-[2-(morpholin-4-yl)ethoxy]benzylidene}-3-oxo-2,3-dihydro-1-benzofuran-7-carboxamide","MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKDIKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVALEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4OQB"
,,,,,,,,,,,,,,,,,"Homo sapiens","PARP1, ADPRT, PPOL"
,,,,,,,,,,,,,,,,"KSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLWLEHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","2","4OQB"
,,,,,,,,,,,,,,,,"GCCTACCGGTTCGCGAACCGGTAGGC",,,"DNA (26-MER)","3","4OQB"
"4OQV",,"X-RAY DIFFRACTION",3.54,65.25,"VAPOR DIFFUSION, HANGING DROP",5.4,"1.76 M Ammonium sulfate, 0.1 M Sodium Acetate, pH 5.4, 1.9 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500481t","2V6","4OQV",42.49,"1.23","1.23","High resolution crystal structure of human dihydroorotate dehydrogenase bound with DSM338 (N-[3,5-difluoro-4-(trifluoromethyl)phenyl]-5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine)","GDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRRDKLAALEHHHHHH","Homo sapiens","DHODH, Dihydroorotate Dehydrogenases","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4OQV"
"4ORG",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"14% PEG3350, 25% isopropanol, 0.1 M Tris, pH 8.0, cryoprotectant: 20% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature13036",,"4ORG",203.72,"3.121","3.121","Crystal structure of human Fab CAP256-VRC26.04, a potent V1V2-directed HIV-1 neutralizing antibody","PVLTQPPSVSAAPGQKVTISCSGSSSNIGNNFVSWYQQRPGTAPSLLIYETNKRPSGIPDRFSGSKSATSATLAITGLQTGDEADYYCATWAASLTSARVFGTGTKVIVSGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CAP256-VRC26.04 light chain","1","4ORG"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGKSLRLSCAASQFSFNRYGMHWVRQAPGKGLEWVAAISYDGTDKYHADKVWGRFTISRDNSKNTLYLQMNSLRAEDTALYYCAKDLREDECEEWWSDYYDFGKQLPCRKSRGVAGIFDKWGQGTMVIVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQ","Homo sapiens",,"CAP256-VRC26.04 heavy chain","2","4ORG"
"4ORR",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Tris, 25% PEG 4000, 2% Ethylene glycol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORR",21.75,"1.4","1.4","Threedimensional structure of the C65A mutant of Human lipocalin-type Prostaglandin D Synthase olo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORR"
"4ORS",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Na Hepes, 2% PEG 400, 2M Ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORS",42.13,"1.4","1.4","Three-dimensional structure of the C65A mutant of Human lipocalin-type Prostaglandin D Synthase apo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORS"
"4ORU",,"X-RAY DIFFRACTION",1.82,32.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.2M Ammonium Sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORU",43.26,"1.55","1.55","Three-dimensional structure of the C65A mutant of Human lipocalin-type Prostaglandin D Synthase holo-form second space group","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORU"
"4ORW",,"X-RAY DIFFRACTION",1.73,28.86,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, 2.0M Ammonium Sulphate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORW",41.92,"1.664","1.664","Three-dimensional structure of the C65A-K59A double mutant of Human lipocalin-type Prostaglandin D Synthase apo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKAAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORW"
"4ORX",,"X-RAY DIFFRACTION",1.81,31.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.2M Ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORX",43.24,"1.6","1.6","Three-dimensional structure of the C65A-K59A double mutant of Human lipocalin-type Prostaglandin D Synthase holo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKAAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORX"
"4ORY",,"X-RAY DIFFRACTION",1.94,36.56,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M Na Acetate, 0.2M Ammonium sulphate, 30% PEG 2000 MME, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4ORY",170.12,"1.8","1.8","Three-dimensional structure of the C65A-K59A double mutant of Human lipocalin-type Prostaglandin D Synthase holo, second crystal form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKAAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4ORY"
"4OS0",,"X-RAY DIFFRACTION",1.86,33.84,"VAPOR DIFFUSION, HANGING DROP",5.6,"02.M Na/K Tartrate, 0.1M Na acetate, 2.0M Ammonium sulphate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4OS0",41.96,"1.75","1.75","Three-dimensional structure of the C65A-W54F double mutant of Human lipocalin-type Prostaglandin D Synthase apo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSFLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4OS0"
"4OS1",,"X-RAY DIFFRACTION",2.05,40.1,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS1",29.39,"2.2","2.2","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK601 (bicyclic 1)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS1"
,,,,,,,,,,,,,,,,"GXALGRGCENHRCLX",,,"bicyclic peptide UK601 (bicyclic 1)","2","4OS1"
"4OS2",,"X-RAY DIFFRACTION",2.05,40.04,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS2",29.38,"1.79","1.79","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK602 (bicyclic 1)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS2"
,,,,,,,,,,,,,,,,"GXLGRGCENHRCLX",,,"bicyclic peptide UK602 (bicyclic 1)","2","4OS2"
"4OS3",,"X-RAY DIFFRACTION",1.87,34.38,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.2M Na/K Tartrate, 0.1M Na acetate, 2.0M Ammonium sulphate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4OS3",41.96,"1.4","1.4","Three-dimensional structure of the C65A-W112F double mutant of Human lipocalin-type Prostaglandin D Synthase apo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHFGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4OS3"
"4OS4",,"X-RAY DIFFRACTION",2.01,38.84,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS4",29.52,"2","2","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK603 (bicyclic 1)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS4"
,,,,,,,,,,,,,,,,"GXALGRGCENHRCLX",,,"bicyclic peptide UK603 (bicyclic 1)","2","4OS4"
"4OS5",,"X-RAY DIFFRACTION",1.99,38.27,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS5",29.33,"2.26","2.26","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK603 (bicyclic 2)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS5"
,,,,,,,,,,,,,,,,"GXALGRGCENHRCLX",,,"bicyclic peptide UK603 (bicyclic 2)","2","4OS5"
"4OS6",,"X-RAY DIFFRACTION",2.05,39.92,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS6",29.32,"1.75","1.75","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK604 (bicyclic 2)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS6"
,,,,,,,,,,,,,,,,"GXLGRGCENHRCLX",,,"bicyclic peptide UK604 (bicyclic 2)","2","4OS6"
"4OS7",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",4.5,"21% PEG4000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nchem.2043",,"4OS7",29.67,"2","2","Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK607 (bicyclic)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4OS7"
,,,,,,,,,,,,,,,,"GXALGRGCENHRCLX",,,"bicyclic peptide UK607 (bicyclic)","2","4OS7"
"4OS8",,"X-RAY DIFFRACTION",1.91,35.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Na Acetate, 2.0M Ammonium sulphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714012462",,"4OS8",41.88,"1.69","1.69","Three-dimensional structure of the C65A-W54F-W112F triple mutant of Human lipocalin-type Prostaglandin D Synthase apo-form","MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSFLREKKAALSMAKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHFGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","4OS8"
"4OSF",,"X-RAY DIFFRACTION",3.74,67.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ejmech.2015.02.012",,"4OSF",38.89,"1.62","1.62","4-(2-isothiocyanatoethyl)phenol inhibitor complexed with Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","4OSF"
"4OSU",,"X-RAY DIFFRACTION",2.82,56.35,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.ppat.1004377",,"4OSU",47.83,"1.87","1.87","Crystal structure of HCMV gB-neutralizing SM5-1 Fab fragment","QVQLVQSGAEVRKPGASVKVSCKASGYSLKDHYMVWVRQAPGQGLEWMGWINPQSGGTGYGQKFQGRVTMTRDTSTNTAYMILSSLRSDDTAVYFCARDGAKTVSNSGLSLLYYHNRLDAWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"SM5-1 Fab Heavy Chain","1","4OSU"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQMVTISCSGSSSNIGKNYVSWYQQLPGAAPKLLIFDNNKRPSGTPDRFSGSKSGTSATLVITGLQTGDEADYYCGTPDRSLSVIFGGGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"SM5-1 Fab Light Chain","2","4OSU"
"4OSX",,"X-RAY DIFFRACTION",2.42,49.13,,7,"2.2 M SODIUM MALONATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1016/j.chembiol.2013.03.006",,"4OSX",64.89,"1.95","1.95","STRUCTURE of UNCLEAVED GLYCINE-BOUND HUMAN L-ASPARAGINASE PROTEIN","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ALP, ASRGL1, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4OSX"
"4OSY",,"X-RAY DIFFRACTION",2.4,48.85,,7,"2.2-2.5 M sodium Malonate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.chembiol.2013.03.006",,"4OSY",64.81,"1.91","1.91","STRUCTURE of FULLY-CLEAVED GLYCINE-BOUND HUMAN L-ASPARAGINASE PROTEIN","HMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4OSY"
"4OT5",,"X-RAY DIFFRACTION",2.25,45.23,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500305p",,"4OT5",33.27,"1.55","1.55","Crystal structure of BTK kinase domain complexed with 4-tert-Butyl-N-(3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4OT5"
"4OT6",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500305p",,"4OT6",33.12,"2.05","2.05","Crystal structure of BTK kinase domain complexed with 4-Methanesulfonyl-N-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4OT6"
"4OT9",,"X-RAY DIFFRACTION",4.99,75.36,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG 4000, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1408552111",,"4OT9",38.47,"3.35","3.35","crystal structure of the C-terminal domain of p100/NF-kB2","MAATVPSRDSGEEAAEPSAPSRTPQCEPQAPEMLQRAREYNARLFGLAQRSARALLDYGVTADARALLAGQRHLLTAQDENGDTPLHLAIIHGQTSVIEQIVYVIHHAQDLGVVNLTNHLHQTPLHLAVITGQTSVVSFLLRVGADPALLDRHGDSAMHLALRAGAGAPELLRALLQSGAPAVPQLLHMPDFEGLYPVHLAVRARSPECLDLLVDSGAEVEATERQGGRTALHLATEMEELGLVTHLVTKLRANVNARTFAGNTPLHLAAGLGYPTLTRLLLKAGADIHAENEEPLCPLPSPPTSDSDSDSEGPEKDTRSSFRGHTPLDLTCSTKVKTLLLNAAQNTMEPPLTPPSPAG","Homo sapiens","NFKB2, LYT10","Nuclear factor NF-kappa-B p100 subunit","1","4OT9"
"4OTD",,"X-RAY DIFFRACTION",2.51,51.03,"VAPOR DIFFUSION",8.5,"100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion",,"10.1371/journal.pone.0103638",,"4OTD",38.34,"2","2","Crystal Structure of PRK1 Catalytic Domain","GSMLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC","Homo sapiens","PKN1, PAK1, PKN, PRK1, PRKCL1","Serine/threonine-protein kinase N1","1","4OTD"
"4OTF",,"X-RAY DIFFRACTION",2.26,45.6,"VAPOR DIFFUSION, HANGING DROP",5.6,"1 uL protein solution (8.1 mg/mL in 10 mM Tris pH 8.5, 100 mM NaCl, 0.5 mM TCEP, 1 mM GDC0834) and 1 uL reservoir solution of 14% PEG 4000, 0.2 M Ammonium Sulfate, 0.1 M Na Acetate-Acetate pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1016/j.bmcl.2015.01.032","2VL","4OTF",32.62,"1.95","1.95","Crystal structure of the kinase domain of Bruton's Tyrosine kinase with GDC0834","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYGN","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","4OTF"
"4OTG",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION",8.5,"100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion",,"10.1371/journal.pone.0103638",,"4OTG",38.78,"2.6","2.6","Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib","GSMLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC","Homo sapiens","PKN1, PAK1, PKN, PRK1, PRKCL1","Serine/threonine-protein kinase N1","1","4OTG"
"4OTH",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION",8.5,"100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion",,"10.1371/journal.pone.0103638","DRN","4OTH",38.8,"1.8","1.8","Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220","GSMLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC","Homo sapiens","PKN1, PAK1, PKN, PRK1, PRKCL1","Serine/threonine-protein kinase N1","1","4OTH"
"4OTI",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION",8.5,"100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion",,"10.1371/journal.pone.0103638","MI1","4OTI",38.65,"1.93","1.93","Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib","GSMLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC","Homo sapiens","PKN1, PAK1, PKN, PRK1, PRKCL1","Serine/threonine-protein kinase N1","1","4OTI"
"4OTP",,"X-RAY DIFFRACTION",2.37,48.03,"VAPOR DIFFUSION",7.5,"28% PEG400, 0.1 M HEPES, pH 7.5, 0.2 M calcium chloride, VAPOR DIFFUSION, temperature 293K",293,"10.1093/nar/gku542",,"4OTP",42.28,"2.7","2.7","Crystal structure of the catalytic domain of the human RioK1 atypical protein kinase in complex with ADP/Mg2+","EADMYRIKDKADRATVEQVLDPRTRMILFKMLTRGIITEINGCISTGKEANVYHASTANGESRAIKIYKTSILVFKDRDKYVSGEFRFRHGYCKGNPRKMVKTWAEKEMRNLIRLNTAEIPCPEPIMLRSHVLVMSFIGKDDMPAPLLKNVQLSESKARELYLQVIQYMRRMYQDARLVHADLSEFNMLYHGGGVYIIDVSQSVEHDHPHALEFLRKDCANVNDFFMRHSVAVMTVRELFEFVTDPSITHENMDAYLSKAMEIASQRTKEERSSQDHVDEEVFKRAYIPRTLNEVKNYERDMDIIMKLKEEDMAMNAQQDNILYQTVTGLKKDLSGVQKVPALLENQVEERT","Homo sapiens","RIOK1, RIO1","Serine/threonine-protein kinase RIO1","1","4OTP"
"4OTQ",,"X-RAY DIFFRACTION",2.26,45.47,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500305p","2V2","4OTQ",33.15,"1.55","1.55","Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4OTQ"
"4OTR",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500305p","2V3","4OTR",33.3,"1.95","1.95","Crystal structure of BTK kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4OTR"
"4OU0",,"X-RAY DIFFRACTION",2.06,40.24,"VAPOR DIFFUSION, SITTING DROP",4.5,"50 mM Sodium Acetate, 20% PEG 3350, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/bi500252w",,"4OU0",8,"1.4","1.4","Crystal Structure of RPA32C","GPGSANGLTVAQNQVLNLIKACPRPEGLNFQDLKNQLKHMSVSSIKQAVDFLSNEGHIYSTVDDDHFKSTDAE","Homo sapiens","REPA2, RFA2, RPA2, RPA32, RPA34","Replication protein A 32 kDa subunit","1","4OU0"
"4OUF",,"X-RAY DIFFRACTION",2.1,41.37,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES-Na pH 7.0, 0.2M KSCN, 25% PEG3350 and 5% Ethylene Glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1319122111",,"4OUF",28.05,"1.4","1.4","Crystal Structure of CBP bromodomain","KKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","4OUF"
"4OUH",,"X-RAY DIFFRACTION",2.13,42.37,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 8000, NaAc, KBr, pH 5.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1080/07391102.2014.963675",,"4OUH",72.84,"2","2","Crystal structure of the FP domain of Human PI31 Proteasome Inhibitor","GPSSPMAGLEVLFASAAPAITCRQDALVCFLHWEVVTHGYCGLGVGDQPGPNDKKSELLPAGWNNNKDLYVLRYEYKDGSRKLLVKAITVESSMILNVLEYGSQQVADLTLNLDDYIDAEHLGDFHRTYKNSEELRSRIVSGIITPIHEQWEKANVSSPHREF","Homo sapiens","HUMAN PI31, PSMF1","Proteasome inhibitor PI31 subunit","1","4OUH"
"4OUL",,"X-RAY DIFFRACTION",1.84,33.04,"VAPOR DIFFUSION",6.6,"15-20% PEG8000, 0.2M calcium acetate, 0.1M carcodylate pH6.6., VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M114.591636",,"4OUL",95.82,"1.949","1.949","Crystal structure of human Caprin-2 C1q domain","MRVAFSAARTSNLAPGTLDQPIVFDLLLNNLGETFDLQLGRFNCPVNGTYVFIFHMLKLAVNVPLYVNLMKNEEVLVSAYANDGAPDHETASNHAILQLFQGDQIWLRLHRGAIYGSSWKYSTFSGYLLYQDLEHHHHHH","Homo sapiens","C1QDC1, CAPRIN2, EEG1, KIAA1873, RNG140","Caprin-2","1","4OUL"
"4OUM",,"X-RAY DIFFRACTION",1.95,36.99,"VAPOR DIFFUSION",5.6,"100mM sodium citrate pH5.6, 12% 2-propanol, 11% PEG4000, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M114.591636",,"4OUM",16.39,"1.491","1.491","Crystal structure of human Caprin-2 C1q domain","MRVAFSAARTSNLAPGTLDQPIVFDLLLNNLGETFDLQLGRFNCPVNGTYVFIFHMLKLAVNVPLYVNLMKNEEVLVSAYANAGAPDHATASNHAILQLFQGDQIWLRLHRGAIYGSSWKYSTFSGYLLYQDLEHHHHHH","Homo sapiens","C1QDC1, CAPRIN2, EEG1, KIAA1873, RNG140","Caprin-2","1","4OUM"
"4OVA",,"X-RAY DIFFRACTION",5.15,76.13,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms7634",,"4OVA",97.5,"3","3","Structure of the two tandem Tudor domains and a new identified KH0 domain from human Fragile X Mental Retardation Protein","MEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIMRNEEASKQL","Homo sapiens","FMR1","Fragile X mental retardation protein 1","1","4OVA"
"4OWZ",,"X-RAY DIFFRACTION",2.74,55.03,"VAPOR DIFFUSION, HANGING DROP",5.2,"Protein was resuspended in 20mM sodium acetate buffer, pH 5.0, 1 uL of sample mixed with 1 uL of crystallisation buffer (0.1M sodium citrate, pH 5.2; 8% Jeffamine M-600; 10mM iron(III) chloride)",293,,,"4OWZ",32.21,"1.47","1.47","Structure of ECP/H15A mutant.","MRPPQFTRAQWFAIQAISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","ECP, RNASE3, RNS3","Eosinophil cationic protein","1","4OWZ"
"4OXB",,"X-RAY DIFFRACTION",1.96,37.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"Protein resuspended in 20mM sodium cacodylate buffer, pH5.0. 1 uL of protein sample mixed with 1 uL of crystallisation buffer (0.2M lithium sulphate, 0.1M TRIS-HCl pH8.5, 15% PEG4000).",289,,,"4OXB",32.71,"1.5","1.5","Structure of ECP with sulphate anions at 1.50 Angstroms","MRPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","ECP, RNASE3, RNS3","Eosinophil cationic protein","1","4OXB"
"4OXC",,"X-RAY DIFFRACTION",1.86,34.04,"LIQUID DIFFUSION",8.5,"PEG 4000, Sodium Acetate",293,"10.1002/prot.24766",,"4OXC",49.69,"2.9","2.9","Crystal structure of XIAP BIR1 domain","MGSSHHHHHHSSGLVPQGSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLE","Homo sapiens","API3, BIRC4, IAP3, XIAP","E3 ubiquitin-protein ligase XIAP","1","4OXC"
"4OXF",,"X-RAY DIFFRACTION",2.73,54.97,"VAPOR DIFFUSION, HANGING DROP",5.2,"Protein resuspended in sodium cacodylate buffer (20mM, pH5.0). 1 uL of protein sample was mixed with 1 uL of crystallisation buffer (0.1M sodium citrate pH5.2, 8% Jeffamine M-600, 10mM iron(III) chloride)",293,,,"4OXF",32.53,"1.5","1.5","Structure of ECP in complex with citrate ions at 1.50 Angstroms","MRPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","ECP, RNASE3, RNS3","Eosinophil cationic protein","1","4OXF"
"4OY9",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, HANGING DROP",7.4,"PEG 8000, calcium chloride, HEPES, dimethylsulfoxyde",293,"10.1107/S2053230X15003878",,"4OY9",23.41,"1.62","1.62","Crystal structure of human P-Cadherin EC1-EC2 in closed conformation","DWVVAPISVPENGKGPFPQRLNQLKSNKDRDTKIFYSITGPGADSPPEGVFAVEKETGWLLLNKPLDREEIAKYELFGHAVSENGASVEDPMNISIIVTDQNDHKPKFTQDTFRGSVLEGVLPGTSVMQVTATDEDDAIYTYNGVVAYSIHSQEPKDPHDLMFTIHRSTGTISVISSGLDREKVPEYTLTIQATDMDGDGSTTTAVAVVEILD","Homo sapiens","CDH3, CDHP","Cadherin-3","1","4OY9"
"4OYA",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480","1VE","4OYA",53.89,"2.03","2.03","Human solAC Complexed with (4-Aminofurazan-3-yl)-[3-(1H-benzoimidazol-2-ylmethoxy)phenyl]methanone","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYA"
"4OYB",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480","1VJ","4OYB",53.85,"1.7","1.7","Crystal Structure Analysis of the solAC","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYB"
"4OYI",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480","1VK","4OYI",53.84,"1.7","1.7","Human solAC Complexed with (4-Amino-furazan-3-yl)-phenyl-methanone","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYI"
"4OYJ",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5",295,"10.1016/j.molcel.2014.03.018",,"4OYJ",277.2,"3","3","Structure of the apo HOIP PUB domain","GPMPGEEEERAFLVAREELASALRRDSGQAFSLEQLRPLLASSLPLAARYLQLDAARLVRCNAHGEPRNYLNTLSTALNILEKYGRNLLSPQRPRYWRGVKFNNPVFRSTVDAVQGGRDVLRLYGYTEEQPDGLSFPEGQEEPDEHQVATVTLEVLLLRTELSLLLQNTHPRQQALEQLLEDKVED","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","4OYJ"
"4OYM",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480","1ZC","4OYM",53.87,"1.7","1.7","Human solAC Complexed with (4-Amino-furazan-3-yl)-(3-methoxy-phenyl)-methanone","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYM"
"4OYN",,"X-RAY DIFFRACTION",3.15,60.9,"VAPOR DIFFUSION, HANGING DROP",9,"1.6 M MgCl2 and 0.1 M bicine pH 9.0",277,"10.1107/S1399004715013073",,"4OYN",22.47,"1.43","1.43","Fifteen minutes iron loaded human H ferritin","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4OYN"
"4OYO",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OYO",54.23,"1.75","1.75","Human solAC Complexed with 4-(2-Chlorophenyl)-3-methyl-1H-pyrazole","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYO"
"4OYP",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OYP",53.66,"2.28","2.28","Human solAC Complexed with 1-Benzofuran-2-carboxylic acid","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYP"
"4OYQ",,"X-RAY DIFFRACTION",2.68,54.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9 M ammonium sulfate, 100 mM Tris pH 8.0, 200 mM NaCl, 4%(v/v) 2-propanol",298,,"1X2","4OYQ",38.29,"1.7","1.7","(6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4OYQ"
"4OYS",,"X-RAY DIFFRACTION",2.95,58.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9 M ammonium sulfate, 100 mM Tris pH 8.5",293,"10.1038/nchembio.1681",,"4OYS",69.43,"2.9","2.9","CRYSTAL STRUCTURE OF VPS34 IN COMPLEX WITH SAR405.","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","Phosphatidylinositol 3-kinase catalytic subunit type 3","1","4OYS"
"4OYW",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OYW",53.59,"1.7","1.7","Crystal Structure of Human Soluble Adenylate Cyclase","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYW"
"4OYX",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OYX",54.05,"1.89","1.89","Human solAC Complexed with AMPCPP","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYX"
"4OYZ",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OYZ",53.62,"1.74","1.74","Human solAC Complexed with Bicarbonate","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OYZ"
"4OZ0",,"X-RAY DIFFRACTION",2,38.2,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M tri-sodium acetate pH 4.5, 0.1 M Bis-Tris pH 5.5, 25% (w/v) PEG 3350",277,"10.1074/jbc.M114.558825",,"4OZ0",25.36,"2.2","2.2","Crystal structure of human CAPERalpha U2AF homology motif (apo-state)","GSVQPLATQCFQLSNMFNPQTEEEVGWDTEIKDDVIEECNKHGGVIHIYVDKNSAQGNVYVKCPSIAAAIAAVNALHGRWFAGKMITAAYVPLPTYHNLFPDSMTATQLLVPSRR","Homo sapiens","CAPER, CAPERalpha, FSAP59, HCC1, RBM39, RNPC2","RNA-binding protein 39","1","4OZ0"
"4OZ2",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480",,"4OZ2",53.95,"2.1","2.1","Human solAC Complexed with 4-(4-Fluorophenyl)-3-methyl-1H-pyrazole","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OZ2"
"4OZ3",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, HANGING DROP",,"1ul of protein solution was mixed with 1ul of reservoir solution (0.1M sodium acetate, pH 4.8, 0.2M trisodium citrate, 16-18% PEG4K and 10% glycerol) and left to equilibrate at 4C",277,"10.1002/cmdc.201300480","1Z8","4OZ3",53.86,"1.7","1.7","Human solAC Complexed with 4-phenyl-3-(trifluoromethyl)-1H-pyrazole","XMNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKV","Homo sapiens","ADCY10, SAC","Adenylate cyclase type 10","1","4OZ3"
"4P01",,"X-RAY DIFFRACTION",2.76,55.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4P01",37.74,"2.07","2.07","Crystal Structure Analysis of Macrophage Migration Inhibitory Factor in complex with N-[(4-cyanophenyl)methyl]methanethioamide","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4P01"
"4P09",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 8.5",293,"10.1016/j.molcel.2014.03.016",,"4P09",20.77,"1.7","1.7","Crystal structure of HOIP PUB domain","GPLGSMPGEEEERAFLVAREELASALRRDSGQAFSLEQLRPLLASSLPLAARYLQLDAARLVRCNAHGEPRNYLNTLSTALNILEKYGRNLLSPQRPRYWRGVKFNNPVFRSTVDAVQGGRDVLRLYGYTEEQPDGLSFPEGQEEPDEHQVATVTLEVLLLRTELSLLLQNTHPRQQALEQLLE","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","4P09"
"4P0C",,"X-RAY DIFFRACTION",1.92,35.8,"VAPOR DIFFUSION, HANGING DROP",,"100 mM sodium acetate, 0.2 M ammonium acetate",293,"10.1016/j.bbrc.2014.02.128",,"4P0C",9.93,"1.339","1.339","Crystal Structure of NHERF2 PDZ1 Domain in Complex with LPA2","MPRLCRLVRGEQGYGFHLHGEKGRRGQFIRRVEPGSPAEAAALRAGDRLVEVNGVNVEGETHHQVVQRIKAVEGQTRLLVVDQMDSTL","Homo sapiens","SLC9A3R2","Na(+)/H(+) exchange regulatory cofactor NHE-RF2/Lysophosphatidic acid receptor 2 chimeric protein","1","4P0C"
,,,,,,,,,,,,,,,,,"Homo sapiens","SLC9A3R2"
"4P0H",,"X-RAY DIFFRACTION",3.72,66.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4P0H",37.38,"1.93","1.93","Crystal Structure Analysis of Macrophage Migration Inhibitory Factor in complex with Dimethylformamide","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4P0H"
"4P0J",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",10.5,"1.2 M NaH2PO4, 0.6 M K2HPO4, 0.1 M CAPS, pH 10.5, 0.2 M LiSO4",298,"10.4049/jimmunol.1400538",,"4P0J",32.95,"2.298","2.298","Crystal Structure of Loop-Swapped Interleukin-36Ra","SLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQELGKSYNTDFYFQQCD","Homo sapiens","IL36RN, FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3, UNQ1896/PRO4342, IL36G, IL1E, IL1F9, IL1H1, IL1RP2, UNQ2456/PRO5737","Interleukin-36 receptor antagonist/Interleukin-36 gamma chimera protein","1","4P0J"
"4P0K",,"X-RAY DIFFRACTION",1.89,34.9,"VAPOR DIFFUSION, SITTING DROP",5.3,"25% (w/v) PEG5000MME, 0.1 M NaAcetate, pH 5.3",298,"10.4049/jimmunol.1400538",,"4P0K",16.92,"1.7","1.7","Crystal Structure of Double Loop-Swapped Interleukin-36Ra","SLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWPEALEQGRGSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQELGKSYNTDFYFQQCD","Homo sapiens","IL36RN, FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3, UNQ1896/PRO4342, IL36G, IL1E, IL1F9, IL1H1, IL1RP2, UNQ2456/PRO5737","Interleukin-36 receptor antagonist/Interleukin-36 gamma chimera protein","1","4P0K"
"4P0L",,"X-RAY DIFFRACTION",1.89,34.8,"VAPOR DIFFUSION, SITTING DROP",5.3,"30% (w/v) PEG5000MME, 0.1 M NaAcetate, pH 5.3",298,"10.4049/jimmunol.1400538",,"4P0L",16.77,"1.55","1.55","Crystal Structure of Double Loop-Swapped Interleukin-36Ra With Additional Point Mutations","SLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWPEALEQGRGSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRADAGLTSSFESAAYPGWFLCTVPEADQPVRLTQELGKSYNTDFYFQQCD","Homo sapiens","IL36RN, FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3, UNQ1896/PRO4342, IL36G, IL1E, IL1F9, IL1H1, IL1RP2, UNQ2456/PRO5737","Interleukin-36 receptor antagonist/Interleukin-36 gamma chimera protein","1","4P0L"
"4P0N",,"X-RAY DIFFRACTION",4.35,71.74,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5",277,"10.1021/ml5000993","1IS, 1IR","4P0N",80.21,"2.08","2.08","Crystal structure of PDE10a with a novel Imidazo[4,5-b]pyridine inhibitor","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4P0N"
"4P0T",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, HANGING DROP",,"100 mM bicine pH 8.5, 11 % MPD, 8 mM spermidine",293.15,"10.7554/eLife.02978",,"4P0T",38.58,"1.493","1.493","Crystal structure of human centromere protein M","GPLGSMSVLRPLDKLPGLNTATILLVGTEDALLQQLADSMLKEDCASELKVHLAKSLPLPSSVNRPRIDLIVFVVNLHSKYSLQNTEESLRHVDASFFLGKVCFLATGAGRESHCSIHRHTVVKLAHTYQSPLLYCDLEVEGFRATMAQRLVRVLQICAGHVPGVSALNLLSLLRS","Homo sapiens","CENPM, C22orf18, ICEN39, PANE1","Centromere protein M","1","4P0T"
"4P0V",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, HANGING DROP",5,"1.2M sodium potassium phosphate, 25% glycerol",293,"10.1073/pnas.1409061111","ZOL","4P0V",40.58,"2.4","2.4","Crystal structure of human farnesyl diphosphoate synthase in complex with zoledronate and taxodione","SDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4P0V"
"4P0W",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, HANGING DROP",5,"1.2M sodium potassium phosphate, 25% glycerol",293,"10.1073/pnas.1409061111","ZOL","4P0W",40.69,"2.406","2.406","Human farnesyl diphosphate synthase in complex with Arenarone and zoledronate","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4P0W"
"4P0X",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, HANGING DROP",5,"1.2M sodium potassium phosphate, 25% glycerol, 1mM GPP",293,"10.1073/pnas.1409061111",,"4P0X",40.66,"2.5","2.5","Human farnesyl diphosphate synthase in complex with Taxodione","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4P0X"
"4P10",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION, HANGING DROP",,"Crystallisation was done using the hanging drop method equilibrating over a well solution containing 10% (w/v) PEG20k, 2% dioxane and 0.1M bicine pH 9.0. Crystals were then soaked in well solution supplemented with 1 mM compound",293,"10.1016/j.bmc.2014.02.010","2B8","4P10",47.01,"2","2","pro-carboxypeptidase U In Complex With 5-(3-aminopropyl)-1-propyl-6,7-dihydro-4H-benzimidazole-5-carboxylic acid","FQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYYEQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQAAKNAIWIDCGIHAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRKNRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNINQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKTSKNTRYTYGQGSETLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVIRNVLEP","Homo sapiens","CPB2","Carboxypeptidase B2","1","4P10"
"4P13",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG4000, 140mm Tris-acetate pH 8.0",293,,,"4P13",173.76,"1.73","1.73","Medium chain acyl-CoA dehydrogenase, K304E mutant","LGFSFEFTEQQKEFQATARKFAREEIIPVAAEYDKTGEYPVPLIRRAWELGLMNTHIPENCGGLGLGTFDACLISEELAYGCTGVQTAIEGNSLGQMPIIIAGNDQQKKKYLGRMTEEPLMCAYCVTEPGAGSDVAGIKTKAEKKGDEYIINGQKMWITNGGKANWYFLLARSDPDPKAPANKAFTGFIVEADTPGIQIGRKELNMGQRCSDTRGIVFEDVKVPKENVLIGDGAGFKVAMGAFDKTRPVVAAGAVGLAQRALDEATKYALERKTFGKLLVEHQAISFMLAEMAMEVELARMSYQRAAWEVDSGRRNTYYASIAKAFAGDIANQLATDAVQILGGNGFNTEYPVEKLMRDAKIYQIYEGTSQIQRLIVAREHIDKYKN","Homo sapiens","ACADM","Medium-chain specific acyl-CoA dehydrogenase, mitochondrial","1","4P13"
"4P1D",,"X-RAY DIFFRACTION",1.89,35.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"Sodium Fluoride, Potassium Fluoride, Cacodylate, MPD",296,,,"4P1D",7.95,"1.55","1.55","Structure of the complex of a bimolecular human telomeric DNA with Coptisine","TAGGGTTAGGGT","Homo sapiens",,"telomeric DNA","1","4P1D"
"4P1R",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane",277,"10.1021/ml5000993","2KR","4P1R",81.94,"2.243","2.243","Crystal Structure of PDE10A with Imidazo[4,5-b]pyridines as Potent and Selective Inhibitors","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4P1R"
"4P22",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Na3Citrate pH 5.6, 3.0 M NH4Ac",294,"10.1080/09168451.2014.923301",,"4P22",96.92,"2.75","2.75","Crystal Structure of N-terminal Fragments of E1","GPHMADLMSSSPLSKKRRVSGPDPKPGSNCSPAQSVLSEVPSVPTNGMAKNGSEADIDEGLYSRQLYVLGHEAMKRLQTSSVLVSGLRGLGVEIAKNIILGGVKAVTLHDQGTAQWADLSSQFYLREEDIGKNRAEVSQPRLAELNSYVPVTAYTGPLVEDFLSGFQVVVLTNTPLEDQLRVGEFCHNRGIKLVVADTRGLFGQLFCDFGEEMILTDSNGEQPLSAMVSMVTKDNPGVVTCLDEARHGFESGDFVSFSEVQGMVELNGNQPMEIKVLGPYTFSICDTSNFSDYIRGGIVSQVKVPKKISFKSLVASLAEPDFVVTDFAKFSRPAQLHIGFQALHQFCAQHGRPPRPRNDEDAAELVALAQAVNARALPAVQQNNLDEDLIRKLAYVAAGDLAPINAFIGGLAAQEVMKACSGKFMPIMQWLYFDALECLPEDKEVL","Homo sapiens","UBA1, A1S9T, UBE1","Ubiquitin-like modifier-activating enzyme 1","1","4P22"
"4P2G",,"X-RAY DIFFRACTION",3.09,60.18,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM sodium citrate
30% (v:v) PEG400",293,"10.1021/bi500294h",,"4P2G",20.25,"1.35","1.35","Crystal structure of DJ-1 in sulfinic acid form (aged crystal)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4P2G"
"4P2K",,"X-RAY DIFFRACTION",2.29,46.35,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M Ammonium citrate tribasic pH7.0, 20% PEG3350",293,,,"4P2K",34.03,"1.499","1.499","Structure of Ephrin type-A receptor 2","MGSSHHHHHHSQDPHTYEDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","4P2K"
"4P34",,"X-RAY DIFFRACTION",3.07,59.96,"VAPOR DIFFUSION, HANGING DROP",8.5,"200 mM sodium citrate
30% (v:v) PEG-400",293,"10.1021/bi500294h",,"4P34",20.17,"1.55","1.55","Crystal structure of DJ-1 in sulfenic acid form (fresh crystal)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4P34"
"4P35",,"X-RAY DIFFRACTION",3.13,60.69,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM TRIS
20% (v:v) PEG-400
Co-crystal with 500 uM Zn(II)",293,"10.1021/bi500294h",,"4P35",20.11,"1.75","1.75","Crystal structure of DJ-1 with Zinc(II) bound (crystal I)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4P35"
"4P36",,"X-RAY DIFFRACTION",3.08,60.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"200 mM Sodium citrate
30% (v:v) PEG-400
500 uM Zinc sulfate",293,"10.1021/bi500294h",,"4P36",20.29,"1.182","1.182","Crystal structure of DJ-1 With Zn(II) bound (crystal 2)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4P36"
"4P38",,"X-RAY DIFFRACTION",3.57,65.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"42% PEG400, 100 mM Tris-HCl pH 8.5 and 2 mM compound",298,"10.1021/jm301252n","21T","4P38",60.84,"2.8","2.8","Human 11beta-Hydroxysteroid Dehydrogenase Type 1 in complex with AZD8329","EFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNWDRFI","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","4P38"
"4P39",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, HANGING DROP",5.6,"20% 2-propanol, 20% PEG 4000, 0.1 M Na citrate pH 5.6",277,"10.1107/S139900471400844X",,"4P39",33.46,"2.401","2.401","Crystal structure of the human C5aR antagonist C5a-A8","GAGAAGSTLQKKIEEIAAKYKHSVVKKCCYDGARVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISFKRS","Homo sapiens","C5, CPAMD4","Complement C5","1","4P39"
"4P3F",,"X-RAY DIFFRACTION",2.13,37.04,"VAPOR DIFFUSION, SITTING DROP",8.5,"K/Na tartrate, PEG5000MME",277,"10.1126/science.1249094",,"4P3F",51.78,"1.699","1.699","Structure of the human SRP68-RBD","MGHHHHHHGSKANKEFGDSLSLEILQIIKESQQQHGLRHGDFQRYRGYCSRRQRRLRKTLNFKMGNRHKFTGKKVTEDLLTDNRYLLLVLMDAERAWSYAMQLKQEANTEPRKRFHLLSRLRKAVKHAEELERLCESNRVDAKTKLEAQAYTAYLSGMLRFEHQEWKAAIEAFNKCKTIYEKLASAFTEEQAVLYNQRVEEISPNIRYCAYNIGDQ","Homo sapiens","SRP68","Signal recognition particle subunit SRP68","1","4P3F"
"4P3N",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION, SITTING DROP",,"Calcium Acetate, PEG4000, Sodium Acetate",291,"10.1038/ncomms7402",,"4P3N",196.09,"2.6","2.6","Structural Basis for Full-Spectrum Inhibition of Threonyl-tRNA Synthetase by Borrelidin 1","MGSSHHHHHHSSGDHRKIGRDQELYFFHELSPGSCFFLPKGAYIYNALIEFIRSEYRKRGFQEVVTPNIFNSRLWMTSGHWQHYSENMFSFEVEKELFALKPMNCPGHCLMFDHRPRSWRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCAMEQIEDEIKGCLDFLRTVYSVFGFSFKLNLSTRPEKFLGDIEVWDQAEKQLENSLNEFGEKWELNSGDGAFYGPKIDIQIKDAIGRYHQCATIQLDFQLPIRFNLTYVSHDGDDKKRPVIVHRAILGSVERMIAILTENYGGKWPFWLSPRQVMVVPVGPTCDEYAQKVRQQFHDAKFMADIDLDPGCTLNKKIRNAQLAQYNFILVVGEKEKISGTVNIRTRDNKVHGERTISETIERLQQLKEFRSKQAEEEF","Homo sapiens","TARS, TARS1","Threonine--tRNA ligase, cytoplasmic","1","4P3N"
"4P42",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION, HANGING DROP",,"PEG 1500, MIB Buffer",295,"10.1038/nature13269",,"4P42",111.12,"2.44","2.44","Extended-Synaptotagmin 2, SMP - C2A - C2B Domains","GSDTERAEWLNKTVKHMWPFICQFIEKLFRETIEPAVRGANTHLSTFSFTKVDVGQQPLRINGVKVYTENVDKRQIILDLQISFVGNCEIDLEIKRYFCRAGVKSIQIHGTMRVILEPLIGDMPLVGALSIFFLRKPLLEINWTGLTNLLDVPGLNGLSDTIILDIISNYLVLPNRITVPLVSEVQIAQLRFPVPKGVLRIHFIEAQDLQGKDTYLKGLVKGKSDPYGIIRVGNQIFQSRVIKENLSPKWNEVYEALVYEHPGQELEIELFDEDPDKDDFLGSLMIDLIEVEKERLLDEWFTLDEVPKGKLHLRLEWLTLMPNASNLDKVLTDIKADKDQANDGLSSALLILYLDSARNLPSGKKISSNPNPVVQMSVGHKAQESKIRYKTNEPVWEENFTFFIHNPKRQDLEVEVRDEQHQCSLGNLKVPLSQLLTSEDMTVSQRFQLSNSGPNSTIKMKIALRVLHLEKRER","Homo sapiens","ESYT2, FAM62B, KIAA1228","Extended synaptotagmin-2","1","4P42"
"4P44",,"X-RAY DIFFRACTION",3.31,62.79,"VAPOR DIFFUSION, HANGING DROP",8,"34% (v/v) pentaerythritol propoxylate PO/OH 5/4, 2 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",288,"10.1111/febs.13557","2F7","4P44",83.06,"1.75","1.75","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor JRB-4-81","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P44"
"4P45",,"X-RAY DIFFRACTION",3.29,62.67,"VAPOR DIFFUSION, HANGING DROP",8,"34% (v/v) pentaerythritol propoxylate PO/OH 5/4, 2 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",288,"10.1111/febs.13557","2F9","4P45",83.7,"1.87","1.87","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor JRB-4-73","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P45"
"4P4B",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2G2","4P4B",83.32,"1.93","1.93","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor CTT54","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4B"
"4P4C",,"X-RAY DIFFRACTION",1.88,34.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulfate, 22.5% PEG 3350",293,"10.1021/jm5009242",,"4P4C",40.79,"1.599","1.599","Human EphA3 Kinase domain in complex with quinoxaline derivatives","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","EPH receptor A3","1","4P4C"
"4P4D",,"X-RAY DIFFRACTION",3.32,62.98,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2GR","4P4D",83.25,"1.65","1.65","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor MP1C","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4D"
"4P4E",,"X-RAY DIFFRACTION",3.33,63.07,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2G4","4P4E",83.52,"1.67","1.67","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor MP1D","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4E"
"4P4F",,"X-RAY DIFFRACTION",3.32,62.96,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2GB","4P4F",83.27,"1.86","1.86","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor NC-2-40","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4F"
"4P4I",,"X-RAY DIFFRACTION",3.35,63.24,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2G5","4P4I",82.92,"1.87","1.87","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4I"
"4P4J",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1111/febs.13557","2H9","4P4J",82.92,"1.66","1.66","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33D","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4P4J"
"4P4S",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, SITTING DROP",7.9,"23-27% PEG 4000, 0.2 M EPPS/KOH pH 7.9, 0.5M glycerol",291,"10.1016/j.str.2014.08.015",,"4P4S",72.23,"3.3","3.3","GMPPCP-bound stalkless-MxA","XXXXXXXXXXXXLPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKLVNEDKWRGKVSYQDYEIEISDASEVEKEINKAQNAIAGEGMGISHELITLEISSRDVPDLTLIDLPGITRVAVGNQPADIGYKIKTLIKKYIQRQETISLVVVPSNVDIATTEALSMAQEVDPEGDRTIGILTKPDLVDKGTEDKVVDVVRNLVFHLKKGYMIVKCRGQQEIQDQLSLSEALQREKIFFENHPYFRDLLEEGKATVPSLAEKLTSELITHISKSLPLLXXXXXXXXXXXXXXXXXX","Homo sapiens","MX1","Interferon-induced GTP-binding protein Mx1","1","4P4S"
,,,,,,,,,,,,,,,,"SQYEEKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKLVNEDKWRGKVSYQDYEIEISDASEVEKEINKAQNAIAGEGMGISHELITLEISSRDVPDLTLIDLPGITRVAVGNQPADIGYKIKTLIKKYIQRQETISLVVVPSNVDIATTEALSMAQEVDPEGDRTIGILTKPDLVDKGTEDKVVDVVRNLVFHLKKGYMIVKCRGQQEIQDQLSLSEALQREKIFFENHPYFRDLLEEGKATVPSLAEKLTSELITHISKSLPLLENQIKETHQRITEELQKYGGDPKAKFLKERLARLTQARRRLAQFPG","Homo sapiens","MX1","Interferon-induced GTP-binding protein Mx1","2","4P4S"
"4P4T",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION, SITTING DROP",9.1,"2.0-2.5M Ammonium sulfate, 0.2M AMPSO/KOH pH 9.1",291,"10.1016/j.str.2014.08.015",,"4P4T",40.76,"2.3","2.3","GDP-bound stalkless-MxA","AENNLSSQYEEKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKLVNEDKWRGKVSYQDYEIEISDASEVEKEINKAQNAIAGEGMGISHELITLEISSRDVPDLTLIDLPGITRVAVGNQPADIGYKIKTLIKKYIQRQETISLVVVPSNVDIATTEALSMAQEVDPEGDRTIGILTKPDLVDKGTEDKVVDVVRNLVFHLKKGYMIVKCRGQQEIQDQLSLSEALQREKIFFENHPYFRDLLEEGKATVPSLAEKLTSELITHISKSLPLLENQIKETHQRITEELQKYGVDIPEGSGSSDKRKFLKERLARLTQARRRLAQFPG","Homo sapiens","MX1","Interferon-induced GTP-binding protein Mx1","1","4P4T"
,,,,,,,,,,,,,,,,,"Homo sapiens","MX1"
"4P4U",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, SITTING DROP",9.1,"2.0-2.5M Ammonium sulfate, 0.2M AMPSO/KOH pH9.1",291,"10.1016/j.str.2014.08.015",,"4P4U",40.97,"1.9","1.9","Nucleotide-free stalkless-MxA","AENNLSSQYEEKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKLVNEDKWRGKVSYQDYEIEISDASEVEKEINKAQNAIAGEGMGISHELITLEISSRDVPDLTLIDLPGITRVAVGNQPADIGYKIKTLIKKYIQRQETISLVVVPSNVDIATTEALSMAQEVDPEGDRTIGILTKPDLVDKGTEDKVVDVVRNLVFHLKKGYMIVKCRGQQEIQDQLSLSEALQREKIFFENHPYFRDLLEEGKATVPSLAEKLTSELITHISKSLPLLENQIKETHQRITEELQKYGVDIGSGSERSDTSDKRKFLKERLARLTQARRRLAQFPG","Homo sapiens","MX1","Interferon-induced GTP-binding protein Mx1","1","4P4U"
,,,,,,,,,,,,,,,,,"Homo sapiens","MX1"
"4P5E",,"X-RAY DIFFRACTION",1.96,37.33,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3K, 200 MM CALCIUM ACETATE, 100 MM TRIS, PH 7.0",291,"10.1016/j.ejmech.2014.07.110","N6P","4P5E",35.37,"1.35","1.35","CRYSTAL STRUCTURE OF HUMAN DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE","MRPALYFCGSIRGGREDRTLYERIVSRLRRFGTVLTEHVAAAELGARGEEAAGGDRLIHEQDLEWLQQADVVVAEVTQPSLGVGYELGRAVAFNKRILCLFRPQSGRVLSAMIRGAADGSRFQVWDYEEGEVEALLDRYFEADPLEHHHHHH","Homo sapiens","DNPH1, C6orf108, RCL","2'-deoxynucleoside 5'-phosphate N-hydrolase 1","1","4P5E"
"4P5Q",,"X-RAY DIFFRACTION",1.87,34.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulf ate, 22.5% PEG 3350",293,"10.1021/jm5009242",,"4P5Q",40.88,"1.35","1.35","Human EphA3 Kinase domain in complex with quinoxaline derivatives","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin type-A receptor 3","1","4P5Q"
"4P5W",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M sodium malonate, 20% PEG 3350",295,"10.1038/ncomms6491",,"4P5W",92.04,"2.4","2.4","Structure of the N- and C-terminal domain fusion of the human mitochondrial aspartate/glutamate carrier Citrin in the calcium-bound state","MSHHHHHHHHSDRAIEGRTATSEAAAKVALTKRADPAELRTIFLKYASIEKNGEFFMSPNDFVTRYLNIFGESQPNPKTVELLSGVVDQTKDGLISFQEFVAFESVLCAPDALFMVAFQLFDKAGKGEVTFEDVKQVFGQTTIHQHIPFNWDSEFVQLHFGKERKRHLTYAEFTQFLLEIQLEHAKQAFVQRDNARTGRVTAIDFRDIMVTIRPHVLTPFVEECLVAAAGGTTSHQVSFSYFNGFNSLLNNMELIRKIYSTLAGTRKDVEVTKEEFVLAAQKFGQVTPMEVDILFQLADLYEPRGRMTLADIERIAPLEEGTLPFNLAEAQRQKASGDSARENLYFQGGVKPMGSEPVPKSRINLPAPNPDHVGGYKLAVATFAGIENKFGLYLPLFKPSVSTSKAIGGGP","Homo sapiens","SLC25A13, ARALAR2","Calcium-binding mitochondrial carrier protein Aralar2,Calcium-binding mitochondrial carrier protein Aralar2","1","4P5W"
,,,,,,,,,,,,,,,,,"Homo sapiens","SLC25A13, ARALAR2"
"4P5X",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M MIB, 25% PEG 1500",295,"10.1038/ncomms6491",,"4P5X",35.84,"2.261","2.261","Structure of the N-terminal domain of the human mitochondrial aspartate/glutamate carrier Aralar in the calcium-bound state","TATSEAVKVQTTKRGDPHELRNIFLQYASTEVDGERYMTPEDFVQRYLGLYNDPNSNPKIVQLLAGVADQTKDGLISYQEFLAFESVLCAPDSMFIVAFQLFDKSGNGEVTFENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQLEHARQAFALKDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGGSISHQVSFSYFNAFNSLLNNMELVRKIYSTLAGTRKDVEVTKEEFAQSAIRYGQVTPLEIDILYQLADLYNASGRLTLADIERIAPLAEGALPYNLAELQRQQ","Homo sapiens","SLC25A12, ARALAR1, AGC1","Calcium-binding mitochondrial carrier protein Aralar1","1","4P5X"
"4P5Z",,"X-RAY DIFFRACTION",1.85,33.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulfate, 22.5% PEG 3350",293,"10.1021/jm5009242","Q7M","4P5Z",40.96,"2.002","2.002","Human EphA3 Kinase domain in complex with quinoxaline derivatives","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin type-A receptor 3","1","4P5Z"
"4P60",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.3M sodium acetate, 0.1M Tris, 8% PEG 20000, 8% PEG 550 MME",295,"10.1038/ncomms6491",,"4P60",71.63,"2.4","2.4","Structure of the N-terminal domain of the human mitochondrial aspartate/glutamate carrier Aralar in the apo state","TATSEAVKVQTTKRGDPHELRNIFLQYASTEVDGERYMTPEDFVQRYLGLYNDPNSNPKIVQLLAGVADQTKDGLISYQEFLAFESVLCAPDSMFIVAFQLFDKSGNGEVTFENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQLEHARQAFALKDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGGSISHQVSFSYFNAFNSLLNNMELVRKIYSTLAGTRKDVEVTKEEFAQSAIRYGQVTPLEIDILYQLADLYNASGRLTLADIERIAPLAEGALPYNLAELQRQQ","Homo sapiens","SLC25A12, ARALAR1, AGC1","Calcium-binding mitochondrial carrier protein Aralar1","1","4P60"
"4P65",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, HANGING DROP",,"sodium citrate, phenol, sodium chloride, zinc acetate, tris",277,"10.1074/jbc.M114.608562",,"4P65",35.62,"1.5","1.5","Crystal structure of an cyclohexylalanine substituted insulin analog.","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","4P65"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGAFYTPAT","Homo sapiens","INS","Insulin","2","4P65"
"4P6E",,"X-RAY DIFFRACTION",2.71,54.63,"EVAPORATION",4.6,"21% PEG 8000, 150 mM ammonium sulfate, 100 mM sodium acetate",295,"10.1021/ml500283g","2FC","4P6E",52.18,"1.8","1.8","Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor","SNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIEHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","4P6E"
"4P6G",,"X-RAY DIFFRACTION",2.59,52.56,"VAPOR DIFFUSION",4.6,"PEG 8000, ammonium sulfate, sodium acetate",295,"10.1021/ml500283g","2FZ","4P6G",102.48,"1.58","1.58","Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor.","ILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIEGHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","4P6G"
"4P6Q",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, SITTING DROP",5.6,"15% PEG 8000, 0.1M ammonium sulphate, 0.01M magnesium chloride, 0.05M 2-(N-morpholino)ethanesulfonic acid",277,"10.1093/nar/gku277",,"4P6Q",33.15,"2","2","The crystal structure of the Split End protein SHARP adds a new layer of complexity to proteins containing RNA Recognition Motifs","FGIKVQNLPVRSTDTSLKDGLFHEFKKFGKVTSVQIHGTSEERYGLVFFRQQEDQEKALTASKGKLFFGMQIEVTAWIGPETESENEFRPLDERIDEFHPKATRTLFIGNLEKTTTYHDLRNIFQRFGEIVDIDIKKVNGVPQYAFLQYCDIASVCKAIKKMDGEYLGNNRLKLGFGKSMPTNCVWLDGLSSNVSDQYLTRHFCRYGPVVKVVFDRLKGMALVLYNEIEYAQAAVKETKGRKIGGNKIKVDFANRESQLAFYHCMEKSGQDIRDFYEMLAERREER","Homo sapiens","SPEN, KIAA0929, MINT, SHARP","Msx2-interacting protein","1","4P6Q"
"4P7A",,"X-RAY DIFFRACTION",2.87,57.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 10% ISOPROPANOL, 0.1 M HEPES",293,"10.1107/S2053230X15010183",,"4P7A",39.11,"2.3","2.3","Crystal Structure of human MLH1","GMSFVAGVIRRLDETVVNRIAAGEVIQRPANAIKEMIENCLDAKSTSIQVIVKEGGLKLIQIQDNGTGIRKEDLDIVCERFTTSKLQSFEDLASISTYGFRGEALASISHVAHVTITTKTADGKCAYRASYSDGKLKAPPKPCAGNQGTQITVEDLFYNIATRRKALKNPSEEYGKILEVVGRYSVHNAGISFSVKKQGETVADVRTLPNASTVDNIRSIFGNAVSRELIEIGCEDKTLAFKMNGYISNANYSVKKCIFLLFINHRLVESTSLRKAIETVYAAYLPKNTHPFLYLSLEISPQNVDVNVHPTKHEVHFLHEESILERVQQHIESKLLGSNSSRMYFTQT","Homo sapiens","MLH1, COCA2","DNA mismatch repair protein Mlh1","1","4P7A"
"4P7E",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG 6000, 100 mM MES pH6, 0.2M LiCl",277,"10.1021/jm501262q","2HB","4P7E",70.04,"2.4","2.4","Triazolopyridine compounds as selective JAK1 inhibitors: from hit identification to GLPG0634","DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","4P7E"
"4P7U",,"X-RAY DIFFRACTION",2.044,39.9,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM sodium citrate, 30% PEG 2000",298,"10.1016/j.pep.2015.06.001",,"4P7U",12.96,"1.502","1.502","Extracellular domain of type II Transforming Growth Factor Beta receptor in complex with NDSB-201","MALCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPTCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD","Homo sapiens","TGFBR2","TGF-beta receptor type-2","1","4P7U"
"4P8Q",,"X-RAY DIFFRACTION",2.81,56.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3000, tris hydrochloride",293,"10.1002/pro.2604",,"4P8Q",205.14,"3.02","3.02","Crystal Structure of Human Insulin Regulated Aminopeptidase with Alanine in Active Site","SATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEYFSLEKIFKELSSYEDFLDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLDVKRMMKTWTLQKGFPLVTVQKKGKELFIQQERFFLNMKPEIQPSDTSYLWHIPLSYVTEGRNYSKYQSVSLLDKKSGVINLTEEVLWVKVNINMNGYYIVHYADDDWEALIHQLKINPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEALFQTDLIYNLLEKLGYMDLASRLVTRVFKLLQNQIQQQTWTDEGTPSMRELRSALLEFACTHNLGNCSTTAMKLFDDWMASNGTQSLPTDVMTTVFKVGAKTDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKLSFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSYTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRLRCVQEALEVIQLNIQWMEKNLKSLTWWL","Homo sapiens","LNPEP, OTASE","Leucyl-cystinyl aminopeptidase","1","4P8Q"
"4P8U",,"X-RAY DIFFRACTION",2.05,39.49,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, Lithium sulfate, Bis Tris",298,"10.1074/jbc.M114.588905",,"4P8U",41.92,"2.4","2.4","The crystal structures of YKL-39 in the absence of chitooligosaccharides was solved to resolutions of 2.4 angstrom","AMADIGSYKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTINSLKTKNPKLKILLSIGGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTVGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKITWLQDQQVPYAVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKSCNQGPYPLVQAVKRSLGSL","Homo sapiens","CHI3L2","Chitinase-3-like protein 2","1","4P8U"
"4P8V",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, Lithium Sulfate, Bis Tris",298,"10.1074/jbc.M114.588905",,"4P8V",42.33,"1.64","1.64","The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc2) were solved to resolutions of 1.5 angstrom","AMADIGSYKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTINSLKTKNPKLKILLSIGGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTVGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKITWLQDQQVPYAVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKSCNQGPYPLVQAVKRSLGSL","Homo sapiens","CHI3L2","Chitinase-3-like protein 2","1","4P8V"
"4P8W",,"X-RAY DIFFRACTION",2.15,42.76,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, Lithium sulfate, Bis Tris",298,"10.1074/jbc.M114.588905",,"4P8W",42.93,"1.87","1.87","The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc4) were solved to resolutions of 1.9 angstrom","AMADIGSYKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTINSLKTKNPKLKILLSIGGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTVGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKITWLQDQQVPYAVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKSCNQGPYPLVQAVKRSLGSL","Homo sapiens","CHI3L2","Chitinase-3-like protein 2","1","4P8W"
"4P8X",,"X-RAY DIFFRACTION",1.96,42.73,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, Lithium sulfate, Bis Tris",298,"10.1074/jbc.M114.588905",,"4P8X",43.14,"2.48","2.48","The crystal structures of YKL-39 in the presence of chitooligosaccharides (GlcNAc6) were solved to resolutions of 2.48 angstrom","AMADIGSYKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTINSLKTKNPKLKILLSIGGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTVGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKITWLQDQQVPYAVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKSCNQGPYPLVQAVKRSLGSL","Homo sapiens","CHI3L2","Chitinase-3-like protein 2","1","4P8X"
"4P90",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, HANGING DROP",7.6,"0.2M ammonium sulphate, 16% PEG 3350, 0.1M Hepes (pH 7.6)",293,,,"4P90",67.42,"2.49","2.49","Crystal structure of the kinase domain of human PAK1 in complex with compound 15","SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","4P90"
"4P9M",,"X-RAY DIFFRACTION",2.44,49.66,"VAPOR DIFFUSION",7,"PEG 6000, HEPES, zinc chloride",298,"10.1016/j.celrep.2014.04.001",,"4P9M",49.75,"2.13","2.13","Crystal structure of 8ANC195 Fab","DIQMTQSPSTLSASIGDTVRISCRASQSITGNWVAWYQQRPGKAPRLLIYRGAALLGGVPSRFSGSAAGTDFTLTIGNLQAEDFGTFYCQQYDTYPGTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"8ANC195 light chain","1","4P9M"
,,,,,,,,,,,,,,,,"QIHLVQSGTEVKKPGSSVTVSCKAYGVNTFGLYAVNWVRQAPGQSLEYIGQIWRWKSSASHHFRGRVLISAVDLTGSSPPISSLEIKNLTSDDTAVYFCTTTSTYDKWSGLHHDGVMAFSSWGQGTLISVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"8ANC195 Fab heavy chain","2","4P9M"
"4PAH",,"X-RAY DIFFRACTION",3.2,62,,6.8,"pH 6.8",,"10.1021/bi9815290",,"4PAH",35.93,"2","2","HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND NOR-ADRENALINE INHIBITOR","TVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVL","Homo sapiens","PAH","PHENYLALANINE HYDROXYLASE","1","4PAH"
"4PBD",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.2 M ammonium tartrate dibasic, 20% PEG3350",291,"10.1016/j.jmb.2014.12.012",,"4PBD",12.74,"1.68","1.68","Crystal structure of the N-terminal CS domain of human Shq1","MAHHHHHHVDDDDKMLTPAFDLSQDPDFLTIAIRVPYARVSEFDVYFEGSDFKFYAKPYFLRLTLPGRIVENGSEQGSYDADKGIFTIRLPKETPGQHFEGLNMLTALLA","Homo sapiens","SHQ1","Protein SHQ1 homolog","1","4PBD"
"4PBX",,"X-RAY DIFFRACTION",5.87,79.04,"VAPOR DIFFUSION, SITTING DROP",6,"10 % PEG 400, 0.01 M magnesium chloride, 0.1 M potassium chloride, 0.05 M MES pH 6.0",293.5,"10.1038/ncomms6209",,"4PBX",64.79,"3.15","3.15","Crystal structure of the six N-terminal domains of human receptor protein tyrosine phosphatase sigma","ETGEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRVRRVAPRFSILPMSHEIMPGGNVNITCVAVGSPMPYVKWMQGAEDLTPEDDMPVGRNVLELTDVKDSANYTCVAMSSLGVIEAVAQITVKSLPKAPGTPMVTENTATSITITWDSGNPDPVSYYVIEYKSKSQDGPYQIKEDITTTRYSIGGLSPNSEYEIWVSAVNSIGQGPPSESVVTRTGEQAPASAPRNVQARMLSATTMIVQWEEPVEPNGLIRGYRVYYTMEPEHPVGNWQKHNVDDSLLTTVGSLLEDETYTVRVLAFTSVGDGPLSDPIQVKTQQGVPGQPMNLRAEARSETSITLSWSPPRQESIIKYELLFREGDHGREVGRTFDPTTSYVVEDLKPNTEYAFRLAARSPQGLGAFTPVVRQRTLGTKHHHHHH","Homo sapiens","PTPRS","Receptor-type tyrosine-protein phosphatase S","1","4PBX"
"4PCE",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Sodium Nitrate, 20% PEG 3350, 10% ethylene glycol",277,"10.1016/j.bmcl.2014.04.017","2N0","4PCE",15.41,"1.293","1.293","Crystal Structure of the first bromodomain of human BRD4 in complex with compound B13","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4PCE"
"4PCI",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.20M Sodium Nitrate, 20% PEG 3350, 10% ethylene glycol",277,"10.1016/j.bmcl.2014.04.017","2NJ","4PCI",15.41,"1.25","1.25","Crystal Structure of the first bromodomain of BRD4 in complex with B16","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4PCI"
"4PCK",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 0.02 M magnesium chloride hexahydrate, 22% w/v Poly(acrylic acid sodium salt) 5100, 15% v/v glycerol",277,"10.1016/j.jmb.2014.12.012",,"4PCK",25.27,"2.401","2.401","Crystal structure of the P22S mutant of N-terminal CS domain of human Shq1","MAHHHHHHVDDDDKMLTPAFDLSQDPDFLTIAIRVSYARVSEFDVYFEGSDFKFYAKPYFLRLTLPGRIVENGSEQGSYDADKGIFTIRLPKETPGQHFEGLNMLTALLA","Homo sapiens","SHQ1","Protein SHQ1 homolog","1","4PCK"
"4PCU",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, HANGING DROP",,"20% (vol/vol) polyethylene glycol monomethyl ether 3350 and 0.34mM SAM",293,"10.1073/pnas.1414545111",,"4PCU",123.65,"3.578","3.578","Crystal structure of delta516-525 E201S human cystathionine beta-synthase with AdoMet","MGSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPSSHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQQRQMVFGVVTAIDLLNFVAAQERDQKELHHHHHH","Homo sapiens","CBS","Cystathionine beta-synthase","1","4PCU"
"4PCW",,"X-RAY DIFFRACTION",1.87,34.21,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 4000, calcium chloride",298.15,"10.1038/jid.2015.102",,"4PCW",45.99,"2.2","2.2","Crystal Structure of the N-terminal Domain of Human Profilaggrin at 2.2 A Resolution","GSMSTLLENIFAIINLFKQYSKKDKNTDTLSKKELKELLEKEFRQILKNPDDPDMVDVFMDHLDIDHNKKIDFTEFLLMVFKLAQAYYESTRKE","Homo sapiens","FLG","Filaggrin","1","4PCW"
"4PDO",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.8 M Na/K L(+)-tartrate, 0.1 M Tris-Cl pH 8.5, 1% (w/v) PEGMME 5000",293,,,"4PDO",68.05,"2.104","2.104","Structure of Ephrin type-A receptor 2","MGSSHHHHHHSQDPHTYEDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","4PDO"
"4PED",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"Seeded microbatch experiment, 5 mg/mL protein 12.5% PEG 3350, 50 mM HEPES pH 7.5, 5 mM MgCl2, 150 mM Am2SO4, 0.15 mM TCEP, 5 microliter sitting drop in bridge of VDX plate, equilibrated against 12.5% PEG 3350, 50 mM HEPES pH 7.5, 150 mM Am2SO4",293,"10.1016/j.molcel.2014.11.002",,"4PED",46.14,"1.64","1.64","Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthes","SSEANAERIVRTLCKVRGAALKLGQMLSIQDDAFINPHLAKIFERVRQSADFMPLKQMMKTLNNDLGPNWRDKLEYFEERPFAAASIGQVHLARMKGGREVAMKIQYPGVAQSINSDVNNLMAVLNMSNMLPEGLFPEHLIDVLRRELALECDYQREAACARKFRDLLKGHPFFYVPEIVDELCSPHVLTTELVSGFPLDQAEGLSQEIRNEICYNILVLCLRELFEFHFMQTDPNWSNFFYDPQQHKVALLDFGATREYDRSFTDLYIQIIRAAADRDRETVRAKSIEMKFLTGYEVKVMEDAHLDAILILGEAFASDEPFDFGTQSTTEKIHNLIPVMLRHRLVPPPEETYSLHRKMGGSFLICSKLKARFPCKAMFEEAYSNYCKRQAQQ","Homo sapiens","ADCK3, CABC1, PP265, COQ8A","Chaperone activity of bc1 complex-like, mitochondrial","1","4PED"
"4PF3",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris pH 8.0, 23% ethanol",293,"10.1016/j.bmc.2014.07.038","HFN","4PF3",32.58,"1.1","1.1","Mineralocorticoid receptor ligand-binding domain with compuond 37a","GSAPAKEPSVNTALVPQLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","4PF3"
"4PF4",,"X-RAY DIFFRACTION",1.99,38.25,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, Ph=7, 2M Ammonium sulfate",292,,,"4PF4",33,"1.13","1.13","1.1A X-RAY STRUCTURE OF THE APO CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE 1, aa 1-277","HMTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","4PF4"
"4PF7",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION",,"20% PEG3350, 0.2 mM sodium thiocyanate",298,"10.1074/jbc.M115.638205","2QW","4PF7",229.97,"2.33","2.33","Crystal structure of insulin degrading enzyme complexed with inhibitor","MGHHHHHHGRAMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4PF7"
"4PF9",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION",,"20% PEG3350, 0.2 mM sodium thiocyanate",298,"10.1074/jbc.M115.638205","2Q6","4PF9",230.59,"2.5","2.5","Crystal structure of insulin degrading enzyme complexed with inhibitor","MGHHHHHHGRAMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4PF9"
"4PFC",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION",,"20% PEG3350, 0.2 mM sodium thiocyanate",298,"10.1074/jbc.M115.638205","2QX","4PFC",230.59,"2.21","2.21","Crystal structure of insulin degrading enzyme complexed with inhibitor","MGHHHHHHGRAMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4PFC"
"4PFJ",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, sodium formate, bis-tris",298,"10.1074/jbc.M114.597153",,"4PFJ",97.52,"2.3","2.3","The structure of bi-acetylated SAHH","MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCNIFSTQNHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYFKDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINVNDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVIITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIGHFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVACAHLGKLNVKLTKLTEKQAQYLGMSCDGPFKPDHYRY","Homo sapiens","AHCY, SAHH","Adenosylhomocysteinase","1","4PFJ"
"4PGF",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, sodium formate, bis-tris",298,"10.1074/jbc.M114.597153",,"4PGF",97.44,"2.59","2.59","The structure of mono-acetylated SAHH","MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCNIFSTQNHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYFKDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINVNDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVIITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIGHFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVACAHLGKLNVKLTKLTEKQAQYLGMSCDGPFKPDHYRY","Homo sapiens","AHCY, SAHH","Adenosylhomocysteinase","1","4PGF"
"4PGT",,"X-RAY DIFFRACTION",2.13,42,,6,"CRYSTALS WERE GROWN IN HANGING DROPS WHICH INITIALLY CONSISTED OF 4.3 MG/ML 
PROTEIN, 0.55 MM GSH CONJUGATE OF (+)-ANTI-BPDE, 0.8 M AMMONIUM SULFATE IN 50 
MM MES BUFFER (PH 6.0). THE DROPS WERE EQUILIBRATED AT 293 K AGAINST WELL 
SOLUTION CONTAINING 1.6 M AMMONIUM SULFATE IN 0.1 M MES BUFFER (PH 6.0).",,"10.1021/bi990668u",,"4PGT",48.55,"2.1","2.1","CRYSTAL STRUCTURE OF HGSTP1-1[V104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYVSLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GTP_HUMAN, GSTP1, FAEES3, GST3","PROTEIN (GLUTATHIONE S-TRANSFERASE)","1","4PGT"
"4PGZ",,"X-RAY DIFFRACTION",2.68,54.16,"VAPOR DIFFUSION, HANGING DROP",,"10%-18% [w/v] PEG 3350, 20 mM cobalt chloride",295,"10.1016/j.molcel.2014.11.021",,"4PGZ",71.05,"2.4","2.4","Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zipper-like mechanism for ligand-dependent or oncogenic receptor tyrosine kinase activation","GAMVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWEDYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILIRLVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDSSAFKHNGTVECKAYNDVGKTSAYFNFAFKEQIHP","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","4PGZ"
"4PH4",,"X-RAY DIFFRACTION",3.6,65.84,"VAPOR DIFFUSION, HANGING DROP",,"VPS34 protein and PIK-III were mixed and incubated on ice for 1 hr (final PIK-III concentration was 1 mM).  Prior to crystallization, the mixture was passed through a 0.2 um filter.  The protein:ligand complex was crystallized using the hanging drop vapor diffusion method in Nextal plates: 6 uL of protein solution was mixed with 4 uL of precipitant, which consisted of 20% (w/v) PEG 3350, 100 mM bis-tris propane, and 200 mM Na-K-phosphate.  The resulting drop was suspended over a reservoir of 0.3 mL of precipitant and sealed with a screw cap.  The crystals grew at 30 degC in approximately 12-24 hr.",303.15,"10.1038/ncb3053","2UG","4PH4",72.26,"2.8","2.8","The crystal structure of Human VPS34 in complex with PIK-III","MSYYHHHHHHDYDIPTTENLYFQGAMGSGIRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK","Homo sapiens","PIK3C3, VPS34","Phosphatidylinositol 3-kinase catalytic subunit type 3","1","4PH4"
"4PHC",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 7 to 9, 0.2 M MgCl2 and 20 to 32.5% PEG 3350",298,"10.1016/j.biochi.2014.08.005",,"4PHC",230.95,"2.844","2.844","Crystal Structure of a human cytosolic histidyl-tRNA synthetase, histidine-bound","MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPLCIC","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","4PHC"
"4PHJ",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN WAS CRYSTALLIZED FROM 12% PEG6000, 20 MM CACL2, 50 MM CACODYLATE BUFFER, PH7.4",293,"10.1016/j.jsb.2014.07.004",,"4PHJ",40.35,"1.6","1.6","The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids: Human unliganded protein","EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS","Homo sapiens","CAPNS1, CAPN4, CAPNS","Calpain small subunit 1","1","4PHJ"
"4PHK",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN WAS CRYSTALLIZED FROM 12% PEG6000, 20 MM CACL2, 50 MM CACODYLATE BUFFER, PH7.4",293,"10.1016/j.jsb.2014.07.004",,"4PHK",40.78,"2.05","2.05","The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids. The complex with (Z)-3-(4-chlorophenyl)-2-mercaptoacrylic acid","EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS","Homo sapiens","CAPNS1, CAPN4, CAPNS","Calpain small subunit 1","1","4PHK"
"4PHM",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, SITTING DROP",,"50 mM sodium cacodylate, 12.5% PEG6000, 20 mM calcium chloride and 10 mM DTT at pH 7.0",293,"10.1016/j.jsb.2014.07.004",,"4PHM",40.95,"2.03","2.03","The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids","EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS","Homo sapiens","CAPNS1, CAPN4, CAPNS","Calpain small subunit 1","1","4PHM"
"4PHW",,"X-RAY DIFFRACTION",4.17,70.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% w/v 1,4-Dioxane",277,"10.1021/jm500713j","2W1","4PHW",82.79,"2.5","2.5","Crystal Structure of PDE10A with 1H-benzimidazol-2-yl(4-((3-(tetrahydro-2H-pyran-4-yl)-2-pyridinyl)oxy)phenyl)methanone","MKHHHHHHHDEVDTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4PHW"
"4PIG",,"X-RAY DIFFRACTION",1.98,37.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M CaCl2, 0.1 M HEPES, 30% PEG 4000",291,"10.1107/S2053230X14019244",,"4PIG",34.61,"1.952","1.952","Crystal structure of the ubiquitin K11S mutant","MQIFVKTLTGSTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2","Ubiquitin","1","4PIG"
"4PIH",,"X-RAY DIFFRACTION",1.85,33.61,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M CaCl2, 0.1 M TRIS, 25% PEG 4000",291,"10.1107/S2053230X14019244",,"4PIH",17.26,"1.5","1.5","X-ray crystal structure of the K33S mutant of ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDSEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2","Ubiquitin","1","4PIH"
"4PIJ",,"X-RAY DIFFRACTION",1.86,33.83,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.2M ammonium sulfate, 25% PEG 4000",291,"10.1107/S2053230X14019244",,"4PIJ",17.44,"1.5","1.5","X-ray crystal structure of the K11S/K63S double mutant of ubiquitin","MQIFVKTLTGSTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQSESTLHLVLRLRG","Homo sapiens","UBA52, UBCEP2","Ubiquitin","1","4PIJ"
"4PIV",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, SITTING DROP",7.6,"25% PEG3350, 0.19 M ammonium sulfate, 5 mM sodium cacodylate, pH 7.6",298,"10.1038/nchembio.1603","2W4","4PIV",146.7,"2.299","2.299","Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and GSK2194069","MQVPILEKFCFTPHTEEGCLSERAALQEELQLCKGLVQALQTKVTQQGLKMVVPGLDGAQIPRDPSQQELPRLLSAACRLQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALKACLDTAVENMPSLKMKVVEVLAGHGHLYSRIPGLLSPHPLLQLSYTATDRHPQALEAAQAELQQHDVAQGQWDPADPAPSALGSADLLVCNCAVAALGDPASALSNMVAALREGGFLLLHTLLRGHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSRVSLRLVGLKKSFYGSTLFLCRRPTPQDSPIFLPVDDTSFRWVESLKGILADEDSARPVWLKAINCATSGVVGLVNCLRREPGGNRLRCVLLSNLSSTSHVPEVDPGSAELQKVLQGDLVMNVYRDGAWGAFRHFLLEEDKGSKTFCPAHKSYIIAGGLGGFGLELAQWLIQRGVQKLVLTSRSGIRTGYQAKQVRRWRRQGVQVQVSTSNISSLEGARGLIAEAAQLGPVGGVFNLAVVLRDGLLENQTPEFFQDVCKPKYSGTLNLDRVTREACPELDYFVVFSSVSCGRGNAGQSNYGFANSAMERICEKRRHEGLPGLAVQWGAIGDVGILVETMSTNDTIVSGTLPQRMASCLEVLDLFLNQPHMVLSSFVLAEKHHHHHH","Homo sapiens","FASN, FAS","Fatty acid synthase","1","4PIV"
,,,,,,,,,,,,,,,,,"Homo sapiens","FASN, FAS"
"4PJ3",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION",6.5,"MES, PEG MME 550",293,"10.1038/nsmb.2951",,"4PJ3",173.11,"2.3","2.3","Structural insight into the function and evolution of the spliceosomal helicase Aquarius, Structure of Aquarius in complex with AMPPNP","NAEFVTQLACKYWAPHIKKKSPFDIKVIEDIYEKEIVKSRFAIRKIMLLEFSQYLENYLWMNYSPEVSSKAYLMSICCMVNEKFRENVPAWEIFKKKPDHFPFFFKHILKAALAETDGEFSLHEQTVLLLFLDHCFNSLEVDLIRSQVQQLISLPMWMGLQLARLELELKKTPKLRKFWNLIKKNDEKMDPEAREQAYQERRFLSQLIQKFISVLKSVPLSEPVTMDKVHYCERFIELMIDLEALLPTRRWFNTILDDSHLLVHCYLSNLVRREEDGHLFSQLLDMLKFYTGFEINDQTGNALTENEMTTIHYDRITSLQRAAFAHFPELYDFALSNVAEVDTRESLVKFFGPLSSNTLHQVASYLCLLPTLPKNEDTTFDKEFLLELLVSRHERRISQIQQLNQMPLYPTEKIIWDENIVPTEYYSGEGCLALPKLNLQFLTLHDYLLRNFNLFRLESTYEIRQDIEDSVSRMKPWQSEYGGVVFGGWARMAQPIVAFTVVEVAKPNIGENWPTRVRADVTINLNVRDHIKDEWEGLRKHDVCFLITVRPTKPYGTKFDRRRPFIEQVGLVYVRGCEIQGMLDDKGRVIEDGPEPRPNLRGESRTFRVFLDPNQYQQDMTNTIQNGAEDVYETFNIIMRRKPKENNFKAVLETIRNLMNTDCVVPDWLHDIILGYGDPSSAHYSKMPNQIATLDFNDTFLSIEHLKASFPGHNVKVTVEDPALQIPPFRITFPVRSGKGKKRKDADVEDEDTEEAKTLIVEPHVIPNRGPYPYNQPKRNTIQFTHTQIEAIRAGMQPGLTMVVGPPGTGKTDVAVQIISNIYHNFPEQRTLIVTHSNQALNQLFEKIMALDIDERHLLRLGHGEEELETEKDFSRYGRVNYVLARRIELLEEVKRLQKSLGVPGDASYTCETAGYFFLYQVMSRWEEYISKVKNKGSTLPDVTEVSTFFPFHEYFANAPQPIFKGRSYEEDMEIAEGCFRHIKKIFTQLEEFRASELLRSGLDRSKYLLVKEAKIIAMTCTHAALKRHDLVKLGFKYDNILMEEAAQILEIETFIPLLLQNPQDGFSRLKRWIMIGDHHQLPPVIKNMAFQKYSNMEQSLFTRFVRVGVPTVDLDAQGRARASLCNLYNWRYKNLGNLPHVQLLPEFSTANAGLLYDFQLINVEDFQGVGESEPNPYFYQNLGEAEYVVALFMYMCLLGYPADKISILTTYNGQKHLIRDIINRRCGNNPLIGRPNKVTTVDRFQGQQNDYILLSLVRTRAVGHLRDVRRLVVAMSRARLGLYIFARVSLFQNCFELTPAFSQLTARPLHLHIIPTEPFPTTRKNGERPSHEVQIIKNMPQMANFVYNMYMHLIQTTHHYHQTLLQLPPAMVEEGEEVQNQETELETEEEAMTVQADIIPSPTDTSCRQETPAFQTDTTPSETGATSTPEAIPALSETTPTVVGAVSAPAEANTPQDATSAPEETKHHHHHHHH","Homo sapiens","AQR, KIAA0560","Intron-binding protein aquarius","1","4PJ3"
"4PJ6",,"X-RAY DIFFRACTION",2.83,56.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3000, tris hydrochloride",293,"10.1002/pro.2604",,"4PJ6",204.62,"2.96","2.96","Crystal Structure of Human Insulin Regulated Aminopeptidase with Lysine in Active Site","SATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEYFSLEKIFKELSSYEDFLDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLDVKRMMKTWTLQKGFPLVTVQKKGKELFIQQERFFLNMKPEIQPSDTSYLWHIPLSYVTEGRNYSKYQSVSLLDKKSGVINLTEEVLWVKVNINMNGYYIVHYADDDWEALIHQLKINPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEALFQTDLIYNLLEKLGYMDLASRLVTRVFKLLQNQIQQQTWTDEGTPSMRELRSALLEFACTHNLGNCSTTAMKLFDDWMASNGTQSLPTDVMTTVFKVGAKTDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKLSFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSYTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRLRCVQEALEVIQLNIQWMEKNLKSLTWWL","Homo sapiens","LNPEP, OTASE","Leucyl-cystinyl aminopeptidase","1","4PJ6"
"4PJT",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION",7.2,"2.1 M AMMONIUM SULFATE, 100mM TRIS, PH 7.2",298,"10.1107/S2053230X14015088","2YQ","4PJT",168.89,"2.35","2.35","Structure of PARP1 catalytic domain bound to inhibitor BMN 673","MGSSHHHHHHSGLVPRGSHMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","4PJT"
"4PJV",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION",7.5,"(W/V) POLYETHYLENE GLYCOL 3350, 333 mM SODIUM CHLORIDE.",289,"10.1107/S2053230X14015088","2YQ","4PJV",84.69,"2.5","2.5","Structure of PARP2 catalytic domain bound to inhibitor BMN 673","MHHHHHHSSGVDLGTENLYFQSMDLRVQELIKLICNVQAMEEMMMEMKYNTKKAPLGKLTVAQIKAGYQSLKKIEDCIRAGQHGRALMEACNEFYTRIPHDFGLRTPPLIRTQKELSEKIQLLEALGDIEIAIKLVKTELQSPEHPLDQHYRNLHCALRPLDHESYEFKVISQYLQSTHAPTHSDYTMTLLDLFEVEKDGEKEAFREDLHNRMLLWHGSRMSNWVGILSHGLRIAHPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQCNELLEANPKAEGLLQGKHSTKGLGKMAPSSAHFVTLNGSTVPLGPASDTGILNPDGYTLNYNEYIVYNPNQVRMRYLLKVQFNF","Homo sapiens","PARP2, ADPRT2, ADPRTL2","Poly [ADP-ribose] polymerase 2","1","4PJV"
"4PK5",,"X-RAY DIFFRACTION",2.66,53.77,"VAPOR DIFFUSION, SITTING DROP",9,"10% polyethylene glycol 20000, 2% Dioxane, 100 mM Bicine",293,"10.1021/ml500247w","PKJ","4PK5",97.19,"2.79","2.79","Crystal structure of the indoleamine 2,3-dioxygenagse 1 (IDO1) complexed with Amg-1","MGSSHHHHHHSSGLVPRGSHMAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","4PK5"
"4PK6",,"X-RAY DIFFRACTION",2.74,55.08,"VAPOR DIFFUSION, SITTING DROP",9,"10% polyethylene glycol 20000, 2% Dioxane, 100 mM Bicine",293,"10.1021/ml500247w","PKL","4PK6",97.14,"3.45","3.45","Crystal structure of the indoleamine 2,3-dioxygenagse 1 (IDO1) complexed with imidazothiazole derivative","MGSSHHHHHHSSGLVPRGSHMAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","4PK6"
"4PKK",,"X-RAY DIFFRACTION",3.7,66.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5",291,,,"4PKK",38.39,"1.78","1.78","Crystal structure of Macrophage Migration inhibitory factor in complex with furan-2-ylmethyl)imino methanethiol","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4PKK"
"4PKZ",,"X-RAY DIFFRACTION",3.72,66.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4PKZ",37.64,"1.9","1.9","Crystal structure of P1M mutant of Macrophage Migration Inhibitory Factor","MMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4PKZ"
"4PLU",,"X-RAY DIFFRACTION",2.73,54.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4PLU",37.7,"1.63","1.63","Crystal structure of Macrophage Migration Inhibitory Factor in complex with benzaldehyde","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4PLU"
"4PLX",,"X-RAY DIFFRACTION",3.56,65.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"Folded RNA was combined with an equal volume of the reservoir solution (50 mM sodium cacodylate pH 6.5, 18 mM magnesium chloride, 2.5 mM spermine and 9% isopropanol)",293,"10.1038/nsmb.2844",,"4PLX",73.72,"3.1","3.1","Crystal structure of the triple-helical stability element at the 3' end of MALAT1","GGAAGGUUUUUCUUUUCCUGAGGCGAAAGUCUCAGGUUUUGCUUUUUGGCCUUUCUUAAAAAAAAAAAAAGCAAAA","Homo sapiens",,"Core ENE hairpin and A-rich tract from MALAT1","1","4PLX"
"4PM0",,"X-RAY DIFFRACTION",3.08,60.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.6 - 0.8M (NH4)2SO4, 3mM mercaptoethanol, 10mM MgCl2, 10mM EDTA, 0.1M Tris HCl, pH 7.5,",277,"10.1021/jm5008215","32V","4PM0",44.88,"2.1","2.1","PDE7A catalytic domain in complex with 2-(Cyclopentylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivative","GSGMKETAAAKPERQHMDSPDLGTDDDDKAMADIGSSNSLNILDDDYNGQAKCMLEKVGNWNFDIFLFDRLTNGNSLVSLTFHLFSLHGLIEYFHLDMMKLRRFLVMIQEDYHSQNPYHNAVHAADVTQAMHCYLKEPKLANSVTPWDILLSLIAAATHDLDHPGVNQPFLIKTNHYLATLYKNTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSHLDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHLGVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWKGLQREQSSSEDTDAAFELNSQLLPQENRLS","Homo sapiens","PDE7A","High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A","1","4PM0"
"4PM1",,"X-RAY DIFFRACTION",2.14,42.53,"VAPOR DIFFUSION, SITTING DROP",6.2,"Protein: 5 mg/ml TTR dialysed against 0.1 M NaCl, 0.05M Na acetate, pH 5.5. 
Precipitant:: 70% (30% PEG 4000, 0.2M imidazole malate, pH 6.0) 30% (18% monomethyl PEG 2000, 0.1 M sodium cacodylate, pH 6.5).
Cryoprotectant: 40% (25 % diethylene glycol + 12.5 % MPD + 37.5 % 2,3-butanediol + 12.5 % 1,4-dioxane) 50% (12.5% MPEG 5K, 25% MPEG 550) 0.1 M (mixed Na propionate, Na cacodylate, Bis-Tris-propane 50% at pH 4.0 and 50% pH 9.5)",293,"10.1016/j.nbt.2014.09.002",,"4PM1",28.38,"1.23","1.23","Human transthyretin (TTR) complexed with 16-alpha-bromo-estradiol","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PM1"
"4PME",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"protein: 5 mg/ml dialysed in 0.1 M NaCl, 0.05 M NaAc, pH 5.5 with 5 milli-M curcumin.
precipitant:: 45% MPEG 2,000, 0.1 M sodium cacodylate, pH 7.5.
Cryoprotectant: 40% mixed (25% dioxane, 25% DMSO, 12.5% ethylene glycol, 12.5% 1,2-propanediol, 12.5% glycerol, 12.5% 2,3-butanediol), 50% (25% MPEG 5000, 0.1 M mixed (Na acetate, ADA, Bicine buffer: 40% pH 4.0 / 60% pH 9.0)",293,"10.1016/j.nbt.2014.09.002",,"4PME",26.76,"1.264","1.264","Human transthyretin (TTR) complexed with ferulic acid and curcumin.","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPK","Homo sapiens","TTR, PALB","Transthyretin","1","4PME"
"4PMF",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"Precipitant: 40% MPEG 2,000, 1% dioxane, 0.1 M sodium cacodylate, pH 7.5.
Cryoprotectant: 40% mixed (25% dioxane, 25% DMSO, 12.5% ethylene glycol, 12.5% 1,2-propanediol, 12.5% glycerol, 12.5% 2,3-butanediol) 50% (25% MPEG 5K, 0.1 M mixed (sodium acetate, ADA, bicine 20% pH 4 and 80% pH 9), 3 milli-M Curcumin for 20 min",293,"10.1016/j.nbt.2014.09.002",,"4PMF",26.49,"1.35","1.35","Human transthyretin (TTR) complexed with curcumin","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","TTR, PALB","Transthyretin","1","4PMF"
"4PML",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PML",105.66,"1.87","1.87","Crystal Structure of human Tankyrase 2 in complex with 3-amino-benzamide.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PML"
"4PMM",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 2.3M AmmoniumAcetate",277,"10.1021/jm5006429","31V","4PMM",34.03,"2","2","The structure of TrkA kinase bound to the inhibitor N-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)-2-{4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}acetamide","CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAHHHH","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","4PMM"
"4PMP",,"X-RAY DIFFRACTION",2.79,55.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 2.3M AmmoniumAcetate",277,"10.1021/jm5006429","31W","4PMP",33.88,"1.8","1.8","The structure of TrkA kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-[4-(trifluoromethoxy)phenyl]urea","CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAHHHH","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","4PMP"
"4PMS",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 2.3M AmmoniumAcetate",277,"10.1021/jm5006429","31X","4PMS",33.89,"2.8","2.8","The structure of TrkA kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid","CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAHHHH","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","4PMS"
"4PMT",,"X-RAY DIFFRACTION",2.8,56.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 2.3M AmmoniumAcetate",277,"10.1021/jm5006429","31Y","4PMT",33.86,"2.1","2.1","The structure of TrkA kinase bound to the inhibitor N~4~-(4-morpholin-4-ylphenyl)-N~6~-(pyridin-3-ylmethyl)pyrido[3,2-d]pyrimidine-4,6-diamine","CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAHHHH","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","4PMT"
"4PNL",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNL",105.51,"1.5","1.5","Crystal structure of TNKS-2 in complex with DR2313.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNL"
"4PNM",,"X-RAY DIFFRACTION",2.14,42.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNM",105.04,"2.19","2.19","Crystal Structure of human Tankyrase 2 in complex with Nu1025.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNM"
"4PNN",,"X-RAY DIFFRACTION",2.18,43.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNN",104.65,"1.65","1.65","Crystal Structure of human Tankyrase 2 in complex with 4HQN.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNN"
"4PNQ",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNQ",104.75,"1.85","1.85","Crystal Structure of human Tankyrase 2 in complex with 5AIQ.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNQ"
"4PNR",,"X-RAY DIFFRACTION",2.17,43.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNR",105.22,"1.71","1.71","Crystal Structure of human Tankyrase 2 in complex with TIQ-A.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNR"
"4PNS",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNS",105.25,"1.65","1.65","Crystal Structure of human Tankyrase 2 in complex with INH2BP.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNS"
"4PNT",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4PNT",104.69,"1.6","1.6","Crystal Structure of human Tankyrase 2 in complex with 1,5-IQD.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4PNT"
"4PNZ",,"X-RAY DIFFRACTION",3.01,59.12,"VAPOR DIFFUSION, HANGING DROP",8,"20-25% PEG4000, 200 mM sodium acetate, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm401992e",,"4PNZ",173.7,"1.9","1.9","Human dipeptidyl peptidase IV/CD26 in complex with the long-acting inhibitor Omarigliptin (MK-3102)","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","ADCP2, CD26, DPP4","Dipeptidyl peptidase 4","1","4PNZ"
"4PO2",,"X-RAY DIFFRACTION",2.28,46.02,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris (pH 5.5), 0.2M Li2SO4, 28~30% PEG3350 in the reservoir and 0.1M Bis-Tris (pH 5.5), 0.2M Li2SO4, 22~25% PEG3350 in the crystallization drop, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1371/journal.pone.0103518",,"4PO2",54.42,"2","2","Crystal Structure of the Stress-Inducible Human Heat Shock Protein HSP70 Substrate-Binding Domain in Complex with Peptide Substrate","MHHHHHHENVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKNALESYAFNMKSAVEDEGLKGKISEADKKKVLDKCQEVISWLDANTLAEKDEFEHKRKELEQVCNPIISGLYQG","Homo sapiens","HSPA1, HSPA1A, HSPA1B, HSX70","Heat shock 70 kDa protein 1A/1B","1","4PO2"
,,,,,,,,,,,,,,,,"NRLLLTG",,,"HSP70 substrate peptide","2","4PO2"
"4POC",,"X-RAY DIFFRACTION",1.96,37.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"35% PEG 2000 MME, 0.05 KBr, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbadis.2014.10.010",,"4POC",54.81,"1.601","1.601","Structure of Triosephosphate Isomerase Wild Type human enzyme.","GDITHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI, TPI1","Triosephosphate isomerase","1","4POC"
"4POD",,"X-RAY DIFFRACTION",1.9,35.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"34% PEG 2000 MME, 0.05 KBr, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbadis.2014.10.010",,"4POD",54.7,"1.99","1.99","Structure of Triosephosphate Isomerase I170V mutant human enzyme.","GDITHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAVGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI, TPI1","Triosephosphate isomerase","1","4POD"
"4POK",,"X-RAY DIFFRACTION",3.22,61.85,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% ethanol, 0.1 M Tris, 60 mg/mL Trx protein, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4POK",48.35,"2.52","2.52","Crystal structures of thioredoxin with mesna at 2.5A resolution","GAGTMVKQIESKTAFQKALKAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKKKLEATINKLV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","4POK"
"4POL",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 0.2 M KCl, 60 mg/mL Trx protein, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4POL",48.77,"2.8","2.8","Crystal structures of thioredoxin with mesna at 2.8A resolution","GAGTMVKQIESKTAFQKALKAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKKKLEATINKLV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","4POL"
"4POM",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",7,"28% PEG3350, 0.2M KCl, 160 mg/mL Trx protein, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4POM",48.49,"1.85","1.85","Crystal structures of thioredoxin with mesna at 1.85A resolution","GAGTMVKQIESKTAFQKALKAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKKKLEATINKLV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","4POM"
"4PP7",,"X-RAY DIFFRACTION",3.14,60.8,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris, pH 9.0, 8% PEG6000, glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.007","2VX","4PP7",71.28,"3.4","3.4","Highly Potent and Selective 3-N-methylquinazoline-4(3H)-one Based Inhibitors of B-RafV600E Kinase","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4PP7"
"4PP9",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",8.5,"sodium nitrate, PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 380K",280,"10.1016/j.bmcl.2014.04.023",,"4PP9",61.31,"2.58","2.58","ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4PP9"
"4PPA",,"X-RAY DIFFRACTION",2.47,50.24,"VAPOR DIFFUSION, HANGING DROP",8.5,"sodium nitrate, PEG3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 380K",280,"10.1016/j.bmcl.2014.04.023","2VU","4PPA",61.25,"2.67","2.67","ITK kinase domain with compound 11 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4PPA"
"4PPB",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"sodium nitrate, PEG3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 380K",280,"10.1016/j.bmcl.2014.04.023","2VV","4PPB",61.34,"2.82","2.82","ITK kinase domain with compound 28 (N-{1-[(1S)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4PPB"
"4PPC",,"X-RAY DIFFRACTION",2.14,42.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"sodium nitrate, PEG3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 380K",280,"10.1016/j.bmcl.2014.04.023","2VW","4PPC",61.34,"2.95","2.95","ITK kinase domain with compound 27 (N-{1-[(1R)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4PPC"
"4PPE",,"X-RAY DIFFRACTION",1.8,31.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"25.5 % (w/v) MPEG 2000, 100 mM hepes pH 6.5, 5 % (w/v), MgSO4, 0.5 % (w/v) beta-mercaptoethanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/embr.201338369",,"4PPE",16.79,"2","2","human RNF4 RING domain","GPLGSGATGLRPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNANTCPTCRKKINHKRYHPIYI","Homo sapiens","RES4-26, RNF4, SNURF","E3 ubiquitin-protein ligase RNF4","1","4PPE"
"4PPI",,"X-RAY DIFFRACTION",3.91,68.55,"VAPOR DIFFUSION, HANGING DROP",9,"1.0M sodium citrate, 0.1M CHES pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/srep10609",,"4PPI",19.41,"2.851","2.851","Crystal structure of Bcl-xL hexamer","MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","4PPI"
"4PPX",,"X-RAY DIFFRACTION",2.37,48.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG3350, 300 mM sodium acetate, pH 9.0, 50 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi500270e",,"4PPX",47.79,"2.08","2.08","DNA Polymerase Beta E295K with Spiroiminodihydantoin in Templating Position","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINKYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","4PPX"
,,,,,,,,,,,,,,,,"CCGACXGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*(SDH)P*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","4PPX"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3'","3","4PPX"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(*GP*TP*CP*GP*G)-3'","4","4PPX"
"4PQ7",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M Na-Citrate, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1155/2014/523210","IL3","4PQ7",30.14,"1.85","1.85","The crystal structure of the human carbonic anhydrase ii in complex with a sulfamide inhibitor","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4PQ7"
"4PQD",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, HANGING DROP",7,"60% v/v TacsimateTM  pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,,,"4PQD",11.84,"1.332","1.332","The longer crystal structure of the grow factor like domain from Beta amypoid precusor protein (APP22-126)","TDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDA","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","4PQD"
"4PQE",,"X-RAY DIFFRACTION",5,75.39,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Imidazol pH=7, 12% PEG 20000, 0.5% Ethyl Acetate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4PQE",59.58,"2.9","2.9","Crystal Structure of Human Acetylcholinesterase","EGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","4PQE"
"4PQN",,"X-RAY DIFFRACTION",1.97,37.58,"VAPOR DIFFUSION, SITTING DROP",6,"PEG6000, NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm500550e","2W6","4PQN",30.7,"1.71","1.71","ITK kinase domain with compound GNE-9822","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4PQN"
"4PQO",,"X-RAY DIFFRACTION",4.61,73.31,"VAPOR DIFFUSION, HANGING DROP",5,"1.8 M ammonium citrate tribasic, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.595959",,"4PQO",15.23,"2.55","2.55","Structure of the human SNX14 PX domain in space group I41","GSNLAAWKISIPYVDFFEDPSSERKEKKERIPVFCIDVERNDRRAVGHEPEHWSVYRRYLEFYVLESKLTEFHGAFPDAQLPSKRIIGPKNYEFLKSKREEFQEYLQKLLQHPELSNSQLLADFLSPN","Homo sapiens","SNX14","Sorting nexin-14","1","4PQO"
"4PQP",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG4000, 0.1 M sodium citrate tribasic, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M114.595959",,"4PQP",61.09,"3","3","Crystal structure of human SNX14 PX domain in space group P43212","GSNLAAWKISIPYVDFFEDPSSERKEKKERIPVFCIDVERNDRRAVGHEPEHWSVYRRYLEFYVLESKLTEFHGAFPDAQLPSKRIIGPKNYEFLKSKREEFQEYLQKLLQHPELSNSQLLADFLSPN","Homo sapiens","SNX14","Sorting nexin-14","1","4PQP"
"4PQW",,"X-RAY DIFFRACTION",2.48,50.49,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, pH 4.6, 2.5 M sodium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2014.03.028",,"4PQW",10.14,"1.47","1.47","Crystal Structure of Phospholipase C beta 3 in Complex with PDZ1 of NHERF1","GMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPEENTQL","Homo sapiens","NHERF, NHERF1, SLC9A3R1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","4PQW"
"4PR4",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",5.5,"di-Ammoniumhydrogen citrate, 5 % m/V PEG6000, DTT= 5.15 g/L, NADP+= 0.66 g/L  
protein 15 mg/ml. Afterwards soaked into MES buffer, MES 50 mM, 25% m/V PEG6000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4PR4",36.78,"1.06","1.06","Human Aldose Reductase complexed with Schl7802 at 1.06 A","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4PR4"
"4PR6",,"X-RAY DIFFRACTION",1.91,35.45,"VAPOR DIFFUSION, SITTING DROP",7,"PEG MME 2000, LITHIUM SULPHATE, SPERMINE, TRIS, COBALT HEXAMMINE, MAGNESIUM  
CHLORIDE, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1093/nar/gku992",,"4PR6",57.96,"2.3","2.3","A Second Look at the HDV Ribozyme Structure and Dynamics.","GGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACACCAUUGCACUCCGGUGGCGAAUGGGACGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACACCAUUGCACUCCGGUGGCGAAUGGGAC",,,"HDV RIBOZYME SELF-CLEAVED","1","4PR6"
,,,,,,,,,,,,,,,,"PETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMA","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","2","4PR6"
"4PR9",,"X-RAY DIFFRACTION",2.45,49.89,"VAPOR DIFFUSION, HANGING DROP",7,"12% PEG3350, 2% tryptone, 0.05 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"4PR9",120.56,"3.2","3.2","Human Vinculin (residues 891-1066) in complex with PIP","GEVINQPMMMAARQLHDEARKWSSKGNDIIAAAKRMALLMAEMSRLVRGGSGTKRALIQCAKDIAKASDEVTRLAKEVAKQCTDKRIRTNLLQVCERIPTISTQLKILSTVKATMLGRTNISDEESEQATEMLVHNAQNLMQSVKETVREAEAASIKIRTDAGFTLRWVAKTPWYQ","Homo sapiens","VCL","Vinculin","1","4PR9"
"4PRF",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, HANGING DROP",6,"SrCl2, NaCl, MPD, Sodium Cacodylate, Spermine-HCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gku992",,"4PRF",36.14,"2.395","2.395","A Second Look at the HDV Ribozyme Structure and Dynamics.","GAUGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACACCAUUGCACUCCGGUGGUGAAUGGGACU",,,"Hepatitis Delta virus ribozyme","1","4PRF"
,,,,,,,,,,,,,,,,"MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMKGT","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","2","4PRF"
"4PRG",,"X-RAY DIFFRACTION",2.68,54.13,,7.5,"pH 7.5",,"10.1073/pnas.96.11.6102",,"4PRG",125.79,"2.9","2.9","0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","HPPARGAMMA, PPARG, NR1C3","PROTEIN (PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA)","1","4PRG"
"4PRJ",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% w/v PEG1500, 0.2 M lithium sulfate, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm500550e","2VU","4PRJ",31.55,"2.8","2.8","Aurora A kinase domain with compound 2 (N-[1-(3-cyanobenzyl)-1H-pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide)","MAKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","4PRJ"
"4PRR",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, HANGING DROP",8,"di-Ammoniumhydrogen citrate pH 5.0, PEG6000= 5 % (m/V), DTT= 5.15 g/L, ADP= 0,66 g/L, protein 15 mg/ml. Soaking conditions: Tris buffer, Tris 100 mM 25 %(m/V) PEG6000 pH 8.0 saturated with the inhibitor, VAPOR DIFFUSION, HANGING DROP",,,,"4PRR",36.77,"1.01","1.01","Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1.01 A","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4PRR"
"4PRT",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, HANGING DROP",8,"50 mM di-Ammoniumhydrogen citrate pH 5.0, PEG6000= 5 % (m/V), DTT= 5,15 g/L,  NADP+= 0,66 g/L, Human Aldose Reductase= 15 mg/ml. Afterwards the crystals have been soaked into Tris buffer, Tris 100 mM 25% (m/V) PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4PRT",36.97,"0.96","0.96","Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID) at 0.96 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4PRT"
"4PRY",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Sodium citrate, pH 5.5, 12% PEG6000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb5004256",,"4PRY",33.21,"1.7","1.7","Caspase-8 specific unnatural amino acid peptides","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHQLHHHHHH","Homo sapiens","CASP3, CASPASE-3 CPP32, CPP32","Caspase-3","1","4PRY"
,,,,,,,,,,,,,,,,"XLETD",,,"Ac-LETD-CHO","2","4PRY"
"4PRZ",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.0 M sodium citrate, 0.1 M HEPES, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb5004256",,"4PRZ",32.4,"2.123","2.123","Caspase-8 specific unnatural amino acid peptides","MSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETDSEEQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDAAALEHHHHHH","Homo sapiens","CASP8, CASP8 MCH5, MCH5","Caspase-8","1","4PRZ"
,,,,,,,,,,,,,,,,"XLETX",,,"(ACE)LET(1U8) PEPTIDE","2","4PRZ"
"4PS0",,"X-RAY DIFFRACTION",2.37,48.02,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.15 M sodium citrate, pH 5.5, 14% PEG 6000, 0.3% sodium azide, 0.01 M DTT, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb5004256",,"4PS0",66.85,"1.63","1.63","Caspase-8 specific unnatural amino acid peptides","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHQLHHHHHH","Homo sapiens","CASP3, CASPASE-3 CPP32, CPP32","Caspase-3","1","4PS0"
,,,,,,,,,,,,,,,,"XLQPX",,,"(BAL)LQ(HYP)(1U8) PEPTIDE","2","4PS0"
"4PS1",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Sodium citrate, pH 5.5, 36% PEG600, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/cb5004256",,"4PS1",129.23,"1.731","1.731","Caspase-8 specific unnatural amino acid peptides","MSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETDSEEQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDAAALEHHHHHH","Homo sapiens","CASP8, CASP8 MCH5, MCH5","Caspase-8","1","4PS1"
,,,,,,,,,,,,,,,,"XLQPX",,,"(BAL)LQ(HYP)(1U8) PEPTIDE","2","4PS1"
"4PS3",,"X-RAY DIFFRACTION",2.32,46.98,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 200 mM lithium sulfate, 10 mM DTT, 10 mM EDTA, 100 mM Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm500362j","2WH","4PS3",111.19,"2.9","2.9","Structure of PI3K gamma in complex with 1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1H-imidazol-4-yl)ethyl]urea","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PI3K gamma, PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4PS3"
"4PS5",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM TG101348, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500072z","2TA","4PS5",31.49,"1.4","1.4","Crystal structure of the first bromodomain of human BRD4 in complex with TG101348","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4PS5"
"4PS7",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris, pH 8.5, 25% w/v PEG3350, 200 mM lithium sulfate, 10 mM DTT, 10 mM EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm500362j","2WJ","4PS7",111.03,"2.69","2.69","Structure of PI3K gamma in complex with N-[6-(pyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PI3K gamma, PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4PS7"
"4PS8",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris, pH 8.5, 25% w/v PEG3350, 200 mM lithium sulfate, 10 mM DTT, 10 mM EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm500362j","2WK","4PS8",111.09,"2.99","2.99","Structure of PI3K gamma in complex with N-[6-(5,6-dimethoxypyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PI3K gamma, PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4PS8"
"4PSF",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, SITTING DROP",7,"2% PEG 400 (v/v), 20% methoxy PEG 5000, 0.1 M imidazole pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.celrep.2014.03.013",,"4PSF",30.92,"1.578","1.578","PIH1D1 N-terminal domain","AHSAALEVLFQGPGQPGFCIKTNSSEGKVFINICHSPSIPPPADVTEEELLQMLEEDQAGFRIPMSLGEPHAELDAKGQGCTAYDVAVNSDFYRRMQNSDFLRELVITIAREGLEDKYNLQLNPEWRMMKNRPFMGSI","Homo sapiens","PIH1D1, NOP17","PIH1 domain-containing protein 1","1","4PSF"
"4PSQ",,"X-RAY DIFFRACTION",3.23,61.86,"VAPOR DIFFUSION, SITTING DROP",8,"1 M ammonium phosphate dibasic, 0.1 M imidazole, pH 8.0, 200 mM sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.04.089","2WL","4PSQ",51.43,"2.4","2.4","Crystal Structure of Retinol-Binding Protein 4 (RBP4) in complex with a non-retinoid ligand","MASMSYYHHHHHHDYDIPTTENLYFQGAMERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL","Homo sapiens","RBP4, PRO2222","Retinol-binding protein 4","1","4PSQ"
"4PT6",,"X-RAY DIFFRACTION",1.46,15.79,,,,,,,"4PT6",38.34,"2.1","2.1","The discobody: an engineered discoidin domain from factor VIII that binds v 3 integrin with antibody-like affinities","MLNSCSMPLGMESKAISDAQITASSYACRGDTCWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSAATSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLYENLYFQ","Homo sapiens","F8, F8C","Coagulation factor VIII","1","4PT6"
"4PTB",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, SITTING DROP",6.5,"22% PEG 20000, 0.1M MES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4PTB",43.7,"1.6","1.6","Crystal structure of human SP100 PHD-Bromodomain in the free state","ENSNICEVCNKWGRLFCCDTCPRSFHEHCHIPSVEANKNPWSCIFCRIKTIQERCPESQSGHQESEVLMRQMLPEEQLKCEFLLLKVYCDSKSCFFASEPYYNREGSQGPQKPMWLNKVKTSLNEQMYTRVEGFVQDMRLIFHNHKEFYREDKFTRLGIQVQDIFEKNFRNIFAIQETSK","Homo sapiens","SP100","Nuclear autoantigen Sp-100","1","4PTB"
"4PTC",,"X-RAY DIFFRACTION",2.93,58.08,"VAPOR DIFFUSION",4,"GSK-3 was mixed with a 10-fold molar excess of 3 (1 mM final concentration). Crystals were grown at 20  C by vapor diffusion in the presence of 25% PEG 1500 and 0.1M MMT pH 4.0. Crystals would nucleate within 1-3 days and continued to grow for an addition 5-10 days before harvesting, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2015.03.046","2WE","4PTC",99.23,"2.711","2.711","Structure of a carboxamide compound (3) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-OXO-4H-1LAMBDA~4~,3-THIAZOLE-5-CARBOXAMIDE) to GSK3b","MHSSHHHHHHSSGENLYFQGHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4PTC"
"4PTE",,"X-RAY DIFFRACTION",3.08,60.09,"VAPOR DIFFUSION",6.5,"GSK-3   was mixed with a 10-fold molar excess of 18 (1 mM final concentration). Crystals grown at 20  C by vapor diffusion in the presence of 20% PEG 3350, 0.20M sodium malonate and 0.1M bis-tris  pH 6.5. Crystals would nucleate within 1-3 days and continued to grow for an addition 5-10 days before harvesting, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2015.03.046","2WF","4PTE",99.17,"2.033","2.033","Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) to GSK3b","MHSSHHHHHHSSGENLYFQGHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4PTE"
"4PTG",,"X-RAY DIFFRACTION",3.05,59.61,"VAPOR DIFFUSION",,"GSK-3   was mixed with a 10-fold molar excess of compound (1 mM final concentration). Crystals were grown at 20  C by vapor diffusion in the presence of 22% PEG 3350 and 3.0% w/v methanol. Crystals would nucleate within 1-3 days and continued to grow for an addition 5-10 days before harvesting., VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2015.03.046","2WG","4PTG",99.22,"2.361","2.361","Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) to GSK3b","MHSSHHHHHHSSGENLYFQGHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","4PTG"
"4PTT",,"X-RAY DIFFRACTION",2.29,46.36,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M Na Acetate, 20% PEG 1500, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.4049/jimmunol.1402890",,"4PTT",48.53,"1.8","1.8","Crystal Structure of anti-23F strep Fab C05","MEIVLTQSPATLSLSPGERGTLSCRASQSVGTYLAWYQHKPGQAPRPLIYDASRRATGIPARFSGSGSGTDFTLTISGLEPEDVAVYYCQHRDSWPPGATFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody pn132p2C05, light chain","1","4PTT"
,,,,,,,,,,,,,,,,"MAQLVESGGGVVQPGRSLTLSCAASGFTFSSHGMHWVRQAPGKGLEWVAVIASHGNVNYYADSVKGRFTISRDNSKNTLSLQMDSLRAEDTAVYYCAKESDSCGGDCSRFAFDVWGHGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTNG","Homo sapiens",,"Antibody pn132p2C05, heavy chain","2","4PTT"
"4PUB",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, SITTING DROP",5.5,"FAB DX-2930 AT 268 UM OR 12.7 MG/ML AGAINST JCSG SCREEN CONDITION H3 AND ADDITIVE SCREEN 25% PEG-3350, 0.1 M BISTRIS PH 5.5, 0.1 M SODIUM CITRATE PH 4.5, 3% V/V DMSO, SUPPLEMENTED WITH 15% V/V ETHYLENE GLYCOL AS CRYO-PROTECTANT, PUCK ID TOZ7-6, CRYSTAL TRACKING ID 243341C6, VAPOR DIFFUSION, SITTING DROP",,"10.1074/jbc.M114.569061",,"4PUB",47.52,"1.75","1.75","Crystal structure of Fab DX-2930","DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"DX-2930 LIGHT CHAIN","2","4PUB"
,,,,,,,,,,,,,,,,"EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"DX-2930 HEAVY CHAIN","1","4PUB"
"4PUU",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",8,"50 mM di-Ammoniumhydrogen citrate pH 5.0, PEG6000= 5 % (m/V), DTT= 5,15 g/L, NADP+= 0,66 g/L  
Human Aldose Reductase= 15 mg/ml. Afterwards the crystals have been transferred into Tris 100 mM 25% (m/V) PEG6000 pH 8.0 saturated with the inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"2WR","4PUU",36.85,"1.14","1.14","Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4PUU"
"4PUW",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, HANGING DROP",5,"Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml.        
9 microliter of the crystallization  solution were mixed with 3 microliter of a 5 mM solution of the inhibitor in 120 mM di-Ammoniumhydrogen citrate pH 5.0 with 25 % (m/V) PEG 6000 and 5 % DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"2WQ","4PUW",37.09,"1.12","1.12","Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4PUW"
"4PUZ",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, HANGING DROP",8.5,"15% PEG 3350, 100mM Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500228a","CG9","4PUZ",68.59,"2.085","2.085","Crystal structure of spleen tyrosine kinase (Syk) in complex with GS-9973","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4PUZ"
"4PV0",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm500228a","CG4","4PV0",32.54,"2","2","Crystal structure of spleen tyrosine kinase (Syk) in complex with an imidazopyrazine inhibitor","VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4PV0"
"4PV7",,"X-RAY DIFFRACTION",3.02,59.28,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG MME 2000, 0.1M Bicine, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 289.0K",289,,,"4PV7",175.33,"3.24","3.24","Cocrystal structure of dipeptidyl-peptidase 4 with an indole scaffold inhibitor","HHHHHHDYDIPTTENLYFQGAMGSSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","ADCP2, CD26, DPP4","Dipeptidyl peptidase 4 soluble form","1","4PV7"
"4PVF",,"X-RAY DIFFRACTION",3.65,66.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-Tris propane pH7.5, 5%glycerol, 12-16% Peg 3350, 0.2M KF, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1111/febs.13211",,"4PVF",107.8,"2.6","2.6","Crystal structure of Homo sapiens holo serine hydroxymethyltransferase 2 (mitochondrial) (SHMT2), isoform 3, transcript variant 5, 483 aa, at 2.6 ang. resolution","MAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","4PVF"
"4PVG",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, HANGING DROP",7.7,"30% w/v polyethylene glycol 3350, 100 mM NaCl, 1mM L88N79 and 100mM HEPES (pH 7.7) , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"2WT","4PVG",35.62,"2.4","2.4","Crystal structure of protein tyrosine phosphatase Shp2 catalytic domain complex with small molecular compound L88N79","MTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4PVG"
"4PVL",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, SITTING DROP",6.4,"2.15M SODIUM MALONATE, 23MG/ML PROTEIN, 100UL DROP, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S2052252514021113",,"4PVL",28.07,"1.851","1.851","X-ray structure of human transthyretin (TTR) at room temperature to 1.9A resolution","GAMGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4PVL"
"4PVM",,"NEUTRON DIFFRACTION, X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, SITTING DROP",6.4,"2.15M SODIUM MALONATE, 23MG/ML PROTEIN, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S2052252514021113",,"4PVM",28.07,"2, 1.95","2, 1.95","Neutron structure of human transthyretin (TTR) at room temperature to 2.0A resolution (Laue)","GAMGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4PVM"
"4PVN",,"NEUTRON DIFFRACTION, X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",6.4,"2.15M SODIUM MALONATE, 23MG/ML PROTEIN, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S2052252514021113",,"4PVN",28.07,"2.3, 1.95","2.3, 1.95","Neutron structure of human transthyretin (TTR) at room temperature to 2.3A resolution (monochromatic)","GAMGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","4PVN"
"4PVP",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M SODIUM MALONATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi300870g",,"4PVP",64.73,"1.85","1.85","Crystal structure of malonate-bound human L-asparaginase protein","GHMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ALP, ASRGL1, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4PVP"
"4PVQ",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, HANGING DROP",5.27,"0.2 M AMMONIUM IODIDE, 2.2 M AMMONIUM SULFATE, PH 5.27, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi300870g",,"4PVQ",66.38,"2.13","2.13","Crystal structure of sulfate-bound human l-asparaginase protein","GHMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ALP, ASRGL1, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4PVQ"
"4PVR",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M SODIUM MALONATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi300870g",,"4PVR",64.89,"1.75","1.75","Crystal structure of partially-cleaved human l-asparaginase protein in complex with l-aspartate","GHMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ALP, ASRGL1, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4PVR"
"4PVS",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M SODIUM MALONATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi300870g",,"4PVS",64.89,"1.84","1.84","Crystal structure of fully-cleaved human l-asparaginase protein in complex with l-aspartate","GHMNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ALP, ASRGL1, CRASH","Isoaspartyl peptidase/L-asparaginase","1","4PVS"
"4PVU",,"X-RAY DIFFRACTION",2.49,50.59,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M Sodium Citrate, pH 8, 0.15M Tris, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cmdc.201402462","MGZ","4PVU",65.72,"2.6","2.6","Crystal structure of the complex between PPARgamma-LBD and the R enantiomer of Mbx-102 (Metaglidasen)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4PVU"
"4PVX",,"X-RAY DIFFRACTION",2.49,50.54,"VAPOR DIFFUSION, HANGING DROP",4.6,"5.6% PEG 4000, 30% glycerol, 0.07M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1371/journal.pone.0186447","YS1","4PVX",43.71,"2.18","2.18","Crystal structure of human FPPS in complex with [({4-[4-(cyclopropyloxy)phenyl]pyridin-2-yl}amino)methanediyl]bis(phosphonic acid)","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4PVX"
"4PVY",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.7M sodium chloride, 15% glycerol, 0.085M sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1371/journal.pone.0186447","JD1","4PVY",43.71,"2.05","2.05","Crystal structure of human FPPS in complex with [({5-[4-(propan-2-yloxy)phenyl]pyridin-3-yl}amino)methanediyl]bis(phosphonic acid)","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4PVY"
"4PW5",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% ethanol and 0.1 M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.molcel.2014.04.003",,"4PW5",116.95,"2.204","2.204","structure of UHRF2-SRA in complex with a 5hmC-containing DNA, complex I","STESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGGIHGRSNDGAYSLVLAGGFADEVDRGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRSFKGRKISKYAPEEGNRYDGIYKVVKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGK","Homo sapiens","UHRF2, NIRF, RNF107","E3 ubiquitin-protein ligase UHRF2","1","4PW5"
,,,,,,,,,,,,,,,,"CTGGTCXGGATG",,,"5hmC-containing DNA1","2","4PW5"
,,,,,,,,,,,,,,,,"CCATCCGGACCA",,,"5hmC-containing DNA2","3","4PW5"
"4PW6",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris  
pH 8.0 and 8% PEG-8000, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.molcel.2014.04.003",,"4PW6",58.51,"3.789","3.789","structure of UHRF2-SRA in complex with a 5hmC-containing DNA, complex II","STESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGGIHGRSNDGAYSLVLAGGFADEVDRGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRSFKGRKISKYAPEEGNRYDGIYKVVKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGK","Homo sapiens","UHRF2, NIRF, RNF107","E3 ubiquitin-protein ligase UHRF2","1","4PW6"
,,,,,,,,,,,,,,,,"GTGATXGAAGTT",,,"5hmC-containing DNA1","2","4PW6"
,,,,,,,,,,,,,,,,"AACTTCGATCAC",,,"5hmC-containing DNA2","3","4PW6"
"4PW7",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% ethanol and 0.1 M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1016/j.molcel.2014.04.003",,"4PW7",116.92,"2.001","2.001","structure of UHRF2-SRA in complex with a 5mC-containing DNA","STESRRDWGRGMACVGRTRECTIVPSNHYGPIPGIPVGSTWRFRVQVSEAGVHRPHVGGIHGRSNDGAYSLVLAGGFADEVDRGDEFTYTGSGGKNLAGNKRIGAPSADQTLTNMNRALALNCDAPLDDKIGAESRNWRAGKPVRVIRSFKGRKISKYAPEEGNRYDGIYKVVKYWPEISSSHGFLVWRYLLRRDDVEPAPWTSEGIERSRRLCLRLQYPAGYPSDKEGK","Homo sapiens","UHRF2, NIRF, RNF107","E3 ubiquitin-protein ligase UHRF2","1","4PW7"
,,,,,,,,,,,,,,,,"CTGGTCCGGATG",,,"5mC-containing DNA1","2","4PW7"
,,,,,,,,,,,,,,,,"CCATCCGGACCA",,,"5mC-containing DNA2","3","4PW7"
"4PW8",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, HANGING DROP",6,"6%-10% MPEG 5000, 10% 2-propanol, 0.1M sodium cacodylate, 0.1M hexammine cobalt(III) chloride, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/prot.24653",,"4PW8",353.17,"2.902","2.902","Human tryptophan 2,3-dioxygenase","SNAPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKF","Homo sapiens","TDO, TDO2","Tryptophan 2,3-dioxygenase","1","4PW8"
"4PWE",,"X-RAY DIFFRACTION",1.73,28.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG400, 0.1M HEPES, 0.4M CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m",,"4PWE",34.69,"1.4","1.4","Crystal structure of V30M mutant human transthyretin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWE"
"4PWF",,"X-RAY DIFFRACTION",1.7,27.85,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 4mM ferulic acid phenethyl ester, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","PWF","4PWF",35.28,"1.6","1.6","Crystal structure of V30M mutant human transthyretin complexed with ferulic acid phenethyl ester","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWF"
"4PWG",,"X-RAY DIFFRACTION",1.7,27.57,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 12mM caffeic acid ethyl ester, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","0XR","4PWG",35.14,"1.798","1.798","Crystal structure of V30M mutant human transthyretin complexed with caffeic acid ethyl ester","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWG"
"4PWH",,"X-RAY DIFFRACTION",1.71,27.9,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 9mM caffeic acid 1,1-dimethylallyl ester, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","PWH","4PWH",35.26,"1.798","1.798","Crystal structure of V30M mutant human transthyretin complexed with caffeic acid 1,1-dimethylallyl ester","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWH"
"4PWI",,"X-RAY DIFFRACTION",1.7,27.66,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 9mM rosmarinic acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","ROA","4PWI",35.41,"1.494","1.494","Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acid","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWI"
"4PWJ",,"X-RAY DIFFRACTION",1.72,28.57,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 8mM nordihydroguaiaretic acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","30Z","4PWJ",35.29,"1.55","1.55","Crystal structure of V30M mutant human transthyretin complexed with nordihydroguaiaretic acid","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWJ"
"4PWK",,"X-RAY DIFFRACTION",1.74,29.17,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 6mM dihydroguaiaretic acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","PWK","4PWK",35.35,"1.59","1.59","Crystal structure of V30M mutant human transthyretin complexed with dihydroguaiaretic acid","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4PWK"
"4PWL",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M Sodium Citrate, pH 8, 0.15M Tris, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cmdc.201402462",,"4PWL",65.72,"2.6","2.6","Crystal structure of the complex between PPARgamma-LBD and the S enantiomer of Mbx-102 (Metaglidasen)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4PWL"
"4PWN",,"X-RAY DIFFRACTION",1.92,35.79,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.35M potassium phosphate, 19% PEG 3350, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1126/scisignal.2005050",,"4PWN",31.63,"1.84","1.84","Crystal structure of Active WNK1 kinase","KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLEKRASFAKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE","Homo sapiens","WNK1, HSN2, KDP, KIAA0344, PRKWNK1","Serine/threonine-protein kinase WNK1","1","4PWN"
"4PWQ",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M Na-citrate, 20% PEG4000, 11% 2-propanole, 10mM sarcosine, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1016/j.jmb.2014.12.005",,"4PWQ",43.52,"1.4","1.4","HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE E1-DOMAIN of THE AMYLOID PRECURSOR PROTEIN","MLEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAIEGRKLAAALEHHHHHH","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","4PWQ"
"4PWY",,"X-RAY DIFFRACTION",3.5,64.7,"VAPOR DIFFUSION",6.7,"2.0 M malonate, pH 6.7, vapor diffusion, temperature 291K",291,,,"4PWY",30.69,"1.9","1.9","Crystal structure of a Calmodulin-lysine N-methyltransferase fragment","GSVRRFESFNLFSVTEGKERETEEEVGAWVQYTSIFCPEYSISLRHNSGSLNVEDVLTSFDNTGNVCIWPSEEVLAYYCLKHNNIFRALAVCELGGGMTCLAGLMVAISADVKEVLLTDGNEKAIRNVQDIITRNQKAGVFKTQKISSCFLRWDNETDVSQLEGHFDIVMCADCLFLDQYRASLVDAIKRLLQPRGKAMVFAPRRGNTLNQFCNLAEKAGFCIQRHENYDEHISNFHSKLKKENPDIYEENLHYPLLLILTKHG","Homo sapiens","CAMKMT, C2orf34, CLNMT","Calmodulin-lysine N-methyltransferase","1","4PWY"
"4PX2",,"X-RAY DIFFRACTION",2.96,58.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris,0.2M NaI,16% PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"2WY","4PX2",146.22,"2.15","2.15","Human GKRP bound to AMG2882 and Sorbitol-6-Phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4PX2"
"4PX3",,"X-RAY DIFFRACTION",3.01,59.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"2WX","4PX3",146.11,"2.43","2.43","Human GKRP bound to AMG-3295 and Sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4PX3"
"4PX5",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16%PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"2WZ","4PX5",146.92,"2.2","2.2","Human GKRP bound to AMG-0696 and Sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4PX5"
"4PX6",,"X-RAY DIFFRACTION",2.23,44.88,"VAPOR DIFFUSION, SITTING DROP",6.2,"20% PEG3350, 0.2M ammonium fluoride, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.03.075","2X6","4PX6",34.25,"1.6","1.6","SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVTDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4PX6"
"4PX9",,"X-RAY DIFFRACTION",2.02,39.22,"VAPOR DIFFUSION, HANGING DROP",7.6,"50 mM Hepes 7.6; 7% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2015.02.015",,"4PX9",100.35,"2.31","2.31","DEAD-box RNA helicase DDX3X Domain 1 with N-terminal ATP-binding Loop","MGSSHHHHHHSSGLVPRGSDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGR","Homo sapiens","DBX, DDX3, DDX3X","ATP-dependent RNA helicase DDX3X","1","4PX9"
"4PXA",,"X-RAY DIFFRACTION",4.06,69.68,"VAPOR DIFFUSION, HANGING DROP",,"1.66 M NaH2PO4  
0.24 M K2HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1016/j.jmb.2015.02.015",,"4PXA",53.59,"3.2","3.2","DEAD-box RNA helicase DDX3X Cancer-associated mutant D354V","MGSSHHHHHHSSGLVPRGSDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLVMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHYKG","Homo sapiens","DBX, DDX3, DDX3X","ATP-dependent RNA helicase DDX3X","1","4PXA"
"4PXJ",,"X-RAY DIFFRACTION",5.23,76.47,"VAPOR DIFFUSION",5.5,"1.6 M SAM, 0.1 M citrate pH 5.5, 2 % PEG 400, VAPOR DIFFUSION, temperature 291K",291,"10.1107/S2053230X16001576",,"4PXJ",21.22,"2.06","2.06","Crystallographic structure of the LZII fragment (anti-parallel orientation) from JIP3","GAMDPEFTKNALNVVKNDLIAKVDQLSGEQEVLRGELEAAKQAKVKLENRIKELEEELKRV","Homo sapiens","MAPK8IP3, JIP3, KIAA1066","C-Jun-amino-terminal kinase-interacting protein 3","1","4PXJ"
"4PXS",,"X-RAY DIFFRACTION",3.03,59.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Bis-tris, 0.2M NaI, 16% PEG8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"2Y6","4PXS",146.32,"2.6","2.6","Human GKRP bound to AMG-0265 (N-[(R)-(2-CHLOROPHENYL){7-[4-(2-HYDROXYPROPAN-2-YL) PYRIDIN-2-YL]-1-BENZOTHIOPHEN-2-YL}METHYL]CYCLOPROPANESULFONAMIDE) and Sorbitol-6-phosphate","MAHHHHHHDEVDMPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLEKKGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQG","Homo sapiens","GCKR","Glucokinase regulatory protein","1","4PXS"
"4PXW",,"X-RAY DIFFRACTION",1.81,32.07,"VAPOR DIFFUSION",7.5,"0.1 M sodium hepes, 0.2 M lithium sulfate, 25% PEG3350, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"4PXW",87.27,"1.72","1.72","Crystal structure of human DCAF1 WD40 repeats (Q1250L)","MHHHHHHSSGRENLYFQGEPKQRRQAPINFTSRLNRRASFPKYGGVDGGCFDRHLIFSRFRPISVFREANEDESGFTCCAFSARERFLMLGTCTGQLKLYNVFSGQEEASYNCHNSAITHLEPSRDGSLLLTSATWSQPLSALWGMKSVFDMKHSFTEDHYVEFSKHSQDRVIGTKGDIAHIYDIQTGNKLLTLFNPDLANNYKRNCATFNPTDDLVLNDGVLWDVRSALAIHKFDKFNMNISGVFHPNGLEVIINTEIWDLRTFHLLHTVPALDQCRVVFNHTGTVMYGAMLQADDEDDLMEERMKSPFGSSFRTFNATDYKPIATIDVKRNIFDLCTDTKDCYLAVIENQGSMDALNMDTVCRLYEVGRQRLAEDEDEE","Homo sapiens","VPRBP, DCAF1, KIAA0800, RIP","Protein VPRBP","1","4PXW"
"4PXX",,"X-RAY DIFFRACTION",1.93,36.18,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M MgCl2, 0.1M Tris-HCl, 30% (w/v) PEG 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4PXX",29.78,"1.851","1.851","Crystal structure of a highly thermal stabilized variant of Human Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPICKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPCLESVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4PXX"
"4PY1",,"X-RAY DIFFRACTION",1.9,35.27,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-tris pH 5.5, 250 mM NaCl, 10 mM TCEP, 33-40% PEG-3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2014.07.052",,"4PY1",36.92,"2.16","2.16","Crystal structure of Tyk2 in complex with compound 15, 6-((2,5-dimethoxyphenyl)thio)-3-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4PY1"
"4PY4",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.2M Sodium-malonate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4PY4",44.02,"2.76","2.76","Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhibitor XL2","KQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","4PY4"
"4PY7",,"X-RAY DIFFRACTION",3.03,59.42,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M calcium acetate, 10% PEG8000, 100 mM Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1128/JVI.00178-14",,"4PY7",93.53,"2.7","2.7","Crystal Structure of Fab 3.1","QVQLVQSGGGVVQPGRSLRLSCAASEFTFRMYATHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSMNTVYLQMNTLRPEDTAVYYCARDLGGYFIRGIMDVWGQGTLVTVSSASTKGPSVFPLAPSSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"antibody 3.1 heavy chain","1","4PY7"
,,,,,,,,,,,,,,,,"ELQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"antibody 3.1 light chain","2","4PY7"
"4PYG",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION, HANGING DROP",6.8,"20mM Mes pH 6.8, 200mM sodium chloride, 20mM MgCl2, 6% PEG 3350, 5mM DTT, 24% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1371/journal.pone.0107005",,"4PYG",237.02,"2.8","2.8","Transglutaminase2 complexed with GTP","MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPALEHHHHHH","Homo sapiens","TGM2","Protein-glutamine gamma-glutamyltransferase 2","1","4PYG"
"4PYI",,"X-RAY DIFFRACTION",1.98,37.97,,7,"pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714012917",,"4PYI",24.5,"1.35","1.35","human apo COMT","MGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4PYI"
"4PYJ",,"X-RAY DIFFRACTION",2.42,49.28,,8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714012917",,"4PYJ",24.56,"1.9","1.9","human apo-COMT, single domain swap","MGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4PYJ"
"4PYK",,"X-RAY DIFFRACTION",2.39,48.61,,7.5,"pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1399004714012917",,"4PYK",24.56,"2.22","2.22","human COMT, double domain swap","MGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4PYK"
"4PYP",,"X-RAY DIFFRACTION",3.55,65.32,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG400, 0.1M MgCl2, 0.1M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature13306",,"4PYP",56.04,"3.166","3.166","Crystal structure of the human glucose transporter GLUT1","MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYTQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVQRAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQVLEHHHHHHHHHH","Homo sapiens","SLC2A1, GLUT1","Solute carrier family 2, facilitated glucose transporter member 1","1","4PYP"
"4PYV",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, HANGING DROP",4.5,"REMARK: HANGING DROP, VAPOR DIFFUSION, 20 DEG C, 1 UL PROTEIN + 1 UL RESERVOIR; PROTEIN SOLUTION: 31.7 MG/ML RENIN, 12.5 MM TRIS PH 8, 25 MM NACL; RESERVOIR SOLUTION: 18% PEG4000, 50 MM NACITRATE PH 4.5, 400 MM NACL; SOAKING: DROP PLUS 2.5 UL RESERVOIR SOLUTION PLUS 10 MM INHIBITOR AND 10% DMSO FOR 30 MIN; CRYO: SOAKING SOLUTION PLUS 15% GLYCEROL., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ml500137b","2XF","4PYV",75.97,"2.65","2.65","Crystal structure of renin in complex with compound4","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4PYV"
"4PYX",,"X-RAY DIFFRACTION",2,38,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V90","4PYX",30.04,"1.8","1.8","Crystal structure of human carbonic anhydrase isozyme II with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4PYX"
"4PYY",,"X-RAY DIFFRACTION",2.04,39.2,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V14","4PYY",29.8,"1.75","1.75","Crystal structure of human carbonic anhydrase isozyme II with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4PYY"
"4PYZ",,"X-RAY DIFFRACTION",3.24,62.09,"VAPOR DIFFUSION, HANGING DROP",5.6,"15% PEG 4000, 0.2 M NH4Ac, 0.1 M NaCitrate pH5.6, vapor diffusion hanging drop, temperature 291K",291,,,"4PYZ",63.47,"2.84","2.84","Crystal structure of the first two Ubl domains of Deubiquitylase USP7","SHHHHHHSSGLVPRGSPQQLVERLQEEKRIEAQKRKERQEAHLYMQVQIVAEDQFCGHQGNDMYDEEKVKYTVFKVLKNSSLAEFVQSLSQTMGFPQDQIRLWPMQARSNGTKRPAMLDNEADGNKTMIELSDNENPWTIFLETVDPELAASGATLPKFDKDHDVMLFLKMYDPKTRSLNYCGHIYTPISCKIRDLLPVMCDRAGFIQDTSLILYEEVKPNLTERIQDYDVSLDKALDELMDGDIIVFQKDDPENDNSELPTAKEYFRDLYHR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","4PYZ"
"4PZ4",,"X-RAY DIFFRACTION",2.99,58.92,"hanging drop",7,"25% PEG 3350, 100 mM NACl, 100 mM HEPES, (5% DMSO), pH 7.0, hanging drop, temperature 277K",277,"10.1107/S2053230X14015532",,"4PZ4",35.51,"1.6","1.6","High-resolution crystal structure of the human CD44 hyaluronan binding domain in new space group","AMAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPS","Homo sapiens","CD44, Cd44 Ly-24, LHR, MDU2, MDU3, MIC4","CD44 antigen","1","4PZ4"
"4PZG",,"X-RAY DIFFRACTION",5.24,76.53,"VAPOR DIFFUSION",7,"4 M sodium nitrate, 0.1 M BIS-TRIS propane pH 7.0, vapor diffusion, temperature 293K",293,"10.1002/prot.24689",,"4PZG",52.87,"2.8","2.8","Crystal structure of human sorting nexin 10 (SNX10)","MFPEQQKEEFVSVWVRDPRIQKEDFWHSYIDYEICIHTNSMCFTMKTSCVRRRYREFVWLRQRLQSNALLVQLPELPSKNLFFNMNNRQHVDQRRQGLEDFLRKVLQNALLLSDSSLHLFLQSHLNSEDIEACVSGQTKYSVEEAIHKFALMNRRFPEEDEEGKKENDIDYDSESSSSGLGHSSDDSSSHGCKVNTAPQESLEHHHHHH","Homo sapiens","SNX10","Sorting nexin-10","1","4PZG"
"4PZH",,"X-RAY DIFFRACTION",2,38,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V13","4PZH",30.19,"1.06","1.06","Crystal structure of human carbonic anhydrase isozyme II with 2,3,5,6-tetrafluoro-4[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4PZH"
"4PZI",,"X-RAY DIFFRACTION",2.8,55.7,,8.5,"25% PEG-3350, 0.2 M ammonium sulfate, 0.1 M TRIS, pH 8.5, temperature 291K",291,"10.1016/j.str.2017.11.022",,"4PZI",15.02,"2.15","2.15","Zinc finger region of MLL2 in complex with CpG DNA","GSHHGKKMRMARCGHCRGCLRVQDCGSCVNCLDKPKFGGPNTKKQCCVYRKCDKIEARKMERLAKKG","Homo sapiens","KMT2B, HRX2, KIAA0304, MLL2, MLL4, TRX2, WBP7","Histone-lysine N-methyltransferase 2B","1","4PZI"
,,,,,,,,,,,,,,,,"GCCACCGGTGGC",,,"DNA (5'-D(*GP*CP*CP*AP*CP*CP*GP*GP*TP*GP*GP*C)-3')","2","4PZI"
"4PZN",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"55% ethylene glycol, 100 mM tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/prot.24645",,"4PZN",47.64,"2.3","2.3","Crystal structure of PHC3 SAM L971E","MEKTRTEPSIWTVDDVWAFIHSLPGCQDIADEFRAQEIDGQALLLLKEDHLMSAMNIKLGPAEKICARINSLKESRHHHHHH","Homo sapiens","EDR3, PH3, PHC3","Polyhomeotic-like protein 3","1","4PZN"
"4PZO",,"X-RAY DIFFRACTION",3.01,59.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0 M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/prot.24645",,"4PZO",57.42,"2.25","2.25","Crystal structure of PHC3 SAM L967R","MEKTRTEPSIWTVDDVWAFIHSLPGCQDIADEFRAQEIDGQALLLLKEDHLMSAMNIKRGPALKICARINSLKESRHHHHHH","Homo sapiens","EDR3, PH3, PHC3","Polyhomeotic-like protein 3","1","4PZO"
"4PZQ",,"X-RAY DIFFRACTION",2.99,58.92,"VAPOR DIFFUSION, SITTING DROP",6,"50MM SODIUM CACODYLATE, 1MM MAGNESIUM CHLORIDE, 5% MPD, 2MM COBALT(II) CHLORIDE, 1MM CHROMOMYCIN A3, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1002/anie.201405637",,"4PZQ",3.41,"2.24","2.24","Crystal Structure of CCG DNA repeats","TCCGCCGCCGA","Homo sapiens",,"DNA (5'-D(*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*A)-3')","1","4PZQ"
"4PZR",,"X-RAY DIFFRACTION",2.42,49.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 16% PEG3350, 3-10% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500380f","COA","4PZR",44.76,"2.099","2.099","Crystal structure of p300 histone acetyltransferase domain in complex with Coenzyme A","KFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQD","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","4PZR"
"4PZS",,"X-RAY DIFFRACTION",2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 16% PEG3350, 3-10% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500380f",,"4PZS",44.59,"1.94","1.94","Crystal structure of p300 histone acetyltransferase domain in complex with Acetyl-Coenzyme A","KFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQD","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","4PZS"
"4PZT",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 16% PEG3350, 3-10% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi500380f",,"4PZT",44.76,"2.8","2.8","Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor, Acetonyl-Coenzyme A","KFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQD","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","4PZT"
"4PZW",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 300K, pH 4.5",300,"10.1016/j.bmcl.2014.04.012","2X4","4PZW",45.88,"1.8","1.8","Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4PZW"
"4PZX",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate pH 4.5, 5% DMSO 
, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmcl.2014.04.012","2X5","4PZX",45.88,"1.8","1.8","Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4PZX"
"4PZY",,"X-RAY DIFFRACTION",1.93,36.18,"VAPOR DIFFUSION, HANGING DROP",8,"30% PEG MME 2000, 0.1M KSCN, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10858-014-9849-8",,"4PZY",39.98,"1.88","1.88","Second-site screening of K-Ras in the presence of covalently attached first-site ligands","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDCYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","K-Ras","1","4PZY"
"4PZZ",,"X-RAY DIFFRACTION",1.9,35.21,"VAPOR DIFFUSION, HANGING DROP",4,"24% PEG 4000, 0.1 M MMT pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10858-014-9849-8",,"4PZZ",20,"1.403","1.403","Second-site screening of K-Ras in the presence of covalently attached first-site ligands","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDCYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","K-Ras","1","4PZZ"
"4Q01",,"X-RAY DIFFRACTION",2.04,39.63,"VAPOR DIFFUSION, HANGING DROP",4.5,"22% PEG 4000, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10858-014-9849-8",,"4Q01",39.88,"1.291","1.291","Second-site screening of K-Ras in the presence of covalently attached first-site ligands","MTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDCYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","K-Ras","1","4Q01"
"4Q02",,"X-RAY DIFFRACTION",1.92,35.91,"VAPOR DIFFUSION, HANGING DROP",5,"28% PEG 4000, 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10858-014-9849-8",,"4Q02",19.98,"1.702","1.702","Second-site screening of K-Ras in the presence of covalently attached first-site ligands","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDCYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4Q02"
"4Q03",,"X-RAY DIFFRACTION",1.92,35.95,"VAPOR DIFFUSION, HANGING DROP",4,"24% PEG 4000, 0.1 M MMT, pH4.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10858-014-9849-8",,"4Q03",20.03,"1.201","1.201","Second-site screening of K-Ras in the presence of covalently attached first-site ligands","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDCYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4Q03"
"4Q06",,"X-RAY DIFFRACTION",2.03,38.9,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V90","4Q06",29.96,"1.15","1.15","Crystal structure of chimeric carbonic anhydrase IX with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKALQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q06"
"4Q07",,"X-RAY DIFFRACTION",2.01,38.4,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V14","4Q07",29.99,"1.15","1.15","Crystal structure of chimeric carbonic anhydrase IX with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKALQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q07"
"4Q08",,"X-RAY DIFFRACTION",1.99,37.7,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V90","4Q08",30.14,"1.07","1.07","Crystal structure of chimeric carbonic anhydrase XII with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q08"
"4Q09",,"X-RAY DIFFRACTION",1.97,37.2,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V14","4Q09",30.12,"1.2","1.2","Crystal structure of chimeric carbonic anhydrase XII with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q09"
"4Q0L",,"X-RAY DIFFRACTION",1.92,35.4,"VAPOR DIFFUSION, SITTING DROP",5,"Crystallization buffer: 0.1M ammonium citrate with pH 5.0 and 18% of   PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/jm501003k","V14","4Q0L",121.71,"2","2","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with inhibitor","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4Q0L"
"4Q0N",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350   
10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4Q0N",139.67,"1.78","1.78","Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand","MHHHHHHSSGVDLGTENLYFQSMSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAIFLRLPSRSELPDYYLTIKKPMDMEKIRSHMMANKYQDIDSMVEDFVMMFNNACTYNEPESLIYKDALVLHKVLLETRRDLEGD","Homo sapiens","BAF180, PB1, PBRM1","Protein polybromo-1","1","4Q0N"
"4Q0O",,"X-RAY DIFFRACTION",2.94,58.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.20M K3(cit), 0.1M BTProp pH 6.5, 20.0% PEG 3350, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4Q0O",14.99,"1.83","1.83","Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand","SMSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAIFLRLPSRSELPDYYLTIKKPMDMEKIRSHMMANKYQDIDSMVEDFVMMFNNACTYNEPESLIYKDALVLHKVLLETRRDLEGD","Homo sapiens","BAF180, PB1, PBRM1","Protein polybromo-1","1","4Q0O"
"4Q18",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2XJ","4Q18",68.11,"2","2","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 4 [1-[5-(4-{[(2,6-diaminopyrimidin-4-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)-2-methoxyphenoxy]-2-methylpropan-2-ol]","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q18"
"4Q19",,"X-RAY DIFFRACTION",2.15,42.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2XL","4Q19",67.02,"2.09","2.09","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 5 {5-(4-{[(4,6-DIAMINOPYRIMIDIN-2-YL)SULFANYL]METHYL}-5-PROPYL-1,3-THIAZOL-2-YL)-2-METHOXYPHENOL}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q19"
"4Q1A",,"X-RAY DIFFRACTION",2.17,43.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2XZ","4Q1A",67.11,"1.9","1.9","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 6 {2-[5-(4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-1,3-thiazol-2-yl)-2-methoxyphenoxy]ethanol}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1A"
"4Q1B",,"X-RAY DIFFRACTION",2.22,44.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2Y0","4Q1B",67.2,"2.15","2.15","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 7 {N-(2-(3-(4-(((4,6-diaminopyrimidin-2-yl)thio)methyl)-5-propylthiazol-2-yl)phenoxy)ethyl)methanesulfonamide}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1B"
"4Q1C",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2XM","4Q1C",67.17,"2","2","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminopyrimidin-2-yl)sulfanyl]methyl}-5-propyl-2,3-dihydro-1,3-thiazol-2-yl]benzene-1,2-diyl}bis(oxy)]diethanol}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1C"
"4Q1D",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2Y1","4Q1D",67.14,"2","2","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 9 {2-{[(1R)-1-{2-[3-(2-fluoroethoxy)-4-methoxyphenyl]-5-propyl-1,3-thiazol-4-yl}ethyl]sulfanyl}pyrimidine-4,6-diamine}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1D"
"4Q1E",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2Y7, 2Y8","4Q1E",67.95,"1.85","1.85","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-fluoroethoxy)-4-methoxyphenyl]-5-methyl-1,3-thiazol 4-yl}ethyl]sulfanyl}pyrimidine-4,6-diamine}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1E"
"4Q1F",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M trisodium citrate dehydrate and 25 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/jm501124j","2XN","4Q1F",67.23,"2.1","2.1","Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-diaminopyrimidin-2-yl)sulfanyl]ethyl}-5-methyl-1,3-thiazol-2-yl)-2-methoxyphenoxy]ethyl}methanesulfonamide}","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","4Q1F"
"4Q1N",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG 4000, 0.6 M NaCl, 0.05M sodium citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ml500137b","2Y9","4Q1N",76.26,"2.09","2.09","Structure-based design of 4-hydroxy-3,5-substituted piperidines as direct renin inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4Q1N"
"4Q1P",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4Q1P",31.4,"1.46","1.46","Galectin-1 in Complex with Ligand NB169","GMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Q1P"
"4Q1R",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4Q1R",31.41,"1.47","1.47","Galectin-1 in Complex with Ligand AN027","GMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Q1R"
"4Q21",,"X-RAY DIFFRACTION",2.25,45.29,,,,,"10.1126/science.2406906",,"4Q21",21.79,"2","2","MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS","Homo sapiens","HRAS, HRAS1","C-H-RAS P21 PROTEIN CATALYTIC DOMAIN","1","4Q21"
"4Q23",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NH4Cl, 20% PEG 6000, 10% Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"RIS","4Q23",43.57,"1.98","1.98","The role of threonine 201 and tyrosine 204 in the human farnesyl pyrophosphate synthase catalytic mechanism and the mode of inhibition by the nitrogen-containing bisphosphonates","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKAAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4Q23"
"4Q26",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4Q26",61.69,"1.399","1.399","Crystal Structure of Galectin-1 in Complex with N-Acetyllactosamine","GMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Q26"
"4Q27",,"X-RAY DIFFRACTION",2.33,47.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4Q27",31.05,"1.2","1.2","Galectin-1 in Complex with a Click-Activated N-Acetyllactosamine","GMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Q27"
"4Q28",,"X-RAY DIFFRACTION",2.46,49.98,"Microbatch crystallization under oil",9,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5). Reservoir solution: 40% PEG 1000, 0.1M magnesium nitrate, 0.1M TAPS, pH 9.0, Microbatch crystallization under oil, temperature 277K",277,,,"4Q28",52.64,"2.64","2.64","Crystal Structure of the Plectin 1 and 2 Repeats of the Human Periplakin. Northeast Structural Genomics Consortium (NESG) Target HR9083A","MGHHHHHHSHMRRSIVVIHPDTGRELSPEEAHRAGLIDWNMFVKLRSQECDWEEISVKGPNGESSVIHDRKSGKKFSIEEALQSGRLTPAQYDRYVNKDMSIQELAVLVSGQK","Homo sapiens","KIAA0568, PPL","Periplakin","1","4Q28"
"4Q2F",,"X-RAY DIFFRACTION",2.34,47.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"4Q2F",31.3,"1.4","1.4","Galectin-1 in Complex with Ligand AN020","GMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Q2F"
"4Q2N",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION",6.5,"20% PEG monomethyl ether 5000, 0.1 M bis-tris (pH 6.5), VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.jmb.2014.08.012",,"4Q2N",66.76,"2","2","INADL PDZ3 in Complex with a Phage-Derived Peptide","GSHMETYNVELVRKDGQSLGIRIVGYVGTSHTGEASGIYVKSIIPGSAAYHNGHIQVNDKIVAVDGVNIQGFANHDVVEVLRNAGQVVHLTLVRRGGGWFLDI","Homo sapiens","INADL, PATJ, CIPP","InaD-like protein","1","4Q2N"
"4Q2O",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION",4.6,"25% PEG 4000, 0.1 M sodium acetate (pH 4.6), 0.1 M Sodium citrate tribasic, 0.2 M ammonium sulfate, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.jmb.2014.08.012",,"4Q2O",61.82,"2.1","2.1","PDLIM4 PDZ in Complex with a Phage-Derived Peptide","GSHMPHSVTLRGPSPWGFRLVGGRDFSAPLTISRVHAGSKAALAALCPGDLIQAINGESTELMTHLEAQNRIKGCHDHLTLSVSRPEAAGGGVESPWL","Homo sapiens","PDLIM4, RIL","PDZ and LIM domain protein 4","1","4Q2O"
"4Q2P",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION",4.6,"30% PEG 4000, 0.1 M sodium acetate (pH 4.6), 0.1 M magnesium chloride, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.jmb.2014.08.012",,"4Q2P",32.28,"2.05","2.05","NHERF3 PDZ2 in Complex with a Phage-Derived Peptide","GSHMQPRLCYLVKEGGSYGFSLKTVQGKKGVYMTDITPQGVAMRAGVLADDHLIEVNGENVEDASHEEVVEKVKKSGSRVMFLLVDKEAAGGGIKITKF","Homo sapiens","PDZK1, CAP70, NHERF3, PDZD1","Na(+)/H(+) exchange regulatory cofactor NHE-RF3","1","4Q2P"
"4Q2Q",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION",7.5,"0.8 M sodium phosphate, 0.8 M potassium phosphate, 0.1 M Hepes, pH 7.5, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.jmb.2014.08.012",,"4Q2Q",11.07,"1.45","1.45","ZO1 PDZ3 in Complex with a Phage-Derived Peptide","GSHMRPSMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKAAGGGLWFSDWL","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","4Q2Q"
"4Q2T",,"X-RAY DIFFRACTION",2.52,51.1,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.085mM Sodium citrate tribasic dehydrate, 24% PEG4000, 0.17M Ammonium acetate, 15% Glycerol, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2014.05.027",,"4Q2T",139.23,"2.4","2.4","Crystal structure of Arginyl-tRNA synthetase complexed with L-arginine","HHHHHHSSGLVPRGSHMASMINIISRLQEVFGHAIKAAYPDLENPPLLVTPSQQAKFGDYQCNSAMGISQMLKTKEQKVNPREIAENITKHLPDNECIEKVEIAGPGFINVHLRKDFVSEQLTSLLVNGVQLPALGENKKVIVDFSSPNIAKEMHVGHLRSTIIGESISRLFEFAGYDVLRLNHVGDWGTQFGMLIAHLQDKFPDYLTVSPPIGDLQVFYKESKKRFDTEEEFKKRAYQCVVLLQGKNPDITKAWKLICDVSRQELNKIYDALDVSLIERGESFYQDRMNDIVKEFEDRGFVQVDDGRKIVFVPGCSIPLTIVKSDGGYTYDTSDLAAIKQRLFEEKADMIIYVVDNGQSVHFQTIFAAAQMIGWYDPKVTRVFHAGFGVVLGEDKKKFKTRSGETVRLMDLLGEGLKRSMDKLKEKERDKVLTAEELNAAQTSVAYGCIKYADLSRNRLNDYIFSFDKMLDDRGNTAAYLLYAFTRIRSIARLANIDEEMLQKAARETKILLDHEKEWKLGRCILRFPEILQKILDDLFLHTLCDYIYELATAFTEFYDSCYCVEKDRQTGKILKVNMWRMLLCEAVAAVMAKGFDILGIKPVQRM","Homo sapiens","RARS, RARS1","Arginine--tRNA ligase, cytoplasmic","1","4Q2T"
"4Q2X",,"X-RAY DIFFRACTION",2.6,52.69,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.085mM Sodium citrate tribasic dehydrate, 24% Polyethylene glycol 4000, 0.17M Ammonium acetate, 15% Glycerol, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2014.05.027",,"4Q2X",139.05,"2.798","2.798","Crystal structure of Arginyl-tRNA synthetase complexed with L-canavanine","HHHHHHSSGLVPRGSHMASMINIISRLQEVFGHAIKAAYPDLENPPLLVTPSQQAKFGDYQCNSAMGISQMLKTKEQKVNPREIAENITKHLPDNECIEKVEIAGPGFINVHLRKDFVSEQLTSLLVNGVQLPALGENKKVIVDFSSPNIAKEMHVGHLRSTIIGESISRLFEFAGYDVLRLNHVGDWGTQFGMLIAHLQDKFPDYLTVSPPIGDLQVFYKESKKRFDTEEEFKKRAYQCVVLLQGKNPDITKAWKLICDVSRQELNKIYDALDVSLIERGESFYQDRMNDIVKEFEDRGFVQVDDGRKIVFVPGCSIPLTIVKSDGGYTYDTSDLAAIKQRLFEEKADMIIYVVDNGQSVHFQTIFAAAQMIGWYDPKVTRVFHAGFGVVLGEDKKKFKTRSGETVRLMDLLGEGLKRSMDKLKEKERDKVLTAEELNAAQTSVAYGCIKYADLSRNRLNDYIFSFDKMLDDRGNTAAYLLYAFTRIRSIARLANIDEEMLQKAARETKILLDHEKEWKLGRCILRFPEILQKILDDLFLHTLCDYIYELATAFTEFYDSCYCVEKDRQTGKILKVNMWRMLLCEAVAAVMAKGFDILGIKPVQRM","Homo sapiens","RARS, RARS1","Arginine--tRNA ligase, cytoplasmic","1","4Q2X"
"4Q2Y",,"X-RAY DIFFRACTION",2.54,51.5,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.085mM Sodium citrate tribasic dehydrate, 24% Polyethylene glycol 4000, 0.17M Ammonium acetate, 15% Glycerol, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2014.05.027",,"4Q2Y",138.7,"2.799","2.799","Crystal structure of Arginyl-tRNA synthetase","HHHHHHSSGLVPRGSHMASMINIISRLQEVFGHAIKAAYPDLENPPLLVTPSQQAKFGDYQCNSAMGISQMLKTKEQKVNPREIAENITKHLPDNECIEKVEIAGPGFINVHLRKDFVSEQLTSLLVNGVQLPALGENKKVIVDFSSPNIAKEMHVGHLRSTIIGESISRLFEFAGYDVLRLNHVGDWGTQFGMLIAHLQDKFPDYLTVSPPIGDLQVFYKESKKRFDTEEEFKKRAYQCVVLLQGKNPDITKAWKLICDVSRQELNKIYDALDVSLIERGESFYQDRMNDIVKEFEDRGFVQVDDGRKIVFVPGCSIPLTIVKSDGGYTYDTSDLAAIKQRLFEEKADMIIYVVDNGQSVHFQTIFAAAQMIGWYDPKVTRVFHAGFGVVLGEDKKKFKTRSGETVRLMDLLGEGLKRSMDKLKEKERDKVLTAEELNAAQTSVAYGCIKYADLSRNRLNDYIFSFDKMLDDRGNTAAYLLYAFTRIRSIARLANIDEEMLQKAARETKILLDHEKEWKLGRCILRFPEILQKILDDLFLHTLCDYIYELATAFTEFYDSCYCVEKDRQTGKILKVNMWRMLLCEAVAAVMAKGFDILGIKPVQRM","Homo sapiens","RARS, RARS1","Arginine--tRNA ligase, cytoplasmic","1","4Q2Y"
"4Q3F",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.2 M Sodium tartrate dibasic dihydrate and 20% w/v Polyethylene glycol 3,350, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1096/fj.14-256636",,"4Q3F",38.23,"1.8","1.8","Human D-DT complexed with tartrate","PFLELDTNLPANRVPAGLEKRLCAAAASILGKPADRVNVTVRPGLAMALSGSTEPCAQLSISSIGVVGTAEDNRSHSAHFFEFLTKELALGQDRILIRFFPLESWQIGKIGTVMTFL","Homo sapiens","DDT","D-dopachrome decarboxylase","1","4Q3F"
"4Q3H",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris HCl, pH 8.5, 8% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbrc.2014.04.085",,"4Q3H",19.83,"1.443","1.443","The crystal structure of NHERF1 PDZ2 CXCR2 complex revealed by the NHERF1 CXCR2 chimeric protein","SMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETSTTL","Homo sapiens","NHERF, NHERF1, SLC9A3R1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","4Q3H"
,,,,,,,,,,,,,,,,,"Homo sapiens","NHERF, NHERF1, SLC9A3R1"
"4Q49",,"NEUTRON DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.20 M sodium citrate 
100 mM Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1502255112",,"4Q49",29.35,"1.8","1.8","Room temperature neutron crystal structure of apo human carbonic anhydrase at pH 7.5","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q49"
"4Q4B",,"X-RAY DIFFRACTION",3.49,64.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 %w/v Polyethylene Glycol 8000, 0.2 M Ammonium Sulphate, 0.1 M Sodium Cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1038/ncomms5321",,"4Q4B",53.19,"2.82","2.82","Crystal structure of LIMP-2 (space group C2221)","ETGVFQKAVDQSIEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMINTGTKHHHHHH","Homo sapiens","CD36L2, LIMP2, LIMPII, SCARB2","Lysosome membrane protein 2","1","4Q4B"
"4Q4C",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, HANGING DROP",7,"12% w/v PEG3350, 20 mM magnesium chloride, 0.1 M HEPES, pH 7.0, 1 mM ATP, 2 mM cadmium chloride, crystals transferred to stabilizing buffer (22% w/v PEG3350, 10 mM magnesium chloride, 0.1 M sodium acetate, pH 5.2) at 277 K overnight (ATP in the crystals was hydrolyzed to ADP) then soaked for three days in stabilizing buffer containing 2 mM 1,5-IP8, VAPOR DIFFUSION, HANGING DROP",277,"10.1002/anie.201404398",,"4Q4C",38.94,"1.9","1.9","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ADP and synthetic 1,5-(PP)2-IP4 (1,5-IP8)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4Q4C"
"4Q4D",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",7,"12% w/v PEG3350, 20 mM magnesium chloride, 0.1 M HEPES, pH 7.0, 1 mM AMP-PNP, 2 mM cadmium chloride, crystals transferred to stabilizing buffer (22% w/v PEG3350, 10 mM magnesium chloride, 0.1 M sodium acetate, pH 5.2) at 277 K overnight (ATP in the crystals was hydrolyzed to ADP) then soaked for three days in stabilizing buffer containing 2 mM 3,5-IP8, VAPOR DIFFUSION, HANGING DROP",277,"10.1002/anie.201404398",,"4Q4D",38.97,"1.85","1.85","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMP-PNP and synthetic 3,5-(PP)2-IP4 (3,5-IP8)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","4Q4D"
"4Q4F",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 %w/v Polyethylene Glycol 8000, 0.2 M Ammonium Sulphate, 0.1 M Sodium Cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1038/ncomms5321",,"4Q4F",53.43,"2.8","2.8","Crystal structure of LIMP-2 (space group C2)","ETGVFQKAVDQSIEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMINTTGKHHHHHH","Homo sapiens","SCARB2, CD36L2, LIMP2, LIMPII","Lysosome membrane protein 2","1","4Q4F"
"4Q50",,"X-RAY DIFFRACTION",3.49,64.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Ammonium Sulfate, 10% glycerol, 100 mM Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.7554/eLife.12792","OHT","4Q50",240.16,"3.07","3.07","The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen","SNAMKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYGLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","4Q50"
"4Q59",,"X-RAY DIFFRACTION",2.91,57.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.05 M potassium phosphate monobasic, 20% PEG8000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"4Q59",52.86,"2.3","2.3","Crystal structure of plectin 1a actin-binding domain","DERDRVQKKTFTKWVNKHLIKAQRHISDLYEDLRDGHNLISLLEVLSGDSLPREKGRMRFHKLQNVQIALDYLRHRQVKLVNIRNDDIADGNPKLTLGLIWTIILHFQISDIQVSGQSEDMTAKEKLLLWSQRMVEGYQGLRCDNFTSSWRDGRLFNAIIHRHKPLLIDMNKVYRQTNLENLDQAFSVAERDLGVTRLLDPEDVDVPQPDEKSIITYVSSLYDAMP","Homo sapiens","PLEC, PLEC1","Plectin","1","4Q59"
"4Q5V",,"X-RAY DIFFRACTION",3.08,60.1,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM KCl, 12.5 mM MgCl2, 25 mM Na-Cacodylate, pH 6.5, 6 % 2-propanol, 2 mM TCEP, VAPOR DIFFUSION, SITTING DROP, temperature 295 K",295,"10.1093/nar/gku1209","2ZE","4Q5V",231.73,"2.52","2.52","Crystal structure of the catalytic core of human DNA polymerase alpha in ternary complex with an RNA-primed DNA template and aphidicolin","GCCUGGAGCGC",,,"RNA primer","2","4Q5V"
,,,,,,,,,,,,,,,,"ATTACTATAGGCGCTCCAGGC",,,"DNA template","3","4Q5V"
,,,,,,,,,,,,,,,,"DEEQVFHFYWLDAYEDQYNQPGVVFLFGKVWIESAETHVSCCVMVKNIERTLYFLPREMKIDLNTGKETGTPISMKDVYEEFDEKIATKYKIMKFKSKPVEKNYAFEIPDVPEKSEYLEVKYSAEMPQLPQDLKGETFSHVFGTNTSSLELFLMNRKIKGPCWLEVKSPQLLNQPVSWCKAEAMALKPDLVNVIKDVSPPPLVVMAFSMKTMQNAKNHQNEIIAMAALVHHSFALDKAAPKPPFQSHFCVVSKPKDCIFPYAFKEVIEKKNVKVEVAATERTLLGFFLAKVHKIDPDIIVGHNIYGFELEVLLQRINVCKAPHWSKIGRLKRSNMPKLGGRSGFGERNATCGRMICDVEISAKELIRCKSYHLSELVQQILKTERVVIPMENIQNMYSESSQLLYLLEHTWKDAKFILQIMCELNVLPLALQITNIAGNIMSRTLMGGRSERNEFLLLHAFYENNYIVPDKQIFRKPQQKLGDEDEEIDGDTNKYKKGRKKAAYAGGLVLDPKVGFYDKFILLLDFNSLYPSIIQEFNICFTTVQRVASEAQKVTEDGEQEQIPELPDPSLEMGILPREIRKLVERRKQVKQLMKQQDLNPDLILQYDIRQKALKLTANSMYGCLGFSYSRFYAKPLAALVTYKGREILMHTKEMVQKMNLEVIYGDTDSIMINTNSTNLEEVFKLGNKVKSEVNKLYKLLEIDIDGVFKSLLLLKKKKYAALVVEPTSDGNYVTKQELKGLDIVRRDWCDLAKDTGNFVIGQILSDQSRDTIVENIQKRLIEIGENVLNGSVPVSQFEINKALTKDPQDYPDKKSLPHVHVALWINSQGGRKVKAGDTVSYVICQDGSNLTASQRAYAPEQLQKQDNLTIDTQYYLAQQIHPVVARICEPIDGIDAVLIATWLGLDPTQFRVHHYHKDEEN","Homo sapiens","POLA1, POLA","DNA polymerase alpha catalytic subunit","1","4Q5V"
"4Q6D",,"X-RAY DIFFRACTION",2.01,38.5,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.3390/molecules191117356","WW3","4Q6D",29.88,"1.12","1.12","Crystal structure of human carbonic anhydrase isozyme II with 4-[(Z)-azepan-1-yldiazenyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q6D"
"4Q6E",,"X-RAY DIFFRACTION",2.03,39,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.3390/molecules191117356","KR5","4Q6E",30,"1.12","1.12","Crystal structure of human carbonic anhydrase isozyme II with 4-{[3-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-oxopropyl]amino}benzene-1-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q6E"
"4Q6F",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",7,"2M malic acid, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2014.10.017",,"4Q6F",28.91,"1.91","1.91","Crystal structure of human BAZ2A PHD zinc finger in complex with unmodified H3K4 histone peptide","HMSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQV","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","4Q6F"
,,,,,,,,,,,,,,,,"ARTKQ",,,"unmodified H3K4 peptide","2","4Q6F"
"4Q6H",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",8,"37% (w/v) polyethylene glycol (PEG) 1000, 0.07 M sodium thiosulfate pentahydrate, 0.1 M Tris pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4Q6H",10.17,"1.903","1.903","CFTR Associated Ligand (CAL) bound to last 6 residues of CFTR (decameric peptide: iCAL36VQDTRL)","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","CFTR-associated ligand","1","4Q6H"
,,,,,,,,,,,,,,,,"VQDTRL",,,"iCAL36-VQDTRL peptide","2","4Q6H"
"4Q6R",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350 20%, TACSIMATE (BUFFERED) 8% PEG, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/jm500338n","30J","4Q6R",114.95,"2.4","2.4","Crystal structure of human sphingosine-1-phosphate lyase in complex with inhibitor 6-[(2R)-4-(4-benzyl-7-chlorophthalazin-1-yl)-2-methylpiperazin-1-yl]pyridine-3-carbonitrile","GPGSQPESLWSRFKKKCFKLTRKMPIIGRKIQDKLNKTKDDISKNMSFLKVDKEYVKALPSQGLSSSAVLEKLKEYSSMDAFWQEGRASGTVYSGEEKLTELLVKAYGDFAWSNPLHPDIFPGLRKIEAEIVRIACSLFNGGPDSCGCVTSGGTESILMACKAYRDLAFEKGIKTPEIVAPQSAHAAFNKAASYFGMKIVRVPLTKMMEVDVRAMRRAISRNTAMLVCSTPQFPHGVIDPVPEVAKLAVKYKIPLHVDACLGGFLIVFMEKAGYPLEHPFDFRVKGVTSISADTHKYGYAPKGSSLVLYSDKKYRNYQFFVDTDWQGGIYASPTIAGSRPGGISAACWAALMHFGENGYVEATKQIIKTARFLKSELENIKGIFVFGNPQLSVIALGSRDFDIYRLSNLMTAKGWNLNQLQFPPSIHFCITLLHARKRVAIQFLKDIRESVTQIMKNPKAKTTGMGAIYGMAQTTVDRNMVAELSSVFLDSLYSTDTVTQGSQMNGSPKPH","Homo sapiens","KIAA1252, SGPL1","Sphingosine-1-phosphate lyase 1","1","4Q6R"
"4Q6S",,"X-RAY DIFFRACTION",1.96,37.09,"VAPOR DIFFUSION, HANGING DROP",7.95,"16% (w/v) polyethylene glycol (PEG), 0.15 M sodium chloride, 0.01 M Tris HCl pH 7.95, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4Q6S",22.8,"1.45","1.45","CFTR Associated Ligand (CAL) PDZ bound to biotinylated peptide BT-L-iCAL36","GPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYV","Homo sapiens","GOPC, CAL, FIG","Golgi-associated PDZ and coiled-coil motif-containing protein","1","4Q6S"
,,,,,,,,,,,,,,,,"XWRFKKANSRLPTSII",,,"BT-L-iCAL36 peptide","2","4Q6S"
"4Q6Y",,"X-RAY DIFFRACTION",2.53,51.33,"VAPOR DIFFUSION, SITTING DROP",5,"0.2 M magnesium chloride, 0.1 M sodium acetate pH 5, and 20% (w/v) PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1016/j.jmb.2014.07.006",,"4Q6Y",105.81,"3","3","Crystal structure of a chemoenzymatic glycoengineered disialylated Fc (di-sFc)","CPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4Q6Y"
"4Q74",,"X-RAY DIFFRACTION",2.38,48.25,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 1500 at 20  C and cryopreserved in well solution containing 25% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1016/j.jmb.2014.07.006",,"4Q74",54.47,"2.19","2.19","F241A Fc","EVQLLETSTCPPCPAPELLGGPSVALFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4Q74"
"4Q78",,"X-RAY DIFFRACTION",2.12,41.9,,,,,"10.1155/2014/389869",,"4Q78",30.02,"1","1","Structure-assisted design of carborane-based inhibitors of carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q78"
"4Q7B",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5,15 g/L NADP+= 0,66 g/L and Human Aldose Reductase= 15 mg/ml.  
Afterwards the crystals were soaked into Tris 100 mM 25% (m/V) PEG6000 saturated with the inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4Q7B",36.81,"1.19","1.19","Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4Q7B"
"4Q7D",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG 3350, 0.1M Sodium Cacodylate. Cryopreserved with 25% glycerol, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1016/j.jmb.2014.07.006",,"4Q7D",52.66,"2.35","2.35","Wild type Fc (wtFc)","CPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4Q7D"
"4Q7H",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",8,"0.2M Lithium citrate tribasic tetrahydrate, 24% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4Q7H",246.22,"2.587","2.587","Crystal structure of SAMHD1 catalytic core with GTP","HHHHHHGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4Q7H"
"4Q7P",,"X-RAY DIFFRACTION",2.07,40.72,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","3MH","4Q7P",29.9,"1.65","1.65","Crystal Structure of 1-hydroxy-3-methylpyridine-2(1H)-thione bound to hCAII","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q7P"
"4Q7S",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","2YU","4Q7S",29.82,"1.8","1.8","Crystal Structure of 1-hydroxy-4-methylpyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q7S"
"4Q7V",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION",8,"Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","5MH","4Q7V",29.9,"1.6","1.6","Crystal structure of 1-hydroxy-5-methylpyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q7V"
"4Q7W",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","6MH","4Q7W",29.92,"1.45","1.45","Crystal structure of 1-hydroxy-6-methylpyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q7W"
"4Q7X",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, SITTING DROP",4.4,"16% PEG 10,000, 0.1M sodium/ammonium acetate, pH 4.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.str.2014.07.008",,"4Q7X",55.46,"2.55","2.55","Neutrophil serine protease 4 (PRSS57) apo form 1","IIGGHEVTPHSRPYMASVRFGGQHHCGGFLLRARWVVSAAHCFSHRDLRTGLVVLGAHVLSTAEPTQQVFGIDALTTHPDYHPMTHANDICLLRLNGSAVLGPAVGLLRLPGRRARPPTAGTRCRVAGWGFVSDFEELPPGLMEAKVRVLDPDVCNSSWKGHLTLTMLCTRSGDSHRRGFCSADSGGPLVCRNRAHGLVSFSGLWCGDPKTPDVYTQVSAFVAWIWDVVRRSSPQPGPLPGTTRPPGEAA","Homo sapiens","PRSS57, PRSSL1, UNQ782/PRO1599","Serine protease 57","1","4Q7X"
"4Q7Y",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",5.5,"23% PEG3350, 0.2 M NaCl, 0.1 M Bis-Tris 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.str.2014.07.008",,"4Q7Y",27.63,"2.7","2.7","Neutrophil serine protease 4 (PRSS57) apo form 2","IIGGHEVTPHSRPYMASVRFGGQHHCGGFLLRARWVVSAAHCFSHRDLRTGLVVLGAHVLSTAEPTQQVFGIDALTTHPDYHPMTHANDICLLRLNGSAVLGPAVGLLRLPGRRARPPTAGTRCRVAGWGFVSDFEELPPGLMEAKVRVLDPDVCNSSWKGHLTLTMLCTRSGDSHRRGFCSADSGGPLVCRNRAHGLVSFSGLWCGDPKTPDVYTQVSAFVAWIWDVVRRSSPQPGPLPGTTRPPGEAA","Homo sapiens","PRSS57, PRSSL1, UNQ782/PRO1599","Serine protease 57","1","4Q7Y"
"4Q7Z",,"X-RAY DIFFRACTION",2.24,45.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG-MME 2000, 0.1 M Tris 8.5, 0.2 M trimethylamine N-oxide, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.str.2014.07.008",,"4Q7Z",28.22,"1.4","1.4","Neutrophil serine protease 4 (PRSS57) with phe-phe-arg-chloromethylketone (FFR-cmk)","IIGGHEVTPHSRPYMASVRFGGQHHCGGFLLRARWVVSAAHCFSHRDLRTGLVVLGAHVLSTAEPTQQVFGIDALTTHPDYHPMTHANDICLLRLNGSAVLGPAVGLLRLPGRRARPPTAGTRCRVAGWGFVSDFEELPPGLMEAKVRVLDPDVCNSSWKGHLTLTMLCTRSGDSHRRGFCSADSGGPLVCRNRAHGLVSFSGLWCGDPKTPDVYTQVSAFVAWIWDVVRRSSPQPGPLPGTTRPPGEAA","Homo sapiens","PRSS57, PRSSL1, UNQ782/PRO1599","Serine protease 57","1","4Q7Z"
"4Q80",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG-3350, 0.2 M potassium acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.str.2014.07.008",,"4Q80",56.29,"3.07","3.07","Neutrophil serine protease 4 (PRSS57) with val-leu-lys-chloromethylketone (VLK-cmk)","IIGGHEVTPHSRPYMASVRFGGQHHCGGFLLRARWVVSAAHCFSHRDLRTGLVVLGAHVLSTAEPTQQVFGIDALTTHPDYHPMTHANDICLLRLNGSAVLGPAVGLLRLPGRRARPPTAGTRCRVAGWGFVSDFEELPPGLMEAKVRVLDPDVCNSSWKGHLTLTMLCTRSGDSHRRGFCSADSGGPLVCRNRAHGLVSFSGLWCGDPKTPDVYTQVSAFVAWIWDVVRRSSPQPGPLPGTTRPPGEAA","Homo sapiens","PRSS57, PRSSL1, UNQ782/PRO1599","Serine protease 57","1","4Q80"
"4Q81",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION",8,"Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","7MH","4Q81",29.91,"1.55","1.55","Crystal structure of 1-hydroxy-4,6-dimethylpyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q81"
"4Q83",,"X-RAY DIFFRACTION",2.1,41.49,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","3FH","4Q83",29.87,"1.55","1.55","Crystal structure of 1-hydroxy-3-(trifluoromethyl)pyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q83"
"4Q87",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","4FH","4Q87",29.95,"1.55","1.55","Crystal structure of 1-hydroxy-4-(trifluoromethyl)pyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q87"
"4Q8E",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 2000-MME, MES, pH 6.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1073/pnas.1405739111",,"4Q8E",55.3,"1.549","1.549","Human DNA polymerase eta inserting dCMPNPP opposite a phenanthriplatin adducted G","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, POLH RAD30 RAD30A XPV, RAD30, RAD30A, XPV","DNA polymerase eta","1","4Q8E"
,,,,,,,,,,,,,,,,"TXCTCACACT",,,"5'-D(*CP*AP*TP*GP*CP*TP*CP*AP*CP*AP*CP*T)-3'","2","4Q8E"
,,,,,,,,,,,,,,,,"AGTGTGAG",,,"5'-D(*AP*GP*TP*GP*TP*GP*AP*G)-3'","3","4Q8E"
"4Q8F",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 2000-MME, MES, pH 6.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1073/pnas.1405739111",,"4Q8F",56.12,"2.797","2.797","Human DNA polymerase eta extending primer immediately after a phenanthriplatin adducted G","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, POLH RAD30 RAD30A XPV, RAD30, RAD30A, XPV","DNA polymerase eta","1","4Q8F"
,,,,,,,,,,,,,,,,"AGTGTGAC",,,"5'-D(*AP*GP*TP*GP*TP*GP*AP*C)-3'","3","4Q8F"
,,,,,,,,,,,,,,,,"ATCXTCACACT",,,"5'-D(*CP*AP*TP*CP*GP*TP*CP*AP*CP*AP*CP*T)-3'","2","4Q8F"
"4Q8X",,"X-RAY DIFFRACTION",2.07,40.51,"VAPOR DIFFUSION",8,"Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","7FH","4Q8X",29.95,"1.55","1.55","Crystal structure of 1-hydroxy-5-(trifluoromethyl)pyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q8X"
"4Q8Y",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","HQT","4Q8Y",29.85,"1.45","1.45","Crystal structure of 2-hydroxyisoquinoline-1(2H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q8Y"
"4Q8Z",,"X-RAY DIFFRACTION",2.07,40.45,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b",,"4Q8Z",29.8,"1.5","1.5","Crystal structure of 1-hydroxy-4-methylpyridin-2(1H)-one bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q8Z"
"4Q90",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION",8,"Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","4H2","4Q90",29.96,"1.54","1.54","Crystal structure of 4-methylpyridine-2(1H)-thione bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q90"
"4Q91",,"X-RAY DIFFRACTION",2.91,57.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.4 M sodium formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4Q91",33.57,"1.799","1.799","Crystal structure of C16A/K12V/C117V/P134V mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPVLLYASNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLVLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4Q91"
"4Q93",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.1 M ammonium sulfate, 0.1 M sodium phosphate monobasic / potassium phosphate dibasic, pH 6-8, 2% acetone, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nature14028",,"4Q93",43.35,"2.1","2.1","Crystal structure of resveratrol bound human tyrosyl tRNA synthetase","MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVILEHHHHHH","Homo sapiens","YARS, YARS1","Tyrosine--tRNA ligase, cytoplasmic","1","4Q93"
"4Q94",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION",,"2.0 M ammonium sulfate, 5% isopropanol, vapor diffusion, temperature 291K",291,"10.1038/nsmb.2853",,"4Q94",36.14,"1.85","1.85","human RPRD1B CID in complex with a RPB1-CTD derived Ser2 phosphorylated peptide","GSSFSESALEKKLSELSNSQHSVQTLSLWLIHHRKHAGPIVSVWHRELRKAKSNRKLTFLYLANDVIQNSKRKGPEFTREFESVLVDAFSHVAREADEGCKKPLERLLNIWQERSVYGGEFIQQLKLSMEDSKSP","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4Q94"
,,,,,,,,,,,,,,,,"XSPSYSPTSPSYSPTSPSYSX",,,"rpb1-ctd","2","4Q94"
"4Q96",,"X-RAY DIFFRACTION",3,59.02,"VAPOR DIFFUSION",7.5,"25% PEG-1500, 0.2M ammonium sulfate, 0.1M HEPES, pH 7.5, vapor diffusion, temperature 291K",291,"10.1038/nsmb.2853",,"4Q96",67.03,"1.85","1.85","CID of human RPRD1B in complex with an unmodified CTD peptide","GSSFSESALEKKLSELSNSQHSVQTLSLWLIHHRKHAGPIVSVWHRELRKAKSNRKLTFLYLANDVIQNSKRKGPEFTREFESVLVDAFSHVAREADEGCKKPLERLLNIWQERSVYGGEFIQQLKLSMEDSKSP","Homo sapiens","RPRD1B, C20orf77, CREPT","Regulation of nuclear pre-mRNA domain-containing protein 1B","1","4Q96"
,,,,,,,,,,,,,,,,"XSPSYSPTSPSYSPTSPSYSX",,,"RPB1-CTD","2","4Q96"
"4Q99",,"X-RAY DIFFRACTION",2.07,40.45,"VAPOR DIFFUSION",8,"Ammonium sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","HT4","4Q99",29.99,"1.5","1.5","Crystal structure of 2-mercapto-4-methylphenol bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q99"
"4Q9G",,"X-RAY DIFFRACTION",2.98,58.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.8 M sodium formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4Q9G",33.56,"1.554","1.554","Crystal structure of K12V/C16S/C117V/P134V mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPVLLYSSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLVLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4Q9G"
"4Q9P",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",8,"1.0 M sodium citrate, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4Q9P",33.31,"1.8","1.8","Crystal structure of C16T/K12V/C117V/P134V mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPVLLYTSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLVLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4Q9P"
"4Q9S",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, HANGING DROP",5.6,"Na acetate, PEG MME2000, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 290.0K",290,"10.1021/jm500669m","30G","4Q9S",32.32,"2.07","2.07","Crystal Structure of human Focal Adhesion Kinase (Fak) bound to Compound1 (3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)","GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","4Q9S"
"4Q9V",,"X-RAY DIFFRACTION",3.77,67.39,"VAPOR DIFFUSION, HANGING DROP",6.7,"0.1M MES6.7,1.95M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ccr.2014.07.025",,"4Q9V",44.22,"2.3","2.3","Crystal structure of TIPE3","AMVFSSKSLALQAQKKILSKIASKTVANMLIDDTSSEIFDELYKVTKEHTHNKKEAHKIMKDLIKVAIKIGILYRNNQFSQEELVIVEKFRKKLNQTAMTIVSFYEVEYTFDRNVLSNLLHECKDLVHELVQRHLTPRTHGRINHVFNHFADVEFLSTLYSLDGDCRPNLKRICEGINKLLDEKVL","Homo sapiens","TNFAIP8L3, TIPE3","Tumor necrosis factor alpha-induced protein 8-like protein 3","1","4Q9V"
"4Q9Y",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION",8,"Ammonium Sulfate, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1021/jm500984b","M3T","4Q9Y",29.97,"1.55","1.55","Crystal structure of 3-methylthiophenol bound to human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Q9Y"
"4Q9Z",,"X-RAY DIFFRACTION",2.97,58.54,,,,,"10.1021/jm500669m","PZW","4Q9Z",79.82,"2.6","2.6","Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)","KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMERLISH","Homo sapiens","PRKCQ, PRKCT","HUMAN PROTEIN KINASE C THETA","1","4Q9Z"
"4QA0",,"X-RAY DIFFRACTION",2.46,49.94,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M tris(hydroxymethyl)aminomethane) (TRIS, pH = 8), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 17% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb5003762","SHH","4QA0",87.55,"2.242","2.242","Crystal structure of C153F HDAC8 in complex with SAHA","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFFYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA0"
"4QA1",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M (Bis(2-hydroxyethyl)-amino-tris(hydroxymethyl)-methane) (BISTRIS, pH = 6.5), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 20% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762",,"4QA1",175.22,"1.92","1.92","Crystal structure of A188T HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDTFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA1"
"4QA2",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M (Bis(2-hydroxyethyl)-amino-tris(hydroxymethyl)-methane) (BISTRIS, pH = 6.5), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 18% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762","SHH","4QA2",87.47,"2.377","2.377","Crystal structure of I243N HDAC8 in complex with SAHA","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQNCESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA2"
"4QA3",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.1 M Bicine (pH = 8.5), 15% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762","TSN","4QA3",87.6,"2.876","2.876","Crystal structure of T311M HDAC8 in complex with Trichostatin A (TSA)","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANMARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA3"
"4QA4",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M Imidazole (pH = 7.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 20% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762",,"4QA4",43.98,"1.98","1.98","Crystal structure of H334R HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDREFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA4"
"4QA5",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M tris(hydroxymethyl)aminomethane) (TRIS, pH = 8.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 8% PEG 35000, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762",,"4QA5",88.61,"1.76","1.76","Crystal structure of A188T/Y306F HDAC8 in complex with a tetrapeptide substrate","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDTFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGFNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA5"
,,,,,,,,,,,,,,,,"XRHKK",,,"tetrapeptide substrate","2","4QA5"
"4QA6",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M tris(hydroxymethyl)aminomethane) (TRIS, pH = 8.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 15% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb5003762",,"4QA6",88.62,"2.053","2.053","Crystal structure of I243N/Y306F HDAC8 in complex with a tetrapeptide substrate","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQNCESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGFNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA6"
,,,,,,,,,,,,,,,,"XRHKK",,,"tetrapeptide substrate","2","4QA6"
"4QA7",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M tris(hydroxymethyl)aminomethane) (TRIS, pH = 8.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 17.5% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/cb5003762",,"4QA7",44.33,"2.31","2.31","Crystal structure of H334R/Y306F HDAC8 in complex with a tetrapeptide substrate","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGFNLANTARCWTYLTGVILGKTLSSEIPDREFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4QA7"
,,,,,,,,,,,,,,,,"XRHKK",,,"tetrapeptide substrate","2","4QA7"
"4QAH",,"X-RAY DIFFRACTION",3.39,63.75,"VAPOR DIFFUSION, HANGING DROP",7,"18~24% (w/v) polyethylene glycol 4000, 100mM Hepes (pH 7.0), 200mM magnesium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.biocel.2014.10.004",,"4QAH",34.98,"2.403","2.403","The second sphere residue T263 is important for function and activity of PTP1B through modulating WPD loop","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQKADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4QAH"
"4QAL",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",8,"0.7 M sodium citrate, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4QAL",33.69,"1.5","1.5","Crystal structure of C117A mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSAKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4QAL"
"4QAP",,"X-RAY DIFFRACTION",3.39,63.71,"VAPOR DIFFUSION, HANGING DROP",7,"8-24% (w/v) polyethylene glycol 4000, 100mM Hepes (pH 7.0), 200mM magnesium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.biocel.2014.10.004",,"4QAP",34.97,"1.903","1.903","The second sphere residue T263 is important for function and activity of PTP1B through modulating WPD loop","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQNADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4QAP"
"4QB3",,"X-RAY DIFFRACTION",2.12,41.91,,8.5,"25% tert-Butanol, 0.1 M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.chembiol.2014.05.009","30M","4QB3",15.46,"0.94","0.94","Crystal structure of the first bromodomain of human BRD4 in complex with Olinone","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4QB3"
"4QBC",,"X-RAY DIFFRACTION",2.77,55.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"4.0 M sodium formate, 0.45 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4QBC",33.65,"1.519","1.519","Crystal structure of C117T mutant of human acidic fibroblast growth factor in sodium formate buffer","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSTKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4QBC"
"4QBE",,"X-RAY DIFFRACTION",3.38,63.58,"VAPOR DIFFUSION, HANGING DROP",7,"18-24% (w/v) polyethylene glycol 4000, 100mM Hepes (pH 7.0), 200mM magnesium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.biocel.2014.10.004",,"4QBE",34.71,"2.292","2.292","The second sphere residue T263 is important for function and activity of PTP1B through modulating WPD loop","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQSADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4QBE"
"4QBM",,"X-RAY DIFFRACTION",2.76,55.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M sodium phosphate monobasic, 0.1M potassium phosphate monobasic, 2 M NaCl, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2014.10.017",,"4QBM",27.38,"1.65","1.65","Crystal structure of human BAZ2A bromodomain in complex with a diacetylated histone 4 peptide (H4K16acK20ac)","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQ","Homo sapiens","BAZ2A, CB1_000449039, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","4QBM"
,,,,,,,,,,,,,,,,"GAKRHRKVL",,,"histone H4 peptide with sequence Gly-Ala-Lys(ac)-Arg-His-Arg-Lys(ac)-Val-Leu","2","4QBM"
"4QBT",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.1 M ammonium sulfate, 0.1 M sodium phosphate monobasic, pH 6-8, 2% acetone, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nature14028",,"4QBT",42.96,"2.1","2.1","Crystal structure of tyrosine bound human tyrosyl tRNA synthetase","MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVILEHHHHHH","Homo sapiens","YARS, YARS1","Tyrosine--tRNA ligase, cytoplasmic","1","4QBT"
"4QBV",,"X-RAY DIFFRACTION",2.76,55.44,"VAPOR DIFFUSION, HANGING DROP",8,"0.9 M sodium citrate, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/jps.24188",,"4QBV",33.75,"1.497","1.497","Crystal structure of C117T mutant of human acidic fibroblast growth factor in sodium citrate buffer","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSTKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4QBV"
"4QBW",,"X-RAY DIFFRACTION",3.48,64.7,"VAPOR DIFFUSION, HANGING DROP",7,"18-24% (w/v) polyethylene glycol 4000, 100mM Hepes (pH 7.0), 200mM magnesium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.biocel.2014.10.004",,"4QBW",34.96,"1.912","1.912","The second sphere residue T263 is important for function and activity of PTP1B through modulating WPD loop","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4QBW"
"4QBX",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, HANGING DROP",5,"Crystallization solution: 50 mM di-Ammoniumhydrogen citrate, PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml.    
Afterwards the crystals were soaked into 120 mM di-Ammoniumhydrogen citrate pH 5.0 25% (m/V) PEG6000 saturated with the inhibitor. The well solution was 120mM di-Ammonium hydrogen citrate with 20% PEG6000 pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4QBX",37.18,"0.98","0.98","Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4QBX"
"4QBZ",,"X-RAY DIFFRACTION",2.56,51.9,"VAPOR DIFFUSION, SITTING DROP",4.8,"12%(w/v) PEG3350, 0.1M sodium citrate, 0.3M potassium formate, pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm500744f",,"4QBZ",192.27,"2","2","Crystal structure of human TLR8 in complex with DS-802","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4QBZ"
"4QC0",,"X-RAY DIFFRACTION",2.4,48.71,"VAPOR DIFFUSION, SITTING DROP",5.2,"12%(w/v) PEG3350, 0.1M sodium citrate, 0.3M potassium formate, pH 5.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm500744f",,"4QC0",189.77,"2.1","2.1","Crystal structure of human TLR8 in complex with XG-1-236","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4QC0"
"4QC1",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M MES, 0.01M zinc sulfatE, 25% PEG methyl ether 550, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2014.10.017",,"4QC1",27.74,"1.99","1.99","Crystal structure of human BAZ2B bromodomain in complex with an acetylated histone 3 peptide (H3K14ac)","SMDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFK","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4QC1"
,,,,,,,,,,,,,,,,"KSTGGKAPRKQ",,,"acetylated histone 3 peptide (H3K14ac)","2","4QC1"
"4QC3",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG 8000, 0.2M calcium acetate, 0.1 M cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2014.10.017",,"4QC3",25.86,"1.6","1.6","Crystal structure of human BAZ2B bromodomain in complex with a diacetylated histone 4 peptide (H4K8acK12ac)","SMDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFK","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4QC3"
,,,,,,,,,,,,,,,,"GKGLGKG",,,"diacetylated histone 4 peptide (H4K8acK12ac)","2","4QC3"
"4QC4",,"X-RAY DIFFRACTION",2.78,55.78,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.9 M sodium citrate, 0.1 M imidazole, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/jps.24188",,"4QC4",33.88,"1.491","1.491","Crystal structure of C117S mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSSKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4QC4"
"4QCL",,"X-RAY DIFFRACTION",4.49,72.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"reservoir solution: 0.8 mm zinc sulfate, 50 mm MES buffer pH 6.5, 8.8% v/v PEG MME 550; cryo solution: 100 mm potassium chloride, 0.8 mm zinc sulfate, 50 mm MES buffer pH 6.5, 1.1 magnesium chloride, 15% v/v PEG MME 550, 15% v/v ethylene glycol;, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"4QCL",116.56,"2.2","2.2","Crystal structure of the catalytic core of human DNA polymerase alpha in ternary complex with an RNA-primed DNA template and dCTP","DEEQVFHFYWLDAYEDQYNQPGVVFLFGKVWIESAETHVSCCVMVKNIERTLYFLPREMKIDLNTGKETGTPISMKDVYEEFDEKIATKYKIMKFKSKPVEKNYAFEIPDVPEKSEYLEVKYSAEMPQLPQDLKGETFSHVFGTNTSSLELFLMNRKIKGPCWLEVKSPQLLNQPVSWCKAEAMALKPDLVNVIKDVSPPPLVVMAFSMKTMQNAKNHQNEIIAMAALVHHSFALDKAAPKPPFQSHFCVVSKPKDCIFPYAFKEVIEKKNVKVEVAATERTLLGFFLAKVHKIDPDIIVGHNIYGFELEVLLQRINVCKAPHWSKIGRLKRSNMPKLGGRSGFGERNATCGRMICDVEISAKELIRCKSYHLSELVQQILKTERVVIPMENIQNMYSESSQLLYLLEHTWKDAKFILQIMCELNVLPLALQITNIAGNIMSRTLMGGRSERNEFLLLHAFYENNYIVPDKQIFRKPQQKLGDEDEEIDGDTNKYKKGRKKAAYAGGLVLDPKVGFYDKFILLLDFNSLYPSIIQEFNICFTTVQRVASEAQKVTEDGEQEQIPELPDPSLEMGILPREIRKLVERRKQVKQLMKQQDLNPDLILQYDIRQKALKLTANSMYGCLGFSYSRFYAKPLAALVTYKGREILMHTKEMVQKMNLEVIYGDTDSIMINTNSTNLEEVFKLGNKVKSEVNKLYKLLEIDIDGVFKSLLLLKKKKYAALVVEPTSDGNYVTKQELKGLDIVRRDWCDLAKDTGNFVIGQILSDQSRDTIVENIQKRLIEIGENVLNGSVPVSQFEINKALTKDPQDYPDKKSLPHVHVALWINSQGGRKVKAGDTVSYVICQDGSNLTASQRAYAPEQLQKQDNLTIDTQYYLAQQIHPVVARICEPIDGIDAVLIATWLGLDPTQFRVHHYHKDEEN","Homo sapiens","POLA, POLA1","DNA polymerase alpha catalytic subunit","1","4QCL"
,,,,,,,,,,,,,,,,"GCCUGGAGCGC",,,"RNA PRIMER","2","4QCL"
,,,,,,,,,,,,,,,,"ATTACTATAGGCGCTCCAGGC",,,"DNA TEMPLATE","3","4QCL"
"4QD6",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Nitrate, 0.1M Bis Tris propane, 20% PEG 3350, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.10.020","30T","4QD6",61.41,"2.45","2.45","ITK kinase domain in complex with inhibitor compound","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4QD6"
"4QDE",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, HANGING DROP",4,"1:1 protein (4 mg/mL in 25 mM sodium chloride, 20 mM Tris-HCl, pH 8.0, 1 mM TCEP) to precipitant (23-25% PEG3350, 0.1 M potassium phosphate monobasic, 0.05 M sodium chloride, 26% glycerol), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4QDE",155.71,"2.9","2.9","Dcps in complex with covalent inhibitor","GADAAPQLGKRKRELDVEEAHAASTEEKEAGVGNGTCAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","m7GpppX diphosphatase","1","4QDE"
"4QDQ",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M HEPES, 0.5 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2015.01.018",,"4QDQ",74.9,"1.95","1.95","Physical basis for Nrp2 ligand binding","GSHMQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWTPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQEYLWSPSAARLVSSRSGWFPRIPQAQPGEEWLQVDLGTPKTVKGVIIQGARGGDSITAVEARAFVRKFKVSYSLNGKDWEYIQDPRTQQPKLFEGNMHYDTPDIRRFDPIPAQYVRVYPERWSPAGIGMRLEVLGCDWTSIIRR","Homo sapiens","NRP2, VEGF165R2","Neuropilin-2","1","4QDQ"
"4QDR",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 18% (w/v) PEG 12000, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2015.01.018",,"4QDR",36.6,"2.4","2.4","Physical basis for Nrp2 ligand binding","GSHMQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWRPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQEYLWSPSAARLVSSRSGWFPRIPQAQPGEEWLQVDLGTPKTVKGVIIQGARGGDSITAVEARAFVRKFKVSYSLNGKDWEYIQDPRTQQPKLFEGNMHYDTPDIRRFDPIPAQYVRVYPERWSPAGIGMRLEVLGCDWT","Homo sapiens","NRP2, VEGF165R2","Neuropilin-2","1","4QDR"
"4QDS",,"X-RAY DIFFRACTION",2.55,51.73,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 1000, 10% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2015.01.018",,"4QDS",42.02,"2.4","2.4","Physical basis for Nrp2 ligand binding","GSHMFQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWTPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQE","Homo sapiens","NRP2, VEGF165R2","Neuropilin-2","1","4QDS"
"4QDV",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, HANGING DROP",,"22-25% PEG3350, 50 mM sodium chloride, 26% glycerol, crystals soaked in 1 mM compound overnight, VAPOR DIFFUSION, HANGING DROP",,,,"4QDV",156.09,"2.8","2.8","Dcps in complex with covalent ligand","GADAAPQLGKRKRELDVEEAHAASTEEKEAGVGNGTCAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","m7GpppX diphosphatase","1","4QDV"
"4QEB",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, HANGING DROP",4.4,"1:1 protein (4 mg/mL in 25 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM TCEP) to precipitant (23-25% PEG3350, 0.1 M potassium phosphate monobasic, 0.05 M sodium chloride, 26% glycerol, crystals soaked in 1 mM inhibitor overnight, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"4QEB",155.08,"3.21","3.21","Dcps in complex with covalent inhibitor targeting Tyrosine","GADAAPQLGKRKRELDVEEAHAASTEEKEAGVGNGTCAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFPPRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNILDKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPLLRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAEVIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS","Homo sapiens","DCPS, DCS1, HINT5, HSPC015","m7GpppX diphosphatase","1","4QEB"
"4QEF",,"X-RAY DIFFRACTION",2.1,41.52,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M Sodium Citrate, 50 mM Tris pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1107/S2053230X14018135","0NM","4QEF",29.5,"1.469","1.469","Human Carbonic Anhydrase II V207I - cyanate inhibitor complex","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECITWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QEF"
"4QEG",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M CaCl2, 30% PEG 3350, 0.1 M Tris, 3% Isopropanol, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,,,"4QEG",10.3,"2","2","Crystal structure of domain I10 from titin (space group P41)","GAMETLHITKTMKNIEVPETKTASFECEVSHFNVPSMWLKNGVEIEMSEKFKIVVQGKLHQLIIMNTSTEDSAEYTFVCGNDQVSATLTVT","Homo sapiens","TTN","Titin","1","4QEG"
"4QEU",,"X-RAY DIFFRACTION",2.31,46.85,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M sodium citrate, 0.2M ammonium sulfate, 30% PEG4000, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/science.1249830",,"4QEU",13.48,"1.5","1.5","Crystal structure of BRD2(BD2) mutant in free form","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGAHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","4QEU"
"4QEV",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes, 0.2M Imidazole, 41% PEG400, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/science.1249830",,"4QEV",14.32,"1.8","1.8","Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE)","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGAHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","4QEV"
"4QEW",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes, 0.2M Imidazole, 41% PEG400, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/science.1249830",,"4QEW",14.34,"1.7","1.7","Crystal structure of BRD2(BD2) mutant with ligand ET bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]BUTANOATE)","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGAHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","4QEW"
"4QF1",,"X-RAY DIFFRACTION",3.07,59.98,"VAPOR DIFFUSION, SITTING DROP",6,"A drop of 0.3 ul protein plus 0.3 ul reservoir, over the 60 ul reservoir which was 0.05 M CaCl2 dihydrate, 0.1 M MES monohydrate pH 6.0, 45% PEG 200., VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.immuni.2014.11.014",,"4QF1",94.82,"2.4","2.4","Crystal structure of unliganded CH59UA, the inferred unmutated ancestor of the RV144 anti-HIV antibody lineage producing CH59","EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDSPRGELPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"CH59UA Fab fragment of heavy chain","1","4QF1"
,,,,,,,,,,,,,,,,"SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHRVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Inferred unmutated ancestor (UA) of anti-HIV antibody CH59","2","4QF1"
"4QF2",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",8,"2M Na/K phosphate, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2014.10.017",,"4QF2",27.29,"1.7","1.7","Crystal structure of human BAZ2A PHD zinc finger in the free form","HMSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQV","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","4QF2"
"4QF3",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, SITTING DROP",7.8,"2.2M Na/K phosphate, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2014.10.017",,"4QF3",13.35,"1.6","1.6","Crystal structure of human BAZ2B PHD zinc finger in the free form","HMSIMKVYCQICRKGDNEELLLLCDGCDKGCHTYCHRPKITTIPDGDWFCPACIAKAS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4QF3"
"4QFC",,"X-RAY DIFFRACTION",2.28,46.2,"VAPOR DIFFUSION, SITTING DROP",6.6,"protein at 2 mg/mL in 50mM sodium phosphate pH 6.6, 10uM FAD against 30%PEG2000MME, 0.1M POTASSIUM THIOCYANATE supplemented with 20% ethylene glycol as cryo-protectant, unique crystal ID 246094_h11, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1042/BSR20140071","31T","4QFC",81.4,"2.4","2.4","Co-crystal structure of compound 3 (4-hydroxy-6-[2-(7-hydroxy-2-oxo-4-phenyl-2h-chromen-6-yl)ethyl]pyridazin-3(2h)-one) and FAD bound to human DAAO at 2.4A","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAMOX, DAO, DAO DAMOX","D-amino-acid oxidase","1","4QFC"
"4QFD",,"X-RAY DIFFRACTION",2.57,52,"VAPOR DIFFUSION, SITTING DROP",7.4,"DAAO AT 2 MG/ML IN 50 MM SODIUM PHOSPHATE PH 6.6, 10 UM FAD INCUBATED WITH 5-FOLD EXCESS OF SEP-0374036 OVERNIGHT AT 277 K, CRYSTALLIZED AGAINST 13.6% PEG3350, 0.1 M TRIS PH 7.4, 150 MM POTASSIUM CITRATE TRIBASIC AND 20 MM GLYCEROL AS CRYO-PROTECTANT, CRYSTAL TRACKING ID  241709B5, UNIQUE PUCK ID XSS6-4, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1042/BSR20140071",,"4QFD",81.28,"2.85","2.85","Co-crystal structure of compound 2 (3-(7-hydroxy-2-oxo-4-phenyl-2H-chromen-6-yl)propanoic acid) and FAD bound to human DAAO at 2.85A","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAMOX, DAO, DAO DAMOX","D-amino-acid oxidase","1","4QFD"
"4QFT",,"X-RAY DIFFRACTION",3.15,60.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Tri-Sodium citrate, 0.1 M Bis-Tris propane, 20% PEG3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0105688",,"4QFT",20.78,"1.76","1.76","Structure of COP9 signalosome complex subunit 6","GPLGSMACGVTGSVSVALHPLVILNISDHWIRMRSQEGRPVQVIGALIGKQEGRNIEVMNSFELLSHTVEEKIIIDKEYYYTKEEQFKQVFKELEFLGWYTTGGPPDPSDIHVHKQVCEIIESPLFLKLNPMTKHTDLPVSVFESVIDIINGEATMLFAELTYTLATEEAERIGVDHVARMTATGS","Homo sapiens","COPS6, CSN6, HVIP","COP9 signalosome complex subunit 6","1","4QFT"
"4QFX",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QFX",259.92,"2.2","2.2","Crystal structure of the tetrameric dGTP/dATP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QFX"
"4QFY",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QFY",259.83,"2.1","2.1","Crystal structure of the tetrameric dGTP/dCTP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QFY"
"4QFZ",,"X-RAY DIFFRACTION",2.29,46.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QFZ",259.81,"2.3","2.3","Crystal structure of the tetrameric dGTP/dTTP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QFZ"
"4QG0",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QG0",259.71,"2.3","2.3","Crystal structure of the tetrameric dGTP/dUTP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QG0"
"4QG1",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QG1",259.82,"2.2","2.2","Crystal structure of the tetrameric GTP/dATP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QG1"
"4QG2",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QG2",257.86,"2.25","2.25","Crystal structure of the tetrameric GTP/dATP/ATP-bound SAMHD1 (RN206) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QG2"
"4QG4",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M SPG, pH 6.5, 25% PEG1500, 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M114.591958",,"4QG4",257.78,"2.1","2.1","Crystal structure of the tetrameric GTP/dATP/ATP-bound SAMHD1 (H210A) mutant catalytic core","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGAGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4QG4"
"4QG6",,"X-RAY DIFFRACTION",4.93,75.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M proline, Hepes pH 7.5, 24% PEG1500, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1007/s13238-015-0132-x",,"4QG6",233.58,"3.207","3.207","crystal structure of PKM2-Y105E mutant","GPGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILERPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4QG6"
"4QG8",,"X-RAY DIFFRACTION",2.42,49.15,"VAPOR DIFFUSION, HANGING DROP",5,"0.2M Malonate pH 5.0, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1007/s13238-015-0132-x",,"4QG8",233.84,"2.3","2.3","crystal structure of PKM2-K305Q mutant","GPGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEQVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4QG8"
"4QG9",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M CaAC2, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1007/s13238-015-0132-x",,"4QG9",233.46,"2.381","2.381","crystal structure of PKM2-R399E mutant","GPGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELERLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4QG9"
"4QGC",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M K2SO4, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1007/s13238-015-0132-x",,"4QGC",234.76,"2.296","2.296","crystal structure of PKM2-K422R mutant","GPGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFRCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4QGC"
"4QGK",,"X-RAY DIFFRACTION",2.75,55.34,"VAPOR DIFFUSION",9.5,"0.2M Li2SO4, 0.1M CHES pH9.5, 1.0M K/Na Tartrate, VAPOR DIFFUSION, temperature 298K",298,"10.1038/ncomms5439",,"4QGK",104.47,"2.1","2.1","Structure of the Human Sjogren Larsson Syndrome enzyme fatty aldehyde dehydrogenase (FALDH)","AMELEVRRVRQAFLSGRSRPLRFRLQQLEALRRMVQEREKDILTAIAADLCKSEFNVYSQEVITVLGEIDFMLENLPEWVTAKPVKKNVLTMLDEAYIQPQPLGVVLIIGAWNYPFVLTIQPLIGAIAAGNAVIIKPSELSENTAKILAKLLPQYLDQDLYIVINGGVEETTELLKQRFDHIFYTGNTAVGKIVMEAAAKHLTPVTLELGGKSPCYIDKDCDLDIVCRRITWGKYMNCGQTCIAPDYILCEASLQNQIVWKIKETVKEFYGENIKESPDYERIINLRHFKRILSLLEGQKIAFGGETDEATRYIAPTVLTDVDPKTKVMQEEIFGPILPIVPVKNVDEAINFINEREKPLALYVFSHNHKLIKRMIDETSSGGVTGNDVIMHFTLNSFPFGGVGSSGMGAYHGKHSFDTFSHQRPCLLKSLKREGANKLRYPPNSQSKVDWGKFFLLKRFN","Homo sapiens","ALDH10, ALDH3A2, FALDH","Fatty aldehyde dehydrogenase","1","4QGK"
"4QGN",,"X-RAY DIFFRACTION",2.99,58.87,"VAPOR DIFFUSION, SITTING DROP",4.5,"Protein: 20 mg/ml in 50 mM Tris-HCl pH 7.8, 150mM NaCl, 2.5mM L-selenomethionine, Crystallization condition: 0.1M sodium acetate, ammonium sulfate pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4QGN",22.57,"3.05","3.05","Human acireductone dioxygenase with iron ion and L-methionine in active center","GAAAMVQAWYMDDAPGDPRQPHRPDPGRPVGLEQLRRLGVLYWKLDADKYENDPELEKIRRERNYSWMDIITICKDKLPNYEEKIKMFYEEHLHLDDEIRYILDGSGYFDVRDKEDQWIRIFMEKGDMVTLPAGIYHRFTVDEKNYTKAMRLFVGEPVWTAYNRPADHFEARGQYVKFLAQTA","Homo sapiens","ADI1, HMFT1638, MTCBP1, NP_060739","1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase","1","4QGN"
"4QGT",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"100mM Hepes, 30% PEG 1000  
Cryo: +10% ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298KK",298,"10.1021/acschembio.5b01035",,"4QGT",54.97,"2.99","2.99","The Crystal Structure of Human IgG Fc Domain with Enhanced Aromatic Sequon","FEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEFANSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Hepatitis B virus receptor binding protein","1","4QGT"
"4QGU",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% (w/v) PEG 3350 and 0.2 M potassium fluoride; 20% (w/v) PEG 3350 and 0.2 M sodium formate; or 20% (w/v) PEG 3350 and 0.2 M lithium acetate dehydrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/jmcb/mjv053",,"4QGU",55.11,"2.545","2.545","protein domain complex with ssDNA","GSHMQVTPRRNVLQKRPVIVKVLSTTKPFEYETPEMEKKIMFHATVATQTQFFHVKVLNTSLKEKFNGKKIIIISDYLEYDSLLEVNEESTVSEAGPNQTFEVPNKIINRAKETLKIDILHKQASGNIVYGVFMLHKKTVNQKTTIYEIQDDRGKMDVVGTGQCHNIPCEEGDKLQLFCFRLRKKNQMSKLISEMHSFIQIKKKTN","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein 16","1","4QGU"
,,,,,,,,,,,,,,,,"AGGCCGGCGTGA",,,"DNA (5'-D(P*AP*GP*GP*CP*CP*GP*GP*CP*GP*TP*GP*A)-3')","2","4QGU"
"4QGV",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis Tris Propane, 0.2 M Sodium Fluoride,  
16% PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja506376j",,"4QGV",31.29,"1.73","1.73","Crystal structure of the R132K:R111L mutant of Cellular Retinoic Acid Binding ProteinII complexed with a synthetic ligand (Merocyanine) at 1.73 angstrom resolution.","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELILTMTADDVVCTKVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4QGV"
"4QGW",,"X-RAY DIFFRACTION",2.33,47.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis Tris Propane,   
0.2M Sodium Floride,    
16% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja506376j",,"4QGW",31.57,"1.77","1.77","Crystal sturcture of the R132K:R111L:L121D mutant of Cellular Retinoic Acid Binding ProteinII complexed with a synthetic ligand (Merocyanine) at 1.77 angstrom resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELIDTMTADDVVCTKVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4QGW"
"4QGX",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M bis Tris Propane, 0.2M Sodium Floride, 16% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja506376j",,"4QGX",31.32,"1.471","1.471","Crystal structure of the R132K:R111L:L121E mutant of Cellular Retinoic Acid Binding ProteinII complexed with a synthetic ligand (Merocyanine) at 1.47 angstrom resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTLELTNDGELIETMTADDVVCTKVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4QGX"
"4QH9",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 0.2M Sodium Chloride, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi500676p",,"4QH9",32.5,"2.175","2.175","Crystal structure of Mn2+ bound human APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","4QH9"
"4QHD",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 0.2M Sodium Chloride, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi500676p",,"4QHD",32.26,"1.65","1.65","Crystal structure of apo human APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","4QHD"
"4QHE",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 0.2M Sodium Chlorid, 19% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi500676p",,"4QHE",32.41,"1.4","1.4","Crystal structure of Mg2+ bound human APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","4QHE"
"4QHO",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, HANGING DROP",5.6,"100mM trisodium citrate, 8% PEG 3350, 4% tert-butanol, 8mg/ml protein, 1mM ZnSO4, 1mM inhibitor, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.1c01204",,"4QHO",57.21,"2.37","2.37","Crystal structure of the human fat mass and obesity associated protein (FTO) in complex with CCO10","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4QHO"
"4QHV",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION, HANGING DROP",6,"60% AmSO4,3% v/v ETOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1107/S2053230X15008468","IXF","4QHV",22.98,"1.61","1.61","Crystal structure of human dihydrofolate reductase as complex with pyridopyrimidine 22 (N~6~-METHYL-N~6~-[4-(PROPAN-2-YL)PHENYL]PYRIDO[2,3-D]PYRIMIDINE-2,4,6-TRIAMINE)","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4QHV"
"4QIA",,"X-RAY DIFFRACTION",3.99,69.18,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1016/j.ejmech.2014.12.005",,"4QIA",229.97,"3.202","3.202","Crystal structure of human insulin degrading enzyme (ide) in complex with inhibitor N-benzyl-N-(carboxymethyl)glycyl-L-histidine","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4QIA"
"4QIB",,"X-RAY DIFFRACTION",2.95,58.3,"VAPOR DIFFUSION, HANGING DROP",7.4,"20 mg/mL protein, 2.0 to 2.4 M ammonium sulfate, 1% poly(ethylene glycol) 400, 100 mM Hepes, 10 mM H2O2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bbadis.2014.12.025",,"4QIB",18.38,"1.865","1.865","Oxidation-Mediated Inhibition of the Peptidyl-Prolyl Isomerase Pin1","GALPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4QIB"
"4QIK",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, SITTING DROP",5.7,"0.1 M sodium citrate/citric acid buffer, pH 5.7, 1.5 M lithium chloride, 18%-21% PEG6000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2857",,"4QIK",90.45,"1.9","1.9","Crystal structure of the ROQ domain of human Roquin in complex with the TNF23 RNA duplex","MASGVEDTKHYEEAKKCVEELALYLKPLSSARGVGLNSTTQSVLSRPMQRKLVTLVHCQLVEEEGRIRAMRAARSLGERTVTELILQHQNPQQLSSNLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRTYEALRREHDSQIVQIAMEAGLRIAPDQWSSLLYGDQSHKSHMQSIIDKLQTPASFAQSVQELTIALQRTGDPANLNRLRPHLELLANIDPSPDAPPPTWEQLENGLVAVRTVVHGLVDYIQNHSKKGADQQQLEHHHHHH","Homo sapiens","RC3H1, KIAA2025, RNF198","Roquin-1","1","4QIK"
,,,,,,,,,,,,,,,,"ACAUGUUUUCUGUGAAAACGGAG",,,"5'-R(*AP*C*AP*UP*GP*UP*UP*UP*UP*CP*UP*GP*UP*GP*AP*AP*AP*AP*CP*GP*GP*AP*G)-3'","2","4QIK"
"4QIL",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",8.2,"0.1 M Tris-HCl, pH 8.2, 0.3 M calcium acetate, 12%-14% PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2857",,"4QIL",86.65,"2.9","2.9","Crystal structure of the ROQ domain of human Roquin in complex with the Hmg19 stem-loop RNA","CUCCCUUCUGUGAAGGGGA",,,"5'-R(*CP*UP*CP*CP*CP*UP*UP*CP*UP*GP*UP*GP*AP*AP*GP*GP*GP*GP*A)-3'","2","4QIL"
,,,,,,,,,,,,,,,,"MASGVEDTKHYEEAKKCVEELALYLKPLSSARGVGLNSTTQSVLSRPMQRKLVTLVHCQLVEEEGRIRAMRAARSLGERTVTELILQHQNPQQLSSNLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRTYEALRREHDSQIVQIAMEAGLRIAPDQWSSLLYGDQSHKSHMQSIIDKLQTPASFAQSVQELTIALQRTGDPANLNRLRPHLELLANIDPSPDAPPPTWEQLENGLVAVRTVVHGLVDYIQNHSKKGADQQQLEHHHHHH","Homo sapiens","RC3H1, KIAA2025, RNF198","Roquin-1","1","4QIL"
"4QIY",,"X-RAY DIFFRACTION",2,38.2,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE, pH 9, 0.2M ammonium sulfate, 2M sodium malonate pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWX","4QIY",120.51,"1.3","1.3","Crystal structure of human carbonic anhydrase isozyme II with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QIY"
"4QIZ",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M ammonium citrate (pH 5.0), 20% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWX","4QIZ",60.6,"1.55","1.55","Crystal structure of human carbonic anhydrase isozyme XIII with inhibitor","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4QIZ"
"4QJ0",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M ammonium citrate pH 7.0, 0.2M ammonium sulfate, 26% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWX","4QJ0",122.43,"1.55","1.55","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with inhibitor","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4QJ0"
"4QJC",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, HANGING DROP",6,"30% AmSO4, 3% v/v ETOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1107/S2053230X15008468","IXE","4QJC",22.42,"1.62","1.62","Human dihydrofolate reductase ternary complex with NADPH and inhibitor 26 (N~6~-METHYL-N~6~-(3,4,5-TRIFLUOROPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,4,6-TRIAMINE)","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","4QJC"
"4QJM",,"X-RAY DIFFRACTION",2.02,38.6,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE pH 9, 0.2M ammonium sulfate, 2M sodium malonate pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","V1F","4QJM",30.28,"1.75","1.75","Crystal structure of human carbonic anhydrase isozyme II with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QJM"
"4QJO",,"X-RAY DIFFRACTION",2.04,39.2,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M ammonium citrate pH 5.0, 20% of PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","V1F","4QJO",122.06,"1.8","1.8","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with inhibitor","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4QJO"
"4QJP",,"X-RAY DIFFRACTION",2.14,42.2,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate (pH 5.5), 0.1M sodium acetate (pH 4.5), 26% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","V1F","4QJP",60.87,"1.62","1.62","Crystal structure of human carbonic anhydrase isozyme XIII with inhibitor","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4QJP"
"4QJW",,"X-RAY DIFFRACTION",2.05,40.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES Sodium pH 7.5, 0.2M calcium chloride, 28% of PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWO","4QJW",122.06,"1.55","1.55","Crystal structure of catalytic domain of human carbonic anhydrase isozyme XII with inhibitor","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4QJW"
"4QJX",,"X-RAY DIFFRACTION",2.15,42.3,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate (pH 5.5), 0.2M sodium acetate (pH 4.5), 28% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWO","4QJX",30.27,"1.95","1.95","Crystal structure of human carbonic anhydrase isozyme XIII with inhibitor","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4QJX"
"4QK1",,"X-RAY DIFFRACTION",1.82,32.56,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M sodium citrate, 50 mM sodium phosphate dibasic, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/febs.13232",,"4QK1",29.32,"1.599","1.599","Structural and Catalytic Effects of Proline Substitution and Surface Loop Deletion in the Extended Active Site of Human Carbonic Anhydrase II - K170P","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTPGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QK1"
"4QK2",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 100 mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/febs.13232",,"4QK2",29.41,"1.519","1.519","Structural and Catalytic Effects of Proline Substitution and Surface Loop Deletion in the Extended Active Site of Human Carbonic Anhydrase II - E234P","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGPGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QK2"
"4QK3",,"X-RAY DIFFRACTION",1.92,35.83,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 100 mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/febs.13232",,"4QK3",28.14,"1.345","1.345","Structural and Catalytic Effects of Proline Substitution and Surface Loop Deletion in the Extended Active Site of Human Carbonic Anhydrase II - [delta]230-240","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QK3"
"4QKB",,"X-RAY DIFFRACTION",2.33,47.29,"EVAPORATION",6,"PEG pH6, EVAPORATION, temperature 277K",277,"10.1074/jbc.M114.590505",,"4QKB",69.24,"2.6","2.6","Crystal structure of seleno-methionine labelled human ALKBH7 in complex with alpha-ketoglutarate and Mn(II)","MWVRGSGPSVLSRLQDAAVVRPGFLSTAEEETLSRELEPELRRRRYEYDHWDAAIHGFRETEKSRWSEASMAIMRRVQAAAFGPGQTLLSSVHVLDLEARGYIKPHVDSIKFCGATIAGLSLLSPSVMRLVHTQEPGEWLELLLEPGSLYILRGSARYDFSHEILRDEESFFGERRIPRGRRISVICRSLPEGMGPGESG","Homo sapiens","ABH7, ALKBH7, SPATA11, UNQ6002/PRO34564","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial","1","4QKB"
"4QKD",,"X-RAY DIFFRACTION",2.31,46.8,"EVAPORATION",6,"PEG pH6, EVAPORATION, temperature 277K",277,"10.1074/jbc.M114.590505",,"4QKD",68.6,"1.35","1.35","Crystal structure of human ALKBH7 in complex with alpha-ketoglutarate and Mn(II)","MWVRGSGPSVLSRLQDAAVVRPGFLSTAEEETLSRELEPELRRRRYEYDHWDAAIHGFRETEKSRWSEASRAILRRVQAAAFGPGQTLLSSVHVLDLEARGYIKPHVDSIKFCGATIAGLSLLSPSVMRLVHTQEPGEWLELLLEPGSLYILRGSARYDFSHEILRDEESFFGERRIPRGRRISVICRSLPEGMGPGESG","Homo sapiens","ABH7, ALKBH7, SPATA11, UNQ6002/PRO34564","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial","1","4QKD"
"4QKF",,"X-RAY DIFFRACTION",2.3,46.5,"EVAPORATION",6,"PEG pH 6 , EVAPORATION, temperature 277K",277,"10.1074/jbc.M114.590505",,"4QKF",68.25,"1.99","1.99","Crystal structure of human ALKBH7 in complex with N-oxalylglycine and Mn(II)","MWVRGSGPSVLSRLQDAAVVRPGFLSTAEEETLSRELEPELRRRRYEYDHWDAAIHGFRETEKSRWSEASRAILRRVQAAAFGPGQTLLSSVHVLDLEARGYIKPHVDSIKFCGATIAGLSLLSPSVMRLVHTQEPGEWLELLLEPGSLYILRGSARYDFSHEILRDEESFFGERRIPRGRRISVICRSLPEGMGPGESG","Homo sapiens","ABH7, ALKBH7, SPATA11, UNQ6002/PRO34564","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial","1","4QKF"
"4QKG",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",3.5,"2M ammonium sulfate, 0.1M sodium citrate, pH 3.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1107/S1399004714027928",,"4QKG",16.01,"1.95","1.95","Monomeric form of human LLT1, a ligand for NKR-P1","ITGQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARCYTERKWICSKSDIHVGTKHHHHHHHHG","Homo sapiens","CLAX, CLEC2B, CLEC2D, LLT1, OCIL","C-type lectin domain family 2 member D","1","4QKG"
"4QKH",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION, SITTING DROP",7,"30%(w/v) polyethylene glycol 6000, 0.1M HEPES, pH 7.0   , VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1107/S1399004714027928",,"4QKH",32.27,"1.8","1.8","Dimeric form of human LLT1, a ligand for NKR-P1","ITGQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARCYTERKWICSKSDIHVGTKHHHHHHHHG","Homo sapiens","CLAX, CLEC2B, CLEC2D, LLT1, OCIL","C-type lectin domain family 2 member D","1","4QKH"
"4QKI",,"X-RAY DIFFRACTION",1.64,25,"VAPOR DIFFUSION, SITTING DROP",7,"30%(w/v) polyethylene glycol 6000, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1107/S1399004714027928",,"4QKI",32.27,"1.8","1.8","Dimeric form of human LLT1, a ligand for NKR-P1","ITGQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARCYTERKWICSKSDIHVGTKHHHHHHHHG","Homo sapiens","CLAX, CLEC2B, CLEC2D, LLT1, OCIL","C-type lectin domain family 2 member D","1","4QKI"
"4QKJ",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, HANGING DROP",4.2,"40%(v/v) PEG300 and 0.1M citrate phosphate buffer, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1107/S1399004714027928",,"4QKJ",15.91,"2.75","2.75","Glycosylated form of human LLT1, a ligand for NKR-P1, in this structure forming hexamers","ITGQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARCYTERKWICSKSDIHVGTKHHHHHHHHG","Homo sapiens","CLAX, CLEC2B, CLEC2D, LLT1, OCIL","C-type lectin domain family 2 member D","1","4QKJ"
"4QKN",,"X-RAY DIFFRACTION",2.93,58.07,"VAPOR DIFFUSION, HANGING DROP",5.6,"100mM sodium citrate, 11.5% PEG3350, 8% isopropanol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gku1276","OGA","4QKN",55.3,"2.2","2.2","Crystal structure of FTO bound to a selective inhibitor","GSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEA","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","4QKN"
"4QKZ",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, HANGING DROP",6,"10 % PEG 6000, 0.2M MES/NAOH, 1M NA PHOSPHATE, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4QKZ",18.93,"1.2","1.2","X-ray structure of the catalytic domain of MMP-8 with the inhibitor ML115","MLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","4QKZ"
"4QL1",,"X-RAY DIFFRACTION",2.14,42.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG 3350, 0.2 M NH4oAC, 0.1 M BisTris pH6.5, vapor diffusion hanging drop, temperature 291K",291,"10.1038/nchembio.1859","35Q","4QL1",69.85,"1.5","1.5","Crystal structure of human WDR5 in complex with compound OICR-9429","GTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","4QL1"
"4QL3",,"X-RAY DIFFRACTION",1.89,34.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate pH4.5, 0.1M Tris pH 8.5, 28% PEG 3,350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1158/1541-7786.MCR-15-0203",,"4QL3",19.9,"1.041","1.041","Crystal Structure of a GDP-bound G12R Oncogenic Mutant of Human GTPase KRas","GMTEYKLVVVGARGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4QL3"
"4QL8",,"X-RAY DIFFRACTION",2.06,40.41,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH (6.5-8.5), 1.5M MgSO4 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm5009049","JAD","4QL8",30.46,"2.1","2.1","Crystal structure of Androgen Receptor in complex with the ligand","GSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","4QL8"
"4QM0",,"X-RAY DIFFRACTION",3.16,61.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Bis-Tris propane pH 8.5, 200- 600 mM Sodium Potassium Tartrate and 10-15% Peg 3350 after 4 days at 19   C, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2014.06.048","39K","4QM0",59.19,"2.195","2.195","Crystal structure of RORc in complex with a tertiary sulfonamide inverse agonist","GSAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGNS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","4QM0"
"4QMD",,"X-RAY DIFFRACTION",1.93,36.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.1M BIS Tris-CL, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/ncomms10827",,"4QMD",42.48,"1.601","1.601","Crystal structure of human envoplakin plakin repeat domain","DDSFPIAGIYDTTTDNKCSIKTAVAKNMLDPITGQKLLEAQAATGGIVDLLSRERYSVHKAMERGLIENTSTQRLLNAQKAFTGIEDPVTKKRLSVGEAVQKGWMPRESVLPHLQVQHLTGGLIDPKRTGRIPIQQALLSGMISEELAQLLQDESSYEKDLTDPISKERLSYKEAMGRCRKDPLSGLLLLPAA","Homo sapiens","EVPL","Envoplakin","1","4QMD"
"4QMI",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL protein was added to an equal volume of a mother liquor containing 28% PEG 4000, 100 mM Tris pH 7.5, and 125 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1091/mbc.E13-08-0501",,"4QMI",53.47,"1.9","1.9","The XMAP215 family drives microtubule polymerization using a structurally diverse TOG array","GSHMNDVVDLLPRTEISDKITSELVSKIGDKNWKIRKEGLDEVAGIINDAKFIQPNIGELPTALKGRLNDSNKILVQQTLNILQQLAVAMGPNIKQHVKNLGIPIITVLGDSKNNVRAAALATVNAWAEQTGMKEWLEGEDLSEELKKENPFLRQELLGWLAEKLPTLRSTPTDLILCVPHLYSCLEDRNGDVRKKAQDALPFFMMHLGYEKMAKATGKLKPTSKDQVLAMLEKAKVNMP","Homo sapiens","chTOG, CKAP5, KIAA0097","Cytoskeleton-associated protein 5","1","4QMI"
"4QMJ",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/ml protein was added to an equal volume of a mother liquor containing 27.5% PEG 4000, 100 mM Tris pH 7.5, and 70 mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1091/mbc.E13-08-0501",,"4QMJ",27.11,"2.498","2.498","The XMAP215 family drives microtubule polymerization using a structurally diverse TOG array","GSHMNDVVDLLPRTEISDKITSELVSKIGDKNWKIRKEGLDEVAGIINDAKFIQPNIGELPTALKGRLNDSNKILVQQTLNILQQLAVAMGPNIKQHVKNLGIPIITVLGDSKNNVRAAALATVNAWAEQTGMKEWLEGEDLSEELKKENPFLRQELLGWLAEKLPTLRSTPTDLILCVPHLYSCLEDRNGDVRKKAQDALPFFMMHLGYEKMAKATGKLKPTSKDQVLAMLEKAKVNMP","Homo sapiens","chTOG, CKAP5, KIAA0097","Cytoskeleton-associated protein 5","1","4QMJ"
"4QML",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM ANP-PNP, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115",,"4QML",35.62,"1.882","1.882","MST3 in complex with AMP-PNP","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QML"
"4QMM",,"X-RAY DIFFRACTION",2.57,52.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM AT-9283, 25 mM TRIS, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","35R","4QMM",35.68,"1.852","1.852","MST3 IN COMPLEX WITH AT-9283, 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMM"
"4QMN",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM BOSUTINIB, 25 mM TRIS, PH 8.0, 50 MM HEPES, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","DB8","4QMN",35.55,"2.091","2.091","MST3 in complex with BOSUTINIB","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMN"
"4QMO",,"X-RAY DIFFRACTION",2.56,52.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM C16, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","34L","4QMO",35.66,"1.898","1.898","MST3 IN COMPLEX WITH Imidazolo-oxindole PKR inhibitor C16","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMO"
"4QMP",,"X-RAY DIFFRACTION",2.5,50.89,,7.5,"12.5 mg/mL MST3, 1 mM CDK2 Inhibitor III, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","DKI","4QMP",35.51,"2","2","MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III, 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMP"
"4QMQ",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM CP-673451, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","34U","4QMQ",35.61,"1.769","1.769","MST3 in complex with CP-673451","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMQ"
"4QMS",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM DASATINIB, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","1N1","4QMS",35.61,"1.883","1.883","MST3 in complex with DASATINIB","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMS"
"4QMT",,"X-RAY DIFFRACTION",2.12,42.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM HESPERADIN, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","H1N","4QMT",35.6,"1.5","1.5","MST3 in complex with HESPERADIN","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","MST3, STK24, STK3","Serine/threonine-protein kinase 24","1","4QMT"
"4QMU",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM JNJ-7706621, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","SKE","4QMU",35.52,"1.546","1.546","MST3 IN COMPLEX WITH JNJ-7706621, 4-({5-AMINO-1-[(2,6-DIFLUOROPHENYL)CARBONYL]-1H-1,2,4-TRIAZOL-3-YL}AMINO)BENZENESULFONAMIDE","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMU"
"4QMV",,"X-RAY DIFFRACTION",2.55,51.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM PF-03814735, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","34W","4QMV",35.62,"2.4","2.4","MST3 IN COMPLEX WITH PF-03814735, N-{2-[(1S,4R)-6-{[4-(CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}-1,2,3,4-TETRAHYDRO-1,4-EPIMINONAPHTHALEN-9-YL]-2-OXOETHYL}ACETAMIDE","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMV"
"4QMW",,"X-RAY DIFFRACTION",2.12,42.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM PP-121, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","KS1","4QMW",35.46,"1.6","1.6","MST3 IN COMPLEX WITH PP-121, 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMW"
"4QMX",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM SARACATINIB,25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM, CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","H8H","4QMX",35.57,"1.882","1.882","MST3 in complex with SARACATINIB","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMX"
"4QMY",,"X-RAY DIFFRACTION",2.1,41.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM STAUROSPORINE, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM, CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","STU","4QMY",35.59,"1.883","1.883","MST3 IN COMPLEX WITH STAUROSPORINE","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMY"
"4QMZ",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM SUNITINIB, 25 mM TRIS, PH 8.0, 50 MM HEPES, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","B49","4QMZ",35.49,"1.88","1.88","MST3 IN COMPLEX WITH SUNITINIB","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QMZ"
"4QN1",,"X-RAY DIFFRACTION",3.26,62.24,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.6 M ammonium formate, 0.1 M Bis-Tris, pH 5.5, in situ proteolysis (1000:1 w/w protein:chymotrypsin) before setup, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4QN1",49.14,"2.48","2.48","Crystal Structure of a Functionally Uncharacterized Domain of E3 Ubiquitin Ligase SHPRH","GTMEELLTSLQKKCGTECEEAHRQLVCALNGLAGIHIIKGEYALAAELYREVLRSSEEHKGKLKTDSLQRLHATHNLMELLIARHPGIPPTLRDGRLEEEAKQLREHYMSKCNTEVAEAQQALYPVQQTIHELQRKIHSNSPWWLNVIHRAIEFTIDEELVQRVRNEITSNYKQQTGKLSMSEKFRDCRGLQFLLTTQMEELNKCQKLVREAVKNLEGPPSRNVIESATVCHLRPARLPLNCCVFCKADELFTEYESKLFSNTVKGQTAIFEEMIEDEEGLVDDRAPTTTRGLWAISETERSMKAILSFAKSHRFDVEFVDEGSTSMDLFEAWKKEYKLLHEYWMALRNRVSAVDELAMATERLRVRDPREPKPNPPVLHIIEPHEVEQNRIKLLNDKAVATSQLQKKLGQLLYLTNLEK","Homo sapiens","SHPRH, KIAA2023","E3 ubiquitin-protein ligase SHPRH","1","4QN1"
"4QN9",,"X-RAY DIFFRACTION",3.17,61.26,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.9 M lithium sulfate, 0.1 M HEPES, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2014.12.018",,"4QN9",97.67,"2.652","2.652","Structure of human NAPE-PLD","MDENESNQSLMTSSQYPKEAVRKRQNSARNSGASDSSRFSRKSFKLDYRLEEDVTKSKKGKDGRFVNPWPTWKNPSIPNVLRWLIMEKDHSSVPSSKEELDKELPVLKPYFITNPEEAGVREAGLRVTWLGHATVMVEMDELIFLTDPIFSSRASPSQYMGPKRFRRSPCTISELPPIDAVLISHNHYDHLDYNSVIALNERFGNELRWFVPLGLLDWMQKCGCENVIELDWWEENCVPGHDKVTFVFTPSQHWCKRTLMDDNKVLWGSWSVLGPWNRFFFAGDTGYCPAFEEIGKRFGPFDLAAIPIGAYEPRWFMKYQHVDPEEAVRIHTDVQTKKSMAIHWGTFALANEHYLEPPVKLNEALERYGLNAEDFFVLKHGESRYLNNDDENF","Homo sapiens","C7orf18, NAPEPLD","N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D","1","4QN9"
"4QNA",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM 2-(4,6- Diamino-1,3,5-triazin-2-yl)phenol, 25 mM TRIS, PH 8.0, 50 MM HEPES, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","X11","4QNA",35.23,"1.849","1.849","MST3 IN COMPLEX WITH 2-(4,6-Diamino-1,3,5-triazin-2-yl)phenol","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QNA"
"4QO3",,"X-RAY DIFFRACTION",2.96,58.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.9 M sodium citrate, 0.1 M imidazole, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4QO3",33.67,"2.047","2.047","Crystal structure of C16S/N18S/K12V/C117V/P134V mutant of human acidic fibroblast growth factor","HHHHHHFNLPPGNYKKPVLLYSSSGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLVLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4QO3"
"4QO4",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 
1.9-2.4 M Ammonium Sulfate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ml500142b","35S","4QO4",11.71,"1.7","1.7","co-crystal structure of MDM2 (17-111) with compound 16, {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-(6-CYCLOPROPYLPYRIDIN-2-YL)PROPYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4QO4"
"4QO7",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, sodium malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.06.076","36V","4QO7",151,"2.14","2.14","Lactate Dehydrogenase A in complex with substituted 3-Hydroxy-2-mercaptocyclohex-2-enone compound 7","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4QO7"
"4QO8",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, sodium malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.06.076","36U","4QO8",151.46,"2.001","2.001","Lactate Dehydrogenase A in complex with substituted 3-Hydroxy-2-mercaptocyclohex-2-enone compound 104","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4QO8"
"4QO9",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL MST3, 1 mM Danusertib, 25 mM TRIS, PH 8.0, 50 MM HEPES pH 7.5, 125 mM SODIUM CHLORIDE, 100 mM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cmdc.201600115","627","4QO9",71.54,"2.2","2.2","MST3 IN COMPLEX WITH Danusertib","GPLGSEFMAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS","Homo sapiens","STK24, MST3, STK3","SERINE/THREONINE-PROTEIN KINASE 24","1","4QO9"
"4QOB",,"X-RAY DIFFRACTION",3.14,60.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"3.6M sodium formate, 0.1M Tris-HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,,"4QOB",22.39,"2.7","2.7","Crystal structure of cPOP1","MGTKREAILKVLENLTPEELKKFKMKLGTVPLREGFERIPRGALGQLDIVDLTDKLVASYYEDYAAELVVAVLRDMRMLEEAARLQRAALEHHHHHH","Homo sapiens","PYDC1, ASC2, ASCI, POP1, PYC1","Pyrin domain-containing protein 1","1","4QOB"
"4QOC",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 
1.9-2.4 M Ammonium Sulfate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.06.073","35T","4QOC",70.5,"1.7","1.7","crystal structure of compound 16 bound to MDM2(17-111), {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-(PYRROLIDIN-1-YLSULFONYL)ETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4QOC"
"4QOD",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES pH7, 1.4M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4QOD",52.64,"1.35","1.35","The value crystal structure of apo quinone reductase 2 at 1.35A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOD"
"4QOE",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 1.4M AmSO4, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4QOE",53.76,"1.45","1.45","The value 'crystal structure of fad quinone reductase 2 at 1.45A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOE"
"4QOF",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES PH7, 1.4M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4QOF",53,"1.55","1.55","Crystal structure of fmn quinone reductase 2 AT 1.55A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOF"
"4QOG",,"X-RAY DIFFRACTION",2.43,49.28,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES PH7, 1.4M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"ML1","4QOG",54.13,"1.4","1.4","Crystal structure of fad quinone reductase 2 in complex with melatonin at 1.4A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOG"
"4QOH",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES PH7, 1.4M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"STL","4QOH",54.21,"1.6","1.6","Crystal structure of fad quinone reductase 2 in complex with resveratrol at 1.6A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOH"
"4QOI",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES PH7, 1.4M AmSO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"ML1","4QOI",53.47,"1.55","1.55","Crystal structure of FMN quinone reductase 2 in complex with melatonin at 1.55A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOI"
"4QOJ",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPEs, 1.4M AmSO4, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"STL","4QOJ",53.46,"1.85","1.85","CRYSTAL STRUCTURE OF FMN QUINONE REDUCTASE 2 IN COMPLEX WITH RESVERATROL AT 1.85A","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4QOJ"
"4QOT",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"12mg/mlATOX-Pt(DACH)(H2O)(SO4), 65% sat Li2SO4, 100mM MES, 60mM NaCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.inorgchem.6b00750",,"4QOT",15.7,"2.2","2.2","Crystal structure of human copper chaperone bound to the platinum ion","MPKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDTLLATLKKTGKTVSYLGLE","Homo sapiens","ATOX1, HAH1","Copper transport protein ATOX1","1","4QOT"
"4QP1",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048",,"4QP1",85.84,"2.7","2.7","Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP1"
"4QP2",,"X-RAY DIFFRACTION",2.78,55.83,,7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048","36R","4QP2",85.49,"2.23","2.23","Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP2"
"4QP3",,"X-RAY DIFFRACTION",2.8,56.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048",,"4QP3",85.79,"2.599","2.599","Crystal Structure of ERK2 in complex with (S)-2-((9H-purin-6-yl)amino)-3-phenylpropan-1-ol","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP3"
"4QP4",,"X-RAY DIFFRACTION",2,38.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048",,"4QP4",85.53,"2.2","2.2","Crystal Structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP4"
"4QP6",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048","36N","4QP6",85.56,"3.1","3.1","Crystal Structure of ERK2 in complex with 5H-pyrrolo[2,3-b]pyrazine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP6"
"4QP7",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048","363","4QP7",85.47,"2.249","2.249","Crystal Structure of ERK2 in complex with 2-(1H-pyrazol-4-yl)-5H-pyrrolo[2,3-b]pyrazine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP7"
"4QP8",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048","362","4QP8",85.62,"2.446","2.446","Crystal Structure of ERK2 in complex with 2-(1H-pyrazol-4-yl)-7-(pyridin-3-yl)-5H-pyrrolo[2,3-b]pyrazine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP8"
"4QP9",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates incubated at 4C, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.08.048","35X","4QP9",42.85,"2.001","2.001","Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QP9"
"4QPA",,"X-RAY DIFFRACTION",2.77,55.54,,,,,"10.1016/j.bmcl.2015.08.048","35W","4QPA",85.96,"2.85","2.85","Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine","MGSHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QPA"
"4QPF",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.5 M sodium chloride, 5 mM magnesium chloride, 15% glycerol, 100 mM sodium acetate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4QPF",43.54,"1.59","1.59","New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4QPF"
"4QPM",,"X-RAY DIFFRACTION",2.29,46.39,,7,"20% PEG3350, 1% Tryptone, 10 mM DTT, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2014.08.020",,"4QPM",83.31,"2.202","2.202","Structure of Bub1 kinase domain","GAMDPEFGRPNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK","Homo sapiens","BUB1, BUB1L","Mitotic checkpoint serine/threonine-protein kinase BUB1","1","4QPM"
"4QPN",,"X-RAY DIFFRACTION",1.67,26.53,"VAPOR DIFFUSION",,"20% PEG-3350, 0.2 M tri-lithium citrate. Protein sample was incubated with SAH overnight. Endopeptidase was added to the protein sample immediately prior to crystallization set up, vapor diffusion, temperature 293K",293,,,"4QPN",25.57,"1.25","1.25","Crystal Structure of Human Methyltransferase-Like Protein 21B","GMADPGPDPESESESVFPREVGLFADSYSEKSQFCFCGHVLTITQNFGSRLGVAARVWDAALSLCNYFESQNVDFRGKKVIELGAGTGIVGILAALQGGDVTITDLPLALEQIQGNVQANVPAGGQAQVRALSWGIDHHVFPANYDLVLGADIVYLEPTFPLLLGTLQHLCRPHGTIYLASKMRKEHGTESFFQHLLPQHFQLELAQRDEDENVNIYRARHREPRPA","Homo sapiens","METTL21B, FAM119B, HCA557A, EEF1AKMT3","Protein-lysine methyltransferase METTL21B","1","4QPN"
"4QPS",,"X-RAY DIFFRACTION",1.93,36.43,"VAPOR DIFFUSION",5.5,"25% PEG-3350, 0.2 M ammonium sulfate and 0.1 M BisTRIS pH 5.5, VAPOR DIFFUSION, temperature 291K",291,"10.1074/jbc.M114.595181",,"4QPS",67.32,"1.8","1.8","Crystal structure of Jak3 complexed to N-[3-(6-Phenylamino-pyrazin-2-yl)-3H-benzoimidazol-5-yl]-acrylamide","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4QPS"
"4QQ5",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 1.0 to 1.2 M (NH4)2SO4, and 10 mM Yttrium (III) Chloride Hexahydrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb500674s",,"4QQ5",36.81,"2.203","2.203","Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Complex With FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVILECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4QQ5"
"4QQ6",,"X-RAY DIFFRACTION",1.7,27.53,"VAPOR DIFFUSION, SITTING DROP",5.6,"2M ammonium sulfate, 0.2M potassium/sodium tartrate, 0.1M sodium citrate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/s41467-022-33229-5",,"4QQ6",7.6,"1.75","1.75","Crystal Structure of tudor domain of SMN1 in complex with a small organic molecule","GKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICE","Homo sapiens","SMN1, SMN, SMNT, SMN2, SMNC","Survival motor neuron protein","1","4QQ6"
"4QQC",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 1.0   1.2 M (NH4)2SO4, 10 mM Yttrium (III) chloride hexahydrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1403438111",,"4QQC",36.89,"2.4","2.4","Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4QQC"
"4QQD",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG-3350, 0.2 M magnesium nitrate, vapor diffusion, sitting drop",,"10.1038/s41467-022-33229-5",,"4QQD",38.21,"2.28","2.28","Crystal Structure of tandem tudor domains of UHRF1 in complex with a small organic molecule","GMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGE","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","4QQD"
"4QQE",,"X-RAY DIFFRACTION",2.02,39.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"37F","4QQE",35.02,"1.8","1.8","Crystal structure of WDR5, WD repeat domain 5 in complex with compound SGC-DS-MT-0345","GTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","BIG3, WDR5","WD repeat-containing protein 5","1","4QQE"
"4QQG",,"X-RAY DIFFRACTION",1.94,36.55,"VAPOR DIFFUSION",,"20% PEG3350, 0.2 M calcium acetate. The protein sample may have been treated with trypsin, VAPOR DIFFUSION, temperature 291K",291,"10.1002/1873-3468.13021",,"4QQG",67.29,"2.8","2.8","Crystal structure of an N-terminal HTATIP fragment","GMAEVGEIIEGCRLPVLRRNQDNEDEWPLAEILSVKDISGRKLFYVHYIDFNKRLDEWVTHERLDLKKIQFPKKEAKTPTK","Homo sapiens","KAT5, HTATIP, TIP60","Histone acetyltransferase KAT5","1","4QQG"
"4QQJ",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris (pH 7.5), 20% (w/v) PEG 1500 and 0.2 M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb500674s",,"4QQJ",36.33,"1.682","1.682","Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutation","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVILECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4QQJ"
"4QQK",,"X-RAY DIFFRACTION",2.92,57.85,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M KSCN, vapor diffusion hanging drop, temperature 291K",291,"10.1042/BCJ20160537",,"4QQK",42.6,"1.88","1.88","Human HMT1 hnRNP methyltransferase-like protein 6 (S. cerevisiae) with GMS","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","4QQK"
"4QQN",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 4000, 0.2 M MgCl2, 0.1 M Tris HCL pH8.5, vapor diffusion hanging drop, temperature 293K",293,"10.1021/acs.jmedchem.7b01674","3BQ","4QQN",38.74,"2.08","2.08","Protein arginine methyltransferase 3 in complex with compound MTV044246","MGSSHHHHHHSSGLVPRGSDLQEDEDGVYFSSYGHYGIHEEMLKDKIRTESYRDFIYQNPHIFKDKVVLDVGCGTGILSMFAAKAGAKKVLGVDQSEILYQAMDIIRLNKLEDTITLIKGKIEEVHLPVEKVDVIISEWMGYFLLFESMLDSVLYAKNKYLAKGGSVYPDICTISLVAVSDVNKHADRIAFWDDVYGFKMSCMKKAVIPEAVVEVLDPKTLISEPCGIKHIDCHTTSISDLEFSSDFTLKITRTSMCTAIAGYFDIYFEKNCHNRVVFSTGPQSTKTHWKQTVFLLEKPFSVKAGEALKGKVTVHKNKKDPRSLTVTLTLNNSTQTYGLQ","Homo sapiens","PRMT3, HRMT1L3","PRMT3 protein","1","4QQN"
"4QQT",,"X-RAY DIFFRACTION",2.17,43.33,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES, 20% (w/v) PEG 4000, 0.2 M Li2SO4 and 0.01 M Taurine, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb500674s",,"4QQT",36.32,"1.501","1.501","Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4QQT"
"4QR3",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm501504k","BNJ","4QR3",15.17,"1.374","1.374","Brd4 Bromodomain 1 complex with its novel inhibitors","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4QR3"
"4QR4",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm501504k","BNK","4QR4",15.2,"1.28","1.28","Brd4 Bromodomain 1 complex with its novel inhibitors","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4QR4"
"4QR5",,"X-RAY DIFFRACTION",2,38.51,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm501504k","BNM","4QR5",15.25,"1.41","1.41","Brd4 Bromodomain 1 complex with its novel inhibitors","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4QR5"
"4QR6",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml.Afterwards the crystals were soaked into Tris 100 mM 25% (m/V) PEG6000 pH 8.0 saturated with the inhibitor.The well solution was for crystallization was 120mM di-Ammonium hydrogen citrate with 20% PEG6000 pH 5.0., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"37V","4QR6",37,"1.05","1.05","Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4QR6"
"4QRC",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES (pH 5.5), 25% (w/v) PEG 4000, 0.15 M (NH4)2SO4 and 4% (v/v) Formamide, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb500674s","0LI","4QRC",37.04,"1.901","1.901","Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinib","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4QRC"
"4QRF",,"X-RAY DIFFRACTION",1.69,27.15,"VAPOR DIFFUSION, HANGING DROP",7,"10-30% PEG400, 0.1M HEPES, 0.2M CaCl2, 1mM caffeic acid phenethyl ester, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm500997m","QAP","4QRF",35.25,"1.8","1.8","Crystal structure of V30M mutant human transthyretin complexed with caffeic acid phenethyl ester","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4QRF"
"4QSA",,"X-RAY DIFFRACTION",2,38,"VAPOR DIFFUSION, SITTING DROP",7,"2M sodium malonate pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0114106","EWW","4QSA",30.11,"1.501","1.501","Crystal structure of human carbonic anhydrase isozyme II with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QSA"
"4QSB",,"X-RAY DIFFRACTION",2.05,39.99,"VAPOR DIFFUSION, SITTING DROP",7,"2.2M sodium malonate pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0114106","EWY","4QSB",30.05,"1.4","1.4","Crystal structure of human carbonic anhydrase isozyme II with 3-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QSB"
"4QSI",,"X-RAY DIFFRACTION",2.04,39.73,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE, pH 9, 3.1M sodium malonate pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0114106","EWZ","4QSI",30.07,"1.95","1.95","Crystal structure of human carbonic anhydrase isozyme II with 5-{[(4-tert-buthyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}-2-chlorobenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QSI"
"4QSJ",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate (pH 5.5), 0.2M sodium acetate (pH 4.5), 28% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0114106","EWW","4QSJ",60.96,"1.7","1.7","Crystal structure of human carbonic anhydrase isozyme XIII with 2-chloro-4-{[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}benzenesulfonamide","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","4QSJ"
"4QSM",,"X-RAY DIFFRACTION",3.5,64.84,"VAPOR DIFFUSION",7,"50 mM LiCl, PEG400 41 % w/v, 100 mM  Bis-tris propane, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S1399004714024791","38K","4QSM",303.31,"3","3","Crystal structure of human muscle L-lactate dehydrogenase in complex with inhibitor 2, 3-{[7-(2,4-dimethoxypyrimidin-5-yl)-3-sulfamoylquinolin-4-yl]amino}benzoic acid","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4QSM"
"4QSP",,"X-RAY DIFFRACTION",4.12,70.12,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSP",16.39,"1.6","1.6","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with acetyl-lysine","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSP"
"4QSQ",,"X-RAY DIFFRACTION",4.05,69.65,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSQ",16.45,"1.8","1.8","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) with bound DMSO","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSQ"
"4QSR",,"X-RAY DIFFRACTION",4.12,70.16,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 45-50% MPD, 0.1 M bis-tris pH 5.5, 0.1 M ammonium phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSR",16.09,"2","2","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) with bound MPD","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSR"
"4QSS",,"X-RAY DIFFRACTION",4.11,70.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 45-50% MPD, 0.1 M bis-tris pH 5.5, 0.1 M ammonium phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSS",16.19,"2","2","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with N-Methyl-2-pyrrolidone (NMP)","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSS"
"4QST",,"X-RAY DIFFRACTION",4.07,69.76,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,"12Q","4QST",16.74,"2.05","2.05","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with 1-methylquinolin 2-one","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QST"
"4QSU",,"X-RAY DIFFRACTION",4.04,69.52,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSU",16.21,"1.9","1.9","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with thymine","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSU"
"4QSV",,"X-RAY DIFFRACTION",4.15,70.38,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSV",16.29,"1.9","1.9","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with thymidine","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSV"
"4QSW",,"X-RAY DIFFRACTION",4.09,69.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSW",16.12,"1.8","1.8","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with 5-methyl uridine","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSW"
"4QSX",,"X-RAY DIFFRACTION",4.01,69.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"apo crystals grew in 1.8-2.2 M ammonium sulphate, 0.1 M Bis-Tris, pH 5.5-6.5. Soaking performed in 28-32% PEG 3350, 50 mM bis-tris pH 5.5, 50 mM ammonium phosphate and 20% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"4QSX",16.09,"1.93","1.93","Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in complex with 3'-deoxy thymidine","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4QSX"
"4QT0",,"X-RAY DIFFRACTION",3.49,64.8,,7.5,"100 mM Bis-tris propane pH 7.0, 20 % PEG 400, and 100 mM LiCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1399004714024791",,"4QT0",303.02,"3.2","3.2","Crystal structure of human muscle L-lactate dehydrogenase in complex with inhibitor 1, 3-{[3-CARBAMOYL-7-(2,4-DIMETHOXYPYRIMIDIN-5-YL)QUINOLIN-4-YL]AMINO}BENZOIC ACID","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFHHHHHH","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4QT0"
"4QT1",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG 3350, 0.1M MES, 0.2M MgCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.09.031","3C9","4QT1",35.99,"2.4","2.4","JAK3 kinase domain in complex with 1-[(3S)-1-isobutylsulfonyl-3-piperidyl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)urea","CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4QT1"
"4QT6",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, SITTING DROP",,"0.5 uL protein (mixed 1:700 w/w chymotrypsin:protein before setup) + 0.5 uL well solution (16% w/v PEG 8000, 0.04 M potassium phosphate monobasic, 20% v/v glycerol) + 0.1 uL 40% formamide (4% final concentration), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4QT6",18.31,"1.64","1.64","Crystal structure of the SPRY domain of human HERC1","GFDPEKAQCCLVENGQILTHGSGGKGYGLASTGVTSGCYQWKFYIVKENRGNEGTCVGVSRWPVHDFNHRTTSDMWLYRAYSGNLYHNGEQTLTLSSFTQGDFITCVLDMEARTISFGKNGEEPKLAFEDVDAAELYPCVMFYSSNPGEKVKICDMQMR","Homo sapiens","HERC1","Probable E3 ubiquitin-protein ligase HERC1","1","4QT6"
"4QTA",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG4000 and 0.2 M ammonium sulphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1038/nchembio.1629","38Z","4QTA",42.81,"1.45","1.45","Structure of human ERK2 in complex with SCH772984 revealing a novel inhibitor-induced binding pocket","SMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QTA"
"4QTB",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.1 M Tris pH 8.0 and 0.2 M lithium sulphate, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1038/nchembio.1629","38Z","4QTB",89.5,"1.4","1.4","Structure of human ERK1 in complex with SCH772984 revealing a novel inhibitor-induced binding pocket","SMAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP","Homo sapiens","ERK1, MAPK3, PRKM3","Mitogen-activated protein kinase 3","1","4QTB"
"4QTC",,"X-RAY DIFFRACTION",3.06,59.86,"VAPOR DIFFUSION, SITTING DROP",6,"51% MPD and 0.1 M SPG pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1038/nchembio.1629","38Z","4QTC",41.6,"1.4","1.4","Structure of human haspin (GSG2) in complex with SCH772984 revealing the first type-I binding mode","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","GSG2, HASPIN","Serine/threonine-protein kinase haspin","1","4QTC"
"4QTD",,"X-RAY DIFFRACTION",2.34,47.53,"VAPOR DIFFUSION, SITTING DROP",,"12-15% PEG3350 and 0.1 M HEPES pH 6.8-7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1038/nchembio.1629","38Z","4QTD",44.78,"1.5","1.5","Structure of human JNK1 in complex with SCH772984 and the AMPPNP-hydrolysed triphosphate revealing the second type-I binding mode","SMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL","Homo sapiens","JNK1, MAPK8, PRKM8, SAPK1, SAPK1C","Mitogen-activated protein kinase 8","1","4QTD"
"4QTE",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG smears (PEG2000, PEG3350, PEG4000 and PEG5000MME), 0.1 M cacodylate pH 5.5 and 0.2 M ammonium sulphate, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1038/nchembio.1629","390","4QTE",43.95,"1.5","1.5","Structure of ERK2 in complex with VTX-11e, 4-{2-[(2-CHLORO-4-FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE","SMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4QTE"
"4QTL",,"X-RAY DIFFRACTION",1.99,37.8,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium BICINE (pH 9), 0.2M ammonium sulfate, 2M sodium malonate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cmdc.201402490","WWO","4QTL",30.05,"1.8","1.8","Crystal structure of human carbonic anhydrase isozyme II with inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QTL"
"4QTX",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4   L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10%     16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QTX",32.28,"1.974","1.974","Caspase-3 Y195A","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QTX"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QTX"
"4QTY",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QTY",29.21,"1.602","1.602","Caspase-3 E190A","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVAADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QTY"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QTY"
"4QU0",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4   L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10%     16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QU0",32.31,"1.954","1.954","Caspase-3 Y195AV266H","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLAAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QU0"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QU0"
"4QU1",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, pH 7.0, 8% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"4QU1",27.62,"1.57","1.57","Crystal structure of human JMJD5 jmj-c domain","GSTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","Lysine-specific demethylase 8","1","4QU1"
"4QU5",,"X-RAY DIFFRACTION",2.16,42.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QU5",32.3,"1.908","1.908","Caspase-3 T140V","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKIVNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHL","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QU5"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QU5"
"4QU8",,"X-RAY DIFFRACTION",2.12,41.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4   L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10%     16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QU8",32.49,"1.715","1.715","Caspase-3 M61A V266H","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGATSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QU8"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QU8"
"4QU9",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QU9",32.61,"1.561","1.561","Caspase-3 F128A","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIAGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHLH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QU9"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QU9"
"4QUA",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUA",32.28,"1.892","1.892","Caspase-3 Y195F","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLFAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHL","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUA"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUA"
"4QUB",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUB",32.62,"1.689","1.689","Caspase-3 K137A","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLAKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUB"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUB"
"4QUD",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4uL drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUD",64.47,"1.995","1.995","Caspase-3 T140F","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKIFNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUD"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUD"
"4QUE",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 uL drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUE",65.85,"1.843","1.843","Caspase-3 Y195FV266H","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLFAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUE"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUE"
,,,,,,,,,,,,,,,,"VDDDM",,,"SHORT PEPTIDE","3","4QUE"
"4QUG",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291 K  by the hanging drop vapor diffusion method using 4 uL drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants. , VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUG",64.47,"1.917","1.917","Caspase-3 M61A","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGATSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUG"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUG"
"4QUH",,"X-RAY DIFFRACTION",2.27,45.72,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291 by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUH",65.36,"1.759","1.759","Caspase-3 T140G","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKIGNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUH"
,,,,,,,,,,,,,,,,"GVDDD",,,"short peptde","2","4QUH"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","3","4QUH"
"4QUI",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 18 oC by the hanging drop vapor diffusion method using 4 uL drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi500874k",,"4QUI",64.91,"1.758","1.758","Caspase-3 F128AV266H","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIAGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYHL","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUI"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUI"
"4QUJ",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 L drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUJ",32.55,"1.498","1.498","Caspase-3 T140GV266H","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKIGNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIHSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUJ"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUJ"
"4QUL",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"Proteins were dialyzed in a buffer of 10 mM Tris-HCl, pH 8.5, 1 mM DTT and concentrated to 10 mg/mL. Inhibitor, Ac-DEVD-CMK reconstituted in DMSO, was then added at a 5:1 inhibitor:peptide ratio (w/w). The protein was diluted to a concentration of 8 mg/mL by adding 10 mM Tris-HCl, pH 8.5, concentrated DTT, and concentrated NaN3 so that the final buffer consisted of 10 mM Tris-HCl, pH 8.5, 10 mM DTT, and 3 mM NaN3. Crystals were obtained at 291K by the hanging drop vapor diffusion method using 4 uL drops that contained equal volumes of protein and reservoir solutions over a 0.5 mL reservoir. The reservoir solutions for optimal crystal growth consisted of 100 mM sodium citrate, pH 5.0, 3 mM NaN3, 10 mM DTT, and 10% 16% PEG 6000 (w/v). Crystals appeared within 3.5 to 6 weeks for all mutants, VAPOR DIFFUSION, HANGING DROP",291,"10.1021/bi500874k",,"4QUL",64.8,"1.898","1.898","Caspase-3 F55W","MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNWHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHL","Homo sapiens","CASP3, CPP32","Caspase-3","1","4QUL"
,,,,,,,,,,,,,,,,"XDEVDX",,,"ACE-ASP-GLU-VAL-ASP-CHLOROMETHYLKETONE INHIBITOR","2","4QUL"
"4QUN",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Hepes, 12% PEG 8000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/scisignal.2005722",,"4QUN",70.15,"1.86","1.86","Crystal structure of the PTPN3 (PTPH1) catalytic domain C842S mutant","MHHHHHHSSGVDLGTENLYFQSNADTLEGSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNLDKNRYKDVLPYDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQVVWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTIAYVSREMLVTNTQTGEEHTVTHLQYVAWPDHGVPDDSSDFLEFVNYVRSLRVDSEPVLVHSSAGIGRTGVLVTMETAMCLTERNLPIYPLDIVRKMRDQRAMMVQTSSQYKFVCEAILRVYEEGLVQM","Homo sapiens","PTPH1, PTPN3","Tyrosine-protein phosphatase non-receptor type 3","1","4QUN"
"4QVX",,"X-RAY DIFFRACTION",1.86,33.94,"VAPOR DIFFUSION, SITTING DROP",8,"10.73 uM compound in DMSO + 2.14 uM protein in 25 mM Tris, 0.1 M sodium chloride, 10% v/v glycerol, 1 mM DTT, pH 8.0 incubated overnight at 277K then concentrated to 12 mg/mL, 1:1 protein solution:reservoir solution (3 M sodium chloride, 0.1 M citric acid, pH 3.5) used in drop, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1021/ml5001867","3CQ","4QVX",38.72,"2.1","2.1","Discovery of a Potent and Selective BCL-XL Inhibitor That Demonstrates Thrombocytopenia and Inhibits Tumor Growth in Vivo","MSQSNRELVVDFLSYKLSQKGYSASGGGGGGGMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKKMQVLVSRIAAWMATYLNDHLEPWIQENGGWATFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","4QVX"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"4QVZ",,"X-RAY DIFFRACTION",2.38,48.21,"VAPOR DIFFUSION, SITTING DROP",7,"27% w/v PEG3350, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1093/hmg/ddu586",,"4QVZ",49.95,"3.195","3.195","FMRP N-terminal domain","HMEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLRQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIMRNEEASKQLESSR","Homo sapiens","FMR1","Fragile X mental retardation protein 1","1","4QVZ"
"4QW2",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"25-30% PEG5000 MME, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, 5 mM CH3Pb, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1093/hmg/ddu586",,"4QW2",50.03,"2.989","2.989","FMRP N-terminal domain (R138Q)","HMEELVVEVRGSNGAFYKAFVKDVHEDSITVAFENNWQPDRQIPFHDVRFPPPVGYNKDINESDEVEVYSRANEKEPCCWWLAKVRMIKGEFYVIEYAACDATYNEIVTIERLRSVNPNKPATKDTFHKIKLDVPEDLQQMCAKEAAHKDFKKAVGAFSVTYDPENYQLVILSINEVTSKRAHMLIDMHFRSLRTKLSLIMRNEEASKQLESSR","Homo sapiens","FMR1","Fragile X mental retardation protein 1","1","4QW2"
"4QX4",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",8,"50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+= 0.66 g/L and Human Aldose Reductase= 15 mg/ml. Afterwards the crystals were soaked into Tris 100 mM 25% (m/V) PEG6000 pH 8.0 saturated with the inhibitor. The well solution for crystallization was 120mM di-Ammonium hydrogen citrate with 20% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm5015814","3E2","4QX4",37.16,"1.259","1.259","Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4QX4"
"4QX5",,"X-RAY DIFFRACTION",1.79,31.31,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, 100mM sodium iodide, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi501012v",,"4QX5",19.56,"1.318","1.318","Neutron diffraction reveals hydrogen bonds critical for cGMP-selective activation: Insights for PKG agonist design","GSTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGTVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGEDVRTANVIAAEAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFAN","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","4QX5"
"4QXG",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM potassium di-hydrogen phosphate, 100 mM MES, pH 6.5 and 20% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1080/19420862.2015.1007810",,"4QXG",47.24,"2.3","2.3","Antigen binding fragment of an anti IFNAR1 antibody","EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"Fab, heavy chain, IgG1","1","4QXG"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab, light chain, IgG1","2","4QXG"
"4QXI",,"X-RAY DIFFRACTION",2.16,43.17,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/acschembio.5b00151","I98","4QXI",36.99,"0.867","0.867","Crystal structure of human AR complexed with NADP+ and AK198","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4QXI"
"4QXK",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",1.84,33.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.4 M Na3Citrate, pH 6.5 and 0.2 M NaI solutions, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi501012v",,"4QXK",17.31,"2.2","2.2","Joint X-ray/neutron structure of PKGIbeta in complex with cGMP","GSTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGTVNVTREDSPSEDPVFLRTLGKGDWFGEKALQGEDVRTANVIAAEAVTCLVIDRDSFKHLIGGLDDVSNKAYEDAEAKAKYEAEAAFFAN","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","4QXK"
"4QXO",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, SITTING DROP",7.8,"2 M LiCl, 10% PEG6000, 0.01 M CaCl2, 0.1 M Tris, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.celrep.2014.08.010","1YE","4QXO",21.93,"1.88","1.88","Crystal structure of hSTING(group2) in complex with DMXAA","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFRDMLPQQNIDRAGIKNRVYSNSVYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4QXO"
"4QXP",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, SITTING DROP",8.1,"0.2 M Li2SO4, 20% PEG 3350, 0.015 mM CYMAL-7, 0.1 M Tris, pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.celrep.2014.08.010",,"4QXP",43.76,"2.51","2.51","Crystal structure of hSTING(G230I) in complex with DMXAA","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTIDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4QXP"
"4QXQ",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.2 M Ca(Ac)2, 15% PEG3000, 0.01 M L-Proline, 0.1 M NaAc, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.celrep.2014.08.010","1YE","4QXQ",43.69,"2.42","2.42","Crystal structure of hSTING(S162A/Q266I) in complex with DMXAA","SVAHGLAWAYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLITLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4QXQ"
"4QXR",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.2 M Ca(Ac)2, 15% PEG3000, 0.1 M LiCl, 0.1 M NaAc, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.celrep.2014.08.010","1YE","4QXR",43.8,"2.37","2.37","Crystal structure of hSTING(S162A/G230I/Q266I) in complex with DMXAA","SVAHGLAWAYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTIDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLITLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","4QXR"
"4QXS",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6 M ammonium phosphate, 20% glycerol, 0.08 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bmcl.2014.12.089","WC1","4QXS",43.88,"1.9","1.9","Crystal structure of human FPPS in complex with WC01088","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4QXS"
"4QXV",,"X-RAY DIFFRACTION",2.13,42.24,,5.5,"WT-TTR CONCENTRATION WAS 5 MG/ML IN 10 MM SODIUMPHOSPHATE PH 7.6, 100 MM POTASSIUMCLORIDE. WT-TTR WAS CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH 5 MOLAR EXCESS OF LUTEOLIN IN 3.5% V/V GLYCEROL AND 1.3-1.6 M SODIUM CITRATE AT PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1371/journal.pone.0128222","LU2","4QXV",28.43,"1.12","1.12","CRYSTAL STRUCTURE of HUMAN TRANSTHYRETIN IN COMPLEX WITH LUTEOLIN AT 1.1 A RESOLUTION","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR, TTR PALB","Transthyretin","1","4QXV"
"4QXW",,"X-RAY DIFFRACTION",3.72,66.9,"VAPOR DIFFUSION, SITTING DROP",8,"50 mM TrisHCL buffer 7.5, 60% Tascimate 8.0, 1% Beta-octyl glucoside, 12% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nature13848",,"4QXW",24.49,"2.04","2.04","Crystal structure of the human CEACAM1 membrane distal amino terminal (N)-domain","QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","4QXW"
"4QXX",,"X-RAY DIFFRACTION",1.46,15.94,"VAPOR DIFFUSION, HANGING DROP",4.2,"2 M ammonium sulfate, 0.1 M phosphate/citrate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.molcel.2015.01.026",,"4QXX",0.49,"1.445","1.445","Structure of the amyloid forming peptide GNLVS (residues 26-30) from the eosinophil major basic protein (EMBP)","GNLVS","Homo sapiens","PRG2, MBP","Bone marrow proteoglycan","1","4QXX"
"4QY3",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5 M (NH4)2SO4, 0.3 M NaCl, 100 mM Tris-HCl (pH 8.2), VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1039/c4cc07320g","3G1","4QY3",29.82,"1.5","1.5","THE CRYSTAL STRUCTURE OF THE COMPLEX of HCAII WITH AN ORTHO-SUBSTITUTED BENZOIC ACID","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4QY3"
"4QY4",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"15% PEG 6K, 8% ethylene glycol, 0.01M ZnCl2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"4QY4",43.34,"1.97","1.97","Crystal structure of the bromodomain of human SMARCA2","SMAEKLSPNPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLGDLEKDVMLLCHNAQTFNLEGSQIYEDSIVLQSVFKSARQKIAKEEE","Homo sapiens","SMARCA2, BAF190B, BRM, SNF2A, SNF2L2","SMARCA2 protein","1","4QY4"
"4QYA",,"X-RAY DIFFRACTION",2.12,42.06,"VAPOR DIFFUSION, HANGING DROP",5.5,"V30M-TTR CONCENTRATION WAS 5 MG/ML IN 10 MM SODIUMPHOSPHATE, PH 7.6, 100 MM POTASSIUMCLORIDE. V30M-TTR WAS CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH 5 MOLAR EXCESS OF LUTEOLIN IN 3.5% V/V GLYCEROL AND 1.3-1.6 M SODIUM CITRATE AT PH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0128222","LU2","4QYA",28.21,"1.7","1.7","Crystal structure of human transthyretin variant V30M in complex with luteolin","GPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4QYA"
"4QYE",,"X-RAY DIFFRACTION",2.49,50.55,"VAPOR DIFFUSION, SITTING DROP",7.4,"15% isopropanol, 12% PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2014.10.063","3DL","4QYE",34.5,"2.05","2.05","CHK1 kinase domain in complex with diarylpyrazine compound 1","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4QYE"
"4QYF",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, SITTING DROP",7.4,"15% isopropanol, 12% PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2014.10.063",,"4QYF",34.51,"2.15","2.15","CHK1 kinase domain in complex with aminopyrazine compound 13","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4QYF"
"4QYG",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, SITTING DROP",7.4,"15% isopropanol, 12% PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2014.10.063","3DW","4QYG",69.19,"1.75","1.75","CHK1 kinase domain in complex with diazacarbazole compound 14","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4QYG"
"4QYH",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION, SITTING DROP",7.4,"15% isopropanol, 12% PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2014.10.063","3DX","4QYH",69.15,"1.9","1.9","CHK1 kinase domain in complex with diazacarbazole GNE-783","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4QYH"
"4QYN",,"X-RAY DIFFRACTION",2.24,45.1,"EVAPORATION",4.6,"30% PEG 4000, 0.1 M sodium acetate, 0.1 M ammonium acetate , pH 4.6, EVAPORATION, temperature 298K",298,"10.1107/S1399004714023839","RTL","4QYN",31.83,"1.19","1.19","The Crystal Structures of holo-wt human Cellular Retinol Binding protein II (hCRBPII) bound to Retinol","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4QYN"
"4QYP",,"X-RAY DIFFRACTION",1.99,38.33,"EVAPORATION",4.6,"30% PEG 4000, 0.1 M sodium acetate, 0.1 M ammonium acetate , pH 4.6, EVAPORATION, temperature 298K",298,"10.1107/S1399004714023839",,"4QYP",63.54,"1.62","1.62","The Crystal Structures of holo-wt human Cellular Retinol Binding protein II (hCRBPII) bound to Retinal","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4QYP"
"4QZS",,"X-RAY DIFFRACTION",2.13,42.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES pH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM HEPES PH7.5, 0.1M AMMONIUM ACETATE 12.5% PEG 3,350, 10% DMSO, 1 MM JQ1, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb5007344","JQ1","4QZS",15.84,"1.45","1.45","Crystal structure of the first bromodomain of human 3-fluoro tyrosine-labeled brd4 in complex with jq1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4QZS"
"4QZT",,"X-RAY DIFFRACTION",1.96,37.17,,4.5,"25% PEG 4000 (40%), 0.1M Sodium Acetate pH 4.5, Ammonium Acetate 0.1M, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004714023839","RTL","4QZT",63.14,"1.9","1.9","Crystal Structure of wild type Human Cellular Retinol Binding Protein II (hCRBPII) bound to retinol at 7 KeV beam energy","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4QZT"
"4QZU",,"X-RAY DIFFRACTION",1.96,37.17,,4.5,"25% PEG 4000 (40%), 0.1M Sodium Acetate pH 4.5, Ammonium Acetate 0.1M, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004714023839","RTL","4QZU",63.7,"1.5","1.5","Crystal Structure of wild type Human Cellular Retinol Binding Protein II (hCRBPII) bound to retinol at 11 KeV beam energy","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4QZU"
"4R06",,"X-RAY DIFFRACTION",2.7,54.43,"VAPOR DIFFUSION, HANGING DROP",8,"Protein ligand complex at 10mg/mL in 20mM Tris 8.0, 10mM NaCl, 1mM TCEP mixed with equal volume of well solution of 2M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/acschembio.5b00580","3E7","4R06",62.98,"2.22","2.22","Crystal Structure of SR2067 bound to PPARgamma","NPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","NR1C3, PPARG, PPARG_HUMAN","Peroxisome proliferator-activated receptor gamma","1","4R06"
"4R07",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, SITTING DROP",5.2,"12-14% (w/v) PEG 3350, 0.2-0.3M potassium formate, 0.1M sodium citrate pH 5.2, VAPOR DIFFUSION, SITTING DROP",,"10.1038/nsmb.2943","URI, UCG","4R07",386.1,"2","2","Crystal structure of human TLR8 in complex with ORN06","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4R07"
"4R08",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, SITTING DROP",5.2,"12-14% (w/v) PEG 3350, 0.2-0.3M potassium formate, 0.1M sodium citrate pH 5.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2943","URI","4R08",385.62,"2.4","2.4","Crystal structure of human TLR8 in complex with ssRNA40","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4R08"
"4R09",,"X-RAY DIFFRACTION",2.81,56.15,"VAPOR DIFFUSION, SITTING DROP",5,"12-14% (w/v) PEG 3350, 0.2-0.3M potassium formate, 0.1M sodium citrate pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2943",,"4R09",383.59,"2.62","2.62","Crystal structure of human TLR8 in complex with ORN06S","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4R09"
"4R0A",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, SITTING DROP",4.8,"12-14% (w/v) PEG 3350, 0.2-0.3M potassium formate, 0.1M sodium citrate pH 4.8 
, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2943","URI","4R0A",96.55,"1.9","1.9","Crystal structure of human TLR8 in complex with uridine mononucleoside","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4R0A"
"4R0B",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, SITTING DROP",,"25 %(w/v) PEG4000, 170 mM ammonium sulfate, 15 %(v/v) glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1042/BJ20141003",,"4R0B",19.66,"2.45","2.45","Structure of dimeric human glycodelin","DIPQTKQDLELPKLAGTWHSMAMATNEISLMATLKAPLRVHITSLLPTPEDNLEIVLHRWENNSCVEKKVLGEKTENPKKFKINYTVANEATLLDTDYDNFLFLCLQDTTTPIQSMMCQYLARVLVEDDEIMQGFIRAFRPLPRHLWYLLDLKQMEEPCRGSAHHHHHH","Homo sapiens","PAEP","Glycodelin","1","4R0B"
"4R0I",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris pH 8.3 0.2M MgCl2, 20% PEG8000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.12.008","3KM","4R0I",27.44,"1.9","1.9","CRYSTAL STRUCTURE of MATRIPTASE in COMPLEX WITH INHIBITOR","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","4R0I"
,,,,,,,,,,,,,,,,"CGLR","Homo sapiens","ST14, PRSS14, SNC19, TADG15","SERINE PROTEASE, MATRIPTASE, MEMBRANE-TYPE SERINE PROTEASE 1, MT-SP1","2","4R0I"
"4R0P",,"X-RAY DIFFRACTION",1.42,13.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"reservoir contained  0.1M Bis-Tris pH 6.5, 3.0M Sodium Chloride, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/ja509648u",,"4R0P",0.72,"1.52","1.52","Ifqins, an amyloid forming segment from human lysozyme spanning residues 56-61","IFQINS","Homo sapiens","LYZ, LZM","Lysozyme C","1","4R0P"
"4R0U",,"X-RAY DIFFRACTION",1.52,19.34,"VAPOR DIFFUSION, HANGING DROP",,"0.2M magnesium formate, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/ja509648u",,"4R0U",0.62,"1.38","1.38","Tgvtava, an amyloid forming segment from alpha synuclein, residues 72-78","TGVTAVA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","4R0U"
"4R0W",,"X-RAY DIFFRACTION",1.4,12.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"isopropanol, sodium cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/ja509648u",,"4R0W",0.65,"1.5","1.5","Vvtgvta, an amyloid forming segment from alpha synuclein, residues 70-76","VVTGVTA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","4R0W"
"4R0X",,"X-RAY DIFFRACTION",2.07,40.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"26% PEG 3350, 0.1 M HEPES, pH 7.5, 0.2 M ammonium acetate, 5% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M115.650655",,"4R0X",13.49,"1.2","1.2","Allosteric coupling of conformational transitions in the FK1 domain of FKBP51 near the site of steroid receptor interaction","MEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPGIPSNATLFFEIELLDFKGE","Homo sapiens","AIG6, FKBP5, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4R0X"
"4R14",,"X-RAY DIFFRACTION",2.68,54.06,"VAPOR DIFFUSION, HANGING DROP",7.7,"0.1M Tris pH 7.7, 26% (w/v) PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bbrc.2014.09.046",,"4R14",43.07,"2.601","2.601","Crystal structure of human CSN6 MPN domain","SVSVALHPLVILNISDHWIRMRSQEGRPVQVIGALIGKQEGRNIEVMNSFELLSHTVEEKIIIDKEYYYTKEEQFKQVFKELEFLGWYTTGGPPDPSDIHVHKQVCEIIESPLFLKLNPMTKHTDLPVSVFESVIDIINGEATMLFAELTYTLATEEAERIGVDHVARMTATGLEHHHHHH","Homo sapiens","COPS6, CSN6, HVIP","COP9 signalosome complex subunit 6","1","4R14"
"4R1F",,"X-RAY DIFFRACTION",2.61,52.85,,,,,"10.1371/journal.pone.0107289",,"4R1F",184.83,"2.51","2.51","Re-refined Human DNA topoisomerase IIa (ATPase and transducer domains) in complex with ADP and SO4","SVERIYQKKTQLEHILLRPDTYIGSVELVTQQMWVYDEDVGINYREVTFVPGLYKIFDEILVNAADNKQRDPKMSCIRVTIDPENNLISIWNNGKGIPVVEHKVEKMYVPALIFGQLLTSSNYDDDEKKVTGGRNGYGAKLCNIFSTKFTVETASREYKKMFKQTWMDNMGRAGEMELKPFNGEDYTCITFQPDLSKFKMQSLDKDIVALMVRRAYDIAGSTKDVKVFLNGNKLPVKGFRSYVDMYLKDKLDETGNSLKVIHEQVNHRWEVCLTMSEKGFQQISFVNSIATSKGGRHVDYVADQIVTKLVDVVKKKNKGGVAVKAHQVKNHMWIFVNALIENPTFDSQTKENMTLQPKSFGSTCQLSEKFIKAAIGCGIVESILNWVKFKAQVQLNKKCS","Homo sapiens","TOP2, TOP2A","DNA topoisomerase 2-alpha","1","4R1F"
"4R1V",,"X-RAY DIFFRACTION",2.12,41.95,,6.5,"PEG 8000, pH 6.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2015.02.002","3E8","4R1V",33.74,"1.2","1.2","Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors","LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4R1V"
"4R1Y",,"X-RAY DIFFRACTION",2.1,41.37,"VAPOR DIFFUSION",6.5,"PEG8000, pH 6.5, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2015.02.002","3EH","4R1Y",34.18,"2","2","Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitor","LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4R1Y"
"4R2U",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, HANGING DROP",8,"1uL protein-ligand complex solution (10mg/mL) was mixed with 1uL well solution (2M ammonium sulfate and 0.1M Tris 8.0), VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/ncomms8443","3JX","4R2U",63.99,"2.3","2.3","Crystal Structure of PPARgamma in complex with SR1664","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","NR1C3, PPARG","Peroxisome proliferator-activated receptor gamma","1","4R2U"
"4R2Y",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"16% PEG3350, 0.2 M NaNO3, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2014.09.009",,"4R2Y",32.41,"1.755","1.755","Crystal structure of APC11 RING domain","VANDENCGICRMAFNGCCPDCKVPGDDCPLVWGQCSHCFHMHCILKWLHAQQVQQHCPMCRQEWKFKE","Homo sapiens","ANAPC11, HSPC214","Anaphase-promoting complex subunit 11","1","4R2Y"
"4R30",,"X-RAY DIFFRACTION",3.68,66.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.10 M lithium sulfate, 0.05 M sodium cacodylate trihydrate, 0.1 M NaCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M114.627406",,"4R30",85.31,"2.3","2.3","Structure of human laforin dual specificity phosphatase domain","NIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHSNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL","Homo sapiens","EPM2A","Laforin","1","4R30"
"4R3C",,"X-RAY DIFFRACTION",2.17,43.25,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.075M Ammonium Acetate, 0.1M BisTris (pH 5.5), 16% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acschemneuro.5b00002","GG5","4R3C",45.07,"2.06","2.06","Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate","MHHHHHHSSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","4R3C"
"4R3E",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M magnesium formate 
15% PEG 3,350, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 291.15K",291.15,"10.1107/S1399004714021695",,"4R3E",20.41,"2","2","Structure of the spliceosomal peptidyl-prolyl cis-trans isomerase Cwc27 from Homo sapiens","GAMSNIYIQEPPTNGKVLLKTTAGDIDIELWSKEAPKACRNFIQLCLEAYYDNTIFHRVVPGFIVQGGDPTGTGSGGESIYGAPFKDEFHSRLRFNRRGLVAMANAGSHDNGSQFFFTLGRADELNNKHTIFGKVTGDTVYNMLRLSEVDIDDDERPHNPHKIKSCEVLFNPFDDIIPRE","Homo sapiens","CWC27, SDCCAG10, UNQ438/PRO871","Peptidyl-prolyl cis-trans isomerase CWC27 homolog","1","4R3E"
"4R3H",,"X-RAY DIFFRACTION",2.3,45.7,"VAPOR DIFFUSION",6.5,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5, vapor diffusion, temperature 293K",293,"10.1038/nchembio.1654",,"4R3H",37.74,"1.9","1.9","The crystal structure of an apo RNA binding protein","GTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","4R3H"
"4R3M",,"X-RAY DIFFRACTION",3.22,61.76,,,,,"10.1039/c4ob01865f",,"4R3M",23.84,"1.8","1.8","Crystal structure of Human Hsp90 with JR9","EVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4R3M"
"4R4B",,"X-RAY DIFFRACTION",3.17,61.18,,4.5,"100 MM NAOAC PH 4.5, 0-2 % V/V ISOPROPANOL, 2 M LI2SO4, 100 MM MGSO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",,"10.1128/JVI.02194-14",,"4R4B",190.81,"2.199","2.199","Crystal structure of the anti-hiv-1 antibody 2.2c","DIQMTQSPSFVSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLVIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLIGLRSFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR","Homo sapiens",,"FAB 2.2C LIGHT CHAIN","1","4R4B"
,,,,,,,,,,,,,,,,"QVQLQQWGAGLLKPSETLSLTCGVYGESLSGHYWSWVRQPPGKRLEWIGEIKHNGSPNYHPSLKSRVTISLDMSKNQFSLNLTSVTAADTAVYFCARRSNWPYLPFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"FAB 2.2C HEAVY CHAIN","2","4R4B"
"4R4C",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/ml5003629","3HS","4R4C",14.11,"1.4","1.4","Structure of RPA70N in complex with 5-(4-((4-(5-carboxyfuran-2-yl)-2-chlorobenzamido)methyl)phenyl)-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4R4C"
"4R4I",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 MM MES, 200 MM CALCIUM ACETATE, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/ml5003629","3HV","4R4I",14.12,"1.4","1.4","Structure of RPA70N in complex with 5-(4-((6-(5-carboxyfuran-2-yl)-1-thioxo-3,4-dihydroisoquinolin-2(1H)-yl)methyl)phenyl)-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4R4I"
"4R4L",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"40% PEG 400, 200 mM Lithium Sulfate, 0.1 M Tris base/ Hydrochloric acid, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/acs.biochem.5b00572",,"4R4L",17.97,"2.245","2.245","Crystal structure of wt cGMP dependent protein kinase I alpha (PKGI alpha) leucine zipper","GSSELEEDFAKILMLKEERIKELEKRLSEKEEEIQELKRKLHKCQSVLP","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","4R4L"
"4R4M",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, HANGING DROP",8.5,"40% PEG 400, 200 mM Lithium Sulfate, 0.1 M Tris base/ Hydrochloric acid, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/acs.biochem.5b00572",,"4R4M",17.77,"1.922","1.922","Crystal structure of C42L cGMP dependent protein kinase I alpha (PKGI alpha) leucine zipper","GSSELEEDFAKILMLKEERIKELEKRLSEKEEEIQELKRKLHKLQSVLP","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","4R4M"
"4R4O",,"X-RAY DIFFRACTION",2.04,39.65,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES, 200 mM Calcium Acetate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/ml5003629","3HW","4R4O",14.09,"1.33","1.33","Crystal structure of RPA70N in complex with 5-(4-((4-(5-carboxyfuran-2-yl)benzyl)carbamothioyl)phenyl)-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4R4O"
"4R4Q",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES, 200 mM Calcium Acetate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/ml5003629",,"4R4Q",14.1,"1.35","1.35","Crystal structure of RPA70N in complex with 5-(3-((N-(4-(5-carboxyfuran-2-yl)benzyl)acetamido)methyl)phenyl)-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4R4Q"
"4R4T",,"X-RAY DIFFRACTION",2.06,40.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES, 200 mM Calcium Acetate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/ml5003629","3J0","4R4T",14.09,"1.28","1.28","Crystal Structure of RPA70N in complex with 5-(4-((4-(5-carboxyfuran-2-yl)phenylthioamido)methyl)phenyl)-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylic acid","GSHMVGQLSRGAIAAIMQKGDTNIKPILQVINIRPITTGNSPPRYRLLMSDGLNTLSSFMLATQLNPLVEEEQLSSNCVCQIHRFIVNTLKDGRRVVILMELEVLKSAEAVGVKIGNPVPYNE","Homo sapiens","RPA1, REPA1, RPA70","Replication protein A 70 kDa DNA-binding subunit","1","4R4T"
"4R59",,"X-RAY DIFFRACTION",2.07,40.55,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium Citrate, 50mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5012935","3J3","4R59",29.76,"1.65","1.65","A Carbonic Anhydrase IX Mimic in Complex with a Carbohydrate-Based Sulfamate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4R59"
"4R5A",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium Citrate, 50mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5012935","3J4","4R5A",29.79,"1.64","1.64","A Carbonic Anhydrase IX Mimic in Complex with a Carbohydrate-Based Sulfamate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4R5A"
"4R5B",,"X-RAY DIFFRACTION",2.1,41.38,,7.8,"1.6 M Sodium Citrate, 50mM Tris-HCl, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm5012935","3J4","4R5B",29.84,"1.5","1.5","Human Carbonic Anhydrase II in Complex with a Carbohydrate-Based Sulfamate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4R5B"
"4R5N",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate, 5% DMSO, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/jm5015132","3J9","4R5N",45.87,"1.8","1.8","8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R5N"
"4R5S",,"X-RAY DIFFRACTION",3.58,65.64,"VAPOR DIFFUSION, HANGING DROP",8,"40% PEG 400, 150mM NaCl, 0.1M HEPES (pH 8.0), 5mM TCEP, 0.1M NDSB-211, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1403438111",,"4R5S",38.37,"3.001","3.001","Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3","GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4R5S"
"4R5W",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, SITTING DROP",5.5,"21% PEG-3350, 0.17M Ammonium Sulfate, 0.09M Bis-Tris, 1mM XAV939, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.jmedchem.6b00990","XAV","4R5W",81.7,"2.84","2.84","Human artd1 (parp1) - catalytic domain in complex with inhibitor xav939","MKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTAHHHHHH","Homo sapiens","ADPRT, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4R5W"
"4R5Y",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris, pH 6.5, 23% PEG3350, 0.2 M magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-15-0262","3K3","4R5Y",67.61,"3.5","3.5","The complex structure of Braf V600E kinase domain with a novel Braf inhibitor","MKKGHHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4R5Y"
"4R68",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, SITTING DROP",7.2,"PEG 3350, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.11.008","W31","4R68",152.37,"2.112","2.112","Lactate Dehydrogenase in complex with inhibitor compound 31","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4R68"
"4R69",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, SITTING DROP",7.2,"PEG3350, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.11.008","W13","4R69",151.88,"3.19","3.19","Lactate Dehydrogenase in complex with inhibitor compound 13","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4R69"
"4R6A",,"X-RAY DIFFRACTION",2.52,51.25,,4.9,"10%(w/v) PEG3350, 0.1M sodium citrate pH 4.9, 0.3M potassium formate, temperature 293K",293,,"HB2","4R6A",192.35,"2.1","2.1","Crystal structure of human TLR8 in complex with Hybrid-2","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","4R6A"
"4R6E",,"X-RAY DIFFRACTION",2.51,50.94,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG-3350, 0.16M Ammonium Sulfate, 0.08M Bis-Tris, 0.001M Niraparib, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.jmedchem.6b00990","3JD","4R6E",162.74,"2.2","2.2","Human artd1 (parp1) - catalytic domain in complex with inhibitor niraparib","MKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTAHHHHHH","Homo sapiens","ADPRT, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4R6E"
"4R6S",,"X-RAY DIFFRACTION",2.66,53.72,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/ncomms8443","3K2","4R6S",64.09,"2.301","2.301","Crystal structure of PPARgammma in complex with SR1663","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVFEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","NR1C3, PPARG","Peroxisome proliferator-activated receptor gamma","1","4R6S"
"4R6V",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 1.0-1.2 M (NH4)2SO4, 10 mM Yitrium (III) Chloride hexahydrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1403438111",,"4R6V",37.06,"2.353","2.353","Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Complex with FIIN-3, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR kinase Gate-Keeper Mutations","MGSSHHHHHHSQDPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVILECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4R6V"
"4R7D",,"X-RAY DIFFRACTION",2.83,56.57,"VAPOR DIFFUSION, SITTING DROP",7.3,"20% PEG 3350, 0.1M HEPES pH 7.3, 0.2M ammonium formate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.jmb.2015.05.016",,"4R7D",380.51,"2.753","2.753","Fab Hu 15C1","QVQLQESGPGLVKPSDTLSLTCAVSGYSITGGYSWHWIRQPPGKGLEWMGYIHYSGYTDFNPSLKTRITISRDTSKNQFSLKLSSVTAVDTAVYYCARKDPSDAFPYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab Hu 15C1 Heavy chain","1","4R7D"
,,,,,,,,,,,,,,,,"EIVLTQSPDFQSVTPKEKVTITCRASQSISDHLHWYQQKPDQSPKLLIKYASHAISGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQGHSFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab Hu 15C1 Light chain","2","4R7D"
"4R7H",,"X-RAY DIFFRACTION",2.45,49.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG8K, 0.2M MGCL AND 0.1M TRIS, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1056/NEJMoa1411366",,"4R7H",39.06,"2.8001","2.8001","Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397","MKKGHHHHHHGQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCTYGDLLNFLRRKAEAMLGPSLSPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDSVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQITSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","4R7H"
"4R7I",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG8K, 0.2M MGCL AND 0.1M TRIS, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1056/NEJMoa1411366",,"4R7I",39.13,"2.75","2.75","Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC","MKKGHHHHHHGQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCTYGDLLNFLRRKAEAMLGPSLSPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDSVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQITSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","4R7I"
"4R7L",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION",6.8,"15% PEG 8000, 0.1mM Na-acetate, 0.1mM Imidazole, 5mM YbCL3, pH 6.8, VAPOR DIFFUSION, temperature 277K",277,,"SHH","4R7L",72.5,"1.66","1.66","Structure of Human Leukotriene A4 Hydrolase in complex with inhibitor H1","MGSSHHHHHHSSGLVPRGSHMPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","4R7L"
"4R7N",,"X-RAY DIFFRACTION",4.16,70.43,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 3350, 0.1M Bis Tris Propane pH 8.5, 0.23M sodium citrate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.jmb.2015.05.016",,"4R7N",478.24,"3.45","3.45","Fab C2E3","QVQLQESGPGLVKPSDTLSLTCAVSGYPIRFGYSWHWIRQPPGKGLEWMGYIHYSGYTDFNPSLKTRITISRDTSKNQFSLKLSSVTAVDTAVYYCARKDSGNYFPYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab C2E3 Heavy chain","1","4R7N"
,,,,,,,,,,,,,,,,"EIVLTQSPDFQSVTPKEKVTITCRASQSISDHLHWYQQKPDQSPKLLIKYASHAISGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQGYDFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab C2E3 Light chain","2","4R7N"
"4R7P",,"X-RAY DIFFRACTION",3.68,66.62,,7.5,"The protein sample contained 10.3 mg/ml of hUGP, 50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM EDTA, 20% (w/v) sucrose and 4 mM UDP-Glc. 1   l of the hUGP   UDP-Glc complex was mixed 1:1 with the reservoir solution containing 100 mM sodium acetate buffer pH 4.8, 520 mM zinc acetate, 6% (w/v) aminocaproic acid and 75 mM ammonium sulfate. , VAPOR DIFFUSION, SITTING DROP, temperature 281.15K",281.15,"10.1038/srep09618",,"4R7P",239.45,"3.35","3.35","Human UDP-glucose pyrophosphorylase isoform 1 in complex with UDP-glucose","MASWSHPQFEKGALVPRGSSRFVQDLSKAMSQDGASQFQEVIRQELELSVKKELEKILTTASSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKSLIGVRNENTFLDLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPVAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIGEGKEYIFVSNIDNLGATVDLYILNHLMNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNAKTLDGGLNVIQLETAVGAAIKSFENSLGINVPRSRFLPVKTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH","Homo sapiens","UGP2, UGP1","UTP--glucose-1-phosphate uridylyltransferase","1","4R7P"
"4R7V",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.1M Tris-HCl, 0.2M (NH4)2SO4, 50mM Guanidine-HCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1002/pro.2549",,"4R7V",20.02,"1.73","1.73","Crystal structure of N-lobe of human ARRDC3(1-165)","MVLGKVKSLTISFDCLNDSNVPVYSSGDTVSGRVNLEVTGEIRVKSLKIHARGHAKVRWTESRNAGSNTAYTQNYTEEVEYFNHKDILIGHERDDDNSEEGFHTIHSGRHEYAFSFELPQTPLATSFEGRHGSVRYWVKAELHRPWLLPVKLKKEFTVFEHIDINLEHHHHHH","Homo sapiens","ARRDC3, KIAA1376","Arrestin domain-containing protein 3","1","4R7V"
"4R7X",,"X-RAY DIFFRACTION",4.11,70.04,"VAPOR DIFFUSION, HANGING DROP",8,"0.75M NH4H2PO4, 0.1M Sodium citrate tribasic dehydrate, 3.0% (W/V) 6-Aminohexanoic acid, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1002/pro.2549",,"4R7X",42.83,"2.61","2.61","Crystal structure of N-lobe of human ARRDC3(1-180)","GAMGSMVLGKVKSLTISFDCLNDSNVPVYSSGDTVSGRVNLEVTGEIRVKSLKIHARGHAKVRWTESRNAGSNTAYTQNYTEEVEYFNHKDILIGHERDDDNSEEGFHTIHSGRHEYAFSFELPQTPLATSFEGRHGSVRYWVKAELHRPWLLPVKLKKEFTVFEHIDINTPSLLSPQAGTKEKT","Homo sapiens","ARRDC3, KIAA1376","Arrestin domain-containing protein 3","1","4R7X"
"4R8M",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"25%(v/v) PEG3350, 0.1M Hepes buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/srep08529",,"4R8M",73.94,"2.1","2.1","Human SIRT2 crystal structure in complex with BHJH-TM1","MDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4R8M"
,,,,,,,,,,,,,,,,"PKKTG",,,"BHJH-TM1 peptide","2","4R8M"
"4R8Q",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION, SITTING DROP",6.29,"TO 15 MG/ML BUB1, ATP WAS ADDED TO A FINAL CONCENTRATION OF 10 MM. SITTING DROPS WERE MADE BY MIXING 1.5 MICROLITERS PROTEIN WITH 1.5 MICROLITERS CRYSTALLIZATION SOLUTION (20% W/V PEG 3350, 0.1 M SODIUM FORMATE PH 6.29, 25 MM DTT) AND EQUILIBRATING AGAINST 200 MICROLITERS OF RESERVOIR SOLUTION. LARGE SINGLE CRYSTALS WERE OBTAINED BY REPEATED SEEDING. THE CRYSTALS WERE CRYO-PROTECTED IN RESERVOIR SOLUTION SUPPLEMENTED WITH 18% V/V GLYCEROL AND THEN FLASH-COOLED IN LIQUID PROPANE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, vapor diffusion, sitting drop",293,"10.1016/j.molcel.2008.09.017",,"4R8Q",42.32,"2.31","2.31","Structure and substrate recruitment of the human spindle checkpoint kinase bub1","GSPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK","Homo sapiens","BUB1, BUB1L","Mitotic checkpoint serine/threonine-protein kinase BUB1","1","4R8Q"
"4R8Y",,"X-RAY DIFFRACTION",2.74,55.04,,,,,"10.1016/j.bmcl.2014.10.006","3KO","4R8Y",93.48,"1.9","1.9","BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((R)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R8Y"
"4R91",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG3350, 200mM K/Na tartrate, 100mM Hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.10.006","3KT","4R91",93.61,"1.58","1.58","BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(cyclopentylamino)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R91"
"4R92",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 200mM K/Na tatrate, 100mM Hepes, pH 7.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2014.10.006","3KU","4R92",93.68,"1.71","1.71","BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(isonicotinamido)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R92"
"4R93",,"X-RAY DIFFRACTION",2.73,55.02,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 200mM K/Na tatrate, 100mM Hepes, pH 7.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2014.10.006","779","4R93",93.86,"1.71","1.71","BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1S,3R)-3-(3-phenylureido)cyclohexyl)methyl)imidazolidin-2-iminium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R93"
"4R95",,"X-RAY DIFFRACTION",2.73,55.02,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 200mM K/Na tatrate, 100mM Hepes, pH 7.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2014.10.006","3KW","4R95",93.87,"1.99","1.99","BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino)quinolin-1-ium","LRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4R95"
"4R9A",,"X-RAY DIFFRACTION",2.06,40.3,,,,,"10.1093/abbs/gmu132",,"4R9A",16.58,"1.197","1.197","Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.0, PEG4000)","GSHMAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4R9A"
"4R9B",,"X-RAY DIFFRACTION",1.99,38.35,,,,,"10.1093/abbs/gmu132",,"4R9B",16.58,"1.2","1.2","Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.0, PEG 6000)","GSHMAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4R9B"
"4R9C",,"X-RAY DIFFRACTION",1.99,38.29,,,,,"10.1093/abbs/gmu132",,"4R9C",16.58,"1.19","1.19","Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.5, PEG6000)","GSHMAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4R9C"
"4R9D",,"X-RAY DIFFRACTION",1.96,37.21,,,,,"10.1093/abbs/gmu132",,"4R9D",16.58,"1.239","1.239","Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.9, PEG6000)","GSHMAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4R9D"
"4R9H",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",7,"25% PEG4000, 0.2 M imidazole-malate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep14651",,"4R9H",47.58,"1.9","1.9","Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolution","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPCDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4R9H"
"4R9J",,"X-RAY DIFFRACTION",2.58,52.4,"EVAPORATION",7,"Protien solution: 5.7 mg/ml in 145 mM NaCl, 50 mM triethanolamine-HCl, pH 7.4. Reservoir solution composed of 15% (w/v) PEG 8000, 200 mM Ca acetate and 0.1 M HEPES. Cryoprotection was achieved by adding PEG 400 to the drop just before flash-cooling the crystal in liquid nitrogen, EVAPORATION, temperature 293K",293,"10.1016/j.febslet.2014.10.042",,"4R9J",76.09,"2.1","2.1","L-ficolin complexed to glucosamine-6-sulfate","PCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRVDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHVSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","Ficolin-2","1","4R9J"
"4R9T",,"X-RAY DIFFRACTION",2.54,51.53,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution: 5.7 mg/ml in 145 mM NaCl, 50 mM triethanolamine-HCl, pH 7.4. Reservoir solution composed of 15% (w/v) PEG 8000, 200 mM Ca acetate and 0.1 M HEPES. Ligand soaking. Cryoprotection was achieved by adding PEG 400 to the drop just before flash-cooling the crystal in liquid nitrogen, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2014.10.042",,"4R9T",75.22,"2.25","2.25","L-ficolin complexed to sulphates","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRVDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHVSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","Ficolin-2","1","4R9T"
"4R9W",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, HANGING DROP",5.6,"2% PEG4000, 17% MPD, 0.1 M sodium acetate pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/ncomms9277",,"4R9W",17.07,"2.5","2.5","Crystal structure of platelet factor 4 complexed with fondaparinux","EAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGPHCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES","Homo sapiens","PF4, CXCL4, SCYB4","Platelet factor 4","1","4R9W"
"4RA2",,"X-RAY DIFFRACTION",3.07,59.97,,5.5,"15(v/v)% PEG8000, pH 5.5, 50mM K2HPO4, 15% 2mMDTT, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,,,"4RA2",40.96,"1.94","1.94","PP2Ca","GAFLDKPKMEKHNAQGQGNGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEKKHGADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEKERIQNAGGSVMIQRVNGSLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGNEELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAPKVSPEAVKKEAELDKYLECRVEEIIKKQGEGVPDLVHVMRTLASENIPSLPPGGELASKRNVIEAVYNRLNPY","Homo sapiens","PPM1A, PPPM1A","Protein phosphatase 1A","1","4RA2"
"4RA3",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION, SITTING DROP",8,"25% v/v PEG4000, 0.1 M sodium chloride, 5 mM thioflavin, 0.1 M HEPES sodium, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep14651",,"4RA3",49,"2.8","2.8","Crystal structure of dimeric S33C beta-2 microglobulin mutant in complex with Thioflavin (ThT) at 2.8 Angstrom resolution","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPCDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RA3"
"4RA4",,"X-RAY DIFFRACTION",2.38,48.23,"VAPOR DIFFUSION",5.5,"25%(w/v) PEG 3350, 0.1M Bis-Tris, 0.2M magnesium chloride, pH 5.5, VAPOR DIFFUSION, temperature 290K",290,"10.1021/jm5013006",,"4RA4",41.27,"2.63","2.63","Crystal Structure of Human Protein Kinase C Alpha in Complex with Compound 28 ((R)-6-((3S,4S)-1,3-Dimethyl-piperidin-4-yl)-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)","ISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVSGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV","Homo sapiens","PRKCA, PKCA, PRKACA","Protein kinase C","1","4RA4"
"4RA5",,"X-RAY DIFFRACTION",2.83,56.55,"VAPOR DIFFUSION, HANGING DROP",4.25,"PEG 3350, MgCl2, sodium acetate and sodium malonate, pH 4.25, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm5013006","3L0","4RA5",80.15,"2.61","2.61","Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)","KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMERLISH","Homo sapiens","PRKCQ, PRKCT","HUMAN PROTEIN KINASE C THETA","1","4RA5"
"4RA8",,"X-RAY DIFFRACTION",4.72,73.94,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Bis-Tris, pH 5.5, 2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2015.01.012",,"4RA8",38.48,"2.6","2.6","Structure analysis of the Mip1a P8A mutant","ASLAADTATACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELS","Homo sapiens","CCL3, G0S19-1, MIP1A, SCYA3","C-C motif chemokine 3","1","4RA8"
"4RAB",,"X-RAY DIFFRACTION",2.25,45.33,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M sodium acetate, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm501416t","3L3","4RAB",100.57,"2.264","2.264","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAB"
"4RAC",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",8,"1 M sodium/potassium tartrate, 0.2 M NaCl, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm501416t","3L4","4RAC",99.85,"2.05","2.05","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAC"
"4RAD",,"X-RAY DIFFRACTION",2.13,42.37,"VAPOR DIFFUSION, HANGING DROP",8,"1 M sodium/potassium tartrate, 0.2 M NaCl, 0.1 M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm501416t",,"4RAD",199.7,"2","2","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAD"
"4RAF",,"X-RAY DIFFRACTION",3.12,60.61,"VAPOR DIFFUSION, HANGING DROP",5.5,"15%(v/v) PEG8000, pH 5.5, 50mM K2HPO4, 2mMDTT, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1038/srep08560",,"4RAF",40.77,"2.001","2.001","Crystal structure of PP2Ca-D38A","GAFLDKPKMEKHNAQGQGNGLRYGLSSMQGWRVEMEAAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEKKHGADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEKERIQNAGGSVMIQRVNGSLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGNEELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAPKVSPEAVKKEAELDKYLECRVEEIIKKQGEGVPDLVHVMRTLASENIPSLPPGGELASKRNVIEAVYNRLNPY","Homo sapiens","PPM1A, PPPM1A","Protein phosphatase 1A","1","4RAF"
"4RAG",,"X-RAY DIFFRACTION",3.08,60.03,"VAPOR DIFFUSION, HANGING DROP",5.5,"15%(v/v) PEG8000, pH 5.5, 50mM K2HPO4, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1038/srep08560",,"4RAG",40.83,"1.85","1.85","CRYSTAL STRUCTURE of PPC2A-D38K","GAFLDKPKMEKHNAQGQGNGLRYGLSSMQGWRVEMEKAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEKKHGADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEKERIQNAGGSVMIQRVNGSLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGNEELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAPKVSPEAVKKEAELDKYLECRVEEIIKKQGEGVPDLVHVMRTLASENIPSLPPGGELASKRNVIEAVYNRLNPY","Homo sapiens","PPM1A, PPPM1A","Protein phosphatase 1A","1","4RAG"
"4RAH",,"X-RAY DIFFRACTION",1.94,36.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% v/v PEG400, 0.2 M calcium chloride dihydrate, 0.1 M HEPES sodium, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep14651",,"4RAH",11.9,"1.4","1.4","Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.4 Angstrom resolution","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPCDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RAH"
"4RAK",,"X-RAY DIFFRACTION",2.43,49.35,,,,,"10.1016/j.bmcl.2014.11.029","652","4RAK",62.37,"2.04","2.04","Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist","MHHHHHHGENLYFQGSEGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","4RAK"
"4RAN",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3000, 0.2 M calcium acetate, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm501416t",,"4RAN",99.46,"2.549","2.549","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAN"
"4RAO",,"X-RAY DIFFRACTION",2.09,41.02,,,,,"10.1021/jm501416t","3L7","4RAO",99.87,"1.871","1.871","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAO"
"4RAQ",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M calcium acetate, 0.1 M Tris-HCl, pH 7.5, 20% PEG3000, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm501416t",,"4RAQ",99.82,"2.53","2.53","Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their pro-drugs as antimalarial agents","ATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","4RAQ"
"4RBL",,"X-RAY DIFFRACTION",3.37,63.53,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.4 M potassium sodium, tartrate tetrahydrate, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4RBL",33.56,"2.55","2.55","Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4RBL"
"4RBO",,"X-RAY DIFFRACTION",4.45,72.35,"VAPOR DIFFUSION, SITTING DROP",5.66,"0.200M calcium acetate, 12.00% 2-propanol, 0.1M sodium cacodylate pH 5.66, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1502855112",,"4RBO",31.87,"3.3","3.3","Crystal structure of a Nanog homeobox (NANOG) from Homo sapiens at 3.30 A resolution","GKKQKTRTVFSSTQLCVLNDRFQRQKYLSLQQMQELSNILNLSYKQVKTWFQNQRMKSKRWQKNNWPKNS","Homo sapiens","NANOGP8, NM_024865, NANOG","Putative homeobox protein NANOGP8","1","4RBO"
,,,,,,,,,,,,,,,,"GGCCCATTCAAG",,,"5'-D(*GP*GP*CP*CP*CP*AP*TP*TP*CP*AP*AP*G)-3'","2","4RBO"
,,,,,,,,,,,,,,,,"CTTGAATGGGCC",,,"5'-D(*CP*TP*TP*GP*AP*AP*TP*GP*GP*GP*CP*C)-3'","3","4RBO"
"4RBP",,"X-RAY DIFFRACTION",2.68,54.09,"VAPOR DIFFUSION, SITTING DROP",5.5,"33% PEG 600, 0.2M imidazole malate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1093/glycob/cwu123",,"4RBP",96.93,"1.85","1.85","Crystal structure of HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomanose","AVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12 light chain","1","4RBP"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Fab 2G12 heavy chain","2","4RBP"
"4RBW",,"X-RAY DIFFRACTION",1.82,32.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES pH 6.5, 0.5M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 294.15K",294.15,"10.1021/jm501824a",,"4RBW",15.65,"1.5","1.5","Crystal structure of human alpha-defensin 5, HD5 (Thr7Arg Glu21Arg mutant)","ATCYCRRGRCATRESLSGVCRISGRLYRLCCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","4RBW"
"4RBX",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"6.6% PEG 8000, 3.3% Isopropanol, 0.2M Ammonium sulfate and 0.1M Hepes pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm501824a",,"4RBX",3.91,"1.1","1.1","Crystal structure of human alpha-defensin 5, HD5 (Glu21Arg mutant)","ATCYCRTGRCATRESLSGVCRISGRLYRLCCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","4RBX"
"4RC2",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.4 M potassium sodium tartrate tetrahydrate, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4RC2",33.65,"2.096","2.096","Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4RC2"
"4RC3",,"X-RAY DIFFRACTION",3.36,63.35,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.4 M potassium sodium tartrate tetrahydrate, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4RC3",33.74,"2.338","2.338","Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4RC3"
"4RC4",,"X-RAY DIFFRACTION",3.37,63.5,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.4 M potassium sodium tartrate tetrahydrate, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4RC4",33.65,"2.651","2.651","Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4RC4"
"4RCD",,"X-RAY DIFFRACTION",2.83,56.54,"VAPOR DIFFUSION",6.6,"21% polyethylene glycol 5000 monomethyl ether, 180 mM sodium citrate, pH 6.6, 200 mM ammonium iodide, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm5012676","3LL","4RCD",46.83,"1.9","1.9","Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitor","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4RCD"
"4RCE",,"X-RAY DIFFRACTION",2.8,56.14,"VAPOR DIFFUSION",6.6,"20% polyethylene glycol 5000 monomethyl ether, 200 mM ammonium iodide, 180 mM sodium citrate, pH 6.6, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm501266w","3LN","4RCE",46.62,"2.4","2.4","Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4RCE"
"4RCF",,"X-RAY DIFFRACTION",2.8,56.15,"VAPOR DIFFUSION",6.6,"21% polyethylene glycol 5000 monomethyl ether, 200 mM ammonium iodide, 180 mM sodium citrate, pH 6.6, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm501266w","3LO","4RCF",46.74,"1.78","1.78","Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4RCF"
"4RCH",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Hepes, pH 7.0, 28% PEG 1500, 5% glycerol, 50 mM glucose, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/jm501204z","3LZ","4RCH",53.59,"2.3","2.3","Discovery of 2-Pyridyl Ureas as Glucokinase Activators","MSGHHHHHHASSGLVPRGSMALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","4RCH"
"4RCI",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION",,"25% PEG-3350, 0.2 M potassium thiocyanate, vapor diffusion, temperature 293K",293,"10.1074/jbc.M115.680389",,"4RCI",93.06,"1.97","1.97","Crystal structure of YTHDF1 YTH domain","GSVESHPVLEKLKAAHSYNPKEFEWNLKSGRVFIIKSYSEDDIHRSIKYSIWCSTEHGNKRLDSAFRCMSSKGPVYLLFSVNGSGHFCGVAEMKSPVDYGTSAGVWSQDKWKGKFDVQWIFVKDVPNNQLRHIRLENNDNKPVTNSRDTQEVPLEKAKQVLKIISSYKHTTSIFDDFAHYEKRQEEEEVVRKERQSRNKQ","Homo sapiens","YTHDF1, C20orf21","YTH domain-containing family protein 1","1","4RCI"
"4RCP",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION",4,"0.2M sodium citrate pH 4.0, 500mM ammonium sulfate, vapor diffusion, temperature 293K",293,"10.1021/jm501147g",,"4RCP",27.63,"1.6","1.6","Crystal structure of Plk1 Polo-box domain in complex with PL-2","CHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNR","Homo sapiens","PLK, PLK1","Serine/threonine-protein kinase PLK1","1","4RCP"
,,,,,,,,,,,,,,,,"XHSTX",,,"PL-2","2","4RCP"
"4RCW",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"100 mM Na-citrate, pH 5.5, 16% isopropanol, and 12% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 296.0K",296,"10.1038/ncomms6423",,"4RCW",54.65,"3.1925","3.1925","Crystal structure of human Slitrk1","CPGGCSCDHIPGSGLKMNCNNRNVSSLADLKPKLSNVQELFLRDNKIHSIRKSHFVDYKNLILLDLGNNNIATVENNTFKNLLDLRWLYMDSNYLDTLSREKFAGLQNLEYLNVEYNAIQLILPGTFNAMPKLRILILNNNLLRSLPVDVFAGVSLSKLSLHNNYFMYLPVAGVLDQLTSIIQIDLHGNPWECSCTIVPFKQWAERLGSEVLMSDLKCETPVNFFRKDFMLLSNDEICPQ","Homo sapiens","SLITRK1, KIAA1910, LRRC12, UNQ233/PRO266","SLIT and NTRK-like protein 1","1","4RCW"
"4RD9",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M Na-Citrate, 0.9 M(NH4)H2PO4, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1107/S1399004714027114",,"4RD9",47.35,"2.6","2.6","X-RAY STRUCTURE OF THE APO FORM OF THE AMYLOID PRECURSOR PROTEIN-LIKE PROTEIN 1 (APLP1) E2 DOMAIN","DGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSE","Homo sapiens","APLP1","Amyloid-like protein 1","1","4RD9"
"4RDA",,"X-RAY DIFFRACTION",5.2,76.36,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1 mM MES/NaOH 9.5% PEG20000, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1107/S1399004714027114",,"4RDA",52.15,"2.497","2.497","X-RAY STRUCTURE OF THE AMYLOID PRECURSOR PROTEIN-LIKE PROTEIN 1 (APLP1) E2 DOMAIN IN COMPLEX WITH A HEPARIN DODECASACCHARIDE","EAEFPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSEL","Homo sapiens","APLP1","Amyloid-like protein 1","1","4RDA"
"4RDD",,"X-RAY DIFFRACTION",2.2,44.13,,7.4,"20% PEG3350, 33 mM citric acid, 67 mM BIS-TRIS propane, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acsmedchemlett.5b00118","3LU","4RDD",32.66,"1.601","1.601","Co-crystal structure of SHP2 in complex with a Cefsulodin derivative","LYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRLEHHHHHH","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","4RDD"
"4RDN",,"X-RAY DIFFRACTION",2.76,55.37,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.2 M Potassium tartrate, 0.1 M Sodium citrate tribasic dehydrate, PH 5.6, 2M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1038/cr.2014.153",,"4RDN",39.68,"2.1","2.1","Structure of YTH-YTHDF2 in complex with m6A","MGSSYHHHHHHSSGENLYFQHMKHGRVFIIKSYSEDDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYNTCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQVLKIIASYKHTTS","Homo sapiens","YTHDF2, HGRG8","YTH domain-containing family protein 2","1","4RDN"
"4RDO",,"X-RAY DIFFRACTION",2.72,54.8,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M Potassium tartrate, 0.1 M Sodium citrate tribasic dehydrate, PH 5.6, 2M Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 283K",283,"10.1038/cr.2014.153",,"4RDO",116.78,"2.15","2.15","Structure of YTH-YTHDF2 in the free state","MGSSYHHHHHHSSGENLYFQHMKHGRVFIIKSYSEDDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYNTCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQVLKIIASYKHTTS","Homo sapiens","YTHDF2, HGRG8","YTH domain-containing family protein 2","1","4RDO"
"4RE8",,"X-RAY DIFFRACTION",3.21,61.67,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1016/j.chembiol.2015.06.023",,"4RE8",57.91,"2.16","2.16","Crystal Structure of TR3 LBD in complex with Molecule 5","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4RE8"
"4RE9",,"X-RAY DIFFRACTION",3.97,68.99,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG5000, 100 mM HEPES, 14% Tacsimate, 10% dioxane, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1038/ncomms9250",,"4RE9",232.23,"2.908","2.908","Crystal structure of human insulin degrading enzyme (IDE) in complex with compound 71290","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","4RE9"
"4RED",,"X-RAY DIFFRACTION",2.4,48.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.5 M HNa2PO4/0.5 M HK2PO4, 0.1 M Tris hydrochloride, pH 8.5, 0.1 M H(NH4)2PO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/cr.2014.150",,"4RED",80.4,"2.95","2.95","Crystal structure of human AMPK alpha1 KD-AID with K43A mutation","MGHHHHHHGSVKIGHYILGDTLGVGTFGKVKVGKHELTGHAVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRASIKDIREHEWFKQDLPKYLFPEDPSYSTTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFL","Homo sapiens","AMPK Alpha1 (11-353), AMPK1, PRKAA1","5'-AMP-activated protein kinase catalytic subunit alpha-1","1","4RED"
"4REE",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1016/j.chembiol.2015.06.023",,"4REE",57.77,"2.37","2.37","Crystal Structure of TR3 LBD in complex with Molecule 6","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4REE"
"4REF",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1016/j.chembiol.2015.06.023",,"4REF",57.97,"2.1","2.1","Crystal Structure of TR3 LBD_L449W in complex with Molecule 2","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFIWRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4REF"
"4REX",,"X-RAY DIFFRACTION",1.77,30.57,,5,"1.5 M ammonium sulphate, 0.1 M sodium acetate, 100 mM proline, 5 mM NDSB-201 and 5mM MBCD, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2015.08.001",,"4REX",5.63,"1.6","1.6","Crystal structure of the first WW domain of human YAP2 isoform","GAMGFEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRKAMLSQ","Homo sapiens","YAP1, YAP65","Yorkie homolog","1","4REX"
"4RFC",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM Tris-HCL pH 7.8, 0.24 mM (final concentration) tert-butyl 6-(4-sulfamoylphenoxy)hexylcarbamate, Vapor diffusion, hanging drop, temperature 298K",298,"10.1021/jm501497m","3O1","4RFC",29.7,"1.645","1.645","Human carbonic anhydrase II in complex with tert-butyl 4-(4-sulfamoylphenoxy)butylcarbamate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RFC"
"4RFD",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM Tris-HCL pH 7.8, 0.24 mM (final concentration) 6-(4-sulfamoyl-phenoxy)-hexyl-ammonium trifluoroacetate salt, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm501497m","3O5, BCT","4RFD",29.9,"1.631","1.631","Human carbonic anhydrase II in complex with 4-(4-sulfamoyl-phenoxy)-butylammonium","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RFD"
"4RFM",,"X-RAY DIFFRACTION",2.01,38.74,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M Magnesium Chloride, 0.1 M Tris.HCl (pH 8.0), 20 % PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm501998m","3P6","4RFM",30.63,"2.1","2.1","ITK kinase domain in complex with compound 1 N-{1-[(1,1-dioxo-1-thian-2-yl)(phenyl)methyl]-1H- pyrazol-4-yl}-5,5-difluoro-5a-methyl-1H,4H,4aH,5H,5aH,6H-cyclopropa[f]indazole-3-carboxamide","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","4RFM"
"4RFQ",,"X-RAY DIFFRACTION",3.17,61.26,"VAPOR DIFFUSION",5.6,"2.0 M ammonium sulfate, 0.2 M potassium/sodium tartrate, 0.1 M sodium citrate, 0.005 M taurine, 0.005 M SAM, pH 5.6, vapor diffusion, temperature 293K",293,,,"4RFQ",33.47,"2.4","2.4","Human Methyltransferase-Like 18","GHKSMENAAPSQDTDSPLSAASSSRNLEPHGKQPSLRAAKEHAMPKDLKKMLENKVIETLPGFQHVKLSVVKTILLKENFPYEGGLKIWECTFDLLAYFTKAKVKFAGKKVLDLGCGSGLLGITAFKGGSKEIHFQDYNSMVIDEVTLPNVVANSTLEDEENDVNEPDVKRCRKPKVTQLYKCRFFSGEWSEFCKLVLSSEKLFVKYDLILTSETIYNPDYYSNLHQTFLRLLSKNGRVLLASKAHYFGVGGGVHLFQKFVEERDVFKTRILKIIDEGLKRFIIEITFKFPG","Homo sapiens","METTL18, ASTP2, C1orf156","Histidine protein methyltransferase 1 homolog","1","4RFQ"
"4RFY",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.11.030","3OU","4RFY",33.29,"1.7","1.7","Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4RFY"
"4RFZ",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.11.030","3OV","4RFZ",33.3,"1.17","1.17","Crystal structure of BTK kinase domain complexed with 6-(dimethylamino)-8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]isoquinolin-1-one","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4RFZ"
"4RG0",,"X-RAY DIFFRACTION",2.26,45.57,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1 M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.11.030","3P0","4RG0",33.16,"2.5","2.5","Crystal structure of BTK kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-1-oxo-3,4-dihydroisoquinolin-6-yl]-2-methyl-propanenitrile","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4RG0"
"4RG1",,"X-RAY DIFFRACTION",2.69,54.21,"VAPOR DIFFUSION, SITTING DROP",,"28% PEG3350, 0.2 M diammonium tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4RG1",75.53,"1.86","1.86","Methyltransferase domain of C9orf114","AEKEDRGRPYTLSVALPGSILDNAQSPELRTYLAGQIARACAIFCVDEIVVFDEEGQDAKTVEGEFTGVGKKGQACVQLARILQYLECPQYLRKAFFPKHQDLQFAGLLNPLDSPHHMRQDEESEFREGIVVDRPTRPGHGSFVNCGMKKEVKIDKNLEPGLRVTVRLNQQQHPDCKTYHGKVVSSQDPRTKAGLYWGYTVRLASCLSAVFAEAPFQDGYDLTIGTSERGSDVASAQLPNFRHALVVFGGLQGLEAGADADPNLEVAEPSVLFDLYVNTCPGQGSRTIRTEEAILISLAALQPGLTQAGARHT","Homo sapiens","C9orf114, SPOUT1","C9orf114","1","4RG1"
"4RG2",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",7.2,"19% PEG3350, 0.15 M DL-malic acid, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/cb500956g","3OO","4RG2",28.74,"1.5","1.5","Tudor Domain of Tumor suppressor p53BP1 with small molecule ligand","GGNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLGPYE","Homo sapiens","TP53BP1","Tumor suppressor p53-binding protein 1","1","4RG2"
"4RG7",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, pH 6.0, 0.2M magnesium chloride, 8% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2014.11.020",,"4RG7",127.79,"4.25","4.25","Crystal structure of APC3","GSMTVLQEPVQAAIWQALNHYAYRDAVFLAERLYAEVHSEEALFLLATCYYRSGKAYKAYRLLKGHSCTTPQCKYLLAKCCVDLSKLAEGEQILSGGVFNKQKSHDDIVTEFGDSACFTLSLLGHVYCKTDRLAKGSECYQKSLSLNPFLWSPFESLCEIGEKPDPDQTFKFTSLQNFSNCLPQIQAFNLQKAAAEGLMSLLREMGKGYLALCSYNCKEAINILSHLPSHHYNTGWVLCQIGRAYFELSEYMQAERIFSEVRRIENYRVEGMEIYSTTLWHLQKDVALSVLSKDLTDMDKNSPEAWCAAGNCFSLQREHDIAIKFFQRAIQVDPNYAYAYTLLGHEFVLTEELDKALACFRNAIRVNPRHYNAWYGLGMIYYKQEKFSLAEMHFQKALDINPQSSVLLCHIGVVQHALKKSEKALDTLNKAIVIDPKNPLCKFHRASVLFANEKYKSALQELEELKQIVPKESLVYFLIGKVYKKLGQTHLALMNFSWAMDLDPKGANNQIKEAIDKRYLPDDEEPITQEEQIMGTDESQESSMTDADDTQLHAAESDEF","Homo sapiens","CDC27, ANAPC3, D0S1430E, D17S978E","Cell division cycle protein 27 homolog","1","4RG7"
,,,,,,,,,,,,,,,,,"Homo sapiens","CDC27, ANAPC3, D0S1430E, D17S978E"
"4RGH",,"X-RAY DIFFRACTION",1.98,37.86,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2M amonium acetate, 0.1M Bis-Tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292.15K",292.15,,,"4RGH",38.1,"1.9","1.9","Human DNA Damage-Inducible Protein: From Protein Chemistry and 3D Structure to Deciphering its Cellular Role","HHHHHHHHHHSSGHIEGRHMQQNIEENMTIAMEEAPESFGQVVMLYINCKVNGHPVKAFVDSGAQMTIMSQACAERCNIMRLVDRRWAGIAKGVGTQKIIGRVHLAQVQIEGDFLPCSFSILEEQPMDMLLGLDMLKRHQCSIDLKKNVLVIGTTGSQTTFLPEGELPE","Homo sapiens","DDI2","Protein DDI1 homolog 2","1","4RGH"
"4RH2",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION",8,"1.6 M sodium citrate, Tris 50 mM, pH 8.0, VAPOR DIFFUSION, temperature 296K",296,,"FC9","4RH2",30.09,"1.3","1.3","Crystal structure of human carbonic anhydrase II in complex with 2-(6-hydroxy-3-Oxo-3H-xanthen-9-yl)-5-{3-1-(4-sulfamoyl-phenyl)-1h-[1,2,3]triazol-4-ylmethyl-thioureido}-benzoic acid","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RH2"
"4RH3",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, HANGING DROP",6,"0,1 M MES pH 6.0 23% v/v MPD, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1042/BJ20150251",,"4RH3",327.13,"3.02","3.02","AMPPCP-bound structure of human platelet phosphofructokinase in an R-state, crystal form II","VPDPTSAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILA","Homo sapiens","PFKF, PFKP","ATP-dependent 6-phosphofructokinase, platelet type","1","4RH3"
"4RHP",,"X-RAY DIFFRACTION",2.2,44.17,"mircobatch under oil",8.5,"100 mM TRIS (pH 8.5), 20% (v/v) PEG 3350, and 200 mM MgCl2  
  
, mircobatch under oil, temperature 291K",291,"10.1073/pnas.1413128111",,"4RHP",54.88,"2.393","2.393","Crystal structure of human COQ9 in complex with a phospholipid, Northeast Structural Genomics Consortium Target HR5043","DQGGEEEEDYESEEQLQHRILTAALEFVPAHGWTAEAIAEGAQSLGLSSAAASMFGKDGSELILHFVTQCNTRLTRVLEEEQKLVQLGQAEKRKTDQFLRDAVETRLRMLIPYIEHWPRALSILMLPHNIPSSLSLLTSMVDDMWHYAGDQSTDFNWYTRRAMLAAIYNTTELVMMQDSSPDFEDTWRFLENRVNDAMNMGHTAKQVKSTGEALVQGLMGAAVTLKNLTGLNQRR","Homo sapiens","COQ9, C16orf49, HSPC326, PSEC0129","Ubiquinone biosynthesis protein COQ9, mitochondrial","1","4RHP"
"4RI0",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION, SITTING DROP",5,"1 M potassium/sodium phosphate buffer, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1371/journal.pone.0131142",,"4RI0",109.13,"3.272","3.272","Serine Protease HtrA3, mutationally inactivated","LHQLSSPRYKFNFIADVVEKIAPAVVHIELFLRHPLFGRNVPLSSGSGFIMSEAGLIITNAHVVSSNSAAPGRQQLKVQLQNGDSYEATIKDIDKKSDIATIKIHPKKKLPVLLLGHSADLRPGEFVVAIGSPFALQNTVTTGIVSTAQREGRELGLRDSDMDYIQTDAIINYGNAGGPLVNLDGEVIGINTLKVTAGISFAIPSDRITRFLTEFQDKQIKDWKKRFIGIRMRTITPSLVDELKASNPDFPEVSSGIYVQEVAPNSPSQRGGIQDGDIIVKVNGRPLVDSSELQEAVLTESPLLLEVRRGNDDLLFSIAPEVVMGGHHHHHH","Homo sapiens","HTRA3, PRSP","Serine protease HTRA3","1","4RI0"
"4RI4",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, SITTING DROP",7.5,"100mM Tris-HCl, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2015.01.017",,"4RI4",70.03,"1.596","1.596","Crystal structure of PTPN3 (PTPH1) Y676I mutant in complex with vanadate","MHHHHHHSSGVDLGTENLYFQSNADTLEGSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNLDKNRIKDVLPYDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQVVWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTIAYVSREMLVTNTQTGEEHTVTHLQYVAWPDHGVPDDSSDFLEFVNYVRSLRVDSEPVLVHCSAGIGRTGVLVTMETAMCLTERNLPIYPLDIVRKMRDQRAMMVQTSSQYKFVCEAILRVYEEGLVQM","Homo sapiens","PTPH1, PTPN3","Tyrosine-protein phosphatase non-receptor type 3","1","4RI4"
"4RI5",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 21% PEG 800, 5% glycerol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2015.01.017",,"4RI5",70.31,"1.26","1.26","Crystal structure of PTPN3 (PTPH1) D811E mutant in complex with metavanadate","MHHHHHHSSGVDLGTENLYFQSNADTLEGSMAQLKKGLESGTVLIQFEQLYRKKPGLAITFAKLPQNLDKNRYKDVLPYDTTRVLLQGNEDYINASYVNMEIPAANLVNKYIATQGPLPHTCAQFWQVVWDQKLSLIVMLTTLTERGRTKCHQYWPDPPDVMNHGGFHIQCQSEDCTIAYVSREMLVTNTQTGEEHTVTHLQYVAWPEHGVPDDSSDFLEFVNYVRSLRVDSEPVLVHCSAGIGRTGVLVTMETAMCLTERNLPIYPLDIVRKMRDQRAMMVQTSSQYKFVCEAILRVYEEGLVQM","Homo sapiens","PTPH1, PTPN3","Tyrosine-protein phosphatase non-receptor type 3","1","4RI5"
"4RI8",,"X-RAY DIFFRACTION",3.14,60.83,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, NaCl, pH 7.0, hanging drop vapor diffusion, temperature 277K, VAPOR DIFFUSION, HANGING DROP",277,"10.1126/science.1258973",,"4RI8",173.02,"2.9","2.9","FAN1 Nuclease bound to 5' phosphorylated p(dG)/3'(dT-dT-dT-dT) double flap DNA","GAHMTRNGPGQTTGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLANPNGQKQQLVDAFLKLAKQRSVIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAVGAKSQSLS","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RI8"
,,,,,,,,,,,,,,,,"TTTGAGGAGTCTTT",,,"DNA (5'-D(*TP*TP*TP*GP*AP*GP*GP*AP*GP*TP*CP*TP*TP*T)-3')","2","4RI8"
,,,,,,,,,,,,,,,,"GAGGCGTG",,,"DNA (5'-D(P*GP*AP*GP*GP*CP*GP*TP*G)-3')","3","4RI8"
,,,,,,,,,,,,,,,,"AACACGCCTAGACTCCTCA",,,"DNA (5'-D(*AP*AP*CP*AP*CP*GP*CP*CP*TP*AP*GP*AP*CP*TP*CP*CP*TP*CP*A)-3')","4","4RI8"
"4RI9",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, NaCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1258973",,"4RI9",181.21,"2.9","2.9","FAN1 Nuclease bound to 5' phosphorylated p(dT)/3'(dT-dT-dT-dT-dT-dT-dT-dT) double flap DNA","SGAHMTRNGPGQTTGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLANPNGQKQQLVDAFLKLAKQRSVIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAVGAKSQSLS","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RI9"
,,,,,,,,,,,,,,,,"TAGCCACGCCT",,,"DNA (5'-D(P*TP*AP*GP*CP*CP*AP*CP*GP*CP*CP*T)-3')","2","4RI9"
,,,,,,,,,,,,,,,,"AGACTCCTCTTTTTTTT",,,"DNA (5'-D(P*AP*GP*AP*CP*TP*CP*CP*TP*CP*TP*TP*TP*TP*TP*TP*TP*T)-3')","3","4RI9"
,,,,,,,,,,,,,,,,"GCTGAGGAGTCT",,,"DNA (5'-D(P*GP*CP*TP*GP*AP*GP*GP*AP*GP*TP*CP*T)-3')","4","4RI9"
,,,,,,,,,,,,,,,,"TTTTTTGAGGCGTG",,,"DNA (5'-D(*TP*TP*TP*TP*TP*TP*GP*AP*GP*GP*CP*GP*TP*G)-3')","5","4RI9"
"4RIA",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, NaCl , pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1258973",,"4RIA",175.56,"3","3","FAN1 Nuclease bound to 5' phosphorylated nicked DNA","GAHMTRNGPGQTTGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLANPNGQKQQLVDAFLKLAKQRSVIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAVGAKSQSLS","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RIA"
,,,,,,,,,,,,,,,,"AGCCACGCCT",,,"DNA (5'-D(P*AP*GP*CP*CP*AP*CP*GP*CP*CP*T)-3')","2","4RIA"
,,,,,,,,,,,,,,,,"AGACTCCTC",,,"DNA (5'-D(P*AP*GP*AP*CP*TP*CP*CP*TP*C)-3')","3","4RIA"
,,,,,,,,,,,,,,,,"TTTTTTGAGGCGTG",,,"DNA (5'-D(*TP*TP*TP*TP*TP*TP*G*AP*GP*GP*CP*GP*TP*G)-3')","4","4RIA"
,,,,,,,,,,,,,,,,"GCTGAGGAGTCT",,,"DNA (5'-D(P*GP*CP*TP*GP*AP*GP*GP*AP*GP*TP*CP*T)-3')","5","4RIA"
"4RIB",,"X-RAY DIFFRACTION",3.27,62.38,"hanging drop vapor diffusion",7,"PEG 3350, NaCl, pH 7.0, hanging drop vapor diffusion, temperature 277K",277,"10.1126/science.1258973",,"4RIB",176.06,"3.25","3.25","FAN1 Nuclease bound to 5' phosphorylated p(dT) single flap DNA","GAHMTRNGPGQTTGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLANPNGQKQQLVDAFLKLAKQRSVIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAVGAKSQSLS","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RIB"
,,,,,,,,,,,,,,,,"TAGCCACGCCTAGACTCCTC",,,"DNA (5'-D(P*TP*AP*GP*CP*CP*AP*CP*GP*CP*CP*TP*AP*GP*AP*CP*TP*CP*CP*TP*C)-3')","2","4RIB"
,,,,,,,,,,,,,,,,"GCTGAGGAGTCT",,,"DNA (5'-D(*GP*CP*TP*GP*AP*GP*GP*AP*GP*TP*CP*T)-3')","3","4RIB"
,,,,,,,,,,,,,,,,"TTTTTTGAGGCGTG",,,"DNA (5'-D(*TP*TP*TP*TP*TP*TP*GP*AP*GP*GP*CP*GP*TP*G)-3')","4","4RIB"
"4RIC",,"X-RAY DIFFRACTION",3.27,62.38,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, NaCl , pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1258973",,"4RIC",172.79,"2.8","2.8","FAN1 Nuclease bound to 5' hydroxyl (dT-dT) single flap DNA","TGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLVNPNGQKQQLVDAFLKLAKQRSVIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAV","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RIC"
,,,,,,,,,,,,,,,,"TTAGCCACGCCTAGACTCCTC",,,"DNA (5'-D(*TP*TP*AP*GP*CP*CP*AP*CP*GP*CP*CP*TP*AP*GP*AP*CP*TP*CP*CP*TP*C)-3')","2","4RIC"
,,,,,,,,,,,,,,,,"GCTGAGGAGTCT",,,"DNA (5'-D(*GP*CP*TP*GP*AP*GP*GP*AP*GP*TP*CP*T)-3')","3","4RIC"
,,,,,,,,,,,,,,,,"TTTTTTGAGGCGTG",,,"DNA (5'-D(*TP*TP*TP*TP*TP*TP*GP*AP*GP*GP*CP*GP*TP*G)-3')","4","4RIC"
"4RID",,"X-RAY DIFFRACTION",4.05,69.66,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, NaCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1258973",,"4RID",145.92,"3.3","3.3","Human FAN1 nuclease","TGHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLVNPNGQKQQLVDAFLKLAKQRSVCTWGKNKPGIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAV","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RID"
"4RIK",,"X-RAY DIFFRACTION",1.52,19.22,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.9M Ammonium Phosphate, 0.1M Sodium Acetate, pH 4.6, vapor diffusion, hanging drop, temperature 273K",273,"10.1038/nature15368",,"4RIK",0.82,"1.854","1.854","Amyloid forming segment, AVVTGVTAV, from the NAC domain of Parkinson's disease protein alpha-synuclein, residues 69-77","AVVTGVTAV","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","4RIK"
"4RIL",,"ELECTRON CRYSTALLOGRAPHY",1.46,15.81,"batch crystallization",4,"1 mg of synthetic peptide GAVVTGVTAVA was dissolved in 1 ml of sterile water and shaken overnight in an orbital mixing plate, pH 4.0, batch crystallization, temperature 310K",310,"10.1038/nature15368",,"4RIL",0.94,"1.43","1.43","Structure of the amyloid forming segment, GAVVTGVTAVA, from the NAC domain of Parkinson's disease protein alpha-synuclein, residues 68-78, determined by electron diffraction","GAVVTGVTAVA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","4RIL"
"4RIO",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, HANGING DROP",5.8,"30% PEG-3350, 200MM MAGNESIUM CHLORIDE 100MM BIS-TRIS PH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.10.061","3QX","4RIO",33.53,"2.69","2.69","Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor","GPASQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","4RIO"
"4RIR",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, SITTING DROP",6,"A drop composed of 0.3 ul protein and 0.3 ul 25 mM MES, pH 6.0, 1.5% PEG 3350 over a reservoir of 50 ul 24% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.ebiom.2015.06.016",,"4RIR",96.24,"2.5","2.5","Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission Risk","EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLGGRYYYDSSGYYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"CH58-UA Fab heavy chain","1","4RIR"
,,,,,,,,,,,,,,,,"NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSSWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH58-UA Fab light chain","2","4RIR"
"4RIU",,"X-RAY DIFFRACTION",2.07,40.5,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium Citrate, 50mM Tris, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.12.030",,"4RIU",29.98,"1.651","1.651","A Carbonic Anhydrase IX Mimic in Complex with a Saccharin-Based Inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RIU"
"4RIV",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2014.12.030","LSA","4RIV",29.72,"1.631","1.631","A Carbonic Anhydrase IX Mimic in Complex with Saccharin","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RIV"
"4RJ3",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 4000, ammonium acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm501578n","3QS","4RJ3",34.47,"1.63","1.63","CDK2 with EGFR inhibitor compound 8","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","4RJ3"
"4RJ4",,"X-RAY DIFFRACTION",3.49,64.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 10,000, ethyene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm501578n","3QW","4RJ4",37.98,"2.78","2.78","EGFR kinase (T790M/L858R) with inhibitor compound 6","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGNS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4RJ4"
"4RJ5",,"X-RAY DIFFRACTION",3.51,64.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 10,000, ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm501578n","3QY","4RJ5",37.94,"3.1","3.1","EGFR kinase (T790M/L858R) with inhibitor compound 5","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGNS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4RJ5"
"4RJ6",,"X-RAY DIFFRACTION",3.47,64.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 10,000, ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm501578n",,"4RJ6",38.04,"2.7","2.7","EGFR kinase (T790M/L858R) with inhibitor compound 4","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGNS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4RJ6"
"4RJ7",,"X-RAY DIFFRACTION",3.5,64.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 10,000, ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm501578n","3R1","4RJ7",38.09,"2.55","2.55","EGFR kinase (T790M/L858R) with inhibitor compound 1","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGNS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4RJ7"
"4RJ8",,"X-RAY DIFFRACTION",3.5,64.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 10,000, ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/jm501578n","3QS","4RJ8",38.04,"2.5","2.5","EGFR kinase (T790M/L858R) with inhibitor compound 8","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGNS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4RJ8"
"4RJT",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, HANGING DROP",7,"0.05 M Sodium Formate, 15% PEG 3350, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi500594x",,"4RJT",165.42,"2.7","2.7","Crystal Structure of Unliganded, Full Length hUGDH at pH 7.0","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","4RJT"
"4RK8",,"X-RAY DIFFRACTION",3.43,64.14,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40 mM UDAO, 20.8 mM, N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, 1 mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4RK8",44.7,"2.22","2.22","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A356","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4RK8"
"4RKA",,"X-RAY DIFFRACTION",3.41,63.89,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40 mM UDAO, 20.8 mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, 1 mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4RKA",44.2,"2.71","2.71","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A347","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4RKA"
"4RKJ",,"X-RAY DIFFRACTION",2.1,41.49,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.2 M K formate and 21% PEG3350, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.biochem.5b00014",,"4RKJ",33.96,"1.7","1.7","Crystal structure of thrombin mutant S195T (free form)","GSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","4RKJ"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDTGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","4RKJ"
"4RKK",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",5,"250 mM maltohexaose, 0.19 M Sodium Acetate, 0.1 M Sodium Citrate, 25.5% PEG3350, 15% Glycerol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.molcel.2014.11.020",,"4RKK",79.73,"2.4","2.4","Structure of a product bound phosphatase","GSHMRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHSNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVC","Homo sapiens","EPM2A","Laforin","1","4RKK"
,,,,,"VAPOR DIFFUSION, HANGING DROP",5,"250 mM maltohexaose, 0.17 M Sodium Acetate, 0.08 M Sodium Citrate, 25.5% PEG4000, 15% Glycerol, 30 mM Sodium Tungstate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277
"4RKO",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, pH 6.5, 15% PEG 6000 and 5% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.biochem.5b00014",,"4RKO",35.73,"1.84","1.84","Crystal structure of thrombin mutant S195T bound with PPACK","IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDTGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","1","4RKO"
,,,,,,,,,,,,,,,,"TFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","2","4RKO"
"4RKW",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION",4.6,"28-32% PEG400, 100 mM citrate, pH 4.6, VAPOR DIFFUSION, temperature 298.0K",298,"10.1523/JNEUROSCI.4751-13.2014",,"4RKW",19.92,"1.5","1.5","Crystal structure of DJ-1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4RKW"
"4RKY",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION",4.6,"28-32% PEG400, 100 mM citrate, pH 4.6, VAPOR DIFFUSION, temperature 298K",298,"10.1523/JNEUROSCI.4751-13.2014",,"4RKY",19.95,"1.5","1.5","Crystal structure of DJ-1 isoform X1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4RKY"
"4RL7",,"X-RAY DIFFRACTION",2.03,39.38,,7.5,"pH 7.5, temperature 297K",297,"10.1093/abbs/gmu132",,"4RL7",16.58,"2","2","Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.5, PEG6000)","GSHMAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4RL7"
"4RLI",,"X-RAY DIFFRACTION",3.45,64.32,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40 mM UDAO, 20.8 mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, 1 mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"3SH","4RLI",43.62,"2.5","2.5","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A048","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4RLI"
"4RLL",,"X-RAY DIFFRACTION",1.98,37.79,"VAPOR DIFFUSION, SITTING DROP",5.6,"Reservoir: 30 % PEG 4000, 0.2 M ammonium acetate, 0.1 M sodium citrate pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.canlet.2014.10.026",,"4RLL",40.49,"1.85","1.85","Crystal structure of human CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CK2A1, CSNK2A1","Casein kinase II subunit alpha","1","4RLL"
"4RLO",,"X-RAY DIFFRACTION",3.27,62.34,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, 3.5M Sodium Formate, with staurosporine, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1021/jm5011868",,"4RLO",67.27,"2.527","2.527","Human p70s6k1 with ruthenium-based inhibitor EM5","KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","4RLO"
"4RLP",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, 3.5M Sodium Formate, with staurosporine, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1021/jm5011868",,"4RLP",33.62,"2.79","2.79","Human p70s6k1 with ruthenium-based inhibitor FL772","KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL","Homo sapiens","RPS6KB1, STK14A","p70S6K1","1","4RLP"
"4RLS",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, sodium malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2014.10.067","49C","4RLS",149.81,"1.91","1.91","Lactate Dehydrogenase in complex with inhibitor compound 47","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","4RLS"
"4RM8",,"X-RAY DIFFRACTION",1.64,25.17,"VAPOR DIFFUSION, HANGING DROP",5.9,"0.1M Bis-Tris pH 5.9, 15% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BCJ20160541",,"4RM8",139.17,"1.9","1.9","Crystal structure of human ezrin in space group P21","GMPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWYFGLHYVDNKGFPTWLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLFFLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVHKSGYLSSERLIPQRVMDQHKLTRDQWEDRIQVWHAEHRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWLGVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILQLCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQLERQQLETEKKRRETVEREKEQMMREKEELMLRLQDYEEKTKKAERELSEQIQRALQLEEERKRAQEEAERLEADRMAALRAKEELERQAVDQIKSQEQLAAELAEYTAKIALLEEARRRKEDEVEEWQHRAKEAQDDLVKTKEELHLVMTAPPPPPPPVYEPVSYHVQESLQDEGAEPTGYSAELSSEGIRDDRNEEKRITEAEKNERVQRQLLTLSSELSQARDENKRTHNDIIHNENMRQGRDKYKTLRQIRQGNTKQRIDEFEAL","Homo sapiens","EZR, VIL2","Ezrin","1","4RM8"
"4RM9",,"X-RAY DIFFRACTION",1.54,19.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris pH 5.5, 18% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BCJ20160541",,"4RM9",69.58,"2","2","Crystal structure of human ezrin in space group C2221","GMPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWYFGLHYVDNKGFPTWLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLFFLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVHKSGYLSSERLIPQRVMDQHKLTRDQWEDRIQVWHAEHRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWLGVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILQLCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQLERQQLETEKKRRETVEREKEQMMREKEELMLRLQDYEEKTKKAERELSEQIQRALQLEEERKRAQEEAERLEADRMAALRAKEELERQAVDQIKSQEQLAAELAEYTAKIALLEEARRRKEDEVEEWQHRAKEAQDDLVKTKEELHLVMTAPPPPPPPVYEPVSYHVQESLQDEGAEPTGYSAELSSEGIRDDRNEEKRITEAEKNERVQRQLLTLSSELSQARDENKRTHNDIIHNENMRQGRDKYKTLRQIRQGNTKQRIDEFEAL","Homo sapiens","EZR, VIL2","Ezrin","1","4RM9"
"4RMA",,"X-RAY DIFFRACTION",2.47,50.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Ammonium sulfate, 0.1M HEPES pH 7.5, 10% isopropanol, 18% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1042/BCJ20160541",,"4RMA",70.35,"1.75","1.75","Crystal structure of the FERM domain of human ezrin","MPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWYFGLHYVDNKGFPTWLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLFFLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVHKSGYLSSERLIPQRVMDQHKLTRDQWEDRIQVWHAEHRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWLGVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILQLCMGNHELYMRRRK","Homo sapiens","EZR, VIL2","Ezrin","1","4RMA"
"4RMG",,"X-RAY DIFFRACTION",2.91,57.71,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M KSCN, 30% (wt/vol) PEG MME 2,000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/ncomms7263","3TE","4RMG",35.57,"1.88","1.88","Human Sirt2 in complex with SirReal2 and NAD+","GHMERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4RMG"
"4RMH",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, SITTING DROP",9,"2.8 M ammonium sulfate, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/ncomms7263","3TE","4RMH",35.63,"1.42","1.42","Human Sirt2 in complex with SirReal2 and Ac-Lys-H3 peptide","GHMERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4RMH"
,,,,,,,,,,,,,,,,"TGGKAPR",,,"Ac-Lys-H3 peptide","2","4RMH"
"4RMJ",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, SITTING DROP",5.75,"18% (wt/vol) PEG 10,000, pH 5.75, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/ncomms7263","NCA","4RMJ",70.67,"1.87","1.87","Human Sirt2 in complex with ADP ribose and nicotinamide","GHMERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4RMJ"
"4RMQ",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",5,"27% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0144061",,"4RMQ",11.98,"1.461","1.461","Crystal structure of the D59N Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKNWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMQ"
"4RMR",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, SITTING DROP",5,"21% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0144061",,"4RMR",12.04,"1.529","1.529","Crystal structure of the D38N Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVNLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMR"
"4RMS",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"27% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0144061",,"4RMS",12.04,"1.7","1.7","Crystal structure of the D53N Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSNLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMS"
"4RMT",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, SITTING DROP",6,"27% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0144061",,"4RMT",12.19,"1.242","1.242","Crystal structure of the D98N Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRNM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMT"
"4RMU",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, SITTING DROP",6,"24% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/s41467-018-04078-y",,"4RMU",12.04,"1.4","1.4","Crystal structure of the D76E Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKEEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMU"
"4RMV",,"X-RAY DIFFRACTION",2.03,39.48,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/s41467-018-04078-y",,"4RMV",12.11,"1.463","1.463","Crystal structure of the D76H Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKHEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMV"
"4RMW",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, SITTING DROP",5.5,"21% PEG4000, 15% glycerol, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/s41467-018-04078-y",,"4RMW",12.04,"1.4","1.4","Crystal structure of the D76A Beta-2 Microglobulin mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKAEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","4RMW"
"4RMZ",,"X-RAY DIFFRACTION",2.6,52.77,"EVAPORATION",6.4,"2.6 - 2.9 M ammonium sulfate, PH 6.4-7.9 , EVAPORATION, temperature 293K",293,,,"4RMZ",70.23,"2.2","2.2","Crystal Structure of IRAK-4","ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","4RMZ"
"4RN0",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M Imidazole (pH=7.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 8% PEG 8000, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.biochem.5b00010","L6G","4RN0",87.96,"1.761","1.761","Crystal structure of S39D HDAC8 in complex with a largazole analogue.","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRADMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4RN0"
"4RN1",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M Imidazole (pH=7.0), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 13% PEG 3350, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.biochem.5b00010",,"4RN1",87.95,"2.18","2.18","Crystal structure of S39D HDAC8 in complex with a largazole analogue.","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRADMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4RN1"
"4RN2",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M BisTris (pH = 6.5), 4 mM tris(2-carboxyethyl)phosphine (TCEP), 8% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/acs.biochem.5b00010","L7G","4RN2",87.79,"2.39","2.39","Crystal structure of S39D HDAC8 in complex with a largazole analogue.","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRADMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","4RN2"
"4RN4",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.9 M ammonium sulfate with 0.1 M Tris buffer, Protein at 14 mg/mL, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm501798g","3T7","4RN4",30.07,"1.53","1.53","Human Carbonic anhydrases II in complex with a acetazolamide derivative comprising one hydrophobic and one hydrophilic tail moiety","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RN4"
"4RN5",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION",6,"100mM MES, 200mM Zinc Acetate, 10% PEG 8000, pH 6.0, VAPOR DIFFUSION, temperature 293K",293,,,"4RN5",18.2,"1.73","1.73","B1 domain of human Neuropilin-1 with acetate ion in a ligand-binding site","GHMFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKIT","Homo sapiens","NRP1, NRP, VEGF165R","Neuropilin-1","1","4RN5"
"4RN6",,"X-RAY DIFFRACTION",2.06,40.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM TRIS PH 8.5, 200 mM LI2SO4 AND 30% PEG 3000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K",295,"10.1074/jbc.M113.451542","15U","4RN6",67.8,"3","3","Structure of prethrombin-2 mutant s195a bound to the active site inhibitor argatroban","EADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","1","4RN6"
"4RNR",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, SITTING DROP",6.2,"40% PEG 400, 0.2 M NaCl, 0.1 M Na/K phosphate, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1128/JVI.02905-14",,"4RNR",97.08,"2.758","2.758","Crystal structure of broadly neutralizing anti-HIV antibody PGT130","QVQLQESGPGLVKPAETLSLTCSVSGESINTGHYYWGWVRQVPGKGLEWIGHIHYTTAVLHNPSLKSRLTIKIYTLRNQITLRLSNVTAADTAVYHCVRSGGDILYYYEWQKPHWFSPWGPGIHVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"PGT130 Heavy Chain","1","4RNR"
,,,,,,,,,,,,,,,,"QSALTQPPSASGSLGQSVTISCNGTSSDIGGWNFVSWYQQFPGRAPRLIIFEVNKRPSGVPGRFSGSKSGNSASLTVSGLQSDDEGQYFCSSLFGRWDVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PGT130 Light Chain","2","4RNR"
"4ROU",,"X-RAY DIFFRACTION",2.05,40.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M MgCl2, 0.1M HEPES pH 7.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"4ROU",72.49,"2.713","2.713","Auto-inhibition Mechanism of Human Mitochondrial RNase P Protein Complex","DIVPMLETLKAFFDFGKDIKDDNYSNKLLDILSYLRNNQLYPGESFAHSIKTWFESVPGKQWKGQFTTVRKSGQCSGCGKTIESIQLSPEEYECLKGKIMRDVIDGGDQYRKTTPQELKRFENFIKSRPPFDVVIDGLNVAKMFPKVRESQLLLNVVSQLAKRNLRLLVLGRKHMLRRSSQWSRDEMEEVQKQASCFFADDISEDDPFLLYATLHSGNHCRFITRDLMRDHKACLPDAKTQRLFFKWQQGHQLAIVNRFPGSKLTFQRILSYDTVVQTTGDSWHIPYDEDLVERCSCEVPTKWLCLHQKT","Homo sapiens","PRORP, KIAA0391, MRPP3","Mitochondrial ribonuclease P protein 3","1","4ROU"
"4ROV",,"X-RAY DIFFRACTION",2.4,48.75,"VAPOR DIFFUSION",6.4,"0.04M citric acid, 0.06M Bis-Tris propane, pH 6.4, 20% w/v polyethylene glycol 3350, VAPOR DIFFUSION, temperature 291.0K",291,"10.1074/jbc.M114.624262",,"4ROV",46.59,"1.8","1.8","The crystal structure of novel APOBEC3G CD2 head-to-tail dimer suggests the binding mode of full-length APOBEC3G to HIV-1 ssDNA","GSHMASLRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIFTARIYDDQGRCQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGCPFQPWDGLDEHSQDLSGRLRAILQNQEN","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","4ROV"
"4ROW",,"X-RAY DIFFRACTION",2.19,43.96,"VAPOR DIFFUSION",5.6,"0.1M sodium citrate tribasic dehydrate pH 5.6, 20% v/v 2-propanol, 20% w/v polyethylene glycol 4000, VAPOR DIFFUSION, temperature 291.0K",291,"10.1074/jbc.M114.624262",,"4ROW",23.25,"1.7","1.7","The crystal structure of novel APOBEC3G CD2 head-to-tail dimer suggests the binding mode of full-length APOBEC3G to HIV-1 ssDNA","GSHMASLRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIFTARIYDDQGRCQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGCPFQPWDGLDEHSQALSGRLRAILQNQEN","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","4ROW"
"4RP6",,"X-RAY DIFFRACTION",1.58,22.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"reservoir contained 0.1 M Tris buffer pH 8.5 and 20% ethanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ccell.2015.12.002",,"4RP6",0.8,"1.703","1.703","Structure of the amyloid-forming segment LTIITLE from p53 (residues 252-258)","LTIITLE","Homo sapiens","TP53, P53","LTIITLE heptapeptide segment from p53","1","4RP6"
"4RP7",,"X-RAY DIFFRACTION",1.5,17.78,"VAPOR DIFFUSION, HANGING DROP",6,"reservoir contained 0.01 M zinc    
chloride, 0.1 M MES buffer pH 6, and 20% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ccell.2015.12.002",,"4RP7",0.75,"1.576","1.576","Structure of the amyloid-forming segment TIITLE from p53 (residues 253-258)","TIITLE","Homo sapiens","TP53, P53","TIITLE hexapeptide segment from p53","1","4RP7"
"4RPP",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Sodium chloride, 0.1M BIS-TRIS propane pH 9.0, 25% PEG1500, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1007/s13238-015-0132-x",,"4RPP",236.25,"2.585","2.585","crystal structure of PKM2-K422R mutant bound with FBP","PLGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFRCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVPX","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4RPP"
"4RPQ",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization solution: 50 mM di-Ammoniumhydrogen citrate pH 5.0 PEG6000= 5 % (m/V) DTT= 5.15 g/L NADP+=0.66 g/L and Human Aldose Reductase= 15 mg/ml. Afterwards the crystals were soaked into Tris 100 mM 25% (m/V) PEG6000 saturated with the inhibitor., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"3UH","4RPQ",36.92,"1.2","1.2","Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)","ASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4RPQ"
"4RPU",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",6.7,"15.0% PEG 8000, 15 mM TCEP, 80 mM sodium cacodylate pH 6.7, 160 mM calcium acetate, 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"4RPU",235.62,"2.265","2.265","Crystal Structure of Human Presequence Protease in Complex with Inhibitor MitoBloCK-60","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILQHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","1","4RPU"
,,,,,,,,,,,,,,,,"MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILQHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","2","4RPU"
"4RPV",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, pH 8.0, 
1.0 M LiCl, 
10-20% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.12.068",,"4RPV",46.71,"3.05","3.05","co-crystal structure of Pim1 with compound 3","HHHHHHMPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSRNATRSHSHSHSPRHSLRHSPGSGSCGSSSGHRPCADILEVGMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4RPV"
"4RQK",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"21 mg/mL protein in 25 mM Tris, pH 7.5, 0.5 M sodium chloride, 1 mM DTT, 15 mM EDTA, 15mM ATP, precipitant: 0.1 M HEPES, pH 7.5, 1.2 M sodium citrate , VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1073/pnas.1415365112",,"4RQK",36.7,"1.55","1.55","Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS1","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","4RQK"
"4RQL",,"X-RAY DIFFRACTION",3.29,62.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, 25% w/v PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1124/mol.114.097014","SNE","4RQL",113.89,"2.105","2.105","Crystal structure of a human cytochrome P450 2B6 (Y226H/K262R) in complex with a monoterpene - sabinene","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","4RQL"
"4RQM",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, HANGING DROP",7,"35% PEG-550 MME, 100mM MES, 5mM zinc sulfate, pH 7.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.str.2017.12.002",,"4RQM",24.44,"1.75","1.75","Crystal structure of the SeMET BICC1 SAM Domain R924E mutant","SNSSFKGSDLPELFSKLGLGKYTDVFQQQEIDLQTFLTLTDQDLKELGITTFGAREKMLLAISELNKNRRK","Homo sapiens","BICC1","Protein bicaudal C homolog 1","1","4RQM"
"4RQN",,"X-RAY DIFFRACTION",1.75,29.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG-550 MME, 100mM MES, 5mM zinc sulfate, pH 6.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.str.2017.12.002",,"4RQN",24.3,"2","2","Crystal structure of the native BICC1 SAM Domain R924E mutant","SNSSFKGSDLPELFSKLGLGKYTDVFQQQEIDLQTFLTLTDQDLKELGITTFGAREKMLLAISELNKNRRK","Homo sapiens","BICC1","Protein bicaudal C homolog 1","1","4RQN"
"4RQQ",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION, SITTING DROP",8,"0.04 M potassium dihydrogen phosphate, 16% w/v polyethylene glycol 8000 and 20% v/v glycerol, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1415789111",,"4RQQ",151.6,"3.1","3.1","Crystal structure of human Fab PGDM1400, a broadly reactive and potent HIV-1 neutralizing antibody","DFVLTQSPHSLSVTPGESASISCKSSHSLIHGDRNNYLAWYVQKPGRSPQLLIYLASSRASGVPDRFSGSGSDKDFTLKISRVETEDVGTYYCMQGRESPWTFGQGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Human anti-HIV-1 antibody PGDM1400 light chain","1","4RQQ"
,,,,,,,,,,,,,,,,"QAQLVQSGPEVRKPGTSVKVSCKAPGNTLKTYDLHWVRSVPGQGLQWMGWISHEGDKKVIVERFKAKVTIDWDRSTNTAYLQLSGLTSGDTAVYYCAKGSKHRLRDYALYDDDGALNWAVDVDYLSNLEFWGQGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"Human anti-HIV-1 antibody PGDM1400 heavy chain","2","4RQQ"
"4RQR",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, HANGING DROP",4.2,"20% PEG 8K, 0.1 M phosphate citrate, 0.2M  NaCl, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.3390/molecules20034928",,"4RQR",12.23,"1.08","1.08","Crystal Structure of Human Glutaredoxin with MESNA","GAGTAQEFVNCKIQPGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLEFVDITATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLVSLQQSGELLTRLKQIGALQ","Homo sapiens","GLRX, GRX","Glutaredoxin-1","1","4RQR"
"4RQV",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"21 mg/mL protein in 25 mM Tris, pH 7.5, 0.5 M sodium chloride, 1 mM DTT, 15 mM EDTA, 15 mM ATP, precipitant: 0.1 M HEPES, pH 7.5, 1.2 M sodium citrate, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1073/pnas.1415365112",,"4RQV",36.65,"1.502","1.502","Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS2","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","4RQV"
"4RQX",,"X-RAY DIFFRACTION",2.78,55.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M ammonium sulfate, 0.1 M MES, 10% dioxane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.3390/molecules20034928",,"4RQX",128,"2.256","2.256","Crystal structure of human peroxiredoxin 4(THIOREDOXIN PEROXIDASE) with MESNA","MGSSHHHHHHSSGLVPRGSHMTTENLYFQGAGTAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","4RQX"
"4RR4",,"X-RAY DIFFRACTION",3.46,64.46,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate pH 4.8, 40 mM UDAO, 20.8 mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, 1 mM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4RR4",43.94,"2.38","2.38","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A367","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","4RR4"
"4RRN",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate pH 4.5, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1021/jm5015132","3UW","4RRN",45.89,"1.8","1.8","8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","4RRN"
"4RRO",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate pH 4.5, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1021/jm5015132","3UX","4RRO",45.9,"1.8","1.8","8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4RRO"
"4RRS",,"X-RAY DIFFRACTION",2.14,42.52,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG3K, 0.1M NaAcetate pH 4.5, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,"10.1021/jm5015132","3UY","4RRS",45.87,"1.8","1.8","8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4RRS"
"4RRT",,"X-RAY DIFFRACTION",3.27,62.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M lithium sulfate monohydrate, 0.1 M HEPES, pH 7.5, 25% w/v PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1124/mol.114.097014","3V4","4RRT",113.95,"2.2","2.2","Crystal structure of a human cytochrome P450 2B6 (Y226H/K262R) in complex with (+)-3-carene","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","4RRT"
"4RS6",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, SITTING DROP",7,"35%(v/v) Tacsimate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2014.11.125",,"4RS6",54.89,"2.6","2.6","Crystal structure of the C domain of Polo like Kinase II in Homo Sapiens","GPLGSPEGTLGSCSSSSECLEDSTMGSVADTVARVLRGCLENMPEADCIPKEQLSTSFQWVTKWVDYSNKYGFGYQLSDHTVGVLFNNGAHMSLLPDKKTVHYYAELGQCSVFPATDAPEQFISQVTVLKYFSHYMEENLMDGGDLPSVTDIRRPRLYLLQWLKSDKALMMLFNDGTFQVNFYHDHTKIIICSQNEEYLLTYINEDRISTTFRLTTLLMSGCSSELKNRMEYALNMLLQRCN","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4RS6"
"4RSG",,"NEUTRON DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7.5,"18mg/mL protein, 0.2M calcium acetate, 20% PEG 3350, 20mM HEPES, 50mM NaCl, 20mM MgCl2, 0.1% N-octy-B-D-glucopyranoside, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M115.679860",,"4RSG",19.42,"1.907","1.907","Neutron crystal structure of Ras bound to the GTP analogue GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4RSG"
"4RSS",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"10-20% (v/v) PEG 3350, 100mM Tris-HCl (pH 8.5) 
, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.09.011","4MG","4RSS",34.32,"1.83","1.83","Crystal structure of tyrosine-protein kinase SYK with an inhibitor","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4RSS"
"4RSV",,"X-RAY DIFFRACTION",2.22,44.68,,7.5,"0.3-0.5M NaCl   
19-23% PEG 3350   
10.52-11.35 mg/ml, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"4RSV",11.42,"2.41","2.41","Human Obscurin Ig58 Domain","TAKNTVVRGLENVEALEGGEALFECQLSQPEVAAHTWLLDDEPVRTSENAEVVFFENGLRHLLLLKNLRPQDSCRVTFLAGDMVTSAFLTVRGGLEHHHHHH","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","4RSV"
"4RSY",,"X-RAY DIFFRACTION",2.29,46.35,"VAPOR DIFFUSION, HANGING DROP",,"13% PEG 8000, 100mM Imidazole pH 6.0-6.8, 100mM Na Acetate, 5mM YbCl3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"B3N","4RSY",72.21,"1.93","1.93","Crystal structures of the Human leukotriene A4 Hydrolase complex with a potential inhibitor H7","MGSSHHHHHHSSGLVPRGSHMPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","4RSY"
"4RT7",,"X-RAY DIFFRACTION",2.58,52.29,"VAPOR DIFFUSION, SITTING DROP",5.5,"100mM Na-Citrate, pH5.5 and 20% PEG3000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1158/2159-8290.CD-15-0060","P30","4RT7",48.76,"3.1","3.1","Crystal Structure of FLT3 with a small molecule inhibitor","MSYYHHHHHHSSGENLYFQGHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV","Homo sapiens","FLT3, CD135, FLK2, STK1","Receptor-type tyrosine-protein kinase FLT3","1","4RT7"
"4RTA",,"X-RAY DIFFRACTION",2.19,43.9,"EVAPORATION",5.9,"0.1M COCADYLATE SODIUM, SODIUM FORMATE 4.2M, pH 5.9, EVAPORATION, temperature 291K",291,"10.1007/s13238-014-0127-z",,"4RTA",24.48,"2.123","2.123","Cystal structure of the Dpy30 for MLL/SET1 COMPASS H3K4 trimethylation","MEPEQMLEGQTQVAENPHSEYGLTDNVERIVENEKINAEKSSKQKVDLQSLPTRAYLDQTVVPILLQGLAVLAKERPPNPIEFLASYLLKNKAQFEDRNLERPHRD","Homo sapiens","DPY30","Protein dpy-30 homolog","1","4RTA"
"4RTT",,"X-RAY DIFFRACTION",1.85,33.56,"VAPOR DIFFUSION",6.25,"2.35M Ammonium Sulphate; 0.1M MES, pH 6.25, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.str.2015.08.009",,"4RTT",20.83,"1.87","1.87","Cyrstal structure of SLIT-ROBO Rho GTPase-activating protein 2 fragment","GAMGSEPIEAIAKFDYVGRTARELSFKKGASLLLYQRASDDWWEGRHNGIDGLIPHQYIVVQDTEDGVVERSSPKSEIEVISEPPEEKVTAR","Homo sapiens","SRGAP2, ARHGAP34, FNBP2, KIAA0456, SRGAP2A","SLIT-ROBO Rho GTPase-activating protein 2","1","4RTT"
"4RUE",,"X-RAY DIFFRACTION",4.97,75.23,"VAPOR DIFFUSION, HANGING DROP",8,"23% PEG400, 2% PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.neuron.2014.11.017",,"4RUE",67.52,"3.3","3.3","Human K2P4.1 (TRAAK) potassium channel, G124I mutant","MTTAPQEPPARPLQAGSGAGPAPGRAMRSTTLLALLALVLLYLVSGALVFRALEQPHEQQAQRELGEVREKFLRAHPCVSDQELGLLIKEVADALGGGADPETQSTSQSSHSAWDLGSAFFFSITIITTIGYGNVALRTDAGRLFCIFYALVGIPLFGILLAGVGDRLGSSLRHGIGHIEAIFLKWHVPPELVRVLSAMLFLLIGCLLFVLTPTFVFCYMEDWSKLEAIYFVIVTLTTVGFGDYVAGADPRQDSPAYQPLVWFWILLGLAYFASVLTTIGNWLRVVSRRTRAEMGGLTAQSNSLEVLFQ","Homo sapiens","KCNK4, TRAAK","Potassium channel subfamily K member 4","1","4RUE"
"4RUF",,"X-RAY DIFFRACTION",5.49,77.58,"VAPOR DIFFUSION, HANGING DROP",8,"24% PEG400, 10mM Sarcosine, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.neuron.2014.11.017",,"4RUF",67.21,"3.4","3.4","Human K2P4.1 (TRAAAK) potassium channel, W262S mutant","MTTAPQEPPARPLQAGSGAGPAPGRAMRSTTLLALLALVLLYLVSGALVFRALEQPHEQQAQRELGEVREKFLRAHPCVSDQELGLLIKEVADALGGGADPETQSTSQSSHSAWDLGSAFFFSGTIITTIGYGNVALRTDAGRLFCIFYALVGIPLFGILLAGVGDRLGSSLRHGIGHIEAIFLKWHVPPELVRVLSAMLFLLIGCLLFVLTPTFVFCYMEDWSKLEAIYFVIVTLTTVGFGDYVAGADPRQDSPAYQPLVSFWILLGLAYFASVLTTIGNWLRVVSRRTRAEMGGLTAQSNSLEVLFQ","Homo sapiens","KCNK4, TRAAK","Potassium channel subfamily K member 4","1","4RUF"
"4RUG",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION",6.25,"2.35M Ammonium Sulphate; 0.1M MES, pH 6.25, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.str.2015.08.009",,"4RUG",20.54,"1.73","1.73","Cyrstal structure of SLIT-ROBO Rho GTPase-activating protein 2 fragment","GAMGSEPIEAIAKFDYVGRTARELSFKKGASLLLYQRASDDWWEGRHNGIDGLIPHQYIVVQDTEDGVVERSSPKSEIEVISEPPEEKVTAR","Homo sapiens","SRGAP2, ARHGAP34, FNBP2, KIAA0456, SRGAP2A","SLIT-ROBO Rho GTPase-activating protein 2","1","4RUG"
"4RUH",,"X-RAY DIFFRACTION",2.18,43.51,"LIQUID DIFFUSION",8,"0.2M Hepes. 25% PPEG 4000, 100mm NaCl, pH 8.0, LIQUID DIFFUSION, temperature 293K",293,,,"4RUH",106.91,"2.25","2.25","Crystal structure of Human Carnosinase-2 (CN2) in complex with inhibitor, Bestatin at 2.25 A","MAALTTLFKYIDENQDRYIKKLAKWVAIQSVSAWPEKRGEIRRMMEVAAADVKQLGGSVELVDIGKQKLPDGSEIPLPPILLGRLGSDPQKKTVCIYGHLDVQPAALEDGWDSEPFTLVERDGKLYGRGSTDDKGPVAGWINALEAYQKTGQEIPVNVRFCLEGMEESGSEGLDELIFARKDTFFKDVDYVCISDNYWLGKKKPCITYGLRGICYFFIEVECSNKDLHSGVYGGSVHEAMTDLILLMGSLVDKRGNILIPGINEAVAAVTEEEHKLYDDIDFDIEEFAKDVGAQILLHSHKKDILMHRWRYPSLSLHGIEGAFSGSGAKTVIPRKVVGKFSIRLVPNMTPEVVGEQVTSYLTKKFAELRSPNEFKVYMGHGGKPWVSDFSHPHYLAGRRAMKTVFGVEPDLTREGGSIPVTLTFQEATGKNVMLLPVGSADDGAHSQNEKLNRYNYIEGTKMLAAYLYEVSQLKD","Homo sapiens","CN2, CNDP dipeptidase 2 (metallopeptidase M20 family) [ Homo sapiens (human), CNDP2, CPGL, PEPA, HEL-S-13","Cytosolic non-specific dipeptidase","1","4RUH"
"4RUI",,"X-RAY DIFFRACTION",2.86,56.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.3 M sodium acetate, 0.1 M sodium cacodylate, and 25% w/v PEG 2K MME, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1124/mol.114.097014",,"4RUI",332.55,"2.61","2.61","Crystal structure of a cytochrome P450 2A6 in complex with a monoterpene - sabinene.","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A3, CYP2A6","Cytochrome P450 2A6","1","4RUI"
"4RUN",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",3.5,"Protein solution: 14 mg/ml protein, 0.2 M imidazole, 0.4 M NaCl, 10 mM Tris-HCl, 1.3 mM Menthol, 3.3 %(v/v) Methanol;  
Reservoir solution: 20 %(w/v) PEG 3350, 0.1 M ammonium citrate, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24797",,"4RUN",37.5,"2.6","2.6","Crystal structure of human odorant binding protein OBPIIa","LSFTLEEEDITGTWYVKAMVVDKDFPEDRRPRKVSPVKVTALGGGNLEATFTFMREDRCIQKKILMRKTEEPGKFSAYGGRKLIYLQELPGTDDYVFYSKDQRRGGLRYMGNLVGRNPNTNLEALEEFKKLVQHKGLSEEDIFMPLQTGSCVLEHHHHHHH","Homo sapiens","OBP2A","Odorant-binding protein 2a","1","4RUN"
"4RUU",,"X-RAY DIFFRACTION",2,38.55,"VAPOR DIFFUSION, HANGING DROP",4,"30 % PEG 4000, 0.1 M Ammonium Acatate, 0.1 M Sodium Acetate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1126/science.1226135",,"4RUU",31.85,"1.4","1.4","Crystal structure of the Q108K:K40L mutant of human Cellular Retinol Binding ProteinII in complex with All-trans-Retinal after 24 hour incubation at 1.4 Angstrom Resolution","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","4RUU"
"4RUX",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-HCl, 3mM 4-(allyloxy)benzenesulfonamide, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2015.02.027","3W3","4RUX",29.87,"1.14","1.14","Crystal structure of human Carbonic Anhydrase II in complex with 4-(allyloxy)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RUX"
"4RUY",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-HCl, 3mM 4-propoxybenzenesulfonamide, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2015.02.027","3W6","4RUY",29.88,"1.14","1.14","Crystal structure of human Carbonic Anhydrase II in complex with 4-propoxybenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RUY"
"4RUZ",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-HCl, 3mM 4-Ethoxybenzenesulfonamide, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2015.02.027","3W8","4RUZ",29.85,"1.63","1.63","Crystal structure of human Carbonic Anhydrase II in complex with 4-ethoxybenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4RUZ"
"4RV6",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",5.9,"27% PEG3350, 0.2 M Ammonium Sulfate, 0.1 M Bis-Tris, 1mM Rucaparib, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.jmedchem.6b00990","RPB","4RV6",158.77,"3.19","3.19","Human ARTD1 (PARP1) catalytic domain in complex with inhibitor Rucaparib","SMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","ADPRT, PARP1, PPOL","Poly [ADP-ribose] polymerase 1","1","4RV6"
"4RVB",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",6.2,"13% PEG 8000, 100MM IMIDAZOLE PH 6.2, 100MM NAACETATE, 5MM YBCL3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4RVB",72.4,"1.93","1.93","Crystal Structure Analysis of the Human Leukotriene A4 Hydrolase","MGSSHHHHHHSSGLVPRGSHMPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","4RVB"
"4RVK",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, SITTING DROP",7.4,"HEPES, isopropanol, PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/acs.jmedchem.5b00464","3XK","4RVK",34.53,"1.85","1.85","CHK1 kinase domain with diazacarbazole compound 8: N-[3-(6-cyano-9H-pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4RVK"
"4RVL",,"X-RAY DIFFRACTION",2.49,50.54,"VAPOR DIFFUSION, SITTING DROP",7.4,"HEPES, isopropanol, PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/acs.jmedchem.5b00464","3XL","4RVL",34.49,"1.85","1.85","CHK1 kinase domain with diazacarbazole compound 7: 3-(2-hydroxyphenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4RVL"
"4RVM",,"X-RAY DIFFRACTION",2.52,51.17,"VAPOR DIFFUSION, SITTING DROP",7.4,"Hepes, isopropanol, PEG 8000, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/acs.jmedchem.5b00464","3X7","4RVM",34.57,"1.86","1.86","CHK1 kinase domain with diazacarbazole compound 19","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","4RVM"
"4RVR",,"X-RAY DIFFRACTION",4.27,71.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% Low Molecular-Weight PEG Smears, 0.1M MES pH 6.5 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution) , VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1021/acs.jmedchem.5b00209","3WQ","4RVR",14.36,"1.98","1.98","Crystal Structure of the bromodomain of human BAZ2B in complex WITH GSK2801","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4RVR"
"4RVT",,"X-RAY DIFFRACTION",2.19,43.76,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.1M MES, 14% v/v PEG 8000, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.201501515","3XM","4RVT",75.57,"2.4","2.4","MAP4K4 in complex with a pyridin-2(1H)-one derivative","GSHMANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSG","Homo sapiens","HGK, KIAA0687, MAP4K4, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4RVT"
"4RWI",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.1 M sodium cacodylate pH 6.4, 30% PEG 8000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acschembio.5b00014",,"4RWI",72.52,"2.292","2.292","Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo","MGHHHHHHMAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIMEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4RWI"
"4RWJ",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.1 M sodium cacodylate pH 6.4, 22% PEG 8000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/acschembio.5b00014","66T","4RWJ",73.38,"2.489","2.489","Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)","MGHHHHHHMAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4RWJ"
"4RWK",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.1 M MES pH 6.6, 34% PEG 8000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acschembio.5b00014",,"4RWK",73.47,"2.982","2.982","Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)","MGHHHHHHMAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIMEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4RWK"
"4RWL",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.1 M sodium cacodylate pH 6.6, 34% PEG 8000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acschembio.5b00014","3ZC","4RWL",72.99,"2.193","2.193","Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide (E3810)","MGHHHHHHMAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","BFGFR, CEK, FGFBR, FGFR1, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4RWL"
"4RX5",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 10000, Li2SO4, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2015.11.076","3YO","4RX5",32.81,"1.356","1.356","Bruton's tyrosine kinase (BTK) with pyridazinone compound 23","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQ","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","4RX5"
"4RX7",,"X-RAY DIFFRACTION",2.26,45.57,"VAPOR DIFFUSION",6,"20% PEG 3350, 0.2M ammonium formate, pH 6.0, vapor diffusion, temperature 293K",293,"10.1021/jm5018863","3YV","4RX7",34.2,"1.8","1.8","SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVTDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4RX7"
"4RX8",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION",7.3,"20% PEG 3350, 0.2M potassium formate, pH 7.3, vapor diffusion, temperature 293K",293,"10.1021/jm5018863","3YX","4RX8",34.22,"1.59","1.59","SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor2","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVTDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4RX8"
"4RX9",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION",6,"20% PEG 3350, 0.2M ammonium formate, pH 6.0, vapor diffusion, temperature 293K",293,"10.1021/jm5018863","3YT","4RX9",34.29,"1.75","1.75","SYK Catalytic Domain Complexed with a Potent Pyrimidine Inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVTDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4RX9"
"4RXA",,"X-RAY DIFFRACTION",2.99,58.86,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.2M NA/K phosphate, 25% glycerol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml500528x","3F2","4RXA",40.65,"2.2","2.2","Crystal structure of human farnesyl diphosphate synthase in complex with BPH-1358","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4RXA"
"4RXJ",,"X-RAY DIFFRACTION",3.1,60.33,"VAPOR DIFFUSION",3.5,"25% w/v PEG3350, 10% citric acid, pH 3.5, vapor diffusion, temperature 293K, VAPOR DIFFUSION",293,"10.1016/j.bbrc.2021.07.017",,"4RXJ",13.22,"2.1","2.1","crystal structure of WHSC1L1-PWWP2","GKAGKKLHYKQIVWVKLGNYRWWPAEICNPRSVPLNIQGLKHDLGDFPVFFFGSHDYYWVHQGRVFPYVEGDKSFAEGQTSINKTFKKALEEAAKRFQELKAQRESKEALEIE","Homo sapiens","WHSC1L1, NSD3, DC28","Histone-lysine N-methyltransferase NSD3","1","4RXJ"
"4RXO",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium chloride, 0.1M Na/K phosphate, and 25% w/v polyethylene glycol 1000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S1399004714027527",,"4RXO",252.68,"2.6","2.6","The structure of GTP-bound SAMHD1","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4RXO"
"4RXP",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M lithium sulfate monohydrate, 0.1M sodium citrate tribasic dihydrate, and 20% w/v polyethylene glycol 1000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S1399004714027527",,"4RXP",128.03,"2.1","2.1","The structure of GTP-dATP-bound SAMHD1","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4RXP"
"4RXQ",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M lithium sulfate monohydrate, 0.1M sodium citrate tribasic dihydrate, and 20% w/v polyethylene glycol 1000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S1399004714027527",,"4RXQ",127.94,"2.1","2.1","The structure of GTP-dUTP-bound SAMHD1","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4RXQ"
"4RXR",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M lithium sulfate monohydrate, 0.1M sodium citrate tribasic dihydrate, and 20% w/v polyethylene glycol 1000 
, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S1399004714027527",,"4RXR",127.94,"2.117","2.117","The structure of GTP-dCTP-bound SAMHD1","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4RXR"
"4RXS",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M lithium sulfate monohydrate, 0.1M sodium citrate tribasic dihydrate, and 20% w/v polyethylene glycol 1000  
, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S1399004714027527",,"4RXS",128,"2.2","2.2","The structure of GTP-dTTP-bound SAMHD1","MGSSHHHHHHSSGENLYFQGSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDIYFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4RXS"
"4RXW",,"X-RAY DIFFRACTION",1.85,33.54,"VAPOR DIFFUSION, HANGING DROP",6.4,"the protein solution consisted 7.5 mg mL-1 Zn-free insulin in 0.02 M HCl, while the reservoir solution contained 1 mM solution of sodium citrate, pH 6.4, (acetone) = 10 %,  16,5 mM solution of  cobalt(II) acetate and redistilled water, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"4RXW",11.75,"1.73","1.73","Crystal Structure of the cobalt human insulin derivative","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","4RXW"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","4RXW"
"4RXX",,"X-RAY DIFFRACTION",2.92,57.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein sample was first mixed Hampton Research Additive Screen H03 40% in 10:1 (V/V) Protein:1,3-propanediol ratio, then set up with 15% PEG8000, 0.2 M MgCl2, 0.1 M HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 291K, VAPOR DIFFUSION, HANGING DROP",291,,,"4RXX",49.66,"2.06","2.06","Crystal Structure of the N-terminal Domain of Human Ubiquitin Specific Protease 38","MDKILEGLVSSSHPLPLKRVIVRKVVESAEHWLDEAQCEAMFDLTTRLILEGQDPFQRQVGHQVLEAYARYHRPEFESFFNKTFVLGLLHQGYHSLDRKDVAILDYIHNGLKLIMSCPSVLDLFSLLQVEVLRMVCERPEPQLCARLSDLLTDFVQCIPKGKLSITFCQQLVRTIGHFQCVSTQERELREYVSQVTKVSNLLQNIWKAEPATLLPSLQEVFASISSTDASFEPSVALASLVQHIPLQMITVLIRSLTTDPNVKDASMTQALCRMIDWLSWPLAQHVDTWVIALLKGLAAVQKFTILIDVTLLKIELVFNRLWFPLVRPGALAVLSHMLLSFQHSPEAFHLIVPHVVNLVHSFKNDGLPSSTAFLVQLTELIHCMMYHYSGFPDLYEPILEAIKDFPKPSEEKIKLILNQSAWTSHHHHHH","Homo sapiens","USP38, KIAA1891","Ubiquitin carboxyl-terminal hydrolase 38","1","4RXX"
"4RXZ",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% isopropanol, 0.1M MES pH 6.5 and 10% PEG5000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/onc.2015.255",,"4RXZ",22.51,"1.55","1.55","Crystal Structure of MDMX phosporylated Tyr99 in complex with a 12-mer peptide","INQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","4RXZ"
,,,,,,,,,,,,,,,,"TSFAEYWNLLSP",,,"12-MER PEPTIDE INHIBITOR","2","4RXZ"
"4RY3",,"X-RAY DIFFRACTION",4.72,73.92,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5M sodium acetate, 0.1M Bis-Tris propane, 10% glycerol, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1007/s13238-014-0128-y",,"4RY3",74.05,"2.802","2.802","Crystal structure of human Fanconi-associated nuclease 1","GHPYYLRSFLVVLKTVLENEDDMLLFDEQEKGIVTKFYQLSATGQKLYVRLFQRKLSWIKMTKLEYEEIALDLTPVIEELTNAGFLQTESELQELSEVLELLSAPELKSLAKTFHLVNPNGQKQQLVDAFLKLAKQRSVCTWGKNKPGIGAVILKRAKALAGQSVRICKGPRAVFSRILLLFSLTDSMEDEDAACGGQGQLSTVLLVNLGRMEFPSYTINRKTHIFQDRDDLIRYAAATHMLSDISSAMANGNWEEAKELAQCAKRDWNRLKNHPSLRCHEDLPLFLRCFTVGWIYTRILSRFVEILQRLHMYEEAVRELESLLSQRIYCPDSRGRWWDRLALNLHQHLKRLEPTIKCITEGLADPEVRTGHRLSLYQRAVRLRESPSCKKFKHLFQQLPEMAVQDVKHVTITGRLCPQRGMCKSVFVMEAGEAADPTTVLCSVEELALAHYRRSGFDQGIHGEGSTFSTLYGLLLWDIIFMDGIPDVFRNACQAFPLDLCTDSFFTSRRPALEARLQLIHDAPEESLRAWVAATWHEQEGRVASLVSWDRFTSLQQAQDLVSCLGGPVLSGVCRHLAADFRHCRGGLPDLVVWNSQSRHFKLVEVKGPNDRLSHKQMIWLAELQKLGAEVEVCHVVAVGGSENLYFQ","Homo sapiens","FAN1, KIAA1018, MTMR15","Fanconi-associated nuclease 1","1","4RY3"
"4RYC",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION, HANGING DROP",4.5,"HANGING DROP, VAPOR DIFFUSION, 20 DEG C, 1 UL PROTEIN + 1 UL RESERVOIR; PROTEIN SOLUTION: 31.7 MG/ML RENIN, 12.5 MM TRIS PH 8, 25 MM NACL; RESERVOIR SOLUTION: 21% PEG4000, 50 MM NACITRATE PH 4.5, 600 MM NACL; SOAKING: DROP PLUS 2.5 UL RESERVOIR SOLUTION PLUS 10 MM COMPOUND AND 10% DMSO FOR 30 MIN; CRYO: SOAKING SOLUTION PLUS 15% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2015.02.039","3ZK","4RYC",76.22,"2.45","2.45","RENIN IN COMPLEXED WITH 4-methoxy-3-(3-methoxypropoxy)-N-{[(3S,4S)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-N-(propan-2-yl)benzamide INHIBITOR","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4RYC"
"4RYD",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 2.8M sodium formate, 15mM Cymal-7, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cmdc.201500103",,"4RYD",320.52,"2.15","2.15","X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba","DVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTASGSLVPRGSHHHHHH","Homo sapiens","FUR, FURIN, PACE, PCSK3","Furin","1","4RYD"
,,,,,,,,,,,,,,,,"XRVRX",,,"para-guanidinomethyl-phenylacetyl-Arg-(3-methylvaline)-Arg-(amidomethyl)benzamidine","2","4RYD"
"4RYG",,"X-RAY DIFFRACTION",3.18,61.31,"VAPOR DIFFUSION, HANGING DROP",4,"HANGING DROP, VAPOR DIFFUSION, 1 UL PROTEIN + 1 UL RESERVOIR; PROTEIN SOLUTION: 9.4 MG/ML RENIN, 12.5 MM TRIS PH 8, 25 MM NACL; RESERVOIR SOLUTION: 18% PEG4000, 50 MM NACITRATE PH 4.0, 600 MM NACL; SOAKING: DROP PLUS 2.5 UL RESERVOIR SOLUTION PLUS 10 MM INHIBITOR 54 AND 10% DMSO FOR 20 MIN; CRYO: SOAKING SOLUTION PLUS 15% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2015.02.039","3ZJ","4RYG",76.3,"2.65","2.65","RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-N-(propan-2-yl)benzamide INHIBITOR","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4RYG"
"4RYL",,"X-RAY DIFFRACTION",2.83,56.57,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350 and 0.2 M di Na tartrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201412154","3ZG","4RYL",38.58,"2.1","2.1","Human Protein Arginine Methyltransferase 3 in complex with 1-isoquinolin-6-yl-3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]urea","MGSSHHHHHHSSGLVPRGSDLQEDEDGVYFSSYGHYGIHEEMLKDKIRTESYRDFIYQNPHIFKDKVVLDVGCGTGILSMFAAKAGAKKVLGVDQSEILYQAMDIIRLNKLEDTITLIKGKIEEVHLPVEKVDVIISEWMGYFLLFESMLDSVLYAKNKYLAKGGSVYPDICTISLVAVSDVNKHADRIAFWDDVYGFKMSCMKKAVIPEAVVEVLDPKTLISEPCGIKHIDCHTTSISDLEFSSDFTLKITRTSMCTAIAGYFDIYFEKNCHNRVVFSTGPQSTKTHWKQTVFLLEKPFSVKAGEALKGKVTVHKNKKDPRSLTVTLTLNNSTQTYGLQ","Homo sapiens","PRMT3, HRMT1L3","PRMT3 protein","1","4RYL"
"4RZ1",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",4,"REMARK: HANGING DROP, VAPOR DIFFUSION, 1 UL PROTEIN + 1 UL RESERVOIR; PROTEIN SOLUTION: 9.4 MG/ML RENIN, 12.5 MM TRIS PH 8, 25 MM NACL; RESERVOIR SOLUTION: 21% PEG4000, 50 MM NACITRATE PH 4.0, 400 MM NACL; SOAKING: DROP PLUS 2.5 UL RESERVOIR SOLUTION PLUS 10 MM compound AND 10% DMSO FOR 20 MIN; CRYO: SOAKING SOLUTION PLUS 15% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2015.02.040","3ZN","4RZ1",76.26,"2.6","2.6","RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methyl)pyrrolidin-3-yl benzylcarbamate INHIBITOR","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4RZ1"
"4RZ9",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, and 15% (w/v) PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4RZ9",21.16,"1.28","1.28","Pre-mRNA-splicing factor 38A AS 1-179","MANRTVKDAHSIHGTNPQYLVEKIIRTRIYESKYWKEECFGLTAELVVDKAMELRFVGGVYGGNIKPTPFLCLTLKMLQIQPEKDIIVEFIKNEDFKYVRMLGALYMRLTGTAIDCYKYLEPLYNDYRKIKSQNRNGEFELMHVDEFIDELLHSERVCDIILPRLQKRYVLEEAEQLEP","Homo sapiens","PRPF38A","Pre-mRNA-splicing factor 38A","1","4RZ9"
"4RZA",,"X-RAY DIFFRACTION",1.8,31.62,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M MES pH 5.0, 16% PEG 3350, 0.2 M (NH4)2SO4, and 5% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"4RZA",24.22,"1.9","1.9","Pre-mRNA-splicing factor 38A AS 1-205","MANRTVKDAHSIHGTNPQYLVEKIIRTRIYESKYWKEECFGLTAELVVDKAMELRFVGGVYGGNIKPTPFLCLTLKMLQIQPEKDIIVEFIKNEDFKYVRMLGALYMRLTGTAIDCYKYLEPLYNDYRKIKSQNRNGEFELMHVDEFIDELLHSERVCDIILPRLQKRYVLEEAEQLEPRVSALEEDMDDVESSEEEEEEDEKLE","Homo sapiens","PRPF38A","Pre-mRNA-splicing factor 38A","1","4RZA"
"4RZE",,"X-RAY DIFFRACTION",3.2,61.52,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, VAPOR DIFFUSION, temperature 277K",277,"10.1038/nchembio.1788",,"4RZE",57.68,"2.49","2.49","Crystal Structure Analysis of the NUR77 Ligand Binding Domain, L437W,D594E mutant","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDWLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMETLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4RZE"
"4RZF",,"X-RAY DIFFRACTION",3.17,61.21,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1038/nchembio.1788",,"4RZF",57.7,"1.99","1.99","Crystal Structure Analysis of the NUR77 Ligand Binding Domain, S441W mutant","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLEWAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4RZF"
"4RZG",,"X-RAY DIFFRACTION",3.19,61.48,"VAPOR DIFFUSION",4.2,"PEG4000, Sodium citrate, Glycerol, pH 4.2, vapor diffusion, temperature 277K",277,"10.1038/nchembio.1788",,"4RZG",57.88,"2.7","2.7","Crystal Structure Analysis of the DNPA-bounded NUR77 Ligand binding Domain","SKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","GFRP1, HMR, NAK1, NR4A1","Nuclear receptor subfamily 4 group A member 1","1","4RZG"
"4RZV",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Tris pH 7.0, 18% (w/v) PEG2000 MME , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"032","4RZV",65.01,"2.994","2.994","Crystal structure of the BRAF (R509H) kinase domain monomer bound to Vemurafenib","RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTHHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4RZV"
"4RZW",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES pH 7.0, 0.2 M Mg(NO3)2, 18% (w/v) PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"B1E","4RZW",64.93,"3.493","3.493","Crystal structure of BRAF (R509H) kinase domain bound to AZ628","RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTHHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4RZW"
"4S0O",,"X-RAY DIFFRACTION",1.97,37.69,"VAPOR DIFFUSION, HANGING DROP",6.2,"1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS , PH 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1016/j.molcel.2016.06.010",,"4S0O",42.33,"1.9","1.9","Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (I)","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTGTWQTVTIFVAGVLTASLTIWKKMG","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","4S0O"
"4S0P",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, HANGING DROP",6.2,"1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2016.06.010",,"4S0P",42.61,"3.252","3.252","Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (II)","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIRDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","4S0P"
"4S0Z",,"X-RAY DIFFRACTION",3.03,59.45,"VAPOR DIFFUSION, SITTING DROP",9,"100 mM Tris-HCl pH 9.0, 200 mM sodium acetate trihydrate, 25% PEG 4000 and 3 mM DTT, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/pro.2762",,"4S0Z",20.47,"1.45","1.45","Crystal structure of M26V human DJ-1","GSHMASKRALVILAKGAEEMETVIPVDVVRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","4S0Z"
"4S1G",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",5,"17%PEG3350, 200mM NaCl 
, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2015.02.003","43T","4S1G",75.83,"2.1","2.1","Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4S1G"
"4S1Y",,"X-RAY DIFFRACTION",2.16,42.97,"VAPOR DIFFUSION, SITTING DROP",7.4,"Crystals of a cisplatin/HSA adduct were obtained by soaking: more in detail, crystals of defatted HSA, grown after four weeks by sitting drop vapour diffusion method at 25   C using a reservoir solution of 30 % w/v polyethylene glycol 3350 in 50 mM potassium phosphate at pH 7.4 and protein concentration of 30 mg mL-1 (see experimental section or further details), were soaked for 24 h in a 0.005 M cisplatin solution in the same reservoir, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1039/c5cc01751c",,"4S1Y",68.07,"3.16","3.16","X-ray structure of human serum albumin complexed with cisplatin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","4S1Y"
"4SKN",,"X-RAY DIFFRACTION",2.44,49.68,,6.5,"pH 6.5",,"10.1038/384087a0",,"4SKN",31.7,"2.9","2.9","A NUCLEOTIDE-FLIPPING MECHANISM FROM THE STRUCTURE OF HUMAN URACIL-DNA GLYCOSYLASE BOUND TO DNA","TGGGXGGCTT",,,"DNA (5'-D(*TP*GP*GP*GP*(D1P)P*GP*GP*CP*TP*T)-3')","1","4SKN"
,,,,,,,,,,,,,,,,"AAAGCCGCCC",,,"DNA (5'-D(*AP*AP*AP*GP*CP*CP*GP*CP*CP*C)-3')","2","4SKN"
,,,,,,,,,,,,,,,,"MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQNPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPRSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG1, UNG15","PROTEIN (URACIL-DNA GLYCOSYLASE)","3","4SKN"
"4TGF",,"SOLUTION NMR",,,,,,,"10.1021/bi00486a005",,"4TGF",5.56,,,"SOLUTION STRUCTURES OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA DERIVED FROM 1*H NMR DATA","VVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLA","Homo sapiens","TGFA","DES-VAL-1,VAL-2,TRANSFORMING GROWTH FACTOR, ALPHA","1","4TGF"
"4THN",,"X-RAY DIFFRACTION",2.58,52.33,,7,"pH 7.0",,"10.1110/ps.8.1.91",,"4THN",37.11,"2.5","2.5","THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN-HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE.","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","ALPHA-THROMBIN","1","4THN"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","ALPHA-THROMBIN","2","4THN"
,,,,,,,,,,,,,,,,"XRATDAGXPESHXGGDYEEIPAAYAE",,,"HIRUNORM IV","3","4THN"
"4TJU",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4TJU",105.34,"1.57","1.57","Crystal Structure of human Tankyrase 2 in complex with 3,4-CPQ-5-C.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TJU"
"4TJW",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660","P34","4TJW",105.09,"1.7","1.7","Crystal Structure of human Tankyrase 2 in complex with PJ-34.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TJW"
"4TJY",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4TJY",104.87,"1.9","1.9","Crystal Structure of human Tankyrase 2 in complex with ABT-888.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TJY"
"4TJZ",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.5M Tris-HCl, 55%(v/v) PEG400",293,"10.1002/anie.201409830",,"4TJZ",15.62,"0.87","0.87","The 0.87 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with capric acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","4TJZ"
"4TK0",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4TK0",105.05,"1.65","1.65","Crystal Structure of human Tankyrase 2 in complex with DPQ.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TK0"
"4TK5",,"X-RAY DIFFRACTION",2.18,43.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4TK5",106.29,"2.02","2.02","Crystal Structure of human Tankyrase 2 in complex with EB47.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TK5"
"4TKB",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCl, 55%(v/v) PEG400",293,"10.1002/anie.201409830",,"4TKB",15.64,"0.86","0.86","The 0.86 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with lauric acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","4TKB"
"4TKF",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660","33C","4TKF",106.12,"2.6","2.6","Crystal Structure of human Tankyrase 2 in complex with IWR-1.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TKF"
"4TKG",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660","09L","4TKG",106.41,"1.95","1.95","Crystal Structure of human Tankyrase 2 in complex with AZD2281.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TKG"
"4TKH",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 55%(v/v) PEG400",293,"10.1002/anie.201409830",,"4TKH",15.39,"0.93","0.93","The 0.93 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with myristic acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","4TKH"
"4TKI",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Sodium, Hepes buffer at pH7.5, 12-15% iso-propanol",293,"10.1107/S1399004714017660",,"4TKI",107.37,"2.15","2.15","Crystal Structure of human Tankyrase 2 in complex with BSI-201.","MGSSHHHHHHSSGRENLYFQGSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEGMV","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4TKI"
"4TKJ",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 55%(v/v) PEG400",293,"10.1002/anie.201409830",,"4TKJ",15.96,"0.87","0.87","The 0.87 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with palmitic acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","4TKJ"
"4TKS",,"X-RAY DIFFRACTION",3.45,64.35,"VAPOR DIFFUSION, HANGING DROP",,"1.0 M sodium/potassium tartrate, 100 mM MES, pH 7.0",293,"10.1107/S1399004714013376",,"4TKS",37.71,"3.2017","3.2017","Native-SAD phasing for human EGFR kinase domain.","GAMGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4TKS"
"4TKW",,"X-RAY DIFFRACTION",2.13,42.17,"VAPOR DIFFUSION",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TKW",27.81,"1.8","1.8","Crystal Structure of Human Transthyretin Leu55Pro Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TKW"
"4TL0",,"X-RAY DIFFRACTION",2.79,55.91,"VAPOR DIFFUSION, SITTING DROP",8,"0.15 ammonium sulfate, 0.1M TRIS, pH 8.0, 15%(w/v) PEG 4000",292,,,"4TL0",38.91,"2.7","2.7","Crystal structure of death-associated protein kinase 1 with a crucial phosphomimicking mutation","GPMTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAEAVNMEKFKKFAARKKWKQSVRLISLCQRLSRSFLSRSNMSVARSD","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","4TL0"
"4TL4",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TL4",27.9,"1.75","1.75","Crystal Structure of Human Transthyretin Val30Met Mutant","KCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TL4"
"4TL5",,"X-RAY DIFFRACTION",2.12,42.06,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TL5",27.92,"1.44","1.44","Crystal Structure of Human Transthyretin Ser85Pro Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGIPPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TL5"
"4TLG",,"X-RAY DIFFRACTION",2.6,52.75,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Magnesium Chloride -- 0.1M tris pH 8.5 -- 25%(w/v) PEG 3350",293,,,"4TLG",94.93,"1.77","1.77","Crystal structure of SEC14-like protein 4 (SEC14L4)","SMSSRVGDLSPQQQEALARFRENLQDLLPILPNADDYFLLRWLRARNFDLQKSEDMLRRHMEFRKQQDLDNIVTWQPPEVIQLYDSGGLCGYDYEGCPVYFNIIGSLDPKGLLLSASKQDMIRKRIKVCELLLHECELQTQKLGRKIEMALMVFDMEGLSLKHLWKPAVEVYQQFFSILEANYPETLKNLIVIRAPKLFPVAFNLVKSFMSEETRRKIVILGDNWKQELTKFISPDQLPVEFGGTMTDPDGNPKCLTKINYGGEVPKSYYLCEQVRLQYEHTRSVGRGSSLQVENEILFPGCVLRWQFASDGGDIGFGVFLKTKMGEQQSAREMTEVLPSQRYNAHMVPEDGSLTCLQAGVYVLRFDNTYSRMHAKKLSYTVEVLLPDKASEETLQSMRPSPTQ","Homo sapiens","SEC14L4, TAP3","SEC14-like protein 4","1","4TLG"
"4TLK",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TLK",28.15,"1.44","1.44","Crystal Structure of Human Transthyretin Ser85Pro/Glu92Pro Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGIPPFHEHAPVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TLK"
"4TLQ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"1.4 M Ammonium Citrate, 0.1 M Sodium Acetate",293,,,"4TLQ",21.86,"2.503","2.503","Crystal structure of C-terminal RNA recognition motif of human ELAV type RNA binding protein-3 at 2.5 Angstrom resolution","GSHMQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY","Homo sapiens","CELF2, BRUNOL3, CUGBP2, ETR3, NAPOR","CUGBP Elav-like family member 2","1","4TLQ"
"4TLS",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TLS",28.08,"1.35","1.35","Crystal Structure of Human Transthyretin Glu92Pro Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAPVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TLS"
"4TLT",,"X-RAY DIFFRACTION",1.95,36.82,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TLT",27.98,"1.7","1.7","Crystal structure of human transthyretin","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TLT"
"4TLU",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,,"4TLU",28.2,"1.75","1.75","Crystal Structure of Human Transthyretin Ala108Trp Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIWALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TLU"
"4TM9",,"X-RAY DIFFRACTION",2.08,40.94,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TM9",28.01,"1.7","1.7","Crystal Structure of Human Transthyretin Thr119Trp Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTWAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TM9"
"4TMF",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH4.0, 0.2M ammonium acetate, 3% isopropanol, 15% PEG10000",298,"10.1021/jm501037u",,"4TMF",60.66,"2.05","2.05","Crystal structure of human CD38 in complex with hydrolysed compound JMS713","EFWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1","1","4TMF"
"4TN6",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M NaAcetate, pH=5.6, 0.2 M Li2SO4, 14-17.5% PEG3350, 3-5.5% 1,3 propandiol",296,,,"4TN6",74.42,"2.41","2.41","CK1d in complex with inhibitor","MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAALVPRGSPGGGSHHHHHH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4TN6"
"4TNB",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",5.5,"21% PEG 3350, 0.15 M Sodium Chloride, 0.1 M BIS-TRIS pH 5.5",277,"10.1074/jbc.M115.647297",,"4TNB",68.25,"2.113","2.113","Crystal Structure of G Protein-Coupled Receptor Kinase 5 in Complex with Sangivamycin","MELENIVANTVLLKAREGGGGKRKGKSKKWKEILKFPHISQCEDLRRTIDRDYCSLCDKQPIGRLLFRQFCETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKKIMTKYLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELFSACAQSVHEYLRGEPFHEYLDSMFFDRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHHENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQEEEAAEVKRHPFFRNMNFKRLEAGMLDPPFVPDPRAVYCKDVLDIEQFSTVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGPNGTLPPDLNRNHPPEPPKKGLLQRLFKRQHQNNSKSSPSSKTSFNHHINSNHVSSNSTGSS","Homo sapiens","GRK5, GPRK5","G protein-coupled receptor kinase 5","1","4TNB"
"4TND",,"X-RAY DIFFRACTION",2.14,42.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.15 M Sodium Chloride, 0.1 M BIS-TRIS pH 6.5
Crystal growth and size improved by using micro-seeding technique",277,"10.1074/jbc.M115.647297",,"4TND",68.47,"1.802","1.802","Crystal Structure of G Protein-Coupled Receptor Kinase 5 in Complex with AMP-PNP","MELENIVANTVLLKAREGGGGKRKGKSKKWKEILKFPHISQCEDLRRTIDRDYCSLCDKQPIGRLLFRQFCETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKKIMTKYLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELFSACAQSVHEYLRGEPFHEYLDSMFFDRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHHENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQEEEAAEVKRHPFFRNMNFKRLEAGMLDPPFVPDPRAVYCKDVLDIEQFSTVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGPNGTLPPDLNRNHPPEPPKKGLLQRLFKRQHQNNSKSSPSSKTSFNHHINSNHVSSNSTGSS","Homo sapiens","GRK5, GPRK5","G protein-coupled receptor kinase 5","1","4TND"
"4TNE",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,"10.1074/jbc.M115.659912",,"4TNE",28.06,"1.55","1.55","Crystal Structure of Human Transthyretin Thr119Tyr Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTYAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TNE"
"4TNF",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,,"4TNF",28.05,"1.6","1.6","Crystal Structure of Human Transthyretin Lys15Trp Mutant","KCPLMVWVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TNF"
"4TNG",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,,"4TNG",27.9,"1.6","1.6","Crystal Structure of Human Transthyretin Thr119Met Mutant","KCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTNPKEHHHHHH","Homo sapiens","TTR, PALB","Transthyretin","1","4TNG"
"4TNP",,"X-RAY DIFFRACTION",2.15,42.73,"BATCH MODE",7.4,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNP",244.34,"2","2","Structural basis of cellular dNTP regulation, SAMHD1-GTP-dCTP-cCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNP"
"4TNQ",,"X-RAY DIFFRACTION",2.13,42.25,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNQ",244.46,"2.55","2.55","Structural basis of cellular dNTP regulation, SAMHD1-GTP-dTTP-dTTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNQ"
"4TNR",,"X-RAY DIFFRACTION",2.24,45.12,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNR",244.04,"2.75","2.75","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dATP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNR"
"4TNS",,"X-RAY DIFFRACTION",1.63,24.58,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 0.1 M HEPES pH7-8.5 and 0.9 M-1.4 M sodium citrate",297,,,"4TNS",33.57,"1.33","1.33","Structure of Pin1 PPIase domain bound with all-trans retinoic acid","MGSSHHHHHHSSGLVPRGSHMLEVLFQGPGSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEQITRTQEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4TNS"
"4TNU",,"X-RAY DIFFRACTION",3.96,68.96,"VAPOR DIFFUSION, HANGING DROP",6,"14% PEG 3350, 0.05M sodium citrate, 0.3M potassium phosphate (dibasic), 3% ethylene glycol, 0.01M DTT",277,"10.1021/bi500719k",,"4TNU",72,"2.9","2.9","Human brain aspartoacylase mutant Y231C complex with intermediate analog (N-phosphonomethyl-L-aspartate)","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDCPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ASPA, ACY2, ASP","Aspartoacylase","1","4TNU"
"4TNX",,"X-RAY DIFFRACTION",2.13,42.37,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNX",242.89,"2.31","2.31","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dGTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNX"
"4TNY",,"X-RAY DIFFRACTION",2.28,46.04,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNY",244.54,"2.6","2.6","Structural basis of cellular dNTP regulation, SAMHD1-dGTP-dATP-dGTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNY"
"4TNZ",,"X-RAY DIFFRACTION",2.28,46.03,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TNZ",244.6,"2.38","2.38","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dTTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TNZ"
"4TO0",,"X-RAY DIFFRACTION",2.16,42.99,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO0",244.44,"2.3","2.3","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP-dCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO0"
"4TO1",,"X-RAY DIFFRACTION",2.28,46.09,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO1",244.39,"2.55","2.55","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dATP/dCTP-dCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO1"
"4TO2",,"X-RAY DIFFRACTION",2.36,47.81,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO2",244.67,"2.27","2.27","Structure basis of cellular dNTP regulation, SAMHD1-dGTP-dGTP-dGTP/dTTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO2"
"4TO3",,"X-RAY DIFFRACTION",2.38,48.35,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO3",244.54,"2.2","2.2","Structural basis of cellular dNTP regulation, SAMHD1-dGTP-dGTP-dCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO3"
"4TO4",,"X-RAY DIFFRACTION",2.4,48.66,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO4",244.6,"2.1","2.1","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dGTP-dCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO4"
"4TO5",,"X-RAY DIFFRACTION",2.38,48.28,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO5",244.4,"2.8","2.8","Structure basis of cellular dNTP regulation, SAMHD1-GTP-dTTP-dCTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO5"
"4TO6",,"X-RAY DIFFRACTION",2.16,43.07,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1073/pnas.1412289111",,"4TO6",244.46,"2.33","2.33","Structure basis of cellular dNTP regulation, SAMHD1-dGTP-dATP-dTTP/dGTP complex","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","4TO6"
"4TOR",,"X-RAY DIFFRACTION",1.93,36.2,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Bis-Tris propane, 0.2M sodium bromide, 25% PEG3350",293.15,"10.1128/MCB.00392-15",,"4TOR",110.75,"1.501","1.501","Crystal structure of Tankyrase 1 with IWR-8","MGSSHHHHHHSSGLEVLFQGPHMASGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEA","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4TOR"
"4TOS",,"X-RAY DIFFRACTION",2.08,40.79,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris pH7.5, 0.2M sodium Acetate, 30% PEG4000",293.15,"10.1128/MCB.00392-15",,"4TOS",54.44,"1.802","1.802","Crystal structure of Tankyrase 1 with 355","MGSSHHHHHHSSGLEVLFQGPHMASGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEA","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4TOS"
"4TOY",,"X-RAY DIFFRACTION",2.21,44.38,"VAPOR DIFFUSION, HANGING DROP",4.5,"15% isopropanol, 25% PEG3350, 0.2M Ammonium citrate pH 4.5",293,"10.1038/nature13601",,"4TOY",49.47,"1.551","1.551","Structure of 35O22 Fab, a HIV-1 neutralizing antibody","EGQLVQSGAELKKPGASVKISCKTSGYRFNFYHINWIRQTAGRGPEWMGWISPYSGDKNLAPAFQDRVIMTTDTEVPVTSFTSTGAAYMEIRNLKFDDTGTYFCAKGLLRDGSSTWLPYLWGQGTLLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQ","Homo sapiens",,"35O22 Fab Heavy chain","1","4TOY"
,,,,,,,,,,,,,,,,"QSVLTQSASVSGSLGQSVTISCTGPNSVCCSHKSISWYQWPPGRAPTLIIYEDNERAPGISPRFSGYKSYWSAYLTISDLRPEDETTYYCCSYTHNSGCVFGTGTKVSVLGQSKANPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"35O22 Fab Light chain","2","4TOY"
"4TPK",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2M ammonium acetate, 24% PEG 3350, 10 mM Tris pH 7.4",293,"10.1021/jm501195e","3F9","4TPK",143.43,"2.7","2.7","Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-methoxyethyl)-2-naphthamide","MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYTSKKESCVGL","Homo sapiens","BCHE, CHE1","Cholinesterase","1","4TPK"
"4TPM",,"X-RAY DIFFRACTION",4.2,70.72,"VAPOR DIFFUSION, HANGING DROP",,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5",277,"10.1016/j.bmc.2014.10.013","35E","4TPM",83.63,"2.77","2.77","Crystal structure of 2-(3-alkoxy-1-azetidinyl) quinolines as PDE10A Inhibitors","MKHHHHHHHDEVDTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4TPM"
"4TPP",,"X-RAY DIFFRACTION",4.17,74.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium Sulfate, 0.1M MES monohydrate, 10% v/v 1,4-Dioxane, pH 6.5",277,"10.1016/j.bmc.2014.10.013","35D","4TPP",83.47,"2.65","2.65","2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors","MKHHHHHHHDEVDTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4TPP"
"4TPT",,"X-RAY DIFFRACTION",2.46,50.08,"BATCH MODE",,"The purified protein was used in crystallisation trials employing both, a standard screen with approximately 1200 different conditions, as well as crystallisation conditions identified using literature data.",293,"10.1021/ml500242y","35H","4TPT",70.04,"2.6","2.6","Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor","DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSMDPFPWQQKVRFAKGIASGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRAPMEKATTKKRTLRKNDRKKRYTVVGNPYWMAPEMLNGKSYDETVDIFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCRLEPESRPAFSKLEDSFEALSLYLGELGIPLPAELEELDHTVSMQYGL","Homo sapiens","LIMK2","LIM domain kinase 2","1","4TPT"
"4TPW",,"X-RAY DIFFRACTION",2.04,39.64,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000 10-20%, 100mM MES pH 6.5, 10% IPN",290,"10.1073/pnas.1410250111","33R, MGP","4TPW",46.3,"1.5","1.5","The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G","MVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","4TPW"
"4TQ8",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, SITTING DROP",5.7,"Protein: 5 mg/ml 1 milli-M ligand
Precipitant: 60% (30% PEG-4K, 0.2 M imidazole
 malate,  pH 6.0) 40% (24% MPEG-5K, 0.1 M sodium  acetate,  pH 5.5) 
Drops: 1 micro-L protein-ligand complex 1 micro-L precipitant.
Cryoprotectant:: 40% (12.5 % diethylene glycol + 12.5 % ethylene glycol + 12.5 % glycerol + 12.5 % 1,2-propanediol + 12.5 % DMSO + 12.5 % 1,4-dioxane), 25% MPEG 5K, 0.1 M sodium propionate, sodium cacodylate, Bis-Tris-propane(65% component A pH 4; 35% B pH 9.5 and 1 milli-M ligand.",293,"10.3109/14756366.2015.1070265",,"4TQ8",28.21,"1.52","1.52","Dual binding mode for 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid binding to Human transthyretin (TTR)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4TQ8"
"4TQ9",,"X-RAY DIFFRACTION",1.95,37.05,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate pH4.5, 0.1M Tris pH 8.5, 24% PEG 3,350",293,"10.1158/1541-7786.MCR-15-0203",,"4TQ9",39.42,"1.491","1.491","Crystal Structure of a GDP-bound G12V Oncogenic Mutant of Human GTPase KRas","GMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4TQ9"
"4TQA",,"X-RAY DIFFRACTION",1.96,37.24,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate pH4.5, 0.1M Tris pH 8.5, 26% PEG 3,350",293,"10.1158/1541-7786.MCR-15-0203",,"4TQA",39.45,"1.13","1.13","Crystal Structure of a GDP-bound G13D Oncogenic Mutant of Human GTPase KRas","GMTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4TQA"
"4TQB",,"X-RAY DIFFRACTION",2.08,40.97,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 4000 12-20%, 100mM MES pH 6.5, 10% IPN",290,"10.1073/pnas.1410250111",,"4TQB",46.32,"1.59","1.59","The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G","MVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","4TQB"
"4TQC",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 4000 12-20%, 100mM MES pH 8.5, 10% IPN",290,"10.1073/pnas.1410250111",,"4TQC",45.97,"1.8","1.8","The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G","MVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","4TQC"
"4TQH",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",5.7,"protein: 5 mg/ml 0.05 M NaCl, 0.05 M Na acetate, pH 5.5 with 1 milli-M ligand.
Precipitant: 60% (30% PEG-4K, 0.2 M imidazole malate,  pH 6.0) and  40% (24% MPEG-5K, 0.1M sodium  acetate, pH 5.5).
Cryoprotectant: 40% (25 % diethylene glycol, 12.5 % MPD, 37.5 % 2,3-butanediol, 12.5 % 1,4-dioxane), 12.5% MPEG 5K, 25% MPEG 550, 100 mM (sodium propionate, sodium cacodylate, Bis-Tris-propane(50% component A pH 4; 50% B pH 9.5) and 1 mM ligand.",293,"10.3109/14756366.2015.1070265",,"4TQH",28.12,"1.511","1.511","Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)ethanoic acid","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4TQH"
"4TQI",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, SITTING DROP",5.7,"protein: TTR 10 mg/ml + ligand 0.66 milli-M in 0.1 M NaCl, 0.05 M Na acetate, pH 5.5.
Precipitant: 70% (30% PEG-4K, 0.2 M imidazole  malate,  pH 6.0) and 30% (12% MPEG-5K, 0.1 M sodium acetate, pH 5.5).
Cryoprotectant: 40% (25 % diethylene glycol, 12.5 % MPD, 37.5 % 2,3-butanediol, 12.5 % 1,4-dioxane), 10% PEG 10K,  0.1 M (mixed sodium propionate, sodium cacodylate, Bis-Tris-propane) (65% component A pH 4; 35% B pH 9.5)",293,"10.3109/14756366.2015.1070265",,"4TQI",28.3,"1.25","1.25","Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid in a dual binding mode","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4TQI"
"4TQN",,"X-RAY DIFFRACTION",1.94,36.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M  MES pH 6.5, 0.1M MgCl2, 20% PEG 6000, 10% EtGly",277,"10.1021/acs.jmedchem.5b00171","UL4","4TQN",14.74,"1.7","1.7","Crystal structure of the bromodomain of human CREBBP in complex with UL04","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","4TQN"
"4TQP",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, SITTING DROP",5.7,"Protein: 5 mg/ml in 0.05 M NaCl, 0.05 M sodium acetate, pH 5.5. 
Precipitant: 60% (30% PEG-4K, 0.2 M imidazole malate, pH 6.0) and 40% (MPEG-5K, 0.1 M sodium  acetate, pH 5.5).
Cryoprotectant: 40% (25 % diethylene glycol, 12.5 % MPD, 37.5 % 2,3-butanediol, 12.5 % 1,4-dioxane), 12.5% MPEG 5K, 25% MPEG 550, 0.1 M (sodium propionate, sodium cacodylate, Bis-Tris-propane: 50% component A pH 4; 50% B pH 9.5) with 1 milli-M ligand.",293,"10.3109/14756366.2015.1070265",,"4TQP",28.46,"1.58","1.58","Human transthyretin (TTR) complexed with (R)-3-(9H-fluoren-9-ylideneaminooxy)-2-methyl-N-(methylsulfonyl) propionamide in a dual binding mode","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4TQP"
"4TRF",,"X-RAY DIFFRACTION",3.7,66.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4TRF",38.11,"1.63","1.63","Crystal structure of Macrophage Migration Inhibitory Factor in complex with N-(pyridin-3-ylmethyl)thioformamide","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4TRF"
"4TRL",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 0.2M Li2SO4, 20% (w/v) PEG3350",293,,,"4TRL",34.11,"2.452","2.452","Structure of Ephrin type-A receptor 2","MGSSHHHHHHSQDPHTYEDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","4TRL"
"4TRU",,"X-RAY DIFFRACTION",2.75,55.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4TRU",37.38,"1.81","1.81","Crystal structure of Q24A Q25A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTAALAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4TRU"
"4TRX",,"SOLUTION NMR",,,,,,,"10.1021/bi00224a017",,"4TRX",11.72,,,"HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REDUCED RECOMBINANT HUMAN THIOREDOXIN IN SOLUTION","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCTPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","THIOREDOXIN","1","4TRX"
"4TS8",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES pH 6.5, 0.1M MgCl2, 20% PEG 3350 10% EtGly",277,,"XZ8","4TS8",14.6,"2","2","Crystal structure of the bromodomain of human CREBBP in complex with XZ08","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","4TS8"
"4TSE",,"X-RAY DIFFRACTION",2.6,52.6,"VAPOR DIFFUSION, HANGING DROP",7.3,"24% v/v PEK2K MME, 0.8M HCOONa using 6 mg/ml protein",293,"10.1016/j.molcel.2015.01.019",,"4TSE",37,"2.057","2.057","Crystal Structure of the Mib Repeat Domain of Mind bomb 1","GPLGSRNPGGLQIGDLVNIDLDLEIVQSLQHGHGGWTDGMFETLTTTGTVCGIDEDHDIVVQYPSGNRWTFNPAVLTKANIVRSGDAAQGAEGGTSQFQVGDLVQVCYDLERIKLLQRGHGEWAEAMLPTLGKVGRVQQIYSDSDLKVEVCGTSWTYNPAAVSKVASAGSAISN","Homo sapiens","MIB1, DIP1, KIAA1323, ZZANK2","E3 ubiquitin-protein ligase MIB1","1","4TSE"
"4TSV",,"X-RAY DIFFRACTION",2.2,44.02,,6.8,"1.4 M SODIUM FORMATE, pH 6.8",,"10.1074/jbc.273.4.2153",,"4TSV",16.58,"1.8","1.8","HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT","PSDKPVAHVVANPQAEGQLQWSNRRANALLANGVELRDNQLVVPIEGLFLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","TUMOR NECROSIS FACTOR-ALPHA","1","4TSV"
"4TT6",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0M Ammonium sulfate, 0.1M Bis-Tris pH5.5",278,"10.1042/BJ20140933",,"4TT6",15.54,"2","2","Crystal structure of ATAD2A bromodomain double mutant N1063A-Y1064A in apo form","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEAAPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TT6"
"4TT7",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"2 uL of 17 mg/mL protein (50 mM Bicine pH 8.4, 150 mM NaCl, 5 mM DTT) with 2 uL of  0.1 M TRIS hydrochloride,  0.2 M Sodium acetate trihydrate, 30% w/v Polyethylene glycol 4,000",293,"10.2147/OTT.S73690",,"4TT7",37.24,"2.1","2.1","Crystal structure of human ALK with a covalent modification","MNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKLEHHHHHH","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","4TT7"
"4TTB",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05 M ammonium sulfate, 25% Pentaerythritol ethoxylate, 50 mM BISTRIS",293.15,"10.1074/jbc.M114.605964",,"4TTB",62.22,"2.447","2.447","Crystal structure of homo sapiens IODOTYROSINE DEIODINASE (IYD) bound to FMN","SGEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTTPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTVHHHHHH","Homo sapiens","IYD, C6orf71, DEHAL1","Iodotyrosine dehalogenase 1","1","4TTB"
"4TTC",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.15 M sodium acetate, 85 mM Tris-HCl, 25.5 % w/v polyethylene glycol 4,000 and 15 % glycerol",293.15,"10.1074/jbc.M114.605964","IYR","4TTC",188.51,"2.65","2.65","Crystal structure of homo sapiens IODOTYROSINE DEIODINASE bound to FMN and mono-iodotyrosine (MIT)","SGEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTTPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTVHHHHHH","Homo sapiens","IYD, C6orf71, DEHAL1","Iodotyrosine dehalogenase 1","1","4TTC"
"4TTE",,"X-RAY DIFFRACTION",4.04,69.53,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.1-2.4M Ammonium Sulfate, 0.1M Bis-Tris pH5.5, 10% Glycerol",298,"10.1042/BJ20140933","36Z","4TTE",15.92,"1.8","1.8","Crystal structure of ATAD2A bromodomain complexed with methyl 3-amino-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzoate","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TTE"
"4TTV",,"X-RAY DIFFRACTION",4.12,70.11,"VAPOR DIFFUSION, SITTING DROP",8,"Tris, PEG8000",291,"10.1038/srep13160",,"4TTV",195.82,"2.8","2.8","Crystal structure of human ThrRS complexing with a bioengineered macrolide BC194","MGSSHHHHHHSSDHRKIGRDQELYFFHELSPGSCFFLPKGAYIYNALIEFIRSEYRKRGFQEVVTPNIFNSRLWMTSGHWQHYSENMFSFEVEKELFALKPMNCPGHCLMFDHRPRSWRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCAMEQIEDEIKGCLDFLRTVYSVFGFSFKLNLSTRPEKFLGDIEVWDQAEKQLENSLNEFGEKWELNSGDGAFYGPKIDIQIKDAIGRYHQCATIQLDFQLPIRFNLTYVSHDGDDKKRPVIVHRAILGSVERMIAILTENYGGKWPFWLSPRQVMVVPVGPTCDEYAQKVRQQFHDAKFMADIDLDPGCTLNKKIRNAQLAQYNFILVVGEKEKISGTVNIRTRDNKVHGERTISETIERLQQLKEFRSKQAEEEF","Homo sapiens","TARS, TARS1","Threonine--tRNA ligase, cytoplasmic","1","4TTV"
"4TU4",,"X-RAY DIFFRACTION",4.05,69.63,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.1-2.4M Ammonium Sulfate, 0.1M Bis-Tris pH 5.5, 10% Glycerol.",298,"10.1042/BJ20140933","37N","4TU4",16.22,"1.73","1.73","Crystal structure of ATAD2A bromodomain complexed with 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[(phenylsulfonyl)amino]benzoicacid","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TU4"
"4TU6",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M Ammonium sulfate, 0.1M Bis-Tris pH 5.5, 25% w/v PEG3350",273,"10.1042/BJ20140933",,"4TU6",62.2,"2.27","2.27","Crystal structure of apo ATAD2A bromodomain with N1064 alternate conformation","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TU6"
"4TUH",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M Mg Acetate, 4% DMSO, 20% PEG3350, 0.1 M Hepes, pH 6.5",293,"10.1021/ml500030p",,"4TUH",149.78,"1.8","1.8","Bcl-xL in complex with inhibitor (Compound 10)","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","4TUH"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"4TUU",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 6K, 0.6 M Na Formate, 0.1M CHES, pH 9.0-10 and 5 mM TCEP, pH 7.0 at a temperature of 20 degC.",293.15,"10.1002/pro.2517",,"4TUU",109.98,"2.64","2.64","Isolated p110a subunit of PI3Ka provides a platform for structure-based drug design","GSVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHH","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","4TUU"
"4TV3",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 6K, 0.6 M Na Formate, 0.1M CHES, pH 9.0-10 and 5 mM TCEP, pH 7.0 at a temperature of 20 degC.",293.15,"10.1002/pro.2517","ML9","4TV3",110.41,"2.85","2.85","Isolated p110a subunit of PI3Ka provides a platform for structure-based drug design","GSVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHH","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","4TV3"
"4TVJ",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG3350, 0.1M Tris",277,"10.1021/acs.jmedchem.6b00990","09L","4TVJ",84.8,"2.1","2.1","HUMAN ARTD2 (PARP2) - CATALYTIC DOMAIN IN COMPLEX WITH OLAPARIB","MHHHHHHSSGVDLGTENLYFQSMDLRVQELIKLICNVQAMEEMMMEMKYNTKKAPLGKLTVAQIKAGYQSLKKIEDCIRAGQHGRALMEACNEFYTRIPHDFGLRTPPLIRTQKELSEKIQLLEALGDIEIAIKLVKTELQSPEHPLDQHYRNLHCALRPLDHESYEFKVISQYLQSTHAPTHSDYTMTLLDLFEVEKDGEKEAFREDLHNRMLLWHGSRMSNWVGILSHGLRIAHPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQCNELLEANPKAEGLLQGKHSTKGLGKMAPSSAHFVTLNGSTVPLGPASDTGILNPDGYTLNYNEYIVYNPNQVRMRYLLKVQFNF","Homo sapiens","PARP2, ADPRT2, ADPRTL2","Poly [ADP-ribose] polymerase 2","1","4TVJ"
"4TVR",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG-3350, 0.2 M
NaCl, 0.1 M HEPES pH 7.5, 5% glycerol",298,,,"4TVR",31.56,"2.29","2.29","Tandem Tudor and PHD domains of UHRF2","GNQPSTSARARLIDPGFGIYKVNELVDARDVGLGAWFEAHIHSVTRASDGQSRGKTPLKNGNIKHKSKENTNKLDSVPSTSNSDCVAADEDVIYHIQYDEYPESGTLEMNVKDLRPRARTILKWNELNVGDVVMVNYNVESPGQRGFWFDAEITTLKTISRTKKELRVKIFLGGSEGTLNDCKIISVDEIFKIERPGAHPLSFADGKFLRRNDPECDLCGGDPEKKCHSCSCRVCGGKHEPNMQLLCDECNVAYHIYCLNPPLDKVPAEEYWYCPSCKTD","Homo sapiens","UHRF2, NIRF, RNF107","E3 ubiquitin-protein ligase UHRF2","1","4TVR"
"4TVZ",,"X-RAY DIFFRACTION",3.64,66.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 mol/L HEPES, 25%(w/v) PEG 3350",289,"10.1007/s13238-014-0087-3",,"4TVZ",99.74,"3.006","3.006","Crystal Structure of SCARB2 in Neural Condition (pH7.5)","IEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMIN","Homo sapiens","SCARB2, CD36L2, LIMP2, LIMPII","Scavenger receptor class B member 2","1","4TVZ"
"4TW0",,"X-RAY DIFFRACTION",3.61,65.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 mol/L ammonium sulfate, 0.1 mol/L sodium acetate trihydrate(pH 4.8), 30% w/v polyethylene glycol monomethyl ether 2000",289,"10.1007/s13238-014-0087-3",,"4TW0",194.73,"3.648","3.648","Crystal Structure of SCARB2 in Acidic Condition (pH4.8)","IEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMI","Homo sapiens","SCARB2, CD36L2, LIMP2, LIMPII","Scavenger receptor class B member 2","1","4TW0"
"4TW2",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 mol/L HEPES (pH 7.5), 
10% v/v 2-Propanol, 
20% w/v Polyethylene glycol 4000",289,"10.1007/s13238-014-0087-3",,"4TW2",97.29,"2.889","2.889","Crystal Structure of SCARB2 in Neural Condition (pH7.5)","IEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMIN","Homo sapiens","SCARB2, CD36L2, LIMP2, LIMPII","Scavenger receptor class B member 2","1","4TW2"
"4TW6",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"25 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",297,"10.1038/nchembio.1699","37L","4TW6",14.85,"1.4","1.4","The Fk1 domain of FKBP51 in complex with iFit1","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4TW6"
"4TW7",,"X-RAY DIFFRACTION",2.04,39.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"28 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1038/nchembio.1699","37K","4TW7",14.83,"1.25","1.25","The Fk1 domain of FKBP51 in complex with iFit4","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4TW7"
"4TW8",,"X-RAY DIFFRACTION",3.1,60.3,"VAPOR DIFFUSION, HANGING DROP",8,"28 % PEG-6000, 2 % DMSO and TrisHCl pH 8.0",293,"10.1038/nchembio.1699",,"4TW8",55.12,"3.003","3.003","The Fk1-Fk2 domains of FKBP52 in complex with iFit-FL","EGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDGGIIRRIQTRGEGYAKPNEGAIVEVALEGYYKDKLFDQRELRFEIGEGENLDLPYGLERAIQRMEKGEHSIVYLKPSYAFGSVGKEKFQIPPNAELKYELHLKSFEKA","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","4TW8"
"4TW9",,"X-RAY DIFFRACTION",2.92,57.81,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium chloride, 1.4 M ammonium sulfate, 0.1 M Bis-Tris",293,"10.1021/jm500600b","386","4TW9",71.19,"2.4","2.4","Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation","MELRVGNRYRLGNKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4TW9"
"4TWC",,"X-RAY DIFFRACTION",2.86,57.03,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M NaCl, 1.4 M (NH4)2SO4, 0.1 M Bis-Tris, pH 5.8",293,"10.1007/s00726-012-1234-x","37J","4TWC",71.36,"1.7","1.7","2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e","MELRVGNRYRLGNKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","4TWC"
"4TWE",,"X-RAY DIFFRACTION",2.76,55.37,"VAPOR DIFFUSION, HANGING DROP",,"0.16 M magnesium formate and 16% (w/v) PEG 3350, pH not adjusted",293,"10.1074/jbc.M114.628149",,"4TWE",167.67,"1.75","1.75","Structure of ligand-free N-acetylated-alpha-linked-acidic-dipeptidase like protein (NAALADaseL)","GLNDIFEAQKIEWHEGSGSGSENLYFQGRSIPKKANSLAPQDLDLEILETVMGQLDAHRIRENLRELSREPHLASSPRDEDLVQLLLQRWKDPESGLDSAEASTYEVLLSFPSQEQPNVVDIVGPTGGIIHSCHRTEENVTGEQGGPDVVQPYAAYAPSGTPQGLLVYANRGAEEDFKELQTQGIKLEGTIALTRYGGVGRGAKAVNAAKHGVAGVLVYTDPADINDGLSSPDETFPNSWYLPPSGVERGSYYEYFGDPLTPYLPAVPSSFRVDLANVSGFPPIPTQPIGFQDARDLLCNLNGTLAPATWQGALGCHYRLGPGFRPDGDFPADSQVNVSVYNRLELRNSSNVLGIIRGAVEPDRYVLYGNHRDSWVHGAVDPSSGTAVLLELSRVLGTLLKKGTWRPRRSIVFASWGAEEFGLIGSTEFTEEFFNKLQERTVAYINVDISVFANATLRVQGTPPVQSVVFSATKEIRSPGPGDLSIYDNWIRYFNRSSPVYGLVPSLGSLGAGSDYAPFVHFLGISSMDIAYTYDRSKTSARIYPTYHTAFDTFDYVDKFLDPGFSSHQAVARTAGSVILRLSDSFFLPLKVSDYSETLRSFLQAAQQDLGALLEQHSISLGPLVTAVEKFEAEAAALGQRISTLQKGSPDPLQVRMLNDQLMLLERTFLNPRAFPEERYYSHVLWAPRTGSVVTFPGLSNACSRARDTASGSEAWAEVQRQLSIVVTALEGAAATLRPVADL","Homo sapiens","NAALADL1, NAALADASEL, NAALADL","N-acetylated-alpha-linked acidic dipeptidase-like protein","1","4TWE"
"4TWK",,"X-RAY DIFFRACTION",4.05,69.68,"VAPOR DIFFUSION, SITTING DROP",,"0.25M  magnesium formate, 0.1M  Sodium Cacodylate pH 6.5, 17%  PEG3000, 5% PEG400",277,,,"4TWK",65.67,"2.6","2.6","Crystal structure of human two pore domain potassium ion channel TREK1 (K2P2.1)","MPTVLASRVESDTTINVMKWKTVSTIFLVVVLYLIIGATVFKALEQPHEISQRTTIVIQKQTFISQHSCVNSTELDELIQQIVAAINAGIIPLGNTSNQISHWDLGSSFFFAGTVITTIGFGNISPRTEGGKIFCIIYALLGIPLFGFLLAGVGDQLGTIFGKGIAKVEDTFIKWNVSQTKIRIISTIIFILFGCVLFVALPAIIFKHIEGWSALDAIYFVVITLTTIGFGDYVAGGSDIEYLDFYKPVVWFWILVGLAYFAAVLSMIGDWLRVISAENLYFQ","Homo sapiens","KCNK2, TREK, TREK1","Potassium channel subfamily K member 2","1","4TWK"
"4TWN",,"X-RAY DIFFRACTION",1.91,35.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulfate, 22.5% PEG 3350",293,"10.1021/ml500355x","B96","4TWN",40.99,"1.706","1.706","Human EphA3 Kinase domain in complex with Birb796","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin type-A receptor 3","1","4TWN"
"4TWO",,"X-RAY DIFFRACTION",1.97,37.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 0.15M ammonium sulfate, 22.5% PEG 3350",293,"10.1021/ml500355x","37W","4TWO",40.83,"2.047","2.047","Human EphA3 Kinase domain in complex with compound 164","MGSSHHHHHHSSGLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin type-A receptor 3","1","4TWO"
"4TWP",,"X-RAY DIFFRACTION",3.37,63.55,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES (pH 7.00)
15.0 %w/v PEG 3350
0.01 M Magnesium chloride hexahydrate
0.0050 M Nickel(II) chloride hexahydrate
5.0 %v/v Glycerol",286.15,"10.1038/nature14119","AXI","4TWP",63.91,"2.4","2.4","The crystal structure of human abl1 T315I gatekeeper mutant kinase domain in complex with axitinib","DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","4TWP"
"4TX0",,"X-RAY DIFFRACTION",2.32,46.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"36 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1021/ol5023195","384","4TX0",14.52,"1.03","1.03","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxyethoxy)-3-(2-methoxyethyl)-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4TX0"
"4TX5",,"X-RAY DIFFRACTION",3.11,60.47,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% MPD, 0.1 M Sodium Acetate, 0.02 M Calcium Chloride.",293,"10.1016/j.bpj.2014.11.3471",,"4TX5",44.66,"1.8","1.8","Crystal structure of Smac-DIABLO (in space group P65)","AVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTFLSQTTYALIEAITEYTKAVYTLTSLYRQYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTGADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQIEELRQKTQEEGEERAESEQEAYLREDLEHHHHHH","Homo sapiens","DIABLO, SMAC","Diablo homolog, mitochondrial","1","4TX5"
"4TXC",,"X-RAY DIFFRACTION",3.06,59.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG6000, 10% ethylene glycol, 0.1M HEPES pH 7.0, 0.2M sodium chloride, 293K,
using previously frozen protein",293,"10.1002/cbic.201402512","38G","4TXC",35.57,"1.951","1.951","Crystal Structure of DAPK1 kinase domain in complex with a small molecule inhibitor","GSSHHHHHHSSGLVPRGSHMTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","4TXC"
"4TXP",,"X-RAY DIFFRACTION",2.67,54.02,"VAPOR DIFFUSION, HANGING DROP",7,"7.5-9% PEG 8000, 20% 1,4 butanediol, 0.1M cacodylate, 0.2M sodium acetate",277.15,"10.1074/jbc.M114.616730",,"4TXP",56.38,"3.01","3.01","Crystal structure of LIP5 N-terminal domain","SMAALAPLPPLPAQFKSIQHHLRTAQEHDKRDPVVAYYCRLYAMQTGMKIDSKTPECRKFLSKLMDQLEALKKQLGDNEAITQEIVGCAHLENYALKMFLYADNEDRAGRFHKNMIKSFYTASLLIDVITVFGELTDENVKHRKYARWKATYIHNCLKNGETP","Homo sapiens","VTA1, C6orf55, HSPC228, My012","Vacuolar protein sorting-associated protein VTA1 homolog","1","4TXP"
"4TY1",,"X-RAY DIFFRACTION",3.19,61.45,"VAPOR DIFFUSION, HANGING DROP",8,"1.0M LiCl, 0.1M TRIS pH8.0, 20% PEG6K",277,"10.1016/j.bmcl.2014.12.067","38W","4TY1",33.53,"2.7","2.7","Crystal structure of human Pim-1 kinase in complex with an aminooxadiazole-indole inhibitor.","MAHHHHHHDEVDGPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4TY1"
"4TY6",,"X-RAY DIFFRACTION",3.51,64.96,"VAPOR DIFFUSION, HANGING DROP",5.6,"100 MM SODIUM ACETATE, PH 4.6, 26%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1021/jm5010607","39D","4TY6",30.8,"1.85","1.85","Factor XIa in complex with the inhibitor 4-{2-[(1S)-1-({[trans-4-(aminomethyl)cyclohexyl]carbonyl}amino)-2-phenylethyl]-1H-imidazol-4-yl}benzamide","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","4TY6"
,,,,,,,,,,,,,,,,"MDDDDKMDNECTTKIKPR","Homo sapiens","F11","CYS-THR-THR-LYS-ILE-LYS-PRO","2","4TY6"
"4TY7",,"X-RAY DIFFRACTION",3.59,65.7,"VAPOR DIFFUSION, HANGING DROP",5.6,"100 MM SODIUM ACETATE, PH 4.6, 26%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1021/jm5010607","39F","4TY7",28.72,"2.09","2.09","Factor XIa in complex with the inhibitor (2S)-6-amino-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-2-ethylhexanamide","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","4TY7"
"4TYE",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, SITTING DROP",,"0.6 M NaH2PO4,
0.6 M KH2PO4,
0.075 M NaHEPES pH 7.5,
24% Glycerol",277.15,"10.1016/j.jmb.2014.09.004",,"4TYE",34.88,"2.8","2.8","Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase","AMGSAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4TYE"
"4TYG",,"X-RAY DIFFRACTION",3.25,62.22,"VAPOR DIFFUSION, SITTING DROP",,"2.5 M Sodium acetate 
0.1 M MES pH 6.5",277.15,"10.1016/j.jmb.2014.09.004",,"4TYG",34.87,"2.4","2.4","Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase","AMGSAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4TYG"
"4TYI",,"X-RAY DIFFRACTION",2.88,57.37,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Citric acid pH 4.0
1.6 M Ammonium sulfate
final pH: 5",277.15,"10.1016/j.jmb.2014.09.004",,"4TYI",35.08,"3.4","3.4","Structural analysis of the human Fibroblast Growth Factor Receptor 4","AMGSAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4TYI"
"4TYJ",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION, SITTING DROP",,"0.4 M Ammonium dihydrogen phosphate",277.15,"10.1016/j.jmb.2014.09.004","0LI","4TYJ",35.47,"2.45","2.45","Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase","AMGSAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4TYJ"
"4TYL",,"X-RAY DIFFRACTION",4.06,69.69,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, pH 5.5, 2.5 M (NH4)2SO4. Ligand-free crystals grown at 277K, then soaked with ligand at 291K",291,"10.1021/jm501035j","39O","4TYL",15.88,"1.85","1.85","Fragment-Based Screening of the Bromodomain of ATAD2","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TYL"
"4TYO",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mM DTT, 100mM Hepes, 0.1% (v/v) NP-40, 1.6M NaCitrate. Compound in 5%DMSO soaked in to apo crystals @ 250uM.",286,"10.1016/j.bmcl.2014.07.044","39X","4TYO",28.26,"1.75","1.75","PPIase in complex with a non-phosphate small molecule inhibitor.","GSHMGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEQITRTQEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4TYO"
"4TZ2",,"X-RAY DIFFRACTION",3.98,69.1,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bis-Tris, pH 6.0, 2.2 M (NH4)2SO4, 10% glycerol",277,"10.1021/jm501035j","39R","4TZ2",15.99,"1.7","1.7","Fragment-Based Screening of the Bromodomain of ATAD2","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TZ2"
"4TZ8",,"X-RAY DIFFRACTION",4.13,70.19,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, pH 5.5, 2.5 M (NH4)2SO4, crystals generated at 277 K, fragment soaked at 291 K overnight",277,"10.1021/jm501035j","39U","4TZ8",15.89,"2.15","2.15","Structure of human ATAD2 bromodomain bound to fragment inhibitor","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","4TZ8"
"4U04",,"X-RAY DIFFRACTION",3.06,59.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 200mM Na K Tartrate, 100mM Bis-Tris Propane 7.5",289,"10.1016/j.str.2014.10.007",,"4U04",79.64,"2.48","2.48","Structure of a eukaryotic fic domain containing protein","GKLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","4U04"
"4U07",,"X-RAY DIFFRACTION",3.02,59.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% peg 3350, 200mM Na K tartrate, 100mM Bist-Tris Propane 7.5",292,"10.1016/j.str.2014.10.007",,"4U07",80.55,"2.64","2.64","ATP bound to eukaryotic FIC domain containing protein","GKLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","4U07"
"4U0I",,"X-RAY DIFFRACTION",2.57,52.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris pH 8.5, 0.9-1.2M ammonium sulfate",293,"10.1158/1078-0432.CCR-14-1397","0LI","4U0I",36.34,"2","2","Crystal structure of KIT in complex with ponatinib","INGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit,Mast/stem cell growth factor receptor Kit","1","4U0I"
"4U0S",,"X-RAY DIFFRACTION",2.99,58.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% peg 3350, 200mM Na K tartrate, 100mM Bis-Tris-Propane 7.5",292,"10.1016/j.str.2014.10.007","ADP","4U0S",80.24,"2.49","2.49","Structure of Eukaryotic fic domain containing protein with ADP","GKLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIGGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","4U0S"
"4U0U",,"X-RAY DIFFRACTION",3.53,65.12,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 200mM Na K tartrate, 100mM Bis-Tris-Propane 7.5",292,"10.1016/j.str.2014.10.007",,"4U0U",80.58,"2.98","2.98","Wild type eukaryotic fic domain containing protein with ADP","GKLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","4U0U"
"4U0Z",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 200mM Na K Tartrate, 100mM Bis-Tris Propane 7.5",292,"10.1016/j.str.2014.10.007",,"4U0Z",320.62,"2.95","2.95","Eukaryotic Fic Domain containing protein with bound APCPP","GKLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","4U0Z"
"4U17",,"X-RAY DIFFRACTION",3.55,65.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"50 mM sodium phosphate pH 6.5",293,,,"4U17",37.61,"1.99","1.99","Swapped dimer of the human Fyn-SH2 domain","GSHMEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHK","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","4U17"
"4U18",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES pH 6.5, 1M ammonium sulphate",295,"10.1111/febs.13179",,"4U18",91.89,"2.64","2.64","Crystal structure of human peroxisomal delta3,delta2, enoyl-CoA isomerase (ISO-ECI2)","MHHHHHHSSGVDLGTENLYFQSMGFETLVVTSEDGITKIMFNRPKKKNAINTEMYHEIMRALKAASKDDSIITVLTGNGDYYSSGNDLTNFTDIPPGGVEEKAKNNAVLLREFVGCFIDFPKPLIAVVNGPAVGISVTLLGLFDAVYASDRATFHTPFSHLGQSPEGCSSYTFPKIMSPAKATEMLIFGKKLTAGEACAQGLVTEVFPDSTFQKEVWTRLKAFAKLPPNALRISKEVIRKREREKLHAVNAEECNVLQGRWLSDECTNAVVNFLSR","Homo sapiens","ECI2, DRS1, HCA88, PECI","Enoyl-CoA delta isomerase 2, mitochondrial","1","4U18"
"4U19",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"100mM HEPES pH 7.5, 10% PEG 6000, 5% MPD",295,"10.1111/febs.13179",,"4U19",91.78,"1.88","1.88","Crystal structure of human peroxisomal delta3,delta2, enoyl-CoA isomerase V349A mutant (ISOA-ECI2)","MHHHHHHSSGVDLGTENLYFQSMGFETLVVTSEDGITKIMFNRPKKKNAINTEMYHEIMRALKAASKDDSIITVLTGNGDYYSSGNDLTNFTDIPPGGVEEKAKNNAVLLREFVGCFIDFPKPLIAVVNGPAVGISVTLLGLFDAVYASDRATFHTPFSHLGQSPEGCSSYTFPKIMSPAKATEMLIFGKKLTAGEACAQGLVTEVFPDSTFQKEVWTRLKAFAKLPPNALRISKEVIRKREREKLHAVNAEECNVLQGRWLSDECTNAAVNFLSR","Homo sapiens","ECI2, DRS1, HCA88, PECI","Enoyl-CoA delta isomerase 2","1","4U19"
"4U1A",,"X-RAY DIFFRACTION",2.6,52.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"160mM calcium acetate, 0.08M sodium cacodylate pH 6.5, 14.4% PEG8000",295,"10.1111/febs.13179",,"4U1A",89.65,"2.85","2.85","Crystal structure of human peroxisomal delta3,delta2, enoyl-CoA isomerase helix-10 deletion mutant (ISOB-ECI2)","MHHHHHHSSGVDLGTENLYFQSMGFETLVVTSEDGITKIMFNRPKKKNAINTEMYHEIMRALKAASKDDSIITVLTGNGDYYSSGNDLTNFTDIPPGGVEEKAKNNAVLLREFVGCFIDFPKPLIAVVNGPAVGISVTLLGLFDAVYASDRATFHTPFSHLGQSPEGCSSYTFPKIMSPAKATEMLIFGKKLTAGEACAQGLVTEVFPDSTFQKEVWTRLKAFAKLPPNALRISKEVIRKREREKLHAVNAEECNVLQGRWLSDECTNAV","Homo sapiens","ECI2, DRS1, HCA88, PECI","Enoyl-CoA delta isomerase 2","1","4U1A"
"4U1B",,"X-RAY DIFFRACTION",2.47,50.29,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 2000, potassium chloride, hepes, sodium chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm501790e","Q08","4U1B",34.87,"1.89","1.89","HsMetAP in complex with (1-amino-2-propylpentyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U1B"
"4U1R",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES, 17-23% v/v MPD",292,"10.1042/BJ20150251",,"4U1R",327.62,"2.8","2.8","ATP-bound structure of human platelet phosphofructokinase in an R-state, crystal form II","VPDPTSAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILA","Homo sapiens","PFKP, PFKF","ATP-dependent 6-phosphofructokinase, platelet type","1","4U1R"
"4U2U",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",,"26.7% PEG 3350, 0.05 M sodium acetate",291,"10.1016/j.molcel.2014.07.016",,"4U2U",37.96,"2.9","2.9","Bak domain swapped dimer induced by BidBH3 with CHAPS","PLGSMSEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHSIARWIAQRGGWVAALNLGNG","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","4U2U"
"4U3Y",,"X-RAY DIFFRACTION",1.99,38.32,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,,,"4U3Y",75.82,"1.45","1.45","Apo Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U3Y"
"4U3Z",,"X-RAY DIFFRACTION",1.97,37.54,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,,,"4U3Z",76.21,"2.09","2.09","APO MAP4K4 T181E Phosphomimetic Mutant","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDREVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U3Z"
"4U40",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,,,"4U40",76.32,"2.3","2.3","Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) Bound to AMPPNP","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U40"
"4U41",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,,"3C8","4U41",76.27,"2.2","2.2","MAP4K4 Bound to inhibitor compound 1","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U41"
"4U42",,"X-RAY DIFFRACTION",2.09,41.23,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,,"3C8","4U42",76.66,"2.504","2.504","MAP4K4 T181E Mutant Bound to inhibitor compound 1","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDREVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U42"
"4U43",,"X-RAY DIFFRACTION",2.06,40.19,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,"10.1016/j.bmcl.2014.07.071","3D8","4U43",75.95,"2.18","2.18","MAP4K4 in complex with inhibitor (compound 6)","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U43"
"4U44",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,"10.1016/j.bmcl.2014.07.071","3D9","4U44",76.25,"2.43","2.43","MAP4K4 in complex with inhibitor (compound 16)","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U44"
"4U45",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M potassium citrate, pH 8.3, 20% PEG 3350",292,"10.1016/j.bmcl.2014.07.071",,"4U45",76.26,"2.58","2.58","MAP4K4 in complex with inhibitor (compound 25)","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","4U45"
"4U5T",,"X-RAY DIFFRACTION",5.86,79.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M ammonium phos., 20% PEG3350, 3% trimethylamine N-oxide",295,"10.1124/mol.112.080820",,"4U5T",9.34,"3.301","3.301","Crystal Structure of VBP Leucine Zipper with Bound Arylstibonic Acid","RDPDLEIRAAFLEKENTALRTEVAELRKEVGRCKNIVSK","Homo sapiens","TEF, KIAA1655","VBP leucine zipper","1","4U5T"
"4U69",,"X-RAY DIFFRACTION",2.57,52.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 2000, potassium chloride, hepes, sodium chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm501790e","Q07","4U69",34.79,"1.6","1.6","HsMetAP complex with (1-amino-2-methylpentyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U69"
"4U6A",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES pH 6.0, 0.1 M ammonium tartrate, 12-16% w/v PEG 3350",293,,,"4U6A",30.44,"2.37","2.37","X-ray crystal structure of human TNKS in complex with a small molecule inhibitor","MHHHHHHSSGVDLGTENLYFQSMQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQ","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4U6A"
"4U6C",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 2000, potassium chloride, hepes, sodium chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm501790e","Q06","4U6C",34.91,"1.91","1.91","HsMetAP in complex with [(1R)-1-amino-3-cyclopentylpropyl]phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U6C"
"4U6E",,"X-RAY DIFFRACTION",2.57,52.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG-MME 2000, 100 mM HEPES, pH=6.0, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm501790e","Q02","4U6E",34.76,"1.9","1.9","HsMetAP in complex with (amino(phenyl)methyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U6E"
"4U6J",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG MME  , 100mM HEPES PH6.0 ,",298,"10.1021/jm501790e",,"4U6J",34.85,"1.56","1.56","HsMetAP in complex with methionine","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U6J"
"4U6Q",,"X-RAY DIFFRACTION",2.3,42.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"75 mM CaCl2, 100 mM Hepes pH 7.5, and 1 mM NADH",277,"10.1021/cb500820b","3CR","4U6Q",39.07,"2.3","2.3","CtBP1 bound to inhibitor 2-(hydroxyimino)-3-phenylpropanoic acid","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNK","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","4U6Q"
"4U6R",,"X-RAY DIFFRACTION",2.91,57.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Ammonium sulfate, 0.1M HEPES, 25% PEG3350, pH7.5",293,"10.1021/ml500315b","3E4","4U6R",53.77,"2.5","2.5","Crystal structure of human IRE1 cytoplasmic domains in complex with a sulfonamide inhibitor.","MGHNHRHKHHHHHHHHENLYFQGPGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","4U6R"
"4U6S",,"X-RAY DIFFRACTION",2.3,42.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM Calcium Chloride, 100 mM Hepes pH 7.5, 2.5 mM NAD+",277,"10.1021/cb500820b",,"4U6S",39.05,"2.1","2.1","CtBP1 in complex with substrate phenylpyruvate","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNK","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","4U6S"
"4U6W",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG-MME, 100mM Hepes, PH 6",298,"10.1021/jm501790e","Q08","4U6W",34.9,"1.83","1.83","HsMetAP (F220M) in complex with 1-amino-2-propylpentyl]phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U6W"
"4U6Z",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG-MME, 100mM HEPES, PH 6",298,"10.1021/jm501790e","Q07","4U6Z",34.87,"1.8","1.8","HsMetAP(F309M) in complex with 1-amino-2-propylpentyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U6Z"
"4U70",,"X-RAY DIFFRACTION",2.6,52.69,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEGMME, 100mM HEPES PH 6.",298,"10.1021/jm501790e","Q04","4U70",34.8,"1.6","1.6","HsMetAP (F309M) in complex with (1-amino-2-cyclohexylethyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U70"
"4U71",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEGMME, 100mM HEPES PH 6",298,"10.1021/jm501790e","Q03","4U71",34.88,"1.8","1.8","HsMetAP(F309M) IN COMPLEX WITH 1- amino(cyclohexyl)methy)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U71"
"4U72",,"X-RAY DIFFRACTION",3.06,59.84,"VAPOR DIFFUSION, HANGING DROP",9.1,"12 % (W/V) PEG 8000, 0.2 M ammonium acetate, 1 mM 4-phenylimidazole, 0.1 M CHES",293,,"PIM","4U72",93.66,"2","2","Crystal structure of 4-phenylimidazole bound form of human indoleamine 2,3-dioxygenase (A260G mutant)","GSHMAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFGGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","4U72"
"4U73",,"X-RAY DIFFRACTION",2.57,52.17,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEGMME, 100mM HEPES PH 6",298,"10.1021/jm501790e","Q02","4U73",34.78,"1.8","1.8","HsMetAP(F309M) IN COMPLEX WITH (amino(phenyl)methyl)phosphonic acid","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U73"
"4U74",,"X-RAY DIFFRACTION",3.1,60.27,"VAPOR DIFFUSION, HANGING DROP",9.1,"12 % (W/V) PEG 8000, 0.2 M ammonium acetate, 1 mM 4-phenylimidazole, 0.1 M CHES",293,,"PIM","4U74",93.71,"2.31","2.31","Crystal structure of 4-phenylimidazole bound form of human indoleamine 2,3-dioxygenase (G262A mutant)","GSHMAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGASAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","4U74"
"4U75",,"X-RAY DIFFRACTION",2.6,52.72,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEGMME, 100mM HEPES PH 6",298,"10.1021/jm501790e",,"4U75",34.84,"1.94","1.94","HsMetAP (F309M) in complex with Methionine","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U75"
"4U76",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEGMME, 100mM HEPES PH 6",298,"10.1021/jm501790e",,"4U76",34.78,"1.87","1.87","HsMetAP (F309M) holo form","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","4U76"
"4U79",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 20mMBMe, 30%PEG550MME, pH7.5",277,"10.1021/ml500315b",,"4U79",42.63,"2.23","2.23","Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor.","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4U79"
"4U7F",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes pH 7.0",298,"10.1021/bi500959t","K25","4U7F",54.35,"1.8","1.8","Reduced quinone reductase 2 in complex with CK2 inhibitor DMAT","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4U7F"
"4U7G",,"X-RAY DIFFRACTION",2.41,49.01,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes pH 7.0",298,"10.1021/bi500959t","K17","4U7G",54.27,"1.96","1.96","Oxidized quinone reductase 2 in complex with CK2 inhibitor TBBz","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4U7G"
"4U7H",,"X-RAY DIFFRACTION",2.4,48.84,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Ammonium sulfate, 0.1M Hepes pH 7.0",298,"10.1021/bi500959t","K25","4U7H",54.35,"1.48","1.48","Oxidized quinone reductase 2 in complex with CK2 inhibitor DMAT","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4U7H"
"4U7L",,"X-RAY DIFFRACTION",3.08,60.05,"EVAPORATION",7,"16% PEG4000
0.1M Hepes pH7.0 
10mM Taurine",293,"10.1016/j.jmb.2015.03.001",,"4U7L",51.6,"2.3","2.3","LRIG1 extracellular domain: Structure and Function Analysis","TCPSRCTCSGDSLDCGGRGLAALPGDLPSSTRSLNLSYNKLSEIDPAGFEDLPNLQEVYLNNNELTAVPSLGAASSHVVSLFLQHNKIRSVEGSQLKAYLSLEVLDLSLNNITEVRNTCFPHGPPIKELNLAGNRIGTLELGAFDGLSRSLLTLRLSKNRITQLPVRAFKLPRLTQLDLNRNRIRLIEGLTFQGLNSLEVLKLQRNNISKLTDGAFWGLSKMHVLHLEYNSLVEVNSGSLYGLTALHQLHLSNNSIARIHRKGWSFCQKLHELVLSFNNLTRLDEESLAELSSLSVLRLSHNSISHIAEGAFKGLRSLRVLDLDHNEISGTIEDTSGAFSGLDSLSKLTLFGNKIKSVAKRAFSGLEGLEHLNLGGNAIRSVQFDAFVKMKNLKELHISSDSFLCDCQLKWLPPWLIGRMLQAFVTATCAHPESLKGQSIFSVPPESFVCDDFLKA","Homo sapiens","LRIG1, LIG1","Leucine-rich repeats and immunoglobulin-like domains protein 1","1","4U7L"
"4U7M",,"X-RAY DIFFRACTION",6.4,80,"EVAPORATION",7,"0.8 M sodium succinate pH 7.0",293,"10.1016/j.jmb.2015.03.001",,"4U7M",32.65,"2.757","2.757","LRIG1 extracellular domain: Structure and Function Analysis","KPQIITQPETTMAMVGKDIRFTCSAASSSSSPMTFAWKKDNEVLTNADMENFVHVHAQDGEVMEYTTILHLRQVTFGHEGRYQCVITNHFGSTYSHKARLTVNVLPSFTKTPHDITIRTTTMARLECAATGHPNPQIAWQKDGGTDFPAARERRMHVMPDDDVFFITDVKIDDAGVYSCTAQNSAGSISANATLTVLETPSLVVPLEDRVVSVGETVALQCKATGNPPPRITWFKGDRPLSLTERHHLTPDNQLLVVQNVVAEDAGRYTCEMSNTLGTERAHSQLSVLLENLY","Homo sapiens","LRIG1, LIG1","Leucine-rich repeats and immunoglobulin-like domains protein 1","1","4U7M"
"4U7Z",,"X-RAY DIFFRACTION",3.3,62.77,"VAPOR DIFFUSION, HANGING DROP",6.9,"The protein was concentrated to 15mg/ml and incubated with 10 fold molar excess inhibitor plus 1mM MgAMP-PNP before crystallization. MEK1 crystals grew from hanging drop vapor diffusion using 12% w/v PEG 8000, 0.4M NH4H2PO4 and 0.1M HEPES pH 6.9 at 18 degC.",291,"10.1016/j.bmcl.2014.08.008","3EW","4U7Z",38.92,"2.805","2.805","Mitogen-Activated Protein Kinase Kinase (MEK1) bound to G805","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLQHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","4U7Z"
"4U80",,"X-RAY DIFFRACTION",3.3,62.71,"VAPOR DIFFUSION, HANGING DROP",6.9,"The protein was concentrated to 15mg/m1 and incubated with 10 fold molar excess inhibitor plus 1mM MgAMP-PNP before crystallization. MEK1 crystals grew from hanging drop vapor diffusion using 12% w/v PEG 8000, 0.4M NH4H2PO4 and 0.1M HEPES pH 6.9 at 18 degC
.",291,"10.1016/j.bmcl.2014.08.008",,"4U80",38.83,"2.8","2.8","MEK 1 kinase bound to G799","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLQHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","4U80"
"4U81",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION, HANGING DROP",6.9,"The protein was concentrated to 15mg/ml and incubated with 10 fold molar excess inhibitor plus 1mM MgAMP-PNP before crystallization. MEK1 crystals grew from hanging drop vapor diffusion using 12% w/v PEG 8000, 0.4M NH4H2PO4 and 0.1M HEPES pH 6.9 at 18 degC.",291,"10.1016/j.bmcl.2014.08.008",,"4U81",38.83,"2.701","2.701","MEK1 Kinase bound to small molecule inhibitor G659","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLQHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","4U81"
"4U84",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH7.5
1 % PEG400
1.2-1.5M Ammonium sulfate",277,"10.1016/j.nbd.2014.12.027",,"4U84",21.76,"1.78","1.78","Human Pin1 with S-hydroxyl-cysteine 113","HHHHHHHHGGLVPRGSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4U84"
"4U85",,"X-RAY DIFFRACTION",2.68,54.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM HEPES pH 7.5
1% PEG400
1.2-1.5M Ammonium sulfate",277,"10.1016/j.nbd.2014.12.027",,"4U85",21.77,"1.7","1.7","Human Pin1 with cysteine sulfinic acid 113","HHHHHHHHGGLVPRGSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4U85"
"4U86",,"X-RAY DIFFRACTION",2.71,54.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM HEPES7.5
1% PEG400
1.2-1.5M Ammonium Sulfate",277,"10.1016/j.nbd.2014.12.027",,"4U86",20.51,"1.6","1.6","Human Pin1 with cysteine sulfonic acid 113","HHHHHHHHGGLVPRGSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","4U86"
"4U8D",,"X-RAY DIFFRACTION",3.48,64.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 8000 10%, Mg(OAc)2 0.2M, cacodylate 0.1M pH 6.5",293,,,"4U8D",43.56,"2.3","2.3","X-ray structure of Mg-bound human sorcin","MAYPGHPGAGGGYYPGGYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMSV","Homo sapiens","SRI","Sorcin","1","4U8D"
"4U8Z",,"X-RAY DIFFRACTION",2.74,55.06,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl (pH 8.5), 180mM MgCl2, 5mM Manganese (II) acetate, 10-17% PEG3350",293,"10.1021/jm5014055","3FE","4U8Z",33.32,"1.63","1.63","Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06447475)","GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQ","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","4U8Z"
"4U93",,"X-RAY DIFFRACTION",2.85,56.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"Protein is used at 10mg/ml.  Crystallant is: 10-20% (w/v) PEG2K MME, 50-200 mM magnesium chloride, 100 mM sodium cacodylate Equal ratio of protein to crystallant use for drops",298,"10.1021/jm501107q","990","4U93",26.98,"1.55","1.55","Crystal Structure of Hsp90-alpha N-domain Bound to the Inhibitor NVP-HSP990","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4U93"
"4U97",,"X-RAY DIFFRACTION",3.35,63.29,"VAPOR DIFFUSION, HANGING DROP",7,"Set up at 10 mg/mL with staurosporine at a 2:1 molar ratio. Mixed with equal volumes 1.6-1.9 M ammonium sulfate, 100 mM
Hepes-NaOH at pH7.",289,"10.1016/j.molcel.2014.08.006",,"4U97",70.86,"2.65","2.65","Crystal Structure of Asymmetric IRAK4 Dimer","GAMGSENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRNIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","4U97"
"4U9A",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/ml IRAK4 mixed with staurosproine at a 2:1 molar excess. Protein solution mixed 1:1 with 1.6-1.9 M ammonium sulfate, 100 mM Hepes-NaOH at pH7.",293,"10.1016/j.molcel.2014.08.006",,"4U9A",70.86,"2.8","2.8","Sulphur Anomalous Crystal Structure of Asymmetric IRAK4 Dimer","GAMGSENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRNIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","4U9A"
"4U9V",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"20% PEG 3350, 100 mM sodium citrate tribasic dihydrate, 100 mM citric acid",298,"10.1016/j.str.2014.10.025",,"4U9V",23.72,"1.78","1.78","Crystal structure of NatD (Naa40p) bound to acetyl CoA","SVCAKVDAANRLGDPLEAFPVFKKYDRNGLNVSIECKRVSGLEPATVDWAFDLTKTNMQTMYEQSEWGWKDREKREEMTDDRAWYLIAWENSSVPVAFSHFRFDVECGDEVLYCYEVQLESKVRRKGLGKFLIQILQLMANSTQMKKVMLTVFKHNHGAYQFFREALQFEIDDSSPSMSGCCGEDCSYEILSRRTKF","Homo sapiens","NAA40, NAT11, PATT1","N-alpha-acetyltransferase 40","1","4U9V"
"4U9Y",,"X-RAY DIFFRACTION",2.11,41.61,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 20% PEG 3350, 0.2M NaBr",293,,,"4U9Y",23.78,"2.201","2.201","Structure of the alpha-tubulin acetyltransferase alpha-TAT1/Mec-17 in complex with CoA","GPGSMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHEFG","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase 1","1","4U9Y"
"4U9Z",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Tris, 25% PEG 3350",293,,,"4U9Z",23.7,"1.802","1.802","Structure of the alpha-tubulin acetyltransferase alpha-TAT1/Mec-17 in complex with CoA","GPGSMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHEFG","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase 1","1","4U9Z"
"4UAI",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, HANGING DROP",6.5,"2 M AmSO4, 2% MPD, 0.1 M MES Sodium Salt pH 6.5",293,"10.1021/jm501194p",,"4UAI",16.43,"1.9","1.9","Crystal structure of CXCL12 in complex with inhibitor","KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1","1","4UAI"
"4UAK",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, SITTING DROP",5.6,"12-18% PEG 3350, 100mM ammonium sulphate, 100mM sodium potassium tartrate, 100mM bis-tris pH 5.6",277,"10.1186/s12964-014-0054-x",,"4UAK",48.63,"1.73","1.73","MRCK beta in complex with ADP","GGSSAKVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKS","Homo sapiens","CDC42BPB, KIAA1124","Serine/threonine-protein kinase MRCK beta","1","4UAK"
"4UAL",,"X-RAY DIFFRACTION",2.3,46,"VAPOR DIFFUSION, SITTING DROP",5.6,"12-18% PEG 3350, 100mM ammonium sulphate, 100mM sodium potassium tartrate, 100mM bis-tris pH 5.6",277,"10.1186/s12964-014-0054-x","3FV","4UAL",48.53,"1.71","1.71","MRCK beta in complex with BDP00005290","GGSSAKVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKS","Homo sapiens","CDC42BPB, KIAA1124","Serine/threonine-protein kinase MRCK beta","1","4UAL"
"4UB0",,"X-RAY DIFFRACTION",2.75,55.3,"VAPOR DIFFUSION, SITTING DROP",,"protein @ 19 mg/ml in 10 mM Tris-HCl, pH 8.0, 100 mM NaCl; 0.018 M of each of the following salt solutions: CaCl2, CoCl2, and CdCl2; 18% PEG 3350 and 5% glycerol",293,"10.1080/19420862.2015.1007816",,"4UB0",46.85,"2.2","2.2","New design for monovalent bispecific IgG through cysteine engineering of the CH1-CL interface","EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVCPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"IgG1, heavy chain","1","4UB0"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPCDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGES","Homo sapiens",,"IgG1, light chain","2","4UB0"
"4UB7",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION",,"4M sodium chloride",293,"10.1021/acschembio.5b00235","3G5","4UB7",40.61,"2.1","2.1","High-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC26) showing an extreme distortion of the ATP-binding loop combined with a pi-halogen bond","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4UB7"
"4UBA",,"X-RAY DIFFRACTION",3.07,59.99,"VAPOR DIFFUSION",,"Reservoir: 30 %(w/v) PEG4000, 0.2 M ammonium acetate, 0.1 M trisodium citrate",293,"10.1021/acschembio.5b00235",,"4UBA",81.01,"2.995","2.995","Low-salt structure of protein kinase CK2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (FLC26)","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","4UBA"
"4UBF",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",6.8,"24 % w/v PEG 1500
20 % v/v Glycerol

Protein crystals appeared after two days and single crystals were used for measurement",292,"10.7554/eLife.06421",,"4UBF",176.44,"3","3","HsMCAK motor domain complex","MGSSHHHHHHSSGLVPRGSSFPNWEFARMIKEFRATLECHPLTMTDPIEEHRICVCVRKRPLNKQELAKKEIDVISIPSKCLLLVHEPKLKVDLTKYLENQAFCFDFAFDETASNEVVYRFTARPLVQTIFEGGKATCFAYGQTGSGKTHTMGGDLSGKAQNASKGIYAMASRDVFLLKNQPCYRKLGLEVYVTFFEIYNGKLFDLLNKKAKLRVLEDGKQQVQVVGLQEHLVNSADDVIKMIDMGSACRTSGQTFANSNSSRSHACFQIILRAKGRMHGKFSLVDLAGNERGADTSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTPFRESKLTQVLRDSFIGENSRTCMIATISPGISSCEYTLNTLRYADRVKELSPHSG","Homo sapiens","KIF2C, KNSL6","Kinesin-like protein KIF2C","1","4UBF"
,,,,,,,,,,,,,,,,"QLEEQASRQISS","Homo sapiens","KIF2C, KNSL6","Kinesin-like protein KIF2C","2","4UBF"
"4UC4",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.06M Divalents (MgCl2/CaCl2), 0.1M Buffer pH8.5 (TRIS/Bicine) and 30% w/v EDO/P8K",288,"10.1038/ncomms13387",,"4UC4",26.75,"2.5612","2.5612","Crystal structure of hybrid tudor domain of human lysine demethylase KDM4B","GSHMRAVSLGQVVITKNRNGLYYRCRVIGAASQTCYEVNFDDGSYSDNLYPESITSRDCVQLGPPSEGELVELRWTDGNLYKAKFISSVTSHIYQVEFEDGSQLTVKRGDIFTLEEELP","Homo sapiens","KDM4B, JHDM3B, JMJD2B, KIAA0876","Lysine-specific demethylase 4B","1","4UC4"
"4UCH",,"X-RAY DIFFRACTION",2.67,53.95,,6.2,"9-11% PEG3350, 10% GLYCEROL, 40 MM CITRIC ACID, 60 MM BIS-TRIS-PROPANE, 5 MM TCEP, pH 6.2",,"10.1021/jm501719e","OLW","4UCH",100.07,"2.2","2.2","Structure of human nNOS R354A G357D mutant heme domain in complex with 3-(((2-((2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYL)AMINO)METHYL) BENZONITRILE","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWKG","Homo sapiens","NOS1","NITRIC OXIDE SYNTHASE, BRAIN","1","4UCH"
"4UEE",,"X-RAY DIFFRACTION",2.2,44.11,,,"0.2 M CALCIUM CHLORIDE, 0.1 M HEPES PH 7.0 AND 20% W/V PEG6000",,,,"4UEE",70.42,"2.27","2.27","Crystal structure of the human CARBOXYPEPTIDASE A1 in complex with the PHOSPHINIC INHIBITOR Acetyl-Leu-Ala-Y(PO2CH2)-homoPhe-OH","ARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHPY","Homo sapiens","CPA1, CPA","CARBOXYPEPTIDASE A1","1","4UEE"
"4UEF",,"X-RAY DIFFRACTION",2.2,44.12,,,,,,,"4UEF",70.52,"1.69","1.69","Crystal structure of the human CARBOXYPEPTIDASE A1 in complex with the PHOSPHINIC INHIBITOR Acetyl-Tyr-Ala-Y(PO2CH2)-homoPhe-OH","ARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHPY","Homo sapiens","CPA1, CPA","CARBOXYPEPTIDASE A1","1","4UEF"
"4UEG",,"X-RAY DIFFRACTION",2.65,53.68,,8.5,"0.3 M MGFORMATE, 0.1 M TRIS PH 8.5 WITH 30 % ETHYLENE GLYCOL IN MOTHER LIQUOR AS CRYOPROTECTANT",,,,"4UEG",66.25,"1.93","1.93","Crystal structure of human glycogenin-2 catalytic domain","MTDQAFVTLATNDIYCQGALVLGQSLRRHRLTRKLVVLITPQVSDLLRRILSKVFDEVIEVNLIDSADYIHLAFLKRPELGLTLTKLHCWTLTHYSKCVFLDADTLVLSNVDELFDRGEFSAAPDPGWPDCFNSGVFVFQPSLHTHKLLLQHAMEHGSFDGADQGLLNSFFRNWSTTDIHKHLPFIYNLSSNTMYTYSPAFKQFGSSAKVVHFLGSMKPWNYKYNPQSGSVLEQGSVSSSQHQAAFLHLWWTVYQNNVLPLYKSVQAENLYFQSHHHHHHDYKDDDDK","Homo sapiens","GYG2","GLYCOGENIN-2","1","4UEG"
"4UEX",,"X-RAY DIFFRACTION",1.84,33.2,"VAPOR DIFFUSION, SITTING DROP",4.8,"SITTING-DROP VAPOUR DIFFUSION: 400 NL DROP (200 NL PROTEIN AT 19.6 MG/ML IN 150 MM NACL, 50 MM TRIS PH 7.4 MIXED WITH 200 NL RESERVOIR SOLUTION) WAS EQUILIBRATED AGAINST A 80 UL RESERVOIR OF 0.2 M LITHIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.8 AND 25% W/V POLYETHYLENE GLYCOL 4000",,"10.1107/S2053230X15008584",,"4UEX",18.61,"1.8","1.8","Structure of human Saposin A at lysosomal pH","MGSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQ","Homo sapiens","PSAP, GLBA, SAP1","PROSAPOSIN","1","4UEX"
"4UEZ",,"X-RAY DIFFRACTION",2.2,44.19,,,"0.2 M CALCIUM CHLORIDE, 0.1 M HEPES PH 7.0 AND 17% W/V PEG6000",,,,"4UEZ",70.55,"2.29","2.29","Crystal structure of the human CARBOXYPEPTIDASE A1 in complex with the PHOSPHINIC INHIBITOR Acetyl-Leu-Phe-Y(PO2CH2)-Phe-OH","ARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHPY","Homo sapiens","CPA1, CPA","HUMAN CARBOXYPEPTIDASE A1","1","4UEZ"
"4UF0",,"X-RAY DIFFRACTION",2.83,56.56,,6.5,"25% PEG3350, 0.1M BIS-TRIS PH 6.5",,"10.1038/nchembio.2087",,"4UF0",112.12,"1.78","1.78","Crystal structure of JmjC domain of human histone demethylase UTY in complex with epitherapuetic compound 2-(((2-((2-(dimethylamino)ethyl) (ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinic acid.","MLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPKNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWRCESNRSHTTIAKYAQYQASSFQESLREENEKRTQHKDHSDNESTSSENSGRRRKGPFKTIKFGTNIDLSDNKKWKLQLHELTKLPAFARVVSAGNLLTHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEDYWGVLNDFCEKNNLNFLMSSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAVGWCNNIAWNVGPLTACQYKLAVERYEWNKLKSVKSPVPMVHLSWNMARNIKVSDPKLFEMIKYCLLKILKQYQTLREALVAAGKEVIWHGRTNEEPAHYCSICEVEVFNLLFVTNESNTQKTYIVHCHDCARKTSKSLENFVVLEQYKMEDLIQVYDQFTLALSLSSSSAENLYFQ","Homo sapiens","UTY, KDM6C","HISTONE DEMETHYLASE UTY","1","4UF0"
,,,,,,,,,,,,,,,,"MLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPKNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWRCESNRSHTTIAKYAQYQASSFQESLREENEKRTQHKDHSDNESTSSENSGRRRKGPFKTIKFGTNIDLSDNKKWKLQLHELTKLPAFARVVSAGNLLTHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEDYWGVLNDFCEKNNLNFLMSSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAVGWCNNIAWNVGPLTACQYKLAVERYEWNKLKSVKSPVPMVHLSWNMARNIKVSDPKLFEMIKYCLLKILKQYQTLREALVAAGKEVIWHGRTNDEPAHYCSICEVEVFNLLFVTNESNTQKTYIVHCHDCARKTSKSLENFVVLEQYKMEDLIEVYDQFTLALSLSSSSAENLYFQ","Homo sapiens","UTY, KDM6C","HISTONE DEMETHYLASE UTY","2","4UF0"
"4UF4",,"X-RAY DIFFRACTION",2,38.56,,,"20% PEG 6000, 0.2M MGCL2, 0.1 M TRIS- HCL BUFFER PH 8.0",,,,"4UF4",94.95,"1.77","1.77","Crystal structure of the human CARBOXYPEPTIDASE A1 in complex with a thiirane mechanism-based inhibitor","MRGLLVLSVLLGAVFGKEDFVGHQVLRISVADEAQVQKVKELEDLEHLQLDFWRGPAHPGSPIDVRVPFPSIQAVKIFLESHGISYEIMIEDVQSLLDEEQEQMFAFRSRARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHPY","Homo sapiens","CPA1, CPA","CARBOXYPEPTIDASE A1","1","4UF4"
"4UF8","10.9","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2015.03.062",,"4UF8",44.48,"10.9, 10.9",,"Electron cryo-microscopy structure of PB1-p62 filaments","SLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEK","Homo sapiens","SQSTM1, ORCA, OSIL","SEQUESTOSOME-1","1","4UF8"
"4UF9","10.3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2015.03.062",,"4UF9",41.11,"10.3, 10.3",,"Electron cryo-microscopy structure of PB1-p62 type T filaments","MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMV","Homo sapiens","SQSTM1, ORCA, OSIL","SEQUESTOSOME-1","1","4UF9"
"4UFA",,"X-RAY DIFFRACTION",2.8,56.8,,8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",,"10.1038/srep13742",,"4UFA",149.8,"1.8","1.8","Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Ac-SD","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4UFA"
"4UFB",,"X-RAY DIFFRACTION",3,58,,8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",,"10.1038/srep13742","PRO","4UFB",300.44,"1.8","1.8","Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Lys-Pro","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","4UFB"
"4UFU",,"X-RAY DIFFRACTION",2.4,49,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","2ZI","4UFU",55.91,"2.1","2.1","Crystal structure of human tankyrase 2 in complex with TA-12","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UFU"
"4UFY",,"X-RAY DIFFRACTION",2.5,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","M3W","4UFY",55.89,"1.7","1.7","Crystal structure of human tankyrase 2 in complex with TA-13","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UFY"
"4UG2",,"X-RAY DIFFRACTION",2.3,51,,,"0.1M ADA, PH7.0, 21.6% PEG 600, 10% CHS",,"10.1124/mol.114.097360","NGI","4UG2",73.76,"2.6","2.6","Thermostabilised HUMAN A2a Receptor with CGS21680 bound","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILVGVLAIPFAIAISTGFCAACHGCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAENLYFQ","Homo sapiens","ADORA2A, ADORA2","THERMOSTABILISED HUMAN A2A RECEPTOR","1","4UG2"
"4UH5",,"X-RAY DIFFRACTION",2.74,55.2,,6.2,"8-9% PED3350 40MM CITRIC ACID 60MM BISTRISPROPANE 10% GLYCEROL 5MM TCEP, pH 6.2",,"10.1021/acs.jmedchem.5b00573","EXI","4UH5",100.02,"1.983","1.983","Structure of human nNOS R354A G357D mutant heme domain in complex with N1-(5-(2-(6-Amino-4-methylpyridin-2-yl)ethyl)pyridin-3-yl)-N1,N2- dimethylethane-1,2-diamine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","NEURONAL NITRIC OXIDE SYNTHASE","1","4UH5"
"4UH6",,"X-RAY DIFFRACTION",2.74,55.2,,6.2,"8-9% PED3350 40MM CITRIC ACID 60MM BISTRISPROPANE 10% GLYCEROL 5MM TCEP, pH 6.2",,"10.1021/acs.jmedchem.5b00573","Q1T","4UH6",100.07,"1.98","1.98","Structure of human nNOS R354A G357D mutant heme domain in complex with 3-(2-(6-Amino-4-methylpyridin-2-yl)ethyl)-5-(methyl(2-(methylamino)ethyl)amino)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","NITRIC OXIDE SYNTHASE, BRAIN","1","4UH6"
"4UHG",,"X-RAY DIFFRACTION",2.5,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","SZ5","4UHG",55.68,"1.7","1.7","Crystal structure of human tankyrase 2 in complex with TA-21","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UHG"
"4UHI",,"X-RAY DIFFRACTION",2.5,52.4,,7.4,"pH 7.4",,"10.1194/jlr.M069229","VFV","4UHI",209.86,"2.04","2.04","HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP","PPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDEVAGMLIGLLLAGQHTSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDLNLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLDFNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFPTVNYTTMIHTPENPVIRYKRRSK","Homo sapiens","CYP51A1, CYP51","STEROL 14-ALPHA DEMETHYLASE","1","4UHI"
"4UHL",,"X-RAY DIFFRACTION",2.7,53.7,,7.4,"pH 7.4",,"10.1194/jlr.M069229","VFV","4UHL",422.11,"2.5","2.5","HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP","GKLPPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDEVAGMLIGLLLAGQHTSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDLNLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLDFNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFPTVNYTTMIHTPENPVIRYKRRSK","Homo sapiens","CYP51A1, CYP51","STEROL 14-ALPHA DEMETHYLASE","1","4UHL"
"4UHR",,"X-RAY DIFFRACTION",3.06,59,,,"0.05 M ACETATE-HCL (PH4.8), 6% SUCROSE, 21.9% PENTHAETHYLENE GLYCOL",,"10.1124/mol.114.097360","NGI","4UHR",36.52,"2.6","2.6","Thermostabilised HUMAN A2a Receptor with CGS21680 bound","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSAAAADILVGVLAIPFAIAISTGFCAACHGCLFIACFVLVLTASSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAENLYFQ","Homo sapiens","ADORA2A, ADORA2","THERMOSTABILISED HUMAN A2A RECEPTOR","1","4UHR"
"4UHW",,"X-RAY DIFFRACTION",2.46,50.1,,,,,"10.1038/nchembio.1895",,"4UHW",149.99,"2.6","2.6","Human aldehyde oxidase","MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICSLYGAAVTTVEGIGSTHTRIHPVQERIAKCHGTQCGFCTPGMVMSIYTLLRNHPEPTLDQLTDALGGNLCRCTGYRPIIDACKTFCKTSGCCQSKENGVCCLDQGINGLPEFEEGSKTSPKLFAEEEFLPLDPTQELIFPPELMIMAEKQSQRTRVFGSERMMWFSPVTLKELLEFKFKYPQAPVIMGNTSVGPEVKFKGVFHPVIISPDRIEELSVVNHAYNGLTLGAGLSLAQVKDILADVVQKLPEEKTQMYHALLKHLGTLAGSQIRNMASLGGHIISRHPDSDLNPILAVGNCTLNLLSKEGKRQIPLNEQFLSKCPNADLKPQEILVSVNIPYSRKWEFVSAFRQAQRQENALAIVNSGMRVFFGEGDGIIRELCISYGGVGPATICAKNSCQKLIGRHWNEQMLDIACRLILNEVSLLGSAPGGKVEFKRTLIISFLFKFYLEVSQILKKMDPVHYPSLADKYESALEDLHSKHHCSTLKYQNIGPKQHPEDPIGHPIMHLSGVKHATGEAIYCDDMPLVDQELFLTFVTSSRAHAKIVSIDLSEALSMPGVVDIMTAEHLSDVNSFCFFTEAEKFLATDKVFCVGQLVCAVLADSEVQAKRAAKRVKIVYQDLEPLILTIEESIQHNSSFKPERKLEYGNVDEAFKVVDQILEGEIHMGGQEHFYMETQSMLVVPKGEDQEMDVYVSTQFPKYIQDIVASTLKLPANKVMCHVRRVGGAFGGKVLKTGIIAAVTAFAANKHGRAVRCVLERGEDMLITGGRHPYLGKYKAGFMNDGRILALDMEHYSNAGASLDESLFVIEMGLLKMDNAYKFPNLRCRGWACRTNLPSNTAFRGFGFPQAALITESCITEVAAKCGLSPEKVRIINMYKEIDQTPYKQEINAKNLIQCWRECMAMSSYSLRKVAVEKFNAENYWKKKGLAMVPLKFPVGLGSRAAGQAAALVHIYLDGSVLVTHGGIEMGQGVHTKMIQVVSRELRMPMSNVHLRGTSTETVPNANISGGSVVADLNGLAVKDACQTLLKRLEPIISKNPKGTWKDWAQTAFDESINLSAVGYFRGYESDMNWEKGEGQPFEYFVYGAACSEVEIDCLTGDHKNIRTDIVMDVGCSINPAIDIGQIEGAFIQGMGLYTIEELNYSPQGILHTRGPDQYKIPAICDMPTELHIALLPPSQNSNTLYSSKGLGESGVFLGCSVFFAIHDAVSAARQERGLHGPLTLNSPLTPEKIRMACEDKFTKMIPRDEPGSYVPWNVPI","Homo sapiens","AOX1, AO","ALDEHYDE OXIDASE","1","4UHW"
"4UHX",,"X-RAY DIFFRACTION",2.45,49.77,,,,,"10.1038/nchembio.1895",,"4UHX",150.87,"2.7","2.7","Human aldehyde oxidase in complex with phthalazine and thioridazine","MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICSLYGAAVTTVEGIGSTHTRIHPVQERIAKCHGTQCGFCTPGMVMSIYTLLRNHPEPTLDQLTDALGGNLCRCTGYRPIIDACKTFCKTSGCCQSKENGVCCLDQGINGLPEFEEGSKTSPKLFAEEEFLPLDPTQELIFPPELMIMAEKQSQRTRVFGSERMMWFSPVTLKELLEFKFKYPQAPVIMGNTSVGPEVKFKGVFHPVIISPDRIEELSVVNHAYNGLTLGAGLSLAQVKDILADVVQKLPEEKTQMYHALLKHLGTLAGSQIRNMASLGGHIISRHPDSDLNPILAVGNCTLNLLSKEGKRQIPLNEQFLSKCPNADLKPQEILVSVNIPYSRKWEFVSAFRQAQRQENALAIVNSGMRVFFGEGDGIIRELCISYGGVGPATICAKNSCQKLIGRHWNEQMLDIACRLILNEVSLLGSAPGGKVEFKRTLIISFLFKFYLEVSQILKKMDPVHYPSLADKYESALEDLHSKHHCSTLKYQNIGPKQHPEDPIGHPIMHLSGVKHATGEAIYCDDMPLVDQELFLTFVTSSRAHAKIVSIDLSEALSMPGVVDIMTAEHLSDVNSFCFFTEAEKFLATDKVFCVGQLVCAVLADSEVQAKRAAKRVKIVYQDLEPLILTIEESIQHNSSFKPERKLEYGNVDEAFKVVDQILEGEIHMGGQEHFYMETQSMLVVPKGEDQEMDVYVSTQFPKYIQDIVASTLKLPANKVMCHVRRVGGAFGGKVLKTGIIAAVTAFAANKHGRAVRCVLERGEDMLITGGRHPYLGKYKAGFMNDGRILALDMEHYSNAGASLDESLFVIEMGLLKMDNAYKFPNLRCRGWACRTNLPSNTAFRGFGFPQAALITESCITEVAAKCGLSPEKVRIINMYKEIDQTPYKQEINAKNLIQCWRECMAMSSYSLRKVAVEKFNAENYWKKKGLAMVPLKFPVGLGSRAAGQAAALVHIYLDGSVLVTHGGIEMGQGVHTKMIQVVSRELRMPMSNVHLRGTSTETVPNANISGGSVVADLNGLAVKDACQTLLKRLEPIISKNPKGTWKDWAQTAFDESINLSAVGYFRGYESDMNWEKGEGQPFEYFVYGAACSEVEIDCLTGDHKNIRTDIVMDVGCSINPAIDIGQIEGAFIQGMGLYTIEELNYSPQGILHTRGPDQYKIPAICDMPTELHIALLPPSQNSNTLYSSKGLGESGVFLGCSVFFAIHDAVSAARQERGLHGPLTLNSPLTPEKIRMACEDKFTKMIPRDEPGSYVPWNVPI","Homo sapiens","AOX1, AO","ALDEHYDE OXIDASE","1","4UHX"
"4UI3",,"X-RAY DIFFRACTION",2.4,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","06R","4UI3",55.56,"2","2","Crystal structure of human tankyrase 2 in complex with TA-26","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI3"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI3"
"4UI4",,"X-RAY DIFFRACTION",2.4,49,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","RJN","4UI4",55.66,"2.4","2.4","Crystal structure of human tankyrase 2 in complex with TA-29","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI4"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI4"
"4UI5",,"X-RAY DIFFRACTION",2.4,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","BJ4","4UI5",55.7,"1.65","1.65","Crystal structure of human tankyrase 2 in complex with TA-41","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI5"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI5"
"4UI6",,"X-RAY DIFFRACTION",2.4,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","ECZ","4UI6",55.72,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with TA-47","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI6"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI6"
"4UI7",,"X-RAY DIFFRACTION",2.4,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","VT3","4UI7",55.63,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with TA-49","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI7"
,,,,,,,,,,,,,,,,"AMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI7"
"4UI8",,"X-RAY DIFFRACTION",2.4,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1016/j.ejmech.2016.04.041","IY5","4UI8",55.6,"2.05","2.05","Crystal structure of human tankyrase 2 in complex with TA-55","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UI8"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UI8"
"4UIJ",,"X-RAY DIFFRACTION",1.94,36.74,,6.5,"1.6M MAGNESIUM SULFATE, 0.1M MES PH 6.5",,"10.1042/BCJ20170527",,"4UIJ",63.01,"2.7","2.7","Crystal structure of the BTB domain of KCTD13","MHHHHHHSSGVDLGTENLYFQSMGPAAYGLKPLTPNSKYVKLNVGGSLHYTTLRTLTGQDTMLKAMFSGRVEVLTDAGGWVLIDRSGRHFGTILNYLRDGSVPLPESTRELGELLGEARYYLVQGLIEDCQLALQQKRETL","Homo sapiens","KCTD13, BACURD1, PDIP1, POLDIP1, FKSG86, PP6832","BTB/POZ DOMAIN-CONTAINING ADAPTER FOR CUL3-MEDIATED RHOA DEGRADATION PROTEIN 1","1","4UIJ"
"4UIT",,"X-RAY DIFFRACTION",2.42,49.24,,,"0.2M ZNAC, 20% PEG3350 20C",293,"10.1021/acs.jmedchem.5b00256","N1D","4UIT",12.72,"1.3","1.3","BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","BROMODOMAIN-CONTAINING PROTEIN 9","1","4UIT"
"4UIU",,"X-RAY DIFFRACTION",2.38,48.23,,6.5,"pH 6.5",,"10.1021/acs.jmedchem.5b00256","TVU","4UIU",12.7,"1.64","1.64","BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2-carboxamide","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","BROMODOMAIN-CONTAINING PROTEIN 9","1","4UIU"
"4UIV",,"X-RAY DIFFRACTION",2.35,47.75,,6.5,"0.1M MORPHEUS BUFFER PH 6.5, 30% MORPHEUS_EDO_P8K,0.1M MORPHEUS AMINO ACIDS 4C",277,"10.1021/acs.jmedchem.5b00256","XZB","4UIV",12.77,"1.72","1.72","BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","BROMODOMAIN-CONTAINING PROTEIN 9","1","4UIV"
"4UIW",,"X-RAY DIFFRACTION",2.38,48.29,,6.5,"0.1M MORPHEUS BUFFER PH 6.5, 30% MORPHEUS_EDO_P8K, 0.1M MORPHEUS AMINO ACIDS AT 4C",277,"10.1021/acs.jmedchem.5b00256","H1B","4UIW",12.79,"1.73","1.73","BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","BROMODOMAIN-CONTAINING PROTEIN 9","1","4UIW"
"4UIX",,"X-RAY DIFFRACTION",2.43,49.45,,,"0.2M CACL2, 0.1M HEPES, PEG 6K 20C",293,"10.1021/acs.jmedchem.5b00256","TVU","4UIX",47,"1.58","1.58","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2- carboxamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHKFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4UIX"
"4UIY",,"X-RAY DIFFRACTION",2.15,42.83,,7.5,"20% PEG3350, 0.2M KSCN, 0.1M BTP PH 7.5",,"10.1021/acs.jmedchem.5b00256","5V2","4UIY",15.77,"1.3","1.3","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH N-(1,1-dioxo-1-thian-4-yl)- 5-methyl-4-oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c- pyridine-2-carboximidamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4UIY"
"4UIZ",,"X-RAY DIFFRACTION",2.17,43.31,,6.5,"0.1M BTP PH 6.5, 20% PEG3350, 0.2M NAFORMATE",,"10.1021/acs.jmedchem.5b00256","N1D","4UIZ",15.72,"1.19","1.19","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-2-(4-methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4UIZ"
"4ULW",,"X-RAY DIFFRACTION",2.16,43.18,,,"20% (W/V) PEG 6000, 0.2 M LITHIUM CHLORIDE, 0.1 M TRIS/HCL PH 8.0",,"10.1038/ncomms6701",,"4ULW",34.49,"1.91","1.91","Crystal structure of the ROQ-domain of human ROQUIN1","QQLSSNLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRTYEALRREHDSQIVQIAMEAGLRIAPDQWSSLLYGDQSHKSHMQSIIDKLQTPA","Homo sapiens","RC3H1, KIAA2025, RNF198","ROQUIN-1","1","4ULW"
"4UM2",,"X-RAY DIFFRACTION",2.32,46.95,,5.5,"50MM MES PH 5.5, 200MM AMMONIUM ACETATE, 2.5% 2-METHYL-2,4-PENTANEDIOL",,"10.1093/nar/gku578",,"4UM2",67.37,"2.1","2.1","Crystal structure of the TPR domain of SMG6","SMELHRLLRVADNQELQLSNLLSRDRISPEGLEKMAQLRAELLQLYERCILLDIEFSDNQNVDQILWKNAFYQVIEKFRQLVKDPNVENPEQIRNRLLELLDEGSDFFDSLLQKLQVTYKFKLEDYMDGLAIRSKPLRKTVKYALISAQRCMICQGDIARYREQASDTANYGKARSWYLKAQHIAPKNGRPYNQLALLAVYTRRKLDAVYYYMRSLAASNPILTAKESLMSLFEETKRKAEQMEKKQHEEFDLSPDQWRKGKKSTFRHVGDDTTRLEIWIHPSHPRSSQGTESGKDSEQENGLGSLSPSDLNKRFILSFLHAHGKLFTRIGMETFPAVAEKVLKEFQVLLQHSPSPIGSTRMLQLMTINMFAVHNSQLKDCFSEECRSVIQEQAAALGLAMFSLLVRRCTCLLKESAKAQLSSPEDQDDQDDIKVSSFVPDLKELLPSVKVWSDWMLGYPDTWNPPPTSLDLPSHVAVDVWSTLADFCNILTAVNQSEVPLYKDPDDDLTLLILEEDRLLSGFVPLLAAPQDPCYVEKTSDKVIAADCKRVTVLKYFLEALCGQEEPLLAFKGGKYVSVAPVPDTMGKE","Homo sapiens","SMG6, C17orf31, EST1A, KIAA0732","TELOMERASE-BINDING PROTEIN EST1A","1","4UM2"
"4UML",,"X-RAY DIFFRACTION",2.4,48.8,,7.5,"20% PEG3350, 10% ETHYLENE GLYCOL, 0.2 M SODIUM/POTASSIUM TARTRATE, pH 7.5",,,,"4UML",25.53,"1.9","1.9","Crystal structure of ganglioside induced differentiation associated protein 2 (GDAP2) macro domain","SMDPLGAPSQFVDVDTLPSWGDSCQDELNSSDTTAEIFQEDTVRSPFLYNKDVNGKVVLWKGDVALLNCTAIVNTSNESLTDKNPVSESIFMLAGPDLKEDLQKLKGCRTGEAKLTKGFNLAARFIIHTVGPKYKSRYRTAAESSLYSCYRNVLQLAKEQSMSSVGFCVINSAKRGYPLEDATHIALRTVRRFLEIHGETIEKVVFAVSDLEEGTYQKLLPLYFPRSLK","Homo sapiens","GDAP2","GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 2","1","4UML"
"4UMP",,"X-RAY DIFFRACTION",2.26,46,,,,,"10.1021/ml5001245","5QM","4UMP",164.24,"2.3","2.3","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGALAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4UMP"
"4UMQ",,"X-RAY DIFFRACTION",3.1,60,,,,,"10.1021/ml5001245",,"4UMQ",41.3,"2.6","2.6","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4UMQ"
"4UMR",,"X-RAY DIFFRACTION",3.1,60,,,,,"10.1021/ml5001245","QBB","4UMR",41.16,"3","3","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQACCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4UMR"
"4UMT",,"X-RAY DIFFRACTION",3.1,60,,,,,"10.1021/ml5001273",,"4UMT",41.39,"1.98","1.98","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4UMT"
"4UMU",,"X-RAY DIFFRACTION",3.1,60,,,,,"10.1021/ml5001273",,"4UMU",41.26,"2.02","2.02","Structure of MELK in complex with inhibitors","MGSSHHHHHHSSGLVPRGSHMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDTAAALVAKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSS","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4UMU"
"4UMX",,"X-RAY DIFFRACTION",2.63,49.5,,8,"PEG 8K 26%, TRIS 100MM PH 8, MALONATE NA 200MM",,"10.1074/jbc.M114.608497","VVS","4UMX",98.22,"1.88","1.88","IDH1 R132H in complex with cpd 1","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC","1","4UMX"
"4UMY",,"X-RAY DIFFRACTION",2.8,55.79,,8,"PEG 5000 MME 22% - BIS-TRIS 100MM PH 6.5 - AMMONIUM SULFATE 220 MM",,"10.1074/jbc.M114.608497",,"4UMY",98.23,"2.07","2.07","IDH1 R132H in complex with cpd 1","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC","1","4UMY"
"4UND",,"X-RAY DIFFRACTION",2.69,54,,6.6,"39% PEGMME2000, 0.2M KSCN, 0.1M HEPES, pH 6.6",,"10.1021/acs.jmedchem.6b00990","2YQ","4UND",84.5,"2.2","2.2","HUMAN ARTD1 (PARP1) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TALAZOPARIB","MHHHHHHSSGVDLGTENLYFQSMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","POLY [ADP-RIBOSE] POLYMERASE 1","1","4UND"
"4UNE",,"X-RAY DIFFRACTION",2.53,51,,4,"0.15 M NA2SO4, PH 4.0, CP 5 MG/ML",,"10.1107/S1399004714017775",,"4UNE",11.8,"1.59","1.59","Human insulin B26Phe mutant crystal structure","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4UNE"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFFTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4UNE"
"4UNG",,"X-RAY DIFFRACTION",1.5,18,,4,"0.035 M (NH4)2SO4, PH 4.0, CP = 5 MG/ML",,"10.1107/S1399004714017775",,"4UNG",11.63,"1.81","1.81","Human insulin B26Asn mutant crystal structure","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4UNG"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFNTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4UNG"
"4UNH",,"X-RAY DIFFRACTION",3,59,,4,"0.08 M NA2SO4, PH 4.0, CP = 5 MG/ML",,"10.1107/S1399004714017775",,"4UNH",5.81,"2.75","2.75","Human insulin B26Gly mutant crystal structure","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4UNH"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFGTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","4UNH"
"4UNK",,"X-RAY DIFFRACTION",2.12,41.54,,8.5,"200 MM AMMONIUM ACETATE, 100 MM TRIS PH 8.5, 25% V/VW/V POLYETHYLENE GLYCOL 3350",,,,"4UNK",53.43,"2","2","Crystal structure of human triosephosphate isomerase (mutant N15D)","GSAPSRKFFVGGNWKMDGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","TRIOSEPHOSPHATE ISOMERASE","1","4UNK"
"4UNL",,"X-RAY DIFFRACTION",2.3,46.67,,5.6,"PROTEIN WAS CRYSTALLIZED FROM: 0.2 M AMMONIUM ACETATE, 0.1 M SODIUM CITRATE TRIBASIC DIHYDRATE PH 5.6, 30% W/V POLYETHYLENE GLYCOL 4,000",,,,"4UNL",53.14,"1.5","1.5","Crystal structure of a single mutant (N71D) of triosephosphate isomerase from human","APSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTDGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","TRIOSEPHOSPHATE ISOMERASE","1","4UNL"
"4UNT",,"X-RAY DIFFRACTION",2.1,41,,8,"0.5M LICL, 1.65M (NH4)2SO4, pH 8",,"10.1074/jbc.M114.585638",,"4UNT",92.75,"2.7","2.7","Induced monomer of the Mcg variable domain","GQSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWEQQHAGKAPKVIIYEVNKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNAVEGTGTKVTVL","Homo sapiens","IGLV2-8","IG LAMBDA CHAIN V-II REGION MGC","1","4UNT"
"4UNU",,"X-RAY DIFFRACTION",1.8,31,,8,"2M NACL, 2M (NH4)2SO4, pH 8",,"10.1074/jbc.M114.585638",,"4UNU",24.95,"0.95","0.95","MCG - a dimer of lambda variable domains","GQSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVL","Homo sapiens","IGLV2-8","IG LAMBDA CHAIN V-II REGION MGC","1","4UNU"
"4UNV",,"X-RAY DIFFRACTION",1.8,31,,4.6,"0.1M CH3COONA PH4.6, 2M (NH4)2SO4",,"10.1074/jbc.M114.585638",,"4UNV",11.75,"1.6","1.6","Covalent dimer of lambda variable domains","GQSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKCPKVIIYEVNKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVCGTGTKVTVL","Homo sapiens","IGLV2-8","IG LAMBDA CHAIN V-II REGION MGC","1","4UNV"
"4UOK","18","ELECTRON MICROSCOPY",,,,,,,"10.1128/JVI.01286-14",,"4UOK",47.06,"18, 18",,"Electron Cryo-microscopy of Venezuelan Equine Encephalitis Virus TC-83 in complex with neutralizing antibody Fab 3B4C-4","QLVQSGAEVKKPGATVKISCKVSGYTFTDYYINWMQQAPGKGLEWIGRIYPGYGNTKYNDKFKGRVTLTADTSTDTAYMELSSLRSEDTAVYFCARSLTFFDVWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"FAB FRAGMENT HEAVY CHAIN","1","4UOK"
,,,,,,,,,,,,,,,,"DIELTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGIPVRFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPFTFGSGTKLEIERADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR","Homo sapiens",,"FAB FRAGMENT LIGHT CHAIN","2","4UOK"
"4UOM","17","ELECTRON MICROSCOPY",,,,,,,"10.1128/JVI.01286-14",,"4UOM",45.55,"17, 17",,"Electron Cryo-microscopy of Venezuelan Equine Encephalitis Virus TC- 83 in complex with neutralizing antibody Fab F5","EVQLQQSGPELVKPGASVKISCKASGYTFTDYYINWMKQKPGQGLEWIGRIYPGYGNTKYNDKFKGKATLTEDTSSNTAYMQLNSLTSEDTAVYFCARSLTFFDVWGAGTTVTVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRD","Homo sapiens",,"FAB FRAGMENT HEAVY CHAIN","1","4UOM"
,,,,,,,,,,,,,,,,"PHSASGPPDQTVTISCSGSSSNIEGNTVNWYQQFPGKAPQLLIYGKDQRPSGVPDRFSASKSGTSASLTISGLQAEDEADYYCAAWDDSLNGWVFGGGTKLTVLGAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNR","Homo sapiens",,"FAB FRAGMENT LIGHT CHAIN","2","4UOM"
"4UOW",,"X-RAY DIFFRACTION",2.95,58.3,"MICROBATCH",3.6,"3.0 M SODIUM CHLORIDE 0.1 M TRI-SODIUM CITRATE PH 3.6 BATCH SETUP",291,"10.1016/j.jmb.2014.11.019",,"4UOW",367.69,"3.3","3.3","Crystal structure of the titin M10-Obscurin Ig domain 1 complex","GIPPKIEALPSDISIDEGKVLTVACAFTGEPTPEVTWSCGGRKIHSQEQGRFHIENTDDLTTLIIMDVQKQDGGLYTLSLGNEFGSDSATVNIHIRS","Homo sapiens","TTN, OBSCN, KIAA1556, KIAA1639","Titin","1","4UOW"
,,,,,,,,,,,,,,,,"SSAPRFLTRPKAFVVSVGKDATLSCQIVGNPTPQVSWEKDQQPVAAGARFRLAQDGDLYRLTILDLALGDSGQYVCRARNAIGEAFAAVGLQV","Homo sapiens","OBSCN, KIAA1556, KIAA1639, TTN","Obscurin","2","4UOW"
"4UP1",,"X-RAY DIFFRACTION",3.29,62.6,,,"25% PEG 4000 30MM AMMONIUM SULFATE 20MM B-MERCAPTOETHANOL 100MM TRIS-HCL PH 9",,"10.1107/S2053230X17007233",,"4UP1",144.27,"2.991","2.991","Crystal structure of native human Thymidylate synthase in active form","MLVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","THYMIDYLATE SYNTHASE","1","4UP1"
"4UP5",,"X-RAY DIFFRACTION",2.31,46.81,,,"60% TACSIMATE, PH 7.",,"10.1021/cb500585s","94W","4UP5",10.85,"1.65","1.65","Crystal structure of the Pygo2 PHD finger in complex with the B9L HD1 domain and a chemical fragment","GVYPCGACRSEVNDDQDAILCEASCQKWFHRECTGMTESAYGLLTTEASAVWACDLCLKTKEGSGSGSGSVYVFTTHLANTAAEAVLQGRADSILAYHQ","Homo sapiens","PYGO2, PP7910, BCL9L, DLNB11","PYGOPUS HOMOLOG 2, B-CELL CLL/LYMPHOMA 9-LIKE PROTEIN","1","4UP5"
"4UPG",,"X-RAY DIFFRACTION",2.58,43.9,,,"20% PEG4000, 0.3 M AMMONIUM SULFATE",,"10.1038/srep16828",,"4UPG",19.77,"2.1","2.1","X-ray structure of calcium-free human sorcin","QTQDPLYGYFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMSV","Homo sapiens","SRI","SORCIN","1","4UPG"
"4URA",,"X-RAY DIFFRACTION",2.71,54.24,,5.9,"0.1M BIS-TRIS PH 5.9, 0.15M AMMONIUM SULFATE, 11% PEG3350",,"10.1039/C4MD00291A","LEL","4URA",84.59,"2.23","2.23","Crystal structure of human JMJD2A in complex with compound 14a","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","LYSINE-SPECIFIC DEMETHYLASE 4A","1","4URA"
"4URJ",,"X-RAY DIFFRACTION",2.7,54,,,"0.8M SODIUM PHOSPHATE MONOBASIC, 0.8M SODIUM PHOSPHATE DIBASIC, 0.1M HEPES PH 7.5",,,,"4URJ",85.11,"2.68","2.68","Crystal structure of human BJ-TSA-9","SMASAEKPYLKEKSSATVYFQTVKHNNIRDLVRRCITRTSQVLVILMDVFTDVEIFCDILEAANKRGVFVCVLLDQGGVKLFQEMCDKVQISDSHLKNISIRSVEGEIYCAKSGRKFAGQIREKFIISDWRFVLSGSYSFTWLCGHVHRNILSKFTGQAVELFDEEFRHLYASSKPVMGLKSPRL","Homo sapiens","FAM83A, TSGP","PROTEIN FAM83A","1","4URJ"
"4URK",,"X-RAY DIFFRACTION",2.37,48,,7.5,"20% PEG3350, 0.1M HEPES (PH 7.5), 5% AMSO4, 10MM DTT",,"10.1016/j.bmcl.2014.07.007","A82","4URK",111.14,"2.9","2.9","PI3Kg in complex with AZD6482","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4URK"
"4USD",,"X-RAY DIFFRACTION",2.6,52,,,,,"10.1038/nbt.3374",,"4USD",69.56,"3.05","3.05","Human STK10 (LOK) with SB-633825","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","SERINE/THREONINE-PROTEIN KINASE 10","1","4USD"
"4USE",,"X-RAY DIFFRACTION",3,59,,6.5,"50% (V/V) PEG 300, 0.1M CACODYLATE PH 6.5, 0.2M MGCL2",,"10.1038/nbt.3374",,"4USE",69.56,"2.65","2.65","Human STK10 (LOK) with SB-633825","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","SERINE/THREONINE-PROTEIN KINASE 10","1","4USE"
"4USF",,"X-RAY DIFFRACTION",2.6,52,,6,"20% PEG6000, 10% ETHYLENE GLYCOL, 0.1 M MES PH 6.0, 0.1 M MGCL2",,"10.1038/nbt.3374",,"4USF",69.98,"1.75","1.75","Human SLK with SB-440719","SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-LIKE SERINE/THREONINE-PROTEIN KINASE","1","4USF"
"4USL",,"X-RAY DIFFRACTION",1.97,37.18,,8.5,"PEG 3350 25% W/V, LISO4 0.5 M, 0.1 M TRIS, PH=8.5, CACL2 0.005M",,"10.1038/srep16828",,"4USL",25.12,"1.65","1.65","The X-ray structure of calcium bound human sorcin","MAYPGHPGAGGGYYPGGYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMSV","Homo sapiens","SRI","SORCIN","1","4USL"
,,,,,,,,,,,,,,,,"MAYPGHPGAGGGYYPGGYGGAPGGPAFPGQTQ","Homo sapiens","SRI","SORCIN","2","4USL"
"4UST",,"X-RAY DIFFRACTION",2.4,54,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1111/febs.12913",,"4UST",54.82,"1.9","1.9","Crystal structure of human soluble Adenylyl Cyclase with pyrophosphate resulting from soaking with GTP and Magnesium","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4UST"
"4USU",,"X-RAY DIFFRACTION",2.4,54,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1111/febs.12913",,"4USU",55.26,"1.95","1.95","Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4USU"
"4USV",,"X-RAY DIFFRACTION",2.4,54,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1111/febs.12913",,"4USV",54.8,"2","2","Crystal structure of human soluble Adenylyl Cyclase with pyrophosphate resulting from soaking with ATP and Calcium","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4USV"
"4USW",,"X-RAY DIFFRACTION",2.4,54,,6,"0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI-SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL",,"10.1111/febs.12913","ATP","4USW",55.01,"2.05","2.05","Crystal structure of human soluble Adenylyl Cyclase with ATP","MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFAGDALLALWRVERKQLKNIITVVIKCSLEIHGLFETQEWEEGLDIRVKIGLAAGHISMLVFGDETHSHFLVIGQAVDDVRLAQNMAQMNDVILSPNCWQLCDRSMIEIESVPDQRAVKVNFLKPPPNFNFDEFFTKCTTFMHYYPSGEHKNLLRLACTLKPDPELEMSLQKYVMESILKQIDNKQLQGYLSELRPVTIVFVNLMFEDQDKAEEIGPAIQDAYMHITSVLKIFQGQINKVFMFDKGCSFLCVFGFPGEKVPDELTHALECAMDIFDFCSQVHKIQTVSIGVASGIVFCGIVGHTVRHEYTVIGQKVNLAARMMMYYPGIVTCDSVTYNGSNLPAYFFKELPKKVMKGVADSGPLYQYWGRTEKVHHHHHH","Homo sapiens","ADCY10, SAC","ADENYLATE CYCLASE TYPE 10","1","4USW"
"4UT2",,"X-RAY DIFFRACTION",2.14,42.64,,9,"19.3 % PEG 3350, 200 MM NACL, 100 MM TRIS PH 9.0 SOAKING IN RESERVOIR ENRICHED BY 25MM ASCORBATE FOR 30 MINUTES CRYOPROTECTION 20% GLYCEROL",,"10.15252/embj.201592394",,"4UT2",74.57,"1.96","1.96","X-ray structure of the human PP1 gamma catalytic subunit treated with ascorbate","MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAEKKKPNATRPVTPPRGMITKQAKK","Homo sapiens","PPP1CC","SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-GAMMA CATALYTIC SUBUNIT","1","4UT2"
"4UT3",,"X-RAY DIFFRACTION",2.46,49.96,,9,"7-12% PEG3350, 0.1 M BICINE, PH 9.0 SOAKING IN RESERVOIR ENRICHED WITH 50MM H2O2 FOR 10 MINS CRYOPROTECTION IN RESEVOIR ENRICHED WITH 25% MPD",,"10.15252/embj.201592394",,"4UT3",74.52,"2.19","2.19","X-ray structure of the human PP1 gamma catalytic subunit treated with hydrogen peroxide","MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAEKKKPNATRPVTPPRGMITKQAKK","Homo sapiens","PPP1CC","SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-GAMMA CATALYTIC SUBUNIT","1","4UT3"
,,,,,,,,,,,,,,,,"MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAEKKKPNATRPVTPPRGMITKQAKK","Homo sapiens","PPP1CC","SERINE/THREONINE-PROTEIN PHOSPHATASE PP1-GAMMA CATALYTIC SUBUNIT","2","4UT3"
"4UT7",,"X-RAY DIFFRACTION",2.21,45,,,"0.1 M MES 6.5 25% (V/V) PEG 550",,"10.1038/nature14130",,"4UT7",31.7,"1.7","1.7","CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","EVQLVESGGGLVRPGGSLRLSCAASGFSYSNHWMHWVRQAPGKGLVWVSRINSDGSTRNYADFVKGRFTISRDNAENTLYLEMNSLTADDTAVYYCVRDGVRFYYDSTGYYPDSFFKYGMDVWGQGTTVTVSSGTGGSGGGGSGGGGSGG","Homo sapiens",,"BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","1","4UT7"
,,,,,,,,,,,,,,,,"GASQSVLTQPVSVSGSPGQSITISCTGTSSNADTYNLVSWYQQRPGKAPKLMIYEGTKRPSGVSNRFSASKSATAASLTISGLQPEDEADYYCCSYATSRTLVFGGGTKLTVVAAADDDDKAGWSHPQFEKGGGSGGGSGGGSSAWSHPQFEK","Homo sapiens",,"BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","2","4UT7"
"4UU6",,"X-RAY DIFFRACTION",2.41,49.07,,7.5,"0.085M TRIS (PH 8), 0.17M NA ACETATE, 19% (V/V) GLYCEROL, 25.9% (W/V) PEG 4000",,"10.1107/S139900471402776X",,"4UU6",9.84,"1.8","1.8","CRYSTAL STRUCTURE OF THE PDZ DOMAIN OF PALS1","GPLGSGETVKIVRIEKARDIPLGATVRNEMDSVIISRIVKGGAAEKSGLLHEGDEVLEINGIEIRGKDVNEVFDLLSDMHGTLTFVLIPS","Homo sapiens","PALS1, MPP5","MAGUK P55 SUBFAMILY MEMBER 5","1","4UU6"
"4UUC",,"X-RAY DIFFRACTION",2.6,52.72,,5.5,"0.2M AMMONIUM ACETATE, 25% PEG3350, 0.1M BIS-TRIS PH 5.5",,,,"4UUC",24,"1.8","1.8","Crystal structure of human ASB11 ankyrin repeat domain","SMADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGHVACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEVHLASPIHEAVKRGHRECMEILLANNVNIDHEVPQLGTPLYVACTYQRVDCVKKLLELGASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQGKSALDLAAPKSSVEQALLLREGPPAL","Homo sapiens","ASB11","ANKYRIN REPEAT AND SOCS BOX PROTEIN 11","1","4UUC"
"4UUD","12.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2014.06.054",,"4UUD",1170.44,"12.5, 12.5",,"Human dynamin 1 K44A superconstricted polymer stabilized with GTP","MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGNINTTTVSTPMPPPVDDSWLQVQSVPAGRRSPTSSPTPQRRAPAVPPARPGSRGPAPGPPPAGSALGGAPPVPSRPGASPDPFGPPPQVPSRPNRAPPGVPSRSGQASPSRPESPRPPFDL","Homo sapiens","DNM1, DNM","DYNAMIN-1","1","4UUD"
,,,,,,,,,,,,,,,,"MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDINTTTVSTPMPPPVDDSWLQVQSVPAGRRSPTSSPTPQRRAPAVPPARPGSRGPAPGPPPAGSALGGAPPVPSRPGASPDPFGPPPQVPSRPNRAPPGVPSRSGQASPSRPESPRPPFDL","Homo sapiens","DNM1, DNM","DYNAMIN-1","2","4UUD"
"4UUH",,"X-RAY DIFFRACTION",2.34,47.42,,6,"0.1 M MES PH 6.0, 0.1 M AMMONIUM TARTARATE, 12-16% W/V PEG 3350",,,,"4UUH",30.43,"2.52","2.52","X-ray crystal structure of human TNKS in complex with a small molecule inhibitor","MHHHHHHSSGVDLGTENLYFQSMQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQ","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","TANKYRASE-1","1","4UUH"
"4UUK","12.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2014.06.054",,"4UUK",1170.44,"12.5, 12.5",,"Human dynamin 1 K44A superconstricted polymer stabilized with GTP strand 2","MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGNINTTTVSTPMPPPVDDSWLQVQSVPAGRRSPTSSPTPQRRAPAVPPARPGSRGPAPGPPPAGSALGGAPPVPSRPGASPDPFGPPPQVPSRPNRAPPGVPSRSGQASPSRPESPRPPFDL","Homo sapiens","DNM1, DNM","DYNAMIN-1","1","4UUK"
,,,,,,,,,,,,,,,,"MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDINTTTVSTPMPPPVDDSWLQVQSVPAGRRSPTSSPTPQRRAPAVPPARPGSRGPAPGPPPAGSALGGAPPVPSRPGASPDPFGPPPQVPSRPNRAPPGVPSRSGQASPSRPESPRPPFDL","Homo sapiens","DNM1, DNM","DYNAMIN-1","2","4UUK"
"4UUQ",,"X-RAY DIFFRACTION",3.02,59,,6,"MES BUFFER 50MM PH6.0, MPD 40%(V/V) AT 4C",277,"10.1038/srep07642",,"4UUQ",71.25,"2.36","2.36","Crystal structure of human mono-glyceride lipase in complex with SAR127303","MHHHHHHMETGPEDPSSMPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP","Homo sapiens","MGLL","MONOGLYCERIDE LIPASE","1","4UUQ"
"4UUU",,"X-RAY DIFFRACTION",2.44,49.66,,,"36% PEG550MME, 0.1M TRIS PH 7.5, 0.2M CALCIUM CHLORIDE",,"10.1074/jbc.M114.610782",,"4UUU",36.44,"1.71","1.71","1.7 A resolution structure of human cystathionine beta-synthase regulatory domain (del 516-525) in complex with SAM","MHHHHHHSSGVDLGTENLYFQSMKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQQRQMVFGVVTAIDLLNFVAAQE","Homo sapiens","CBS","CYSTATHIONINE BETA-SYNTHASE","1","4UUU"
"4UV0",,"X-RAY DIFFRACTION",3.1,60,,,"5MM HEPES, 30 MM NACL, 10 MM NA2SO4,0.5 MMDTT,25% (W/V) PEGMME2000",,,,"4UV0",37.32,"2.49","2.49","Structure of a semisynthetic phosphorylated DAPK","GPMTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKACAVNMEKFKKFAARKKWKQSVRLISLCQRLSRS","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","4UV0"
"4UV4",,"X-RAY DIFFRACTION",4.3,71,,,"0.1 M TRIS-HCL PH 7.5-8.0, 18% PEG8000, 0.18-0.2 M MGCL2",,"10.4161/19420862.2014.985158",,"4UV4",49.95,"3.08","3.08","Crystal structure of anti-FPR Fpro0165 Fab fragment","EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMNWVRQAPGKGLEWVGRVKSKTDGGAADYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDQLGYDFWNGYYTDTLYYYFGMDVWGPGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"FPRO0165 FAB","1","4UV4"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQPLLAMDGHNYLDWYLQKPGQSPQVLIYQSKWRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FPRO0165 FAB","2","4UV4"
"4UVL",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVL",55.65,"2","2","Crystal structure of human tankyrase 2 in complex with 5-amino-1,2- dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVL"
"4UVN",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVN",55.94,"2.2","2.2","Crystal structure of human tankyrase 2 in complex with 5-amino-3-(4- chlorophenyl)-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVN"
"4UVO",,"X-RAY DIFFRACTION",2.45,50,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVO",55.92,"1.85","1.85","Crystal structure of human tankyrase 2 in complex with 5-amino-3-(4- methoxyphenyl)-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVO"
"4UVP",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVP",55.57,"1.75","1.75","Crystal structure of human tankyrase 2 in complex with 5-amino-3- ethyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAM","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVP"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","2","4UVP"
"4UVS",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVS",55.58,"2","2","Crystal structure of human tankyrase 2 in complex with 5-amino-3- pentyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVS"
"4UVT",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVT",55.77,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 5-amino-4- methyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVT"
"4UVU",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061","U1T","4UVU",56.03,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 1-((4-(5- methyl-1-oxo-1,2-dihydroisoquinolin-3-yl)phenyl)methyl)pyrrolidin-1- ium","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVU"
"4UVV",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061","W8L","4UVV",55.93,"1.9","1.9","Crystal structure of human tankyrase 2 in complex with 3-(4- chlorophenyl)-5-methyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVV"
"4UVW",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061","NYJ","4UVW",55.61,"2.1","2.1","Crystal structure of human tankyrase 2 in complex with 4,5-dimethyl-3- phenyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVW"
"4UVX",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061","H2W","4UVX",55.85,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 3-(4- chlorophenyl)-5-fluoro-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVX"
"4UVY",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061","SGW","4UVY",55.87,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 3-(4- chlorophenyl)-5-methoxy-1,2- dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVY"
"4UVZ",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.06.061",,"4UVZ",55.89,"1.6","1.6","Crystal structure of human tankyrase 2 in complex with 5-amino-3- phenyl-1,2-dihydroisoquinolin-1-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UVZ"
"4UW1",,"X-RAY DIFFRACTION",2.12,53.7,,6,"0.1M MES PH 6.0, 0.1M AMMONIUM TATRATE, 12-16% PEG 3350",,,,"4UW1",238.79,"3.37","3.37","X-ray crystal structure of human TNKS in complex with a small molecule inhibitor","MHHHHHHSSGVDLGTENLYFQSMQGTNPYLTFHCVNQGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQ","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","TANKYRASE-1","1","4UW1"
"4UW3",,"X-RAY DIFFRACTION",1.77,30.61,,,"0.05 M BIS TRIS PROPANE PH7, 17 % PEG 3350",,"10.1111/febs.13140",,"4UW3",31.04,"1.479","1.479","Human galectin-7 in complex with a galactose based dendron D1.","MSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","HUMAN GALECTIN-7","1","4UW3"
"4UW4",,"X-RAY DIFFRACTION",2.05,39.91,"VAPOR DIFFUSION, HANGING DROP",,"0.05 M BIS TRIS PROPANE PH 7, 17% PEG 3350",289,"10.1111/febs.13140",,"4UW4",31.53,"1.766","1.766","Human galectin-7 in complex with a galactose based dendron D2-1.","MSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","GALECTIN-7","1","4UW4"
"4UW5",,"X-RAY DIFFRACTION",2.22,44.6,,,"0.05M BIS TRIS PROPANE PH7, 14% PEG 3350",,"10.1111/febs.13140",,"4UW5",93.26,"2.04","2.04","Human galectin-7 in complex with a galactose based dendron D2-2.","MSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","HUMAN GALECTIN-7","1","4UW5"
"4UW6",,"X-RAY DIFFRACTION",2.14,42.49,,,"0.05M BISTRIS PROPANE PH7, 17% PEG 3350",,"10.1111/febs.13140",,"4UW6",32,"1.79","1.79","Human galectin-7 in complex with a galactose based dendron D3","MSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","GALECTIN-7","1","4UW6"
"4UWB",,"X-RAY DIFFRACTION",2.7,54,,,"20% PEG8000, 20% ETHLYENE GLYCOL, 0.2M AMMONIUM SULPHATE, 0.1M PCTP PH 6.75",,"10.1002/rcm.9130",,"4UWB",71.44,"2.31","2.31","Fibroblast growth factor receptor 1 kinase in complex with JK-P5","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","FIBROBLAST GROWTH FACTOR RECEPTOR 1","1","4UWB"
"4UWC",,"X-RAY DIFFRACTION",2.83,56.5,,,"20% PEG8000, 20% ETHYLENE GLYCOL, 0.2M AMMONIUM SULPHATE, 0.1M PCTP PH 6.75",,"10.1002/rcm.9130",,"4UWC",72.46,"1.96","1.96","Fibroblast growth factor receptor 1 kinase in complex with JK-P3","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","FIBROBLAST GROWTH FACTOR RECEPTOR 1","1","4UWC"
"4UWD",,"X-RAY DIFFRACTION",2.6,52.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES PH6.5, 1.7M AMMONIUM SULFATE, 1% DIOXANE, 0.002M MNCL2, SITTING DROP, 293K",293,"10.1042/BJ20140779","UN9","4UWD",28.45,"1.721","1.721","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) D315E VARIANT in complex with Mn(II) and N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (IOX3/UN9)","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVENPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","4UWD"
"4UWF",,"X-RAY DIFFRACTION",3.1,60,,8,"NA-MALONATE 1.4M, TRIS 100MM PH 8 AT 19C",292,"10.1021/jm5013352",,"4UWF",69.01,"2.99","2.99","Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3","1","4UWF"
"4UWG",,"X-RAY DIFFRACTION",3.41,63.9,,8.5,"AMMONIUM SULFATE 2M - TRIS 100MM PH 8.5",,"10.1021/jm5013352",,"4UWG",69.28,"2.7","2.7","Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3","1","4UWG"
"4UWH",,"X-RAY DIFFRACTION",2.89,57,,7.5,"NA CITRATE 1M PH8.0, pH 7.5",,"10.1021/jm5013352","JXM","4UWH",69.07,"1.93","1.93","Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3","1","4UWH"
"4UWK",,"X-RAY DIFFRACTION",3.32,62.7,,8.5,"AMMONIUM SULFATE 1.8M - TRIS 100MM PH 8.5",,"10.1021/jm5013352",,"4UWK",69.25,"2.83","2.83","Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3","1","4UWK"
"4UWL",,"X-RAY DIFFRACTION",3.3,62.9,,7.5,"1.8M AMMONIUM SULFATE, 100MM TRIS PH 8",,"10.1021/jm5013352",,"4UWL",69.19,"2.8","2.8","Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors","GAMSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3","1","4UWL"
"4UWY",,"X-RAY DIFFRACTION",2.37,48.03,,7.5,"20 % PEG 5K MME, 0.1 M TRIS, PH 7.5, 0.2 M (NH4)2SO4",,"10.1016/j.ebiom.2015.02.009",,"4UWY",70.83,"2.305","2.305","FGFR1 Apo structure","MVAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","FIBROBLAST GROWTH FACTOR RECEPTOR 1","1","4UWY"
"4UX4",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1016/j.bmc.2015.05.005",,"4UX4",55.8,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with 1-methyl-7-(4- methylphenyl)-5-oxo-5,6-dihydro-1,6-naphthyridin-1-ium","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4UX4"
"4UXB",,"X-RAY DIFFRACTION",2.54,52.44,,5.5,"25% PEG3350 0.2M AMMONIUM SULFATE, 0.1M BIS-TRIS PH 5.5, 1MM PJ34",,"10.1021/acs.jmedchem.6b00990","P34","4UXB",79.46,"3.22","3.22","Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor PJ34","SMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","POLY ADP-RIBOSE POLYMERASE 1","1","4UXB"
"4UXL",,"X-RAY DIFFRACTION",2.7,55,"VAPOR DIFFUSION, HANGING DROP",5.6,"CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES C BY MIXING 1.5 MICROLITERS OF SOLUTION CONTAINING A 1:3 MOLAR RATIO OF PHOSPHORYLATED ROS1 KD (12.2MG/ML) TO PF-06463922 AND 1.5 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 25% (W/V) PEG 3350, 0.6M POTASSIUM THIOCYANATE AND 0.1M SODIUM CITRATE TRIBASIC DIHYDRATE, PH5.6. CRYSTALS WERE FLASH-FROZEN IN LIQUID NITROGEN AFTER TRANSFER TO 2 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 25% (V/V) GLYCEROL AS A CRYOPROTECTANT.",286,"10.1073/pnas.1420785112","5P8","4UXL",37.42,"2.4","2.4","Structure of Human ROS1 Kinase Domain in Complex with PF-06463922","MAHHHHHHDYGIPTTENLYFQGSIENLPAFPREKLTLRLLLGSGAFGEVYEGTAVDILGVGSGEIKVAVKTLKKGSTDQEKIEFLKEAHLMSKFNHPNILKQLGVCLLNEPQYIILELMEGGDLLTYLRKARMATFYGPLLTLVDLVDLCVDISKGCVYLERMHFIHRDLAARNCLVSVKDYTSPRIVKIGDFGLARDIYKNDYYRKRGEGLLPVRWMAPESLMDGIFTTQSDVWSFGILIWEILTLGHQPYPAHSNLDVLNYVQTGGRLEPPRNCPDDLWNLMTQCWAQEPDQRPTFHRIQDQLQLFRNFFLNSIYKSRDE","Homo sapiens","ROS1, MCF3, ROS","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","1","4UXL"
"4UXQ",,"X-RAY DIFFRACTION",2.19,43.86,,,"0.1MPCTP, PH4.5 0.1M (NH4)2SO4, 15% PEG3350",,"10.1016/j.str.2014.09.019","0LI","4UXQ",35.08,"1.85","1.85","FGFR4 in complex with Ponatinib","GSAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1","4UXQ"
"4UXU",,"X-RAY DIFFRACTION",3.1,61,,7.5,"0.1 M HEPES PH 7.5, 15% PEG 20000, 7.5% ETHANOL",,"10.1038/nsmb.2900",,"4UXU",54.05,"1.71","1.71","Crystal Structure of the Extracellular Domain of the Human Alpha9 Nicotinic Acetylcholine Receptor In Complex with Methyllycaconitine","ADGKYAQKLFNDLFEDYSNALRPVEDTDKVLNVTLQITLSQIKDMDERNQILTAYLWIRQIWHDAYLTWDRDQYDGLDSIRIPSDLVWRPDIVLYNKADDESSEPVNTNVVLRYDGLITWDAPAITKSSCVVDVTYFPFDNQQCNLTFGSWTYNGNQVDIFNALDSGDLSDFIEDVEWEVHGMPAVKNVISYGCCSEPYPDVTFTLLLKRRSHHHHHH","Homo sapiens","CHRNA9, NACHRA9","NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-9","1","4UXU"
"4UY1",,"X-RAY DIFFRACTION",2.17,43.33,,6,"40% PEG 400, 0.1 M BIS-TRIS PH 6.0",,"10.1016/j.bmcl.2014.09.058","TJM","4UY1",31.27,"2.2","2.2","Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors","GILELAGTVGCVGPRTPIAYMKYGCFCGLGGHGQPRDAIDWCCHGHDCCYTRAEEAGCSPKTERYSWQCVNQSVLCGPAENKCQELLCKCDQEIANCLAQTEYNLKYLFYPQFLCEPDSPKCDQGILELAG","Homo sapiens","PLA2G10","GROUP 10 SECRETORY PHOSPHOLIPASE A2","1","4UY1"
"4UY9",,"X-RAY DIFFRACTION",3.86,68.17,,,,,"10.1158/0008-5472.CAN-15-0701-T",,"4UY9",73.23,"2.81","2.81","Structure of MLK1 kinase domain with leucine zipper 1","GQLLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEESGFFEMPKDSFHCLQDNWKHEIQEMFDQLRAKEKELRTWEEELTRAAL","Homo sapiens","MAP3K9, MLK1, PRKE1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","1","4UY9"
"4UYA",,"X-RAY DIFFRACTION",2.37,47.71,,,,,"10.1158/0008-5472.CAN-15-0701-T",,"4UYA",39.05,"2.8","2.8","Structure of MLK4 kinase domain with ATPgammaS","MGHHHHHHGGGENLYFQGSPVHVAFERLELKELIGAGGFGQVYRATWQGQEVAVKAARQDPEQDAAAAAESVRREARLFAMLRHPNIIELRGVCLQQPHLCLVLEFARGGALNRALAGRRIPPHVLVNWAVQIARGMLYLHEEAFVPILHRDLKSSNILLLEKIEHDDICNKTLKITDFGLAREWHRTTKMATAGAYAWMAPEVIKSSLFSKGSDIWSYGVLLWELLTGEVPYRGIDGLAVAYGVAVNKLTLPIPSTCPEPFAKLMKECWQQDPHIRPSFALILEQLTAIEGAVMTEMPQESFHSMQDDWKLEIQQMFDELRTKEKELRSREEELTRAAL","Homo sapiens","MAP3K21, KIAA1804, MLK4","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLK4","1","4UYA"
"4UYB",,"X-RAY DIFFRACTION",3.27,62.44,,,"20% PEG6000, 0.8M LITHIUM CHLORIDE, 0.1M CITRATE PH 4.2",,,,"4UYB",46.58,"1.5","1.5","Crystal structure of SEC14-like protein 3","SMSGRVGDLSPKQAETLAKFRENVQDVLPALPNPDDYFLLRWLRARNFDLQKSEALLRKYMEFRKTMDIDHILDWQPPEVIQKYMPGGLCGYDRDGCPVWYDIIGPLDPKGLLFSVTKQDLLKTKMRDCERILHECDLQTERLGKKIETIVMIFDCEGLGLKHFWKPLVEVYQEFFGLLEENYPETLKFMLIVKATKLFPVGYNLMKPFLSEDTRRKIIVLGNNWKEGLLKLISPEELPAQFGGTLTDPDGNPKCLTKINYGGEIPKSMYVRDQVKTQYEHSVQINRGSSHQVEYEILFPGCVLRWQFSSDGADIGFGVFLKTKMGERQRAGEMTEVLPSQRYNAHMVPEDGNLTCSEAGVYVLRFDNTYSFVHAKKVSFTVEVLLPDEGMQKYDKELTPV","Homo sapiens","SEC14L3, TAP2","SEC14-LIKE PROTEIN 3","1","4UYB"
"4UYD",,"X-RAY DIFFRACTION",1.8,31.73,,,"20% PEG3350, 0.2M NAAC",,"10.1021/ml5002932","V1T","4UYD",18.31,"1.37","1.37","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-dimethyl-2-oxo-2,3- dihydro-1H-1,3-benzodiazole-5-carboxamide","GSSHHHHHHSSGMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRGRGR","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4UYD"
"4UYE",,"X-RAY DIFFRACTION",2.58,54.42,,6.5,"0.1 M MES/IMIDAZOLE PH 6.5, 10% MORPHEUS DIVALENTS MPD_P1K_P3350",,"10.1021/ml5002932","9F9","4UYE",28.7,"1.65","1.65","BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide","GQQIAMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEK","Homo sapiens","BRPF1, BR140","PEREGRIN","1","4UYE"
"4UYF",,"X-RAY DIFFRACTION",2.07,40.44,,5.5,"0.1M BIS TRIS PH 5.5, 18% PEG3350, 0.2M (NH4)2SO4 20C",293,"10.1021/jm5010539","73B","4UYF",55.49,"1.6","1.6","N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)","GSSHHHHHHSSGLVPRGSHMSNPKNPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4UYF"
,,,,,,,,,,,,,,,,"GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","2","4UYF"
"4UYG",,"X-RAY DIFFRACTION",2.08,40.94,,5,"83MM NAAC, PH 5.0 33.3% PEG3350, 0.167M (NH4)2SO4.",,"10.1021/jm5010539","73B","4UYG",110.55,"2.5","2.5","C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)","MGSSHHHHHHSSGLVPRGSHMHQSSKKGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPDEPLEPGPLPVSTAMPPGL","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4UYG"
"4UYH",,"X-RAY DIFFRACTION",2.02,38.96,,7,"0.1M HEPES PH 7.0, 26% PEG3350, 0.2M (NH4)2SO4 20C",293,"10.1021/jm5010539","9S3","4UYH",54.81,"1.73","1.73","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2H)-yl)ethanone","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4UYH"
"4UYI",,"X-RAY DIFFRACTION",3.5,65,,6.5,"0.2M MAGNESIUM CHLORIDE, 25% PEG3350, 0.1M BIS-TRIS PH 6.5",,,,"4UYI",16.74,"1.86","1.86","Crystal structure of the BTB domain of human SLX4 (BTBD12)","MHHHHHHSSGVDLGTENLYFQSMGRTLLSLGLLVADFGAMVNNPHLSDVQFQTDSGEVLYAHKFVLYARCPLLIQYVNNEGFSAIEDGVETQRVLLGDVSTEAARTFLHYLYTADTGLPPGLSSELSSLAHRFGVSELVHLCEQVPIATDSE","Homo sapiens","SLX4, BTBD12, KIAA1784, KIAA1987","STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT SLX4","1","4UYI"
"4UYN",,"X-RAY DIFFRACTION",2.15,42.2,,8,"PEG3350 21% TRIS 50MM PH 8",,"10.1021/jm501326k","Y3M","4UYN",33.82,"1.9","1.9","SAR156497 an exquisitely selective inhibitor of Aurora kinases","MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALEHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4UYN"
"4UYU",,"X-RAY DIFFRACTION",2.31,46.66,,7.5,"20 %W/V PEG 3350 0.1 M BT PROPANE PH 6.5 0.2 M NAI",,"10.1038/nature14259",,"4UYU",89.04,"2.3","2.3","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I IODIDE COMPLEX - 2.3A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UYU"
"4UYW",,"X-RAY DIFFRACTION",2.32,47.03,,8,"pH 8.0",,"10.1038/nature14259",,"4UYW",88.15,"1.7","1.7","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I HEPARIN FRAGMENT COMPLEX - 1.7A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UYW"
"4UZ0",,"X-RAY DIFFRACTION",3.44,64.26,,8.2,"0.1 M IMIDAZOLE PH 8.2, 0.6 M DIAMMONIUM PHOSPHATE",,"10.1038/srep09847",,"4UZ0",21.53,"2.399","2.399","Crystal Structure of apoptosis repressor with CARD (ARC)","MGNAQERPSETIDRERMRLVETLQADSGLLLDALLARGVLTGPEYEALDALPDAERRVRRLLLLVQGKGEAACQELLRCAQRTAGAPDPAWDWQH","Homo sapiens","NOL3, ARC, NOP","NUCLEOLAR PROTEIN 3","1","4UZ0"
"4UZ1",,"X-RAY DIFFRACTION",1.9,34,,4.6,"1.5 M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",,"10.1038/nature14259",,"4UZ1",44.17,"1.4","1.4","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","NOTUM","1","4UZ1"
"4UZ5",,"X-RAY DIFFRACTION",2.5,52,,6,"10 %W/V PEG4000, 0.01 M CACL2, 0.05 M NACACOD PH 6.0, 0.20 M KCL, 1 MM HEPARIN HEXAMER",,"10.1038/nature14259",,"4UZ5",43.82,"2.1","2.1","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","NOTUM","1","4UZ5"
"4UZ6",,"X-RAY DIFFRACTION",2.6,53,,7.5,"20 %W/V PEG3350, 0.2 M AMMONIUM SULFATE 20MM SOS, pH 7.5",,"10.1038/nature14259",,"4UZ6",89.61,"1.9","1.9","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM V - SOS COMPLEX - 1.9A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UZ6"
"4UZ7",,"X-RAY DIFFRACTION",2.3,47,,8.5,"20 %V/V GLYCEROL 24 %W/V PEG4000 0.160 M MGCL2 0.080 M TRIS-HCL PH 8.5 20MM SOS",,"10.1038/nature14259",,"4UZ7",87.17,"2.2","2.2","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VI - 2.2A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UZ7"
"4UZ9",,"X-RAY DIFFRACTION",2.7,55,,6.5,"200 MM AMMONIUM SULFATE 100 MM MES 6.5 35 % W/V PEP 629 20MM SOS",,"10.1038/nature14259",,"4UZ9",44.81,"2.2","2.2","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VII - SOS COMPLEX - 2.2A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UZ9"
"4UZA",,"X-RAY DIFFRACTION",3,59,,6.3,"0.630 M K2HPO4 1.170 M NAH2PO4 6.300 PH FINAL PH",,"10.1038/nature14259",,"4UZA",43.74,"2.4","2.4","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VIII - PHOSPHATE COMPLEX - 2.4A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMSSLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UZA"
"4UZD",,"X-RAY DIFFRACTION",3.66,68,,7,"4% PEG 4000, 50 MM HEPES PH 7",,"10.1021/jm501326k","QMN","4UZD",67.59,"3.2","3.2","SAR156497 an exquisitely selective inhibitor of Aurora kinases","MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALEHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4UZD"
"4UZH",,"X-RAY DIFFRACTION",2,38.5,,7.5,"28% PEG 400, 200 MM NAACETATE, 5MM DTT, 100 MM TRIS PH 8",,"10.1021/jm501326k","JVE","4UZH",33.63,"2","2","SAR156497 an exquisitely selective inhibitor of Aurora kinases","MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALEHHHHHH","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA 2 KINASE DOMAIN","1","4UZH"
"4UZL",,"X-RAY DIFFRACTION",2.2,45,,5,"10 %W/V POLYETHYLENE GLYCOL 6000, 0.1 M CITRATE PH 5.0",,"10.1038/nature14259",,"4UZL",88.62,"2.1","2.1","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I MYRISTOLEATE COMPLEX - 2.1A","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSAAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTHHHHHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","PROTEIN NOTUM HOMOLOG","1","4UZL"
"4V01",,"X-RAY DIFFRACTION",2.67,53.87,,,"20% PEG8000, 20MM AMMONIUM SULPHATE, 20% ETHYLENE GLYCOL, 100MM PCTP PH6.75",,"10.1016/j.str.2014.09.019","0LI","4V01",72.53,"2.33","2.33","FGFR1 in complex with ponatinib (co-crystallisation).","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, hCG_23105","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1","4V01"
"4V04",,"X-RAY DIFFRACTION",2.67,53.87,,,"18-20% (W/V) PEG 8000, 200MM AMMONIUM SULPHATE, 100MM PCTP PH6.75, 20% (V/V) ETHYLENE GLYCOL",,"10.1016/j.str.2014.09.019","0LI","4V04",72.5,"2.12","2.12","FGFR1 in complex with ponatinib.","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, hCG_23105","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1","4V04"
"4V05",,"X-RAY DIFFRACTION",2.67,53.9,,,,,"10.1016/j.str.2014.09.019",,"4V05",71.89,"2.57","2.57","FGFR1 in complex with AZD4547.","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, hCG_23105","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1","4V05"
"4V06",,"X-RAY DIFFRACTION",2.7,54,,,"0.20M SODIUM ACETATE; 0.1M BIS-TRIS- PROPANE PH 6.5; 20.0% PEG 3350; 10.0% ETHYLENE GLYCOL",,,,"4V06",80.75,"2.63","2.63","Crystal structure of human tryptophan hydroxylase 2 (TPH2), catalytic domain","LYFQSMLEDVPWFPRKISELDKCSHRVLMYGSELDADHPGFKDNVYRQRRKYFVDVAMGYKYGQPIPRVEYTEEETKTWGVVFRELSKLYPTHACREYLKNFPLLTKYCGYREDNVPQLEDVSMFLKERSGFTVRPVAGYLSPRDFLAGLAYRVFHCTQYIRHGSDPLYTPEPDTCHELLGHVPLLADPKFAQFSQEIGLASLGASDEDVQKLATCYFFTIEFGLCKQEGQLRAYGAGLLSSIGELKHALSDKACVKAFDPKTTCLQECLITTFQEAYFVSESFEEAKEKMRDFAKSITRPFSVYFNPYTQSIEILKDTRSIENVVQDLRSDLNTVCDALNKMNQYLGI","Homo sapiens","TPH2, NTPH","TRYPTOPHAN 5-HYDROXYLASE 2","1","4V06"
"4V0G",,"X-RAY DIFFRACTION",2.44,49.51,,,,,,,"4V0G",65.71,"3","3","JAK3 in complex with a covalent EGFR inhibitor","IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGEPSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML","Homo sapiens","JAK3","TYROSINE-PROTEIN KINASE JAK3","1","4V0G"
,,,,,,,,,,,,,,,,"IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGEPSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML","Homo sapiens","JAK3","TYROSINE-PROTEIN KINASE JAK3","2","4V0G"
"4V0H",,"X-RAY DIFFRACTION",2.46,50.01,,5.5,"0.1 M BIS-TRIS PH5.5 0.18 M AMMONIUM ACETATE 25% PEG 3350",,"10.7554/eLife.39865",,"4V0H",109.64,"1.79","1.79","Human metallo beta lactamase domain containing protein 1 (hMBLAC1)","MRTEPLCGASPLLVPGDPYSVVVLLQGYAEPEGVGDAVRADGSVTLVLPQTRGPASSHRESPRGSGGAEAALEEAARGPILVDTGGPWAREALLGALAGQGVAPGDVTLVVGTHGHSDHIGNLGLFPGAALLVSHDFCLPGGRYLPHGLGEGQPLRLGPGLEVWATPGHGGQRDVSVVVAGTALGTVVVAGDVFERDGDEDSWQALSEDPAAQERSRKRVLVVADVVVPGHGPPFRVLREASQPETEGGGNSQQEPVVGDEEPALH","Homo sapiens","MBLAC1","METALLO-BETA-LACTAMASE DOMAIN-CONTAINING PROTEIN 1 1","1","4V0H"
"4V0P",,"X-RAY DIFFRACTION",3.31,62.85,,,"0.1M MG FORMATE, 15% PEG 3350",,"10.1371/journal.pone.0148762",,"4V0P",24.12,"2.07","2.07","Crystal structure of the MAGE homology domain of human MAGE-A3","SMEFQAALSRKVAELVHFLLLKYRAREPVTKAEMLGSVVGNWQYFFPVIFSKASSSLQLVFGIELMEVDPIGHLYIFATCLGLSYDGLLGDNQIMPKAGLLIIVLAIIAREGDCAPEEKIWEELSVLEVFEGREDSILGDPKKLLTQHFVQENYLEYRQVPGSDPACYEFLWGPRALVETSYVKVLHHMVKISGGPHISYPPLHEWVLREGEE","Homo sapiens","MAGEA3, MAGE3","MELANOMA-ASSOCIATED ANTIGEN 3","1","4V0P"
"4V1P",,"X-RAY DIFFRACTION",2.49,50.56,,,,,"10.4049/jimmunol.1401064",,"4V1P",21.7,"2.04","2.04","BTN3 Structure","RHSAYNEWKKALFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALSICP","Homo sapiens","BTN3A1, BTF5","BUTYROPHILIN SUBFAMILY 3 MEMBER A1","1","4V1P"
"4V24",,"X-RAY DIFFRACTION",2.73,54.9,,5.5,"37.5% MPD, 0. 1 M BISTRIS PH 5.5 AND 0.1 M AMMONIUM ACETATE",,"10.1021/ml5004074","GYR","4V24",83.33,"1.8","1.8","Sphingosine kinase 1 in complex with PF-543","SMEPRVEVMDPAGGPRGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSGDGLMHEVVNGLMERPDWETAIQKPLCSLPAGSGNALAASLNHYAGYEQVTNEDLLTNCTLLLCRRLLSPMNLLSLHTASGLRLFSVLSLAWGFIADVDLESEKYRRLGEMRFTLGTFLRLAALRTYRGRLAYLPVGRVGSKTPASPVVVQQGPVDAHLVPLEEPVPSHWTVVPDEDFVLVLALLHSHLGSEMFAAPMGRCAAGVMHLFYVRAGVSRAMLLRLFLAMEKGRHMEYECPYLVYVPVVAFRLEPKDGKGVFAVDGELMVSEAVQGQVHPNYFWMVS","Homo sapiens","SPHK1, SK1, SPHK, SPK","SPHINGOSINE KINASE 1","1","4V24"
"4V25",,"X-RAY DIFFRACTION",3.12,60.61,,5.8,"0.1 M SODIUM ACETATE PH 5.8, 0.125 M MAGNESIUM CHLORIDE AND 6% ISOPROPANOL, 4OC",,"10.18632/oncotarget.2656","SZ6","4V25",47.23,"2.6","2.6","VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context- dependent cytostasis in cancer cells","MRWVWALLKNASLAGSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING)] KINASE ISOZYME 2, MITOCHONDRIAL","1","4V25"
"4V26",,"X-RAY DIFFRACTION",3.12,60.59,,5.8,"pH 5.8",,"10.18632/oncotarget.2656",,"4V26",47.21,"2.49","2.49","VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context- dependent cytostasis in cancer cells","MRWVWALLKNASLASAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING)] KINASE ISOZYME 2, MITOCHONDRIAL","1","4V26"
"4V2A",,"X-RAY DIFFRACTION",2.26,45.57,,,,,"10.1016/j.neuron.2014.10.008",,"4V2A",33.78,"2.4","2.4","human Unc5A ectodomain","MAVRPGLWPALLGIVLAAWLRGSGAQQSATVANPVPGANPDLLPHFLVEPEDVYIVKNKPVLLVCKAVPATQIFFKCNGEWVRQVDHVIERSTDGSNGLPTMEVRINVSRQQVEKVFGLEEYWCQCVAWSSSGTTKSQKAYIRIAYLRKNFEQEPLAKEVSLEQGIVLPCRPPEGIPPAEVEWLRNEDLVDPSLDPNVYITREHSLVVRQARLADTANYTCVAKNIVARRRSASAAVIVYVDGSWSPWSKWSACGLDCTHWRSRECSDPAPRNGGEECQGTDLDTRNCTSDLCVHTASGPEDV","Homo sapiens","UNC5A, KIAA1976, UNC5H1","NETRIN RECEPTOR UNC5A","1","4V2A"
"4V2B",,"X-RAY DIFFRACTION",2.09,41.26,,,,,"10.1016/j.neuron.2014.10.008",,"4V2B",36.26,"2","2","rat Unc5D Ig domain 1","MGTGAADRSRGARWWLPWLGLCFWAAGAEAARGADSGEVLPDSIPSAPGTLPHFIEEPEDAYIIKSNPIALRCKARPAMQIFFKCNGEWVHQNEHVSEESLDESSGLKVREVFINVTRQQVEDFHGPEDYWCQCVAWSHLGTSKSRKASVRIAYLRKNFEQ","Homo sapiens",,"PROTEIN UNC5D","1","4V2B"
"4V2D",,"X-RAY DIFFRACTION",2.16,43.14,,,,,"10.1016/j.neuron.2014.10.008",,"4V2D",36.81,"2.5","2.5","FLRT2 LRR domain","CPSVCRCDRNFVYCNERSLTSVPLGIPEGVTVLYLHNNQINNAGFPAELHNVQSVHTVYLYGNQLDEFPMNLPKNVRVLHLQENNIQTISRAALAQLLKLEELHLDDNSISTVGVEDGAFREAISLKLLFLSKNHLSSVPVGLPVDLQELRVDENRIAVISDMAFQNLTSLERLIVDGNLLTNKGIAEGTFSHLTKLKEFSIVRNSLSHPPPDLPGTHLIRLYLQDNQINHIPLTAFANLRKLERLDISNNQLRMLTQGVFDHLSNLKQLTARNNPWFCDCSIKWVTEWLKYIPSSLNVRGFMCQGPEQVRGMAVRALNMNLLSCP","Homo sapiens",,"FIBRONECTIN LEUCINE RICH TRANSMEMBRANE PROTEIN 2","1","4V2D"
"4V2O",,"X-RAY DIFFRACTION",2.77,50,,6.5,"0.1M MES, PH 6.0, 30% PEG6000",,"10.1002/cmdc.201500494","CLQ","4V2O",27.93,"2.13","2.13","Structure of saposin B in complex with chloroquine","GASGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDE","Homo sapiens","PSAP, GLBA, SAP1","SAPOSIN-B","1","4V2O"
"4V3U",,"X-RAY DIFFRACTION",3.22,61.8,,6.2,"11-13% PEG3350, 40MM CITRIC ACID 60MM BIS-TRIS-PROPANE, 10% GLYCEROL, 5 MM TCEP, pH 6.2",,"10.1021/jm501719e","EG8","4V3U",199.88,"2.3","2.3","Structure of human nNOS R354A G357D mutant heme domain in complex with N-2-(2-(1H-imidazol-1-yl)pyrimidin-4-yl)ethyl-3-(pyridin-3-yl) propan-1-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVW","Homo sapiens","NOS1","NITRIC OXIDE SYNTHASE, BRAIN","1","4V3U"
"4V6B",,"X-RAY DIFFRACTION",3.16,61.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM MES pH 6.5, 5% w/v PEG 6000, 2% v/v Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M109.042986",,"4V6B",3095.37,"2.85","2.85","Crystal structure of human ferritin Phe167SerfsX26 mutant.","RMSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLSSKGSLSSTTKSLLSPATSEGPLAK","Homo sapiens","FTL","Ferritin","1","4V6B"
"4W1O",,"X-RAY DIFFRACTION",2.73,54.98,,,,,"10.1021/jm500378a",,"4W1O",167.34,"2.2","2.2","PDE4D complexed with inhibitor","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELT","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","4W1O"
"4W4N",,"X-RAY DIFFRACTION",2.72,54.8,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.2M calcium acetate, 0.1M sodium cacodylate, 19% PEG 8000",293,"10.1038/ncomms7866",,"4W4N",53.09,"1.8","1.8","Crystal structure of human Fc at 1.80 A","HTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4W4N"
"4W4V",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, HANGING DROP",,"EG 3350, ammonium tartrate",277,"10.1038/srep08047","3H8","4W4V",42.71,"2.01","2.01","JNK2/3 in complex with 3-(4-{[(2-chlorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-4-yl)benzamide","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","c-Jun N-terminal kinase 3","1","4W4V"
"4W4W",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium tartrate",277,"10.1038/srep08047","3HJ","4W4W",42.67,"1.9","1.9","JNK2/3 in complex with N-(2-methylpyridin-4-yl)-3-{4-[(phenylcarbamoyl)amino]-1H-pyrazol-1-yl}benzamide","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","c-Jun N-terminal kinase 3","1","4W4W"
"4W4X",,"X-RAY DIFFRACTION",2.39,48.5,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium tartrate",277,"10.1038/srep08047",,"4W4X",42.69,"2.65","2.65","JNK2/3 in complex with 3-(4-{[(4-fluorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-4-yl)benzamide","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","c-jun NH2-terminal kinase 3","1","4W4X"
"4W4Y",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, HANGING DROP",,"EG 3350, ammonium tartrate",277,"10.1038/srep08047","3HQ","4W4Y",42.69,"2.3","2.3","JNK2/3 in complex with 3-(4-{[(4-methylphenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-4-yl)benzamide","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","c-jun NH2-terminal kinase 3","1","4W4Y"
"4W5I",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",277,"10.1016/j.bmc.2015.05.005","3GX","4W5I",55.69,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with 1-methyl-7-phenyl-1,2,3,4,5,6-hexahydro-1,6- naphthyridin-5-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","4W5I"
"4W5S",,"X-RAY DIFFRACTION",2.85,56.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% Peg 3350, PCTP Buffer pH 6.5, 100 mM MgCl2",293,"10.1021/ml5003663",,"4W5S",24.66,"2.8","2.8","Tankyrase in complex with compound","AGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNALAYAEYVIYRGEQAYPEYLITYQIMKPE","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4W5S"
"4W6E",,"X-RAY DIFFRACTION",2.86,56.92,"VAPOR DIFFUSION, SITTING DROP",5,"1.4 Sodium Formate, 0.1 Sodium Acetate pH 5",293,"10.1021/ml5003663","3J5","4W6E",24.75,"1.95","1.95","Human Tankyrase 1 with small molecule inhibitor","SMTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPE","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","4W6E"
"4W79",,"X-RAY DIFFRACTION",2.67,53.96,"VAPOR DIFFUSION, HANGING DROP",6,"PROTEIN SOLUTION (10 MG/ML SE-MET        
PROTEIN, 0.050 M SODIUM CHLORIDE, 0.003 M SODIUM AZIDE, 0.0003 M    
TCEP, BIS-TRIS PH 7.0) MIXED IN A 1:1 RATIO WITH THE WELL SOLUTION (1% ETHYLENE GLYCOL, 1.8 M AMMONIUM SULFATE, 0.10 M MES PH 6.0). CRYOPROTECTED IN FOUR STAGES WITH WELL SOLUTION USING 0 TO 25 % ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1371/journal.pone.0111142",,"4W79",24.64,"1.5","1.5","Crystal Structure of Human Protein N-terminal Glutamine Amidohydrolase","SEGNGPAAVHYQPASPPRDACVYSSCYCEENVWKLCEYIKNHDQYPLEECYAVFISNERKMIPIWKQQARPGDGPVIWDYHVVLLHVSSGGQSFIYDLDTVLPFPCLFDTYVEDAIKSDDDIHPQFRRKFRVICADSYLKNFASDRSHMKDSSGNWREPPPPYPCIETGDSKMNLNDFISMDPKVGWGAVYTLSEFTHRFGS","Homo sapiens","WDYHV1, C8orf32, NTAQ1","Protein N-terminal glutamine amidohydrolase","1","4W79"
"4W7P",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES PH 5.5, 50 mM CACL2, 7% PEG 3350",293,"10.1016/j.bmcl.2014.09.002","3J7","4W7P",190.84,"2.8","2.8","Crystal Structure of ROCK 1 bound to YB-15-QD37","GASTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSAN","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","4W7P"
"4W7T",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, HANGING DROP",6.5,"Protein is used at 12mg/ml  crystallant is: 20% (w/v) PEG2K MME, 200 mM magnesium chloride, 100 mM sodium cacodylate Apo crystals are grown with equal volumes of protein to crystallant. Compound is dissolved to 200mM in equal volumes of EtOH:PEG400:DMI, then diluted into crystallant for a working stock of 4mM.  1ul of compound working stock is added to a drop containing Apo Hsp90 crystals.  Soak for 3 days.",298,"10.1021/jm501107q","3JC","4W7T",26.86,"1.8","1.8","Crystal Structure of Hsp90-alpha N-domain Bound to the Inhibitor NVP-HSP990","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4W7T"
"4W7Y",,"X-RAY DIFFRACTION",4.04,69.56,"VAPOR DIFFUSION",4.6,"Grown in 34% 2-methyl-2,4-pentanediol (MPD), 100 mM Na acetate pH 4.6 and 20 mM CaCl2 using SeMet labeled protein purified in 20 mM Tris pH 8, 150 mM NaCl and 2 mM tris(2-carboxyethyl)phosphine  (TECEP) and concentrated to ~13 mg/mL.",292.15,"10.1039/c4cc07326f",,"4W7Y",15.76,"2.5","2.5","Dimeric BAP29 vDED with disulfide bonds in crystal contacts","SMDEECVLEAENKKLVEDQEKLKTELRKTSDALSKAQNDVMEMKMQSERLSKEYDQLLKEHSEL","Homo sapiens","BCAP29, BAP29","B-cell receptor-associated protein 29","1","4W7Y"
"4W7Z",,"X-RAY DIFFRACTION",4.65,73.57,"VAPOR DIFFUSION",4.6,"The crystal grew in 1.8 M ammonium sulfate, 100 mM Na acetate pH 4.6 and 5 mM TCEP using protein purified in 20 mM Tris pH 8, 150 mM NaCl and 0.5 mM TCEP and concentrated to ~14 mg/mL",277.15,"10.1039/c4cc07326f",,"4W7Z",31.77,"2.2","2.2","Tetrameric BAP29 vDED without disulfide bonds","SMDEECVLEAENKKLVEDQEKLKTELRKTSDALSKAQNDVMEMKMQSERLSKEYDQLLKEHSEL","Homo sapiens","BCAP29, BAP29","B-cell receptor-associated protein 29","1","4W7Z"
"4W80",,"X-RAY DIFFRACTION",4.86,74.67,"VAPOR DIFFUSION",4.6,"Grown in 1.8 M ammonium sulfate, 100 mM Na acetate pH 4.6 using protein purified in 20 mM Tris pH 8, 150 mM NaCl and 0.5 mM TCEP.",277.15,"10.1039/c4cc07326f",,"4W80",31.13,"3.2","3.2","Tetrameric BAP29 vDED with disulfide bonds in crystal contacts","SMDEECVLEAENKKLVEDQEKLKTELRKTSDALSKAQNDVMEMKMQSERLSKEYDQLLKEHSEL","Homo sapiens","BCAP29, BAP29","B-cell receptor-associated protein 29","1","4W80"
"4W82",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis Tris pH 6.5, 100 mM MgCl2, 19% (w/v) PEG 3350",296,"10.1074/jbc.M114.608547",,"4W82",73.66,"1.7","1.7","Enoyl-acyl carrier protein-reductase domain from human fatty acid synthase","AHAFVSTLTRGDLSSIRWVCSSLRHAQPTCPGAQLCTVYYASLNFRDIMLATGKLSPDAIPGKWTSQDSLLGMEFSGRDASGKRVMGLVPAKGLATSVLLSPDFLWDVPSNWTLEEAASVPVVYSTAYYALVVRGRVRPGETLLIHSGSGGVGQAAIAIALSLGCRVFTTVGSAEKRAYLQARFPQLDSTSFANSRDTSFEQHVLWHTGGKGVDLVLNSLAEEKLQASVRCLATHGRFLEIGKFDLSQNHPLGMAIFLKNVTFHGVLLDAFFNESSADWREVWALVQAGIRDGVVRPLKCTVFHGAQVEDAFRYMAQGKHIGKVVVQVLAEEPEAVLKG","Homo sapiens","FASN, FAS","Fatty acid synthase","1","4W82"
"4W8D",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCL (pH 8.5), 180mM MgCl2, 5mM Manganese acetate, 10-17% PEG 3350",293,"10.1021/jm5014055",,"4W8D",33.24,"1.77","1.77","Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06454589).","GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQ","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24 36 kDa subunit","1","4W8D"
"4W8E",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl (pH 8.5), 180mM MgCl2, 5mM Manganese acetate, 10-17% PEG3350",293,"10.1021/jm5014055","3JB","4W8E",33.43,"1.79","1.79","Structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06645342)","GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQS","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24 36 kDa subunit","1","4W8E"
"4W93",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"58% MPD, 100 mM sodium cacodylate",300,"10.1038/nchembio.1865","3L9","4W93",57.24,"1.352","1.352","Human pancreatic alpha-amylase in complex with montbretin A","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","4W93"
"4W9N",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 mM NADP+ and 2 mM triclosan cocrystallized with 2.625 M sodium chloride, 100 mM imidazole pH 7.5, microseeded",296,"10.1074/jbc.M114.608547","TCL","4W9N",148.29,"1.84","1.84","Enoyl-acyl carrier protein-reductase domain from human fatty acid synthase complexed with triclosan","AHAFVSTLTRGDLSSIRWVCSSLRHAQPTCPGAQLCTVYYASLNFRDIMLATGKLSPDAIPGKWTSQDSLLGMEFSGRDASGKRVMGLVPAKGLATSVLLSPDFLWDVPSNWTLEEAASVPVVYSTAYYALVVRGRVRPGETLLIHSGSGGVGQAAIAIALSLGCRVFTTVGSAEKRAYLQARFPQLDSTSFANSRDTSFEQHVLWHTGGKGVDLVLNSLAEEKLQASVRCLATHGRFLEIGKFDLSQNHPLGMAIFLKNVTFHGVLLDAFFNESSADWREVWALVQAGIRDGVVRPLKCTVFHGAQVEDAFRYMAQGKHIGKVVVQVLAEEPEAVLKG","Homo sapiens","FASN, FAS","Enoyl-[acyl-carrier-protein] reductase","1","4W9N"
,,,,,,,,,,,,,,,,"AHAFVSTLTRGDLSSIRWVCSSLRHAQPTCPGAQLCTVYYASLNFRDIMLATGKLSPDAIPGKWTSQDSLLGMEFSGRDASGKRVMGLVPAKGLATSVLLSPDFLWDVPSNWTLEEAASVPVVYSTAYYALVVRGRVRPGETLLIHSGSGGVGQAAIAIALSLGCRVFTTVGSAEKRAYLQARFPQLDSTSFANSRDTSFEQHVLWHTGGKGVDLVLNSLAEEKLQASVRCLATHGRFLEIGKFDLSQNHPLGMAIFLKNVTFHGVLLDAFFNESSADWREVWALVQAGIRDGVVRPLKCTVFHGAQVEDAFRYMAQGKHIGKVVVQVLAEEPEAVLKG","Homo sapiens","FASN, FAS","Enoyl-[acyl-carrier-protein] reductase","2","4W9N"
"4W9O",,"X-RAY DIFFRACTION",2.04,39.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"34 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1002/anie.201408776",,"4W9O",29.38,"1.27","1.27","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1R)-1,2-dihydroxyethyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4W9O"
"4W9P",,"X-RAY DIFFRACTION",2.06,40.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"34 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1002/anie.201408776",,"4W9P",29.38,"1.5","1.5","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-dihydroxyethyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4W9P"
"4W9Q",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"37 % PEG-3350, 8 % DMSO, 2 mM ligand, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1002/anie.201408776",,"4W9Q",14.6,"1.08","1.08","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-5-ethyl-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","4W9Q"
"4W9W",,"X-RAY DIFFRACTION",2.82,56.44,"VAPOR DIFFUSION, SITTING DROP",7.4,"4M sodium formate, freshly purified protein",293,"10.1016/j.str.2015.12.015",,"4W9W",35.39,"1.72","1.72","Crystal Structure of BMP-2-inducible kinase in complex with small molecule AZD-7762","VGVRVFAVGRHQVTLEESLAEGGFSTVFLVRTHGGIRCALKRMYVNNMPDLNVCKREITIMKELSGHKNIVGYLDCAVNSISDNVWEVLILMEYCRAGQVVNQMNKKLQTGFTEPEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLNDGGNYVLCDFGSATNKFLNPQKDGVNVVEEEIKKYTTLSYRAPEMINLYGGKPITTKADIWALGCLLYKLCFFTLPFGESQVAICDGNFTIPDNSRYSRNIHCLIRFMLEPDPEHRPDIFQVSYFAFKFAAADCPVSNINNSSIPSALPEPMTAS","Homo sapiens","BMP2K, BIKE, HRIHFB2017","BMP-2-inducible protein kinase","1","4W9W"
"4W9X",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, SITTING DROP",5.5,"4M sodium chloride, 0.1M bis-Tris pH 5.5, freshly purified protein",293,"10.1016/j.str.2015.12.015",,"4W9X",35.29,"2.14","2.14","Crystal Structure of BMP-2-inducible kinase in complex with baricitinib","SMSVGVRVFAVGRHQVTLEESLAEGGFSTVFLVRTHGGIRCALKRMYVNNMPDLNVCKREITIMKELSGHKNIVGYLDCAVNSISDNVWEVLILMEYCRAGQVVNQMNKKLQTGFTEPEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLNDGGNYVLCDFGSATNKFLNPQKDGVNVVEEEIKKYTTLSYRAPEMINLYGGKPITTKADIWALGCLLYKLCFFTLPFGESQVAICDGNFTIPDNSRYSRNIHCLIRFMLEPDPEHRPDIFQVSYFAFKFAAADCPVSNINNSSIPSALPEPMTASE","Homo sapiens","BMP2K, BIKE, HRIHFB2017","BMP-2-inducible protein kinase","1","4W9X"
"4W9Y",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, HANGING DROP",8,"34% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",288,,,"4W9Y",82.73,"1.64","1.64","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a glutamyl sulfamide inhibitor CJC47","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4W9Y"
"4WA7",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M MMT pH 4.0, 24% PEG6000",293,"10.1158/1541-7786.MCR-15-0203",,"4WA7",19.78,"1.986","1.986","Crystal Structure of a GDP-bound Q61L Oncogenic Mutant of Human GT- Pase KRas","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGLEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","4WA7"
"4WA9",,"X-RAY DIFFRACTION",3.09,60.15,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1 M Ammonium Chloride
20.0 %w/v PEG 3350
5.0 %v/v Ethylene glycol",294.15,"10.1038/nature14119","AXI","4WA9",66.85,"2.2","2.2","The crystal structure of human abl1 wild type kinase domain in complex with axitinib","GSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","4WA9"
"4WAA",,"X-RAY DIFFRACTION",2.24,45.11,"VAPOR DIFFUSION, SITTING DROP",4,"20% PEG3350, 8% Tacsimate pH 4",300,"10.1038/s41598-017-01258-6",,"4WAA",31.17,"2.35","2.35","Crystal structure of Nix LIR-fused human LC3B_2-119","GSPPAGLNEEWVELGSPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","4WAA"
"4WAE",,"X-RAY DIFFRACTION",2.48,50.42,"VAPOR DIFFUSION, SITTING DROP",,"10% w/v PEG 4000, 20% v/v glycerol
0.1 M MOPS/HEPES-Na pH 7.5",293,"10.1021/acs.jmedchem.5b00499",,"4WAE",65.77,"3.318","3.318","Phosphatidylinositol 4-kinase III beta crystallized with ATP","SWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRS","Homo sapiens","PI4KB, PIK4CB","Phosphatidylinositol 4-kinase beta,Phosphatidylinositol 4-kinase beta","1","4WAE"
,,,,,,,,,,,,,,,,,"Homo sapiens","PI4KB, PIK4CB"
"4WAG",,"X-RAY DIFFRACTION",2.48,50.4,"VAPOR DIFFUSION, SITTING DROP",,"10% w/v PEG 4000, 20% v/v glycerol
0.1 M MOPS/HEPES-Na pH 7.5",293,"10.1021/acs.jmedchem.5b00499",,"4WAG",65.58,"3.407","3.407","Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor","SWLLRLFESKLFDISMAISYLYNSKEPGVQAYIGNRLFCFRNEDVDFYLPQLLNMYIHMDEDVGDAIKPYIVHRCRQSINFSLQCALLLGAYSSDMHISTQRHSRGTKLRKLILSDELKPAHRKRELPSLSPAPDTGLSPSKRTHQRSKSDATASISLSSNLKRTASNPKVENEDEELSSSTESIDNSFSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRRDPEDPSAVALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMRS","Homo sapiens","PI4KB, PIK4CB","Phosphatidylinositol 4-kinase beta,Phosphatidylinositol 4-kinase beta","1","4WAG"
,,,,,,,,,,,,,,,,,"Homo sapiens","PI4KB, PIK4CB"
"4WAU",,"X-RAY DIFFRACTION",2.75,55.34,"VAPOR DIFFUSION, HANGING DROP",,"100 mM bicine pH 8.5, 11 % MPD, 8 mM spermidine",293.15,"10.1038/nmeth.3211",,"4WAU",38.49,"2.2","2.2","Crystal structure of CENP-M solved by native-SAD phasing","GPLGSMSVLRPLDKLPGLNTATILLVGTEDALLQQLADSMLKEDCASELKVHLAKSLPLPSSVNRPRIDLIVFVVNLHSKYSLQNTEESLRHVDASFFLGKVCFLATGAGRESHCSIHRHTVVKLAHTYQSPLLYCDLEVEGFRATMAQRLVRVLQICAGHVPGVSALNLLSLLRS","Homo sapiens","CENPM, C22orf18, ICEN39, PANE1","Centromere protein M","1","4WAU"
"4WB9",,"X-RAY DIFFRACTION",2.27,45.9,"EVAPORATION",7,"PEG3350, sodium chloride, 100mM BisTris Buffer, ytterbium chloride, NAD, sitting drop",300,"10.1016/j.cbi.2014.10.028",,"4WB9",56.04,"2.07","2.07","Human ALDH1A1 complexed with NADH","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLNDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","4WB9"
"4WBE",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",8,"22% PEG750MME, 0.1 M Tris, 0.1 M potassium fluoride, 10% glycerol",298,,,"4WBE",42.74,"2.05","2.05","Crystal structure of the HR-1 domain of human caprin-1 in the C121 space group","RREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSEEELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERVFQSNYFDSTHN","Homo sapiens","CAPRIN1, GPIAP1, GPIP137, M11S1, RNG105","Caprin-1","1","4WBE"
"4WBH",,"X-RAY DIFFRACTION",1.82,32.58,"VAPOR DIFFUSION",6,"30% PEG3350, 
100mM BisTris 6.0, 
5% Glycerol, 
200mM Ammonium Sulfate",293,"10.1038/nature14259",,"4WBH",106.66,"2.2","2.2","STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I APO - 2.2A","ETGRTEAAPAAGQPVESFPLDFTAVEGNMDSFMAQVKSLAQSLYPCSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRCPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTVRDQFTGQEMNVAQFLMHMGFDMQTVAQPQGLEPSELLGMLSNGSGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Protein notum homolog","1","4WBH"
"4WBK",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCl, 38% PEG3350",293,"10.1021/jp510384f",,"4WBK",15.16,"1.37","1.37","The 1.37 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with stearic acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","4WBK"
"4WBP",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG600, 0.1 M Tris, 0.1 M Calcium acetate, 10% glycerol",298,,,"4WBP",28.68,"2.5","2.5","Crystal structure of the HR-1 domain of human caprin-1 in the P3121 space group","RREQLMREEAEQKRLKTVLELQYVLDKLGDDEVRTDLKQGLNGVPILSEEELSLLDEFYKLVDPERDMSLRLNEQYEHASIHLWDLLEGKEKPVCGTTYKVLKEIVERVFQSNYFDSTHN","Homo sapiens","CAPRIN1, GPIAP1, GPIP137, M11S1, RNG105","Caprin-1","1","4WBP"
"4WCO",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate, pH6.5, 0.2 M zinc acetate and 5% (w/v) PEG8000",293,"10.1002/eji.201545509",,"4WCO",43.38,"2.46","2.46","Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A","MLQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARCYTERKWICSKSDIHV","Homo sapiens","CLEC2D, CLAX, LLT1, OCIL","C-type lectin domain family 2 member D","1","4WCO"
"4WCU",,"X-RAY DIFFRACTION",2.74,55.08,,,,,"10.1021/jm500378a","3KQ","4WCU",167.44,"2.35","2.35","PDE4 complexed with inhibitor","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELT","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","4WCU"
"4WD4",,"X-RAY DIFFRACTION",1.83,32.69,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM HEPES, pH 7.4; 2.1 M (NH4)2SO4; 0.9% 1,6-hexane-diol; BIG_CHAP",293,"10.1021/acs.biochem.6b00562",,"4WD4",136.11,"2.95","2.95","Crystal structure of human HO1 H25R","GSHMMERPQPDSMPQDLSEALKEATKEVRTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKRLHEVGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATKFKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRAPGLRQRASNKVQDSAPVETPRGKPPLNTRSQAPLLRWVLTLSFLVATVAVGLYAM","Homo sapiens","HMOX1, HO, HO1","Heme oxygenase 1","1","4WD4"
"4WD5",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes (pH 7.5), 21% PEG6000, 0.3 M NaCl, and 5 mM tris(2-carboxyethyl)-
phosphine (TCEP)",293,,,"4WD5",75.78,"3.3","3.3","Crystal structure of EGFR 696-1022 T790M in complex with QL-X138","GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4WD5"
"4WDT",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium citrate, 0.4 M ammonium acetate, 2.5% (v/v) 2-methyl-2,4-pentanediol, 22-30% (w/v) PEG4000",298,"10.1107/S1399004715002175","WDT","4WDT",38.99,"1.5","1.5","17beta-HSD5 in complex with 2-nitro-5-(phenylsulfonyl)phenol","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4WDT"
"4WDU",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium citrate, 0.4 M ammonium acetate, 2.5% (v/v) 2-methyl-2,4-pentanediol, 22-30% (w/v) PEG4000",298,"10.1107/S1399004715002175","WDU","4WDU",39.03,"1.7","1.7","17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4WDU"
"4WDW",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M HEPES, 0.2M ammonium dihydrogen phosphate, 20-25% (w/v) PEG3350",298,"10.1107/S1399004715002175","WDW","4WDW",77.9,"1.94","1.94","17beta-HSD5 in complex with 3,6-dihydropyridin-1(2H)-yl(5-methyl-1H-indol-2-yl)methanone","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4WDW"
"4WDX",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M HEPES, 0.2M ammonium dihydrogen phosphate, 20-25% (w/v) PEG3350",298,"10.1107/S1399004715002175","WDX","4WDX",77.99,"1.64","1.64","17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanone","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4WDX"
"4WEV",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM sodium cacodylate",293,"10.1016/j.cbi.2014.12.018","SUZ","4WEV",37.51,"1.453","1.453","Crystal structure of human AKR1B10 complexed with NADP+ and sulindac","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPRDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4WEV"
"4WFS",,"X-RAY DIFFRACTION",3.06,58.85,"VAPOR DIFFUSION, HANGING DROP",,"Protein 8 mg/mL in Tris 25 mM pH 8.0 NaCl 150 mM
Precipitant: Ammonium sulfate 2.2 M, isopropanol 2% v/v",292,"10.1093/nar/gkv989",,"4WFS",37.68,"2.68","2.68","Crystal Structure of tRNA-dihydrouridine(20) synthase catalytic domain","MHHHHHHLILAPMVRVGTLPMRLLALDYGADIVYCEELIDLKMIQCKRVVNEVLSTVDFVAPDDRVVFRTCEREQNRVVFQMGTSDAERALAVARLVENDVAGIDVNMGCPKQYSTKGGMGAALLSDPDKIEKILSTLVKGTRRPVTCKIRILPSLEDTLSLVKRIERTGIAAIAVHGRKREERPQHPVSCEVIKAIADTLSIPVIANGGSHDHIQQYSDIEDFRQATAASSVMVARAAMWNPSIFLKEGLRPLEEVMQKYIRYAVQYDNHYTNTKYCLCQMLREQLESPQGRLLHAAQSSREICEAFGLGAFYEETTQELDAQQAR","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","4WFS"
"4WFT",,"X-RAY DIFFRACTION",2.12,41.85,"VAPOR DIFFUSION, HANGING DROP",,"Protein 20 mg/mL
precipitant: HEPES 100 mM pH 6.5, sodium acetate 100 mM, PEG 2000 MME 30%",292,"10.1093/nar/gkv989",,"4WFT",41.19,"1.7","1.7","Crystal structure of tRNA-dihydrouridine(20) synthase dsRBD domain","MTSEQTGEPAEDTSGVIKMAVKFDRRAYPAQITPKMCLLEWCRREKLAQPVYETVQRPLDRLFSSIVTVAEQKYQSTLWDKSKKLAEQAAAIVCLRSQGLPEGRLGEESPSLHKHHHHHH","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","4WFT"
"4WG0",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, SITTING DROP",3.5,"2M ammonium sulfate,
5-10% glycerol,
0.1 M citric acid pH 3.5",298,"10.1107/S2052252515000238",,"4WG0",28.65,"1.82","1.82","Crystal structure of a tridecameric superhelix","XEKNALLRYLLDKDX","Homo sapiens","NCOA2, BHLHE75, SRC2, TIF2","Nuclear receptor coactivator 2","1","4WG0"
"4WGK",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, HANGING DROP",4.6,"10% PEG 1000, 0.2M Lithium sulfate, 0.1M citrate phosphate buffer, pH 4.6",289.15,"10.1016/j.str.2015.06.013",,"4WGK",155.83,"2.582","2.582","Crystal structure of human neutral ceramidase with Zn-bound phosphate","FSGYHIGVGRADCTGQVADINLMGYGKSGQNAQGILTRLYSRAFIMAEPDGSNRTVFVSIDIGMVSQRLRLEVLNRLQSKYGSLYRRDNVILSGTHTHSGPAGYFQYTVFVIASEGFSNQTFQHMVTGILKSIDIAHTNMKPGKIFINKGNVDGVQINRSPYSYLQNPQSERARYSSNTDKEMIVLKMVDLNGDDLGLISWFAIHPVSMNNSNHLVNSDNVGYASYLLEQEKNKGYLPGQGPFVAAFASSNLGDVSPNILGPRCINTGESCDNANSTCPIGGPSMCIAKGPGQDMFDSTQIIGRAMYQRAKELYASASQEVTGPLASAHQWVDMTDVTVWLNSTHASKTCKPALGYSFAAGTIDGVGGLNFTQGKTEGDPFWDTIRDQILGKPSEEIKECHKPKPILLHTGELSKPHPWHPDIVDVQIITLGSLAITAIPGEFTTMSGRRLREAVQAEFASHGMQNMTVVISGLCNVYTHYITTYEEYQAQRYEAASTIYGPHTLSAYIQLFRNLAKAIATDTVANLSRGPEPPFFKQLIVPLIPSIVDRAPKGRTFGDVLQPAKPEYRVGEVAEVIFVGANPKNSVQNQTHQTFLTVEKYEATSTSWQIVCNDASWETRFYWHKGLLGLSNATVEWHIPDTAQPGIYRIRYFGHNRKQDILKPAVILSFEGTSPAFEVVTIHHHHHH","Homo sapiens","ASAH2, HNAC1","Neutral ceramidase","1","4WGK"
"4WH7",,"X-RAY DIFFRACTION",3.13,60.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"(NH4)2SO4, Tris, TCEP",298,"10.1021/cb500883h","8H8","4WH7",22.26,"1.62","1.62","Structure of the CDC25B Phosphatase Catalytic Domain with Bound Ligand","GSSDSDHRELIGDYSKAFLLQTVDGKHQDLKYISPETMVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKRVILIFHSEFSSERGPRMCRFIRERDRAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQDYRPMNHEAFKDELKTFRLKTRSWA","Homo sapiens","CDC25B, CDC25HU2","M-phase inducer phosphatase 2","1","4WH7"
"4WH9",,"X-RAY DIFFRACTION",3.18,61.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"(NH4)2SO4, Tris, TCEP",298,"10.1021/cb500883h","3M8","4WH9",22.2,"1.5","1.5","Structure of the CDC25B Phosphatase Catalytic Domain with Bound Inhibitor","GSSDSDHRELIGDYSKAFLLQTVDGKHQDLKYISPETMVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKRVILIFHSEFSSERGPRMCRFIRERDRAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQDYRPMNHEAFKDELKTFRLKTRSWA","Homo sapiens","CDC25B, CDC25HU2","M-phase inducer phosphatase 2","1","4WH9"
"4WHC",,"X-RAY DIFFRACTION",3.09,60.18,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3000, 100 mM Imidazole pH 8.0, 200 mM ZnAc",295,,,"4WHC",23.89,"2.705","2.705","Human CEACAM6 N-domain","AKLTIESTPFNVAEGKEVLLLAHNLPQNRIGYSWYKGERVDGNSLIVGYVIGTQQATPGPAYSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM6, NCA","Carcinoembryonic antigen-related cell adhesion molecule 6","1","4WHC"
"4WHD",,"X-RAY DIFFRACTION",3.86,68.17,"VAPOR DIFFUSION, HANGING DROP",4.2,"PEG 3000, NaCl, Phosphate-Citrate",295,,,"4WHD",26.56,"2.5","2.5","Human CEACAM1 N-domain homodimer","AQLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","4WHD"
"4WHF",,"X-RAY DIFFRACTION",3.18,61.33,"VAPOR DIFFUSION, HANGING DROP",4.2,"PEG4000, Sodium citrate, Glycerol",277,"10.1016/j.chembiol.2015.06.023",,"4WHF",58.23,"2.27","2.27","Crystal Structure of TR3 LBD in complex with 1-(3,4,5-trihydroxyphenyl)decan-1-one","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","4WHF"
"4WHG",,"X-RAY DIFFRACTION",3.21,61.69,"VAPOR DIFFUSION, HANGING DROP",4.2,"PEG4000, Sodium citrate, Glycerol",277,"10.1016/j.chembiol.2015.06.023",,"4WHG",58.2,"2.18","2.18","Crystal Structure of TR3 LBD in complex with Molecule 3","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","4WHG"
"4WHJ",,"X-RAY DIFFRACTION",2.72,54.71,"MICROBATCH",,"0.1 M MES, 5% PEG4000, 10% 2-Propanol, 0.05 M magnesium chloride",298,"10.1016/j.chom.2014.09.021",,"4WHJ",147.78,"3.2","3.2","Myxovirus Resistance Protein 2 (MxB)","MGSSHHHHHHSQDPGPENNLYSQYEQKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKQPCEAWAGRISYRNTELELQDPGQVEKEIHKAQNVMAGNGRGISHELISLEITSPEVPDLTIIDLPGITRVAVDNQPRDIGLQIKALIKKYIQRQQTINLVVVPCNVDIATTEALSMAHEVDPEGDRTIGILTKPDLMDRGTEKSVMNVVRNLTYPLKKGYMIVKCRGQQEITNRLSLAEATKKEITFFQTHPYFRVLLEEGSATVPRLAERLTTELIMHIQKSLPLLEGQIRESHQKATEELRRCGADIPSQEADKMFFLIEKIKMFNQDIEKLVEGEEVVRENETRLYNKIREDFKNWVGILATNTQKVKNIIHEEVEKYEKQAAAAELLGFVNYKTFEIIVHQYIQQLVEPALSMLQKAMEIIQQAFINVAKKHFGEFFNLNQTVQSTIEDIKVKHTAKAENMIQLQFRMEQMVFCQDQIYSVVLKKVREEIFNPLGTPSQNMKLNSHFPSNESSVSSFTEIGIHLNAYFLETSKRLANQIPFIIQYFMLRENGDSLQKAMMQILQEKNRYSWLLQEQSETATKRRILKERIYRLTQARHALCQFSSKEIH","Homo sapiens","MX2","Interferon-induced GTP-binding protein Mx2","1","4WHJ"
"4WHU",,"X-RAY DIFFRACTION",1.96,37.11,"VAPOR DIFFUSION, HANGING DROP",,"obtained through screen with Hampton Research kits (HT and Index)",277,,"3OT","4WHU",14.69,"2.11","2.11","BROMO domain of CREB binding protein","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","4WHU"
"4WHW",,"X-RAY DIFFRACTION",1.92,35.85,"VAPOR DIFFUSION, HANGING DROP",,"Screen using Hampton Research HT and Index kits",277,,"3OT","4WHW",15.63,"1.345","1.345","Direct photocapture of bromodomains using tropolone chemical probes","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4WHW"
"4WHZ",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium tartrate pH 7.0, 20 % PEG 3350",277,"10.1021/jm501256y","3NL","4WHZ",44.59,"1.79","1.79","Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4WHZ"
"4WI2",,"X-RAY DIFFRACTION",2.85,56.87,"VAPOR DIFFUSION, HANGING DROP",,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI2",50.38,"1.9","1.9","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc (wild-type)","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI2"
"4WI3",,"X-RAY DIFFRACTION",2.81,56.27,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI3",50.11,"2.703","2.703","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A","GPSVFLFPPKPKDTLMASRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI3"
"4WI4",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI4",50.24,"2.8","2.8","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation S254A","PSVFLFPPKPKDTLMIARTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI4"
"4WI5",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI5",50.25,"2.8","2.8","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310A","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLAQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI5"
"4WI6",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI6",50.23,"2.201","2.201","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation N434A","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHAHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI6"
"4WI7",,"X-RAY DIFFRACTION",2.69,54.34,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI7",50.19,"1.9","1.9","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H435A","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNAYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI7"
"4WI8",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI8",50.03,"2.8","2.8","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation Y436A","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHATQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI8"
"4WI9",,"X-RAY DIFFRACTION",2.69,54.32,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 6000, 0.1 M MES, 25% v/v ethylene glycol",291,,,"4WI9",50,"2.65","2.65","Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A/H310A","GPSVFLFPPKPKDTLMASRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLAQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4WI9"
"4WII",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.9 M AMMONIUM SULFATE, 0.1 M TRIS,
 20% ETHYLENE GLYCOL (V/V), PH 8.5, VAPOR DIFFUSION, HANGING DROP,
 TEMPERATURE 293K",293,"10.1093/nar/gkv156",,"4WII",60.78,"2.05","2.05","HUMAN SPLICING FACTOR, CONSTRUCT 3","GAMEGFKANLSLLRRPGEKTYTQRCRLFVGNLPADITEDEFKRLFAKYGEPGEVFINKGKGFGFIKLESRALAEIAKAELDDTPMRGRQLRVRFATHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLL","Homo sapiens","SFPQ, PSF","Splicing factor, proline- and glutamine-rich","1","4WII"
"4WIJ",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, SITTING DROP",7,"26% (V/V) 1,4 DIOXANE, 0.05M MOPS, 50
 MM MAGNESIUM CHLORIDE HEXAHYDRATE, 1 MM SPERMINE, PH 7.0, VAPOR
 DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1093/nar/gkv156",,"4WIJ",77.07,"3.49","3.49","HUMAN SPLICING FACTOR, CONSTRUCT 1","GAMEGFKANLSLLRRPGEKTYTQRCRLFVGNLPADITEDEFKRLFAKYGEPGEVFINKGKGFGFIKLESRALAEIAKAELDDTPMRGRQLRVRFATHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLLRQDLMRRQEELRRMEELHNQEMQKRKEMQLRQEEERRRREEEMMIRQREMEEQMRRQREESYS","Homo sapiens","SFPQ, PSF","Splicing factor, proline- and glutamine-rich","1","4WIJ"
"4WIK",,"X-RAY DIFFRACTION",2.92,57.95,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M SODIUM PHOSPHATE DIBASIC
 DIHYDRATE, 22% (W/V) POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION,
 SITTING DROP, TEMPERATURE 293K",293,"10.1093/nar/gkv156",,"4WIK",56.02,"3","3","HUMAN SPLICING FACTOR, CONSTRUCT 2","GAMAHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLLRQDLMRRQEELRRMEELHNQEMQKRKEMQLRQEEERRRREEEMMIRQREMEEQMRRQREESYS","Homo sapiens","SFPQ, PSF","Splicing factor, proline- and glutamine-rich","1","4WIK"
"4WIP",,"X-RAY DIFFRACTION",3.56,65.49,"VAPOR DIFFUSION, SITTING DROP",8.5,"grew in PEG400 (cryo condition) over night",292,"10.1038/ncomms7718",,"4WIP",33.63,"2.691","2.691","DIX domain of human Dvl2","MGETKVIYHLDEEETPDLVKIPVPAERITLGDFKSVLQRPAGAKYFFKSMDQDFGVVKEEISDDNARLPCFNGRVVSWLVSSDNPQPEMAPPVHEPR","Homo sapiens","DVL2","Segment polarity protein dishevelled homolog DVL-2","1","4WIP"
"4WIV",,"X-RAY DIFFRACTION",2.2,44.6,"VAPOR DIFFUSION, SITTING DROP",7.4,"Crystals of inhibitor-free BRD4-BD1 were first obtained in a drop with equal volumes of BD1 at 12 mg/ml and a precipitant solution containing 100mM sodium nitrate, 5% ethylene glycol, and 18% (w/v) PEG3350, as precipitant. Rod-like crystals were typically grown in 10 days reaching a maximal size of 0.05x0.05x0.4 mm3. Then, native crystals were transferred and soaked in 1 mM UMB32 in the same crystallization buffer for 7 days.",295,"10.1021/jm501120z","3P2","4WIV",15.77,"1.56","1.56","Crystal Structure of the first bromodomain of human BRD4 in complex with a novel inhibitor UMB32 (N-TERT-BUTYL-2-[4-(3,5-DIMETHYL-1,2-OXAZOL-4-YL) PHENYL]IMIDAZO[1,2-A]PYRAZIN-3-AMINE)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4WIV"
"4WJ8",,"X-RAY DIFFRACTION",2.26,45.53,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, sodium cacodylate, Triethanolamine, MgCl2, KCl",291.15,,,"4WJ8",242.86,"2.87","2.87","Human Pyruvate Kinase M2 Mutant C424A","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCASGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","4WJ8"
"4WJ9",,"X-RAY DIFFRACTION",2.26,45.67,"EVAPORATION",7,"PEG3350, sodium chloride, 100 mM Bis Tris Buffer, ytterbium chloride, sitting drop",300,"10.1016/j.cbi.2014.10.028",,"4WJ9",55.11,"1.74","1.74","Structure of Human apo ALDH1A1","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLSDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","4WJ9"
"4WJA",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.24M Ammonium sulfate, 0.1M Bis-Tris, pH 5.5",289,"10.1038/ncomms7233",,"4WJA",34.61,"2.6","2.6","Crystal Structure of PAXX","MGSSHHHHHHSQGSEFMDPLSPPLCTLPPGPEPPRFVCYCEGEESGEGDRGGFNLYVTDAAELWSTCFTPDSLAALKARFGLSAAEDITPRFRAACEQQAVALTLQEDRASLTLSGGPSALAFDLSKVPGPEAAPRLRALTLGLAKRVWSLERRLAAAEET","Homo sapiens","C9orf142, PAXX, XLS","Uncharacterized protein C9orf142","1","4WJA"
"4WJL",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, SITTING DROP",5.5,"Crystals formed within 2-4 weeks using 100 micrometers of reservoir solution consisting of 20%(w/v) PEG 1500, 0.2 M MgCl2, 0.1 M sodium cacodylate pH 5.5.",293,"10.1038/srep08769",,"4WJL",168.73,"3.4","3.4","Structure of human dipeptidyl peptidase 10 (DPPY): a modulator of neuronal Kv4 channels","SETRLSLEDLFRKDFVLHDPEARWINDTDVVYKSENGHVIKLNIETNATTLLLENTTFVTFKASRHSVSPDLKYVLLAYDVKQIFHYSYTASYVIYNIHTREVWELNPPEVEDSVLQYAAWGVQGQQLIYIFENNIYYQPDIKSSSLRLTSSGKEEIIFNGIADWLYEEELLHSHIAHWWSPDGERLAFLMINDSLVPTMVIPRFTGALYPKGKQYPYPKAGQMNPTIKLYVVNLYGPTHTLELMPPDSFKSREYYITMVKWVSNTKTVVRWLNRAQNISILTVCETTTGACSKKYEMTSDTWLSQQNEEPVFSRDGSKFFMTVPVKQGGRGEFHHIAMFLIQSKSEQITVRHLTSGNWEVIKILAYDETTQKIYFLSTESSPRGRQLYSASTEGLLNRQCISCNFMKEQCTYFDASFSPMNQHFLLFCEGPRVPVVSLHSTDNPAKYFILESNSMLKEAILKKKIGKPEIKILHIDDYELPLQLSLPKDFMDRNQYALLLIMDEEPGGQLVTDKFHIDWDSVLIDMDNVIVARFDGRGSGFQGLKILQEIHRRLGSVEVKDQITAVKFLLKLPYIDSKRLSIFGKGYGGYIASMILKSDEKLFKCGSVVAPITDLKLYASAFSERYLGMPSKEESTYQAASVLHNVHGLKEENILIIHGTADTKVHFQHSAELIKHLIKAGVNYTMQVYPDEGHNVSEKSKYHLYSTILKFFSDCLKE","Homo sapiens","DPP10, DPRP3, KIAA1492","Inactive dipeptidyl peptidase 10","1","4WJL"
"4WJX",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION, HANGING DROP",,"25 % (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate (PST) at pH 7.2",290,"10.1107/S139900471500783X",,"4WJX",42.52,"1","1","Crystal structure of human chitotriosidase-1 catalytic domain at 1.0 A resolution","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLVPRGSHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","4WJX"
"4WK7",,"X-RAY DIFFRACTION",2.01,38.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, Bis-Tris",293,"10.1021/jm501522n","3PQ","4WK7",25.98,"1.24","1.24","Crystal structure of human ADAMTS-4 in complex with inhibitor (compound 1, 2-(4-chlorophenoxy)-N-{[(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methyl} acetamide)","FASLSRFVETLVVADDKMAAFHGAGLKRYLLTVMAAAAKAFKHPSIRNPVSLVVTRLVILGSGEEGPQVGPSAAQTLRSFCAWQRGLNTPEDSDPDHFDTAILFTRQDLCGVSTCDTLGMADVGTVCDPARSCAIVEDDGLQSAFTAAHELGHVFNMLHDNSKPCISLNGPLSTSRHVMAPVMAHVDPEEPWSPCSARFITDFLDNGYGHCLLDKPEAPLHLPVTFPDVHHHHHH","Homo sapiens","ADAMTS4, KIAA0688, UNQ769/PRO1563","A disintegrin and metalloproteinase with thrombospondin motifs 4","1","4WK7"
"4WK9",,"X-RAY DIFFRACTION",2.23,44.88,"VAPOR DIFFUSION, HANGING DROP",,"25 % (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate at pH 7.2, 0.3mM 4-methylumbelliferyl triacetylchitotrioside",290,"10.1107/S139900471500783X",,"4WK9",42.65,"1.102","1.102","Crystal structure of human chitotriosidase-1 catalytic domain in complex with chitobiose (0.3mM) at 1.10 A resolution","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLVPRGSHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","4WK9"
"4WKA",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, HANGING DROP",,"23 % (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate (PST) at pH 7.2",290,"10.1107/S139900471500783X",,"4WKA",42.52,"0.95","0.95","Crystal structure of human chitotriosidase-1 catalytic domain at 0.95 A resolution","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLVPRGSHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","4WKA"
"4WKE",,"X-RAY DIFFRACTION",2.01,38.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, Bis-Tris",293,"10.1021/jm501522n","3PU","4WKE",26.25,"1.62","1.62","Crystal structure of human ADAMTS-4 in complex with inhibitor 5-chloro-N-{[(4R)-2,5-dioxo-4-(1,3-thiazol-2-yl)imidazolidin-4-yl]methyl}-1-benzofuran-2-carboxamide (compound 10)","FASLSRFVETLVVADDKMAAFHGAGLKRYLLTVMAAAAKAFKHPSIRNPVSLVVTRLVILGSGEEGPQVGPSAAQTLRSFCAWQRGLNTPEDSDPDHFDTAILFTRQDLCGVSTCDTLGMADVGTVCDPARSCAIVEDDGLQSAFTAAHELGHVFNMLHDNSKPCISLNGPLSTSRHVMAPVMAHVDPEEPWSPCSARFITDFLDNGYGHCLLDKPEAPLHLPVTFPDVHHHHHH","Homo sapiens","ADAMTS4, KIAA0688, UNQ769/PRO1563","A disintegrin and metalloproteinase with thrombospondin motifs 4","1","4WKE"
"4WKF",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, HANGING DROP",,"25 % (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate at pH 7.2
2.5mM 4-methylumbelliferyl triacetylchitotrioside",290,"10.1107/S139900471500783X",,"4WKF",42.65,"1.101","1.101","Crystal structure of human chitotriosidase-1 catalytic domain in complex with chitobiose (2.5mM) at 1.10 A resolution","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLVPRGSHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","4WKF"
"4WKH",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, HANGING DROP",,"25 % (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate at pH 7.2, 0.3mM 4-methylumbelliferyl triacetylchitotrioside",290,"10.1107/S139900471500783X",,"4WKH",42.65,"1.05","1.05","Crystal structure of human chitotriosidase-1 catalytic domain in complex with chitobiose (1mM) at 1.05 A resolution","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLVPRGSHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","4WKH"
"4WKI",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, Bis-Tris",293,"10.1021/jm501522n","3PW","4WKI",26.12,"1.6","1.6","Crystal structure of human ADAMTS-4 in complex with inhibitor 5-CHLORO-N-{[(4S)-4-(1-METHYL-1H-IMIDAZOL-2-YL)-2,5-DIOXOIMIDAZOLIDIN-4-YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (compound 11)","FASLSRFVETLVVADDKMAAFHGAGLKRYLLTVMAAAAKAFKHPSIRNPVSLVVTRLVILGSGEEGPQVGPSAAQTLRSFCAWQRGLNTPEDSDPDHFDTAILFTRQDLCGVSTCDTLGMADVGTVCDPARSCAIVEDDGLQSAFTAAHELGHVFNMLHDNSKPCISLNGPLSTSRHVMAPVMAHVDPEEPWSPCSARFITDFLDNGYGHCLLDKPEAPLHLPVTFPDVHHHHHH","Homo sapiens","ADAMTS4, KIAA0688, UNQ769/PRO1563","A disintegrin and metalloproteinase with thrombospondin motifs 4","1","4WKI"
"4WKQ",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M MES, pH 7.0, 1 M sodium citrate",291,,,"4WKQ",38.24,"1.85","1.85","1.85 angstrom structure of EGFR kinase domain with gefitinib","GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4WKQ"
"4WL0",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M KCl, 0.025 M MgCl2, 0.05 M Na Cacodylate, 15% iso-Propanol",292,"10.1042/BJ20150251",,"4WL0",333.4,"2.89","2.89","Ligand-free structure of human platelet phosphofructokinase in an R-state, crystal form I","MASWSHPQFEKGADDDDKVPDPTSAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILA","Homo sapiens","PFKP, PFKF","ATP-dependent 6-phosphofructokinase, platelet type","1","4WL0"
"4WL4",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M sodium citrate, Tris 50 mM",296,,"FC5","4WL4",29.59,"1.1","1.1","Crystal structure of human carbonic anhydrase II in complex with the 6-hydroxy-chromene-2-thione inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4WL4"
"4WLE",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1M Na2HPO4, citric acid, 40% (v/v) polyethylene glycol 300",288,,,"4WLE",144.19,"1.9","1.9","Crystal structure of citrate bound MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLE"
"4WLF",,"X-RAY DIFFRACTION",2.48,50.36,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M Na2HPO4:citric acid, 40% (v/v) polyethylene glycol 300, 10% DMSO",288,,,"4WLF",144.34,"2.2","2.2","Crystal structure of L-malate bound MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLF"
"4WLH",,"X-RAY DIFFRACTION",2.16,43.09,"VAPOR DIFFUSION, HANGING DROP",7.3,"29% PEG 4000, 0.2 M sodium acetate, 0.1 M Tris",298,"10.1002/pro.3119",,"4WLH",96.31,"1.28","1.28","High resolution crystal structure of human kynurenine aminotransferase-I bound to PLP cofactor","MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFMLNQYTKTFGYPPLTKILASFFGELLGQEIDPLRNVLVTVGGYGALFTAFQALVDEGDEVIIIEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVLNTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTLTIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFRQPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDEPYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKVEL","Homo sapiens","KYAT1, CCBL1","Kynurenine--oxoglutarate transaminase 1","1","4WLH"
"4WLJ",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, HANGING DROP",7.3,"5 mM AOAA, 29% PEG 4000, 0.2 M sodium acetate, 0.1 M Tris",298,"10.1002/pro.3119",,"4WLJ",96.5,"1.54","1.54","High resolution crystal structure of human kynurenine aminotransferase-I in complex with aminooxyacetate","MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFMLNQYTKTFGYPPLTKILASFFGELLGQEIDPLRNVLVTVGGYGALFTAFQALVDEGDEVIIIEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVLNTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTLTIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFRQPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDEPYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKVEL","Homo sapiens","CCBL1, KYAT1","Kynurenine--oxoglutarate transaminase 1","1","4WLJ"
"4WLN",,"X-RAY DIFFRACTION",2.45,49.81,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M Na2HPO4:citric acid, 40% (v/v) polyethylene glycol 300, 10% DMSO",288,,,"4WLN",144.56,"2.28","2.28","Crystal structure of apo MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLN"
"4WLO",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M Na2HPO4:citric acid, 40% (v/v) polyethylene glycol 300, 10% DMSO",288,,,"4WLO",146.61,"2.5","2.5","Crystal structure of oxaloacetate and NADH bound MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLO"
"4WLU",,"X-RAY DIFFRACTION",2.47,50.12,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M Na2HPO4:citric acid, 40% (v/v) polyethylene glycol 300, 10% DMSO",288,,,"4WLU",146.61,"2.14","2.14","Crystal structure of L-malate and NAD bound MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLU"
"4WLV",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M Na2HPO4:citric acid, 40% (v/v) polyethylene glycol 300, 10% DMSO",288,,,"4WLV",146.84,"2.4","2.4","Crystal structure of NAD bound MDH2","MGSSHHHHHHSSGLVPRGSHMSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK","Homo sapiens","MDH2","Malate dehydrogenase, mitochondrial","1","4WLV"
"4WMH",,"X-RAY DIFFRACTION",2.41,48.86,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 1.5K and 100mM BTP pH 7.0",298,,,"4WMH",24.31,"2.5","2.5","Structure of heme oxygenase-2 containing residues 1-288 lacking the membrane spanning region","ADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQCPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNEL","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","4WMH"
"4WMQ",,"X-RAY DIFFRACTION",2.2,44.21,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Bis-Tris, 25% PEG 3350",298,"10.1038/nsmb.3053",,"4WMQ",68.76,"1.8","1.8","Structure of Human Intelectin-1","TDWSHPQFEKSTDEANTYFKEWTCSSSPSLPRSCKEIKDECPSAFDGLYFLRTENGVIYQTFCDMTSGGGGWTLVASVHENDMRGKCTVGDRWSSQQGSKAVYPEGDGNWANYNTFGSAEAATSDDYKNPGYYDIQAKDLGIWHVPNKSPMQHWRNSSLLRYRTDTGFLQTLGHNLFGIYQKYPVKYGEGKCWTDNGPVIPVVYDFGDAQKTASYYSPYGQREFTAGFVQFRVFNNERAANALCAGMRVTGCNTEHHCIGGGGYFPEASPQQCGDFSGFDWSGYGTHVGYSSSREITEAAVLLFYR","Homo sapiens","ITLN1, INTL, ITLN, LFR, UNQ640/PRO1270","Intelectin-1","1","4WMQ"
"4WMR",,"X-RAY DIFFRACTION",1.95,36.84,"VAPOR DIFFUSION, SITTING DROP",7,"10 mg/ml MCL1, 16% PEG8000, 20% GLYCEROL, 40MM KH2PO4, 2MM ligand 1, 2MM ZINC CHLORIDE, 9.98 MG/ML MCL1",298,"10.1371/journal.pone.0125010",,"4WMR",18.34,"1.7","1.7","STRUCTURE OF MCL1 BOUND TO BRD inhibitor ligand 1 AT 1.7A","SELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","4WMR"
"4WMY",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Bis-Tris, 25% PEG 3350",298,"10.1038/nsmb.3053","3S6","4WMY",69.2,"1.601","1.601","Structure of Human intelectin-1 in complex with allyl-beta-galactofuranose","TDWSHPQFEKSTDEANTYFKEWTCSSSPSLPRSCKEIKDECPSAFDGLYFLRTENGVIYQTFCDMTSGGGGWTLVASVHENDMRGKCTVGDRWSSQQGSKAVYPEGDGNWANYNTFGSAEAATSDDYKNPGYYDIQAKDLGIWHVPNKSPMQHWRNSSLLRYRTDTGFLQTLGHNLFGIYQKYPVKYGEGKCWTDNGPVIPVVYDFGDAQKTASYYSPYGQREFTAGFVQFRVFNNERAANALCAGMRVTGCNTEHHCIGGGGYFPEASPQQCGDFSGFDWSGYGTHVGYSSSREITEAAVLLFYR","Homo sapiens","ITLN1, INTL, ITLN, LFR, UNQ640/PRO1270","Intelectin-1","1","4WMY"
"4WN1",,"X-RAY DIFFRACTION",2.11,41.61,"VAPOR DIFFUSION, SITTING DROP",6,"bis-tris propane, magnesium sulfate, PEG3350",298,"10.1016/j.bmc.2014.11.039",,"4WN1",79.81,"3.13","3.13","Crystal structure of PDE10A in complex with 1-methyl-5-(1-methyl-3-{[4-(quinolin-2-yl)phenoxy]methyl}-1H-pyrazol-4-yl)pyridin-2(1H)-one","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4WN1"
"4WN5",,"X-RAY DIFFRACTION",1.92,36.06,"VAPOR DIFFUSION, SITTING DROP",5.9,"3% PEG 400, 1.95 M ammonium sulfate, 0.1 M sodium acetate",291,"10.1038/srep12698",,"4WN5",27.36,"1.15","1.15","Crystal structure of the C-terminal Per-Arnt-Sim (PASb) of human HIF-3alpha9 bound to 18:1-1-monoacylglycerol","GSHMGRGAFLSRHSLDMKFTYCDDRIAEVAGYSPDDLIGCSAYEYIHALDSDAVSKSIHTLLSKGQAVTGQYRFLARSGGYLWTQTQATVVSGGRGPQSESIVCVHFLISQVEET","Homo sapiens","HIF3A, BHLHE17, MOP7, PASD7","Hypoxia-inducible factor 3-alpha","1","4WN5"
"4WNC",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",5,"20% (w/v) PEG6000, 0.1 M sodium acetate, 0.01 M ZnCl2",298,"10.1074/jbc.M114.618165",,"4WNC",293.28,"1.99","1.99","Crystal structure of human wild-type GAPDH at 1.99 angstroms resolution","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","4WNC"
"4WNI",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, HANGING DROP",,"20% (w/v) PEG3350, 0.02 M ZnCl2",298,"10.1074/jbc.M114.618165",,"4WNI",146.7,"2.3","2.3","Crystal structure of the T229K mutant of human GAPDH at 2.3 angstroems resolution","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLKGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","4WNI"
"4WNJ",,"X-RAY DIFFRACTION",2.13,42,"VAPOR DIFFUSION, HANGING DROP",7,"Protein (5 mg/ml) in 20 mM sodium phosphate at pH 7. The reservoir solution  was 2.0 M ammonium sulfate, 0.1 M KCl, 0.05 M sodium phosphate, pH 7.0",298,"10.1107/S1399004715010585",,"4WNJ",28.01,"1.398","1.398","Crystal structure of Transthyretin-quercetin complex","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4WNJ"
"4WNM",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",,"100 mM MES pH 5.3, 150 mM Ammonium sulfate, and 22% PEG 3350",278,"10.1371/journal.pone.0145705","3RT","4WNM",35.42,"2.5","2.5","SYK catalytic domain in complex with a potent triazolopyridine inhibitor","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4WNM"
"4WNO",,"X-RAY DIFFRACTION",2,38.64,"VAPOR DIFFUSION, HANGING DROP",,"1.55 M sodium malonate pH 7.0,  0.35 M sodium malonate pH 5.0",298,"10.1021/cb500835z","3RF","4WNO",32.68,"1.56","1.56","Structure of ULK1 bound to an inhibitor","GGGSMEPGRGGTETVGKFEFSRKDLIGHGAFAVVFKGRHRAAHDLEVAVKCINKKNLAKSQTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMAATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFLDASPS","Homo sapiens","ULK1, KIAA0722","Serine/threonine-protein kinase ULK1","1","4WNO"
"4WNP",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, HANGING DROP",,"1.55 M sodium malonate pH 7.0,  0.35 M sodium malonate pH 5.0",298,"10.1021/cb500835z","3RJ","4WNP",131.05,"1.88","1.88","Structure of ULK1 bound to a potent inhibitor","GGGSMEPGRGGTETVGKFEFSRKDLIGHGAFAVVFKGRHRAAHDLEVAVKCINKKNLAKSQTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMAATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFLDASPS","Homo sapiens","ULK1, KIAA0722","Serine/threonine-protein kinase ULK1","1","4WNP"
"4WNQ",,"X-RAY DIFFRACTION",1.97,37.65,"VAPOR DIFFUSION, HANGING DROP",8.1,"27% PEG 1500, 0.1M Sodium Malonate-Imidazole-Borate (2:3:3 molar ratio)",293,"10.1084/jem.20141764",,"4WNQ",101.05,"1.8","1.8","THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION","HMAQKVTQAQSSVSMPVRKAVTLNCLYETSWWSYYIFWYKQLPSKEMIFLIRQGSDEQNAKSGRYSVNFKKAAKSVALTISALQLEDSAKYFCALGVTGKLTFGQGTILTVHPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"TCR Variable Delta 1 chain and TCR constant Alpha chain","1","4WNQ"
,,,,,,,,,,,,,,,,"HMGAVVSQHPSRVISKSGTSVKIECRSLDFQATTMFWYRQFPKQSLMLMATSNEGSKATYEQGVEKDKFLINHASLTLSTLTVTSAHPEDSSFYICSAPGGVGAFFGQGTRLTVVEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain","2","4WNQ"
"4WNS",,"X-RAY DIFFRACTION",2.13,42,"VAPOR DIFFUSION, HANGING DROP",7,"The protein (5 mg/ml) was in 20 mM sodium phosphate at pH 7. Reservoir solution: 2.0 M ammonium sulfate, 0.1 M KCl, 0.05 M sodium phosphate, pH 7.0",293,"10.1107/S1399004715010585",,"4WNS",28.24,"1.399","1.399","Crystal structure of Transthyretin complexed with pterostilbene","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4WNS"
"4WNT",,"X-RAY DIFFRACTION",3.24,62.06,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. Ajmalicine was added to the mother liquor after crystallization of the P450 2D6 thiordidazine complex.",298,"10.1074/jbc.M114.627661","AJN","4WNT",109.6,"2.6","2.6","Human Cytochrome P450 2D6 Ajmalicine Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4WNT"
"4WNU",,"X-RAY DIFFRACTION",3.21,61.72,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. Quinidine was added to the mother liquor after crystallization of the P450 2D6 thiordidazine complex.",298,"10.1074/jbc.M114.627661","QDN","4WNU",220.25,"2.26","2.26","Human Cytochrome P450 2D6 Quinidine Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4WNU"
"4WNV",,"X-RAY DIFFRACTION",3.22,61.81,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. Quinine was added to the mother liquor after crystallization of the P450 2D6 thiordidazine complex.",298,"10.1074/jbc.M114.627661","QI9","4WNV",219.83,"2.35","2.35","Human Cytochrome P450 2D6 Quinine Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4WNV"
"4WNW",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, HANGING DROP",,"PEG-3350,ammonium sulphate,sodium cacodylate,potassium phosphate,NaCl,glycerol,beta-mercaptoethanol,prinomastat,HEGA-10,CHAPS",298,"10.1074/jbc.M114.627661",,"4WNW",109.54,"3.299","3.299","Human Cytochrome P450 2D6 Thioridazine Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4WNW"
"4WO0",,"X-RAY DIFFRACTION",2.13,42,"VAPOR DIFFUSION, HANGING DROP",7,"The protein (5 mg/ml) was in 20 mM sodium phosphate at pH 7. The reservoir solution was 2.0 M ammonium sulfate, 0.1 M KCl, 0.05 M sodium phosphate, pH 7.0.",293,"10.1107/S1399004715010585","AGI","4WO0",28.1,"1.339","1.339","Crystal structure of transthyretin in complex with apigenin","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4WO0"
"4WO1",,"X-RAY DIFFRACTION",2.11,41.62,"LIPIDIC CUBIC PHASE",6.07,"0.1 M bis-tris propane chloride pH 6.07, 19.7 %w/v PEG 3350, 0.27 M calcium chloride",293,"10.1016/j.celrep.2015.04.045",,"4WO1",15.5,"2.14","2.14","Crystal structure of the DAP12 transmembrane domain in lipid cubic phase","CSTVSPGVLAGIVVGDLVLTVLIALAVYFLGRL","Homo sapiens","TYROBP, DAP12, KARAP","TYRO protein tyrosine kinase-binding protein","1","4WO1"
"4WO2",,"X-RAY DIFFRACTION",1.9,35.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"MPD, POTASSIUM CHLORIDE, MAGNESIUM
 CHLORIDE, POTASSIUM CACODYLATE, PH 6.5, VAPOR DIFFUSION, HANGING
 DROP, TEMPERATURE 283K",283,,,"4WO2",14.29,"1.82","1.82","CRYSTAL STRUCTURE OF HUMAN NATIVE CKIT PROTO-ONCOGENE PROMOTER QUADRUPLEX DNA","AGGGAGGGCGCTGGGAGGAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3')","1","4WO2"
"4WO3",,"X-RAY DIFFRACTION",1.87,34.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% MPD, 10 MM MAGNESIUM CHLORIDE, 50
 MM POTASSIUM CHLORIDE, AND 50 MM SODIUM CACODYLATE AT PH 6.5,
 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 283K",283,,,"4WO3",14.25,"2.73","2.73","THE SECOND C-KIT DNA QUADRUPLEX CRYSTAL STRUCTURE","AGGGAGGGCGCTGGGAGGAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3')","1","4WO3"
"4WO5",,"X-RAY DIFFRACTION",2.13,42.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, 0.2 M trimethylamine-N-oxide, 20% (w/v) PEG-MME 2,000",295,"10.1038/nsmb.2924","324","4WO5",69.06,"2.83","2.83","Crystal structure of a BRAF kinase domain monomer","MGSSHHHHHHSSGETVRFQGRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4WO5"
"4WOH",,"X-RAY DIFFRACTION",2.4,48.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"21 mg/mL protein incubated with 10 mM 4-ntirophenolphosphate well solution: 0.1M Tris pH 8.5, 0.2M magnesium chloride, 20% w/v polyethylene glycol 3350",293,"10.1107/S2053230X15000217",,"4WOH",18.94,"1.34","1.34","Structure of of human dual-specificity phosphatase 22 (E24A/K28A/K30A/C88S) complexed with 4-nitrophenolphosphate","GGPMGNGMNKILPGLYIGNFKDARDAAQLSANAVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHSLAGVSRSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPNVGFQRQLQEFEKHEVHQYRQWLKEEYGESPLQDAE","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","4WOH"
"4WOL",,"X-RAY DIFFRACTION",1.88,34.43,"LIPIDIC CUBIC PHASE",,"12.4% w/v PEG 3350, 0.149 M potassium thiocyanate",293,"10.1016/j.celrep.2015.04.045",,"4WOL",11.46,"1.77","1.77","Crystal Structure of the DAP12 transmembrane domain in lipidic cubic phase","CSTVSPGVLAGIVVGDLVLTVLIALAVYFLGRL","Homo sapiens","TYROBP, DAP12, KARAP","TYRO protein tyrosine kinase-binding protein","1","4WOL"
"4WOT",,"X-RAY DIFFRACTION",3.17,61.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"The purified protein was used in crystallisation trials employing
both, a standard screen with approximately 1200 different conditions,
as well as crystallisation conditions identified using literature
data. Conditions initially obtained have been optimised using standard
strategies, systematically varying parameters critically influencing
crystallisation, such as temperature, protein concentration,
drop ratio, and others. These conditions were also refined by systematically
varying pH or precipitant concentrations. The final selected condition included PEG, at pH 6.5. Crystals were rhombic in shape and grew over a period of one week to the final size",293,"10.1021/acs.jmedchem.5b00308","3SG","4WOT",183.95,"2.93","2.93","ROCK2 IN COMPLEX WITH 1426382-07-1","AGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","4WOT"
"4WOV",,"X-RAY DIFFRACTION",1.97,39.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG5000 (methyl ether), 200 mM ammonium sulfate and 100 mM sodium cacodylate buffer, pH 6.5",295,"10.1074/jbc.M114.619502","3SM","4WOV",72.24,"1.8","1.8","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH BMS-066 AKA 2-METHOXY-N-({6-[3-METHYL-7-(METHYLAMINO)-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0, 6]DODECA-1(9),2(6),4,7,11-PENTAEN-11-YL]PYRIDIN-2-YL}METHY L)ACETAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","4WOV"
"4WP0",,"X-RAY DIFFRACTION",2.02,39.18,"VAPOR DIFFUSION, HANGING DROP",7.3,"29% PEG 4000, 0.2 M sodium acetate, 0.1 M Tris",298,,,"4WP0",215.29,"3","3","Crystal structure of human kynurenine aminotransferase-I with a C-terminal V5-hexahistidine tag","MAKQLQARRLDGIDYNPWVEFVKLASEHDVVNLGQGFPDFPPPDFAVEAFQHAVSGDFMLNQYTKTFGYPPLTKILASFFGELLGQEIDPLRNVLVTVGGYGALFTAFQALVDEGDEVIIIEPFFDCYEPMTMMAGGRPVFVSLKPGPIQNGELGSSSNWQLDPMELAGKFTSRTKALVLNTPNNPLGKVFSREELELVASLCQQHDVVCITDEVYQWMVYDGHQHISIASLPGMWERTLTIGSAGKTFSATGWKVGWVLGPDHIMKHLRTVHQNSVFHCPTQSQAAVAESFEREQLLFRQPSSYFVQFPQAMQRCRDHMIRSLQSVGLKPIIPQGSYFLITDISDFKRKMPDLPGAVDEPYDRRFVKWMIKNKGLVAIPVSIFYSVPHQKHFDHYIRFCFVKDEATLQAMDEKLRKWKVELENLYFQGKGGRADPAFLYKVVRMNEDLGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","CCBL1, KYAT1","Kynurenine--oxoglutarate transaminase 1","1","4WP0"
"4WP7",,"X-RAY DIFFRACTION",2.25,45.42,"EVAPORATION",7,"PEG3350, sodium chloride, 100mM BisTris Buffer, ytterbium chloride, sitting drop
Ligand soak overnight",298,"10.1021/jm501900s","3SR","4WP7",55.72,"1.8","1.8","Structure of human ALDH1A1 with inhibitor CM026","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLSDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","4WP7"
"4WPN",,"X-RAY DIFFRACTION",2.26,45.46,"EVAPORATION",7,"PEG3350, sodium chloride, 100mM Bis Tris, ytterbium chloride, sitting drop, Ligand soak overnight",298,"10.1021/jm501900s","3ST","4WPN",55.77,"1.95","1.95","Structure of human ALDH1A1 with inhibitor CM053","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLNDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","4WPN"
"4WQ2",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",7,"3 UL PROTEIN (10 MG/ML PEF(S), 5 MM SODIUM CACODYLATE, 2 MM EDTA, 5 MM BME, 1 MM CALCIUM CHLORIDE, PH 7.0) + 3 UL PRECIPITANT (50 MM SODIUM CACODYLATE, 12.5% PEG6000, 20 MM CALCIUM CHLORIDE, PH 7.0) + 1 UL WATER",294,"10.1039/c5sc01158b","3SU","4WQ2",41.2,"1.64","1.64","Human calpain PEF(S) with (Z)-3-(6-bromondol-3-yl)-2-mercaptoacrylic acid bound","EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS","Homo sapiens","CAPNS1, CAPN4, CAPNS","Calpain small subunit 1","1","4WQ2"
"4WQ3",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, SITTING DROP",7,"3 UL PROTEIN (10 MG/ML PEF(S), 5 MM SODIUM CACODYLATE, 2 MM EDTA, 5 MM BME, 1 MM CALCIUM CHLORIDE, PH 7.0) + 3 UL PRECIPITANT (50 MM SODIUM CACODYLATE, 12.5% PEG6000, 20 MM CALCIUM CHLORIDE, PH 7.0) + 1 UL WATER",294,"10.1039/c5sc01158b","3SU","4WQ3",41.55,"1.79","1.79","Human calpain PEF(S) with (2Z,2Z')-2,2'-disulfanediylbis(3-(6-bromoindol-3-yl)acrylic acid) bound","EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIYKQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLTMYS","Homo sapiens","CAPNS1, CAPN4, CAPNS","Calpain small subunit 1","1","4WQ3"
"4WQ6",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION, HANGING DROP",,"crystals were grown from 0.2uL + 0.2uL drops containing 6mg/mL Nampt, 0.1M Sodium phosphate, 25-29% polyethylene glycol 3350, 0.2M NaCl, 1mM compound",292,"10.1016/j.bmcl.2014.12.026","3TQ","4WQ6",115.95,"1.72","1.72","The crystal structure of human Nicotinamide phosphoribosyltransferase (NAMPT) in complex with N-(4-{(S)-[1-(2-methylpropyl)piperidin-4-yl]sulfinyl}benzyl)furo[2,3-c]pyridine-2-carboxamide inhibitor (compound 21)","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","4WQ6"
"4WQN",,"X-RAY DIFFRACTION",2.81,56.18,"VAPOR DIFFUSION, HANGING DROP",4.3,"0.1M phosphate-citric pH 4.3, 0.2M Lithium Sulfate, 10% PEG8000",277,"10.1038/cr.2014.152",,"4WQN",40.19,"2.121","2.121","Crystal structure of N6-methyladenosine RNA reader YTHDF2","GSSEPHPVLEKLRSINNYNPKDFDWNLKHGRVFIIKSYSEDDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYNTCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQVLKIIASYKHTTSI","Homo sapiens","YTHDF2, HGRG8","YTH domain-containing family protein 2","1","4WQN"
"4WR7",,"X-RAY DIFFRACTION",2.36,47.5,"VAPOR DIFFUSION, SITTING DROP",8.4,"0.1M TrisHCl (pH 8.5), 0.2M sodium acetate (pH 8.3), 28% PEG3350",291,"10.1016/j.bpc.2015.05.009","3TV, ACT","4WR7",58.76,"1.5","1.5","Crystal structure of human carbonic anhydrase isozyme I with 2,3,5,6-Tetrafluoro-4-(propylthio)benzenesulfonamide.","MSPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","4WR7"
"4WR8",,"X-RAY DIFFRACTION",2.88,57.4,"VAPOR DIFFUSION, HANGING DROP",7,"2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol",293.15,"10.1021/ja512112j","3TX","4WR8",229.28,"2.6","2.6","Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4WR8"
"4WRB",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol",293.15,"10.1021/ja512112j","3TW","4WRB",38.7,"1.81","1.81","Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-190)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4WRB"
"4WRG",,"X-RAY DIFFRACTION",3.25,62.21,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M MES, 1 M sodium citrate",291,,,"4WRG",37.8,"1.9","1.9","1.9 angstrom structure of EGFR kinase domain","GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","4WRG"
"4WRH",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20% PEG 3350",291,,,"4WRH",39.26,"1.6","1.6","AKR1C3 complexed with breakdown product of N-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4H-1,2,4-triazol-4-yl)amino)methyl)-6-methoxyphenoxy)acetamide","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4WRH"
"4WRS",,"X-RAY DIFFRACTION",3.37,63.46,"VAPOR DIFFUSION, HANGING DROP",8,"1.0M LiCl, 0.1M TRIS, 20% PEG6K",277,"10.1016/j.bmcl.2014.12.068","3U1","4WRS",33.68,"2.2","2.2","Crystal structure of human Pim-1 kinase in complex with an azaspiro pyrazinyl-indazole inhibitor.","MAHHHHHHDEVDGPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4WRS"
"4WSQ",,"X-RAY DIFFRACTION",3.14,60.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.005M zinc acetate, 20% PEG3350",293,"10.1016/j.str.2015.12.015",,"4WSQ",72.88,"1.95","1.95","Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with small molecule inhibitor","GLGSGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGMKCALKRMFVNNEHDLQVCKREIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGSATNKFQNPQTEGVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPFGESQVAICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNSPIPAKLPEPVKASEAAAK","Homo sapiens","AAK1, KIAA1048","AP2-associated protein kinase 1","1","4WSQ"
"4WSY",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION, HANGING DROP",8,"1.0M LiCl, 0.1M TRIS, 20% PEG6K",277,"10.1016/j.bmcl.2014.12.091","3U5","4WSY",33.5,"2.3","2.3","Crystal structure of human Pim-1 kinase in complex with a thiazolamine-indazole inhibitor.","MAHHHHHHDEVDGPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4WSY"
"4WT2",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",5,"1.4M Ammonium Sulfate, 0.1M Sodium Citrate",277,"10.1021/jm501550p","3UD","4WT2",12.98,"1.42","1.42","Co-crystal Structure of MDM2 in Complex with AM-7209","MSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","4WT2"
"4WT6",,"X-RAY DIFFRACTION",3.4,63.83,"VAPOR DIFFUSION, HANGING DROP",8,"1.0M LiCl, 0.1M TRIS, 20% PEG6K",277,"10.1016/j.bmcl.2014.12.091","3U6","4WT6",33.53,"2.3","2.3","Crystal structure of human Pim-1 kinase in complex with a thiadiazolamine-indole inhibitor.","MAHHHHHHDEVDGPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4WT6"
"4WTU",,"X-RAY DIFFRACTION",2.81,56.27,"VAPOR DIFFUSION, HANGING DROP",6.6,"21% PEG 5000 MME, 190 mM sodium citrate, 200 mM ammonium iodide",298,"10.1021/ml500458t","3UT","4WTU",46.96,"1.85","1.85","Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4WTU"
"4WTW",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Tris-HCl, 12.5% glycerol, 36% PEG 600, 0.5 M (NH4)2SO4",277,"10.1107/S1399004715002485",,"4WTW",22.17,"1.606","1.606","Crystal structure of the third FnIII domain of integrin beta4","GSHMVPDTPTRLVFSALGPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITI","Homo sapiens","ITGB4","Integrin beta-4","1","4WTW"
"4WTX",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Sodium Acetate (pH 4.2), 0.7 M NaH2PO4, 1.05 M K2HPO4, 2 mM DTT",277,"10.1107/S1399004715002485",,"4WTX",10.6,"1.5","1.5","Crystal structure of the fourth FnIII domain of integrin beta4","GSHMSAPGPLVFTALSPDSLQLSWERPRRPNGDIVGYLVTCEMAQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQARTTEGFGPEREGIITIES","Homo sapiens","ITGB4","Integrin beta-4","1","4WTX"
"4WUA",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M sodium citrate, 0.2M ammonium acetate, 5%PEG6000",293,"10.1124/mol.114.097345","3UL","4WUA",46.18,"2","2","Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340","GSHMPEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS","Homo sapiens","SRPK1","SRSF protein kinase 1, linker, SRSF protein kinase 1","1","4WUA"
"4WUK",,"X-RAY DIFFRACTION",2.6,52.6,"VAPOR DIFFUSION, SITTING DROP",10,"1.8 M ammonium sulfate, 0.1 M CHES",293,"10.1107/S2053230X14027599",,"4WUK",48.54,"1.7","1.7","Crystal structure of apo CH65 Fab","EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYHINWVRQAPGQGLEWMGWIHPNSGDTNYAQKFQGWVTMTRDTAISTAYMEVNGLKSDDTAVYYCARGGLEPRSVDYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"CH65 heavy chain","1","4WUK"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSVAPGQTARITCGGNDIGRKSVHWNQQKPGQAPVLVVCYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVIFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH65 light chain","2","4WUK"
"4WUN",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,"10.1107/S1399004714027539",,"4WUN",71.63,"1.65","1.65","Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","4WUN"
"4WUP",,"X-RAY DIFFRACTION",2.37,47.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"Crystallization buffer: 0.1M TrisHCl (pH 8.5), 
0.2M ammonium acetate and 24% of PEG4000",291,"10.1016/j.bpc.2015.05.009","ACT, 3UF","4WUP",58.43,"1.75","1.75","Crystal structure of human carbonic anhydrase isozyme I with 4-[(2-Hydroxyethyl)thio]benzenesulfonamide","MSPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","4WUP"
"4WUQ",,"X-RAY DIFFRACTION",2.36,47.5,"VAPOR DIFFUSION, SITTING DROP",8.4,"Crystallization buffer: 0.1M TrisHCl (pH 8.5), 
0.2M sodium acetate (pH 8.3), 28% of PEG3350.",291,"10.1016/j.bpc.2015.05.009","3UG","4WUQ",58.53,"1.75","1.75","Crystal structure of human carbonic anhydrase isozyme I with 2,3,5,6-Tetrafluoro-4-piperidin-1-ylbenzenesulfonamide","MSPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","4WUQ"
"4WUY",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",9,"100 mM Tris HCl pH 8.6, 14% PEG 20K and 200 mM Sodium Chloride",281,"10.1074/jbc.M114.626861","3UJ, SAH","4WUY",52.27,"1.63","1.63","Crystal Structure of Protein Lysine Methyltransferase SMYD2 in complex with LLY-507, a Cell-Active, Potent and Selective Inhibitor","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESHEGHHHHHH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","4WUY"
"4WV5",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, SITTING DROP",8,"11 mg/ml protein in 25mM Tris-HCl, 150 mM NaCl, 1 mM TCEP was mixed 1:1 with reservior solution containing 0.1 M Sodium Acetate, pH 4.5, 2M Ammonium Sulfate",294,"10.1016/j.chembiol.2014.11.007",,"4WV5",33.06,"2.04","2.04","HEAT SHOCK PROTEIN 70 SUBSTRATE BINDING DOMAIN","GSDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKNALE","Homo sapiens","HSPA1A, HSPA1, HSX70, HSPA1B, HSP72","Heat shock 70 kDa protein 1A/1B","1","4WV5"
"4WV7",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, SITTING DROP",8,"10 mg/ml covalently modified protein in 25 mM Tris-HCl, 50 mM NaCl, 1 mM TCEP was mixed 1:1 with reservior solution containing 0.1 M HEPES, pH 7.0, 70% 2-methyl-2,4-pentanediol",294,"10.1016/j.chembiol.2014.11.007",,"4WV7",33.64,"2.42","2.42","HEAT SHOCK PROTEIN 70 SUBSTRATE BINDING DOMAIN WITH COVALENTLY LINKED NOVOLACTONE","GSDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKNALE","Homo sapiens","HSPA1A, HSPA1, HSX70, HSPA1B, HSP72","Heat shock 70 kDa protein 1A/1B","1","4WV7"
"4WVL",,"X-RAY DIFFRACTION",4.37,71.87,"VAPOR DIFFUSION, SITTING DROP",4.9,"A 5-fold excess of 50 mM 5-iodotubercidin (in DMSO) was mixed with protein and crystallized by using the hanging-drop vapor diffusion method at 20 degree in conditions containing 1.8 M (NH4)2SO4, 0.1 M NaAc-pH4.9. Crystals were transferred into stabilization buffer (2.5 M (NH4)2SO4, 0.1 M NaAc-pH4.9, 0.5 M NaCl), incubated with 100 uM inhibitor.",293,"10.1021/cb500796d",,"4WVL",41.54,"2.41","2.41","Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacement","MGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQR","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","4WVL"
"4WVS",,"X-RAY DIFFRACTION",1.68,29.01,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were grown in 0.98 M Ammonium Sulfate and 0.1 M Ammonium Formate. Single crystals grew after streak seeding",291,"10.1021/jm501892g",,"4WVS",12.48,"2.09","2.09","Crystal structure of XIAP-BIR2 domain complexed with (S)-3-(4-methoxyphenyl)-2-((S)-2-((S)-1-((S)-2-((S)-2-(methylamino)propanamido)pent-4-ynoyl)pyrrolidine-2-carboxamido)-3-phenylpropanamido)propanoic acid","MGSSHHHHHHSSGETVRFQGHMRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVL","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4WVS"
,,,,,,,,,,,,,,,,"AXPFX",,,"3,11-DIFLUORO-6,8,13-TRIMETHYL-8H-QUINO[4,3,2-KL]ACRIDIN-13-IUM","2","4WVS"
"4WVT",,"X-RAY DIFFRACTION",1.67,28.73,"VAPOR DIFFUSION, HANGING DROP",,".98 M Ammonium Sulfate and .1M Ammonium Formate.  Single crystals formed after streak seeding.",291,"10.1021/jm501892g",,"4WVT",24.41,"1.96","1.96","Crystal structure of XIAP-BIR2 domain complexed with ligand bound","MGSSHHHHHHSSGETVRFQGHMRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVL","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4WVT"
,,,,,,,,,,,,,,,,"AFPFFX",,,"3,11-DIFLUORO-6,8,13-TRIMETHYL-8H-QUINO[4,3,2-KL]ACRIDIN-13-IUM","2","4WVT"
"4WVU",,"X-RAY DIFFRACTION",1.73,28.97,"VAPOR DIFFUSION, HANGING DROP",,".98 M AMMONIUM SULFATE and .1 M AMMONIUM FORMATE.  Grew single crystals after streak seeding.",291,"10.1021/jm501892g",,"4WVU",12.36,"2.02","2.02","CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND","MGSSHHHHHHSSGETVRFQGHMRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFACGGKLKNWEPGDRAWSEHRRHFPNCFFVL","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","4WVU"
,,,,,,,,,,,,,,,,"AVXFX",,,"3,11-DIFLUORO-6,8,13-TRIMETHYL-8H-QUINO[4,3,2-KL]ACRIDIN-13-IUM","2","4WVU"
"4WW6",,"X-RAY DIFFRACTION",2,38.2,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.25 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1016/j.bpc.2015.05.009","3TV","4WW6",30.5,"1.06","1.06","Crystal structure of human carbonic anhydrase isozyme II with 2,3,5,6-Tetrafluoro-4-(propylthio)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4WW6"
"4WW8",,"X-RAY DIFFRACTION",2.08,40.5,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer: 0.1M ammonium citrate (pH 7.0), 0.2M ammonium sulfate and 30% PEG4000.",291,"10.1016/j.bpc.2015.05.009","VD9","4WW8",121.66,"1.42","1.42","Crystal structure of human carbonic anhydrase isozyme XII with 4-Propylthiobenzenesulfonamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","4WW8"
"4WWN",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% PEG 3350, 100 mM Tris (pH 7.3), 245 mM ammonium sulfate, 1 mM dithiothreitol, 1 mM EDTA",298,"10.1021/jm501624r",,"4WWN",110.34,"2.7","2.7","Crystal structure of human PI3K-gamma in complex with (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine AMG319 inhibitor","SEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4WWN"
"4WWO",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% PEG 3350, 100 mM Tris (pH 7.3), 250 mM ammonium sulfate, 1 mM dithiothreitol",298,"10.1021/jm501624r","3VD","4WWO",110.57,"2.3","2.3","Crystal structure of human PI3K-gamma in complex with phenylquinoline inhibitor N-{(1S)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}-9H-purin-6-amine","SEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4WWO"
"4WWP",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",7.3,"21% PEG 3350, 100 mM Tris (pH 7.3), 250 mM ammonium sulfate, 1 mM dithiothreitol",298,"10.1021/jm501624r","3VE","4WWP",110.56,"2.4","2.4","Crystal structure of human PI3K-gamma in complex with pyridinylquinoline inhibitor N-{(1S)-1-[8-chloro-2-(2-methylpyridin-3-yl)quinolin-3-yl]ethyl}-9H-purin-6-amine","SEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4WWP"
"4WWQ",,"X-RAY DIFFRACTION",2.85,56.92,"VAPOR DIFFUSION, HANGING DROP",7,"1.1 M sodium malonate, 0.1 M HEPES pH 7.0, 0.5%(v/v) Jeffamine ED-2001",293,"10.1021/acs.jmedchem.5b00609",,"4WWQ",27.49,"1.8","1.8","Apo structure of the Grb7 SH2 domain","GSPASGTSLSAAIHRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSMDDGQTRFTDLLQLVEFHQLNRGILPCLLRHCCTRVAL","Homo sapiens","GRB7","Growth factor receptor-bound protein 7","1","4WWQ"
"4WXI",,"X-RAY DIFFRACTION",3.48,64.61,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 MM SODIUM ACETATE, PH 4.6, 26%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1016/j.bmcl.2014.12.050",,"4WXI",28.39,"2.6","2.6","FACTOR XIA IN COMPLEX WITH THE INHIBITOR trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl}-4-(aminomethyl)cyclohexanecarboxamide","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","COAGULATION FACTOR XI, LIGHT CHAIN","1","4WXI"
"4WXQ",,"X-RAY DIFFRACTION",2.09,41.09,"VAPOR DIFFUSION, HANGING DROP",,"Peg 3000
Peg 2000
MES pH 6.0",289.15,"10.1093/hmg/ddu730",,"4WXQ",33.24,"2.15","2.15","Crystal Structure of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","4WXQ"
"4WXS",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, HANGING DROP",,"Peg 3000
CAPSO
Peg 400",289.15,"10.1093/hmg/ddu730",,"4WXS",32,"1.9","1.9","Crystal Structure of the E396D SNP Variant of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDDAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","4WXS"
"4WXU",,"X-RAY DIFFRACTION",2,38.38,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350
Bis-Tris pH 6
magnesium formate",289.15,"10.1093/hmg/ddu730",,"4WXU",32.51,"2.092","2.092","Crystal Structure of the Selenomthionine Incorporated Myocilin Olfactomedin Domain E396D Variant.","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDDAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","4WXU"
"4WXX",,"X-RAY DIFFRACTION",3.74,67.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"45% PEG200, 50 mM CaCl2, 0.1 mM MES",289,"10.1016/j.jmb.2015.06.001","SAH","4WXX",285.63,"2.622","2.622","The crystal structure of human DNMT1(351-1600)","SPKCIQCGQYLDDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYEALPQHKLTCFSVYCKHGHLCPIDTGLIEKNIELFFSGSAKPIYDDDPSLEGGVNGKNLGPINEWWITGFDGGEKALIGFSTSFAEYILMDPSPEYAPIFGLMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGLNLNRFTEDSLLRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQARRQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKRRRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLAEMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEDLYPEHYRKYSDYIKGSNLDAPEPYRIGRIKEIFCPKKSNGRPNETDIKIRVNKFYRPENTHKSTPASYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPECVQVYSMGGPNRFYFLEAYNAKSKSFEDPPNHARSPGNKGKGKGKGKGKPKSQACEPSEPEIEIKLPKLRTLDVFSGCGGLSEGFHQAGISDTLWAIEMWDPAAQAFRLNNPGSTVFTEDCNILLKLVMAGETTNSRGQRLPQKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFLLENVRNFVSFKRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEKLPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITVRDTMSDLPEVRNGASALEISYNGEPQSWFQRQLRGAQYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTMARKLRYTHHDRKNGRSSSGALRGVCSCVEAGKACDPAARQFNTLIPWCLPHTGNRHNHWAGLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTYRLFGNILDKHRQVGNAVPPPLAKAIGLEIKLCMLAKALTRVW","Homo sapiens","DNMT1, AIM, CXXC9, DNMT","DNA (cytosine-5)-methyltransferase 1","1","4WXX"
"4WY1",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 200;0.1 M sodium acetate, pH 5.2-5.4; protein buffer is NaBorate, pH 8.5",298,"10.1021/jm501833t","3VO","4WY1",45.44,"1.98","1.98","Crystal structure of human BACE-1 bound to Compound 24B","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4WY1"
"4WY6",,"X-RAY DIFFRACTION",2.81,56.23,"VAPOR DIFFUSION, SITTING DROP",6.9,"20% PEG5000MME 200 mM NaI, 200 mM NaCitrate, PH 6.9, BACE (8.3 mg/ml in 20 mM Tris, 250 mM NaCl, pH 7.5)",298,"10.1021/jm501833t","3VP","4WY6",47.7,"2.1","2.1","Crystal structure of human BACE-1 bound to Compound 36","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4WY6"
"4WYT",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"3.0 M sodium chloride, 0.1M Tris-Hcl",298,"10.1042/BJ20141473",,"4WYT",22.28,"2.6","2.6","Crystal Structure of Scribble PDZ34 tandem at 2.6 Angstroms","LAAALEGPYPVEEIRLPRAGGPLGLSIVGGSDHSSHPFGVQEPGVFISKVLPRGLAARSGLRVGDRILAVNGQDVRDATHQEAVSALLRPCLELSLLVRRDPAPPGLRELCIQKAPGERLGISIRGGARGHAGNPRDPTDEGIFISKVSPTGAAGRDGRLRVGLRLLEVNQQSLLGLTHGEAVQLLRSVGDTLTVLVCDGFEASTDAALEVS","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","Protein scribble homolog","1","4WYT"
"4WYV",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.05M MES, 0.2M KCL, 0.01M MGCL2, 5%
 PEG8000, PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.jmb.2014.11.013",,"4WYV",221,"3","3","Crystal Structure of Human Translin in Open Conformation","MRGSHHHHHHGSMSVSEIFVELQGFLAAEQDIREEIRKVVQSLEQTAREILTLLQGVHQGAGFQDIPKRCLKAREHFGTVKTHLTSLKTKFPAEQYYRFHEHWRFVLQRLVFLAAFVVYLETETLVTREAVTEILGIEPDREKGFHLDVEDYLSGVLILASELSRLSVNSVTAGDYSRPLHISTFINELDSGFRLLNLKNDSLRKRYDGLKYDVKKVEEVVYDLSIRGFNKETAAACVEK","Homo sapiens","TSN","Translin","1","4WYV"
"4WZ6",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Magnesium Chloride, 0.1M Tris-HCl pH8.5, 33% PEG 4000",283,"10.1002/pro.2821","ATP","4WZ6",32.92,"2.05","2.05","Human CFTR aa389-678 (NBD1), deltaF508 with three solubilizing mutations, bound ATP","STTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLSFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQNSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLRPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVS","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","4WZ6"
"4WZG",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG3350, MES, NACL, BME",293,"10.1080/15548627.2015.1076605",,"4WZG",25.11,"1.9","1.9","Structure of human ATG101","MNCRSEVLEVSVEGRQVEEAMLAVLHTVLLHRSTGKFHYKKEGTYSIGTVGTQDVDCDFIDFTYVRVSSEELDRALRKVVGEFKDALRNSGGDGLGQMSLEFYQKKKSRWPFSDECIPWEVWTVKVHVVALATEQERQICREKVGEKLCEKIINIVEVMNRHEYLPKMPTQSEVDNVFDTGLRDVQPYLYKISFQITDALGTSVTTTMRRLIKDTLAL","Homo sapiens","ATG101, C12orf44, PP894","Autophagy-related protein 101","1","4WZG"
"4WZI",,"X-RAY DIFFRACTION",2.6,52.66,"VAPOR DIFFUSION",7.5,"21% PEG 3350, 0.1 M potassium iodide, 0.1 M HEPES",298,"10.1073/pnas.1419906112",,"4WZI",150.13,"2.58","2.58","Crystal structure of crosslink stabilized long-form PDE4B","MAGLNDIFEAQKIEWHENLYFQGSDYKDDDDKDLVPRGSMATFPGHSQRREAFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWALDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRCGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTAIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHADIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHAADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMADKHTACVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDAQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLAVIDPENRDSLGETDIDIATEDKSPVDT","Homo sapiens","PDE4B, DPDE4","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","4WZI"
"4WZP",,"X-RAY DIFFRACTION",1.92,36,"VAPOR DIFFUSION, SITTING DROP",7.4,"30% (w/v) PEG 8000, 0.2 M ammonium sulfate",293,"10.15252/embj.201489847",,"4WZP",69.93,"1.9","1.9","Ser65 phosphorylated ubiquitin, major conformation","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","ubiquitin","1","4WZP"
"4WZR",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, HANGING DROP",,"20-25% PEG 3350, 0.2 M sodium malonate",293,"10.1073/pnas.1407634112",,"4WZR",119.51,"2.154","2.154","Crystal structure of human Puf-A","SRQLSDKTNYDIVVRAKQMWEILRRKDCDKEKRVKLMSDLQKLIQGKIKTIAFAHDSTRVIQCYIQYGNEEQRKQAFEELRDDLVELSKAKYSRNIVKKFLMYGSKPQIAEIIRSFKGHVRKMLRHAEASAIVEYAYNDKAILEQRNMLTEELYGNTFQLYKSADHPTLDKVLELQPEKLELIMDEMKQILTPMAQKEAVIKHSLVHKVFLDFFTYAPPKLRSEMIEAIREAVVYLAHTHDGARVAMHCLWHGTPKDRKVIVKTMKTYVEKVANGQYSHLVLLAAFDCIDDTKLVKQIIISEIISSLPSIVNDKYGRKVLLYLLSPRDPAHTVREIIEVLQKGDGNAHSKKDTEVRRRELLESISPALLSYLQEHAQEVVLDKSACVLVSDILGSATGDVQPTMNAIASLAATGLHPGGKDGELHIAEHPAGHLVLKWLIEQDKKMKENGREGCFAKTLVEHVGMKNLKSWASVNRGAIILSSLLQSCDLEVANKVKAALKSLIPTLEKTKSTSKGIEILLEKLST","Homo sapiens","KIAA0020, XTP5, PUM3, cPERP-C, PUF-A","Pumilio domain-containing protein KIAA0020","1","4WZR"
"4WZV",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, SITTING DROP",7.25,"protein: 5mg/mL hMMP9-WT with 120 milli-M acetohydroxamic acid. Reservoir: 
36% MPEG 5K, 90mM bicine, pH 7.25. Cryoprotectant: 40% MPEG 5K, 5% Di-ethyleneglycol, 10% AAB buffer, pH 8.0",293,"10.1021/acs.jmedchem.5b00367","E40","4WZV",38.44,"1.65","1.65","Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9,Matrix metalloproteinase-9","1","4WZV"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"4X08",,"X-RAY DIFFRACTION",1.98,38.01,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS GREW FROM A CRYSTALLISATION CONDITION BASED ON 0.2M LITHIUM SULPHATE, 0.1M TRIS BUFFER, pH8.5 AND 15% PEG4000",293,,,"4X08",32.95,"1.34","1.34","Structure of H128N/ECP mutant in complex with sulphate anions at 1.34 Angstroms.","MRPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVNLDTTI","Homo sapiens","RNASE3, ECP, RNS3","Eosinophil cationic protein","1","4X08"
"4X09",,"X-RAY DIFFRACTION",1.79,31.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M AMMONIUM SULPHATE, 0.1M SODIUM, CACODYLATE, 0.05M SODIUM CHLORIDE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293 K",293,"10.1042/BCJ20160245",,"4X09",15.28,"1.722","1.722","Structure of human RNase 6 in complex with sulphate anions","MWPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRRHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL","Homo sapiens","RNASE6, RNS6","Ribonuclease K6","1","4X09"
"4X0F",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION",7.5,"20% PEG 3350, 0.2M potassium iodide",293,"10.1073/pnas.1419906112",,"4X0F",150.63,"3.22","3.22","Crystal structure of crosslink stabilized long-form PDE4B in complex with (R)-(-)-rolipram","MAGLNDIFEAQKIEWHENLYFQGSDYKDDDDKDLVPRGSMATFPGHSQRREAFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWALDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRCGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTAIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHADIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHAADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMADKHTACVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQAMIPQAPAPPLDEQNRDAQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLAVIDPENRDSLGETDIDIATEDKSPVDT","Homo sapiens","PDE4B, DPDE4","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","4X0F"
"4X0K",,"X-RAY DIFFRACTION",2.33,47.16,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M HEPES (pH 7.5), 100 mM calcium acetate, 20-26% (w/v) PEG 8000, and 3% 1-propanol",298,"10.1107/S1399004715001856",,"4X0K",102.89,"2.04","2.04","Engineered Fab fragment specific for EYMPME (EE) peptide","QVQLQQSGPEDVKPGASVKISCKASGYSLSTSGMGVNWVKQSPGKGLEWLAHIYWDDDKRYNPSLKSRATLTVDKSSSTVYLELRSLTSEDSSVYYCARRGGSSHYYAMDYWGQGTTVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTGGGGDYKDDDDK","Homo sapiens",,"Fab fragment heavy chain","1","4X0K"
,,,,,,,,,,,,,,,,"KDIVMTQTPSSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGIYYCFQGSLVPPTFGAGTKLELKRGAAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECGGGGHHHHHHHHHH","Homo sapiens",,"Fab fragment light chain","2","4X0K"
"4X0M",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X0M",35.14,"1.68","1.68","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X0M"
"4X0R",,"X-RAY DIFFRACTION",6.32,80.53,"VAPOR DIFFUSION, HANGING DROP",,"0.1mol/L sodium acetate at pH 4.5 with 6% PEG 4000",291,"10.1016/j.bbrc.2014.11.058",,"4X0R",56.44,"2.905","2.905","Crystal structure of human MxB stalk domain","SQEADKMFFLIEKIKMFNQDIEKLVEGEEVVRENETRLYNKIREDFKNWVGILATNTQKVKNIIHEEVEKYEKQAAAAELLGFVNYKTFEIIVHQYIQQLVEPALSMLQKAMEIIQQAFINVAKKHFGEFFNLNQTVQSTIEDIKVKHTAKAENMIQLQFRMEQMVFKLNSHFPSNESSVSSFTEIGIHLNAYFLETSKRLANQIPFIIQYFMLRENGDSLQKAMMQILQEKNRYSWLL","Homo sapiens","MX2","Interferon-induced GTP-binding protein Mx2","1","4X0R"
"4X0T",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, SITTING DROP",,"The reservoir contained 0.1 M magnesium formate dihydrate, 15% w/v PEG 3350 and 0.1 M Hepes.  The enzyme stock solution included 3 mg/mL ALDH7A1, 200 micromolar 4-diethyaminobenzaldehyde and 5 mM NAD+.",293,"10.1021/cb500977q",,"4X0T",225.84,"2.4","2.4","Structure ALDH7A1 inactivated by 4-diethylaminobenzaldehyde and complexed with NAD+","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","4X0T"
"4X0U",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir contained 0.2 M MgCl2, 25% (w/v) PEG3350, 0.1 M Tris at pH of 8.2, 1% DMSO, 200 micromolar 4-diethylaminobenzaldehyde.  Protein stock solution contained 3 mg/mL ALDH7A1 and 200 micromolar DEAB.",293,"10.1021/cb500977q",,"4X0U",223.21,"1.95","1.95","Structure ALDH7A1 inactivated by 4-diethylaminobenzaldehyde","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","4X0U"
"4X1B",,"X-RAY DIFFRACTION",3.99,69.16,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M PIPES, 17% PEG3350, 18% Glycerol",298,"10.1039/c4cc09642h",,"4X1B",75.53,"2.45","2.45","Human serum transferrin with ferric ion bound at the C-lobe only","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","4X1B"
"4X1D",,"X-RAY DIFFRACTION",3.95,68.85,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M PIPES, 17% PEG3350, 18% Glycerol",298,"10.1039/c4cc09642h",,"4X1D",151.3,"2.8","2.8","Ytterbium-bound human serum transferrin","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","4X1D"
"4X1F",,"X-RAY DIFFRACTION",2.6,52.5,"VAPOR DIFFUSION, HANGING DROP",7.1,"100 mM NaCl, 100 mM Imidazole, 10% Isopropanol",291,"10.1038/ncomms9089","3WF","4X1F",36.81,"2","2","Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiol","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","4X1F"
"4X1G",,"X-RAY DIFFRACTION",2.6,52.5,"VAPOR DIFFUSION, HANGING DROP",7.1,"50 mM NaCl, 50 mM LiCl, 100 mM Imidazole, 10% Isopropanol",291,"10.1038/ncomms9089","3WF, 3WG","4X1G",37.2,"2.25","2.25","Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiol and the pesticide trans-nonachlor","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","4X1G"
"4X1J",,"X-RAY DIFFRACTION",2.55,56.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"12.5% w/v PEG 1000, 12.5% w/v  PEG 3350, 12.5% v/v MPD, 0.1 MES/imidazole (pH 6.5) and 0.02M of several amino acids (sodium L-glutamate, DL-alanine, glycine, DL-lysine HCl, DL-serine)",293,"10.1074/jbc.M114.628412",,"4X1J",25.75,"2.5","2.5","X-ray crystal structure of the dimeric BMP antagonist NBL1","AAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCFSYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPSHEGL","Homo sapiens","NBL1, DAN, DAND1","Neuroblastoma suppressor of tumorigenicity 1","1","4X1J"
"4X1L",,"X-RAY DIFFRACTION",2.03,39.32,"VAPOR DIFFUSION, HANGING DROP",6,"PFN1 crystals were grown by hanging drop vapor diffusion after mixing the PFN1 protein with a 1:1 ratio of reservoir solution at 298K for WT. Reservoir solution for WT contained 50 mM KH2PO4, 36% (wt/vol) PEG 8,000 and 100 mM MES pH 6.0.",298,"10.1073/pnas.1424108112",,"4X1L",15.17,"2.16","2.16","Structural basis for mutation-induced destabilization of Profilin 1 in ALS","MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKEGVHGGLINKKCYEMASHLRRSQY","Homo sapiens","PFN1","Profilin-1","1","4X1L"
"4X1M",,"X-RAY DIFFRACTION",2.02,39.08,"VAPOR DIFFUSION, HANGING DROP",6,"PFN1 crystals were grown by hanging drop vapor diffusion after mixing the PFN1 protein with a 1:1 ratio of reservoir solution at 298K for E117G. Reservoir solution for E117G contained 50 mM KH2PO4, 41% (wt/vol) PEG 8,000 and 100 mM MES",298,"10.1073/pnas.1424108112",,"4X1M",15,"2.17","2.17","Structural basis for mutation-induced destabilization of Profilin 1 in ALS","MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLMGKGGVHGGLINKKCYEMASHLRRSQY","Homo sapiens","PFN1","Profilin-1","1","4X1M"
"4X21",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION, SITTING DROP",7,"HEPES, sodium chloride, magnesium chloride, beta-mercaptoethanol
ethylene glycole, zwittergent 3-14, AMP-PCP
Bis-Tris, sodium chloride, PEG 3350, glycerole",292.15,"10.1021/jacs.5b07090","3WH","4X21",85.57,"1.95","1.95","The MAP kinase JNK3 as target for halogen bonding","GGSMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4X21"
"4X25",,"X-RAY DIFFRACTION",2.02,41.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"750 mM sodium citrate, 200 mM NaCl and 100 mM tris",291,"10.1073/pnas.1424108112",,"4X25",30.08,"2.23","2.23","Structural basis for mutation-induced destabilization of Profilin 1 in ALS","MAGWNAYIDNLMADGTCQDAAIVGYKDSPSVWAAVPGKTFVNITPAEVGVLVGKDRSSFYVNGLTLGGQKCSVIRDSLLQDGEFSMDLRTKSTGGAPTFNVTVTKTDKTLVLLTGKEGVHGGLINKKCYEMASHLRRSQY","Homo sapiens","PFN1","Profilin-1","1","4X25"
"4X2F",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X2F",35.23,"1.49","1.49","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X2F"
"4X2G",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X2G",35.35,"1.51","1.51","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X2G"
"4X2I",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, SITTING DROP",8.5,"BRD4-BD1 protein at 1mM, 2.682 M Formate, 10% Glycerol, 0.1 M Tris-HCL pH 8.5",277,"10.1021/ml500411h","3X0","4X2I",15.24,"1.2","1.2","Discovery of benzotriazolo diazepines as orally-active inhibitors of BET bromodomains: Crystal structure of BRD4 with CPI-13","GSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4X2I"
"4X2J",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X2J",35.23,"1.69","1.69","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X2J"
"4X2K",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X2K",35.23,"1.69","1.69","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X2K"
"4X2L",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, SITTING DROP",6.9,"20% PEG5000MME, 200 mM NaI, 200 mM NaCitrate, PH 6.9, BACE (8.3 mg/ml in 20 mM Tris, 250 mM NaCl, pH 7.5)",298,"10.1021/jm501833t","3WP","4X2L",47.42,"2.55","2.55","Crystal structure of human BACE-1 bound to Compound 6","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4X2L"
"4X2N",,"X-RAY DIFFRACTION",2.11,41.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 240 mM Li2SO4, 24% PEG 4000, pH 7.5",293,"10.1021/jm501597j",,"4X2N",34.98,"1.8","1.8","Selection of fragments for kinase inhibitor design: decoration is key","GTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","4X2N"
"4X2Q",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, HANGING DROP",8.5,"TCEP, HEPES, KCl, EDTA, PEG8000, imidazole",298,,,"4X2Q",224.74,"2.94","2.94","Crystal Structure of Human Aldehyde Dehydrogenase, ALDH1a2","HHHHHHASLHLLPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS","Homo sapiens","ALDH1A2, RALDH2","Retinal dehydrogenase 2","1","4X2Q"
"4X30",,"X-RAY DIFFRACTION",2.6,52.64,"EVAPORATION",7.4,"PEG3350, (NH4)2SO4, NaCl, Tris-HCl",293,,,"4X30",45.21,"1.55","1.55","Crystal structure of human Thyroxine-binding globulin complexed with thyroine at 1.55 Angstrom resolution","ASPEGKVTACHSSQPNATLYKMSSINADFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTEA","Homo sapiens","SERPINA7, TBG","Thyroxine-binding globulin","1","4X30"
"4X3J",,"X-RAY DIFFRACTION",2.36,47.99,"VAPOR DIFFUSION, HANGING DROP",7,"0.1	M Tris/HCl pH 7.0
0.05 M NaCl
0.03 M Lithiumsulfat",293,"10.1021/jm501597j",,"4X3J",37.25,"2.5","2.5","Selection of fragments for kinase inhibitor design: decoration is key","ALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEE","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","4X3J"
"4X3R",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, HANGING DROP",8,"33% pentaerythritol propoxylate
(Hampton Research), 1.5% PEG 3350 (Fluka),  100 mM Tris HCl",289.15,"10.1021/acs.jmedchem.5b00278","686","4X3R",87.65,"1.86","1.86","Avi-GCPII structure in complex with FITC-conjugated GCPII-specific inhibitor","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","4X3R"
"4X3V",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION",7.9,"0.1 M Tris-HCl pH 7.9, 0.2 M LiSO4, 19% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/acs.jmedchem.5b00929",,"4X3V",181.74,"3.7","3.7","Crystal structure of human ribonucleotide reductase 1 bound to inhibitor","MHVIKRDGRQERVMFDKITSRIQKLCYGLNMDFVDPAQITMKVIQGLYSGVTTVELDTLAAETAATLTTKHPDYAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRPAANPIQFTLNKEKLKDKEKVSKEEEEKERNTAAMVCSLENRDECLMCGS","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","4X3V"
"4X41",,"X-RAY DIFFRACTION",3.27,67.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"150mM D-glucose, 100mM HEPES/MOPS pH7.5, 40% Glycerol/PEG4000",298,"10.1021/acs.biochem.5b00995",,"4X41",83.61,"3.5","3.5","Crystal Structure of Protein Arginine Methyltransferase PRMT8","MHHHHHHSSGVDLGTENLYFQSNGMSKLLNPEEMTSRDYYFDSYAHFGIHEEMLKDEVRTLTYRNSMYHNKHVFKDKVVLDVGSGTGILSMFAAKAGAKKVFGIECSSISDYSQKIIKANHLDNIITIFKGKVEEVELPVEKVDIIISEWMGYCLFYESMLNTVIFARDKWLKPGGLMFPDRAALYVVAIEDRQYKDFKIHWWENVYGFDMTCIRDVAMKEPLVDIVDPKQVVTNACLIKEVDIYTVKTEELSFTSAFCLQIQRNDYVHALVTYFNIEFTKCHKKMGFSTAPDAPYTHWKQTVFYLEDYLTVRRGEEIYGTISMKPNAKNVRDLDFTVDLDFKGQLCETSVSNDYKMR","Homo sapiens","PRMT8, HRMT1L3, HRMT1L4","Protein arginine N-methyltransferase 8","1","4X41"
"4X44",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION, HANGING DROP",8.5,"25.5% PEG 4000, 85mM Tris pH 8.5, 170mM Sodium acetate, 15% Glycerol",291,,,"4X44",20.14,"2.0535","2.0535","Crystal Structure of Mutant R89Q of human Adenine phosphoribosyltransferase","MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKQGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","4X44"
"4X45",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"22,5% PEG 4000, 85mM Tris pH8.5, 170mM Sodium Acetate, 15% Glycerol",291,,,"4X45",39.43,"1.75","1.75","Crystal Structure of F173G Mutant of Human APRT","MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPGFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","4X45"
"4X4L",,"X-RAY DIFFRACTION",2.24,45.12,"EVAPORATION",7,"PEG3350, sodium chloride, 100mM Bis Tris Buffer, ytterbium chloride, sitting drop",298,"10.1021/jm501900s","3XG","4X4L",56.51,"1.85","1.85","Structure of human ALDH1A1 with inhibitor CM037","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLSDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","4X4L"
"4X4W",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M Ammonium Sulfate, 0.05M Na Citrate pH 5.5",290,"10.1016/j.cell.2015.01.005",,"4X4W",97.45,"1.9","1.9","Crystal structure of the full-length human mitochondrial CCA-adding enzyme","MFTMKLQSPEFQSLFTEGLKSLTELFVKENHELRIAGGAVRDLLNGVKPQDIDFATTATPTQMKEMFQSAGIRMINNRGEKHGTITARLHEENFEITTLRIDVTTDGRHAEVEFTTDWQKDAERRDLTINSMFLGFDGTLFDYFNGYEDLKNKKVRFVGHAKQRIQEDYLRILRYFRFYGRIVDKPGDHDPETLEAIAENAKGLAGISGERIWVELKKILVGNHVNHLIHLIYDLDVAPYIGLPANASLEEFDKVSKNVDGFSPKPVTLLASLFKVQDDVTKLDLRLKIAKEEKNLGLFIVKNRKDLIKATDSSDPLKPYQDFIIDSREPDATTRVCELLKYQGEHCLLKEMQQWSIPPFPVSGHDIRKVGISSGKEIGALLQQLREQWKKSGYQMEKDELLSYIKKTLEHHHHHH","Homo sapiens","TRNT1, CGI-47","CCA tRNA nucleotidyltransferase 1, mitochondrial","1","4X4W"
"4X4X",,"X-RAY DIFFRACTION",2.74,55,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5 M sodium formate, 100 mM sodium acetate (pH 4.5)",293,,,"4X4X",52.6,"2.25","2.25","Retrofitting antibodies with stabilizing mutations. Herceptin scFv mutant.","FASTEVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDVWGQGTLVTVSSGGGGSGGGGSGGGGST","Homo sapiens",,"Human Variable Heavy Chain of Herceptin","1","4X4X"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSADFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK","Homo sapiens",,"Human Variable Light Chain of Herceptin","2","4X4X"
"4X4Z",,"X-RAY DIFFRACTION",3.2,61,"VAPOR DIFFUSION, SITTING DROP",7,"1.1 M Sodium Malonate, 100 mM HEPES (pH 7.0), 1% (v/v) Jeffamine ED-2003",293,,,"4X4Z",23.35,"1.8","1.8","Retrofitting antibodies with stabilizing mutations. Herceptin VL mutant F53D.","DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASDLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK","Homo sapiens",,"Herceptin VL domain with F53D mutation","1","4X4Z"
"4X52",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION, SITTING DROP",6.4,"25% PEG3350, 0.4M Ammonium sulfate, 0.1M Bis-Tris, 10mM 3-Aminobenzamide",277,"10.1074/jbc.M114.630160",,"4X52",81.99,"2.08","2.08","Human PARP13 (ZC3HAV1), C-Terminal PARP Domain (H810N; N830Y variant)","SMKKYKLSEIHHLHPEYVRVSEHFKASMKNFKIEKIKKIENSELLDKFTWKKSQMKEEGKLLFYATSRAYVESICSNNFDSFLHETNENKYGKGIYFAKDAIYSHKYCPYDAKNVVMFVAQVLVGKFIEGNITYTSPPPQFDSCVDTRSNPSVFVIFQKDQVYPQYVIEYTED","Homo sapiens","ZC3HAV1, ZC3HDC2, PRO1677","Zinc finger CCCH-type antiviral protein 1","1","4X52"
"4X5O",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, HANGING DROP",7,"0.29 mM potassium sodium tartrate tetrahydrate, 18 % polyethylene glycol 3350",293,,,"4X5O",114.98,"2.8","2.8","Human histidine tRNA synthetase","MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPLCIC","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","4X5O"
"4X5Y",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen",283,"10.1016/j.ccell.2015.02.016","3XW","4X5Y",56.15,"1.59","1.59","Menin in complex with MI-503","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4X5Y"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"4X5Z",,"X-RAY DIFFRACTION",2.28,46.1,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen",283,"10.1016/j.ccell.2015.02.016","3XY","4X5Z",55.84,"1.86","1.86","menin in complex with MI-136","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","4X5Z"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"4X6H",,"X-RAY DIFFRACTION",1.86,33.85,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M Tri-Sodium Citrate, 2.4 M Ammonium Sulfate",295,"10.1021/acs.jmedchem.5b00746","I37","4X6H",24.74,"1","1","Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4X6H"
"4X6I",,"X-RAY DIFFRACTION",1.85,33.65,"VAPOR DIFFUSION, SITTING DROP",,"Lithium sulfate 0.2M,
Sodium acetate 0.1M,
Peg 8000 30%",295,"10.1021/acs.jmedchem.5b00746","3Y1","4X6I",24.38,"1.87","1.87","Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4X6I"
"4X6J",,"X-RAY DIFFRACTION",2.05,39.99,"VAPOR DIFFUSION, SITTING DROP",,"Potassium  chloride 0.2M,
HEPES 0.05M,
5/4 PO/OH 35%",295,"10.1021/acs.jmedchem.5b00746",,"4X6J",24.26,"1.59","1.59","Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","4X6J"
"4X6M",,"X-RAY DIFFRACTION",3.57,65.56,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 MM SODIUM ACETATE, PH 4.6, 26%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1016/j.bmcl.2015.01.028","3Y3","4X6M",28.8,"2.4","2.4","FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl}-3-[2-(aminomethyl)-5-chlorobenzyl]urea","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI, light chain","1","4X6M"
"4X6O",,"X-RAY DIFFRACTION",3.55,65.35,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 MM SODIUM ACETATE, PH 4.6, 26%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1016/j.bmcl.2015.01.028","3Y4","4X6O",28.96,"2.1","2.1","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (4-{4-chloro-2-[(1S)-1-({3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]propanoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI, light chain","1","4X6O"
"4X6P",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",5,"100 MM SODIUM CITRATE, PH 5.0, 36%(w/v) PEG4000",277,"10.1016/j.bmcl.2015.01.028","3YU","4X6P",56,"1.93","1.93","FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-amino-1H-indazol-6-yl)-1H-imidazol-2-yl]-2-phenylethyl}-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI, light chain","1","4X6P"
"4X6X",,"X-RAY DIFFRACTION",2.57,52.2,"VAPOR DIFFUSION, SITTING DROP",7.3,"20%(w/v) PEG8000, 200mM sodium iodide",277,"10.1016/j.bmcl.2015.02.076","S74","4X6X",78.26,"1.8","1.8","Human soluble epoxide hydrolase in complex with a three substituted cyclopropane derivative","MKKGHHHHHHTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4X6X"
"4X6Y",,"X-RAY DIFFRACTION",2.53,51.41,"VAPOR DIFFUSION, SITTING DROP",7.3,"20%(w/v) PEG8000, 200mM sodium iodide",277,"10.1016/j.bmcl.2015.02.076","S94","4X6Y",77.97,"2.1","2.1","Human soluble epoxide hydrolase in complex with a cyclopropyl urea derivative","MKKGHHHHHHTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4X6Y"
"4X7H",,"X-RAY DIFFRACTION",2.88,57.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"14% PEG 3350, 0.3M Sodium Sulfate, 0.1M BTP pH 6.5",277,"10.1021/jm5017494","3Z2","4X7H",37.58,"2","2","Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7H"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7I",,"X-RAY DIFFRACTION",2.59,52.47,"VAPOR DIFFUSION, HANGING DROP",,"PEG8000, sodium cacodylate, ammonium sulfate, pH 7.4",277,"10.1523/JNEUROSCI.4129-14.2015","3YS","4X7I",98.91,"1.77","1.77","Crystal Structure of BACE with amino thiazine inhibitor LY2886721","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4X7I"
"4X7J",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Na/K Tartrate",277,"10.1021/jm5017494","3Z1","4X7J",37.45,"2.3","2.3","Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7J"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7K",,"X-RAY DIFFRACTION",2.92,57.86,"VAPOR DIFFUSION, HANGING DROP",7,"0.18M Na/K Tartrate, 5% PEG-3350, 0.1M HEPES pH 7.0",277,"10.1021/jm5017494","3Z3","4X7K",37.62,"1.8","1.8","Co-crystal Structure of PERK bound to 4-{2-amino-3-[5-fluoro-2-(methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7K"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7L",,"X-RAY DIFFRACTION",2.93,58.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.18M Na/K Tartrate, 0.1M MES pH 6.5",277,"10.1021/jm5017494","3Z4","4X7L",37.6,"1.9","1.9","Co-crystal Structure of PERK bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7L"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7N",,"X-RAY DIFFRACTION",2.91,57.75,"VAPOR DIFFUSION, HANGING DROP",7,"0.4M Na/K Tartrate, 0.1M HEPES pH 7.0",277,"10.1021/jm5017494","3Z5","4X7N",37.49,"2.35","2.35","Co-crystal Structure of PERK bound to 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7N"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7O",,"X-RAY DIFFRACTION",3.59,65.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.15M NaCl, 0.1M MES pH 6.5, 12% PEG-3350",277,"10.1021/jm5017494",,"4X7O",37.3,"2.65","2.65","Co-crystal Structure of PERK bound to 1-[5-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone inhibitor","GSSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRNLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRS","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3","1","4X7O"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK3, PEK, PERK"
"4X7Q",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7,"Sodium Potassium Phosphate",298,"10.1016/j.bmcl.2014.12.041","3YR","4X7Q",69.53,"2.33","2.33","PIM2 kinase in complex with Compound 1s","SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP","Homo sapiens","PIM2","Serine/threonine-protein kinase pim-2","1","4X7Q"
"4X7T",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, SITTING DROP",,"HEPES, Polyvinyl Pyrrolidone K15, Lithium Sulphate",293,"10.1107/S2053230X15004100",,"4X7T",95.34,"3","3","Structure of Omalizumab Fab fragment, crystal form 2","EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Omalizumab-Fab Heavy chain","1","4X7T"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab-Fab Light chain","2","4X7T"
"4X8C",,"X-RAY DIFFRACTION",2.78,55.81,"VAPOR DIFFUSION",7.8,"100 mM imidazole, pH 7.8, 200 mM Li2SO4, 2 mM TCEP, 6-7.5% PEG 2K MME",293,"10.1038/nchembio.1735",,"4X8C",75.47,"3.1","3.1","Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with GSK147","GPLGSPEFMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHGPPAKKKSTGSSTWPLDPGVEVTLTMKVASGSTGDQKVQISYYGPKTPPVKALLYLTGVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHAGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","4X8C"
"4X8G",,"X-RAY DIFFRACTION",3.01,59.14,"VAPOR DIFFUSION",7.8,"100 mM imidazole, pH 7.8, 200 mM Li2SO4, 2 mM TCEP, 6-7.5% PEG 2K MME",293,"10.1038/nchembio.1735",,"4X8G",75.51,"3.29","3.29","Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with GSK199","GPLGSPEFMAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHGPPAKKKSTGSSTWPLDPGVEVTLTMKVASGSTGDQKVQISYYGPKTPPVKALLYLTGVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHAGTNVRRKPFSFKWWNMVP","Homo sapiens","PADI4, PADI5, PDI5, PAD4","Protein-arginine deiminase type-4","1","4X8G"
"4X8S",,"X-RAY DIFFRACTION",3.83,67.92,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/jm501982k","3Z7","4X8S",35.04,"2.1","2.1","FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4X8S"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4X8S"
"4X8T",,"X-RAY DIFFRACTION",3.53,65.19,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/jm501982k","3Z8","4X8T",34.74,"2.2","2.2","FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4X8T"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4X8T"
"4X8U",,"X-RAY DIFFRACTION",3.86,68.13,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/jm501982k","3ZB","4X8U",34.94,"2.1","2.1","FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4X8U"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4X8U"
"4X8V",,"X-RAY DIFFRACTION",3.87,68.2,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/jm501982k","3Z9","4X8V",35.31,"2.5","2.5","FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}carbamate)","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","4X8V"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","4X8V"
"4X8Y",,"X-RAY DIFFRACTION",3.72,66.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.26M ammonium sulfate, 0.1M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/ncomms11030",,"4X8Y",31.02,"1.95","1.95","Crystal structure of human PGRMC1 cytochrome b5-like domain","GPLGSPEFDFTPAELRRFDGVQDPRILMAINGKVFDVTKGRKFYGPEGPYGVFAGRDASRGLATFCLDKEALKDEYDDLSDLTAAQQETLSDWESQFTFKYHHVGKLLKEGEEPTVYSDEEEPKDESARKND","Homo sapiens","PGRMC1, HPR6.6, PGRMC","Membrane-associated progesterone receptor component 1","1","4X8Y"
"4X90",,"X-RAY DIFFRACTION",3.28,62.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 3.5% PEG 8000, 28% MPD, 300 mM (NH4)2HPO4",277,"10.1038/ncomms7250",,"4X90",179.15,"1.84","1.84","Crystal structure of Lysosomal Phospholipase A2","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X90"
"4X91",,"X-RAY DIFFRACTION",3.23,61.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 3.5% PEG 8000, 28% MPD, 300 mM (NH4)2HPO4",277,"10.1038/ncomms7250",,"4X91",179.92,"2.3","2.3","Crystal structure of Lysosomal Phospholipase A2 in complex with Isopropyl dodec-11-enylfluorophosphonate (IDFP)","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X91"
"4X92",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Na cacodylate pH 6.5, 10% PEG 8000, 200 mM Mg(CH3COO) in the presence of DOPC liposomes",277,"10.1038/ncomms7250",,"4X92",43.99,"3","3","Crystal structure of Lysosomal Phospholipase A2-S165A","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHAMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X92"
"4X93",,"X-RAY DIFFRACTION",4.01,69.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES pH 7.5, 30% PEG MME 550, 50 mM MgCl2",277,"10.1038/ncomms7250",,"4X93",88.96,"2.6","2.6","Crystal structure of Lysosomal Phospholipase A2 crystallized in the presence of methyl arachidonyl fluorophosphonate (tetragonal form)","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X93"
"4X94",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, HANGING DROP",3,"100 mM citric acid pH 3, 0.8 M ammonium sulfate ; crystallized in the presence of methyl arachidonyl fluorophosphonate",277,"10.1038/ncomms7250",,"4X94",44.72,"2.7","2.7","Crystal structure of Lysosomal Phospholipase A2 crystallized in the presence of methyl arachidonyl fluorophosphonate (hexagonal form)","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X94"
"4X95",,"X-RAY DIFFRACTION",3.7,66.77,"VAPOR DIFFUSION, HANGING DROP",3.5,"100 mM Na citrate pH 3.5-4, 20% PEG 3350, and 100 mM NaCl",297,"10.1038/ncomms7250",,"4X95",89.48,"3.08","3.08","Crystal structure of fully glycosylated Lysosomal Phospholipase A2 in complex with methyl arachidonyl fluorophosphonate (MAFP)","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X95"
"4X96",,"X-RAY DIFFRACTION",13.89,87,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na acetate pH 5.0, 13% isopropanol, and 200 mM CaCl2",277,"10.1038/ncomms7250",,"4X96",180.34,"8.69","8.69","Low resolution crystal structure of Lecithin:Cholesterol Acyltransferase (LCAT; residues 21-397)","HTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAHHHHHH","Homo sapiens","LCAT","Phosphatidylcholine-sterol acyltransferase","1","4X96"
"4X97",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 3.5% PEG 8000, 28% MPD, 300 mM (NH4)2HPO4",277,"10.1038/ncomms7250",,"4X97",178.87,"2.65","2.65","Crystal structure of Lysosomal Phospholipase A2 in complex with methyl arachidonyl fluorophosphonate (MAFP)","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","4X97"
"4X98",,"X-RAY DIFFRACTION",3.81,67.71,"VAPOR DIFFUSION, HANGING DROP",4.5,"3M NaCl, 0.1M sodium acetate, pH 4.5",293,"10.1016/j.molimm.2015.02.017",,"4X98",51.34,"2.499","2.499","Immunoglobulin Fc heterodimer variant","TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTENQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSWLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4X98"
,,,,,,,,,,,,,,,,"PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPRVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLVSDGSFTLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","2","4X98"
"4X99",,"X-RAY DIFFRACTION",3.69,66.68,"VAPOR DIFFUSION, HANGING DROP",4.5,"3M NaCl, 0.1M sodium acetate, pH 4.5",293,"10.1016/j.molimm.2015.02.017",,"4X99",53.1,"2.498","2.498","Immunoglobulin Fc heterodimers variant","TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVCTLPPSRDELTENQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSWLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","4X99"
,,,,,,,,,,,,,,,,"TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPRVYTLPPCRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLVSDGSFTLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","2","4X99"
"4X9Y",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"58% MPD, 100 mM sodium cacodylate, Quercitrin was added to saturating conditions into the crystal droplet.",293,,,"4X9Y",56.01,"1.07","1.07","Wild-Type Human Pancreatic Alpha-Amylase at True Atomic Resolution (1.07 A)","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","4X9Y"
"4XAO",,"X-RAY DIFFRACTION",2.63,53,"VAPOR DIFFUSION, HANGING DROP",7.1,"100 mM Imidazole, 10% Isopropanol",291,"10.1038/ncomms9089",,"4XAO",36.46,"2.58","2.58","Crystal structure of the hPXR-LBD obtained in presence of the pesticide trans-nonachlor","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","4XAO"
"4XAQ",,"X-RAY DIFFRACTION",2.75,55.2,"VAPOR DIFFUSION",,"100mM MES pH 6 + 25% PEG 4K + 200mM Ammonium Sulfate",295,"10.1021/jm501612y","40F","4XAQ",112.09,"2.21","2.21","mGluR2 ECD and mGluR3 ECD with ligands","MALGSLLALLALLLLWGAVAEGPAKKVLTLEGDLVLGGLFPVHQKGGPAEDCGPVNEHRGIQRLEAMLFALDRINRDPHLLPGVRLGAHILDSCSKDTHALEQALDFVRASLSRGADGSRHICPDGSYATHGDAPTAITGVIGGSYSDVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFFQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFELEARARNISVATSEKVGRAMSRAAFEGVVRALLQKPSARVAVLFTRSEDARELLAASQRLNASFTWVASDGWGALEEVVAGSEGAAEGAITIELASYPISDFASYFQSLDPWNNSRNPWFREFWEQRFRCSFRQRDCAAHSLRAVPFEQESKIMFVVNAVYAMAHALHNMHRALCPNTTRLCDAMRPVNGRRLYKDFVLNVKFDAPFRPADTHNEVRFDRFGDGIGRYNIFTYLRAGSGRYRYQKVGYWAEGLTLDTSLIPWASPSAGEGHHHHHH","Homo sapiens","GRM2, GPRC1B, MGLUR2","Metabotropic glutamate receptor 2","1","4XAQ"
"4XAR",,"X-RAY DIFFRACTION",2.47,50.15,"VAPOR DIFFUSION",,"20% PEG 3350, 200mM Ammonium Iodide",295,"10.1021/jm501612y","40F","4XAR",59.98,"2.26","2.26","mGluR2 ECD and mGluR3 ECD complex with ligands","MALKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNISIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSEGHHHHHH","Homo sapiens","GRM3, GPRC1C, MGLUR3","Metabotropic glutamate receptor 3","1","4XAR"
"4XAS",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION",,"100mM Sodium Acetate pH 4.6 + 23% PEG 10K",295,"10.1021/jm501612y","40H","4XAS",111.85,"2.35","2.35","mGluR2 ECD ligand complex","MALGSLLALLALLLLWGAVAEGPAKKVLTLEGDLVLGGLFPVHQKGGPAEDCGPVNEHRGIQRLEAMLFALDRINRDPHLLPGVRLGAHILDSCSKDTHALEQALDFVRASLSRGADGSRHICPDGSYATHGDAPTAITGVIGGSYSDVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFFQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFELEARARNISVATSEKVGRAMSRAAFEGVVRALLQKPSARVAVLFTRSEDARELLAASQRLNASFTWVASDGWGALEEVVAGSEGAAEGAITIELASYPISDFASYFQSLDPWNNSRNPWFREFWEQRFRCSFRQRDCAAHSLRAVPFEQESKIMFVVNAVYAMAHALHNMHRALCPNTTRLCDAMRPVNGRRLYKDFVLNVKFDAPFRPADTHNEVRFDRFGDGIGRYNIFTYLRAGSGRYRYQKVGYWAEGLTLDTSLIPWASPSAGEGHHHHHH","Homo sapiens","GRM2, GPRC1B, MGLUR2","Metabotropic glutamate receptor 2","1","4XAS"
"4XAT",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, SITTING DROP",,"Hepes pH 7.5
PEG 400
PEG 3000
Glycerol",289.15,"10.1371/journal.pone.0130888",,"4XAT",30.94,"2.113","2.113","Crystal structure of the olfactomedin domain from noelin/pancortin/olfactomedin-1","LRAGMQKLACGKLTGISDPVTVKTSGSRFGSWMTDPLAPEGDNRVWYMDGYHNNRFVREYKSMVDFMNTDNFTSHRLPHPWSGTGQVVYNGSIYFNKFQSHIIIRFDLKTETILKTRSLDYAGYNNMYHYAWGGHSDIDLMVDESGLWAVYATNQNAGNIVVSRLDPVSLQTLQTWNTSYPKRSAGEAFIICGTLYVTNGYSGGTKVHYAYQTNASTYEYIDIPFQNKYSHISMLDYNPKDRALYAWNNGHQILYNVTLFHVIRSDEL","Homo sapiens","OLFM1, NOE1, NOEL1","Noelin","1","4XAT"
"4XB0",,"X-RAY DIFFRACTION",3,59.03,"VAPOR DIFFUSION, SITTING DROP",,"1.26 M sodium phosphate, 0.14 M potassium phosphate",291,"10.1002/prot.24804",,"4XB0",50.49,"2.701","2.701","Structure of the Plk2 polo-box domain","MGSVADTVARVLRGCLENMPEADCIPKEQLSTSFQWVTKWVDYSNKYGFGYQLSDHTVGVLFNNGAHMSLLPDKKTVHYYAELGQCSVFPATDAPEQFISQVTVLKYFSHYMEENLMDGGDLPSVTDIRRPRLYLLQWLKSDKALMMLFNDGTFQVNFYHDHTKIIICSQNEEYLLTYINEDRISTTFRLTTLLMSGCSSELKNRMEYALNMLLQRCN","Homo sapiens","PLK2, SNK","Serine/threonine-protein kinase PLK2","1","4XB0"
"4XBG",,"X-RAY DIFFRACTION",2.72,54.4,"VAPOR DIFFUSION",,"Reservoir: 0.2 M potassium formate, 35% PEG 3350",293,"10.1016/j.immuni.2015.12.001",,"4XBG",287.13,"2.73","2.73","Crystal structure of human 4E10 Fab in complex with phosphatidic acid (06:0 PA): 2.73 A resolution","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 Fab light chain","1","4XBG"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab heavy chain","2","4XBG"
"4XBL",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 0.2M Lithium Sulfate, 30% (w/v) PEG3350, TEMPERATURE 298 K",298,"10.1371/journal.pone.0125946",,"4XBL",34.83,"1.931","1.931","Crystal Structure of Human Galectin-1 in Complex with Type 1 N-acetyllactosamine","GSSHHHHHHSSGLVPRGSHMACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4XBL"
"4XBM",,"X-RAY DIFFRACTION",3.77,67.39,"VAPOR DIFFUSION, HANGING DROP",,"0.4M potassium thiocyanate
16% PEG3350
0.1M Bis-tris propane pH 7.5
5mM CaCl2",293,"10.1042/BJ20150010",,"4XBM",115.03,"3.2","3.2","X-ray crystal structure of Notch ligand Delta-like 1","SSGVFELKLQEFVNKKGLLGNRNCCRGGAGPPPCACRTFFRVCLKHYQASVSPEPPCTYGSAVTPVLGVDSFSLPDGGGADSAFSNPIRFPFGFTWPGTFSLIIEALHTDSPDDLATENPERLISRLATQRHLTVGEEWSQDLHSSGRTDLKYSYRFVCDEHYYGEGCSVFCRPRDDAFGHFTCGERGEKVCNPGWKGPYCTEPICLPGCDEQHGFCDKPGECKCRVGWQGRYCDECIRYPGCLHGTCQQPWQCNCQEGWGGLFCNQDLNYCTHHKPCKNGATCTNTGQGSYTCSCRPGYTGATCELGIDECDPSPCKNGGSCTDLENSYSCTCPPGFYGKICELSAMTCADGPCFNGGRCSDSPDGGYSCRCPVGYSGFNCEKKIDYCSSSPCSNGAKCVDLGDAYLCRCQAGFSGRHCDDNVDDCASSPCANGGTCRDGVNDFSCTCPPGYTGRNCSAPVSRCEHAPCHNGATCHQRGHGYVCECARSYGGPNCQFLLPELPPGPAVVDLTEKLEGQGGPFPWENLYFQ","Homo sapiens","DLL1, UNQ146/PRO172","Delta-like protein 1","1","4XBM"
"4XBN",,"X-RAY DIFFRACTION",1.89,34.92,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH8.5, 0.2M Magnesium Chloride, 30% (w/v) PEG 4000, temperature 298K",298,"10.1371/journal.pone.0125946",,"4XBN",18.26,"2.208","2.208","Crystal Structure of Human Galectin-3 CRD in Complex with Type 1 N-acetyllactosamine","GSSHHHHHHSSGLVPRGSHMPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","4XBN"
"4XBP",,"X-RAY DIFFRACTION",2.29,47.9,"VAPOR DIFFUSION",8.5,"Sitting drops contain 4E10 Fab at 10 mg/ml, 10 mM Phosphatidylethanolamine (06:0 PE) sample stock mixed (1:1 ratio) with reservoir solution of 20% PEG 6000, 0.1M Tris, pH 8.5",293,"10.1016/j.immuni.2015.12.001",,"4XBP",190.4,"2.94","2.94","Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylethanolamine (06:0 PE)","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 FAB LIGHT CHAIN","1","4XBP"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab heavy chain","2","4XBP"
"4XBQ",,"X-RAY DIFFRACTION",1.66,25.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5, 0.2M Lithium Sulfate, 0.1M Sodium Acetate, 25% (w/v) PEG 4000, temperature 298K",298,"10.1371/journal.pone.0125946",,"4XBQ",35.04,"2.234","2.234","Crystal Structure of Human Galectin-7 in Complex with Type 1 N-acetyllactosamine","GSSHHHHHHSSGLVPRGSHMSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","4XBQ"
"4XC4",,"X-RAY DIFFRACTION",1.87,34.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.3M MAGNESIUM SULFATE, 0.1M MES",298,,,"4XC4",11.86,"1.499","1.499","Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","4XC4"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","4XC4"
"4XCC",,"X-RAY DIFFRACTION",2.96,58,"VAPOR DIFFUSION",7,"Sitting drops contain 4E10 Fab at 10 mg/ml, 10 mM Phosphatidylcholine (06:0 PC) sample mixed (1:1 v/v) with a reservoir solution of 0.2 M di-sodium tartrate, 20% PEG 3350",293,"10.1016/j.immuni.2015.12.001",,"4XCC",47.67,"2.81","2.81","Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylcholine (06:0 PC); I422 space group","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 Fab light chain","1","4XCC"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab Heavy chain","2","4XCC"
"4XCE",,"X-RAY DIFFRACTION",2.94,57.8,"VAPOR DIFFUSION",6.5,"Sitting drops contain 4E10 Fab at 10 mg/ml, 10 mM Phosphatidylcholine (06:0 PC) sample mixed (1:1 v/v) with reservoir solution of 0.2 M potassium sodium tartrate, 20% PEG3350",293,"10.1016/j.immuni.2015.12.001",,"4XCE",142.73,"2.93","2.93","Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylcholine (06:0 PC); C2 space group","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 Fab light chain","1","4XCE"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab heavy chain","2","4XCE"
"4XCN",,"X-RAY DIFFRACTION",2.72,54.7,"VAPOR DIFFUSION",6.5,"Drop contains 10 mg/ml 4E10 Fab, 10 mM 06:0 PA mixed 1:1 v/v with a reservoir solution of 0.2 M potassium formate, 20% PEG 3350",293,"10.1016/j.immuni.2015.12.001",,"4XCN",286.57,"2.9","2.9","Crystal structure of human 4E10 Fab in complex with phosphatidic acid (06:0 PA); 2.9 A resolution","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 Fab light chain","1","4XCN"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab heavy chain","2","4XCN"
"4XCR",,"X-RAY DIFFRACTION",2.31,46.86,"EVAPORATION",5.5,"0.1 M Bis Tris  and 2.0 M ammonium sulfate",293,"10.1073/pnas.1511308112",,"4XCR",21.9,"3.602","3.602","Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant I35A","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSAKGLTEGLHGFHVHGAGGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKAGAGAGSRLASGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","4XCR"
"4XCS",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, HANGING DROP",8,"100mM imidazole, 0.8M potassium sodium tartrate, 200mM sodium chloride, pH 8.0, Temperature 295K",295,,,"4XCS",147.89,"2.1","2.1","Human peroxiredoxin-1 C83S mutant","MGSSHHHHHHSSGLVPRGSHMSSGNAKIGHPAPNFKATAVMPDGQFKDISLSDYKGKYVVFFFYPLDFTFVCPTEIIAFSDRAEEFKKLNCQVIGASVDSHFSHLAWVNTPKKQGGLGPMNIPLVSDPKRTIAQDYGVLKADEGISFRGLFIIDDKGILRQITVNDLPVGRSVDETLRLVQAFQFTDKHGEVCPAGWKPGSDTIKPDVQKSKEYFSKQK","Homo sapiens","PRDX1, PAGA, PAGB, TDPX2","Peroxiredoxin-1","1","4XCS"
"4XCT",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"protein: hMMP-9-WT at 337 micro-M with 120 milli-M acetohydroxamic acid. 
precipitant: 40.5% MPEG 5,000, 180 mM imidazole piperidine, pH 8.5.
Cryoprotectant: 40% CryoProtX-C1, 10% PEG 10K, 10% PCTP 50/50",293,"10.1021/acs.jmedchem.5b00367","N73","4XCT",18.97,"1.3","1.3","Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9 catalytic domain.","DLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9,Matrix metalloproteinase-9","1","4XCT"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"4XCU",,"X-RAY DIFFRACTION",2.03,39.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"16% PEG 3350, 0.2M lithium sulfate, 0.1M bis-tris pH 4.5",277,"10.1158/2159-8290.CD-14-1029",,"4XCU",34.47,"1.71","1.71","Crystal Structure of FGFR4 with an Irreversible Inhibitor","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","4XCU"
"4XCX",,"X-RAY DIFFRACTION",5.21,76.38,"VAPOR DIFFUSION, SITTING DROP",8.6,"2.4 M NACL, 0.1 M TRIS-HCL, PH 8.6,4% 1,3-PROPANEDIOL",293,,,"4XCX",28.73,"2.84","2.84","METHYLTRANSFERASE DOMAIN OF SMALL RNA 2'-O-METHYLTRANSFERASE","GNFEEVPRETAIQFKPPLYRQRYQFVKNLVDQHEPKKVADLGCGDTSLLRLLKVNPCIELLVGVDINEDKLRWRGDSLAPFLGDFLKPRDLNLTITLYHGSVVERDSRLLGFDLITCIELIEHLDSGDLARFPEVVFGYLSPSMIVISTPNSEFNPLFPSVTLRDSDHKFEWTRMEFQTWALYVANRYDYSVEFTGVGEPPAGAENVGYCTQIGIFRKNGGKATESCLSEQHDQHVYKAVFTTSYPSLQ","Homo sapiens","HENMT1, C1orf59","Small RNA 2'-O-methyltransferase","1","4XCX"
"4XCY",,"X-RAY DIFFRACTION",2.79,55.6,"VAPOR DIFFUSION",6,"DROP CONTAINS 10 MG/ML 4E10 FAB, 10 MM PHOSPHATIDYLGLYCEROL (06:0 PG) MIXED 1:1 V/V WITH RESERVOIR SOLUTION OF 0.2 M SODIUM IODIDE, 20% PEG 3350, PH 6.0, VAPOR DIFFUSION, TEMPERATURE 293K",293,"10.1016/j.immuni.2015.12.001",,"4XCY",286.43,"3.96","3.96","Crystal structure of human 4E10 Fab in complex with phosphatidylglycerol (06:0 PG)","EIVLTQSPGTQSLSPGERATLSCRASQSVGNNKLAWYQQRPGQAPRLLIYGASSRPSGVADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGQSLSTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4E10 Fab light chain","1","4XCY"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKRPGSSVTVSCKASGGSFSTYALSWVRQAPGRGLEWMGGVIPLLTITNYAPRFQGRITITADRSTSTAYLELNSLRPEDTAVYYCAREGTTGWGWLGKPIGAFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"4E10 Fab heavy chain","2","4XCY"
"4XDE",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, SITTING DROP",,"1.2 M Ammonium sulphate, 0.05 M tri-sodium citrate, 3%(w/v) isopropanol.",293,"10.1111/jth.12849",,"4XDE",28.19,"2.14","2.14","Coagulation Factor XII protease domain crystal structure","RSVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVSLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVSHHTGTRHHHHHH","Homo sapiens","F12","Coagulation factor XII","1","4XDE"
"4XDG",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4M Ammonium Sulphate; 100 mM Hepes pH7.5",293,"10.3390/molecules22020210",,"4XDG",54.49,"1.5","1.5","Crystal Structure of Quinone Reductase II in complex with 2-(4-aminophenyl)-5-methoxy-1-oxy-indol-3-one molecule","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4XDG"
"4XDH",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Ammonium Sulphate, 100 mM Bicine pH8",291,"10.3390/molecules22020210",,"4XDH",54.49,"1.9","1.9","Crystal Structure of Quinone Reductase II in complex with a 2-(4-methoxy-phenyl)-5-methoxy-indol-3-one molecule","MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","4XDH"
"4XDJ",,"X-RAY DIFFRACTION",3.93,68.75,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M KCl, 0.1M sodium cacodylate pH6.5, 22% (w/v) PEG1500 + 3% (v/v) Methanol",277,"10.1126/science.1261512",,"4XDJ",128.37,"3.8","3.8","Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in an alternate conformation (FORM 2)","MGLQTVMKWKTVVAIFVVVVVYLVTGGLVFRALEQPFESSQKNTIALEKAEFLRDHVCVSPQELETLIQHALDADNAGVSPIGNSSNNSSHWDLGSAFFFAGTVITTIGYGNIAPSTEGGKIFCILYAIFGIPLFGFLLAGIGDQLGTIFGKSIARVEKVFRKKQVSQTKIRVISTILFILAGCIVFVTIPAVIFKYIEGWTALESIYFVVVTLTTVGFGDFVAGGNAGINYREWYKPLVWFWILVGLAYFAAVLSMIGDWLRVLSKKTKEEVGEAENLYFQ","Homo sapiens","KCNK10, TREK2","POTASSIUM CHANNEL SUBFAMILY K MEMBER 10","1","4XDJ"
"4XDK",,"X-RAY DIFFRACTION",3.85,68.07,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M KCl, 0.2M  ammonium formate, 0.1M  Tris pH 7, 31%  pentaerythritol ethoxylate 15/04",277,"10.1126/science.1261512",,"4XDK",130,"3.6","3.6","Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with norfluoxetine","MGLQTVMKWKTVVAIFVVVVVYLVTGGLVFRALEQPFESSQKNTIALEKAEFLRDHVCVSPQELETLIQHALDADNAGVSPIGNSSNNSSHWDLGSAFFFAGTVITTIGYGNIAPSTEGGKIFCILYAIFGIPLFGFLLAGIGDQLGTIFGKSIARVEKVFRKKQVSQTKIRVISTILFILAGCIVFVTIPAVIFKYIEGWTALESIYFVVVTLTTVGFGDFVAGGNAGINYREWYKPLVWFWILVGLAYFAAVLSMIGDWLRVLSKKTKEEVGEAENLYFQ","Homo sapiens","KCNK10, TREK2","Potassium channel subfamily K member 10","1","4XDK"
"4XDL",,"X-RAY DIFFRACTION",3.75,67.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M KCl, 0.1M MES pH 6.5, 0.05M magnesium chloride, 0.001M cadmium chloride, 18% (v/v) PEG500 Dimethylether",277,"10.1126/science.1261512",,"4XDL",129.41,"3.5","3.5","Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with a brominated fluoxetine derivative.","MGLQTVMKWKTVVAIFVVVVVYLVTGGLVFRALEQPFESSQKNTIALEKAEFLRDHVCVSPQELETLIQHALDADNAGVSPIGNSSNNSSHWDLGSAFFFAGTVITTIGYGNIAPSTEGGKIFCILYAIFGIPLFGFLLAGIGDQLGTIFGKSIARVEKVFRKKQVSQTKIRVISTILFILAGCIVFVTIPAVIFKYIEGWTALESIYFVVVTLTTVGFGDFVAGGNAGINYREWYKPLVWFWILVGLAYFAAVLSMIGDWLRVLSKKTKEEVGEAENLYFQ","Homo sapiens","KCNK10, TREK2","Potassium channel subfamily K member 10","1","4XDL"
"4XDO",,"X-RAY DIFFRACTION",2.62,52.99,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.8 M Lithium chloride, 0.1 M Tris pH 8.5, 28 % w/v PEG 4000",291.15,"10.1177/1087057115575689","OGA","4XDO",79.91,"1.97","1.97","Crystal structure of human KDM4C catalytic domain with OGA","LNPSCKIMTFRPSMEEFREFNKYLAYMESKGAHRAGLAKVIPPKEWKPRQCYDDIDNLLIPAPIQQMVTGQSGLFTQYNIQKKAMTVKEFRQLANSGKYCTPRYLDYEDLERKYWKNLTFVAPIYGADINGSIYDEGVDEWNIARLNTVLDVVEEECGISIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHFGEPKSWYAIPPEHGKRLERLAQGFFPSSSQGCDAFLRHKMTLISPSVLKKYGIPFDKITQEAGEFMITFPYGYHAGFNHGFNCAESTNFATVRWIDYGKVAKLCTCRKDMVKISMDIFVRKFQPDRYQLWKQGKDIYTIDHTK","Homo sapiens","KDM4C, GASC1, JHDM3C, JMJD2C, KIAA0780","Lysine-specific demethylase 4C","1","4XDO"
"4XDP",,"X-RAY DIFFRACTION",2.61,52.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.8 M Lithium chloride, 0.1 M TRIS pH 8.5, 28 % w/v PEG 4000",291.15,"10.1177/1087057115575689",,"4XDP",80.07,"2.07","2.07","Crystal structure of human KDM4C catalytic domain bound to tris","LNPSCKIMTFRPSMEEFREFNKYLAYMESKGAHRAGLAKVIPPKEWKPRQCYDDIDNLLIPAPIQQMVTGQSGLFTQYNIQKKAMTVKEFRQLANSGKYCTPRYLDYEDLERKYWKNLTFVAPIYGADINGSIYDEGVDEWNIARLNTVLDVVEEECGISIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHFGEPKSWYAIPPEHGKRLERLAQGFFPSSSQGCDAFLRHKMTLISPSVLKKYGIPFDKITQEAGEFMITFPYGYHAGFNHGFNCAESTNFATVRWIDYGKVAKLCTCRKDMVKISMDIFVRKFQPDRYQLWKQGKDIYTIDHTK","Homo sapiens","KDM4C, GASC1, JHDM3C, JMJD2C, KIAA0780","Lysine-specific demethylase 4C","1","4XDP"
"4XDX",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.17 M Ammonium acetate, 0.085 M Sodium citrate tribasic dihydrate pH 5.6, 20% w/v Polyethylene glycol 4,000, 15% v/v Glycerol",291,,,"4XDX",8.24,"0.95","0.95","The crystal structure of soluble human interleukin 8 expressed in Pichia pastoris","KELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS","Homo sapiens","CXCL8, IL8","Interleukin-8","1","4XDX"
"4XE1",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, HANGING DROP",,"AMMONIUM SULPHATE 2.6M, TRIS-HCL 0.1M, SODIUM CHLORIDE 0.3M, 4-HYDROXYMERCURYBENZOATE",293,"10.1039/c4ob02648a","IL5","4XE1",30.33,"1.8","1.8","Human carbonic anhydrase II in complex with 6-SULFAMOYL-SACCHARIN","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4XE1"
"4XE4",,"X-RAY DIFFRACTION",3.64,66.19,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5,1.6M Ammonium sulphate, 2%(w/v) PEG1000.",293,"10.1111/jth.12849",,"4XE4",28.35,"2.4","2.4","Coagulation Factor XII protease domain crystal structure","VVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVSLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVSHHTGTRHHHHHH","Homo sapiens","F12","Coagulation factor XII","1","4XE4"
"4XEM",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION",8.5,"PEG3350",293,,,"4XEM",54.04,"1.278","1.278","Crystal Structure of wild type human AlaRS catalytic domain","MGSSHHHHHHSSGLVPRGSHMDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALELLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGDTGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDTGMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLADHARTITVALADGGRPDNTGRGYVLRRILRRAVRYAHEKLNASRGFFATLVDVVVQSLGDAFPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGFPVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGK","Homo sapiens","AARS, AARS1","Alanine--tRNA ligase, cytoplasmic","1","4XEM"
"4XEO",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION",7.5,"PEG3350",293,,,"4XEO",108.23,"1.38","1.38","Crystal Structure of human AlaRS catalytic domain with R329H mutation","MGSSHHHHHHSSGLVPRGSHMDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALELLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGDTGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDTGMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLADHARTITVALADGGRPDNTGRGYVLRRILHRAVRYAHEKLNASRGFFATLVDVVVQSLGDAFPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGFPVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGK","Homo sapiens","AARS, AARS1","Alanine--tRNA ligase, cytoplasmic","1","4XEO"
"4XEY",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M sodium citrate, 8% PEG 8000",293,"10.1042/BJ20141492","1N1","4XEY",94.7,"2.891","2.891","Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase","MASVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVLEHHHHHH","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","4XEY"
"4XFS",,"X-RAY DIFFRACTION",1.83,32.7,"VAPOR DIFFUSION, SITTING DROP",7,"47% PEG 2K MME, 0.1M HEPES, 5% DMSO",298,"10.1107/S2053230X15006871",,"4XFS",36.51,"1.91","1.91","Structure of IL-18 SER Mutant I","YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVKCEKISTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILAAADAAGDRSIMFTVQNED","Homo sapiens","IL18, IGIF, IL1F4","Interleukin-18","1","4XFS"
"4XFT",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"35% PEG 3350, 0.1M MES, 5% DMSO",298,"10.1107/S2053230X15006871",,"4XFT",36.2,"2","2","Structure of IL-18 SER Mutant III","YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVACAAASTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED","Homo sapiens","IL18, IGIF, IL1F4","Interleukin-18","1","4XFT"
"4XFU",,"X-RAY DIFFRACTION",1.93,36.26,"VAPOR DIFFUSION, SITTING DROP",,"35% PEG 3350, 0.1M Tris, 0.1M Sodium Acetate",298,"10.1107/S2053230X15006871",,"4XFU",36.31,"2.85","2.85","Structure of IL-18 SER Mutant V","YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQRRGMAVTISVACAAASTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRRVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED","Homo sapiens","IL18, IGIF, IL1F4","Interleukin-18","1","4XFU"
"4XG2",,"X-RAY DIFFRACTION",2.06,40.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831",,"4XG2",33.9,"2.21","2.21","Crystal structure of ligand-free Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG2"
"4XG3",,"X-RAY DIFFRACTION",2.12,42.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20% (v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X3G","4XG3",68.78,"2.3","2.3","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG3"
"4XG4",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X4G","4XG4",34.36,"2.3","2.3","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG4"
"4XG6",,"X-RAY DIFFRACTION",2.13,42.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X6G","4XG6",34.27,"2.4","2.4","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG6"
"4XG7",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X7G","4XG7",34.29,"1.76","1.76","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG7"
"4XG8",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X8G","4XG8",68.65,"2.4","2.4","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG8"
"4XG9",,"X-RAY DIFFRACTION",2.12,41.85,"VAPOR DIFFUSION, HANGING DROP",8.5,"10~20%(v/v) PEG3350, 100 mM Tris-HCl",278,"10.1111/febs.13831","X9G","4XG9",68.68,"2.91","2.91","Crystal structure of an inhibitor-bound Syk","EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","4XG9"
"4XGL",,"X-RAY DIFFRACTION",2.84,56.74,"VAPOR DIFFUSION, HANGING DROP",6,"potassium citrate, PEG3350, magnesium chloride",298,"10.1093/nar/gkv481",,"4XGL",44.37,"1.8","1.8","Structure of the nuclease subunit of human mitochondrial RNase P (MRPP3) at 1.8A","SMTLEPRGYSLLIRGLIHSDRWREALLLLEDIKKVITPSKKNYNDCIQGALLHQDVNTAWNLYQELLGHDIVPMLETLKAFFDFGKDIKDDNYSNKLLDILSYLRNNQLYPGESFAHSIKTWFESVPGKQWKGQFTTVRKSGQCSGCGKTIESIQLSPEEYECLKGKIMRDVIDGGDQYRKTTPQELKRFENFIKSRPPFDVVIDGLNVAKMFPKVRESQLLLNVVSQLAKRNLRLLVLGRKHMLRRSSQWSRDEMEEVQKQASCFFADDISEDDPFLLYATLHSGNHCRFITRDLMRDHKACLPDAKTQRLFFKWQQGHQLAIVNRFPGSKLTFQRILSYDTVVQTTGDSWHIPYDEDLVERCSCEVPTKWLCLHQKT","Homo sapiens","KIAA0391, MRPP3, PRORP","Mitochondrial ribonuclease P protein 3","1","4XGL"
"4XGM",,"X-RAY DIFFRACTION",2.81,56.27,"VAPOR DIFFUSION, HANGING DROP",7,"HEPES, PEG 6000, magnesium chloride",298,"10.1093/nar/gkv481",,"4XGM",44.37,"1.98","1.98","Structure of the nuclease subunit of human mitochondrial RNase P (MRPP3) at 1.98A","SMTLEPRGYSLLIRGLIHSDRWREALLLLEDIKKVITPSKKNYNDCIQGALLHQDVNTAWNLYQELLGHDIVPMLETLKAFFDFGKDIKDDNYSNKLLDILSYLRNNQLYPGESFAHSIKTWFESVPGKQWKGQFTTVRKSGQCSGCGKTIESIQLSPEEYECLKGKIMRDVIDGGDQYRKTTPQELKRFENFIKSRPPFDVVIDGLNVAKMFPKVRESQLLLNVVSQLAKRNLRLLVLGRKHMLRRSSQWSRDEMEEVQKQASCFFADDISEDDPFLLYATLHSGNHCRFITRDLMRDHKACLPDAKTQRLFFKWQQGHQLAIVNRFPGSKLTFQRILSYDTVVQTTGDSWHIPYDEDLVERCSCEVPTKWLCLHQKT","Homo sapiens","KIAA0391, MRPP3, PRORP","Mitochondrial ribonuclease P protein 3","1","4XGM"
"4XH3",,"X-RAY DIFFRACTION",1.64,25.23,"VAPOR DIFFUSION, HANGING DROP",7,"20% (w/v) glycerol, 18% PEG 1500, 100 mM Hepes, 5 mM DTT",291,"10.1016/j.devcel.2015.03.003",,"4XH3",46.77,"2.1","2.1","Mechanistic insights into anchorage of the contractile ring from yeast to humans","GHMCQVNIKQKMQELNNEINMQQTVIYQASQALNCCVDEEHGKGSLEEAEAERLLLIATGKRTLLIDELNKLKNEGPQRKNKASPQSEFMPSKGSVTLSEIRLPLKADFVCSTVQKPDAANYYYLIILKAGAENMVATPLASTSNSLNGDALTFTTTFTLQDVSNDFEINIEVYSLVQKKDPSGLDKKKKTSKSKAITPKRLLTSITTKSNIHSSVMASPGGLSAVRTSNFALVGSYTLSLSSVGNTKFVLDKVPFLSSLEGHIYLKIKCQVNSSVEERGFLTIFEDVSGFGAWHRRWCVLSGNCISYWTYPDDEKRKNPIGRINLANCTSRQIEPANREFCARRNTFELITVRPQREDDRETLVSQCRDTLCVTKNWLSADTKEERDLWMQKLNQVLVDIRLWQPDACYKPIGKP","Homo sapiens","ANLN","Actin-binding protein anillin","1","4XH3"
"4XH6",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION, HANGING DROP",7.1,"1M NaOAc, 0.1M Imidazole",277,"10.1021/acs.jnatprod.5b00324","HUL","4XH6",34.26,"2.04","2.04","Crystal structure of proto-oncogene kinase Pim1 bound to hispidulin","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVDHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4XH6"
"4XHD",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1M imidazole pH 7.8, 8-10%(V/V)isopropanol. Apo crystal was soaked with 5 mM compound 1 
and Crystals  harvested next day using 32% ethylene glycol as cryoprotectant",293,"10.1016/j.jmb.2014.12.022",,"4XHD",36.74,"2.4","2.4","STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH COMPOUND-1","MKKHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","4XHD"
"4XHK",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION",5.5,"0.1M BisTRIS pH 5.5, 0.2M NaCl, 1.5M Ammonium Sulfate",298,"10.1016/j.bmcl.2014.12.041","3YR","4XHK",36.37,"1.9","1.9","PIM1 kinase in complex with Compound 1s","GPMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","4XHK"
"4XHT",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION",8,"25% PEG 3350, 200mM sodium acetate",298,"10.1016/j.molcel.2015.07.031",,"4XHT",46.08,"1.651","1.651","Crystal structure of Timeless_PAB domain native form","GSHMVLSNENLGQSLHQEGFSIPLLWLQNCLIRAADDREEDGCSQAVPLVPLTEENEEAMENEQFQQLLRKLGVRPPASGQETFWRIPAKLSPTQLRRAAASL","Homo sapiens","TIMELESS, TIM, TIM1, TIMELESS1","Protein timeless homolog","1","4XHT"
"4XHW",,"X-RAY DIFFRACTION",3.03,59.4,"VAPOR DIFFUSION",8,"25% PEG 3350, 200mM sodium acetate",298,"10.1016/j.molcel.2015.07.031",,"4XHW",46.68,"2.85","2.85","Crystal structure of Timeless_PAB domain in SeMet-labelled form","GSHMVLSNENLNQSLHQEGFSIPLLWLQNCLIRAADDREEDGCSQAVPLVPLTEENEEAMENEQFQQLLRKLGVRPPASGQETFWRIPAKLSPTQLRRAAASL","Homo sapiens","TIMELESS, TIM, TIM1, TIMELESS1","Protein timeless homolog","1","4XHW"
"4XHZ",,"X-RAY DIFFRACTION",6.76,81.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES (pH6.5), 1.6M NaCl",277.15,"10.1038/ncomms13458",,"4XHZ",37.59,"2.803","2.803","Crystal Structure of Human Protocadherin-15 EC8-10","MSPVFTNSTYTVLVEENLPAGTTILQIEAKDVDLGANVSYRIRSPEVKHFFALHPFTGELSLLRSLDYEAFPDQEASITFLVEAFDIYGTMPPGIATVTVIVKDMNDYPPVFSKRIYKGMVAPDAVKGTPITTVYAEDADPPGLPASRVRYRVDDVQFPYPASIFEVEEDSGRVITRVNLNEEPTTIFKLVVVAFDDGEPVMSSSATVKILVLHPGEIPRFTQEEYRPPPVSELATKGTMVGVISAAAINQSIVYSIVSGNEEDTFGINNITGVIYVNGPLDYETRTSYVLRVQADSLEVVLANLRVPSKSNTAKVYIEIQDENNHPPVFLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","4XHZ"
"4XI3",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, HANGING DROP",6.6,"33% PEG 3,350, 100 mM Tris pH 6.6, 250 mM MgCl2",298,,"29S","4XI3",112.96,"2.491","2.491","Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHR","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","4XI3"
"4XI6",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, HANGING DROP",7.6,"1.5 M (NH4)2SO4, 20% v/v glycerol, HEPES pH 7.6",293.15,"10.1016/j.molcel.2015.01.019",,"4XI6",42.47,"2.04","2.04","Crystal structure of the MZM-REP domains of Mind bomb 1","SRVMVEGVGARVVRGPDWKWGKQDGGEGHVGTVRSFESPEEVVVVWDNGTAANYRCSGAYDLRILDSAPTGIKHDGTMCDTCRQQPIIGIRWKCAECTNYDLCTVCYHGDKHHLRHRFYRITTPGSERVLLESRRKSKKITARGIFAGARVVRGVDWQWEDQDGGNGRRGKVTEIQDWSASSPHSAAYVLWDNGAKNLYRVGFEGMSDLKCVQDAKGGSFYRDHCPVLGEQNGNRNPGGLQIGDLVNIDLDLEIVQSLQHGHGGWTDGMFETLTTTGTVCGIDEDHDIVVQYPSGNRWTFNPAVLTKASQFQVGDLVQVCYDLERIKLLQRGHGEWAEAMLPTLGKVGRVQQIYSDSDLKVEVCGTSWTYNPAAVSKVAS","Homo sapiens","MIB1, DIP1, KIAA1323, ZZANK2","E3 ubiquitin-protein ligase MIB1","1","4XI6"
,,,,,,,,,,,,,,,,,"Homo sapiens","MIB1, DIP1, KIAA1323, ZZANK2"
"4XII",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000 12%
0.1M Ammonium acetate",293,"10.1016/j.bmc.2015.06.010","40V","4XII",129.52,"2.7","2.7","X-ray structure of human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-8-hydroxy-N-(2-methoxyethyl)-5-nitroquinoline-7-carboxamide","EDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWK","Homo sapiens","BCHE, CHE1","Cholinesterase","1","4XII"
"4XIP",,"X-RAY DIFFRACTION",2.87,57.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% PEGMME2K, 100MM MGCL2, 100mM cacodylate buffer pH 6.5",277,"10.1016/j.bmcl.2015.01.023","40W","4XIP",26.48,"1.7","1.7","Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4XIP"
"4XIQ",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% PEGMME2K, 100MM MGCL2, 100MM      
CACODYLATE PH 6.5",277,"10.1016/j.bmcl.2015.01.023","40Y","4XIQ",26.71,"1.84","1.84","Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4XIQ"
"4XIR",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% PEGMME2K, 100MM MGCL2, 100MM      
REMARK 280  CACODYLATE PH 6.5",277,"10.1016/j.bmcl.2015.01.023","40X","4XIR",26.69,"1.7","1.7","Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4XIR"
"4XIT",,"X-RAY DIFFRACTION",2.87,57.18,"VAPOR DIFFUSION, HANGING DROP",,"20-25% PEGMME2K, 100MM MGCL2, 100MM      
REMARK 280  CACODYLATE PH 6.5",277,"10.1016/j.bmcl.2015.01.023","40Z","4XIT",26.73,"1.86","1.86","Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors","GSLHMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","4XIT"
"4XJ0",,"X-RAY DIFFRACTION",2.92,57.94,"EVAPORATION",7.5,"10% PEG3350, 0.2 M proline, and 0.1 M HEPES pH7.5, in a 24-well Linbro plates",277,"10.1021/jm501921k","41B","4XJ0",82.26,"2.58","2.58","Crystal structure of ERK2 in complex with an inhibitor 14K","EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","4XJ0"
"4XJJ",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM sodium citrate, 30% PEG 2000",298,,,"4XJJ",13,"1.4","1.4","Extracellular domain of type II Transforming Growth Factor Beta receptor in complex with 2-(2-Hydroxyethyl)NDSB-201","MALCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPTCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPD","Homo sapiens","TGFBR2","TGF-beta receptor type-2","1","4XJJ"
"4XJS",,"X-RAY DIFFRACTION",1.95,36.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein concentration was 7mgs/ml. Crystals were grown from 23% PEG3350, 0.1mM BisTrisPropane at 22 deg C (2+2uL drops over a 500uL well). Crystals were soaked with 5mM inhibitor for 24 hours prior to data collection. Crystals were flash frozen in PFO.",295,"10.1021/acs.jmedchem.5b00992","733","4XJS",30.96,"2.8","2.8","Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-8-carboxamide]","RGKNPEDWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1","1","4XJS"
"4XJT",,"X-RAY DIFFRACTION",1.95,36.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein concentration 7mgs/ml. Crystals were grown from 23% PEG3350, 0.1mM BisTrisPropane at 22 deg C (2+2uL drops over a 500uL well). Crystals were soaked with 5mM inhibitor for 24 hours prior to data collection. Crystals were flash frozen in PFO.",295,"10.1021/acs.jmedchem.5b00992","41Z","4XJT",31.26,"2.6","2.6","Human CD38 complexed with inhibitor 2 [4-[(2,6-dimethylbenzyl)amino]-2-methylquinoline-8-carboxamide]","RGKNPEDWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1","1","4XJT"
"4XJV",,"X-RAY DIFFRACTION",3.02,62.95,"VAPOR DIFFUSION, HANGING DROP",7.6,"Rod-shaped crystals of TE2 (10 mg/ml with 10 mM fresh DTT) were grown using the vapor diffusion method at 25 C, using a 1:1 drop to well ratio. The well solutions contained 1.64 M NaH2PO4, 0.42 M K2HPO4 and 50 mM HEPES. Crystals were cryoprotected by transfer to paratone.",298,"10.1074/jbc.M115.702597",,"4XJV",30.64,"2.8","2.8","Crystal structure of human thioesterase 2","GIDPFTMERGDQPKRTRNENIFNCLYKNPEATFKLICFPWMGGGSTHFAKWGQDTHDLLEVHSLRLPGRESRVEEPLENDISQLVDEVVCALQPVIQDKPFAFFGHSMGSYIAFRTALGLKENNQPEPLHLFLSSATPVHSKAWHRIPKDDELSEEQISHYLMEFGGTPKHFAEAKEFVKQCSPIIRADLNIVRSCTSNVPSKAVLSCDLTCFVGSEDIAKDMEAWKDVTSGNAKIYQLPGGHFYLLDPANEKLIKNYIIKCLEVSSISNF","Homo sapiens","OLAH, THEDC1","S-acyl fatty acid synthase thioesterase, medium chain","1","4XJV"
"4XKI",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 2% v/v Polyethylene glycol 400 and 0.1 M sodium HEPES pH 7.5",298,,,"4XKI",35.23,"2","2","Human Fibroblast Growth Factor - 1 (FGF-1) mutant S116R","MHHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGRCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Fibroblast growth factor 1","1","4XKI"
"4XKX",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% polyethylene glycol 5000 MME, 200 mM ammonium iodide, 170 mM sodium citrate, pH 6.6, 3% dimethylsulfoxide, apo crystals soaked with 1 mM inhibitor for 4 h",298,"10.1016/j.bmcl.2014.12.092","43K","4XKX",46.96,"1.8","1.8","Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4XKX"
"4XLD",,"X-RAY DIFFRACTION",2.54,51,"VAPOR DIFFUSION, SITTING DROP",8,"3-4 M Sodium Formate",291,"10.1107/S1399004715010342","BRL","4XLD",34.16,"2.45","2.45","Crystal structure of the human PPARg-LBD/rosiglitazone complex obtained by dry co-crystallization and in situ diffraction","MGSSHHHHHHSSGLVPRGSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4XLD"
"4XLV",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM Tris-HCl, pH 7.5, 26% (w/v) polyethylene glycol (PEG) 4000, 200 mM MgCl2, and 5 mM DTT",277,"10.1038/ncomms7406",,"4XLV",37.91,"2.3","2.3","Crystal structure of the activated insulin receptor tyrosine kinase dimer","QPDGPLGPLFASSNPEYLSASDVFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENK","Homo sapiens","INSR","Insulin receptor","1","4XLV"
"4XMB",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium chloride, 20% w/v PEG3350",277.15,"10.1016/j.ejmech.2015.08.049","41P","4XMB",32.27,"2.428","2.428","Crystal structure of 2,2'-(naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetamide bound to human Keap1 Kelch domain","APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","4XMB"
"4XML",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 8000, Tris, glycerol",296,"10.1128/JVI.01280-15",,"4XML",47.23,"2.68","2.68","Crystal structure of Fab of HIV-1 gp120 V3-specific human monoclonal antibody 2424","DIVMNQSPPSLAVTPGEPASISCRASQSLLYSDGHNYLDWYLQKPGQAPQLLIYLGSTRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQPLQSYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR","Homo sapiens",,"Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424","1","4XML"
,,,,,,,,,,,,,,,,"EVQLVGSGGGLIQPGGSLRLSCAASDFSVSEYYMTWVRQAPGKGLEWVAVLYKDGSQFYAPSVKGRFIVSRDNSKNSLYLQMNNLRGEDTAVYFCARENADYGSDYYFGMDVWGQGTAVAVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSSVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEP","Homo sapiens",,"Heavy chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424","2","4XML"
"4XMO",,"X-RAY DIFFRACTION",2.04,39.75,"VAPOR DIFFUSION, HANGING DROP",7.8,"12% PEG 4000, 100 mM HEPES, pH 7.8, 6% isopropanol, 3% ethanol, 40 mM beta-mercaptoethanol",298,"10.1021/jm501913a","46G","4XMO",35.64,"1.75","1.75","Crystal structure of c-Met in complex with (R)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4XMO"
"4XNC",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",7.3,"25% (w/v) PEG4000",298,"10.1107/S1399004715010342",,"4XNC",17.9,"2.23","2.23","Crystal structure at room temperature of cyclophilin D in complex with an inhibitor","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","4XNC"
"4XO6",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG3350, 0.1M SODIUM CACODYLATE, 0.2M AMMONIUM SULFATE, PH 6.0",293,"10.1042/BCJ20160083",,"4XO6",76.39,"1.2","1.2","Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one","SVDDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4XO6"
"4XO7",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG3350, 0.1M SODIUM CACODYLATE, 0.2M AMMONIUM SULFATE, PH 6.0",293,"10.1042/BCJ20160083",,"4XO7",75.82,"1.75","1.75","Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","4XO7"
"4XOF",,"X-RAY DIFFRACTION",1.77,30.5,"VAPOR DIFFUSION, HANGING DROP",,"25% (w/v) PEG 1450, 50mM HEPES pH 7.0",293,"10.1038/ncomms9361",,"4XOF",8.58,"1.15","1.15","Observing the overall rocking motion of a protein in a crystal - Orthorhombic Ubiquitin crystals without Zinc.","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","1","4XOF"
"4XOK",,"X-RAY DIFFRACTION",2,38.49,"VAPOR DIFFUSION, HANGING DROP",7,"20mg/ml Ubi in 20mM NH4Ac pH4.3, 50mM HEPES pH7.0,
35% PEG 1500, 25mM Zn Acetate",293,"10.1038/ncomms9361",,"4XOK",26.12,"2.2","2.2","Observing the overall rocking motion of a protein in a crystal.","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","4XOK"
"4XOL",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, HANGING DROP",6.33,"100mM MES pH 6.33, 20% PEG 3350, 100mM Zn Acetate.",293,"10.1038/ncomms9361",,"4XOL",17.48,"2.91","2.91","Observing the overall rocking motion of a protein in a crystal - Cubic Ubiquitin crystals.","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","4XOL"
"4XOS",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3000, 0.1M Hepes pH 7.5, 0.2M NaCl",294,"10.1107/S2053230X15006457",,"4XOS",34.8,"1.559","1.559","ANP32A LRR domain","GPHMEMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD","Homo sapiens","ANP32A, C15orf1, LANP, MAPM, PHAP1","Acidic leucine-rich nuclear phosphoprotein 32 family member A","1","4XOS"
"4XP7",,"X-RAY DIFFRACTION",2.13,40.2,"VAPOR DIFFUSION, SITTING DROP",4,"0.1 M MES Malic Tris pH 4, 25% PEG 1500",292,"10.1107/S1399004715009220",,"4XP7",39.13,"1.9","1.9","Crystal structure of Human tRNA dihydrouridine synthase 2","GSHMASMILNSLSLCYHNKLILAPMVRVGTLPMRLLALDYGADIVYCEELIDLKMIQCKRVVNEVLSTVDFVAPDDRVVFRTCEREQNRVVFQMGTSDAERALAVARLVENDVAGIDVNMGCPKQYSTKGGMGAALLSDPDKIEKILSTLVKGTRRPVTCKIRILPSLEDTLSLVKRIERTGIAAIAVHGRKREERPQHPVSCEVIKAIADTLSIPVIANGGSHDHIQQYSDIEDFRQATAASSVMVARAAMWNPSIFLKEGLRPLEEVMQKYIRYAVQYDNHYTNTKYCLCQMLREQLESPQGRLLHAAQSSREICEAFGLGAFYEETTQELDAQQARLSAKTSE","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","4XP7"
"4XQ7",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris pH 7.5, 200 mM LiSO4 and 20% (w/v) polyethylene glycol (PEG) 3350.",277,"10.1093/nar/gkv389",,"4XQ7",41.81,"1.6","1.6","The crystal structure of the OAS-like domain (OLD) of human OASL","MALMQELYSTPASRLDSFVAQWLQPHREWKEEVLDAVRTVEEFLRQEHFQGKRGLDQDVRVLKVVKVGSFGNGTVLRSTREVELVAFLSCFHSFQEAAKHHKDVLRLIWKTMWQSQDLLDLGLEDLRMEQRVPDALVFTIQTRGTAEPITVTIVPAYRALGPSLPNSQPPPEVYVSLIKACGGPGNFCPSFSELQRNFVKHRPTKLKSLLRLVKHWYQQYVKARSPRANLPPLYALELLTIYAWEMGTEEDENFMLDEGFTTVMDLLLEYEVICIYWTKYYTLHNAIIEDCVRKQLKKERPIILDPADPTLNVAEGYRWDIVAQRASQCLKQDCCYDNRENPISSWNVKRGSSHHHHHH","Homo sapiens","OASL, TRIP14","2'-5'-oligoadenylate synthase-like protein","1","4XQ7"
"4XQR",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"17% PEG 4000, 8.5% 2-propanol, 15% glycerol, 0.09 M HEPES",295.15,,,"4XQR",43.24,"2.15","2.15","Crystal structure of unliganded human FPPS at 2.15 angstrom resolution","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4XQR"
"4XQS",,"X-RAY DIFFRACTION",2.74,55.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.36 M magnesium sulfate, 15% glycerol, 0.085 M MES",295.15,,,"4XQS",43.36,"2.3","2.3","Crystal structure of human FPPS in complex with one magnesium ion","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4XQS"
"4XQT",,"X-RAY DIFFRACTION",2.77,55.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.36 M magnesium sulfate, 15% glycerol, 0.085 M MES",295.15,,,"4XQT",43.41,"2.1","2.1","Crystal structure of human FPPS in complex with three magnesium ions","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","4XQT"
"4XRX",,"X-RAY DIFFRACTION",2.77,55.52,"EVAPORATION",5.6,"10 mM NADPH and 10 mM CaCl2 in a solution of 1.75 M (NH4)2SO4 and 0.1 M NaAc (pH 5.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.5b00684","42V","4XRX",95.13,"3.2","3.2","Crystal structure of a metabolic reductase with (E)-5-((1-methyl-5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)pyridin-2(1H)-one","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4XRX"
"4XRY",,"X-RAY DIFFRACTION",3.16,61.04,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. Beta-secretase inhibitor was added to the mother liquor after crystallization of the P450 2D6 thiordidazine ternary complex.",298,"10.1021/acs.jmedchem.5b00191","SI5","4XRY",219.96,"2.5","2.5","Human Cytochrome P450 2D6 BACE1 Inhibitor 5 Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4XRY"
"4XRZ",,"X-RAY DIFFRACTION",3.15,61.01,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. Beta-secretase inhibitor was added to the mother liquor after crystallization of the P450 2D6 thiordidazine ternary complex.",298,"10.1021/acs.jmedchem.5b00191","SI6","4XRZ",220.04,"2.4","2.4","Human Cytochrome P450 2D6 BACE1 Inhibitor 6 Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","4XRZ"
"4XS2",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, HANGING DROP",6.4,"1.80 to 2.0 M Sodium Malonate pH 7.4, 0.2 M Sodium Acetate, 25 mM Hexamminecobalt(III)chloride, 0.05%w/v Pluronic-F-68",289,"10.1016/j.bmcl.2015.03.043",,"4XS2",137.74,"2.73","2.73","Irak4-inhibitor co-structure","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","4XS2"
"4XS3",,"X-RAY DIFFRACTION",2.8,56.05,"EVAPORATION",5.6,"10 mM NADPH and 10 mM CaCl2 in a solution of 1.75 M (NH4)2SO4 and 0.1 M NaAc (pH 5.6), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.5b00684","42W","4XS3",95.54,"3.291","3.291","Crystal structure of a metabolic reductase with (E)-1-benzyl-5-((1-methyl-5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)pyridin-2(1H)-one","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","4XS3"
"4XSK",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",4.6,"2.2 M ammonium sulfate, 5% PEG 400, 50 mM sodium citrate (pH 4.6)",298,,,"4XSK",28.43,"1.5","1.5","Structure of PAItrap, an uPA mutant","IIGGEFTTIENQPWFAAIYRRHRRGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGLGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","4XSK"
"4XSV",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",6.6,"17% PEG3350, 0.2M magnesium formate, 0.1M HEPES, 0.01M CTP, 0.01M magnesium chloride",293,,,"4XSV",39.69,"2.7","2.7","Human CTP: Phosphoethanolamine Cytidylyltransferase in complex with CTP","SMGGRRAVRVWCDGCYDMVHYGHSNQLRQARAMGDYLIVGVHTDEEIAKHKGPPVFTQEERYKMVQAIKWVDEVVPAAPYVTTLETLDKYNCDFCVHGNDITLTVDGRDTYEEVKQAGRYRECKRTQGVSTTDLVGRMLLVTKAHHSSQEMSSEYREYADSFGKCPGGRNPWTGVSQFLQTSQKIIQFASGKEPQPGETVIYVAGAFDLFHIGHVDFLEKVHRLAERPYIIAGLHFDQEVNHYKGKNYPIMNLHERTLSVLACRYVSEVVIGAPYAVTAELLSHFKVDLVCHGKTEIIPDRDGSDPYQEPKRRGIFRQIDSGSNLTTDLIVQRIITNRLEY","Homo sapiens","PCYT2","Ethanolamine-phosphate cytidylyltransferase","1","4XSV"
"4XTA",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, HANGING DROP",,"1 M sodium citrate, 0.1 M HEPES pH 7.5, and 10 mM MgCl2",291,"10.1621/nrs.13004","DIF","4XTA",64.06,"2.5","2.5","MECHANISMS OF PPARgamma ACTIVATION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4XTA"
"4XTB",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, HANGING DROP",8,"1.55 M lithium sulphate 
0.1 M Bis-Tris propane (pH 8.0)",293,"10.15252/embr.201540436",,"4XTB",14.28,"1.5","1.5","Crystal structure of the N-terminal domain of the human mitochondrial calcium uniporter","MNHKVHHHHHHMVTVVYQNGLPVISVRLPSRRERCQFTLKPISDSVGVFLRQLQEEDRGIDRVAIYSPDGVRVAASTGIDLLLLDDFKLVINDLTYHVRPPKRDLLSHENAATLNDVKTLVQQ","Homo sapiens","MCU, C10orf42, CCDC109A","Calcium uniporter protein, mitochondrial","1","4XTB"
"4XUA",,"X-RAY DIFFRACTION",4.16,70.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"36% Low Molecular Weight PEG Smears (LMW PEG smears), 0.1M MES pH 6.5 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution)",277.15,"10.1021/jm501963e","43C","4XUA",14.22,"1.75","1.75","Crystal Structure of the bromodomain of human BAZ2B in complex with E11919 BAZ2-ICR analogue","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4XUA"
"4XUB",,"X-RAY DIFFRACTION",4.16,70.46,"VAPOR DIFFUSION, SITTING DROP",6,"34% Low Molecular Weight PEG Smears (LMW PEG smears), 0.1M MES pH 6.0 (Ligand soaking performed in low-molecular-weight PEG smears stabilizing solution)",277.14,"10.1021/jm501963e","43D","4XUB",14.16,"1.98","1.98","Crystal Structure of the bromodomain of human BAZ2B in complex with BAZ2-ICR chemical probe","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","4XUB"
"4XUC",,"X-RAY DIFFRACTION",2.53,51.41,"VAPOR DIFFUSION",,"0.1M MES, pH 6.5, 0.1M NaOAc, 30% PEG 2000MME; MA000417 (PEGsII), drop b10 :100uM ligand, 11mg/ml protein",298,"10.1021/ml500502d","43G","4XUC",25.14,"1.8","1.8","Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd18 (1-(biphenyl-3-yl)-3-hydroxypyridin-4(1H)-one)","NLLAGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4XUC"
"4XUD",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION",7,"0.1M HEPES, 30% PEG 6000; MA000474 (JCSG core IV), drop e12 :100uM ligand, 12mg/ml protein",298,"10.1021/ml500502d","43H","4XUD",25.18,"2.4","2.4","Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd32 ([1-(biphenyl-3-yl)-5-hydroxy-4-oxo-1,4-dihydropyridin-3-yl]boronic acid)","NLLAGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4XUD"
"4XUE",,"X-RAY DIFFRACTION",3.71,66.81,"VAPOR DIFFUSION",,"0.1M Tris, 0.2M Lithium Sulfate, 20% PEG 4000; MA000598 (PEGsII), drop c11 :100uM ligand, 7.5mg/ml protein",298,"10.1021/ml500502d","43J","4XUE",49.24,"2.3","2.3","Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd27b","AGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","4XUE"
"4XUF",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Tris-HCl, pH 7.5, 32% PEG 3350",294,"10.1371/journal.pone.0121177","P30","4XUF",69.09,"3.2","3.2","Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)","DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL","Homo sapiens","FLT3, CD135, FLK2, STK1","Receptor-type tyrosine-protein kinase FLT3","1","4XUF"
"4XUH",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, SITTING DROP",,"25% (w/v) PEG 6000 and 0.1 M Tris-HCl pH 8.5.",291,"10.1621/nrs.13004","SFI","4XUH",64.83,"2.22","2.22","PPARgamma ligand binding domain in complex with sulindac sulfide","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4XUH"
"4XUM",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, HANGING DROP",,"0.95 M sodium citrate and 0.1 M HEPES pH 8.0",291,"10.1621/nrs.13004","IMN","4XUM",64.54,"2.4","2.4","PPARgamma ligand binding domain in complex with indomethacin","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","4XUM"
"4XUU",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M ammonium sulfate, 0.1 M Tris-HCl pH 8.0, and 20% PEG3350. Long rod-shaped crystals formed within 2-3 days.",300.15,,,"4XUU",78.95,"2.62","2.62","The hSac2 domain from human phosphoinositide phosphatase Sac2","SRSHQELISQLLQSYMKLLLPDDEKFHGGWALIDCDPSLIDATHRDVDVLLLLSNSAYYVAYYDDEVDKVNQYQRLSLENLEKIEIGPEPTLFGKPKFSCMRLHYRYKEASGYFHTLRAVMRNPEEDGKDTLQCIAEMLQITKQAMGSDLPIIEKKLEAKASKPHEDII","Homo sapiens","INPP5F, KIAA0966, SAC2, MSTP007, MSTP047","Phosphatidylinositide phosphatase SAC2","1","4XUU"
"4XV1",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, SITTING DROP",6,"100MM BISTRIS AT PH 6.0, 12.5% 2,5-
 HEXANEDIOL, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 277K",277,"10.1038/nature14982","904","4XV1",67.1,"2.47","2.47","B-Raf Kinase V600E oncogenic mutant in complex with PLX7904","MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4XV1"
"4XV2",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M BISTRIS AT PH 6.0, 12.5% 2,5-
 HEXABEDIOL, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 277K",277,"10.1038/nature14982","P06","4XV2",67.63,"2.5","2.5","B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib","MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4XV2"
"4XV3",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M BISTRIS AT PH 6.0, 12.5% 2,5-
 HEXABEDIOL, 12% PEG3350, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 277K",277,"10.1038/nature14982",,"4XV3",67.05,"2.8","2.8","B-Raf Kinase V600E oncogenic mutant in complex with PLX7922","MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4XV3"
"4XV9",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M MES AT PH6.0, 35% (V/V) 2-METHYL-
 2,4-PENTANEDIOL 0.2M LI2SO4, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 277K",277,"10.1038/nature14982","1OO","4XV9",33.91,"2","2","B-Raf Kinase domain in complex with PLX5568","MKKGHHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","4XV9"
"4XVD",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium citrate, 0.4 M ammonium acetate, 2.5% (v/v) 2-methyl-2,4-pentanediol, 22-30% (w/v) PEG4000",298,"10.1107/S1399004715002175",,"4XVD",78.2,"2.81","2.81","17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4XVD"
"4XVE",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M sodium citrate, 0.4 M ammonium acetate, 2.5% (v/v) 2-methyl-2,4-pentanediol, 22-30% (w/v) PEG4000",298,"10.1107/S1399004715002175","WDS","4XVE",39.16,"1.55","1.55","17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3H)-one","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","4XVE"
"4XVQ",,"X-RAY DIFFRACTION",1.88,34.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"152mM Ca(OAc)2, 24.8% PEG 3350, 4.8% stabilization buffer at pH 7.5.",291.15,"10.1096/fj.15-271510",,"4XVQ",19.5,"1.887","1.887","H-Ras Y137E","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSEGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4XVQ"
"4XVR",,"X-RAY DIFFRACTION",1.91,35.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"139mM Ca(OAc)2, 22.6% PEG 3350, 13% stabilization buffer at pH 7.5",291.15,"10.1096/fj.15-271510",,"4XVR",19.45,"2.031","2.031","H-Ras Y137F","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSFGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","4XVR"
"4XW0",,"X-RAY DIFFRACTION",2.32,46.98,"VAPOR DIFFUSION, SITTING DROP",,"40 mM magnesium sulphate, HEPES and 1.3 M lithium sulphate",292,"10.1261/rna.052399.115",,"4XW0",6.47,"1.81","1.81","Crystal structure of (GCCU(G-LNA)CCUGC)2 duplex","GCCUGCCUGC","Homo sapiens",,"RNA (5'-R(*GP*CP*CP*UP*(LCG)P*CP*CP*UP*GP*C)-3')","1","4XW0"
"4XW1",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"10 mM magnesium acetate, sodium cacodylate and 1.3 M Li2SO4.",292,"10.1261/rna.052399.115",,"4XW1",2.84,"2.302","2.302","Crystal structure of (GCCU(G-LNA)CCUG)2 duplex","GCCUGCCUG","Homo sapiens",,"RNA (5'-R(*GP*CP*CP*UP*(LCG)P*CP*CP*UP*G)-3')","1","4XW1"
"4XW2",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M sodium malonate pH 7.0, 20% (w/v) PEG 3350",293,"10.1074/jbc.M116.732222",,"4XW2",22.94,"2.001","2.001","Structural basis for simvastatin competitive antagonism of complement receptor 3","GAMGSPQEDSDIAFLIDGSGSIIPHDFRRMKEFVSTVMEQLKKSKTLFSLMQYSEEFRIHFTFKEFQNNPNPRSLVKPITQLLGRTHTATGIRKVVRELFNITNGARKNAFKILVVITDGEKFGDPLGYEDVIPEADREGVIRYVIGVGDAFRSEKSRQELNTIASKPPRDHVFQVNNFEALKTIQNQLREKGFAIEG","Homo sapiens","ITGAM, CD11B, CR3A","Integrin alpha-M","1","4XW2"
"4XW3",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"35 % (v/v) PEG 600, 0.1 M tri-Sodium-citrate pH 5.5 - crystals appeared after 3 days and grew as single crystals",293,"10.1107/S2053230X15013709",,"4XW3",49.29,"2","2","Crystal structure of the SPRY domain of the human DEAD-box protein DDX1","GSQEGKKGKTTIKTGASVLNKWQMNPYDRGSAFAIGSDGLCCQSREVKEWHGCRATKGLMKGKHYYEVSCHDQGLCRVGWSTMQASLDLGTDKFGFGFGGTGKKSHNKQFDNYGEEFTMHDTIGCYLDIDKGHVKFSKNGKDLGLAFEIPPHMKNQALFPACVLKNAELKFNFGEEEFKFPPKDGFVALSKAPDGYIVKSQHSGNAQVTQTKFLEHHHHHH","Homo sapiens","DDX1, hCG_15914","ATP-dependent RNA helicase DDX1","1","4XW3"
"4XWH",,"X-RAY DIFFRACTION",5.94,79.3,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.0 M lithium sulfate, 0.01 M nickel chloride, 0.1 M Tris",291,"10.1016/j.jsb.2019.02.005",,"4XWH",83.18,"2.32","2.32","Crystal structure of the human N-acetyl-alpha-glucosaminidase","DEAREAAAVRALVARLLGPGPAADFSVSVERALAAKPGLDTYSLGGGGAARVRVRGSTGVAAAAGLHRYLRDFCGCHVAWSGSQLRLPRPLPAVPGELTEATPNRYRYYQNVCTQSYSFVWWDWARWEREIDWMALNGINLALAWSGQEAIWQRVYLALGLTQAEINEFFTGPAFLAWGRMGNLHTWDGPLPPSWHIKQLYLQHRVLDQMRSFGMTPVLPAFAGHVPEAVTRVFPQVNVTKMGSWGHFNCSYSCSFLLAPEDPIFPIIGSLFLRELIKEFGTDHIYGADTFNEMQPPSSEPSYLAAATTAVYEAMTAVDTEAVWLLQGWLFQHQPQFWGPAQIRAVLGAVPRGRLLVLDLFAESQPVYTRTASFQGQPFIWCMLHNFGGNHGLFGALEAVNGGPEAARLFPNSTMVGTGMAPEGISQNEVVYSLMAELGWRKDPVPDLAAWVTSFAARRYGVSHPDAGAAWRLLLRSVYNCSGEACRGHNRSPLVRRPSLQMNTSIWYNRSDVFEAWRLLLTSAPSLATSPAFRYDLLDLTRQAVQELVSLYYEEARSAYLSKELASLLRAGGVLAYELLPALDEVLASDSRFLLGSWLEQARAAAVSEAEADFYEQNSRYQLTLWGPEGNILDYANKQLAGLVANYYTPRWRLFLEALVDSVAQGIPFQQHQFDKNVFQLEQAFVLSKQRYPSQPRGDTVDLAKKIFLKYYPRWVAGSW","Homo sapiens","NAGLU, UFHSD1","Alpha-N-acetylglucosaminidase","1","4XWH"
"4XWX",,"X-RAY DIFFRACTION",2.86,56.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8 M sodium/potassium tartrate, 0.1 M Hepes pH 7.5",277.15,,,"4XWX",18.53,"1.87","1.87","Crystal structure of the PTB domain of SHC","SMGWLHPNDKVMGPGVSYLVRYMGCVEVLQSMRALDFNTRTQVTREAISLVCEAVPGAKGATRRRKPCSRPLSSILGRSNLKFAGMPITLTVSTSSLNLMAADCKQIIANHHMQSISFASGGDPDTAEYVAYVAKDPVNQRACHILECPEGLAQDVISTIGQAFELR","Homo sapiens","SHC1, SHC, SHCA","SHC-transforming protein 1","1","4XWX"
"4XWY",,"X-RAY DIFFRACTION",4.58,73.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"2% W/V PEG1000, 2.5% V/V glycerol, 1.7 M Ammonium sulfate, 0.1 M Hepes",277,"10.1016/j.neuron.2015.05.033","43O","4XWY",124.46,"2.35","2.35","Crystal structure of human sepiapterin reductase in complex with an N-acetylserotinin analogue","MHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","4XWY"
"4XX3",,"X-RAY DIFFRACTION",3.22,61.86,"VAPOR DIFFUSION, HANGING DROP",,"Reservoir 15% PEG3350, 625 mM NaCl and citrate buffer pH 4.6",295,"10.1016/j.bmcl.2015.02.003","70X","4XX3",75.76,"2.4","2.4","Renin in complex with (S)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4XX3"
"4XX4",,"X-RAY DIFFRACTION",3.25,62.17,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG3350, 625 mM NaCl and citrate buffer pH 4.6",295,"10.1016/j.bmcl.2015.02.003","70Y","4XX4",75.59,"2.4","2.4","Renin in complex with (4S)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)tetrahydropyrimidin-2(1H)-iminium","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","4XX4"
"4XX5",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 200 MM LITHIUM SULFATE,10 MM DTT, 10 MM EDTA, 100 MM TRIS",298,,"43R","4XX5",111.06,"2.76","2.76","Structure of PI3K gamma in complex with an inhibitor","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4XX5"
"4XX7",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION, HANGING DROP",,"2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4XX7",37.39,"1.77","1.77","Crystal structure of M2A mutant of human macrophage migration inhibitory factor","PAFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4XX7"
"4XX8",,"X-RAY DIFFRACTION",2.74,55.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5",291,"10.1016/j.chembiol.2015.08.006",,"4XX8",37.53,"1.77","1.77","Crystal structure of Pro1 deletion mutant of human macrophage migration inhibitory factor","MFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","4XX8"
"4XX9",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"Precipitant: 0.1M HEPES, pH 7.5, 1.2M Na Citrate. Protein (21 mg/mL): 25mM Tris, pH 7.5, 0.5M NaCl, 1mM DTT, 15mM EDTA, 15mM ATP",291,"10.1021/acs.jmedchem.5b01216","RF4","4XX9",36.83,"1.4","1.4","Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RF4","AMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","4XX9"
"4XXO",,"X-RAY DIFFRACTION",3.19,61.38,"VAPOR DIFFUSION, SITTING DROP",6,"diamond shaped crystals of 50 uM x 20 uM grew after 3 years of incubation",277,"10.1016/j.str.2015.03.016",,"4XXO",47.13,"2.843","2.843","Crystal Structure of Human APOBEC3A","GPGHMEASPASGPRHLMDPHIFTSNFNNGIGRHKTYLCYEVERLDNGTSVKMDQHRGFLHNQAKNLLCGFYGRHAALRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFKHCWDTFVDHQGAPFQPWDGLDEHSQALSGRLRAILQNQGN","Homo sapiens","APOBEC3A","DNA dC->dU-editing enzyme APOBEC-3A","1","4XXO"
"4XXS",,"X-RAY DIFFRACTION",2.78,55.7,"VAPOR DIFFUSION, HANGING DROP",6.6,"BACE1 lacking the pro-segment was concentrated to ~14 mg/mL in 20 mM Tris pH 7.4 and 250 mM NaCl.  Crystallization was carried out by the vapor diffusion method against 200 mM sodium citrate tribasic dihydrate, 22% PEG 5K monomethyl ether and 200 mM ammonium iodide.",291,"10.1021/acs.jmedchem.5b00191","SI5","4XXS",47.48,"1.86","1.86","Crystal structure of BACE1 with a pyrazole-substituted tetrahydropyran thioamidine","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4XXS"
"4XY2",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, SITTING DROP",6,"Bis-tris propane, Magnesium sulfate, PEG3350",298,"10.1016/j.bmc.2015.04.052","490","4XY2",79.82,"2.03","2.03","Crystal structure of PDE10A in complex with ASP9436","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","4XY2"
"4XY8",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M NaBr, 0.1M BTProp pH 7.5, 20.0% PEG 3350, 10.0% EtGly,",277,"10.1021/jm501893k","43U","4XY8",14.65,"1.7","1.7","Crystal Structure of the bromodomain of BRD9 in complex with a 2-amine-9H-purine ligand","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","4XY8"
"4XY9",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M NaNO3, 20.0% PEG 3350, 10.0% EtGly",277,"10.1021/jm501893k","43U","4XY9",15.48,"1.83","1.83","Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-amine-9H-purine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4XY9"
"4XYA",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG3350, 10% ethylene glycol, 0.1M bis-tris-propane pH 8.5, 0.2M sodium sulfate",277,"10.1021/jm501893k","43S","4XYA",15.49,"2.05","2.05","Crystal Structure of the first bromodomain of human BRD4 in complex with a 2-amine-9H-purine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","4XYA"
"4XYF",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",7.8,"13% PEG 4000, 100 mM HEPES, 6% (v/v) isopropanol, 3% (v/v) ethanol, 40 mM beta-mercaptoethanol",298,"10.1021/jm501913a","44X","4XYF",35.66,"1.85","1.85","Crystal structure of c-Met in complex with (S)-5-(8-fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","4XYF"
"4XYJ",,"X-RAY DIFFRACTION",2.68,54.07,"MICROBATCH",7,"200 mM potassium thiocyanate, pH 7, and 20% (w/v) PEG 3350",293,"10.1038/nature14405",,"4XYJ",718.84,"3.1","3.1","Crystal structure of human phosphofructokinase-1 in complex with ATP and Mg, Northeast Structural Genomics Consortium Target HR9275","MSYYHHHHHHDYDIPTTENLYFQGAMDPMDADDSRAPKGSLRKFLEHLSGAGKAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILAKYKASYDVSDSGQLEHVQPWSV","Homo sapiens","PFKP, PFKF","ATP-dependent 6-phosphofructokinase, platelet type","1","4XYJ"
"4XYK",,"X-RAY DIFFRACTION",2.53,50,"MICROBATCH",7.4,"200 mM potassium sodium tartrate tetrahydrate, pH 7.4, and 20% (w/v) PEG 3350.",293,"10.1038/nature14405",,"4XYK",359.43,"3.4","3.4","Crystal structure of human phosphofructokinase-1 in complex with ADP, Northeast Structural Genomics Consortium Target HR9275","MSYYHHHHHHDYDIPTTENLYFQGAMDPMDADDSRAPKGSLRKFLEHLSGAGKAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILAKYKASYDVSDSGQLEHVQPWSV","Homo sapiens","PFKP, PFKF","ATP-dependent 6-phosphofructokinase, platelet type","1","4XYK"
"4XZ0",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, ammonium sulfate, TCEP",293,"10.1042/BJ20140793",,"4XZ0",30.1,"2","2","ZAP-70-tSH2:compound-A complex","GPHMPDPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSA","Homo sapiens","ZAP70, SRK","Tyrosine-protein kinase ZAP-70","1","4XZ0"
"4XZ2",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1 M KCl, 0.025 M MgCl2, 0.05 M Na Cacodylate, 15% iso-Propanol",292,"10.1042/BJ20150251",,"4XZ2",335.95,"2.67","2.67","Human platelet phosphofructokinase in an R-state in complex with ADP and F6P, crystal form I","MASWSHPQFEKGADDDDKVPDPTSAIGVLTSGGDAQGMNAAVRAVVRMGIYVGAKVYFIYEGYQGMVDGGSNIAEADWESVSSILQVGGTIIGSARCQAFRTREGRLKAACNLLQRGITNLCVIGGDGSLTGANLFRKEWSGLLEELARNGQIDKEAVQKYAYLNVVGMVGSIDNDFCGTDMTIGTDSALHRIIEVVDAIMTTAQSHQRTFVLEVMGRHCGYLALVSALACGADWVFLPESPPEEGWEEQMCVKLSENRARKKRLNIIIVAEGAIDTQNKPITSEKIKELVVTQLGYDTRVTILGHVQRGGTPSAFDRILASRMGVEAVIALLEATPDTPACVVSLNGNHAVRLPLMECVQMTQDVQKAMDERRFQDAVRLRGRSFAGNLNTYKRLAIKLPDDQIPKTNCNVAVINVGAPAAGMNAAVRSAVRVGIADGHRMLAIYDGFDGFAKGQIKEIGWTDVGGWTGQGGSILGTKRVLPGKYLEEIATQMRTHSINALLIIGGFEAYLGLLELSAAREKHEEFCVPMVMVPATVSNNVPGSDFSIGADTALNTITDTCDRIKQSASGTKRRVFIIETMGGYCGYLANMGGLAAGADAAYIFEEPFDIRDLQSNVEHLTEKMKTTIQRGLVLRNESCSENYTTDFIYQLYSEEGKGVFDCRKNVLGHMQQGGAPSPFDRNFGTKISARAMEWITAKLKEARGRGKKFTTDDSICVLGISKRNVIFQPVAELKKQTDFEHRIPKEQWWLKLRPLMKILA","Homo sapiens","PFKP, PFKF","ATP-dependent 6-phosphofructokinase, platelet type","1","4XZ2"
"4XZ4",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 200MM Lithium Sulfate, 10 MM DTT, 10 MM EDTA, 100 MM Tris",298,,"456","4XZ4",111.06,"2.6","2.6","Structure of PI3K gamma in complex with an inhibitor","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","4XZ4"
"4XZG",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION",,"PEG 3350",293,"10.1074/jbc.M115.643643",,"4XZG",138.06,"2.4","2.4","Crystal structure of HIRAN domain of human HLTF","MRGSHHHHHHGSENLYFQGGSVLFGSLRGHVVGLRYYTGVVNNNEMVALQRDPNNPYDKNAIKVNNVNGNQVGHLKKELAGALAYIMDNKLAQIEGVVPFGANNAFTMPLHMTFWGKEENRKAVSDQLKKHGFKLGPA","Homo sapiens","HLTF, HIP116A, RNF80, SMARCA3, SNF2L3, ZBU1","Helicase-like transcription factor","1","4XZG"
"4XZH",,"X-RAY DIFFRACTION",1.87,34.11,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, ammonium citrate, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201500393","48I","4XZH",73.96,"1","1","Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4XZH"
"4XZI",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, HANGING DROP",8,"10 mM Tris-HCl,  pH 8.0, 20% polyethylene glycol, PEG 6000",277,"10.1002/cmdc.201500393","F49","4XZI",37.25,"2.45","2.45","Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","4XZI"
"4XZL",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM sodium cacodylate",293,"10.1002/cmdc.201500393","F49","4XZL",37.81,"1.7","1.7","Crystal structure of human AKR1B10 complexed with NADP+ and JF0049","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPRDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4XZL"
"4XZM",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM sodium cacodylate",293,"10.1002/cmdc.201500393",,"4XZM",37.22,"1.75","1.75","Crystal structure of the methylated wild-type AKR1B10 holoenzyme","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4XZM"
"4XZN",,"X-RAY DIFFRACTION",2.56,52.04,"VAPOR DIFFUSION, HANGING DROP",9,"30% PEG 6000, 100 mM sodium cacodylate",293,"10.1002/cmdc.201500393",,"4XZN",37.25,"1.7","1.7","Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzyme","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPRDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNLLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","4XZN"
"4XZP",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 16% PEG 8000, 0.2 M calcium acetate hydrate",294,"10.1038/srep33633",,"4XZP",19.35,"1.48","1.48","Crystal structure of the N-terminal domain of human galectin-4","MGSSHHHHHHSSGLVPRGSHMAYVPAPGYQPTYNPTLPYYQPIPGGLNVGMSVYIQGVASEHMKRFFVNFVVGQDPGSDVAFHFNPRFDGWDKVVFNTLQGGKWGSEERKRSMPFKKGAAFELVFIVLAEHYKVVVNGNPFYEYGHRLPLQMVTHLQVDGDLQLQSINFIGG","Homo sapiens","LGALS4","Galectin-4","1","4XZP"
"4Y03",,"X-RAY DIFFRACTION",3.09,60.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"K3(citrate), 20% PEG3350, 10% EtGly",277,,,"4Y03",29.76,"1.94","1.94","Crystal Structure of the fifth bromodomain of human PB1 in complex with salicylic acid","SMSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAIFLRLPSRSELPDYYLTIKKPMDMEKIRSHMMANKYQDIDSMVEDFVMMFNNACTYNEPESLIYKDALVLHKVLLETRRDLEGD","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","4Y03"
"4Y05",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M AMMONIUM SULFATE, 10% ETHYLENEGLYCOL, 0.1M TRIS-HCL PH8.0",293,"10.1074/jbc.M115.646919",,"4Y05",44.17,"2.59","2.59","KIF2C short Loop2 construct","MGRMKRAQEYDSSFPNWEFARMIKEFRATLECHPLTMTDPIEEHRICVCVRKRPLNKQELAKKEIDVISIPSKCLLLVHEKVDYLENQAFCFDFAFDETASNEVVYRFTAAPLVQTIFEGGKATCFAYGQTGSGKTHTMGGDLSGKAQNASKGIYAMASADVFLLKNQPCYRKLGLEVYVTFFEIYNGKLFDLLNKKAKLRVLEDGKQQVQVVGLQEHLVNSADDVIKMIDMGSACRTSGQTFANSNSSRSHACFQIILRAKGRMHGKFSLVDLAGNERGADTSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTPFRESKLTQVLRDSFIGENSRTCMIATISPGISSCEYTLNTLRYADRVKELSPHSGPSGEQLEHHHHHH","Homo sapiens","KIF2C, KNSL6","Kinesin-like protein KIF2C","1","4Y05"
"4Y07",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.2M MgCl2, 0.1M Hepes pH8.4 and 15% ethanol",277,"10.1107/S2053230X1501554X",,"4Y07",44.77,"2.507","2.507","Crystal structure of the HECT domain of human WWP2","DRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2","1","4Y07"
"4Y08",,"X-RAY DIFFRACTION",3.16,61.09,"VAPOR DIFFUSION, HANGING DROP",9,"2.0 M magnesium chloride and 0.1 M BICINE at pH 9.0",281,"10.1107/S1399004715013073",,"4Y08",22.04,"1.34","1.34","ONE MINUTE IRON LOADED HUMAN H FERRITIN","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","4Y08"
"4Y0J",,"NEUTRON DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",6,"Large drops 500 microliters in 9-well glass plate in sandwich box set-up. Crystals took 3 months to grow to maximal size.",293,"10.1073/pnas.1502255112",,"4Y0J",29.14,"2","2","H/D exchanged human carbonic anhydrase II pH 6 room temperature neutron crystal structure.","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4Y0J"
"4Y14",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",7.4,"Tris, pH 7.4, 20% PEG8000, 0.2 M MgCl2",277,"10.1172/JCI80323","C0A","4Y14",73.16,"1.898","1.898","Structure of protein tyrosine phosphatase 1B complexed with inhibitor (PTP1B:CPT157633)","GHMASMEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","4Y14"
"4Y1U",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y1U",34.62,"1.762","1.762","Complex of human Galectin-1 and Galbeta1-4GlcNAc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y1U"
"4Y1V",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y1V",34.62,"2.32","2.32","Complex of human Galectin-1 and Galbeta1-3GlcNAc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y1V"
"4Y1X",,"X-RAY DIFFRACTION",2.05,39.91,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y1X",34.74,"2.45","2.45","Complex of human Galectin-1 and Galbeta1-4(6OSO3)GlcNAc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y1X"
"4Y1Y",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y1Y",34.57,"1.86","1.86","Complex of human Galectin-1 and (6OSO3)Galbeta1-3GlcNAc","MGSSHHHHHHSSGLVPRGSHMGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y1Y"
"4Y1Z",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y1Z",34.64,"2.23","2.23","Complex of human Galectin-1 and Galbeta1-4(6CO2)GlcNAc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y1Z"
"4Y20",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y20",35.07,"2.204","2.204","Complex of human Galectin-1 and NeuAcalpha2-3Galbeta1-4Glc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y20"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","2","4Y20"
"4Y22",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,,,"4Y22",34.2,"2.5","2.5","Complex of human Galectin-1 and (3OSO3)Galbeta1-3GlcNAc","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y22"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","2","4Y22"
"4Y24",,"X-RAY DIFFRACTION",2.42,49.24,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris (pH 8.0), 0.2 M Li2SO4, 30% (w/v) PEG 3350",298,"10.1038/srep29457","TD2","4Y24",34.96,"2.32","2.32","Complex of human Galectin-1 and TD-139","MGSSHHHHHHSSGLVPRGSHMCGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","4Y24"
"4Y26",,"X-RAY DIFFRACTION",1.7,27,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES (pH 7.5), 0.2M Li2SO4, 0.1M NaOAc, 25% (w/v) PEG 4000",298,,,"4Y26",35.09,"2.611","2.611","Complex of human Galectin-7 and Galbeta1-3(6OSO3)GlcNAc","MGSSHHHHHHSSGLVPRGSHMVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","4Y26"
"4Y2B",,"X-RAY DIFFRACTION",2.81,56.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.6 - 0.8M (NH4)2SO4, 3mM mercaptoethanol, 10mM MgCl2, 10mM EDTA, 0.1M Tris HCl",277,"10.1016/j.bmcl.2015.03.031","EPK","4Y2B",44.95,"2.2","2.2","Co-crystal structure of 3-ethyl-2-(isopropylamino)-7-(pyridin-3-yl)thieno[3,2-d]pyrimidin-4(3H)-one bound to PDE7A","GSGMKETAAAKFERQHMDSPDLGTDDDDKAMADIGSSNSLNILDDDYNGQAKCMLEKVGNWNFDIFLFDRLTNGNSLVSLTFHLFSLHGLIEYFHLDMMKLRRFLVMIQEDYHSQNPYHNAVHAADVTQAMHCYLKEPKLANSVTPWDILLSLIAAATHDLDHPGVNQPFLIKTNHYLATLYKNTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSHLDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHLGVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWKGLQREQSSSEDTDAAFELNSQLLPQENRLS","Homo sapiens","PDE7A","High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A","1","4Y2B"
"4Y2E",,"X-RAY DIFFRACTION",2.3,46.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes,MOPS pH 7.5, 0.009 nitrate-sulfate-phosphate mixture, 37.5% v/v MPD-PEG1000-PEG3350; Morpheus Crystallization screen #32",292,"10.1107/S2053230X1500504X",,"4Y2E",67.42,"1.67","1.67","Crystal structure of the catalytic domain of human dual-specificity phosphatase 7 (C232S)","SQPAFPVQILPYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPISDHWSQNLSQFFPEAISFIDEARSKKCGVLVHSLAGISRSVTVTVAYLMQKMNLSLNDAYDFVKRKKSNISPNFNFMGQLLDFERTLGLS","Homo sapiens","DUSP7, PYST2","Dual specificity protein phosphatase 7","1","4Y2E"
"4Y2H",,"X-RAY DIFFRACTION",2.82,56.4,"VAPOR DIFFUSION, HANGING DROP",,"MgCl, MES buffer pH 6.5,  Isopropanol,  PEG 4000",291.15,"10.1021/acsmedchemlett.5b00071","49K","4Y2H",80.61,"2.37","2.37","Crystal structure of human protein arginine methyltransferase PRMT6 bound to SAH and an aryl pyrazole inhibitor","SIAAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIAPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","4Y2H"
"4Y2J",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49G","4Y2J",63.75,"2.15","2.15","Structure of soluble epoxide hydrolase in complex with N-[(1-methyl-1H-pyrazol-3-yl)methyl]-2-phenylethanamine","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2J"
"4Y2P",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","3C5","4Y2P",63.74,"2.05","2.05","Structure of soluble epoxide hydrolase in complex with N-methyl-1-[3-(pyridin-3-yl)phenyl]methanamine","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2P"
"4Y2Q",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49N","4Y2Q",63.77,"2.4","2.4","Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)pyridin-2-yl]piperazine","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2Q"
"4Y2R",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083",,"4Y2R",63.73,"2.45","2.45","Structure of soluble epoxide hydrolase in complex with 2-(piperazin-1-yl)nicotinonitrile","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2R"
"4Y2S",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49P","4Y2S",63.77,"2.3","2.3","Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-4-ol","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2S"
"4Y2T",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49Q","4Y2T",63.78,"2.4","2.4","Structure of soluble epoxide hydrolase in complex with 3-[4-(benzyloxy)phenyl]propan-1-ol","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2T"
"4Y2U",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49R","4Y2U",63.79,"2.75","2.75","Structure of soluble epoxide hydrolase in complex with tert-butyl 1,2,3,4-tetrahydroquinolin-3-ylcarbamate","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2U"
"4Y2V",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","4A5","4Y2V",63.78,"2.4","2.4","Structure of soluble epoxide hydrolase in complex with (4-bromo-3-cyclopropyl-1H-pyrazol-1-yl)acetic acid","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2V"
"4Y2X",,"X-RAY DIFFRACTION",2.38,48.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","4A0","4Y2X",63.82,"2.5","2.5","Structure of soluble epoxide hydrolase in complex with 2-({[2-(adamantan-1-yl)ethyl]amino}methyl)phenol","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2X"
"4Y2Y",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"Potassium phosphate, Ammonium dihydrogen phosphate, PEG3350",298,"10.1016/j.bmc.2015.03.083","49Z","4Y2Y",63.79,"2.3","2.3","Structure of soluble epoxide hydrolase in complex with 2-(2-fluorophenyl)-N-[(5-methyl-2-thienyl)methyl]ethanamine","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","4Y2Y"
"4Y30",,"X-RAY DIFFRACTION",2.8,56.14,"VAPOR DIFFUSION, HANGING DROP",,"MgCl, MES buffer pH 6.5,  Isopropanol,  PEG 4000",291.15,"10.1021/acsmedchemlett.5b00071","49L","4Y30",81,"2.1","2.1","Crystal structure of human protein arginine methyltransferase PRMT6 bound to SAH and EPZ020411","DGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIAPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELQAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","4Y30"
"4Y33",,"X-RAY DIFFRACTION",3.18,61.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"15%(v/v) ethanol, imidazole pH8.0, 0.2M magnesium chloride",289,"10.1107/S1399004715012948",,"4Y33",212.62,"2.7","2.7","Crystal of NO66 in complex with Ni(II)and N-oxalylglycine (NOG)","GGEPAWDSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRVPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGLPIRWEAGEPVNVGAQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALN","Homo sapiens","NO66, C14orf169, MAPJD, RIOX1","Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66","1","4Y33"
"4Y3K",,"X-RAY DIFFRACTION",3.22,61.84,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M ammonium sulfate, 0.52 mM heparin oligosacchraide dp4, 0.1 M sodium citrate",292,"10.1042/BJ20150643",,"4Y3K",96.02,"2.2","2.2","Structure of Vaspin mutant E379S","GHHHHHHHHHHSSGHIEGRHMKPSFSPRNYKALSEVQGWKQRMAAKELARQNMDLGFKLLKKLAFYNPGRNIFLSPLSISTAFSMLCLGAQDSTLDEIKQGFNFRKMPEKDLHEGFHYIIHELTQKTQDLKLSIGNTLFIDQRLQPQRKFLEDAKNFYSAETILTNFQNLEMAQKQINDFISQKTHGKINNLIENIDPGTVMLLANYIFFRARWKHEFDPNVTKEEDFFLEKNSSVKVPMMFRSGIYQVGYDDKLSCTILEIPYQKNITAIFILPDEGKLKHLEKGLQVDTFSRWKTLLSRRVVDVSVPRLHMTGTFDLKKTLSYIGVSKIFEEHGDLTKIAPHRSLKVGEAVHKAELKMDERGTEGAAGTGAQTLPMSTPLVVKIDKPYLLLIYSEKIPSVLFLGKIVNPIGK","Homo sapiens","SERPINA12","Serpin A12","1","4Y3K"
"4Y40",,"X-RAY DIFFRACTION",3.27,62.34,"VAPOR DIFFUSION, HANGING DROP",4,"6 % (w/v) polyethylene glycol 6000, 0.1 M citirc acid pH 3.5 -4.5",291,"10.1042/BJ20150643",,"4Y40",95.7,"2.2","2.2","Structure of Vaspin mutant D305C V383C","GHHHHHHHHHHSSGHIEGRHMKPSFSPRNYKALSEVQGWKQRMAAKELARQNMDLGFKLLKKLAFYNPGRNIFLSPLSISTAFSMLCLGAQDSTLDEIKQGFNFRKMPEKDLHEGFHYIIHELTQKTQDLKLSIGNTLFIDQRLQPQRKFLEDAKNFYSAETILTNFQNLEMAQKQINDFISQKTHGKINNLIENIDPGTVMLLANYIFFRARWKHEFDPNVTKEEDFFLEKNSSVKVPMMFRSGIYQVGYDDKLSCTILEIPYQKNITAIFILPDEGKLKHLEKGLQVDTFSRWKTLLSRRVVCVSVPRLHMTGTFDLKKTLSYIGVSKIFEEHGDLTKIAPHRSLKVGEAVHKAELKMDERGTEGAAGTGAQTLPMETPLCVKIDKPYLLLIYSEKIPSVLFLGKIVNPIGK","Homo sapiens","SERPINA12","Serpin A12","1","4Y40"
"4Y46",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium tartrate",277,"10.1021/ml500474d","4F2","4Y46",42.67,"2.04","2.04","Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4Y46"
"4Y4R",,"X-RAY DIFFRACTION",4.34,71.65,"VAPOR DIFFUSION, SITTING DROP",,"1.0M ammonium monohydric phosphate, 0.1M acetate pH4.5",289,"10.1107/S1399004715012948",,"4Y4R",103.31,"3.3","3.3","Crystal structure of ribosomal oxygenase NO66 dimer mutant","GGEPAWDSPLRRVLAELNRIPSSRRRAARLFEWLIAPMPPDHFYRRLWEREAVLVRRQDHTYYQGLFSTADLDSMLRNEEVQFGQHLDAARYINGRRETLNPPGRALPAAAWSLYQAGCSLRLLCPQAFSTTVWQFLAVLQEQFGSMAGSNVYLTPPNSQGFAPHYDDIEAFVLQLEGRKLWRVYRPRVPTEELALTSSPNFSQDDLGEPVLQTVLEPGDLLYFPRGFIHQAECQDGVHSLHLTLSTYQRNTWGDFLEAILPLAVQAAMEENVEFRRGLPRDFMDYMGAQHSDSKDPRRTAFMEKVRVLVARLGHFAPVDAVADQRAKDFIHDSLPPVLTDRERALSVYGGGGQLTTETEVHMLQDGIARLVGEGGHLFLYYTVENSRVYHLEEPKCLEIYPQQADAMELLLGSYPEFVRVGDLPCDSVEDQLSLATTLYDKGLLLTKMPLALN","Homo sapiens","NO66, C14orf169, MAPJD, RIOX1","Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66","1","4Y4R"
"4Y5H",,"X-RAY DIFFRACTION",2.46,49.99,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium tartrate",277,"10.1021/ml500474d","519","4Y5H",42.65,"2.055","2.055","Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors","MAMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","4Y5H"
"4Y5U",,"X-RAY DIFFRACTION",2.33,47.28,"VAPOR DIFFUSION, HANGING DROP",,"0.1M imidazole (pH 7.5), 0.2M Li2SO4, 12% PEG3000",289,"10.1073/pnas.1611228113",,"4Y5U",123.21,"2.708","2.708","Transcription factor","SNAQFRHLPMPFHWKQEELKFKTGLRRLQHRVGEIHLLREALQKGAEAGQVSLHSLIETPANGTGPSEALAMLLQETTGELEAAKALVLKRIQIWKRQQQLAGNGAPFEESLAPLQERCESLVDIYSQLQQEVGAAGGELEPKTRASLTGRLDEVLRTLVTSCFLVEKQPPQVLKTQTKFQAGVRFLLGLRFLGAPAKPPLVRADMVTEKQARELSVPQGPGAGAESTGEIINNTVPLENSIPGNCCSALFKNLLLKKIKRCERKGTESVTEEKCAVLFSASFTLGPGKLPIQLQALSLPLVVIVHGNQDNNAKATILWDNAFSEMDRVPFVVAERVPWEKMCETLNLKFMAEVGTNRGLLPEHFLFLAQKIFNDNSLSMEAFQHRSVSWSQFNKEILLGRGFTFWQWFDGVLDLTKRCLRSYWSDRLIIGFISKQYVTSLLLNEPDGTFLLRFSDSEIGGITIAHVIRGQDGSPQIENIQPFSAKDLSIRSLGDRIRDLAQLKNLYPKKPKDEAFRSHYKPEQMGKDGRGYVPATIKMTVERDQPLPT","Homo sapiens","STAT6","Signal transducer and activator of transcription 6","1","4Y5U"
"4Y62",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, ammonium sulfate, MOPS, MnCl2",293,,,"4Y62",41.84,"1.6","1.6","AAGlyB in complex with amino-acid analogues","MAEVLRTLAGKPKCHALRPMILFLIMLVLVLFGYGVLSPRSLMPGSLERGFCMAVREPDHLQRVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4Y62"
"4Y63",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350
ammonium sulfate
MOPS
MnCl2",293,,,"4Y63",41.78,"1.3","1.3","AAGlyB in complex with amino-acid analogues","MAEVLRTLAGKPKCHALRPMILFLIMLVLVLFGYGVLSPRSLMPGSLERGFCMAVREPDHLQRVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4Y63"
"4Y64",,"X-RAY DIFFRACTION",1.94,36.7,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, ammonium sulfate, MOPS, MnCl2",293,,,"4Y64",41.7,"1.6","1.6","AAGlyB in complex with amino-acid analogues","MAEVLRTLAGKPKCHALRPMILFLIMLVLVLFGYGVLSPRSLMPGSLERGFCMAVREPDHLQRVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","4Y64"
"4Y6D",,"X-RAY DIFFRACTION",1.86,33.75,"VAPOR DIFFUSION, HANGING DROP",,"16-20% PEG 6K, 50mM Mes-NaOH pH 5.7-6.0, 5 mM CaCl2, and 50 mM NaCl",293,,"48U","4Y6D",44.23,"1.55","1.55","Factor Xa complex with GTC000101","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y6D"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y6D"
"4Y6Q",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",,"PEG 2000",293,"10.1021/acs.biochem.5b00150",,"4Y6Q",136.15,"1.9","1.9","Human SIRT2 in complex with 2-O-myristoyl-ADP-ribose","GSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","4Y6Q"
"4Y71",,"X-RAY DIFFRACTION",1.87,34.22,"VAPOR DIFFUSION, HANGING DROP",,"16 - 20 % PEG 6000, 50 mM MES-NaOH (pH 5.7-6.0), 5 mM calcium chloride,  50 mM sodium chloride",293,,,"4Y71",44.31,"1.8","1.8","Factor Xa complex with GTC000398","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y71"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y71"
"4Y73",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, HANGING DROP",6.4,"0.03 M hexammine cobalt (III) chloride
0.2 M sodium acetate
0.05 w/v pluronic F-68
1.9 M sodium malonate pH 6.4",291,"10.1021/acsmedchemlett.5b00107","XPY","4Y73",137.74,"2.14","2.14","Crystal structure of IRAK4 kinase domain with inhibitor","GVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","4Y73"
"4Y76",,"X-RAY DIFFRACTION",1.89,34.76,"VAPOR DIFFUSION, HANGING DROP",5.75,"18% PEG 6000, 100 mm MES PH 5.75, 10 mm calcium chloride",293,"10.1021/jm060870c",,"4Y76",44.35,"2","2","Factor Xa complex with GTC000401","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y76"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y76"
"4Y79",,"X-RAY DIFFRACTION",1.89,34.92,"VAPOR DIFFUSION, HANGING DROP",5.75,"18% PEG 6000,  100 mM MES PH5.75, 10 mM calcium chloride",293,"10.1021/jm060870c","4O6","4Y79",44.27,"2.1","2.1","Factor Xa complex with GTC000406","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y79"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y79"
"4Y7A",,"X-RAY DIFFRACTION",1.93,36.22,"VAPOR DIFFUSION, HANGING DROP",,"18% PEG 6000,  100 mM MES PH 5.75, 10 mM calcium chloride",293,,,"4Y7A",44.3,"1.99","1.99","Factor Xa complex with GTC000422","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y7A"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y7A"
"4Y7B",,"X-RAY DIFFRACTION",1.88,34.59,"VAPOR DIFFUSION, HANGING DROP",5.75,"18% PEG 6000,  100 mM MES PH 5.75, 10 mM calcium chloride",293,,,"4Y7B",44.36,"1.79","1.79","Factor Xa complex with GTC000441","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","Coagulation factor X","1","4Y7B"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","Coagulation factor X","2","4Y7B"
"4Y7I",,"X-RAY DIFFRACTION",2.93,57.98,"VAPOR DIFFUSION",,"10mM N-(2-Acetamido)iminodiacetic acid, 1.0M ammonium phosphate dibasic",293,"10.1107/S139900471500927X",,"4Y7I",91.09,"2.802","2.802","Crystal Structure of MTMR8","MRESGWKLIDPISDFGRMGIPNRNWTITDANRNYEICSTYPPEIVVPKSVTLGTVVGSSKFRSKERVPVLSYLYKENNAAICRCSQPLSGFYTRCVDDELLLEAISQTNPGSQFMYVVDTRPKLNAMANRAAGKGYENEDNYANIRFRFMGIENIHVMRSSLQKLLEVCELKTPTMSEFLSGLESSGWLRHIKAIMDAGIFITKAVKVEKASVLVHSSDGWDRTAQVCSVASILLDPFYRTFKGLMILIEKEWISMGHKFSQRCGHLDGDSKEVSPIFTQFLDCIWQLMEQFPCAFEFNENFLLEIHDHVFSCQFGNFLGNCQKDREDLRVYEKTHSVWPFLVQRKPDFRNPLYKGFTMYGVLNPSTVPYNIQFWCGMYNRFDKLEHHHHHH","Homo sapiens","MTMR8","Myotubularin-related protein 8","1","4Y7I"
"4Y83",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",7.6,"Reservoir solution: 8% (w/v) PEG4000, 12% (v/v) ethylene glycol, 7% (v/v) iso-propanol",298,"10.1074/jbc.M115.648097",,"4Y83",113.87,"2.89","2.89","Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione","GPSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGRYQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVEIQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKGLDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVILCRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPGMRELIEASLERNPNHRPRAADLLKHEALNPPREDQ","Homo sapiens","MAP3K8, COT, ESTF","Mitogen-activated protein kinase kinase kinase 8","1","4Y83"
"4Y85",,"X-RAY DIFFRACTION",2.4,48.68,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1 M HEPES pH 7.2, 24% PEGMME 550, 0.05 M MgCl2",298,"10.1074/jbc.M115.648097","499","4Y85",113.85,"2.33","2.33","Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine","GPSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGRYQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVEIQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKGLDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVILCRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPGMRELIEASLERNPNHRPRAADLLKHEALNPPREDQ","Homo sapiens","MAP3K8, COT, ESTF","Mitogen-activated protein kinase kinase kinase 8","1","4Y85"
"4Y86",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION, HANGING DROP",7.4,"The PDE9A2 (8-10 mg/mL) in a buffer of 50 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM mercaptoethanol, and 1 mM EDTA was mixed with 2 mM C33 and crystallized against a well buffer of 1.8 - 2.0 M sodium formate.",277,"10.1124/mol.115.099747","49D, 49E","4Y86",124.47,"2.01","2.01","Crystal structure of PDE9 in complex with racemic inhibitor C33","MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4Y86"
"4Y87",,"X-RAY DIFFRACTION",3.04,59.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"The PDE9A2 (8-10 mg/mL) in a buffer of 50 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM mercaptoethanol, and 1 mM EDTA was mixed with 2 mM C33 or (R)-C33 and crystallized against a well buffer of 1.8 - 2.0 M sodium formate.",277,"10.1124/mol.115.099747",,"4Y87",124.47,"3.1","3.1","Crystal structure of phosphodiesterase 9 in complex with (R)-C33 (6-{[(1R)-1-(4-chlorophenyl)ethyl]amino}-1-cyclopentyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one)","MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4Y87"
"4Y88",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",3.5,"1.2M Ammmonium Sulphate, 0.1M Citric Acid, pH 3.5",293,"10.1073/pnas.1509511112",,"4Y88",12.6,"1.45","1.45","Crystal structure of the N-terminal domain of CEACAM8","AQLTIEAVPSNAAEGKEVLLLVHNLPQDPRGYNWYKGETVDANRRIIGYVISNQQITPGPAYSNRETIYPNASLLMRNVTRNDTGSYTLQVIKLNLMSEEVTGQFSVH","Homo sapiens","CEACAM8, CGM6","Carcinoembryonic antigen-related cell adhesion molecule 8","1","4Y88"
"4Y89",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"18% PEG 8000, 0.1 M Tris, pH 8.5, 0.2M Magnesium Chloride",293,"10.1107/S2053230X15013576",,"4Y89",49.93,"1.47","1.47","Crystal structure of the N-terminal domain of CEACAM7","AQTNIDVVPFNVAEGKEVLLVVHNESQNLYGYNWYKGERVHANYRIIGYVKNISQENAPGPAHNGRETIYPNGTLLIQNVTHNDAGIYTLHVIKENLVNEEVTRQFYVF","Homo sapiens","CEACAM7, CGM2","Carcinoembryonic antigen-related cell adhesion molecule 7","1","4Y89"
"4Y8A",,"X-RAY DIFFRACTION",3.08,60.02,"VAPOR DIFFUSION, HANGING DROP",4.6,"10% PEG 8000, 0.1 M Sodium Acetate, pH 4.6, 0.2 M Zinc Acetate",293,"10.1073/pnas.1509511112",,"4Y8A",24.65,"1.83","1.83","Crystal Structure of the N-terminal domain of CEACAM6","AKLTIESTPFNVAEGKEVLLLAHNLPQNRIGYSWYKGERVDGNSLIVGYVIGTQQATPGPAYSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM6, NCA","Carcinoembryonic antigen-related cell adhesion molecule 6","1","4Y8A"
"4Y8C",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 3.0 M sodium formate, soaked in crystallization buffer + 2 mM (S)-C33 at 298K for 1 day",277,"10.1124/mol.115.099747","49D","4Y8C",124.47,"2.7","2.7","Crystal structure of phosphodiesterase 9 in complex with (S)-C33","MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","4Y8C"
"4Y8W",,"X-RAY DIFFRACTION",2.13,42.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"12 mg/mL protein, 0.05 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonate (HEPES), 0.1 M ammonium sulfate and 12.5% (w/v) polyethylene glycol 3350",291,"10.1074/jbc.M115.646307",,"4Y8W",166.79,"2.64","2.64","Crystal Structure of Human Cytochrome P450 21A2 Progesterone Complex","MAKKTSSKGKLPPLAPGFLHLLQPDLPIYLLGLTQKFGPIYRLHLGLQDVVVLNSKRTIEEAMVKKWADFAGRPEPLTYKLVSRNYPDLSLGDYSLLWKAHKKLTRSALLLGIRDSMEPVVEQLTQEFCERMRAQPGTPVAIEEEFSLLTCSIICYLTFGDKIKDDNLMPAYYKCIQEVLKTWSHWSIQIVDVIPFLRFFPNPGLRRLKQAIEKRDHIVEMQLRQHKESLVAGQWRDMMDYMLQGVAQPSMEEGSGQLLEGHVHMAAVDLLIGGTETTANTLSWAVVFLLHHPEIQQRLQEELDHELGPGASSSRVPYKDRARLPLLNATIAEVLRLRPVVPLALPHRTTRPSSISGYDIPEGTVIIPNLQGAHLDETVWERPHEFWPDRFLEPGKNSRALAFGCGARVCLGEPLARLELFVVLTRLLQAFTLLPSGDALPSLQPLPHCSVILKMQPFQVRLQPRGMGAHSPGQSQHHHHHH","Homo sapiens","P450-CYP21B, CYP21A2, hCG_1999926, CYP21, CYP21B","Cytochrome P450 21-hydroxylase","1","4Y8W"
"4Y8X",,"X-RAY DIFFRACTION",3.59,65.73,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 26% w/v MEPEG2000, 200 mM ammonium sulfate (crystals were grown at pH4.6 and transferred to pH 7 prior to soaking with compound)",277,"10.1021/acsmedchemlett.5b00066",,"4Y8X",28.95,"1.9","1.9","Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XIa","1","4Y8X"
"4Y8Y",,"X-RAY DIFFRACTION",3.58,65.69,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, pH 4.6, 26% w/v MEPEG2000, 200 mM ammonium sulfate",277,"10.1021/acsmedchemlett.5b00066",,"4Y8Y",28.87,"2.6","2.6","Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-(morpholin-4-yl)-3-oxopropyl]-1H-imidazol-5-yl}phenyl)carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XIa","1","4Y8Y"
"4Y8Z",,"X-RAY DIFFRACTION",3.59,65.73,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate, pH 4.6, 26% w/v MEPEG2000, 200 mM ammonium sulfate (crystals were grown at pH4.6 and transferred to pH 7 prior to soaking with compound)",277,"10.1021/acsmedchemlett.5b00066","4CE","4Y8Z",28.67,"2.2","2.2","Factor XIa in complex with the inhibitor (2E)-N-[(1S)-1-[5-chloro-4-(4-hydroxy-2-oxo-1,2-dihydroquinolin-6-yl)-1H-imidazol-2-yl]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enamide","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XIa","1","4Y8Z"
"4Y9B",,"X-RAY DIFFRACTION",1.74,29.19,"VAPOR DIFFUSION, HANGING DROP",5.5,"16% PEG400, 0.1M NaOAc, 0.2 M CaCl2",293,"10.1038/srep13570",,"4Y9B",35.62,"1.4","1.4","Crystal structure of V30M mutated transthyretin in complex with alpha-mangostin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4Y9B"
"4Y9C",,"X-RAY DIFFRACTION",1.69,27.22,"VAPOR DIFFUSION, HANGING DROP",5.8,"20% PEG400, 0.092 M MES, 0.1 M KBr",293,"10.1038/srep13570",,"4Y9C",35.99,"1.49","1.49","Crystal structure of V30M mutated transthyretin with bromide in complex with alpha-mangostin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4Y9C"
"4Y9E",,"X-RAY DIFFRACTION",1.69,27.22,"VAPOR DIFFUSION, HANGING DROP",5.5,"16% PEG400, 0.1 M NaOAc, 0.2 M CaCl2",293,"10.1038/srep13570",,"4Y9E",35.62,"1.49","1.49","Crystal structure of V30M mutated transthyretin in complex with gamma-mangostin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4Y9E"
"4Y9F",,"X-RAY DIFFRACTION",1.68,26.97,"VAPOR DIFFUSION, HANGING DROP",5.8,"20% PEG400, 0.092 M MES, 0.1 M KBr",293,"10.1038/srep13570",,"4Y9F",36.12,"1.5","1.5","Crystal structure of V30M mutated transthyretin with bromide in complex with gamma-mangostin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4Y9F"
"4Y9G",,"X-RAY DIFFRACTION",1.7,27.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"16% PEG400, 0.1 M NaOAc, 0.2 M CaCl2",293,"10.1038/srep13570",,"4Y9G",35.51,"1.89","1.89","Crystal structure of V30M mutated transthyretin in complex with 3-isomangostin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4Y9G"
"4YAB",,"X-RAY DIFFRACTION",2.28,46.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4CN","4YAB",43.58,"1.9","1.9","Crystal structure of TRIM24 PHD-bromodomain complexed with 1-methyl-5-(2-methyl-1 3-thiazol-4-yl)-2 3-dihydro-1H-indol-2-one (1)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YAB"
"4YAD",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","5UO, 4A7","4YAD",43.91,"1.73","1.73","Crystal structure of TRIM24 PHD-bromodomain complexed with 2,4-dimethoxy-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)benzene-1-sulfonamide (3b)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YAD"
"4YAT",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4A8","4YAT",43.59,"2.18","2.18","Crystal structure of TRIM24 PHD-bromodomain complexed with N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-4-methoxybenzene-1-sulfonamide (5b)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YAT"
"4YAX",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4AE","4YAX",43.97,"2.25","2.25","Crystal structure of TRIM24 PHD-bromodomain complexed with N-[6-(4-methoxyphenoxy)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]benzenesulfonamide (5g)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YAX"
"4YBI",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, HANGING DROP",7.4,"PEG8000, sodium cacodylate, ammonium sulfate",277,"10.1523/JNEUROSCI.3647-11.2011","4B2","4YBI",98.95,"1.84","1.84","Crystal structure of BACE with amino thiazine inhibitor LY2811376","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","4YBI"
"4YBM",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4BJ","4YBM",44.61,"1.46","1.46","Crystal structure of TRIM24 PHD-bromodomain complexed with N-{6-[3-(benzyloxy)phenoxy]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-dimethoxybenzene-1-sulfonamide (7b)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YBM"
"4YBP",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION",6,"12% PEG3350, 8% Tacsimate pH = 6.0.",277,"10.1021/jacs.6b03681",,"4YBP",15.83,"1.831","1.831","Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human cellular retinoic acid binding proteinii with retinal after 24 hour incubation at 1.83 angstrom resolution - thermodynamic product - 1st cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YBP"
"4YBS",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4BK","4YBS",22.03,"1.83","1.83","Crystal structure of TRIM24 PHD-bromodomain complexed with N-{1,3-dimethyl-6-[3-(2-methylpropoxy)phenoxy]-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-1,2-dimethyl-1H-imidazole-4-sulfonamide (7g)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YBS"
"4YBT",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","5UB, 4BV","4YBT",22.04,"1.82","1.82","Crystal structure of TRIM24 PHD-bromodomain complexed with N-{1,3-dimethyl-2-oxo-6-[3-(oxolan-3-ylmethoxy)phenoxy]-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-1-methyl-1H-imidazole-4-sulfonamide (7l)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YBT"
"4YBU",,"X-RAY DIFFRACTION",3.16,61.04,"VAPOR DIFFUSION",6,"12% PEG3350, 8% Tacsimate, pH = 6.0",277,"10.1021/jacs.6b03681",,"4YBU",15.83,"1.924","1.924","Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human Cellular Retinoic Acid Binding ProteinII in complex with Retinal after 24 h incubation and 1 hour UV irradiation at 1.92 angstrom - 1st cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YBU"
"4YC1",,"X-RAY DIFFRACTION",3.24,62.06,"VAPOR DIFFUSION, HANGING DROP",4.5,"25% PEG4k, 0.2 Ammonium sulphate, 0.1 M Sodium Acetate",298,,,"4YC1",55.2,"2","2","Structure of the human TSG101-UEV domain in the P321 space group","MRGSHHHHHHGMASMAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRP","Homo sapiens","TSG101","Tumor susceptibility gene 101 protein","1","4YC1"
"4YC8",,"X-RAY DIFFRACTION",3.08,60.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 22% PEG 3350, 100 mM NaOAc",293,"10.1021/acschembio.5b01018","4B7","4YC8",68.02,"2.9","2.9","C-Helix-Out Binding of Dasatinib Analog to c-Abl Kinase","GHMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","4YC8"
"4YC9",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.2-2.4M ammonium sulfate, 0.1M HEPES buffer pH 7.5, 2% PEG400 and 8-9% glycerol",298,"10.1021/acs.jmedchem.5b00405","4C1","4YC9",22.18,"1.82","1.82","Crystal structure of TRIM24 PHD-bromodomain complexed with N-(6-{3-[4-(dimethylamino)butoxy]-5-propoxyphenoxy}-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-3,4-dimethoxybenzene-1-sulfonamide (8i)","SPNEDWCAVCQNGGELLCCEKCPKVFHLSCHVPTLTNFPSGEWICTFCRDLSKPEVEYDCDAPSHNSEKKKTEGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","4YC9"
"4YCE",,"X-RAY DIFFRACTION",3.18,61.37,"VAPOR DIFFUSION",6,"12% PEG3350, 8% Tacsimate pH 6.0",277,"10.1021/jacs.6b03681",,"4YCE",15.83,"1.953","1.953","Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human cellular retinoic acid binding proteinii with retinal at 1.95 angstrom- visible light irradiated crystal for 1 hour - 2nd cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YCE"
"4YCH",,"X-RAY DIFFRACTION",3.19,61.43,"VAPOR DIFFUSION",6,"12% PEG 3350, 8% Tacsimate pH 6.0",277,"10.1021/jacs.6b03681",,"4YCH",15.83,"1.96","1.96","Crystal Structure of R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human Cellular Retinoic Acid Binding ProteinII with Retinal at 1.96 Angstrom - UV irradiated Crystal for 1 hour - 2nd cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YCH"
"4YD8",,"X-RAY DIFFRACTION",2.66,54,"VAPOR DIFFUSION, HANGING DROP",6.1,"10% w/v PEG 4000, 0.1M tri-sodium citrate pH 6.1, and 0.15M ammonium sulfate",291,"10.1074/jbc.M115.649202",,"4YD8",93.04,"1.8","1.8","Bardet-Biedl Syndrome 9 Protein (aa1-407), Homo sapiens","GPGSMSLFKARDWWSTILGDKEEFDQGCLCLANVDNSGNGQDKIIVGSFMGYLRIFSPHPAKTGDGAQAEDLLLEVDLRDPVLQVEVGKFVSGTEMLHLAVLHSRKLCVYSVSGTLGNVEHGNQCQMKLMYEHNLQRTACNMTYGSFGGVKGRDLICIQSMDGMLMVFEQESYAFGRFLPGFLLPGPLAYSSRTDSFLTVSSCQQVESYKYQVLAFATDADKRQETEQQKLGSGKRLVVDWTLNIGEQALDICIVSFNQSASSVFVLGERNFFCLKDNGQIRFMKKLDWSPSCFLPYCSVSEGTINTLIGNHNNMLHIYQDVTLKWATQLPHIPVAVRVGCLHDLKGVIVTLSDDGHLQCSYLGTDPSLFQAPNVQSRELNYDELDVEMKELQKIIKDVNKSQGVWPMTER","Homo sapiens","BBS9, PTHB1","Protein PTHB1","1","4YD8"
"4YDA",,"X-RAY DIFFRACTION",3.17,61.19,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG3350, 8% Tacsimate pH 6.0",277,"10.1021/jacs.6b03681",,"4YDA",15.83,"1.951","1.951","Crystal structure of R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human cellular retinoic acid binding proteinii with retinal at 1.95 angstrom - after 1hour visible light irradiation - 3rd cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YDA"
"4YDB",,"X-RAY DIFFRACTION",3.21,61.63,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG3350, 8% Tacsimate pH 6.0",277,"10.1021/jacs.6b03681",,"4YDB",15.83,"2.03","2.03","Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y mutant of human Cellular Retinoic Acid Binding Protein II in complex with Retinal at 2.03 angstrom -UV irradiated crystal- 3rd cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YDB"
"4YDM",,"X-RAY DIFFRACTION",2.27,41.18,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol",298,"10.1021/jacs.5b03042",,"4YDM",28.36,"1.25","1.25","High resolution crystal structure of human transthyretin bound to ligand and conjugates of 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)phenyl fluorosulfate","GPTGTGESKCPLMVXVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4YDM"
"4YDN",,"X-RAY DIFFRACTION",2.33,42.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"The wt-TTR was concentrated to 4 mg/ml in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method, crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at ph 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 m sodium citrate, ph 5.5, containing 10% v/v glycerol, vapor diffusion, sitting drop, temperature 298.0",298,"10.1021/jacs.5b03042",,"4YDN",28.85,"1.35","1.35","High resolution crystal structure of human transthyretin bound to ligand and conjugates of 4-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)phenyl fluorosulfate","GPTGTGESKCPLMVXVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","4YDN"
"4YDP",,"X-RAY DIFFRACTION",1.91,35.45,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 6000, imidazole",295.15,,,"4YDP",18.98,"1.4","1.4","Crystal structure of N-terminal PDZ domain of ZASP in complex with myotilin C-terminal peptide.","AMAYSVTLTGPGPWGFRLQGGKDFNMPLTISRITPGSKAAQSQLSQGDLVVAIDGVNTDTMTHLEAQNKIKSASYNLSLTLQKSK","Homo sapiens","LDB3, KIAA0613, ZASP","LIM domain-binding protein 3","1","4YDP"
"4YDX",,"X-RAY DIFFRACTION",3.22,61.81,"VAPOR DIFFUSION, HANGING DROP",6,"2M lithium sulfate, 0.1M MES, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1107/S139900471500629X",,"4YDX",7.82,"1.602","1.602","Crystal structure of cisplatin bound to a human copper chaperone (monomer) - new refinement","PKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDTLLATLKKTGKTVSYLGLE","Homo sapiens","ATOX1, HAH1","Copper transport protein ATOX1","1","4YDX"
"4YE6",,"X-RAY DIFFRACTION",4.73,74,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M calcium acetate, 0.1M Tris, pH 6.0, 12.5% (w/v) PEG 3,350, 60mM gly-gly-gly",289.15,"10.1093/nar/gkw082",,"4YE6",88.06,"2.4","2.4","The crystal structure of the intact human GlnRS","HMAALDSLSLFTSLGLSEQKARETLKNSALSAQLREAATQAQQTLGSTIDKATGILLYGLASRLRDTRRLSFLVSYIASKKIHTEPQLSAALEYVRSHPLDPIDTVDFERECGVGVIVTPEQIEEAVEAAINRHRPQLLVERYHFNMGLLMGEARAVLKWADGKMIKNEVDMQVLHLLGPKLEADLEKKFKVAKARLEETDRRTAKDVVENGETADQTLSLMEQLRGEALKFHKPGENYKTPGYVVTPHTMNLLKQHLEITGGQVRTRFPPEPNGILHIGHAKAINFNFGYAKANNGICFLRFDDTNPEKEEAKFFTAICDMVAWLGYTPYKVTYASDYFDQLYAWAVELIRRGLAYVCHQRGEELKGHNTLPSPWRDRPMEESLLLFEAMRKGKFSEGEATLRMKLVMEDGKMDPVAYRVKYTPHHRTGDKWCIYPTYDYTHCLCDSIEHITHSLCTKEFQARRSSYFWLCNALDVYCPVQWEYGRLNLHYAVVSKRKILQLVATGAVRDWDDPRLFTLTALRRRGFPPEAINNFCARVGVTVAQTTMEPHLLEACVRDVLNDTAPRAMAVLESLRVIITNFPAAKSLDIQVPNFPADETKGFHQVPFAPIVFIERTDFKEEPEPGFKRLAWGQPVGLRHTGYVIELQHVVKGPSGCVESLEVTCRRADAGEKPKAFIHWVSQPLMCEVRLYERLFQHKNPEDPTEVPGGFLSDLNLASLHVVDAALVDCSVALAKPFDKFQFERLGYFSVDPDSHQGKLVFNRTVTLKEDPGKV","Homo sapiens","QARS, QARS1","Glutamine--tRNA ligase","1","4YE6"
"4YE8",,"X-RAY DIFFRACTION",4.7,73.83,"VAPOR DIFFUSION, HANGING DROP",5.5,"ammonium acetate, bis-tris, 17% (w/v) PEG 10,000",289,"10.1093/nar/gkw082",,"4YE8",88.03,"3.3","3.3","The crystal structure of the Y57H mutant of human GlnRS","HMAALDSLSLFTSLGLSEQKARETLKNSALSAQLREAATQAQQTLGSTIDKATGILLHGLASRLRDTRRLSFLVSYIASKKIHTEPQLSAALEYVRSHPLDPIDTVDFERECGVGVIVTPEQIEEAVEAAINRHRPQLLVERYHFNMGLLMGEARAVLKWADGKMIKNEVDMQVLHLLGPKLEADLEKKFKVAKARLEETDRRTAKDVVENGETADQTLSLMEQLRGEALKFHKPGENYKTPGYVVTPHTMNLLKQHLEITGGQVRTRFPPEPNGILHIGHAKAINFNFGYAKANNGICFLRFDDTNPEKEEAKFFTAICDMVAWLGYTPYKVTYASDYFDQLYAWAVELIRRGLAYVCHQRGEELKGHNTLPSPWRDRPMEESLLLFEAMRKGKFSEGEATLRMKLVMEDGKMDPVAYRVKYTPHHRTGDKWCIYPTYDYTHCLCDSIEHITHSLCTKEFQARRSSYFWLCNALDVYCPVQWEYGRLNLHYAVVSKRKILQLVATGAVRDWDDPRLFTLTALRRRGFPPEAINNFCARVGVTVAQTTMEPHLLEACVRDVLNDTAPRAMAVLESLRVIITNFPAAKSLDIQVPNFPADETKGFHQVPFAPIVFIERTDFKEEPEPGFKRLAWGQPVGLRHTGYVIELQHVVKGPSGCVESLEVTCRRADAGEKPKAFIHWVSQPLMCEVRLYERLFQHKNPEDPTEVPGGFLSDLNLASLHVVDAALVDCSVALAKPFDKFQFERLGYFSVDPDSHQGKLVFNRTVTLKEDPGKV","Homo sapiens","QARS, QARS1","Glutamine--tRNA ligase","1","4YE8"
"4YE9",,"X-RAY DIFFRACTION",4.85,74.64,"VAPOR DIFFUSION, SITTING DROP",5.5,"ammonium acetate, bis-tris, PEG 20,000, EDTA",289,"10.1093/nar/gkw082",,"4YE9",88.1,"2.7","2.7","The crystal structure of the G45V mutant of human GlnRS","HMAALDSLSLFTSLGLSEQKARETLKNSALSAQLREAATQAQQTLVSTIDKATGILLYGLASRLRDTRRLSFLVSYIASKKIHTEPQLSAALEYVRSHPLDPIDTVDFERECGVGVIVTPEQIEEAVEAAINRHRPQLLVERYHFNMGLLMGEARAVLKWADGKMIKNEVDMQVLHLLGPKLEADLEKKFKVAKARLEETDRRTAKDVVENGETADQTLSLMEQLRGEALKFHKPGENYKTPGYVVTPHTMNLLKQHLEITGGQVRTRFPPEPNGILHIGHAKAINFNFGYAKANNGICFLRFDDTNPEKEEAKFFTAICDMVAWLGYTPYKVTYASDYFDQLYAWAVELIRRGLAYVCHQRGEELKGHNTLPSPWRDRPMEESLLLFEAMRKGKFSEGEATLRMKLVMEDGKMDPVAYRVKYTPHHRTGDKWCIYPTYDYTHCLCDSIEHITHSLCTKEFQARRSSYFWLCNALDVYCPVQWEYGRLNLHYAVVSKRKILQLVATGAVRDWDDPRLFTLTALRRRGFPPEAINNFCARVGVTVAQTTMEPHLLEACVRDVLNDTAPRAMAVLESLRVIITNFPAAKSLDIQVPNFPADETKGFHQVPFAPIVFIERTDFKEEPEPGFKRLAWGQPVGLRHTGYVIELQHVVKGPSGCVESLEVTCRRADAGEKPKAFIHWVSQPLMCEVRLYERLFQHKNPEDPTEVPGGFLSDLNLASLHVVDAALVDCSVALAKPFDKFQFERLGYFSVDPDSHQGKLVFNRTVTLKEDPGKV","Homo sapiens","QARS, QARS1","Glutamine--tRNA ligase","1","4YE9"
"4YEA",,"X-RAY DIFFRACTION",3.24,62.06,"VAPOR DIFFUSION, HANGING DROP",6,"1.5 M LITHIUM SULFATE, 0.1M MES, 50 MM NACL, PH 6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K",294,"10.1107/S139900471500629X",,"4YEA",14.91,"2.14","2.14","Crystal structure of cisplatin bound to a human copper chaperone (dimer) - new refinement","PKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDTLLATLKKTGKTVSYLGLE","Homo sapiens","ATOX1, HAH1","Copper transport protein ATOX1","1","4YEA"
"4YEP",,"X-RAY DIFFRACTION",2.82,56,"VAPOR DIFFUSION, HANGING DROP",8,"15% PEG 3350, 20% ethylene glycol, 50 mM sodium phosphate pH 8.0",293,"10.1111/febs.13319",,"4YEP",44.36,"1.19","1.19","L4b Domain of Human Laminin alpha-2","GAFLIRTWVTLKAEQTILPLVDEALQHTTTKGIVFQHPEIVAHMDLMREDLHLEPFYWKLPEQFEGKKLMAYGGKLKYAIYFEAREETGFSTYNPQVIIRGGTPTHARIIVRHMAAPLIGQLTRHEIEMTEKEWKYYGDDPRVHRTVTREDFLDILYDIHYILIKATYGNFMRQSRISEISMEVA","Homo sapiens","LAMA2, LAMM","Laminin subunit alpha-2","1","4YEP"
"4YEQ",,"X-RAY DIFFRACTION",6.25,80.32,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium malonate, 100 mM MgCl2, 10% PEG 200, 100 mM Tris, pH 7.0",293,"10.1111/febs.13319",,"4YEQ",23.65,"3.2","3.2","L4b Domain of Human Laminin alpha-2","EAKGLIRTWVTLKAEQTILPLVDEALQHTTTKGIVFQHPEIVAHMDLMREDLHLEPFYWKLPEQFEGKKLMAYGGKLKYAIYFEAREETGFSTYNPQVIIRGGTPTHARIIVRHMAAPLIGQLTRHEIEMTEKEWKYYGDDPRVHRTVTREDFLDILYDIHYILIKATYGNFMRQSRISEISMEVAEQGRGTTMTPPADLIEK","Homo sapiens","LAMA2, LAMM","Laminin subunit alpha-2","1","4YEQ"
"4YFF",,"X-RAY DIFFRACTION",3.02,59.27,"VAPOR DIFFUSION, HANGING DROP",7,"8% PEG3350, 0.1M ammonium sulfate, and 0.1M Hepes pH 7.0",277,"10.1021/acs.jmedchem.5b00931","4CV","4YFF",141.42,"3.07","3.07","TNNI3K complexed with inhibitor 2","GGDGSYVSVPSPLGKIKSMTKEKADILLLRAGLPSHFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAAADMAYHHIRPPIGYSIPKPISSLLIRGWNACPEGRPEFSEVVMKLEECLCNIELMS","Homo sapiens","TNNI3K, CARK","Serine/threonine-protein kinase TNNI3K","1","4YFF"
"4YFI",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, HANGING DROP",7,"0.3 M NaK tartrate, 0.1M HEPES pH7",277,"10.1021/acs.jmedchem.5b00931","4CW","4YFI",150.29,"2.7","2.7","TNNI3K complexed with inhibitor 1","GKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKEKADILLLRAGLPSHFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAADMDMAYHHIRPPIGYSIPKPISSLLIRGWNACPEGRPEFSEVVMKLEECLCNIELMS","Homo sapiens","TNNI3K, CARK","Serine/threonine-protein kinase TNNI3K","1","4YFI"
"4YFP",,"X-RAY DIFFRACTION",3.22,61.76,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG3350, 0.1M Malonate pH 6.0",277,"10.1021/jacs.6b03681",,"4YFP",15.86,"1.951","1.951","CRYSTAL STRUCTURE OF THE R111K:Y134F:T54V:R132Q:P39Y:R59Y MUTANT OF HUMAN CELLULAR RETINOIC ACID BINDING PROTEIN II WITH RETINAL AFTER 20 MINUTES INCUBATION AT 1.95 ANGSTROM RESOLUTION-Kinetic Product","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YFP"
"4YFQ",,"X-RAY DIFFRACTION",3.2,61.58,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG3350, 0.1M Malonate pH 6.0",277,"10.1021/jacs.6b03681",,"4YFQ",15.86,"1.62","1.62","CRYSTAL STRUCTURE OF THE R111K:Y134F:T54V:R132Q:P39Y:R59Y MUTANT OF HUMAN CELLULAR RETINOIC ACID BINDING PROTEINII WITH RETINAL AFTER 24 HOURS INCUBATION AT 1.62 ANGSTROM RESOLUTION - Thermodynamic product - 1st cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YFQ"
"4YFR",,"X-RAY DIFFRACTION",3.22,61.86,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG3350, 0.1M Malonate pH 6.0",277,"10.1021/jacs.6b03681",,"4YFR",15.86,"1.952","1.952","Crystal structure of the R111K:Y134F:T54V:R132Q:P39Y:R59Y mutant of human Cellular Retinoic Acid Binding Protein II with Retinal at 1.95 Angstrom Resolution - UV irradiated crystal for 30 minutes - 1st Cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YFR"
"4YGG",,"X-RAY DIFFRACTION",3.25,62.13,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG3350, 0.1M Malonate pH 6.0",277,"10.1021/jacs.6b03681",,"4YGG",15.86,"1.9","1.9","CRYSTAL STRUCTURE OF R111K:Y134F:T54V:R132Q:P39Y:R59Y MUTANT OF HUMAN CELLULAR RETINOIC ACID BINDING PROTEIN II WITH RETINAL AT 1.9 ANGSTROM RESOLUTION - VISIBLE LIGHT IRRADIATED CRYSTAL - 2ND CYCLE","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YGG"
"4YGH",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG3350, 0.1M Malonate pH 6.0",277,"10.1021/jacs.6b03681",,"4YGH",15.86,"2.1","2.1","Crystal Structure of R111K:Y134F:T54V:R132Q:P39Y:R59Y mutant of human Cellular Retinoic Acid Binding Protein II with Retinal at 2.1 Angstrom resolution - UV irradiated crystal - 2nd cycle","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","4YGH"
"4YGJ",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8",277,"10.1021/jacs.5b00187","BR","4YGJ",29.86,"1.1","1.1","NaBr--Interactions between Hofmeister Anions and the Binding Pocket of a Protein","HHWGYGGHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4YGJ"
"4YGK",,"X-RAY DIFFRACTION",2.13,42.29,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8",277,"10.1021/jacs.5b00187","SCN","4YGK",29.14,"1.5","1.5","NaSCN--Interactions between Hofmeister Anions and the Binding Pocket of a Protein","HHWGYGGHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","4YGK"
